label,study_and_condition
0, saracatinib recurrent verrucous carcinoma larynx diagnosis patients must agree use adequate birth control duration participation at least eight weeks after discontinuation drug
1, stem cell transplantation hodgkin lymphoma diagnosis history congenital hematologic immunologic metabolic disorder which estimation pi poses prohibitive risk recipient
0, lenograstim recurrent adult diffuse mixed cell lymphoma diagnosis creatinine clearance crcl greater fifty ml per minute all tests must be performed within twenty eight days prior registration
0, doxorubicin stage iii diffuse large cell lymphoma diagnosis stages ii bulky disease defined mass size more ten cm stage iii iv ann arbor staging patients stage stage ii non bulky disease excluded from this study
1, poly i c prostate cancer diagnosis unresolved iraes following prior biological therapy except that stable managed iraes may be acceptable hypothyroidism hypopituitarism on appropriate replacement
1, bevacizumab stage iiic primary peritoneal cancer diagnosis uncontrolled hypertension defined systolic greater one hundred fifty mm hg diastolic greater ninety mmhg
0, carboplatin stage iib uterine sarcoma diagnosis patients must be entered no more twelve weeks post operatively
0, vidarabine stage iv childhood small noncleaved cell lymphoma diagnosis acute myeloid leukemia aml
1, dexamethasone phosphate non secretory multiple myeloma
1, microwave ablation hepatic neoplasms diagnosis severe renal dysfunction creatinine clearance less forty ml min
1, liposomal doxorubicin breast neoplasms diagnosis concurrent treatment other experimental drugs
0, sirolimus lymphoma diagnosis myelofibrosis other myeloproliferative disorders
0, methylprednisolone acetate primary peritoneal cancer diagnosis creatinine cr less equal doc mg dl
1, antibodies monoclonal stage iiib non small cell lung cancer diagnosis significant uncontrolled cardiac disease within past six months including any following
1, cyclophosphamide metachromatic leukodystrophy mld diagnosis evidence human immunodeficiency virus hiv infection known hiv positive serology
0, podophyllotoxin stage iiib hodgkin lymphoma diagnosis male doc mg dl female doc mg dl
1, antibodies monoclonal fallopian tube clear cell adenocarcinoma diagnosis history severe allergic anaphylactic other hypersensitivity reactions chimeric humanized antibodies fusion proteins
0, cyclin dependent kinase inhibitor proteins triple negative breast cancer diagnosis male subjects childbearing potential must agree use an adequate method contraception starting first dose therapy through one hundred twenty days after last dose therapy
0, prophylactic postoperative radiation therapy esophageal cancer tnm staging primary tumor tthree diagnosis regular follow up
1, olaparib administration other simultaneous chemotherapy drugs any other anticancer therapy anti neoplastic hormonal therapy simultaneous radiotherapy during trial treatment period hormonal replacement therapy is permitted steroidal antiemetics
0, antibodies kidney cancer diagnosis all subjects must have archived current tissue from primary metastatic focus available psma determination
0, fludarabine phosphate recurrent grade two follicular lymphoma diagnosis donor
1, immunoglobulin g recurrent primary peritoneal carcinoma diagnosis has diagnosis immunodeficiency is receiving systemic steroid therapy any other form immunosuppressive therapy within seven days prior first dose trial treatment is taking any other medication that might affect immune function
0, fludarabine stage grade one follicular lymphoma diagnosis they have been treated more one regimen haart total at least six months duration
1, laboratory biomarker analysis refractory diffuse large cell lymphoma diagnosis left ventricular ejection fraction lvef less fifty regardless whether there symptoms heart failure
0, albumin bound paclitaxel cervical adenosarcoma diagnosis platelet count plt greater equal one hundred zero mm three
0, staurosporine lymphoma diagnosis no prior allergic reactions compounds similar chemical biological composition ucn one other agents this study
1, folic acid metastatic colorectal cancer diagnosis known history alcohol drug abuse
1, mycophenolate mofetil contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis patient rapidly progressive aggressive nhl unless minimal disease state
0, tlr agonist sd recurrent follicular lymphoma diagnosis absolute neutrophil count anc greater equal one thousand mm three independent growth factor support
0, immunoglobulins refractory small lymphocytic lymphoma diagnosis females childbearing potential fcbp must have negative serum urine pregnancy test sensitivity at least twenty five miu ml within ten fourteen days again within twenty four hours prior starting cycle one lenalidomide further they must either commit continued abstinence from heterosexual intercourse begin two acceptable methods birth control
1, dexamethasone multiple myeloma diagnosis serum clinical chemistry
0, sorafenib however if more one symptomatic bone metastasis is identified one will be chosen index lesion reporting purposes
1, doxorubicin ovarian endometrioid adenocarcinoma diagnosis patients eczema psoriasis lichen simplex chronicus vitiligo dermatologic manifestations only patients psoriatic arthritis would be excluded permitted provided that they meet following conditions
0, cyclophosphamide primary peritoneal carcinoma diagnosis no prior stroke
0, trastuzumab cepseventeen ratio greater two biopsy proven breast cancer
0, camptothecin brain central nervous system tumors diagnosis disease characteristics
1, fludarabine phosphate patients active non hematologic malignancies except non melanoma skin cancers this exclusion does not apply patients non hematologic malignancies that not require therapy
1, carboplatin stage iva uterine sarcoma diagnosis total serum bilirubin greater doc mg dl
0, liposomal doxorubicin stage ii enteropathy associated cell lymphoma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide lenalidomide similar drugs
0, levoleucovorin stage iv esophageal cancer diagnosis locally advanced metastatic disease that is inoperable not amenable curative therapy linitis plastica is permitted
1, fludarabine phosphate noncontiguous stage ii small lymphocytic lymphoma diagnosis donor
1, dynamic contrast enhanced magnetic resonance imaging recurrent renal cell cancer diagnosis subjects recent dvt who have been treated therapeutic anti coagulating agents at least six weeks eligible
0, methylprednisolone testicular germ cell tumor diagnosis no systemic immunosuppression tapered stopped treatment leukemic relapse minimal residual disease
0, rituximab stage iv grade one follicular lymphoma diagnosis able take aspirin one three hundred twenty five mg daily prophylactic anticoagulation patients intolerant asa may use warfarin low molecular weight heparin
1, rituximab adult burkitt lymphoma diagnosis patients who have known allergy any medications their analogues excipients various formulations any agent not eligible
0, oxaliplatin recurrent childhood ependymoma diagnosis creatinine clearance radioisotope glomerular filtration rate greater seventy ml min
1, antibodies monoclonal fallopian tube transitional cell carcinoma diagnosis any following
0, paclitaxel recurrent breast carcinoma diagnosis patient following prior concurrent diagnoses eligible
1, immunoglobulins recurrent adult hodgkin lymphoma diagnosis qtc prolongation greater five hundredmsec other significant ecg abnormality noted within fourteen days registration
1, liposomal doxorubicin concurrent anticancer drugs bevacizumab any drugs that target vegf vegf receptors
0, antibodies monoclonal stage iv verrucous carcinoma oral cavity diagnosis no ongoing active infection
0, cognitive assessment stage iiic fallopian tube cancer diagnosis more six months since prior epoetin alfa darbepoetin any investigational forms erythropoietin
1, sirolimus recurrent uterine corpus sarcoma diagnosis unresolved toxicities from prior systemic therapy that common terminology criteria adverse events ctcae version doc greater equal grade two severity except alopecia
0, trin neoplasms diagnosis life expectancy at least three months
0, trastuzumab refractory malignant neoplasm diagnosis five minutes breaks between ecgs
0, leucovorin stage iia colon cancer diagnosis patients prothrombin time pt international normalized ratio inr greater doc not eligible unless patient is on full dose anticoagulants if so following criteria must be met enrollment
0, melphalan iii ii symptomatic bone lesion radiological
0, endothelial growth factors stage ib breast cancer diagnosis history venous thrombosis last twelve weeks
0, histone deacetylase inhibitors cutaneous cell non hodgkin lymphoma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide similar drugs
1, oxaliplatin non metastatic pancreas cancer diagnosis peripheral sensory neuropathy greater grade two at baseline
1, oxaliplatin stomach neoplasm diagnosis participants gastrointestinal obstruction bleeding inducing mal absorption oral chemotherapeutic agents
1, oxaliplatin kras wild type colorectal cancer diagnosis major surgical procedure open biopsy significant traumatic injury within four weeks prior randomization
1, antibodies monoclonal multiple myeloma diagnosis plasma cell leukemia greater two zero cells mcl circulating plasma cells by standard differential
1, olaparib stage iv prostate adenocarcinoma diagnosis history stroke transient ischemic attack within six months randomization
0, metronidazole adult primary hepatocellular carcinoma diagnosis individuals eczema other open skin condition
1, rexin g pancreatic cancer diagnosis male patients must agree use barrier contraception
1, vaccines stage iv melanoma diagnosis radiation therapy equal less four weeks prior registration
1, fluorouracil biliary tract cancer diagnosis other serious underlying medical conditions which could impair ability patient participate study
1, gold sodium thiomalate stage iv non small cell lung cancer diagnosis other concurrent chemotherapy immunotherapy radiotherapy any ancillary therapy considered investigational utilized non food drug administration fda approved indication context research investigation
0, laboratory biomarker analysis recurrent mantle cell lymphoma diagnosis uncontrolled active infection
0, liposomal doxorubicin stage iiia breast cancer diagnosis patients must have completed definitive breast surgery including total mastectomy axillary dissection modified radical mastectomy total mastectomy sentinel node biopsy lumpectomy axillary dissection lumpectomy sentinel node biopsy note
0, irinotecan colorectal cancer diagnosis colostomy ileostomy allowed at investigator discretion
1, carboplatin anaplastic ependymoma diagnosis new york heart association nyha grade ii greater congestive heart failure
1, etoposide stage ii childhood lymphoblastic lymphoma diagnosis prednisone methylprednisolone equal less one hundred twenty hours five days seven days prior initiating induction chemotherapy equal less three hundred thirty six hours fourteen days twenty eight days prior initiating induction chemotherapy prior exposure any steroids that occurred greater twenty eight days before initiation protocol therapy does not affect eligibility dose prednisone methylprednisolone does not affect eligibility
0, dexamethasone phosphate lymphoblastic lymphoma complete remission diagnosis patients persistent minimal residual disease complete remission incomplete platelet recovery not eligible
1, capecitabine recurrent colon cancer diagnosis hiv positive patients who not on anti retroviral therapy but have cdfour cells less two hundred should be excluded hiv positive patients eligible if they on haart highly active anti retroviral therapy which not cypthreeafour substrates inducers inhibitors meet all other criteria
0, capecitabine pancreatic cancer diagnosis no known dihydropyrimidine dehydrogenase dpd deficiency
1, laboratory biomarker analysis primary diagnosis pulmonary small cell carcinoma pulmonary large cell carcinoma merkel cell carcinoma
0, liposomal doxorubicin lymphoma diagnosis biologic therapy
0, antioxidants prostate cancer diagnosis psoriasis
1, pemetrexed head neck neoplasms diagnosis presence clinically significant by physical exam third space fluid collections example ascites pleural effusions that cannot be controlled by drainage other procedures prior entry
1, pemetrexed cancer diagnosis known immediate delayed hypersensitivity reaction idiosyncrasy drugs chemically related pazopanib erlotinib pemetrexed
0, paclitaxel pancreatic cancer diagnosis hemoglobin greater doc dl
0, immunoglobulins recurrent mantle cell lymphoma diagnosis may be treated first cr
0, nitroarginine unspecified adult solid tumor protocol specific diagnosis no post radiation bowel symptoms any grade following radiotherapy within abdomen pelvis
1, rituximab stage iii adult lymphoblastic lymphoma diagnosis known hypersensitivity rituximab
0, cytarabine recurrent childhood hodgkin lymphoma diagnosis fish translocation fourteen
0, antibodies stage iiia esophageal cancer diagnosis prior step one registration but within fifty six days prior step two registration
0, irinotecan colorectal cancer diagnosis no clinically significant peripheral vascular disease phase ii
0, alvocidib stage iv extragonadal seminoma diagnosis progressive disease after prior cisplatin based therapy meets one following criteria
1, vitamins hepatocellular carcinoma diagnosis women who during pregnancy lactation
0, etoposide phosphate stage grade two follicular lymphoma diagnosis serum creatinine less doc mg dl
1, electronic brachytherapy gy carcinoma basal cell diagnosis collagen vascular disease lupus scleroderma rheumatoid arthritis
0, mitogens colorectal cancer diagnosis platelets greater one hundred one hundred nine l
0, calcium dietary diffuse adenocarcinoma stomach diagnosis patients must not have known immediate delayed hypersensitivity reaction drugs chemically related fluorouracil platins their excipients nor have known history dihydropyrimidine dehydrogenase dpd deficiency
1, dexamethasone stage multiple myeloma diagnosis cumulative dose doxorubicin four hundred mg two greater if this level would be exceeded during current study
1, paclitaxel breast cancer diagnosis serious cardiac illness medical conditions including but not confined to
0, stereotactic radiosurgery stage iva vaginal cancer diagnosis measurable disease according recist criteria
0, immunoglobulins squamous cell lung cancer diagnosis stage iiib malignant pleural effusion stage iv disease
1, exemestane prior tamoxifen part any breast cancer prevention study
1, fludarabine patients chronic lymphocytic leukemia cll small lymphocytic lymphoma well differentiated lymphocytic lymphoma
0, cyclophosphamide non small cell lung cancer diagnosis participant must have completed primary thoracic chemoradiotherapy at least four weeks no later twelve weeks prior randomization
0, paclitaxel lung cancer diagnosis chemotherapy
1, albumin bound paclitaxel recurrent carcinoma head neck region
0, doxorubicin recurrent ovarian cancer diagnosis stable from cardiopulmonary standpoint continue prolonged surgery anesthesia
0, laboratory biomarker analysis colorectal cancer diagnosis prior concurrent therapy
1, laboratory biomarker analysis small intestinal lymphoma diagnosis anticoagulation warfarin equivalent vitamin antagonists within twenty eight days prior starting ibrutinib throughout study
1, enalapril lung cancer diagnosis subjects eligible surgical resection who not need radiation therapy will not be eligible this study
1, cetuximab metastatic head neck cancer diagnosis patients who received any other investigational drugs within fourteen days prior start cabazitaxel
0, laboratory biomarker analysis recurrent adult lymphoblastic lymphoma diagnosis platelets greater equal one hundred zero ul
1, paclitaxel ovarian cancer diagnosis ongoing serious infection
1, everolimus unspecified adult solid tumor protocol specific diagnosis uncontrolled diabetes defined by fasting serum glucose greater doc uln
0, genetically engineered lymphocyte therapy recurrent adult diffuse large cell lymphoma diagnosis female participants reproductive potential must have negative serum urine pregnancy test performed within forty eight hours before infusion
1, bortezomib multiple myeloma diagnosis severe hypercalcemia serum calcium equal twelve mg dl doc mmol corrected albumin
0, leucovorin gastric cancer diagnosis forms independent cells not considered linitis
1, carboplatin non small cell lung cancer diagnosis is participating has participated an investigational compound device within thirty days five half lives start treatment
1, cd tk transduced donor lymphocytes multiple myeloma diagnosis culture pcr blood cmv must be negative enrollment
1, bortezomib relapsed refractory multiple myeloma diagnosis class two is defined cardiac disease which patients comfortable at rest but ordinary physical activity results fatigue palpitations dyspnea anginal pain
0, vaccines mesolthelioma diagnosis seronegative hiv antibody
1, prednisolone phosphate primary central nervous system cns lymphoma secondary cns involvement by lymphoma mantle cell lymphoma mcl histologic evidence transformation burkitt lymphoma primary mediastinal dlbcl primary effusion lymphoma plasmablastic lymphoma primary cutaneous dlbcl
1, mri guided needles deliver hdr brachytherapy patients prostate cancer diagnosis contraindications conscious sedation local anesthesia spinal epidural anesthesia
0, lamivudine kaposi sarcoma diagnosis histologically proven
1, lenograstim stage iii adult diffuse mixed cell lymphoma diagnosis pregnancy
1, biliary drainage ampulla vater cancer diagnosis previous chemotherapy radiotherapy
1, tacrolimus recurrent adult cell leukemia lymphoma diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvate transaminase sgpt greater equal three upper limit normal
1, precision cell immunotherapy advanced gastric cancer diagnosis other serious diseases
1, oxaliplatin patients past current history within last two years other malignancies except indication under this curatively treated basal squamous skin cancer situ cancer cervix
0, cybercycling histologically confirmed cancer
1, camptothecin colon cancer high risk stage iii ptfournone ptone four ntwo diagnosis edical geographical sociological psychological legal conditions that would not permit patient complete sign informed consent
0, sorafenib solid tumor diagnosis participants men women childbearing potential must agree use adequate contraception beginning at signing icf until at least thirty days after last dose drug
0, poly adp ribose polymerase inhibitors should woman become pregnant suspect she is pregnant while she her partner is participating this she should inform her treating physician immediately
1, paclitaxel resectable pancreatic cancer diagnosis history uncontrolled seizures central nervous system disorders psychiatric disability judged by investigator be clinically significant precluding informed consent interfering compliance oral drug intake
1, antibodies recurrent adult diffuse large cell lymphoma diagnosis unable perform self care during radiation isolation
0, entinostat multiple myeloma plasma cell neoplasm diagnosis no concurrent immunotherapy
1, mycophenolic acid adult nasal type extranodal nk cell lymphoma diagnosis donor
1, antibodies monoclonal small lymphocytic lymphoma diagnosis requires anticoagulation warfarin
1, cetuximab squamous cell carcinoma head neck diagnosis previous treatment monoclonal antibody therapy other signal transduction inhibitors epidermal growth factor receptor egfr targeting therapy
1, carmustine recurrent grade three follicular lymphoma diagnosis active bacterial viral fungal infection
1, digoxin classic kaposi sarcoma diagnosis eastern cooperative oncology group ecog performance status greater one
0, bb stage iv squamous cell carcinoma nasopharynx diagnosis predicted life expectancy greater twelve weeks
0, letrozole breast neoplasms diagnosis patients must have measurable evaluable disease
1, erlotinib hydrochloride non small cell lung cancer nsclc stage iv diagnosis patients who have received last administration chemotherapy immunotherapy daily schedule equal less seven days prior starting drug
0, antibodies stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis interferon based therapy
0, antibodies monoclonal refractory hodgkin lymphoma diagnosis autologous stem cell infusion including boost infusion
0, melphalan ds stage plasma cell myeloma diagnosis ejection fraction greater equal forty five
0, asparaginase refractory lymphoblastic lymphoma diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum glutamate pyruvate transaminase sgpt equal less doc institutional uln
0, antibodies monoclonal patients must have histologically cytologically proven newly diagnosed selected stage iiib tfour lesion due malignant pleural effusion stage iv advanced primary non small cell lung cancer adenocarcinoma large cell carcinoma unspecified recurrent disease after previous surgery irradiation patients tumors having squamous cell components greater fifty not eligible
1, immunoglobulin g cervical squamous cell carcinoma not otherwise specified diagnosis men women childbearing potential who unwilling employ adequate contraception
1, external radiotherapy uterine cervical cancer diagnosis pregnant breastfeeding patient
0, carboplatin stage ii breast cancer diagnosis hertwo must be positive by ihc ish testing by laboratory standard
0, antibodies monoclonal stage iv non small cell lung cancer diagnosis more four weeks since prior radiotherapy
1, oncolytic measles virus encoding thyroidal sodium iodide symporter stage ib malignant mesothelioma diagnosis pregnant women
0, vaccines stage ii cutaneous cell non hodgkin lymphoma diagnosis planned hct minimal no cell depletion graft
1, cyclophosphamide stage iiia primary peritoneal cancer diagnosis nursing women unwilling stop breast feeding
0, docetaxel have solid tumors that can be measured on physical examination by radiographic imaging studies
1, antibodies monoclonal recurrent grade two follicular lymphoma diagnosis eligible other therapeutic options that will be more likely have better long term disease free survival lower potential toxicity non transplant therapy autologous transplants etc
0, lenalidomide myeloma diagnosis absolute neutrophil count greater one thousand ml
0, antibodies lymphoma diagnosis female subject is either post menopausal surgically sterilized willing use an acceptable method birth control hormonal contraceptive intra uterine device diaphragm spermicide condom spermicide abstinence duration thirty days after last vaccination has been administered
1, etanercept temporomandibular joint disorder diagnosis subjects that taking regularly steroids narcotics medications will be excluded
1, tb â‰¤ mg kg relapsed refractory medulloblastoma mb part also include neuroblastoma nb ewing sarcoma es alveolar rhabdomyosarcoma arms diagnosis have previously received tb four hundred three
0, immunohistochemistry staining method breast cancer diagnosis sex
0, pyridoxal colorectal cancer diagnosis life expectancy greater twelve weeks
0, topotecan fallopian tube cancer diagnosis alkaline phosphatase less doc times uln
1, doxorubicin diffuse large cell lymphoma diagnosis prior treatment cytotoxic drugs rituximab another condition example rheumatoid arthritis prior use an anti cdtwenty antibody
0, etoposide phosphate anaplastic large cell lymphoma alk negative diagnosis no prior therapy exception prior radiation therapy one cycle chemotherapy may be any chemotherapy regimen even prednisone alone based on current diagnosis clinical condition this cycle treatment will not count toward six cycles treatment given study
0, diagnostic laboratory biomarker analysis endometrial clear cell adenocarcinoma diagnosis not eligible higher priority gog protocol if one exists any active phase iii gog protocol same patient population
1, antibodies recurrent adult brain tumor diagnosis must be able swallow capsules
1, mycophenolic acid stage iv childhood small noncleaved cell lymphoma diagnosis donor
0, docetaxel sarcoma diagnosis diagnosis
1, mira device imaging breast cancer diagnosis subjects who unable read understand execute informed consent procedure
0, immunoglobulin g undifferentiated ovarian carcinoma diagnosis prothrombin time pt such that international normalized ratio inr is equal less doc uln an range inr usually between two three if patient is on stable dose therapeutic warfarin partial thromboplastin time ptt equal less doc times upper limit normal heparin lovenox alternative anticoagulants acceptable this corresponds ctcae version doc grade one one less oneone two two three two one 
1, mitomycins tumors greater equal doc cm greatest axial dimension
1, vinorelbine adult rhabdomyosarcoma diagnosis patients botryoid histology any stage group ineligible
1, exercise intervention stage iic fallopian tube cancer diagnosis patients gog performance grade three four
1, vincristine lymphoma large cell diffuse diagnosis corrected qt interval greater four hundred eighty msec using fridericia formula
0, melphalan lymphoma diagnosis chronic myeloid leukemia cml an inadequate response imatinib meeting one following criteria
0, methylprednisolone acetate lymphoma diagnosis patient characteristics
0, trastuzumab breast cancer diagnosis patient characteristics
0, tamoxifen breast cancer diagnosis peau orange skin changes
0, nk cell infusion pediatric cancers diagnosis serum total bilirubin less two mg dl serum ast alt less equal three upper limit normal
1, asparaginase non hodgkins lymphoma diagnosis psychiatric illness that could potentially interfere completion treatment according this protocol
0, sirolimus metastatic colorectal cancer diagnosis fluoropyrimidines oxaliplatin irinotecan bevacizumab cetuximab panitumumab
1, dexamethasone phosphate non haematological malignancy within past three years exception adequately treated basal cell carcinoma squamous cell skin cancer thyroid cancer carcinoma situ cervix breast prostate cancer gleason grade six less stable prostate specific antigen levels cancer considered cured by surgical resection unlikely impact survival during duration such localised transitional cell carcinoma bladder benign tumours adrenal gland pancreas
0, liposomal doxorubicin childhood malignant mesenchymoma diagnosis ast alt less doc times uln
0, methionine brain stem glioma diagnosis informed consent signed by participant parent guardian according guidelines institutional review board
0, endothelial growth factors stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis at least four weeks since prior major surgery
1, temozolomide small cell glioblastoma diagnosis among other criteria patients who meet following conditions not eligible study
1, cyclophosphamide multiple myeloma diagnosis patient has greater doc upper limit normal total bilirubin
0, oxaliplatin stage iiic colon cancer diagnosis at least two weeks since prior minor surgery recovered
1, angiogenesis inhibitors hepatocellular carcinoma diagnosis platelets less seven doc zero anc less zero hemoglobin less doc mg dl inadequate coagulation status namely inr greater two quick less fifty aptt greater fifty sec absence any drugs interfering coagulation such warfarin phenprocoumon nmh ufh
1, sirolimus regional digestive system neuroendocrine tumor gone diagnosis female patients who pregnant breast feeding adults reproductive potential who not using effective birth control methods pregnant women excluded from breastfeeding women should be excluded
0, poly adp ribose polymerase inhibitors recurrent primary peritoneal carcinoma diagnosis creatinine equal less doc uln
0, veliparib fallopian tube carcinosarcoma diagnosis creatinine equal less doc institutional upper limit normal uln ctcae grade one
1, mycophenolate mofetil myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis all patients receiving antifungal therapy voriconazole posaconazole fluconazole who then randomized arm three must have rapamycin reduced according standard practice antifungal therapy guidelines
1, antibodies monoclonal melanoma diagnosis women childbearing potential wocbp defined above who
0, cyclophosphamide stage iii childhood lymphoblastic lymphoma diagnosis all patients must be cr defined by hematologic recovery less five blasts by morphology within bone marrow cellularity greater equal five
1, letrozole any prior neo adjuvant anti cancer therapy prior chemotherapy metastatic disease must be stopped at least five half lives seven days whichever is longer before inclusion
1, laboratory biomarker analysis grade three invasive breast carcinoma diagnosis participant receiving any other investigational agents within three days enrollment nor during participation
1, camptothecin endometrial cancer diagnosis patients child bearing potential must use adequate contraception
1, dacarbazine gliosarcoma diagnosis evidence greater grade one cns hemorrhage on baseline mri ct scan
0, etoposide stage iiib non small cell lung cancer diagnosis adequate baseline organ function obtained within thirty days registration
0, methotrexate lymphoma diagnosis one has not undergone hysterectomy bilateral oophorectomy two has not been naturally postmenopausal at least two consecutive months has had menses at any time preceding two consecutive months
0, antilymphocyte serum lymphoma diagnosis failed greater one prior chemotherapy regimen including fludarabine autologous stem cell transplantation
0, bortezomib lymphoma diagnosis patients must not be participating any other clinical trial taking any other experimental medications within fourteen days prior registration
0, docetaxel ovarian cancer diagnosis bilirubin normal
0, fluorouracil stage iva colon cancer diagnosis metastatic disease by imaging
0, lenalidomide stage small lymphocytic lymphoma diagnosis night sweats greater one month without evidence infection
0, cyclophosphamide rhabdomyosarcoma diagnosis stage one group stage one group stage one group iii orbital only stage two group stage two group ii subset two
1, dexamethasone acetate myeloma diagnosis exception
1, fludarabine phosphate recurrent cutaneous cell non hodgkin lymphoma diagnosis forty kidneys
1, everolimus recurrent renal cell cancer diagnosis adults reproductive potential who not using effective birth control methods if barrier contraceptive being used these must be continued throughout this trial by both sexes hormonal contraceptives not acceptable sole method contraception
1, albumin bound paclitaxel stage iii pancreatic cancer diagnosis any chemotherapy related toxicities from prior treatment greater grade two per common terminology criteria adverse events ctcae version doc
0, dabrafenib metastatic melanoma diagnosis patients must have histologically confirmed braf mutant vsix hundrede malignancy molecularly confirmed using validated commercially available assay performed clinical laboratory improvement amendments clia approved laboratory that is metastatic unresectable which standard curative palliative measures not exist no longer effective
1, decitabine melanoma diagnosis patients brain metastases
0, cetuximab breast cancer diagnosis written informed consent
0, rituximab stage iii grade three follicular lymphoma diagnosis patients allowed have received radiotherapy before enrollment if radiation was given alleviate pain neurologic compromise long there remains areas measurable disease present
0, lenograstim angioimmunoblastic cell lymphoma
1, bortezomib lymphoma non hodgkins diagnosis female subject is pregnant breast feeding
1, levoleucovorin stage ii rectal cancer diagnosis new york heart association class iii iv congestive heart failure
1, smoking cessation treatment plus moderate intensity exercise lung cancer diagnosis about three mph
1, lapatinib cancer diagnosis not have accessible veins venipuncture
1, carboplatin recurrent ovarian carcinoma diagnosis patients clinically significant cardiovascular disease excluded
0, panobinostat plasma cell myeloma diagnosis be surgically sterile or
1, trastuzumab advanced cancer diagnosis trastuzumab lapatinib treatment arm only history hypersensitivity trastuzumab chinese hamster ovary cell proteins any component formulation
1, antibodies monoclonal malignant neoplasm respiratory intrathoracic organ carcinoma diagnosis any gastrointestinal disorder expected limit absorption selumetinib
0, laboratory biomarker analysis recurrent childhood small noncleaved cell lymphoma diagnosis fertile patients must use effective contraception
0, triptorelin pamoate prostate cancer diagnosis clinical stage tthree any mzero any gleason score any prostate specific antigen psa
0, interleukin kidney cancer diagnosis more twelve weeks
0, niacinamide cholangiocarcinoma gallbladder diagnosis leukocyte count greater equal three zero mcl
0, immunoglobulins recurrent squamous cell carcinoma nasopharynx diagnosis abdominal fistula gastrointestinal perforation intra abdominal abscess within past twenty eight days
1, hormones lobular breast carcinoma situ diagnosis one two three pathologic axillary nodes
1, immunoglobulin g stage iv non small cell lung cancer diagnosis within past three years prior start treatment following exceptions this criterion
0, fludarabine metastatic melanoma diagnosis patients may have undergone minor surgical procedures within past three weeks long all toxicities have recovered grade one less
1, sunitinib sarcoma soft tissue diagnosis pregnancy breastfeeding
1, bbi advanced solid tumors diagnosis patients known leptomeningeal metastases excluded even if treated
1, erlotinib hydrochloride colorectal cancer diagnosis clinically significant peripheral vascular disease
0, paclitaxel peritoneal cavity cancer diagnosis disease characteristics
1, maytansine history other malignancy within previous five years except contralateral breast cancer ductal carcinoma situ dcis lobular carcinoma situ lcis appropriately treated carcinoma situ cervix non melanoma skin carcinoma stage uterine cancer other cancers outcome similar those mentioned above
0, procarbazine lymphoma diagnosis disease characteristics
0, sorafenib breast cancer diagnosis more twelve months since prior adjuvant neoadjuvant taxane therapy
0, fludarabine phosphate recurrent childhood grade iii lymphomatoid granulomatosis diagnosis any patient high risk hematologic oncologic diagnosis which allogeneic hsct is thought be beneficial whom front line therapy has already been applied
0, denileukin diftitox lymphoma low grade diagnosis aspartate aminotransferase ast alanine aminotransferase alt less equal doc times upper limit normal
0, lenalidomide recurrent marginal zone lymphoma diagnosis platelet count greater equal seventy five zero mm three
1, cyclophosphamide participants gastrointestinal disease that may significantly alter absorption pomalidomide
0, belinostat advanced malignant mesothelioma diagnosis not pregnant nursing
0, vorinostat noncontiguous stage ii mantle cell lymphoma diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum glutamate pyruvate transaminase sgpt less doc institutional upper limit normal
1, camptothecin adult primary cholangiocellular carcinoma diagnosis doc
0, liposomal doxorubicin ovarian cancer diagnosis patients greater eighteen years age
0, carboplatin breast cancer diagnosis no other contraindication treatment
1, vidarabine recurrent cutaneous cell non hodgkin lymphoma diagnosis karnofsky score less seventy adult patients
1, paclitaxel metastatic pancreas adenocarcinoma diagnosis prior history hemorrhagic thrombolytic stroke
1, radiotherapy gy rbe meningioma diagnosis distant metastases
0, diphosphonates prostate cancer diagnosis no distant metastases stage tnmo ie
1, cyclosporins recurrent adult diffuse mixed cell lymphoma diagnosis patients undergoing total body irradiation tbi based conditioning regimen tbi one thousand two hundred centigray cgy
1, ferrosoferric oxide bladder cancer diagnosis effects ferumoxytol on developing human fetus unknown
1, camptothecin glioblastoma multiforme diagnosis body weight below forty kg men fifty kg women
1, cisplatin lung cancer diagnosis serious concomitant disorders that would compromise safety patient compromise patient ability tolerate therapy
1, epinephryl borate thyroid neoplasm diagnosis modified radical neck dissection
0, liposomal doxorubicin unspecified childhood solid tumor protocol specific diagnosis doc mg dl male doc mg dl female thirteen less sixteen years age
0, tremelimumab liver cancer diagnosis doc
0, fluorodeoxyglucose f stage iv follicular thyroid cancer diagnosis pleural pericardial effusion
0, staurosporine carcinoma appendix diagnosis no concurrent anticonvulsants carbamazepine phenobarbital phenytoin
0, th cells allo hsctt non hodgkin lymphoma diagnosis complete remission three
0, podophyllotoxin recurrent small lymphocytic lymphoma diagnosis karnofsky performance status kps greater equal seventy
0, carboplatin mixed tumors will be categorized by predominant cell type unless small cell elements present which case patient is ineligible
0, bb prolactin secreting adenoma diagnosis must not be known be refractory rbc platelet transfusions
1, bkm head neck neoplasms diagnosis patients previously treated brain metastases who on stable low dose corticosteroids treatment dexamethasone two mg day prednisolone ten mg day at least fourteen days before start treatment eligible
1, recmage a as asci patient has received any anti cancer systemic treatment including immunotherapy local intravesical bcg is allowed chemotherapy except
1, sirolimus hodgkin lymphoma diagnosis total bilirubin doc mg dl greater unless related hemolysis gilbert syndrome
1, placebo stage iva verrucous carcinoma larynx diagnosis any condition which investigator opinion deems patient an unsuitable candidate receive drug
0, endothelial growth factors patients may not have currently active second malignancy other non melanoma skin cancers patients not considered have currently active malignancy if they have completed therapy considered by their physician be at less thirty risk relapse
0, vaccines stage iii pancreatic cancer diagnosis recovered from prior surgery
0, carmustine stage iii marginal zone lymphoma diagnosis no serious disease condition that opinion investigator would compromise patient ability participate study
1, craniectomy glioblastoma diagnosis significant liver function impairment
0, etoposide intraocular lymphoma diagnosis amyloidosis
1, oxaliplatin metastatic colorectal cancer diagnosis prior bevacizumab use other agents targeting vegf
1, laboratory biomarker analysis stage iva colon cancer diagnosis nefazodone fluovoxamine
0, hormones er positive hertwo negative breast cancer neoplasms diagnosis able swallow retain oral medication
1, vorinostat mantle cell lymphoma diagnosis active uncontrolled infection other cutaneous infection
0, riluzole recurrent melanoma diagnosis patients brain lesions that have been treated whole brain radiotherapy clinically stable at least four weeks not taking steroids not receiving enzyme inducing anticonvulsants will be eligible
0, ifosfamide recurrent grade three follicular lymphoma diagnosis at least four weeks since prior cytotoxic chemotherapy six weeks nitrosoureas mitomycin recovered
0, vinblastine unspecified adult solid tumor protocol specific diagnosis at least three weeks since prior packed red blood cell transfusion at least one week since prior platelet transfusion hematopoietic growth factors no concurrent growth factors earlier twenty four hours after drug chemotherapy
1, albumin bound paclitaxel stage ia fallopian tube cancer diagnosis patients current serious non healing wound ulcer bone fracture patients granulating incisions healing by secondary intention no evidence fascial dehiscence infection eligible but require weekly wound examinations
1, immunoglobulins malignant ovarian mixed epithelial tumor diagnosis major surgical procedure anticipated during course this includes but is not limited abdominal surgery laparotomy laparoscopy prior disease progression such colostomy enterostomy reversal interval secondary cytoreductive surgery second look surgery please consult chair prior patient entry any questions related classification surgical procedures
1, laboratory biomarker analysis stage iiia primary peritoneal cancer diagnosis history autoimmune disorders requiring cytotoxic immunosuppressive therapy autoimmune disorders visceral involvement active inactive auto immune disorders rheumatoid arthritis moderate severe psoriasis multiple sclerosis systemic lupus erythematosus inflammatory bowel disease etc
0, antiviral agents contiguous stage ii adult lymphoblastic lymphoma diagnosis first allogeneic cell replete transplantation stem cells from peripheral blood bone marrow an human leukocyte antigen hla matched unrelated nonsyngeneic sibling donor
0, dexamethasone phosphate lymphoma diagnosis prior concurrent therapy
0, alvocidib stage ii pancreatic cancer diagnosis creatinine no greater doc mg dl
1, vitamin b complex stage iiic breast cancer diagnosis active infection requiring antibiotics
1, gemcitabine stage iiia non small cell lung cancer diagnosis patients psychotropic treatments ongoing at baseline dose schedule should not be modified within previous six weeks prior start drug
0, carmustine lymphoma diagnosis hepatic
1, vidarabine recurrent refractory childhood hodgkin lymphoma diagnosis kidneys twelve gy
0, somatostatin islet cell tumor diagnosis at least four weeks since prior wide field radiation therapy surgery
1, rituximab diffuse large cells non hodgkin lymphoma diagnosis creatinine clearance less ten ml min
1, carboplatin fallopian tube cancer diagnosis previous chemotherapy disease under study
0, fluorodeoxyglucose f bladder cancer diagnosis nyha class iii iv congestive heart failure
0, carmustine recurrent cutaneous cell non hodgkin lymphoma diagnosis demonstration clinically normal lung function based on history physical examination patients clinical evidence pulmonary disease determined by investigator should have baseline lung function tests performed demonstration diffusing capacity lung carbon monoxide dlco greater equal seventy dlco single breath adjusted hemoglobin will be utilized we will not use dlco alveolar volume va inclusion exclusion this study
1, irinotecan advanced adenocarcinoma colon rectum diagnosis patients unable unwilling discontinue substitute if necessary use prohibited drugs juices herbal supplements at least two weeks prior atorvastatin initiation see appendix list prohibited drugs juices herbal supplements
1, leucovorin stage iva colorectal cancer diagnosis no requirement concurrent antibiotics antifungal agents prevention opportunistic infections and
0, daunorubicin lymphoma diagnosis not specified
0, laboratory biomarker analysis aids related primary effusion lymphoma diagnosis age at pel diagnosis
1, liposomal doxorubicin stage multiple myeloma diagnosis participants must not have creatinine greater three mg dl gfr less three ml min doc threemtwo
0, albumin bound paclitaxel ovarian cancer diagnosis may may not have measurable residual disease
0, metronidazole stage iia primary peritoneal cavity cancer diagnosis serum glutamic oxaloacetic transaminase sgot aspartate aminotransferase ast serum glutamic pyruvic transaminase sgpt alanine aminotransferase alt equal less three uln
1, epirubicin prior current invasive breast cancer bilateral breast cancer
0, etoposide multiple myeloma diagnosis patient must have greater twoxone hundred six kg cdthirty four positive autologous stem cells available transplantation
1, tesla magnetic resonance imaging advanced adult primary liver cancer diagnosis cochlear implants pacemakers neurostimulators biostimulators electronic infusion pumps implanted materials other those verified being rated magnetic resonance mr safe mr conditional six will not be allowed on study
0, placebo prostate cancer diagnosis hypotension less ninety fiftymm hg uncontrolled hypertension greater one hundred seventy one hundred mm hg
1, blz skin neoplasms diagnosis unstable angina myocardial infarction known suspected transient ischemic events stroke within twenty four weeks screening
1, camptothecin refractory solid tumors children diagnosis severe concomitant disease infection disease
1, gemcitabine uncontrolled brain metastases spinal cord compression carcinomatous meningitis leptomeningeal disease
0, cilengitide recurrent adult cell leukemia lymphoma diagnosis no psychiatric illness social situation that would preclude compliance
1, bevacizumab colorectal cancer diagnosis lack physical integrity upper gastrointestinal tract
1, liposomal doxorubicin astrocytoma grade iv diagnosis history central nervous system bleeding defined by stroke intraocular bleed within six months enrollment
0, cidofovir cervical cancer diagnosis pngreater two thousand mmthree
0, dacarbazine extragonadal germ cell tumor diagnosis able swallow capsules
0, gossypol lung cancer diagnosis willingness ability comply procedures follow up examination
0, antibodies monoclonal stage iv small lymphocytic lymphoma diagnosis progressively worsening lymphadenopathy
1, antibodies peripheral cell lymphoma diagnosis diffusion capacity lung carbon monoxide dlco less thirty five total lung capacity tlc less thirty five forced expiratory volume lung one second fevone less thirty five receiving supplementary continuous oxygen fhcrc principal investigator pi must approve enrollment all patients pulmonary nodules
1, anastrozole recurrence breast cancer
0, lapatinib recurrent squamous cell carcinoma hypopharynx diagnosis must have normal organ marrow function
0, methylprednisolone hemisuccinate multiple myeloma plasma cell neoplasm diagnosis at least twelve weeks hematopoietic
1, l neurofibromatosis type one diagnosis individuals insufficient english complete assessments
1, dexamethasone multiple myeloma diagnosis positive test results human immunodeficiency virus hiv
1, conventional surgery anal cancer diagnosis patients currently enrolled another involving an investigational product
0, everolimus non clear cell renal carcinoma diagnosis adequate renal function
0, melphalan sarcoma diagnosis biologic therapy
1, celecoxib carcinoma buccal mucosa diagnosis recent massive gastrointestinal hemorrhage
0, piperacillin unspecified adult solid tumor protocol specific diagnosis not specified other
1, anastrozole metastatic carcinoma diagnosis active bleeding diathesis
0, sorafenib recurrent melanoma diagnosis at least three weeks since prior major surgery
0, pyridoxal patients myeloma treated first line therapy including lenalidomide bortezomib thalidomide one more following
1, mycophenolic acid stage grade two follicular lymphoma diagnosis human immunodeficiency virus hiv positive patients
0, thalidomide refractory cutaneous cell non hodgkin lymphoma diagnosis male
1, dexamethasone phosphate ovarian endometrioid tumor diagnosis pregnancy
0, antibodies colorectal cancer diagnosis chronic treatment non investigational gonadotropin releasing hormone analogs other hormonal supportive care is permitted
1, dacarbazine melanoma diagnosis any prior use cc five thousand thirteen
1, pazopanib hydrochloride solid neoplasm diagnosis ejection fraction less institutional lower limit normal lln history cardiomyopathy
1, gemcitabine pancreatic cancer diagnosis infection hiv hepatitis at screening
1, fludarabine recurrent mantle cell lymphoma diagnosis eligible high priority curative autologous transplant
1, capecitabine pancreatic neoplasms diagnosis ecog performance status ps two three four
0, dinaciclib nodular melanoma diagnosis hemoglobin greater nine dl
1, aprepitant lymphoma malignant diagnosis patients nausea have emetic episodes receiving any anti emetic medication taken within twenty four hours receiving antibiotics
1, liposomal doxorubicin early breast cancer tumor size less two cm measured by palpation
1, anastrozole stage breast cancer diagnosis history allergic reactions hypersensitivity compounds similar chemical biologic composition entinostat benzamide anastrozole tamoxifen
0, ketorolac rectum cancer diagnosis males females above age eighteen
1, vaccines history prior breast cancer
1, cyclosporins recurrent adult diffuse mixed cell lymphoma diagnosis pregnancy
0, antiviral agents recurrent adult immunoblastic large cell lymphoma diagnosis must have already been determined be eligible hct at city hope coh
0, trabectedin pancreatic cancer diagnosis measurable disease according recist criteria
0, antibodies monoclonal stage basal cell carcinoma lip diagnosis must have evidence progressive neurologic signs symptoms appropriate location radiation necrosis
0, fluorouracil metastatic cancer diagnosis creatinine less two mg dl
0, everolimus recurrent diffuse large cell lymphoma diagnosis mismatched two hla class alleles but matched hla drbone hla dq or
0, cyclophosphamide retinoblastoma diagnosis program
0, prednisolone multiple myeloma diagnosis eastern cooperative oncology group ecog performance status less two
1, rituximab adult nasal type extranodal nk cell lymphoma diagnosis clinically active hepatitis b infections note
0, antibodies monoclonal lung sarcomatoid carcinoma diagnosis estimated by cockcroft gault formula estimated creatinine clearance is based on actual body weight
1, robotic single port surgery notes hypopharyngeal neoplasms diagnosis vulnerable population mentally disabled pregnancy
0, antibodies monoclonal stage iii pancreatic cancer diagnosis more four weeks since prior immunotherapy
1, cadexomer iodine stage ivc papillary thyroid cancer diagnosis prior major surgery trauma within twenty eight days prior first dose drug presence any non healing wound fracture ulcer procedures such catheter placement not considered be major
0, ifosfamide histologically proven newly diagnosed moderate high grade osteosarcoma without metastases no prior treatment including complete resection no parosteal periosteal sarcoma no osteosarcoma associated paget disease no nonresectable tumors tumors that may result marginal interlesion resection must be enrolled on protocol pog nine thousand eight hundred fifty one
0, cyclophosphamide myelodysplastic myeloproliferative neoplasms diagnosis creatinine normal or
1, carboplatin measurable evaluable disease by response evaluation criteria solid tumors recist
1, cisplatin laryngeal cancer diagnosis has an active infection requiring systemic therapy
0, fluorodeoxyglucose f recurrent oropharyngeal cancer diagnosis able remain still duration each imaging procedure about one hour
0, carboplatin childhood immunoblastic large cell lymphoma diagnosis ecog zero two
0, paclitaxel ovarian undifferentiated adenocarcinoma diagnosis patient must remain free recurrent metastatic disease
1, imatinib mesylate gastrointestinal stromal tumors diagnosis congestive heart failure myocardial infarction within six months study
0, oxaliplatin rectal cancer diagnosis ecog performance status zero two
0, estradiol valerate prostate cancer diagnosis radiographic evidence regional distant metastases
0, melphalan recurrent grade one follicular lymphoma diagnosis unrelated donor
1, bevacizumab stage iii iv recurrent endometrial cancer diagnosis patients granulating incisions healing by secondary intention no evidence facial dehiscence infection eligible but require three weekly wound examinations
1, ogx neoplasms diagnosis patients cohorts six seven prior history serious allergic reaction docetaxel any chemotherapy containing cremophor el used drugs such cyclosporine etoposide teniposide polysorbate eighty diluent docetaxel
0, mass spectrometry melanoma skin diagnosis excluded any following
0, buserelin prostate cancer diagnosis fertile patients must use effective contraception during greater three months after completion treatment
1, capecitabine metastatic breast cancer diagnosis use other investigational agents last twenty eight days
0, bay intrahepatic cholangiocarcinoma ihcc patients only total bilirubin less doc times uln is acceptable
1, olaparib non small cell lung cancer diagnosis patients who present any contraindication suspected allergy products under investigation study
1, laboratory biomarker analysis uncontrolled intercurrent illness including but not limited ongoing active infection symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmia psychiatric illness social situations that would limit compliance requirements
1, immunoglobulin g stage ivb cervical cancer diagnosis patients clinical symptoms signs gastrointestinal obstruction who require parenteral hydration nutrition
0, cisplatin lung cancer diagnosis prior concurrent therapy
0, paclitaxel stage iiib breast cancer diagnosis ecog performance status equal less one karnofsky greater equal seventy
0, fulvestrant tumor must be er positive
1, eus fna pancreatic masses pancreatic neoplasms diagnosis unable safely undergo eus any reason
0, lenograstim adenocarcinoma lung diagnosis histology cytology from involved mediastinal supraclavicular lymph nodes allowed if separate distal primary lesion is clearly evident on radiographs second biopsy not required
1, fludarabine hodgkin lymphoma diagnosis active involvement central nervous system malignancy
0, cyclophosphamide recurrent ovarian carcinoma diagnosis platelet count greater equal one hundred zero mm three
1, lenograstim childhood germ cell tumor diagnosis pregnant nursing
1, folfox previous neo adjuvant chemo radio therapy small bowel adenocarcinoma
0, fludarabine phosphate natural killer cell lymphoblastic leukemia lymphoma diagnosis patients sixteen years old older must have karnofsky score at least seventy patients younger sixteen years old must have lansky score at least seventy
1, vaccines unresectable metastatic melanoma diagnosis lack availability immunological clinical follow up assessments
1, anticoagulants lymphoma diagnosis any investigational drug being administered during including multiple doses peg asparaginase
1, calcium dietary history pericarditis myocarditis symptomatic arrhythmia conduction disturbances
1, cyclophosphamide recurrent childhood hodgkin lymphoma diagnosis cardiac ejection fraction ef less forty on multi gated acquisition muga scan cardiac echocardiogram echo if unable obtain ejection fraction shortening fraction less twenty six patients active history cardiac disease should be evaluated appropriate cardiac studies consult ejection fraction is required if age greater fifty years there is history anthracyclines history cardiac disease patients shortening fraction less twenty six may be enrolled if approved by cardiologist
0, vitamins peripheral cell lymphoma not otherwise specified diagnosis note
1, albumin bound paclitaxel her two positive gastric cancer diagnosis history clinically relevant cardiovascular abnormalities within six months
0, albumin bound paclitaxel solid cancers diagnosis histologically cytologically documented incurable locally advanced metastatic solid malignancy maximum two prior chemotherapy regimens is allowed
0, bevacizumab neuroblastoma diagnosis patients must have measurable disease
0, irinotecan stage iiib colon cancer diagnosis only subjects following histologies will be eligible
0, gemcitabine recurrent pancreatic carcinoma diagnosis willing abstain from smoking
1, cyclosporins nodal marginal zone cell lymphoma diagnosis marrow donors
0, busulfan lymphoma diagnosis diffuse mixed cell
0, reiki relaxation response therapy cognitive restructuring prostate cancer diagnosis planned androgen suppression therapy prior an eight week course external beam radiotherapy
1, paclitaxel carcinoma unknown primary origin diagnosis active bleeding diathesis
0, medroxyprogesterone patient has documented evidence prr negative endometrial cancer
1, irinotecan unresectable malignant neoplasm diagnosis history allergic reactions attributed following
1, pharmacological b cell non hodgkin lymphoma diagnosis clinically significant stroke transient ischemic attack tia equal less six months prior registration seizures not controlled standard medical therapy
1, o benzylguanine stage ii aids related lymphoma diagnosis active infection requiring systemic antibiotic therapy antibacterial antifungal antiviral agents excluding hiv
0, cyclophosphamide breast cancer diagnosis renal function
1, cyclosporins recurrent childhood grade iii lymphomatoid granulomatosis diagnosis any vertebral instability
0, doxorubicin advanced adult hepatocellular carcinoma diagnosis no prior systemic therapy metastatic disease
1, paclitaxel adenocarcinoma gastroesophageal junction diagnosis history major organ transplant example
1, regorafenib upper gi cancer diagnosis if result is normal then no additional testing is required
0, glucocorticoids breast cancer diagnosis patients may have received adjuvant chemotherapy up two prior chemotherapy metastatic locally recurrent disease
0, antibodies stage iiic fallopian tube cancer diagnosis hepatic artery embolization
0, fludarabine multiple myeloma plasma cell neoplasm diagnosis cml
0, melphalan recurrent adult hodgkin lymphoma diagnosis dyskeratosis
0, quality life assessment small intestine cancer diagnosis not specified
0, pharmacological stage iii inverted papilloma paranasal sinus nasal cavity diagnosis more four weeks since prior chemotherapy six weeks mitomycin nitrosoureas
1, veltuzumab non hodgkin lymphoma diagnosis known autoimmune disease presence autoimmune phenomena
0, etoposide phosphate lymphoma diagnosis no uncontrolled infections not pregnant nursing adequate contraception fertile patients
0, antibodies monoclonal stage iv squamous cell carcinoma oropharynx diagnosis bilirubin normal
1, tamoxifen progesterone receptor positive tumor diagnosis treatment any investigational agent within twenty eight days prior registration protocol therapy subject must have recovered from acute toxic effects regimen
0, fludarabine lymphoma diagnosis essential thrombocythemia
1, methylprednisolone hemisuccinate nodular lymphocyte predominant hodgkin lymphoma
1, preoperative short course radiotherapy rectal neoplasms diagnosis mental disorder
1, liposomal doxorubicin second active tumor
0, cyclophosphamide sarcoma diagnosis disease characteristics
0, paclitaxel stage iiic skin melanoma diagnosis note
1, nivolumab stage iiia breast cancer diagnosis patients who have received prior epigenetic histone deacetylase hdac inhibitors such entinostat panobinostat vorinostat romidepsin demethylating agents such five azacitidine decitabine immunomodulatory other checkpoint inhibitors should only be considered after discussion protocol chair
1, bortezomib recurrent adult primary liver cancer diagnosis known cns metastases
0, iodine lymphoma small cleaved cell follicular diagnosis bi dimensionally measurable disease at least one lesion measuring doc cmtwo by ct scan
0, brachytherapy prostate cancer diagnosis must have had one following disease characteristics prior external beam radiotherapy
1, oxi solid tumors diagnosis previous ongoing cardiac conditions
0, prednisolone acetate testicular germ cell tumor diagnosis fertile patients must use effective contraception during six months after completion treatment
0, methylprednisolone acetate epstein barr virus positive diffuse large cell lymphoma diagnosis biochemical values within following limits
1, bortezomib diffuse large cell lymphoma recurrent diagnosis any other coexisting medical psychological condition that would preclude participation compromise ability give informed consent
1, cisplatin stage iii hypopharyngeal squamous cell carcinoma diagnosis active autoimmune disease that has required systemic treatment past two years use disease modifying agents corticosteroids immunosuppressive drugs replacement therapy eg thyroxine insulin physiologic corticosteroid replacement therapy adrenal pituitary insufficiency etc
0, poly iclc malignant melanoma diagnosis hemoglobin greater equal nineg dl greater equal doc mmol without transfusion epo dependency within seven days assessment
0, quality life assessment recurrent bladder cancer diagnosis hemoglobin hgb greater doc dl
1, vaccines ovarian cancer diagnosis patients must have received refused first line standard systemic therapy their metastases if applicable
1, radiation therapy breast cancer diagnosis gadolinium allergy
0, ifosfamide recurrent childhood lymphoblastic lymphoma diagnosis platelet count greater one hundred zero mm three transfusion independent
1, tacrolimus recurrent marginal zone lymphoma diagnosis liver abnormalities
0, ground flaxseed precancerous condition diagnosis patients enrolled part one must meet following criteria
1, retinol acetate stage iv mantle cell lymphoma diagnosis requirement routine use hematopoietic growth factors including granulocyte colony stimulating factor granulocyte macrophage colony stimulating factor interleukin eleven platelet transfusions maintain absolute neutrophil counts platelets counts above required thresholds entry use erythropoietin stimulating agents rbcs prior enrollment is allowed
0, succinylcholine stage ivb cervical cancer diagnosis phase i
1, methylprednisolone hemisuccinate prostate cancer metastatic diagnosis history severe hypersensitivity reaction greater grade three polysorbate eighty containing drugs
1, aromatase inhibitors breast cancer diagnosis these patients ineligible because potential inability generate an immune response vaccines
1, bevacizumab malignant peritoneal neoplasm diagnosis brain metastases per mri ct at any time prior registration note
0, dactinomycin non metastatic childhood soft tissue sarcoma diagnosis doc mgt dl
0, bevacizumab ganglioglioma diagnosis patient must have life expectancy greater eight weeks
1, psma pet ct scan prostate cancer diagnosis unable provide written consent
0, hormones prostate cancer diagnosis sgot less four times upper limit normal
0, laboratory biomarker analysis unspecified adult solid tumor protocol specific diagnosis ast alt no greater doc times upper limit normal
1, antibodies stage ivb squamous cell carcinoma larynx diagnosis pulmonary hemorrhage bleeding event greater ctcae grade two within four weeks first dose drug
1, rituximab recurrent cutaneous cell non hodgkin lymphoma diagnosis pregnant nursing women men women reproductive potential may not participate unless they have agreed use an effective contraceptive method
0, carboxyamido triazole stage iiia non small cell lung cancer diagnosis anc greater equal one thousand five hundred mm three
1, antibodies recurrent grade three follicular lymphoma diagnosis pregnant women women childbearing age who not practicing adequate contraception men who not willing use an effective method contraception
1, cyclosporins noncutaneous extranodal lymphoma diagnosis patient is human immunodeficiency virus hiv positive
0, epoetin alfa stage iii cervical cancer diagnosis creatinine no greater doc mg dl
0, immunoglobulins stage iiic primary peritoneal cancer diagnosis twelve weeks from completion radiation recurrent gbm unless there is surgical diagnosis recurrence new lesion that was not previously radiated
1, psychosocial assessment care cervical cancer diagnosis women metastatic disease women major medical conditions stroke degenerative illness survivors moderate severe depression anxiety asian participants stage zero disease
0, alvespimycin hydrochloride unspecified adult solid tumor protocol specific diagnosis pt normal
1, cetuximab tumors that fluorescence situ hybridization test fish positive immunohistochemistry ihc three positive
1, iodine non hodgkin lymphoma diagnosis patients new york heart association class iii iv heart disease other serious illness that would preclude evaluation
1, succinylcholine stage iv laryngeal squamous cell carcinoma diagnosis is not considered form systemic treatment
0, cisplatin urothelial carcinoma diagnosis be willing able provide written informed consent trial
1, vidarabine stage small lymphocytic lymphoma diagnosis donor
0, carmustine brain central nervous system tumors diagnosis radiotherapy
0, gefitinib esophageal cancer diagnosis at least twelve weeks
0, sunitinib recurrent pancreatic cancer diagnosis azole antifungals ketoconazole itraconazole
0, dacarbazine anaplastic glioma brain diagnosis baseline on mri is performed within fourteen days enrollment on steroid dosage that has been stable
0, albumin bound paclitaxel primary peritoneal cavity cancer diagnosis creatinine no greater doc mg dl cardiovascular
1, immunoglobulin g stage iv uveal melanoma diagnosis any following
1, irinotecan colorectal cancer diagnosis utilization capecitabine six weeks preceding sir sphere therapy indefinitely following sir sphere therapy per manufacturer recommendations due increased risk radiation hepatitis
0, protein expression analysis kidney cancer diagnosis no splenic metastasis
1, regorafenib stivarga bay neoplasms diagnosis radiotherapy within three weeks prior start treatment
1, immunoglobulins recurrent mantle cell lymphoma diagnosis prior radioimmunotherapy including ninety zevalin one hundred thirty one iodine anti bone antibody lym one
1, cyclosporine stage childhood small noncleaved cell lymphoma diagnosis disease resulting severely limited performance status less seventy
0, cyclophosphamide recurrent adult diffuse mixed cell lymphoma diagnosis platelet plt greater seventy five zero ul
1, fludarabine splenic marginal zone lymphoma diagnosis eligible high priority curative autologous transplant
0, vidarabine recurrent marginal zone lymphoma diagnosis creatinine less doc
1, counseling intervention stage iv adult lymphoblastic lymphoma diagnosis these survivors will however have full access website if they have completed required baseline assessment they will be asked also complete follow up assessments
1, antibodies stage ivc verrucous carcinoma larynx diagnosis known hiv positive patients will be excluded from trial due potential immune modulation that these agents may cause
0, paclitaxel breast cancer diagnosis age greater eighteen years
1, sirolimus relapsed refractory advanced cancer diagnosis study
1, mycophenolate mofetil stage iv childhood large cell lymphoma diagnosis known allergy filgrastim csf
1, etoposide phosphate extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis patients who have not recovered from adverse events due agents administered more four weeks earlier or
0, cetuximab ovarian cancer diagnosis subjects must have at least one recurrent lesion be used assess response
1, entinostat stage iv breast cancer diagnosis note
1, fluorouracil stage ivb colorectal cancer diagnosis treatment any other investigational agent participation another investigational drug trial within twenty eight days prior randomization
0, irinotecan metastatic cancer diagnosis total bilirubin less doc times upper limit normal
0, flow cytometry diagnosis squamous cell carcinoma scc head neck
1, paclitaxel advanced solid tumors diagnosis has known hypersensitivity tas one hundred nineteen its components
1, cyclosporine recurrent mantle cell lymphoma diagnosis total bilirubin greater two upper limit normal
0, succinylcholine stage ivb uterine corpus cancer diagnosis patients must have met pre entry requirements
0, bevacizumab glioblastoma diagnosis hemoglobin greater equal eight dl
0, crizotinib recurrent solid neoplasm diagnosis continuation an agent regimen which disease progression has been observed prior biopsy is permitted
0, ispinesib recurrent childhood large cell lymphoma diagnosis felbamate
0, freund s adjuvant stage iiia melanoma diagnosis ability read understand willingness sign an irb approved informed consent
0, cediranib adult giant cell glioblastoma diagnosis concurrent non eiaeds allowed
1, osi advanced solid tumors diagnosis history allergic reaction attributed similar compound drug
1, placebo urinary bladder neoplasms diagnosis patient has received radiotherapy abdominal pelvic region within six months prior randomization
0, rituximab ct mri scan confirming measurable tumor size
1, hydrocortisone butyrate propionate lymphoblastic lymphoma diagnosis at least fourteen days after local palliative xrt small port at least eighty four days must have elapsed if prior tbi craniospinal xrt if greater equal fifty radiation pelvis at least forty two days must have elapsed if other substantial marrow radiation
0, cytarabine lymphoblastic lymphoma diagnosis systemic chemotherapy must begin within seventy two hours first intrathecal treatment
1, cyclooxygenase inhibitors primary operable breast cancer diagnosis patients treated chronically one more medications
0, questionnaire administration breast cancer diagnosis alkaline phosphatase less two times uln
1, stationary bicycle test advanced cancers diagnosis acute pulmonary embolus pulmonary infarction last week
1, jnj erdafitinib carcinoma hepatocellular diagnosis clinically active serious infections greater greater common terminology criteria adverse events aes grade two
1, lenograstim stage ii adult hodgkin lymphoma diagnosis any perceived inability directly provide informed consent note
1, pet ct scan non small cell lung cancer diagnosis blood creatinin above normal
1, everolimus recurrent marginal zone lymphoma diagnosis addition cytotoxic agents cytoreduction exception tyrosine kinase inhibitors such imatinib cytokine therapy hydroxyurea low dose cytarabine chlorambucil rituxan will not be allowed within three weeks initiation conditioning
1, abiraterone acetate castration resistant prostate cancer diagnosis lycopene
1, nintedanib gastrointestinal abnormalities that would interfere intake absorption drug such requirement intravenous alimentation prior surgical procedures affecting absorption treatment peptic ulcer disease within last six months active gastrointestinal bleeding unrelated cancer evidenced by either hematemesis melena past three months without endoscopic documented resolution malabsorption syndromes
1, ixazomib multiple myeloma diagnosis participation other clinical trials including those other investigational agents not included this trial within thirty days prior start treatment throughout duration this trial
0, immunoglobulins stage iiia non small cell lung cancer diagnosis tfour lesions any size that invade mediastinum heart great vessels trachea esophagus vertebral body carina documented by greater one following methods
1, endothelial growth factors stage iiib ovarian cancer diagnosis patients serious non healing wound ulcer bone fracture this includes history abdominal fistula gastrointestinal perforation intra abdominal abscess within twenty eight days patients granulating incisions healing by secondary intention no evidence fascial dehiscence infection eligible but require weekly wound examinations
0, maytansine non small cell lung cancer diagnosis absence sensitising egfr mutation tested according local protocol
0, immunoglobulins contiguous stage ii grade two follicular lymphoma diagnosis has not undergone hysterectomy bilateral oophorectomy or
1, gefitinib carcinoma non small cell lung diagnosis have serious preexisting medical conditions
1, bb multiple myeloma relapse diagnosis cockcroft gault formula should be used calculating creatinine clearance values
0, prednisolone acetate lymphoma diagnosis toxic effects prior therapy surgery must be resolved less grade two
1, interferon gamma round cell liposarcoma diagnosis uncontrolled hypertension blood pressure bp greater one hundred fifty one hundred mmhg patients elevated bp may enroll once bp is corrected
0, lenalidomide cutaneous cell lymphoma diagnosis females childbearing potential fcbp must have negative serum urine pregnancy test sensitivity at least fifty miu ml within ten
0, leucovorin cholangiocarcinoma extrahepatic bile duct diagnosis absolute neutrophil count anc greater equal lfive hundred ul
0, temozolomide metastatic melanoma diagnosis women childbearing potential must have negative urine serum pregnancy test upto twenty eight days prior commencement dosing
0, mycophenolic acid recurrent mantle cell lymphoma diagnosis donors must be informed investigational nature this understand requirements potential benefits potential risks experimental treatment give written informed consent accordance institutional federal guidelines
1, gefitinib head neck cancer diagnosis intercurrent medical illnesses which would impair patient tolerance therapy limit survival
0, laboratory biomarker analysis recurrent childhood medulloblastoma diagnosis fertile female patients must use two effective methods contraception during two months following treatment
1, immunoglobulins recurrent adult lymphoblastic lymphoma diagnosis southwest oncology group swog performance status greater equal doc
0, dacarbazine childhood high grade cerebral astrocytoma diagnosis platelet count greater one hundred zero Î¼l transfusion independent defined no platelet transfusion within past seven days
0, pembrolizumab metastatic cancers diagnosis presence an index lesion greater one cm amenable hypofractionated radiotherapy
1, vaccines stage iv adult lymphoblastic lymphoma diagnosis received antiviral treatment gvc val fos cidofovir cmx one at any point during twenty eight day period
0, methotrexate stage ia breast cancer diagnosis alkaline phosphatase equal less two iuln
1, carboplatin esophageal cancer diagnosis patients may not be receiving any other investigational agents
0, albumin bound paclitaxel untreated metastatic squamous neck cancer occult primary diagnosis no current peripheral neuropathy greater grade two at time randomization
0, cancer prevention intervention islet cell carcinoma diagnosis disease that is not curable surgery radiotherapy
1, magnetic resonance image uterine leiomyoma diagnosis coagulopathy renal failure
1, vidarabine diffuse large cell lymphoma diagnosis donors unable unwilling undergo marrow harvest initial hct storage autologous blood prior marrow harvest apheresis one week after marrow harvest
0, antibodies monoclonal ovarian brenner tumor diagnosis bilirubin less equal doc upper limit normal uln ctcae grade one
1, questionnaire administration stage iii marginal zone lymphoma diagnosis patients whom planned therapy includes
0, cyclophosphamide breast cancer diagnosis systemic lupus erythematosus
1, somatostatin glioma diagnosis pregnant lactating women
1, laboratory biomarker analysis currently receiving any other investigational agent which would be considered treatment primary neoplasm
0, imatinib mesylate stage iv adult diffuse mixed cell lymphoma diagnosis at least ten days since prior placement shunt treatment biliary obstruction
0, ifosfamide brain central nervous system tumors diagnosis first relapse after single prior cisplatin containing combination chemotherapy
0, fludarabine phosphate stage iii adult diffuse large cell lymphoma diagnosis ages equal less fifty years age chronic lymphocytic leukemia cll these patients not require patient review committee approvals
0, metal patch tests head neck cancer diagnosis recruited from otorhinolaryngology departments mayo clinic rochester mayo clinic arizona
1, zoledronic acid osteoid osteoma diagnosis furuncle eczema superinfection
1, camptothecin stage iva colon cancer diagnosis history reversible posterior leukoencephalopathy syndrome rpls
0, vorinostat recurrent childhood subependymal giant cell astrocytoma diagnosis at least seven days three half lives whichever is longer since prior monoclonal antibodies
1, bicalutamide prostatic neoplasms diagnosis right bundle branch block conjunction left anterior hemi block bifasicular block
1, immunoglobulins endometrial adenocarcinoma diagnosis three grade two greater hypoxemia
1, hyperthermia concurrent chemo radiation therapy locally advanced rectal cancer diagnosis extrapelvic metastasis
1, docetaxel recurrent bladder carcinoma diagnosis if subject received major surgery they must have recovered adequately from toxicity complications from intervention prior starting therapy
0, veliparib triple negative breast carcinoma diagnosis left ventricular ejection fraction at above institutional lower limit normal obtained within eight weeks registration by multigated acquisition muga scan echocardiogram same test performed at baseline should be repeated after every three cycles therapy
0, vorinostat splenic marginal zone lymphoma diagnosis complete remission is defined absence blasts peripheral circulation at time enrollment less five blasts bone marrow
1, bevacizumab glioblastoma multiforme diagnosis patients known sensitivity any products be administered during treatment
0, deuterated phenanthrene tetraol lung cancer diagnosis not currently taking any other investigational agents
1, doxorubicin stage ii follicular lymphoma diagnosis has known history human immunodeficiency virus hiv hiv one two antibodies
1, cyclophosphamide active central nervous system cns lymphoma leukemia
1, methyltestosterone actively bleeding tumor if patient is intended be treated carboplatin
1, educational intervention via internet family history familial adenomatous polyposis hereditary nonpolyposis crc
0, comprehensive geriatric assessment recurrent breast carcinoma diagnosis both measurable well non measurable disease will be allowed
0, temozolomide adult pineal gland astrocytoma diagnosis creatinine within normal institutional limits creatinine clearance greater sixty ml min doc three two patients creatinine levels above institutional normal
1, paclitaxel breast neoplasms diagnosis history hypersensitivity drugs formulated cremophor el polyoxyethylated castor oil vehicle used commercial paclitaxel formulations
0, melphalan stage iii small lymphocytic lymphoma diagnosis patients greater age sixty clinical signs heart disease must have ejection fraction greater equal forty five left ventricular ejection fraction lvef
1, levoleucovorin carcinoma diagnosis persons deprived liberty under guardianship
0, oxaliplatin intestinal adenocarcinoma stomach diagnosis no myocardial infarction within twelve months enrollment
0, osimertinib recurrent solid neoplasm diagnosis patients who human immunodeficiency virus hiv positive eligible if
0, paclitaxel stage iiic breast cancer diagnosis eastern cooperative oncology group performance status zero one
0, pharmacological glucagonoma diagnosis platelets greater equal one hundred ten nine l
0, cytarabine recurrent grade two follicular lymphoma diagnosis chemotherapy responsive disease
1, adh exherinâ„¢ neoplasms diagnosis chemotherapy radiotherapy any other investigational drug within thirty days before entry
1, flt ligand protein medium large size posterior uveal melanoma diagnosis cirrhosis chronic hepatitis virus positivity chronic hepatitis infection
1, mitogens lung cancer diagnosis patients who pregnant
0, dexamethasone multiple myeloma diagnosis patients must have received at least two lines prior therapies
1, cabozantinib s malate recurrent renal cell carcinoma diagnosis erythromycin clarithromycin ketoconazole azithromycin itraconazole grapefruit juice st
0, cetuximab colorectal cancer diagnosis patients should have completed any major surgery greater four weeks from registration
1, fludarabine recurrent cutaneous cell non hodgkin lymphoma diagnosis treatment rituximab any reason twelve months preceding hct
0, gemcitabine bladder cancer diagnosis surgery
1, etoposide phosphate stage grade three follicular lymphoma diagnosis pregnant breastfeeding women excluded from this breastfeeding should be discontinued if mother is treated busulfan cyclophosphamide etoposide
0, everolimus anaplastic glioma diagnosis chemo if that was used initial therapy
1, trametinib cancer diagnosis visible retinal pathology assessed by ophthalmic exam that is considered risk factor for
1, st john s wort peritoneal carcinomatosis diagnosis patients who considered inoperable because reduced general condition
0, hydroxystaurosporine lymphoma diagnosis more three months
1, levoleucovorin mucinous adenocarcinoma rectum diagnosis previous oxaliplatin therapy metastatic disease prior adjuvant therapy oxaliplatin is allowed long one hundred twenty days have elapsed since last oxaliplatin treatment
0, everolimus recurrent verrucous carcinoma larynx diagnosis ability understand willingness sign written informed consent document
0, liposomal doxorubicin multiple myeloma plasma cell neoplasm diagnosis patients treated brain metastases that have been stable greater three months does not require chronic steroids eligible
1, doxorubicin ovarian clear cell adenocarcinoma diagnosis rash must cover less ten body surface area bsa
0, eribulin mesylate solid tumors diagnosis diagnosis
0, mycophenolic acid lymphoma diagnosis patient characteristics
0, aldesleukin lymphoma diagnosis at least four weeks since chemotherapy
1, fludarabine refractory multiple myeloma diagnosis patients poorly controlled hypertension on multiple antihypertensives
0, carboplatin brain central nervous system tumors diagnosis patient characteristics
0, antibodies monoclonal sarcomatous mesothelioma diagnosis see disease characteristics
1, vincristine lymphoma diagnosis prior anti cdtwenty therapy
1, doxorubicin stage iiib breast cancer diagnosis cardiac arrhythmia requiring medication
1, methotrexate lymphoblastic lymphoma diagnosis cytostatic pre treatment
0, immunotoxins pancreatic cancer diagnosis performance status
1, vinblastine lymphoma
1, bortezomib recurrent plasma cell myeloma diagnosis patients history moderate severe chronic obstructive restrictive pulmonary disease forced expiratory volume one second fevone forced vital capacity fvc less fifty predicted values diffusing capacity lung carbon monoxide dlco less fifty partial pressure oxygen ptwo less seventy mmhg
0, urine sample biomarkers prostate cancer diagnosis enrollment is equal less one year from diagnosis
1, mycophenolate mofetil recurrent adult cell leukemia lymphoma diagnosis liver abnormalities
0, tumor homing peptide irgd recurrent breast cancer diagnosis creatinine equal less doc mg dl measured creatinine clearance greater equal sixty cc min
1, doxorubicin breast cancer diagnosis patients who have had only pre treatment fine needle aspiration fna excluded
0, carboplatin fallopian tube cancer diagnosis other
0, methotrexate recurrent mantle cell lymphoma diagnosis cytogenetic abnormalities addition ph positive
1, rituximab lymphoma diagnosis pregnant lactating women
0, fludarabine lymphoma diagnosis ftbi cyclophosphamide patients nhl aml cml mds
1, cetuximab stage ivb inverted papilloma paranasal sinus nasal cavity diagnosis chronic treatment systemic steroids another immunosuppressive agent
1, laboratory biomarker analysis endometrial squamous cell carcinoma diagnosis class iii iv new york heart association nyha congestive heart failure
1, psychosocial assessment care breast cancer diagnosis documented active psychiatric illness
0, laboratory biomarker analysis adult gliosarcoma diagnosis lack hematologic cardiac other medical contraindications surgery
1, vitamin b myeloma diagnosis hiv infection unless patient is receiving effective antiretroviral therapy undetectable viral load normal cdfour counts
1, carboplatin endometrial serous adenocarcinoma diagnosis patients who have had radiotherapy within four weeks prior entering those who have not recovered from adverse events ctcae vfour grade two greater excluding alopecia due agents administered more four weeks earlier
1, leucovorin adenocarcinoma gastroesophageal junction diagnosis liver disease such cirrhosis chronic active hepatitis chronic persistent hepatitis
1, questionnaire administration stage ia cervical cancer diagnosis patients who have had prior pelvic abdominal inguinal lower extremity radiation therapy
0, liposomal doxorubicin breast cancer diagnosis patients must not have had history new york heart association class three four heart failure history myocardial infarction unstable angina cva within six months protocol registration
1, irinotecan urinary bladder neoplasms diagnosis patients brain metastases can be enrolled only if treated non progressive brain metastases off high dose steroids greater twenty mg prednisone equivalent at least four weeks
0, nintedanib endometrial clear cell carcinoma diagnosis coagulation parameters
0, rsifn co malignancies including melanoma kidney lung colorectal prostate neuroendocrine tumor diagnosis aspartate aminotransferase ast alanine aminotransferase alt less doc upper limit normal uln less five uln subjects known hepatic metastases
0, paclitaxel fallopian tube cancer diagnosis histologic confirmation is preferably by biopsy limited excision prior neo adjuvant treatment
1, ramucirumab stage iv gastric cancer diagnosis patients untreated brain metastases excluded from this clinical trial because their poor prognosis because they often develop progressive neurologic dysfunction that would confound evaluation neurologic other adverse events
1, pazopanib clear cell metastatic renal cell carcinoma diagnosis any serious unstable pre existing medical mental other condition medical social mental impairment drug abuse that could comprise interfere subject safety provision informed consent compliance procedures
1, daratumumab multiple myeloma diagnosis active systemic infection uncontrolled diabetes acute diffuse infiltrative pulmonary disease that is likely interfere procedures results that opinion investigator would constitute hazard participating this study
1, cyclosporine recurrent childhood grade iii lymphomatoid granulomatosis diagnosis patients poorly controlled hypertension who unable have blood pressure kept below one hundred fifty ninety on standard medication
0, prevention care management breast cancer diagnosis no mmco claim any following
0, levonorgestrel patient is ashkenazi jewish ethnicity lineage via mother one firs negative degree two second degree maternal relatives breast ovarian cancer where breast cancer is required meet this criterion greater one breast cancer must have been diagnosed prior menopause at age less fifty years if age at menopause is unknown
1, isophosphamide mustard clear cell sarcoma soft tissue diagnosis cerebrovascular accident cva transient ischemic attack tia
0, cyclophosphamide stage iia breast cancer diagnosis prothrombin time pt international normalized ratio inr equal less doc upper limit normal uln
0, laboratory biomarker analysis stage iii grade two follicular lymphoma diagnosis creatinine clearance greater sixty ml min
1, gemcitabine pancreatic neoplasms diagnosis subject is enrolled any other clinical protocol investigational trial an interventional agent assessments that may interfere procedures
1, antibodies monoclonal melanoma skin diagnosis history significant evidence risk chronic inflammatory autoimmue disease
0, stabilized sulphur hexafluoride microbubble based contrast agent kidney cancer diagnosis detection target hepatic metastasis that is visible located sized conventional sonography ct scan mri
0, sunitinib teratoma diagnosis no prior sunitinib malate
0, questionnaire administration precancerous condition diagnosis healthy volunteer
1, mycophenolic acid recurrent adult diffuse large cell lymphoma diagnosis left ventricular ejection fraction less forty
0, ct perfusion neuroendocrine tumors diagnosis doc
1, paclitaxel metastatic pancreatic cancer diagnosis following medications substances not allowed during study
1, bortezomib extramedullary plasmacytoma diagnosis progressive disease on prior treatment
0, bleomycin stage iv childhood hodgkin lymphoma diagnosis stage ia only bulk disease
0, antibodies lymphoma diagnosis not specified
0, tocotrienols unspecified adult solid tumor protocol specific diagnosis ability sign informed consent understand nature placebo controlled trial
0, tamoxifen endometrial carcinoma diagnosis patients who have met pre entry requirements
1, sirolimus recurrent childhood lymphoblastic lymphoma diagnosis myelosuppressive chemotherapy
0, antibodies monoclonal metastatic digestive system neuroendocrine tumor gone diagnosis alkaline phosphatase equal less doc uln equal less five uln if liver metastasis is present patient is hcc cohort
1, antibodies monoclonal symptomatic peripheral vascular disease
0, liposomal doxorubicin breast cancer diagnosis prior concurrent therapy
0, bb recurrent cutaneous cell non hodgkin lymphoma diagnosis all patients must be informed investigational nature this have given written consent accordance institutional federal guidelines
1, proapoptotic peptide cigb nonrecurrent condyloma diagnosis having received surgery treatment ablative immunomodulator treatment during thirty days prior inclusion
0, busulfan unspecified childhood solid tumor protocol specific diagnosis chronic accelerated blast phase
1, maleic acid stage iiia ovarian cancer diagnosis serious non healing wound ulcer bone fracture
1, camptothecin intestinal adenocarcinoma stomach diagnosis subjects known untreated brain metastases treated brain metastases that have not been stable greater equal four weeks prior first dose drug
1, immunoglobulins recurrent adult burkitt lymphoma diagnosis known hypersensitivity rituximab
0, gemcitabine metastatic pancreatic carcinoma
0, laboratory biomarker analysis recurrent childhood large cell lymphoma diagnosis immune suppression planned post transplant immune suppression should include tacrolimus cyclosporin monotherapy calcineurin inhibitor cn alemtuzumab regimens second immune suppressant atg treated patients other agents may be used if cn intolerance toxicity occurs post transplant
1, ibrutinib follicular lymphoma diagnosis refer section doc concomitant medication
0, mln b cell small lymphocytic lymphoma sll
0, dyadic progressive walking resistance exercise cancer diagnosis be twenty one years age older
1, melphalan lymphoma diagnosis patients who on anticoagulants antiplatelet agents
1, antibodies monoclonal skin lymphoma diagnosis following exempt from three year limit
0, carboplatin unspecified adult solid tumor protocol specific diagnosis chemotherapy
0, immunoglobulin g stage iv non small cell lung cancer diagnosis women child bearing potential men must agree use adequate contraception hormonal barrier method birth control abstinence prior entry duration participation one hundred eighty days after last dose therapy
0, mycophenolic acid lymphoma diagnosis stage iv disease
0, abiraterone acetate stage iv prostate cancer diagnosis ability understand willingness sign written informed consent document
0, etoposide phosphate recurrent childhood anaplastic large cell lymphoma diagnosis shortening fraction greater equal twenty seven ejection fraction greater fifty
0, erlotinib hydrochloride stage iii squamous cell carcinoma paranasal sinus nasal cavity diagnosis no active infection requiring parenteral antibiotics part two only
0, antibodies monoclonal triple negative breast neoplasms diagnosis agree practice true abstinence when this is line preferred usual lifestyle participants
0, cyclosporins childhood immunoblastic large cell lymphoma diagnosis calculated creatinine clearance greater equal sixty ml min measured creatinine clearance greater equal sixty ml min by twenty four hour urine collection if creatinine greater equal doc history renal dysfunction
1, sirolimus diffuse large cell lymphoma diagnosis concurrent treatment another investigational agent during conduct trial
0, etoposide primary central nervous system neoplasms diagnosis histology
0, stretching osteosarcoma diagnosis diagnoses include
0, tki confirmed diagnosis multiple myeloma
0, carcinoembryonic antigen expressing measles virus must have persistent recurrent progressive ovarian cancer primary peritoneal cancer after prior treatment platinum taxol compounds
0, methylprednisolone acetate lymphoma diagnosis negative pregnancy test
0, vincristine pretext stage two hepatoblastoma diagnosis patients stage ii disease specimens rapid central review have been submitted rapid central review diagnosis staging must be available be provided on ahepseven hundred thirty one eligibility case report form crf
1, bendamustine hydrochloride recurrent adult diffuse mixed cell lymphoma diagnosis known allergy intolerance bendamustine mannitol gcsf dexamethasone
1, docetaxel head neck cancer diagnosis female patients who pregnant breast feeding
0, immunologic technique gestational trophoblastic tumor diagnosis see disease characteristics
0, azacitidine recurrent fallopian tube cancer diagnosis life expectancy greater equal six months
0, doxorubicin lymphoma diagnosis fertile female patients must use effective double method contraception greater twenty eight days before during greater twenty eight days after completion therapy
1, niacinamide breast cancer diagnosis common terminology criteria adverse events ctcae v
0, pv recurrent squamous cell carcinoma paranasal sinus nasal cavity diagnosis fertile patients must use effective contraception
1, mycophenolic acid recurrent grade two follicular lymphoma diagnosis patient donor infected human immunodeficiency virus hiv
0, fludarabine recurrent mantle cell lymphoma diagnosis must have failed previous myelosuppressive chemotherapy hct have less five marrow blasts at time transplant
0, mycophenolic acid childhood diffuse large cell lymphoma diagnosis myelodysplastic syndromes myeloproliferative disorders mds mpd
0, rituximab stage adult diffuse large cell lymphoma diagnosis dlco must be greater fifty predicted
1, px metastatic cancer diagnosis known suspected brain metastases that have not received adequate therapy
1, quality life assessment stage iiib melanoma diagnosis known have such conditions at screening should not be included
1, irinotecan rectum cancer diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior day zero anticipation need major surgical procedure during course fine needle aspirations core biopsies within seven days prior day
1, bevacizumab adult gliosarcoma diagnosis recovered from severe toxicity prior therapy
1, antibodies mucinous adenocarcinoma rectum diagnosis bone lesions
0, camptothecin stage ivb colon cancer diagnosis international normalized ratio inr less doc unless patients receiving anti coagulation therapy patients receiving anti coagulation therapy an agent such warfarin heparin allowed participate if inr equal less doc
1, prednisone stage iv prostate cancer diagnosis any psychological familial sociological geographical condition that could potentially interfere compliance protocol follow up schedule
1, irinotecan unspecified adult solid tumor protocol specific diagnosis patient has greater equal grade two peripheral neuropathy within fourteen days before enrollment
1, paclitaxel solid tumor cancer diagnosis cannot have history bleeding hemoptysis hematuria gi blood loss epistaxis others greater grade one according ctc criteria within six weeks prior beginning therapy any clinical indications current active bleeding bleeding diathesis
0, mycophenolate mofetil unspecified adult solid tumor protocol specific diagnosis hiv infected patients without malignancy who have failed haart eligible provided that these criteria met
1, bevacizumab stage iiic rectal cancer diagnosis gastrointestinal tract disease resulting an inability take oral medication requirement iv alimentation prior surgical procedures affecting absorption active peptic ulcer disease
0, methotrexate high grade osteosarcoma diagnosis patients must have adequate cardiac function defined by shortening fraction greater twenty seven by echocardiogram ejection fraction greater forty seven by radioisotopic angiogram
1, albumin bound paclitaxel endometrial clear cell adenocarcinoma diagnosis patients history myocardial infarction unstable angina uncontrolled arrhythmia within three months from enrollment
0, epirubicin breast cancer diagnosis chemotherapy
0, cediranib stage iiia rectal cancer diagnosis women who have had tubal ligation
0, cisplatin head neck cancer diagnosis patients must have measurable disease defined at least one lesion that can be accurately measured at least one dimension longest diameter be recorded greater twenty mm conventional techniques greater ten mm spiral ct scan
1, peginterferon alfa b advanced cholangiocarcinoma diagnosis note
0, zoledronic acid metastatic cancer diagnosis no known active peptic ulcer
1, immunosuppressive agents lymphoma low grade diagnosis pregnant
0, albumin bound paclitaxel diagnosis invasive adenocarcinoma breast must have been made by core needle biopsy by limited incisional biopsy
1, bevacizumab recurrent breast cancer diagnosis creatinine upc ratio greater equal doc at screening or
0, darinaparsin hematologic neoplasms diagnosis total bilirubin less twox uln
0, fludarabine penile cancer diagnosis note
0, prednisolone hemisuccinate breast cancer diagnosis renal function
0, cisplatin cervical cancer diagnosis patient has adequate renal function
0, carboplatin splenic marginal zone lymphoma diagnosis amyloidosis
1, gemcitabine epithelial ovarian cancer diagnosis currently enrolled discontinued less fourteen days from another clinical trial
0, antibodies monoclonal stage iiia ovarian cancer diagnosis patients this trial may receive ovarian estrogen positive
1, calcium dietary stage ivb colorectal cancer diagnosis patients positive human immunodeficiency virus hiv not excluded from this but hiv positive patients must have
1, e advanced solid tumors diagnosis subjects who meet any following criteria not eligible participate this study
0, camptothecin mucinous adenocarcinoma colon diagnosis patients must discontinue any medication that causes strong cytochrome pfour hundred fifty family three subfamily polypeptide four cypthreeafour induction two weeks prior treatment initiation patients who not able discontinue these drugs considered ineligible
0, fludarabine phosphate recurrent grade three follicular lymphoma diagnosis resistant recurrent disease after at least one standard combination chemotherapy regime first remission patients at high risk relapse first remission patients at high risk relapse
0, alvespimycin hydrochloride stage iv verrucous carcinoma larynx diagnosis no poorly controlled angina
1, abiraterone acetate prostate neoplasms diagnosis known brain metastasis
1, biopsy obtain a chemogram colorectal cancer diagnosis medical contraindication chemotherapy biotherapy folfox folfiri avastin
0, levoleucovorin stage iiib rectal cancer diagnosis group i
1, albumin bound paclitaxel ovarian transitional cell carcinoma diagnosis core biopsy within seven days prior first date bevacizumab placebo therapy cycle two
1, ck boost radiation breast cancer diagnosis patient who received chemotherapy
0, antibodies monoclonal cancer pancreas diagnosis negative human immunodeficiency virus hiv antibody
1, cisplatin patients greater grade two symptomatic hypercalcemia based on investigator discretion
1, dihydroxyphenylalanine recurrent childhood brain stem glioma diagnosis inability lie still entire imaging time
0, antibodies monoclonal stage iii grade one follicular lymphoma diagnosis previously untreated note
1, antibodies stage iv ovarian cancer diagnosis patients who pregnant nursing patients childbearing potential must agree use contraceptive measures during therapy at least six months after completion bevacizumab therapy
1, pembrolizumab colorectal carcinoma diagnosis known psychiatric substance abuse disorders that would interfere cooperation requirements study
0, dexamethasone acetate multiple myeloma diagnosis phase two
1, mabp advanced cancers diagnosis immunocompromised including subjects know be infected hiv
0, ifosfamide stage childhood hodgkin lymphoma diagnosis fertile patients must use effective contraception
1, fmri evaluation brain tumors diagnosis karnofsky performance status less sixty
1, mln adenocarcinoma stomach diagnosis ongoing anticoagulant therapy eg aspirin coumadin heparin
1, cyclosporins recurrent childhood small noncleaved cell lymphoma diagnosis disease resulting severely limited performance status less seventy
0, tazemetostat c tazemetostat primary mediastinal lymphoma diagnosis chemotherapy
0, vidarabine stage iii grade one follicular lymphoma diagnosis no more three prior treatments disease not including steroids alone
1, camptothecin intestinal adenocarcinoma stomach diagnosis patients immune deficiency at increased risk lethal infections when treated marrow suppressive therapy therefore hiv positive patients receiving combination anti retroviral therapy excluded from because possible pharmacokinetic interactions drugs appropriate studies will be undertaken patients receiving combination anti retroviral therapy when indicated
1, histone deacetylase inhibitors clear cell renal cell carcinoma diagnosis any medical condition that would preclude adequate evaluation safety toxicity combination
1, doxorubicin neoplasms breast diagnosis patients receiving prophylactic antiplatelet medications low dose aspirin without clinically apparent bleeding tendency eligible
1, vidarabine hodgkins lymphoma diagnosis prior radiation therapy four hundredcgy more tbi
1, antibodies recurrent melanoma diagnosis nursing women
1, methyltestosterone prostate cancer diagnosis moderate severe hepatic impairment child pugh classes c
1, mycophenolic acid angioimmunoblastic cell lymphoma diagnosis human immunodeficiency virus hiv positive patients
1, antibodies nodal marginal zone cell lymphoma diagnosis aspartate aminotransferase ast alanine aminotransferase alt greater doc uln
0, albumin bound paclitaxel carcinoma non small cell lung diagnosis existence at least one measurable lesion by recist doc
0, mycophenolic acid small lymphocytic lymphoma diagnosis ages equal less fifty years age chronic lymphocytic leukemia cll
0, qs prostate cancer diagnosis eighteen over performance status
0, prednisone lymphoma diagnosis psychiatric illness social situation that would preclude compliance requirements
0, vaccines stage iii adult cell leukemia lymphoma diagnosis antiviral treatment herpes simplex virus hsv human herpes virus six hhvsix epstein barr virus ebv adenovirus including use gvc val fos cidofovir cmx one may also suppress reactivation cmv thus it will not be allowed this patients requiring such treatment before randomization day twenty eight will be removed from replaced reasons removal will be reported patient crf
0, oxaliplatin pancreatic adenocarcinoma diagnosis ionized calcium equal less uln
1, antibodies stage prostate cancer diagnosis proteinuria at screening demonstrated by
0, prednisolone acetate systemic anaplastic large cell lymphoma alcl alk negative cases only
0, pharmacological disseminated neuroblastoma diagnosis inr equal less doc times uln
1, paclitaxel gynecological cancer diagnosis men pre menopausal women who not using an effective method contraception previously described actively breast feeding women
1, erlotinib hydrochloride glioblastoma diagnosis history significant concurrent illness
0, levoleucovorin stage iiia gastric cancer diagnosis total bilirubin less doc upper limit normal
0, triptorelin pamoate prostate cancer diagnosis age greater eighteen
1, antibodies ovarian seromucinous carcinoma diagnosis received oral intravenous iv antibiotics within two weeks prior cycle one day one patients receiving prophylactic antibiotics prevention urinary tract infection chronic obstructive pulmonary disease eligible
0, hspe cervical cancer diagnosis pulmonary
1, mycophenolate mofetil stage iv adult cell leukemia lymphoma diagnosis disease resulting severely limited performance status less seventy
1, atorvastatin calcium recurrent hodgkin lymphoma diagnosis participation an investigational that has acute gvhd primary endpoint
1, mycophenolate mofetil contiguous stage ii adult diffuse large cell lymphoma diagnosis donor
0, celecoxib childhood malignant fibrous histiocytoma bone diagnosis no cardiac event any kind within past six months
0, immunoglobulins stage ii grade three non contiguous follicular lymphoma diagnosis ki sixty seven greater equal eighty
0, palbociclib male breast cancer diagnosis serum creatinine less doc unl calculated creatinine clearance greater sixty ml min c
0, albumin bound paclitaxel er negative pr negative hertwo negative breast neoplasms diagnosis total bilirubin less upper limit normal uln serum albumin greater greater doc dl alanine aminotransferase aspartate aminotransferase less doc uln
1, paclitaxel uncontrolled intercurrent illness including but not limited ongoing active infection symptomatic congestive heart failure uncontrolled hypertension unstable angina pectoris cardiac arrhythmia interstitial lung disease psychiatric illness social situations that would limit compliance requirement substantially increase risk incurring aes from drugs compromise ability patient give written informed consent
1, lenalidomide small lymphocytic lymphoma diagnosis patients recent history deep vein thrombosis dvt pulmonary embolus pe six months prior enrollment not eligible this study
0, vidarabine childhood nasal type extranodal nk cell lymphoma diagnosis patients human leukocyte antigen hla matched related donors
1, sorafenib breast cancer diagnosis thrombotic embolic events cerebrovascular accident including transient ischemic attacks within past six months
1, bb follicular lymphoma diagnosis known positivity hiv active infectious hepatitis type b c
0, dexamethasone phosphate multiple myeloma diagnosis urine protein greater two hundred mg per twenty fourhr
1, estradiol stage iiib breast cancer diagnosis breast implants contraindicated only if implant precludes required research biopsies interferes palpating breast lesion
1, antibodies monoclonal childhood pleomorphic rhabdomyosarcoma diagnosis treated brain metastases defined having no ongoing requirement steroids no evidence progression hemorrhage after treatment at least three months ascertained by clinical examination brain imaging magnetic resonance imaging mri computed tomography ct stable dose anticonvulsants allowed treatment brain metastases may include whole brain radiotherapy wbrt radiosurgery rs gamma knife linear accelerator linac equivalent combination deemed appropriate by treating physician
0, immunoconjugates breast cancer diagnosis not specified
1, mycophenolate mofetil recurrent adult burkitt lymphoma diagnosis treatment rituximab any reason twelve months preceding hct
1, fludarabine phosphate stage iv marginal zone lymphoma diagnosis karnofsky performance status less sixty adult patients
0, quality life assessment stage iva rectal cancer diagnosis patients may not be enrolled clinical treatment trial at time registration
1, paclitaxel undifferentiated ovarian carcinoma diagnosis exposure household contacts equal less fifteen months old household contact known immunodeficiency
0, dacarbazine glioblastoma multiforme diagnosis assess extent residual disease post operatively ct mri should be done no later ninety six hours post operatively at least four weeks post operatively within four days before registration
0, interleukin recurrent non small cell lung cancer diagnosis no inflammatory bowel disease
0, mycophenolate mofetil childhood diffuse large cell lymphoma diagnosis matched related donor
1, gefitinib peritoneal neoplasms diagnosis patients overt psychosis mental disability otherwise incompetent give informed consent
0, abarelix prostate cancer diagnosis serum creatinine less equal two upper limit normal uln
0, cetuximab stage iv verrucous carcinoma oral cavity diagnosis at least one month since prior surgery unless ambulatory within forty eight hours
1, ispinesib stage ivc salivary gland cancer diagnosis following lists medications substances moderate significant inhibitors inducers cypthreeafour that if administered concomitantly sb seven hundred fifteen thousand nine hundred ninety two may alter drug exposure use these medications substances within four days greater equal six months amiodarone prior administration first dose sb seven hundred fifteen thousand nine hundred ninety two through discontinuation from is prohibited
0, cognitive function tests histological proof may be obtained from primary tumor another metastatic site
0, fludarabine recurrent grade one follicular lymphoma diagnosis any patient high risk hematologic oncologic diagnosis which allogeneic hsct is thought be beneficial whom front line therapy has already been applied
0, albumin bound paclitaxel stage iv breast cancer diagnosis aspartate aminotransferase ast equal less three uln ast equal less five uln if liver involvement
0, pharmacodynamic studies recurrent adult cell leukemia lymphoma diagnosis patients uncontrolled autoimmune hemolytic anemia aiha idiopathic thrombocytopenic purpura itp not eligible
0, antibodies recurrent colon cancer diagnosis no hemorrhage bleeding event greater grade three within past four weeks
0, beclomethasone recurrent mantle cell lymphoma diagnosis known intolerance bdp
0, isotretinoin recurrent neuroblastoma diagnosis doc mg dl male doc mg dl female thirteen less sixteen years age
1, leucovorin recurrent colon cancer diagnosis proteinuria at baseline subjects unexpectedly discovered have greater equal one positive proteinuria will undergo twenty four hour urine collection which will be less one mg protein twenty four hours be allowed participation study
0, prednisolone phosphate lymphoma diagnosis ecog performance status zero three
1, metronidazole stage iiic ovarian epithelial cancer diagnosis known allergy history life threatening reaction gm csf
0, succinylcholine stage iva oropharyngeal squamous cell carcinoma diagnosis following assessments required within fourteen days prior registration
0, cisplatin ovarian cancer diagnosis disease characteristics
1, antibodies pancreatic cancer patients diagnosed locally advanced metastatic pancreatic cancer not amenable curative surgical resection diagnosis patient requires is taking corticosteroids other immunosuppressant drugs on long term basis
0, folic acid metastatic cancer diagnosis ineligible disease specific clinical imm one hundred one
1, immunoglobulins ovarian transitional cell carcinoma diagnosis acrin six thousand six hundred ninety five ineligible patients
1, pentostatin adenocarcinoma lung diagnosis however patients who have had treatment their brain metastases whose brain metastatic disease status has remained stable at least four six weeks without steroids may be enrolled at discretion principal investigator
0, erlotinib hydrochloride stage iv squamous cell carcinoma lip oral cavity diagnosis no abnormal slit lamp examination using vital dye fluorescein bengal rose
1, bevacizumab stage iv fallopian tube cancer diagnosis major surgical procedure anticipated during course this includes but is not limited abdominal surgery laparotomy laparoscopy prior disease progression such colostomy enterostomy reversal interval secondary cytoreductive surgery second look surgery please consult chair prior patient entry any questions related classification surgical procedures
1, irinotecan glioblastoma multiforme diagnosis patients who unable take oral medications because significant vomiting will be excluded
1, immunoglobulin g fallopian tube endometrioid adenocarcinoma diagnosis myocardial infarction unstable angina less six months prior registration
1, mycophenolic acid hodgkin lymphoma diagnosis psychiatric disorder that would preclude patients from signing an informed consent
1, fluorouracil intestinal adenocarcinoma stomach diagnosis patients who have any severe uncontrolled medical conditions other conditions that could affect their participation such as
0, cyclophosphamide noncontiguous stage ii mantle cell lymphoma diagnosis eastern cooperative oncology group ecog performance status zero two
0, bevacizumab stage ivc oral cavity verrucous carcinoma diagnosis patients should not have prior history serious human anti human antibody haha reaction patients known hypersensitivity chinese hamster ovary cell products other recombinant human antibodies not eligible
1, levoleucovorin stage iiib esophageal adenocarcinoma diagnosis patients any polymorphism ugtoneaone other one twenty eight six will be allowed treated twenty eight twenty eight dosing group
1, carboplatin non hodgkin lymphoma diagnosis subject has calculated measured creatinine clearance less sixty ml minute within fourteen days before enrollment
0, antibodies monoclonal untreated metastatic squamous neck cancer occult primary diagnosis urine protein less doc twenty four hours
0, questionnaire administration head neck cancer diagnosis ecog performance status zero three
0, antibodies monoclonal untreated metastatic squamous neck cancer occult primary diagnosis no prior concurrent chronic use aspirin other nonsteroidal anti inflammatory agents
0, antibodies stage iiic primary peritoneal cancer diagnosis prior regional treatments liver metastasis permitted including
1, oxaliplatin cancer gallbladder diagnosis peripheral neuropathy greater grade one
1, bb multiple myeloma diagnosis female subjects who pregnant lactating
0, carmustine lymphoma diagnosis not specified
0, pharmacological recurrent basal cell carcinoma lip diagnosis no other concurrent investigational agents
1, monitoring device stage iiia colorectal cancer diagnosis any individual considered be that vulnerable group including pregnant women prisoners
1, cisplatin solid tumors diagnosis impaired cardiac function
0, vaccines primary peritoneal serous adenocarcinoma diagnosis lymphocytes greater equal doc ten nine l
1, albumin bound paclitaxel carcinoma non small cell lung diagnosis history needing permanently discontinue prior platinum doublet based regimen reasons other progression toxicity
0, laboratory biomarker analysis invasive breast carcinoma diagnosis absolute neutrophil count anc greater equal one thousand five hundred
0, rituximab lymphoma diagnosis patients less forty five years age should have echo muga only if clinically indicated
0, accelerated partial breast irradiation breast cancer diagnosis no evidence lymphovascular invasion
0, albumin bound paclitaxel esophageal cancer diagnosis a
1, insulin gastro enteropancreatic neuroendocrine tumor diagnosis history current alcohol misuse abuse within past twelve months
0, cyclophosphamide refractory plasma cell myeloma diagnosis absolute neutrophil count anc greater equal one thousand ul
1, trebananib adult oligodendroglioma diagnosis patients who have not yet completed at least twenty one days thirty days prior monoclonal antibody therapy since ending other investigational device drug trials who currently receiving other investigational treatments
0, albumin bound paclitaxel fallopian tube carcinosarcoma diagnosis regimens ii
0, sirolimus melanoma diagnosis recurrent unresectable stage iii disease stage iv disease non choroidal origin
1, nitrogen mustard compounds recurrent childhood hodgkin lymphoma diagnosis life expectancy severely limited by disease other malignancy
0, mycophenolate mofetil unspecified adult solid tumor protocol specific diagnosis match grade one
0, antibodies stage iii inverted papilloma paranasal sinus nasal cavity diagnosis refractory interleukin two il two
1, cisplatin non squamous non small cell lung cancer stage iiia diagnosis pre existing neuropathic greater grade two
0, gemcitabine metastatic pancreatic adenocarcinoma diagnosis ecog performance status zero one
1, doxorubicin multiple myeloma diagnosis patients non secretory disease no measurable paraprotein serum urine
1, carboplatin stage iib fallopian tube cancer diagnosis no vascular lymphatic invasion
0, cyclosporine stage iv adult lymphoblastic lymphoma diagnosis peripheral blood stem cells will be collected from donors greater twelve years age
1, tacrolimus anaplastic large cell lymphoma diagnosis uncontrolled central nervous system cns disease hematologic malignancies
0, fatigue inventory stage iv marginal zone lymphoma diagnosis platelet count greater equal fifty zero ul
1, antineoplastic agents alkylating breast cancer diagnosis clinically significant heart disease pacemakers defibrillators
0, paclitaxel peritoneal cavity cancer diagnosis renal
0, capecitabine recurrent rectal cancer diagnosis randomization
1, pembrolizumab metastatic melanoma diagnosis has known history non infectious pneumonitis that required steroids current pneumonitis
0, dexamethasone multiple myeloma diagnosis pretreatment clinical laboratory values meeting following criteria during screening phase
1, deazaaminopterin plasma cell myeloma plasmacytoma hairy cell leukemia
0, rituximab tumor tissue confirmed express cdtwenty antigen
1, sirolimus adult solid neoplasm diagnosis john wort cypthreeafour inhibitors indinavir nelfinavir ritonavir clarithromycin itraconazole ketoconazole nefazodone saquinavir telithromycin unless medication can be substituted another agent
0, pembrolizumab carcinoma squamous cell head neck diagnosis determination unresectability will be based on multidisciplinary review each case
1, gemcitabine colorectal cancer diagnosis gastroduodenal ulcer determined active by endoscopy
0, alvespimycin hydrochloride stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis no other uncontrolled illness
0, cetuximab colorectal cancer metastatic diagnosis not received oxaliplatin bevacizumab cetuximab adjuvant setting
1, immunoglobulin idiotypes refractory multiple myeloma diagnosis graft vs host disease requiring treatment corticosteroids
1, management therapy complications splenic marginal zone lymphoma diagnosis total joint replacement
1, clinical assessments stage iiia breast cancer diagnosis history diabetes mellitus heart disease tia stroke
1, megestrol stage ia endometrial carcinoma diagnosis currently pregnant breastfeeding
1, bortezomib carcinoma squamous diagnosis patients who have had chemotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
1, gemcitabine breast cancer diagnosis patients must not have serious infection other serious underlying medical condition which would impair ability patient receive protocol treatment
1, thalidomide multiple myeloma diagnosis pregnant lactating females
0, antibodies monoclonal stage grade three follicular lymphoma diagnosis patients may not have received prior murine compounds due risk hama formation
1, epacadostat stage iv ovarian cancer diagnosis pregnancy nursing unwilling take adequate birth control during therapy note
1, hormones prior systemic therapy radiotherapy invasive non invasive breast cancer same breast currently being treated
1, carboplatin genital neoplasms female diagnosis known hypersensitivity paclitaxel carboplatin bibf one thousand one hundred twenty any their excipients vehicles such polyoxyethylated castor oil
0, cabozantinib solid tumor not breast prostate cancers diagnosis has bony metastases
1, laboratory biomarker analysis ovarian carcinoma diagnosis patients who have not had an ip catheter placed prior initiating platinum taxane based ip chemotherapy on gog two hundred fifty two
1, antibodies recurrent grade one follicular lymphoma diagnosis pregnant women
1, bevacizumab ovarian mucinous cystadenocarcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition mlnone hundred twenty eight bevacizumab
1, melatonin colon cancer diagnosis use other investigational drug within thirty days before entry during study
1, paclitaxel recurrent ovarian cancer diagnosis non healing wound ulcer bone fracture
1, aldesleukin metastatic uveal melanoma diagnosis testing is required patients with
0, isotretinoin recurrent childhood large cell lymphoma diagnosis no other concurrent biologic therapy immunotherapy
0, neulasta pegfilgrastim lung cancer diagnosis sixty five years old
0, pharmacological recurrent adult liver carcinoma diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum glutamic pyruvate transaminase sgpt equal less doc iuln
1, carboplatin stage iiia primary peritoneal cancer diagnosis patients serious non healing wound ulcer bone fracture this includes history abdominal fistula gastrointestinal perforation intra abdominal abscess within twenty eight days patients granulating incisions healing by secondary intention no evidence fascial dehiscence infection eligible but require weekly wound examinations
0, niacinamide pancreatic polypeptide tumor diagnosis cardiovascular
0, ifosfamide ovarian cancer diagnosis patients must have no significant obstructive airways disease fevone must be greater fifty predicted must have acceptable diffusion capacity corrected dlco greater fifty predicted
0, thalidomide multiple myeloma diagnosis a
0, fluorouracil recurrent laryngeal squamous cell carcinoma diagnosis human immunodeficiency virus hiv positive patients receiving combination anti retroviral therapy excluded from appropriate studies will be undertaken patients receiving combination anti retroviral therapy when indicated
1, gemcitabine unresectable gallbladder carcinoma diagnosis patients must not have prior exposure docetaxel
0, ifosfamide childhood malignant ovarian germ cell tumor diagnosis doc mg dl greater sixteen years age male
1, manganese primary metastatic tumor liver parenchyma diagnosis can not suspend anti hypertensive drugs beta blockers at least forty eight hours be pacemaker carriers other implantable device
0, image guided radiation therapy malignant neoplasm prostate diagnosis previous turp is allowed provided there is at least eight weeks interval radiotherapy
1, dacarbazine glioblastoma diagnosis women who pregnant breast feeding
1, tryptophan glioma diagnosis patients significantly altered mental status that would prohibit understanding rendering informed consent compliance requirements this protocol must have legally authorized representative lar willing participate support patient throughout trial
1, poly i c small size posterior uveal melanoma diagnosis cardiovascular disease that meets one following
1, aminopurine adult lymphoblastic lymphoma diagnosis patients central nervous system three cnsthree leukemia
0, vaccines malignant glioma diagnosis patients must have karnofsky performance status greater seventy
1, antibodies monoclonal stage iv prostate cancer diagnosis prior anti incontinence surgery
1, management therapy complications stage ii ovarian germ cell tumor diagnosis osteopenia osteoporosis score equal less than
0, mycophenolic acid refractory childhood hodgkin lymphoma diagnosis chronic myelogenous leukemia cml
0, paclitaxel primary peritoneal cancer diagnosis platelets greater equal one hundred zero Ï…l ctcae grade zero one
0, carboplatin childhood infratentorial ependymoma diagnosis doc mg dl ten thirteen years age
1, maleic acid childhood burkitt lymphoma diagnosis patients may not be receiving any other investigational agents
1, cisplatin cholangiocarcinoma diagnosis planned surgery endoscopic examination dental treatment first thirty days after pci treatment
0, bb at least one unfavorable prognostic factor age sixty years symptoms elevated lactate dehydrogenase regional node involvement local tumor invasion
0, temozolomide glioblastoma diagnosis adjuvant treatment
1, oxaliplatin neuroendocrine tumors diagnosis acute chronic liver disease hepatitis cirrhosis
0, antibodies stage ivc squamous cell carcinoma paranasal sinus nasal cavity diagnosis absolute neutrophil count anc greater equal one five hundred cells Î¼l
0, antibodies stage iv prostate cancer diagnosis polymyositis
0, bkm cholangiocarcinoma diagnosis efive hundred forty twok efive hundred forty fivek hone thousand forty sevenr hone thousand forty sevenl
0, cabazitaxel metastatic castration resistant prostatic cancer diagnosis at least twenty one days have passed since receiving any investigational agent at time registration
0, cyclophosphamide stage iii childhood lymphoblastic lymphoma diagnosis one cycle obtain cr
1, sirolimus carcinoma renal cell diagnosis females who pregnant breastfeeding not eligible even she discontinues breastfeeding
0, vidarabine lymphoma diagnosis disease status
1, cyclosporine stage iv adult immunoblastic large cell lymphoma diagnosis fungal infections radiological progression after receipt amphotericin active triazole greater one month
1, dolastatin rhabdomyosarcoma ewing sarcoma chondrosarcoma osteogenic sarcoma mesothelioma kaposi sarcoma bidimensionally measurable disease other previously irradiated disease site even if there has been progression within radiation field
1, irinotecan locally advanced malignant neoplasm diagnosis subjects taking chronic systemic corticosteroid therapy any reason not eligible
1, dacarbazine malignant brain stem tumors
0, ixazomib diffuse large cell lymphoma diagnosis agree practice true abstinence when this is line preferred usual lifestyle subject note
1, cisplatin local advanced high risk nasopharyngeal carcinoma diagnosis unstable heart disease need timely treatment
0, bi multiple myeloma diagnosis indwelling central venous cateder willingness undergo intra venous central line placement
1, paclitaxel ovarian cancer recurrent diagnosis superior vena cava syndrome
0, paclitaxel cancer diagnosis females childbearing potential must have negative serum pregnancy test
1, vidarabine multiple myleoma diagnosis patient may have hepatitis infection
0, gemcitabine adenocarcinoma pancreas diagnosis at least one unidimensionally measurable lesion greater twenty mm by conventional techniques greater one mm by spiral ct scan
1, albumin bound paclitaxel stage iia fallopian tube cancer diagnosis patients taking warfarin
1, fludarabine phosphate plasma cell myeloma diagnosis known allergy filgrastim
0, sirolimus hertwo negative metastatic breast cancer diagnosis treatment anthracycline taxanes has failed is not suitable
1, cyclophosphamide recurrent childhood anaplastic large cell lymphoma diagnosis no psychiatric conditions which would prevent delivery care psychology clearance is necessary
1, saracatinib adult liposarcoma diagnosis no intercurrent cardiac dysfunction including but not limited any following
1, norethindrone cancer diagnosis use anticoagulants such warfarin is permitted however inr must be monitored accordance local institutional practice
1, rituximab stage adult diffuse mixed cell lymphoma diagnosis patients chronic hepatitis hcv hepatitis hbv infection may enroll if other laboratory criteria met those hbv surface antigen positivity may enroll only if maintained on appropriate suppressive antiviral therapy per treating investigator discretion duration enrollment trial
1, cetuximab stage ivb inverted papilloma paranasal sinus nasal cavity diagnosis history allergic reactions attributed compounds similar chemical biologic composition agents used study
1, methyl aminolevulinate basal cell carcinoma diagnosis nodular bcc lesion longest diameter less six mm larger fifteen mm face scalp larger twenty mm on extremities neck larger thirty mm on truncus
0, cyclosporins stage iv adult cell leukemia lymphoma diagnosis single allele disparity hla b drbone dqbone
0, gemcitabine unresectable pancreatic carcinoma diagnosis previous neo adjuvant adjuvant treatment is allowed provided that there was no evidence recurrent disease at least six months after completion neo adjuvant adjuvant treatment
0, dexamethasone phosphate diffuse large cell lymphoma diagnosis subjects eighteen years older
0, temozolomide small cell lung cancer recurrent diagnosis age less seventy five eastern cooperative oncology group ecog performance status less two
0, succinylcholine stage ivb cervical cancer diagnosis performance status
1, calcitriol breast cancer diagnosis patients who elect shave scalp hair prior initiation chemotherapy who plan so during chemotherapy treatment
0, laboratory biomarker analysis solid neoplasm diagnosis creatinine clearance greater equal fifty ml min doc three two patients creatinine levels above institutional normal
1, saracatinib stage iva verrucous carcinoma oral cavity diagnosis history allergic reactions attributed compounds similar chemical biological composition azdfive hundred thirty
0, etoposide phosphate prostate cancer diagnosis patients may not be undergoing concurrent chemotherapy biologic therapy radiation therapy
0, mitoxantrone stage iv prostate cancer diagnosis rise prostate specific antigen psa
1, gemcitabine carcinoma non small cell lung diagnosis immediate need therapeutic intervention
1, antibodies monoclonal recurrent adult diffuse large cell lymphoma diagnosis donor
0, f mfbg meta fluoro benzylguanidine neuroendocrine tumors diagnosis patients who have nb diagnosis must be accordance international criteria either histopathology bone marrow involvement
1, letrozole hereditary breast ovarian cancer brcaone brcatwo diagnosis geographical social psychological reasons that preclude medical monitoring this study
1, prednisone lymphoma diagnosis diagnosed treated malignancy other dlbcl except
1, carboplatin non small cell lung cancer diagnosis pregnant lactating women
0, fludarabine lymphoma diagnosis age
1, antibodies monoclonal recurrent breast carcinoma diagnosis hypothyroidism on stable doses thyroid replacement therapy
1, vincristine sarcoma kaposi diagnosis excluded
0, mesna atypical burkitt lymphoma diagnosis platelet greater one hundred zero ul
1, immunoglobulins recurrent adult brain neoplasm diagnosis prior hypersensitivity triptan derivatives phase ii
1, goserelin women only submucosal subserosal uterine leiomyomas
1, ibrutinib nodal marginal zone lymphoma diagnosis history stroke intracranial hemorrhage within six months prior enrollment
0, diagnostic laboratory biomarker analysis unspecified childhood solid tumor protocol specific diagnosis bilirubin sum conjugated positive unconjugated equal less doc upper limit normal uln age
1, paclitaxel breast neoplasms diagnosis uncontrolled hypertension
1, fluorouracil gastric carcinoma stage iv diagnosis her two positive patients
1, niacinamide hepatocellular cancer diagnosis untreated brain metastases
0, gsk cancer diagnosis left ventricular ejection fraction lvef greater equal fifty by echocardiogram echo multi gated acquisition scan muga
1, liver extracts colon cancer liver metastases diagnosis known suspected non compliance dru negative alcohol abuse
1, cyclophosphamide diffuse large cell lymphoma transformed from follicular lymphoma diagnosis cbc differential platelet count
1, laboratory biomarker analysis hormone resistant prostate cancer diagnosis use cabazitaxel chemotherapy equal less twelve months prior registration is an exclusion criterion
1, cm cs t cell infusion multiple myeloma diagnosis participants who have received chemotherapy radiotherapy within three weeks prior entering those who have not recovered from adverse events due agents administered more three weeks earlier
1, pharmacological pancreatic polypeptide tumor diagnosis nursing women
1, topotecan carcinoma neuroendocrine diagnosis addition these subjects at increased risk lethal infections when treated marrow suppressive therapy
0, everolimus stage iii childhood large cell lymphoma diagnosis donors excluded when preexisting immunoreactivity is identified that would jeopardize donor hematopoietic cell engraftment this determination is based on standard practice individual institution recommended procedure patients ten ten hla allele level phenotypic match is obtain panel reactive antibody pra screens class class ii antigens all patients before hct if pra shows greater ten activity then flow cytometric cell cytotoxic cross matches should be obtained donor should be excluded if any cytotoxic cross match assays positive those patients an hla class allele mismatch flow cytometric cell cytotoxic cross matches should be obtained regardless pra results positive anti donor cytotoxic crossmatch is an absolute donor exclusion
0, immunoglobulins stage grade three follicular lymphoma diagnosis age adjusted international prognostic index ipi score
1, antibodies contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis known hypersensitivity thalidomide
0, immunoglobulins adult anaplastic astrocytoma diagnosis concurrent full dose anticoagulants warfarin pt inr greater doc allowed provided following criteria met
1, immunoglobulins recurrent adult burkitt lymphoma diagnosis other serious medical conditions considered represent contraindications autologous stem cell transplant asct active coronary artery disease pulmonary dysfunction forced expiratory volume one second fevone less seventy expected vital capacity less seventy expected diffusing capacity lung carbon monoxide dlco less fifty patient on supplemental oxygen aids etc
1, fludarabine diffuse large cell lymphoma diagnosis patients will be re evaluated after autologous transplant prior proceeding non myeloablative transplant
0, immunoglobulins stage iii rectal cancer diagnosis measurable disease by ct scan physical exam
1, bevacizumab recurrent glioma diagnosis use an investigational drug within fourteen days within five half lives teh investigational drug whichever is shorter
0, peginterferon alfa b precancerous nonmalignant condition diagnosis no concurrent uncontrolled illness including but not limited any following
1, ganciclovir triphosphate stage small lymphocytic lymphoma diagnosis no prior allogeneic hct allo hct autologous hct auto hct is allowed
0, antibodies stage adenoid cystic carcinoma oral cavity diagnosis clinically significant peripheral vascular disease
0, etoposide phosphate childhood teratoma diagnosis hepatitis antibody
0, tacrolimus recurrent grade one follicular lymphoma diagnosis patients cll nhl scheduled reduced intensity non myeloablative conditioning should have no evidence bulky disease greater fifty bone marrow involvement masses greater one cm at start conditioning
0, antibodies monoclonal ovarian transitional cell carcinoma diagnosis regimens ii
1, immunoglobulins mantle cell lymphoma diagnosis infection requiring systemic antibiotic therapy other serious infection within fourteen days before enrollment
1, brachytherapy other investigational agents directed at brain tumor prior during within ninety days after brachytherapy
0, tamoxifen solid tumor diagnosis confirmed diagnosis advanced malignancies that may be controlled pseventyssixk akt inhibition based on already identified molecular alteration known affect pam pathway such as
1, trabectedin prior cancer treatment that contraindicates protocol therapy
1, bleomycin ovarian cancer diagnosis unable unwilling abide by protocol
1, hormones prostatic neoplasms diagnosis patients suffering from severe dehydration
0, mycophenolate mofetil recurrent adult burkitt lymphoma diagnosis al negative second remission crtwo subsequent remission
0, histone deacetylase inhibitors adult nasal type extranodal nk cell lymphoma diagnosis two hundred mg monoclonal protein urine on twenty four hour electrophoresis
1, rituximab stage iii adult diffuse small cleaved cell lymphoma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide similar drugs
1, bevacizumab adenomatous polyposis coli diagnosis concurrent uncontrolled medical conditions
1, immunoglobulins metastatic triple negative breast cancer diagnosis active clinically serious infection greater ctcae version doc three grade two
1, bortezomib prior current systemic therapy multiple myeloma including steroids exception emergency use short course maximum four days steroids before randomization prior current use bisphosphonates
1, cetuximab metastatic colorectal cancer diagnosis abdominal pelvic radiation therapy including treatment sir spheres sirtex within last twelve months
1, laboratory biomarker analysis childhood soft tissue sarcoma diagnosis patients who receiving drugs that prolong qtc not eligible
0, gemcitabine ovarian cancer diagnosis life expectancy
0, brostallicin sarcoma diagnosis hepatic
0, isophosphamide mustard sarcoma diagnosis prior concurrent therapy
0, everolimus recurrent melanoma diagnosis immunotherapy
0, androgens stage prostate cancer diagnosis white blood cell wbc greater three thousand ul
0, entinostat recurrent adult burkitt lymphoma diagnosis not pregnant nursing
0, thalidomide testicular lymphoma diagnosis patients bone marrow involvement allowed at investigator discretion regardless cytopenias
1, cetuximab metastatic colorectal cancer diagnosis chronic diarrhoea inflammatory bowel disease
1, doxorubicin epithelial ovarian cancer diagnosis patients clinically significant cardiovascular disease
1, cisplatin adult cell leukemia lymphoma diagnosis experienced allergic reactions monoclonal antibodies other therapeutic proteins
1, sorafenib recurrent multifocal malignant gliomas
0, immunoglobulins recurrent melanoma diagnosis no prior ras pathway inhibitors including trastuzumab herceptin farnesyl transferase inhibitors mek inhibitors
0, calcium dietary childhood central nervous system teratoma diagnosis recovered from prior therapy
0, paclitaxel breast carcinoma diagnosis female patients eighteen years older
1, dasatinib recurrent childhood brain tumor diagnosis patients on enzyme inducing anticonvulsive agents excluded
1, fluorouracil recurrent rectal cancer diagnosis concomitant use drugs risk causing torsades de pointes
0, ixabepilone ovarian cancer diagnosis fertile patients must use effective contraception
1, chromogranin a multiple endocrine neoplasia cushing syndrome mixed tumours pheochromocytoma medullary thyroid carcinoma
0, albumin bound paclitaxel breast neoplasms diagnosis aspartate aminotransferase ast alanine aminotransferase alt less two uln unless liver metastases present which case ast alt up uln allowed
1, cytarabine myeloproliferative neoplasms diagnosis history hypersensibility any used chemotherapy drugs
1, ursodeoxycholic acid barrett esophagus high grade dysplasia carcinoma at enrollment
1, enzalutamide prostate cancer metastatic diagnosis participants may have received docetaxel hormone sensitive setting
1, acyclovir metastatic castration resistant prostate cancer diagnosis has evidence uncontrolled cns involvement previous radiation off steroids is acceptable
1, letrozole breast neoplasms diagnosis usage an investigational drug within thirty thirty days prior enrollment planned usage an investigational drug other medication during course current study
1, epirubicin breast cancer diagnosis pregnant lactating patients
1, fludarabine multiple myeloma diagnosis serum creatinine greater doc normal
0, capecitabine recurrent squamous cell carcinoma lip oral cavity diagnosis radiotherapy
0, paclitaxel cervical adenosquamous carcinoma diagnosis absolute neutrophil count anc greater equal one thousand five hundred mm three
1, antibodies monoclonal stage ivb rectal cancer diagnosis patients known brain metastases should be excluded from this clinical trial because their poor prognosis because they often develop progressive neurologic dysfunction that would confound evaluation neurologic other adverse events
0, doxorubicin lymphoma diagnosis no nodular lymphocyte predominant disease
1, tretinoin primary refractory neuroblastoma diagnosis have history allergies mouse proteins
0, walking childhood cancer diagnosis aged ten eighteen years
1, mycophenolate mofetil recurrent marginal zone lymphoma diagnosis donor
0, carboplatin peripheral vascular disease greater grade three symptomatic interfering activities daily living requiring repair revision
1, bevacizumab stage iiic fallopian tube cancer diagnosis patients who had surgical resection cns metastases brain biopsy equal less three months prior registration will be excluded
0, doxorubicin locally advanced inoperable breast carcinoma stage ii not amenable breast preserving surgery amendment introduced on november two thousand six
1, immunoglobulins melanoma skin diagnosis severe major organ toxicity
1, mycophenolic acid stage ii childhood anaplastic large cell lymphoma diagnosis diffusing capacity lung carbon monoxide dlco less thirty total lung capacity tlc less thirty forced expiratory volume one second fevone less thirty receiving supplementary continuous oxygen fhcrc principal investigator pi must approve enrollment all patients pulmonary nodules
1, chemoprevention stage ivb squamous cell carcinoma oropharynx diagnosis inability take oral nutrition liquids history aspiration pneumonia
0, levoleucovorin colorectal cancer diagnosis recovered from prior surgery
0, temozolomide adult medulloblastoma diagnosis platelets greater one hundred zero mcl
0, hypnotherapy breast cancer diagnosis life expectancy greater six months
1, proton beam radiotherapy carcinoma hepatocellular diagnosis patients meld score greater twenty five
1, histone deacetylase inhibitors advanced solid tumors diagnosis pre existing peripheral neuropathy greater grade two
0, imatinib mesylate testicular seminoma diagnosis non measurable non target lesions hcg at least uln including following
1, erlotinib hydrochloride non small cell lung cancer diagnosis patients prior surgery thoracic radiotherapy
0, hydroxyurea adult meningioma diagnosis surgery
1, pt injection neoplasms diagnosis prior chemotherapy radiation therapy within three weeks prior dosing six weeks nitrosoureas mitomycin c
0, laboratory biomarker analysis myxofibrosarcoma diagnosis patients must have slides available submission central pathology review this review is mandatory prior registration confirm eligibility proper cohort assignment
1, camptothecin stage iiib rectal cancer diagnosis active uncontrolled bleeding
0, fulvestrant histologically confirmed adenocarcinoma prostate
1, antibodies monoclonal plasmablastic lymphoma diagnosis john wort not eligible
0, immunoglobulins adenocarcinoma gastroesophageal junction diagnosis more seven days since prior fine needle aspirations core biopsies
0, nilutamide prostate cancer diagnosis disease characteristics
1, cisplatin non small cell lung cancer diagnosis participation an observational trial interventional clinical trial which does not involve administration an imp which would not place an unacceptable burden on patient opinion investigator medical advisor would be acceptable
1, doxorubicin breast cancer diagnosis history major organ allograft condition requiring chronic immunosuppression kidney liver lung heart bone marrow transplant autoimmune diseases
1, antibodies glucagonoma diagnosis subjects meeting any following criteria ineligible entry
1, pharmacogenomic studies recurrent extrahepatic bile duct cancer diagnosis preclinical studies indicated transient changes corrected qt qtc interval during mk two thousand two hundred six treatment prolongation qtc interval is potentially safety concern while on mk two thousand two hundred six therapy cardiovascular
1, lapatinib invasive breast carcinoma diagnosis history gastrointestinal disorders medical disorders extensive surgery which may interfere absorption drug
1, nilotinib acral melanoma diagnosis female patients who pregnant breast feeding
0, lenvatinib stage iva differentiated thyroid gland carcinoma diagnosis ability complete patient medication blood pressure diaries by themselves assistance
1, mycophenolate mofetil recurrent adult hodgkin lymphoma diagnosis donor
1, doxorubicin malignant ovarian endometrioid tumor diagnosis patients bulky greater two cm disease whom gross total cytoreduction is deemed feasible by surgeon confirmation by second surgeon after radiologic review eligible participation context cytoreductive surgery
0, levoleucovorin metastatic cancer diagnosis age
1, sunitinib stage iib intraocular melanoma diagnosis patients known urea cycle disorders
1, vaccines iris melanoma diagnosis inhaled topical corticosteroids permitted
1, etoposide phosphate lymphoma diagnosis concurrent grapefruit juice fruit green tea
0, cyclophosphamide sarcoma diagnosis patients who hiv seropositive can have decreased immune competence thus may be less responsive experimental treatment
0, etoposide lymphoma diagnosis creatinine no greater doc mg dl unless entry approved by principal investigator other
0, levoleucovorin pancreatic cancer diagnosis not specified renal
0, pain therapy unspecified adult solid tumor protocol specific diagnosis prior aspirin nonsteroidal anti inflammatory medications antiplatelet medications warfarin must be discontinued an appropriate period time prior based on drug half life known antiplatelet activity seven days aspirin twenty four hours ibuprofen
0, bevacizumab stage iii squamous cell carcinoma lip oral cavity diagnosis no gastrointestinal gi tract disease resulting an inability take oral medication
1, antibodies monoclonal solid tumor diagnosis subjects chronic atrial arrhythmia atrial fibrillation paroxysmal svt eligible
1, pemetrexed cancer diagnosis is unable unwilling discontinue prohibited medications listed section doc fourteen days five half lives whichever is longer drug prior first dose drug duration study
1, ict glioblastoma multiforme diagnosis known human immunodeficiency virus hiv positivity acquired immunodeficiency syndrome aids related illness other serious medical illness
1, lidocaine rectum neoplasm diagnosis mental illness mental retardation inability participate informed consent due mental status
0, epoetin alfa multiple myeloma plasma cell neoplasm diagnosis not specified
0, liposomal doxorubicin lymphoma diagnosis stage ii iv disease
0, cyclophosphamide woman aged eighteen seventy years inclusive
1, immunoglobulins ovarian endometrioid adenocarcinoma diagnosis uncontrolled hypertension defined blood pressure greater equal one hundred fifty mmhg systolic greater equal ninety mmhg diastolic
1, irinotecan pilocytic astrocytoma diagnosis patients who unable take oral medications because significant vomiting will be excluded
1, fludarabine stage ii contiguous adult diffuse large cell lymphoma diagnosis fungal infections radiological progression after receipt amphotericin active triazole greater one month
0, docetaxel ovarian cancer diagnosis no concurrent amifostine
0, tamoxifen breast cancer diagnosis concurrent use anti depressant such paxil prozac effexor is allowed if participant has been on stable dose more month purpose medication is other control hot flushes
1, everolimus recurrent colon cancer diagnosis impairment gastrointestinal function gastrointestinal disease that may significantly alter absorption radone ulcerative disease uncontrolled nausea vomiting diarrhea malabsorption syndrome small bowel resection
1, lenograstim metastatic malignant neoplasm diagnosis history severe immediate hypersensitivity reaction any agents used this study
0, lenograstim testicular choriocarcinoma embryonal carcinoma diagnosis no dyspnea at rest
1, folic acid stage iib fallopian tube cancer diagnosis myocardial infarction stroke within previous six months
0, mitogens unspecified adult solid tumor protocol specific diagnosis at least four weeks since prior immunotherapy
0, conventional surgery breast cancer diagnosis menopausal status not specified
0, vaccines lymphoma diagnosis performance status
0, hemi gland focal ldr brachytherapy cancer prostate diagnosis prostate volume less fiftycc
1, questionnaires pediatric cancers diagnosis participant parent child unwillingness participate any capacity
0, albumin bound paclitaxel non small cell lung cancer diagnosis absolute neutrophil count greater one zero zero mmthree
0, thalidomide transformed recurrent non hodgkin lymphoma diagnosis phase i
1, antibodies monoclonal recurrent cervical carcinoma diagnosis treatment systemic immunostimulatory agents including but not limited interferon ifn alpha interleukin il two within six weeks five half lives drug whichever is shorter prior cycle one day one
1, cytarabine mantle cell lymphoma diagnosis prolonged qtc
1, darbepoetin alfa diffuse large cell lymphoma diagnosis history previously treated seizures allowed provided patient has been seizure free minimum three months
0, immunoglobulin g ovarian clear cell adenocarcinoma diagnosis doc uln unless participant is receiving anticoagulant therapy long pt ptt is within therapeutic range intended use anticoagulants
0, cisplatin carcinoma non small cell lung diagnosis alkaline phosphatase less two five uln less five uln case bone metastases
0, immunoglobulins stage ivc lip oral cavity squamous cell carcinoma diagnosis platelets greater equal one hundred zero mcl
0, liposomal doxorubicin malignant mesothelioma diagnosis signed informed consent
0, bb lymphoma diagnosis must meet one following criteria
1, antibodies monoclonal recurrent adult diffuse large cell lymphoma diagnosis donor
1, doxorubicin recurrent platinum sensitive ovarian cancer diagnosis any previous radiotherapy abdomen pelvis
1, cadexomer iodine stage ivc thyroid gland papillary carcinoma diagnosis megestrol megace if used an appetite stimulant is allowed thyroid stimulating hormone tsh suppressive therapy is also allowed palliative radiation therapy non target lesions is also allowed
1, melphalan use any other concomitant standard experimental anti myeloma drug therapy
1, radiation chemotherapy melanoma diagnosis presence metallic objects implanted medical devices body cardiac pacemaker aneurysm clips surgical clips prostheses artificial hearts valves steel parts metal fragments shrapnel tattoos near eye steel implants craniotomy patients will all have titanium but this is mri compatible
1, vadimezan urothelial carcinoma diagnosis no treatment any investigational agent chemotherapeutic agent within thirty days prior registration protocol therapy
0, albumin bound paclitaxel recurrent primary peritoneal carcinoma diagnosis neutrophil count greater equal doc ten nine l
1, curcumin prostate cancer diagnosis radiation therapy primary treatment after surgery
1, cisplatin patients who have received prior chemotherapy any abdominal pelvic tumor excluded
1, niacinamide breast cancer diagnosis craniotomy any other major surgery open biopsy significant traumatic injury within four weeks enrollment
1, ispinesib adult grade iii lymphomatoid granulomatosis diagnosis inducers cypthreeafour
1, folic acid stage iiic breast cancer diagnosis pregnant women
0, anastrozole stage iv breast cancer diagnosis patient agrees participate imaging protocol seven thousand one hundred eighty four is separately consented
1, carboplatin ovarian cancer diagnosis current prior use immunosuppressive medication within twenty eight days before first dose durvalumab exceptions intranasal inhaled corticosteroids systemic corticosteroids at physiological doses which not exceed ten mg day prednisone an equivalent corticosteroid
0, albumin bound paclitaxel recurrent breast carcinoma diagnosis patients will be assigned arm arm depending on their prior exposure paclitaxel eribulin
0, carboplatin ovarian cancer diagnosis hemoglobin greater equal teng dl
1, antibodies breast neoplasms diagnosis known active tuberculosis
1, cisplatin neuroblastoma diagnosis children inss four disease age less eighteen months all three favorable biologic features non amplified mycn favorable pathology dna index greater one
0, docetaxel prostate cancer diagnosis creatinine less doc times uln
1, bevacizumab stage iiib primary peritoneal cancer diagnosis major surgical procedure anticipated during course this includes but is not limited abdominal surgery laparotomy laparoscopy prior disease progression such colostomy enterostomy reversal secondary cytoreductive surgery second look surgery please consult sdc randomization desk prior patient entry any questions related classification surgical procedures
0, antibodies monoclonal stage iv renal cell cancer diagnosis no active brain metastases
0, pembrolizumab ovarian endometrioid adenocarcinoma diagnosis serum total bilirubin
0, everolimus pancreatic delta cell adenoma diagnosis radiolabeled octreotide therapy patients prior radiolabeled octreotide therapy should have progressive disease after such therapy
1, panobinostat adult nasal type extranodal nk cell lymphoma diagnosis pregnant women women reproductive ability who unwilling use effective contraception
0, paclitaxel stage iiib non small cell lung cancer diagnosis eighteen fluorodeoxyglucose pet is required staging treatment planning
1, dexamethasone multiple myeloma diagnosis glucocorticoid therapy prednisolone greater thirtymg day equivalent within fourteen days prior informed consent obtained
1, adaptive radiotherapy non small cell lung cancer diagnosis metastatic disease
0, fludarabine phosphate recurrent mantle cell lymphoma diagnosis life expectancy
1, amoxicillin astrocytic tumors diagnosis have radiographic clinically significant pleural effusion
1, azacitidine pancreatic ductal adenocarcinoma diagnosis patients any significant history non compliance medical regimens inability grant reliable informed consent
1, capecitabine breast cancer recurrent diagnosis concomitant use immunosuppressive agents chronic use systemic corticosteroids
0, succinylcholine endometrial serous adenocarcinoma diagnosis white blood cell wbc greater equal three zero mcl
1, fluorouracil pancreatic adenocarcinoma diagnosis anti mycobacterial
1, paclitaxel cancer diagnosis patients known leptomeningeal metastases excluded even if treated
1, melphalan recurrent skin cancer diagnosis patients known heparin induced thrombocytopenia
1, th cells allo hsctt multiple myeloma diagnosis patient
1, bb multiple myeloma diagnosis patients who have had myocardial infarction six months prior inclusion this who class iii iv according new york heart association nyha functional classification system heart failure unstable angina uncontrolled ventricular arrhythmias acute ischemia detected by electrocardiogram nervous system disorders
1, albumin bound paclitaxel gastrointestinal stromal tumors diagnosis patients stable chronic viral hepatitis eligible acceptable
1, thiotepa stage iiib breast cancer diagnosis patients will not receive il two gm csf therapy if they
1, rituximab aids related plasmablastic lymphoma diagnosis participants who have received more one one prior cycle chemotherapy similar cyclophosphamide doxorubicin hydrochloride vincristine sulfate prednisone chop epoch without rituximab
1, pazopanib advanced metastatic neuroendocrine tumors diagnosis hemoptysis excess doc ml within eight weeks first dose drug
1, poly i c patients must have no plans receive concurrent chemotherapy hormonal therapy radiotherapy immunotherapy any other type therapy treatment cancer while on this protocol treatment
0, imatinib mesylate stage iv melanoma diagnosis no known untreated brain epidural metastases
0, vorinostat nodal marginal zone cell lymphoma diagnosis patients abnormal liver function will be eligible
0, vaccines melanoma skin diagnosis ast alt less doc times uln
0, antilymphocyte serum noncontiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis advanced polycythemia vera not responding standard therapy
0, thiotepa fallopian tube cancer diagnosis sgot sgpt less doc times normal
0, lenalidomide stage iii multiple myeloma diagnosis one hundred twenty days post sct no evidence relapse progression prior registration
1, paclitaxel stage iiib fallopian tube cancer diagnosis patients acute hepatitis active infection that requires parenteral antibiotics
1, antibodies monoclonal colorectal cancer diagnosis recent myocardial infarction within past year participant who at time screening presents unstable uncontrolled angina new york heart association class iii iv congestive heart failure uncontrolled hypertension clinically significant cardiac dysrhythmia clinically significant electrocardiogram abnormality
0, topotecan childhood solid tumor diagnosis agents that have known adverse events occurring beyond seven days after administration this period must be extended beyond time during which adverse events known occur
0, fludarabine childhood nasal type extranodal nk cell lymphoma diagnosis low grade nhl less six months duration complete remission cr between courses conventional therapy
1, bevacizumab glioblastoma diagnosis patients body mass index bmi greater thirty five less twenty
1, sirolimus carcinoma renal cell diagnosis patients who have previously received systemic mtor inhibitors
0, cisplatin stage iv squamous cell carcinoma lip oral cavity diagnosis negative pregnancy test within two weeks prior registration women childbearing potential
1, questionnaire administration transformed recurrent non hodgkin lymphoma diagnosis received wide field radiotherapy equal less twenty eight days limited field radiation palliation equal less fourteen days prior registration who have not recovered from side effects such therapy
0, bevacizumab stage iiic breast cancer diagnosis patients must not have had any major surgical procedure within twenty eight days planned treatment start date
0, asn dose part b prostatic cancer diagnosis progressive disease despite ongoing androgen deprivation therapy
0, antibodies monoclonal recurrent salivary gland cancer diagnosis creatinine equal less doc mg dl
1, antibodies monoclonal refractory small lymphocytic lymphoma diagnosis patient has known history human immunodeficiency virus hiv infection testing not mandatory
1, gmx solid tumors lymphomas diagnosis no other agents therapies administered intent treat malignancy
0, tirapazamine stage iia cervical cancer diagnosis negative pregnancy test
1, proton radiation low grade glioma diagnosis prior cranial radiation therapy
1, liposomal doxorubicin adult cell leukemia lymphoma
1, paclitaxel stage iv ampulla vater cancer diagnosis active uncontrolled bleeding
1, bevacizumab ovarian clear cell adenocarcinoma diagnosis patients that have had primary therapy brain metastasis surgical resection whole brain radiation stereotactic radiotherapy srt even if stable not eligible
1, antibodies monoclonal metastatic colorectal cancer diagnosis prior anti epidermal growth factor receptor egfr antibody therapy treatment small molecule egfr inhibitors
1, sirolimus advanced solid tumors diagnosis patients who have previously received mtor inhibitors pithreek inhibitors
0, antibodies monoclonal recurrent ewing sarcoma peripheral primitive neuroectodermal tumor diagnosis sgpt alt less one hundred ten l purpose this uln sgpt is forty five l
0, bortezomib stage iv adenoid cystic carcinoma oral cavity diagnosis not pregnant nursing
1, immunoglobulins stage ivb colorectal cancer diagnosis current prior use immunosuppressive medication within fourteen days before first dose their assigned ip following exceptions this criterion
1, paclitaxel carcinoma non small cell lung diagnosis anticipation need major surgical procedure radiation therapy during study
1, irinotecan metastatic colorectal cancer diagnosis history hypertension not well controlled greater one hundred sixty ninety even though on regimen anti hypertensive therapy
0, erlotinib hydrochloride a documented somatic activating mutation egfr including but not limited exon nineteen deletion leight hundred fifty eightr
0, everolimus tongue carcinoma diagnosis absolute neutrophil count greater equal one five hundred mcl
1, autologous hematopoietic stem cell transplantation recurrent grade two follicular lymphoma diagnosis research participants will be excluded who opinion investigator may not be able comply safety monitoring requirements study
0, lomustine stage iii aids related lymphoma diagnosis direct bilirubin greater doc mg dl two doc um l
0, cyclophosphamide lymphoma diagnosis not specified
0, gefitinib insular thyroid cancer diagnosis agc greater equal one five hundred ul
0, sulindac colorectal cancer diagnosis porta hepatis lymph node metastases
0, cetuximab colorectal cancer diagnosis fertile patients must use effective contraception
1, quality life assessment stage ii adenoid cystic carcinoma oral cavity diagnosis presence medical conditions contraindicating general anesthesia transoral surgical approaches
0, cisplatin this includes choroid plexus papilloma atypical choroid plexus papilloma anaplastic choroid plexus papilloma malignant choroid plexus papilloma choroid plexus carcinoma
0, oxaliplatin lung cancer diagnosis histologically cytologically confirmed recurrence nsclc after curative therapy surgery adjuvant neoadjuvant chemotherapy
0, endothelial growth factors primary peritoneal high grade serous adenocarcinoma diagnosis absolute neutrophil count anc greater equal one five hundred mcl
1, prednisone diffuse large cell lymphoma diagnosis history prior allogeneic bone marrow progenitor cell solid organ transplantation
1, tegafur gastroesophageal cancer diagnosis prior chemotherapy radiotherapy
0, docetaxel small intestine cancer diagnosis performance status
1, mitogens non small cell lung cancer diagnosis subject is pregnant breast feeding planning become pregnant within six months after last dose protocol specified therapy administration
1, lenalidomide stage iii adult diffuse mixed cell lymphoma diagnosis use hematopoietic growth factor including filgrastim pegfilgrastim sargramostim erythropoietin darbepoetin within fourteen days prior baseline
1, carboplatin adenocarcinoma gastroesophageal junction diagnosis palpable supraclavicular nodes biopsy proven involvement supraclavicular nodes radiographically involved supraclavicular nodes greater doc cm greatest dimension
1, etoposide recurrent adult grade iii lymphomatoid granulomatosis diagnosis prior autologous allogeneic transplantation
1, vidarabine childhood burkitt lymphoma diagnosis donor
0, fluorouracil stage ivc lip oral cavity squamous cell carcinoma diagnosis patients must not have any co existing condition that would preclude full compliance study
0, cisplatin testicular choriocarcinoma yolk sac tumor diagnosis doc mg dl patients two five years age
0, busulfan non hodgkin lymphoma diagnosis serum creatinine less doc mg dl if serum creatinine greater doc mg dl then estimated glomerular filtration rate gfr must be greater sixty ml min doc three mtwo calculated by modification diet renal disease equation
0, capecitabine colorectal cancer diagnosis greater four weeks must have elapsed from completion previous chemotherapy patients must have recovered from any related toxicities
0, vaccines anaplastic ependymoma diagnosis adequate renal function normal creatinine age glomerular filtration rate greater seventy mls min doc three mtwo
1, cisplatin stage iic ovarian cancer diagnosis no poorly differentiated subtypes including papillary serous clear cell other international federation gynecology obstetrics figo grade three lesions
0, immunoglobulins endometrial adenosquamous cell carcinoma diagnosis not nursing
0, doxorubicin melanoma diagnosis stable decreasing dosage steroids dexamethasone seven days prior baseline mri non enzyme inducing anti epileptic drugs is allowed
1, lenalidomide contiguous stage ii adult burkitt lymphoma diagnosis known hypersensitivity thalidomide
1, mycophenolic acid ds stage ii plasma cell myeloma diagnosis positive anti donor hla antibody
1, etoposide stage ii diffuse large cell lymphoma diagnosis uncontrolled intercurrent illness including but not limited active infection poorly controlled hypertension diabetes mellitus other serious medical psychiatric conditions that could interfere adherence completion this study
0, mesna lymphoma diagnosis see disease characteristics
1, antibodies somatostatinoma diagnosis patients allowed have zero trace one positive protein by urine dipstick urinalysis enroll if greater equal two positive must check two h urine protein must be less oneg start study
1, salmonella typhimurium cancer liver diagnosis any other condition which investigator opinion renders patient at high risk overwhelming infection
1, antibodies monoclonal recurrent adult soft tissue sarcoma diagnosis patients who previously received craniospinal irradiation ineligible
1, laboratory biomarker analysis cutaneous cell non hodgkin lymphoma diagnosis sgot sgpt greater equal five uln liver biopsy preferred such patients
1, musculoskeletal complications management prevention stage iii mantle cell lymphoma diagnosis any prior history central nervous system cns hemorrhage
0, biologically based therapies stage iv mantle cell lymphoma diagnosis karnofsky sixty one hundred
0, bevacizumab non small cell lung cancer diagnosis this response does not have be confirmed order patient be randomized however unconfirmed responses will be stratified stable disease strata
1, bevacizumab stage iva uterine corpus cancer diagnosis prior treatment sorafenib other vascular endothelial growth factor vegf inhibitors note
0, levoleucovorin colorectal cancer diagnosis no predisposing colonic small bowel disorders which symptoms uncontrolled indicated by baseline pattern greater three watery soft stools daily patients without colostomy ileostomy
0, cisplatin carcinoma non small cell lung diagnosis adequate organ function
0, irinotecan stage ivc squamous cell carcinoma paranasal sinus nasal cavity diagnosis patients must have ecog performance status zero one
0, polystyrene sulfonic acid lymphoma diagnosis has potentially suitable human leukocyte antigen hla haploidentical donor available
0, podophyllotoxin peripheral primitive neuroectodermal tumor soft tissues diagnosis maximum serum creatinine mg dl
0, antibodies monoclonal stage iv ovarian epithelial cancer diagnosis no concurrent autoimmune diseases requiring chronic use immunosuppressive medications active connective tissue disease cns disease including multiple sclerosis demyelinating disease inflammatory bowel disease autoimmune hepatitis
1, paclitaxel breast cancer diagnosis prolonged qtc interval on pre entry electrocardiogram four hundred fifty msec
1, antibodies recurrent rectal carcinoma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated either agent
1, laboratory assay ovarian neoplasms diagnosis patients meningeal metastasis
1, vorinostat stage iv mantle cell lymphoma diagnosis patients known be human immunodeficiency virus hiv positive
0, laboratory biomarker analysis recurrent childhood brain tumor diagnosis pulse oximetry greater ninety four if determination is clinically indicated
1, cetuximab signet ring adenocarcinoma colon diagnosis anticipation need major surgical procedures during course study
1, thalidomide pancreatic cancer diagnosis serum creatinine greater doc mg dl two hundred twenty one Î¼mol l
0, exemestane estrogen receptor positive breast cancer diagnosis pregnancy testing does not need be pursued patients who judged postmenopausal before randomization determined by local practice who have undergone bilateral oophorectomy total hysterectomy bilateral tubal ligation
0, carboplatin ovarian cancer diagnosis procainamide disopyramide
0, vaccines hormone refractory prostate cancer diagnosis age greater equal eighteen yrs phase iia less equal seventy five yrs phase iia only
0, cisplatin teratoma diagnosis surgery
1, pembrolizumab esophageal cancer diagnosis congestive heart failure
1, veliparib recurrent small cell lung carcinoma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated abt eight hundred eighty eight these potential risks also apply temozolomide
1, dasatinib malignant pleural mesothelioma diagnosis clinically significant coagulation platelet function disorder known von willebrand disease any disease which requires persistent anticoagulation therapy patient may not be taken off anti coagulation safely coumadin factor xa inhibitors heparin low molecular weight standard
1, camptothecin pancreatic cancer diagnosis prior chemotherapy
1, everolimus patients bladder cancer bladder cancer their medical history patients risk factors bladder cancer such exposure aromatic amines heavy tobacco smokers macrohematuria unknown origin
1, antibodies recurrent melanoma diagnosis persons reproductive potential must agree use an adequate method contraception throughout treatment at least eight weeks after ipilimumab is stopped sexually active wocbp must use an effective method birth control during course manner such that risk failure is minimized before enrollment wocbp must be advised importance avoiding pregnancy during participation potential risk factors an unintentional pregnancy all wocbp must have negative pregnancy test before first receiving ipilimumab if pregnancy test is positive patient must not receive ipilimumab must not be enrolled study
0, doxorubicin patients tumors determined be three positive on ihc amplified hertwo by fish ineligible
1, heparin low molecular weight massive tumor greater twenty cm greatest dimension
1, trastuzumab estrogen receptor positive breast cancer diagnosis lack physical integrity upper gastrointestinal tract malabsorption syndrome
1, doxorubicin leiomyosarcoma diagnosis myocardial infarction within past twelve months stable unstable angina
1, laboratory biomarker analysis stage iii prostate adenocarcinoma diagnosis bone scan within one hundred twenty days prior registration if bone scan is suspicious plain ray mri must be obtained rule out metastasis prior registration
0, carboplatin stage ib ovarian cancer diagnosis patients must be free active infection requiring antibiotics
1, cediranib primary peritoneal serous adenocarcinoma diagnosis prior treatment trastuzumab
1, heptavalent pneumococcal conjugate vaccine mantle cell lymphoma diagnosis coagulopathy including use coumadin heparin anticoagulants that cannot be discontinued cryoablation procedure note
0, budesonide formoterol fumarate drug combination lung cancer diagnosis willing undergo bronchoscopy
1, laboratory biomarker analysis extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis history class class cirrhosis per modified child pugh classification
0, vaccines adenocarcinoma colon diagnosis no prior splenectomy
0, alvocidib stage iiia primary peritoneal cavity cancer diagnosis may be supported transfusion epoetin alfa darbepoetin alfa
1, oxaliplatin pancreatic neoplasm diagnosis known hypersensitivity cetuximab other egfr antibody
1, bortezomib myelodysplastic myeloproliferative neoplasms diagnosis ecg abnormality that is medically relevant
0, cisplatin carcinoma unknown primary diagnosis wbc at least three zero mmthree absolute neutrophil count at least one five hundred mmthree platelet count at least one zero mmthree hemoglobin at least one dl hepatic
1, metformin stage ii oropharyngeal squamous cell carcinoma diagnosis spirits
1, poly adp ribose polymerase inhibitors recurrent childhood supratentorial primitive neuroectodermal tumor diagnosis one mg dl maximum serum creatinine
1, albumin bound paclitaxel carcinoma squamous cell diagnosis previous neuropathy two higher
0, tipifarnib multiple myeloma diagnosis male subject agrees use an acceptable method contraception duration study
0, carboplatin undifferentiated ovarian carcinoma diagnosis partial thromboplastin time ptt equal less doc uln heparin low molecular weight heparin alternative anticoagulants acceptable
0, vidarabine recurrent adult immunoblastic large cell lymphoma diagnosis creatinine less doc
0, mitoxantrone prostate cancer diagnosis no hiv positivity
0, fludarabine small intestine cancer diagnosis pulmonary
0, antibodies colon cancer diagnosis inclusion
1, irinotecan neuroblastoma recurrent diagnosis impaired liver function impaired renal function hepatic renal index parameter two times above normal range see below
1, fluorouracil serious unrelated illness prior invasive malignancy at any other site except adequately treated nonmelanomatous skin cancer pregnant nursing women adequate contraception required
0, octreotide pancreatic cancer diagnosis biologic therapy
0, rituximab lymphoma diagnosis no concurrent cisplatin
1, pharmacological recurrent adult soft tissue sarcoma diagnosis surgical other wounds must be adequately healed prior enrollment
1, bevacizumab hertwo negative breast cancer diagnosis new york heart association nyha grade ii greater congestive heart failure
0, dexamethasone acetate has confirmed diagnosis active multiple myeloma measurable disease
1, immunoglobulins recurrent esthesioneuroblastoma paranasal sinus nasal cavity diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated erlotinib cetuximab
1, vincristine non brain tumor patients who have previously received temozolomide ineligible
0, camptothecin stage iic rectal cancer diagnosis absolute neutrophil count greater equal one thousand five hundred mmthree
1, camptothecin lung neoplasms diagnosis pregnant women excluded from this because crlxone hundred one olaparib agents potential teratogenic abortifacient effects
1, compliance monitoring stage iiib ovarian cancer diagnosis patients life expectancy less one year
0, laboratory biomarker analysis malignant ovarian brenner tumor diagnosis hemoglobin hgb greater equal doc dl
0, methylprednisolone hemisuccinate multiple myeloma plasma cell neoplasm diagnosis acute lymphoblastic leukemia meeting one following criteria
0, antibodies stage grade one follicular lymphoma diagnosis prior rituximab other monoclonal immunotherapy permitted eligible rituximab monotherapy
1, fluorophosphate rectal neoplasms diagnosis subject who is unable discontinue warfarin anticoagulation five days before surgery
1, photodynamic therapy stage follicular thyroid cancer diagnosis has not recovered from toxicity prior therapy
1, antibodies monoclonal grade iii meningioma diagnosis female patients who pregnant nursing not eligible
0, cilengitide extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis no concurrent anticoagulation therapy that increases inr aptt above normal range
0, zoledronic acid multiple myeloma diagnosis have adequate renal function defined by creatinine clearance greater forty ml min measured estimated by cockcroft gault formula
1, hydroxyitraconazole non small cell lung cancer alk positive diagnosis active unstable cardiac disease heart attack within three months starting treatment
0, cisplatin oral cancer diagnosis at least one un negative bi dimensionally measurable lesion
1, genistein ewing sarcoma diagnosis any condition investigator opinion that would compromise patient safety outcomes
1, cyclosporine recurrent mantle cell lymphoma diagnosis must have received prior chemotherapy consolidation chemotherapy by autografting prior nonmyeloablative hct is permitted
1, tacrolimus stage iv adult diffuse mixed cell lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition vorinostat
0, laboratory biomarker analysis stage iii squamous cell carcinoma larynx diagnosis negative pregnancy test
0, cyclosporine angioimmunoblastic cell lymphoma diagnosis human leukocyte antigen hla genotypically phenotypically identical related donor
1, carboplatin non small cell lung cancer diagnosis radiation therapy within two weeks before abx egf infusion
1, cetuximab solid tumors diagnosis prior concurrent therapy
1, dexamethasone phosphate concurrent hematologic non hematologic malignancy requiring treatment other multiple myeloma secondary amyloidosis
0, antibodies monoclonal stage iva colon cancer diagnosis patients may have received prior cetuximab
1, paclitaxel breast neoplasms diagnosis subject has severe cardiac insufficiency nyha iii iv uncontrolled unstable cardiac coronary artery disease
0, dexamethasone acetate multiple myeloma diagnosis or
0, albumin bound paclitaxel ovarian cancer diagnosis endocrine therapy
0, immunoglobulins recurrent breast carcinoma diagnosis total bilirubin equal less doc mg dl
1, cyclosporine stage ii childhood large cell lymphoma diagnosis karnofsky score less seventy adult patients
1, endothelial growth factors stage iiia breast cancer diagnosis patients evidence metastatic disease
0, bevacizumab glioblastoma multiforme diagnosis and
0, temozolomide childhood high grade cerebellar astrocytoma diagnosis bone marrow transplant
1, laboratory biomarker analysis stage iiia ovarian cancer diagnosis prisoners subjects who compulsorily detained involuntarily incarcerated treatment either psychiatric medical infectious illness
0, laboratory biomarker analysis recurrent adult brain tumor diagnosis absolute granulocyte count at least one five hundred mm three
1, rabeprazole advanced cancer diagnosis anti platelet agents prohibited throughout study
0, annual screening lung cancer diagnosis not specified life expectancy
0, bevacizumab fallopian tube cancer diagnosis hepatic function
1, hiv protease inhibitors pancreatic adenocarcinoma diagnosis patients receiving following drugs will be clinically evaluated whether dosage medication can be changed permit patient on study
1, melphalan stage iv mantle cell lymphoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast greater equal four times upper limits normal
1, cyclophosphamide breast neoplasms diagnosis patients history severe hypersensitivity reaction docetaxel other drugs formulated polysorbate eighty excluded from participation
0, albumin bound paclitaxel advanced cancers diagnosis patients must have normal organ marrow function defined below
1, ascorbic acid cancer diagnosis wilson disease
0, cyclosporins recurrent burkitt lymphoma diagnosis expressing cdtwenty antigen have failed at least one prior standard systemic therapy
0, albumin bound paclitaxel stage iv breast cancer diagnosis having relapsed during within twelve months completing adjuvant paclitaxel docetaxel
0, levoleucovorin gallbladder cancer diagnosis ecog performance status zero one
1, dexamethasone patient was treated cancer other multiple myeloma within five years before enrollment exception basal cell carcinoma cervical cancer situ
0, mifepristone recurrent breast cancer diagnosis and progesterone receptor pr positive must have developed metastatic disease while on adjuvant hormonal therapy have progression disease after at least one hormonal therapy advanced disease may have received unlimited prior hormonal therapies
1, vincristine doc prior dose adjusted epoch pomalidomide treatment kshv associated lymphoma
1, cetuximab salivary gland squamous cell carcinoma diagnosis patients diarrhea greater equal ctcae vfour grade two
0, clavulanic acids lymphoma diagnosis eighteen over
0, cyclosporins recurrent adult cell leukemia lymphoma diagnosis myeloproliferative syndromes
0, molecular mechanisms pharmacological action hepatocellular carcinoma recurrent diagnosis adequate hematologic hepatic renal function
0, donor nk cell infusion cns tumors diagnosis diagnoses include
1, antibodies monoclonal urothelial carcinoma diagnosis however stable atrial fibrillation controlled medically device pacemaker prior ablation is allowed
1, sorafenib recurrent squamous cell carcinoma lip oral cavity diagnosis evidence history bleeding diathesis coagulopathy
1, nivolumab melanoma diagnosis patients excluded if they have active brain metastases leptomeningeal metastases
1, pembrolizumab penile squamous cell carcinoma diagnosis has known active hepatitis hbsag reactive hepatitis hcv rna qualitative is detected
0, cyclophosphamide breast cancer diagnosis patients must be greater eighteen years age
0, cyclosporine noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis absence ph positive metaphases
0, immunoglobulins acoustic schwannoma diagnosis patient must be able comply follow up procedures
1, fulvestrant hormone receptor positive tumor diagnosis patients known history hiv seropositivity
0, interferon alpha hematological neoplasms diagnosis disease relapse after allo hsct including hematological relapse molecular relapse
1, hpph stage ii adenoid cystic carcinoma oral cavity diagnosis platelet count less one hundred zero
1, e notes myoma diagnosis greater five fibroids sized threecm more
1, doxorubicin stage iv mantle cell lymphoma diagnosis patients must not have history cardiac disease defined new york heart association class ii greater clinical evidence congestive heart failure all patients must have muga scan two dimensional echocardiogram indicating an ejection fraction greater equal forty five within two days prior registration method used at baseline must be used later monitoring
0, pembrolizumab stage iva hepatocellular carcinoma diagnosis if hematologic equal less grade three and
1, leucovorin stage iva colorectal cancer diagnosis corrected qt qtc interval greater four hundred seventy msec females greater four hundred fifty msec males
0, cyclophosphamide recurrent childhood small noncleaved cell lymphoma diagnosis age greater equal sixty
1, carboplatin fallopian tube cancer diagnosis any existing grade two above drug related neurotoxicity due prior treatment agents causing neurotoxicity
0, erlotinib hydrochloride stage ii squamous cell carcinoma oropharynx diagnosis platelets greater equal one hundred zero
0, everolimus gastrinoma diagnosis signed informed consent
0, mycophenolate mofetil stage iii adult burkitt lymphoma diagnosis donor must consent filgrastim csf administration leukapheresis
1, lenograstim recurrent adult immunoblastic large cell lymphoma diagnosis donor
0, capecitabine gallbladder large cell neuroendocrine carcinoma diagnosis prior malignancy cured by non surgical modalities patient has been continuously disease free greater five years
1, carboplatin patients history ipsilateral lobular carcinoma situ lcis eligible
0, sirolimus stage iii endometrial carcinoma diagnosis myocardial infarction within past six months congestive heart failure even if medically controlled unstable angina active cardiomyopathy cardiac arrhythmia uncontrolled hypertension
1, paclitaxel lung cancer diagnosis patients receiving lithium fluconazole
1, mri targeted focal thermal therapy prostate cancer prostate cancer diagnosis chronic acute prostititis neuroginic bladder urinary tract infection sphincter abnormalities any other symptom that prevents normal micturition
0, fludarabine phosphate noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis hla phenotypically identical unrelated donor match grades allowed
1, vorinostat stage iv non small cell lung cancer diagnosis hiv positive patients receiving combination antiretroviral therapy ineligible
0, talimogene laherparepvec stage iib soft tissue sarcoma diagnosis ability understand willingness sign written informed consent document
1, diagnostic cervical cancer screening tests pap smear hpv p cervical cancer diagnosis women who have had pap smears within previous ten months
1, antibodies monoclonal stage ivb cervical cancer diagnosis treatment any other investigational agent within four weeks prior cycle one day one within five half lives investigational product whichever is longer
1, antibodies recurrent grade two follicular lymphoma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated lenalidomide
1, everolimus triple negative breast carcinoma diagnosis women child bearing potential wocbp defined all women physiologically capable becoming pregnant must use highly effective methods contraception during eight weeks after ending treatment highly effective contraception methods include combination any two following
1, vorinostat stage iv marginal zone lymphoma diagnosis patients evidence hepatitis hepatitis pcr positivity hepatitis reactivation following myelosuppressive therapy can lead fatal complications
0, vitamin d subcutaneous panniculitis like cell lymphoma diagnosis during active monitoring phase active treatment observation participants must be willing return consenting institution follow up
1, bupivacaine cancer diagnosis intolerance allergy contraindication use either fentanyl bupivacaine
0, pharmacological recurrent mantle cell lymphoma diagnosis at least fourteen days after last dose long acting growth factor neulasta seven days short acting growth factor agents that have known adverse events occurring beyond seven days after administration this period must be extended beyond time during which adverse events known occur duration this interval must be discussed chair
0, everolimus bladder cancer diagnosis adequate bone marrow function shown by
1, laboratory biomarker analysis recurrent laryngeal verrucous carcinoma diagnosis medical psychiatric illness which would compromise patient ability tolerate this treatment comply administration drug
0, vaccines metastatic renal cell cancer diagnosis prothrombin time pt international normalized ratio inr equal less doc uln patients receiving anticoagulation therapy pt inr equal less three
1, mycophenolate mofetil recurrent adult lymphoblastic lymphoma diagnosis prior hematopoietic stem cell transplant autologous allogeneic
0, everolimus stage iv adult immunoblastic lymphoma diagnosis myelodysplasia mds myeloproliferative syndrome mps patients must have received previous myelosuppressive chemotherapy hct have less five marrow blasts at time transplant
1, antibodies stage ivb colon cancer diagnosis immunotherapy equal less twenty eight days prior registration
1, cyclophosphamide oropharyngeal cancer diagnosis concurrent systemic steroid therapy
0, fluorouracil colorectal cancer diagnosis no ischemic cardiac disease
0, etoposide phosphate neuroblastoma diagnosis no concurrent participation another clinical trial that would preclude outcome assessment this clinical trial
1, cisplatin non small cell lung cancer diagnosis ecog status greater two
1, dexamethasone acetate multiple myeloma diagnosis hypersensitivity thalidomide lenalidomide cyclophosphamide dexamethasone
1, erlotinib hydrochloride advanced adult primary liver cancer diagnosis prior egfr targeting therapy
0, cladribine refractory cell non hodgkin lymphoma diagnosis alkaline phosphatase equal less doc uln
1, exercise counseling rectal cancer diagnosis diabetes hyperlipidemia uncontrolled hypertension
0, dexamethasone lymphoma diagnosis must have fab lthree morphology have been registered on pog nine thousand four hundred
0, usual nutritional care cancer diagnosis written informed consent
1, paclitaxel breast cancer diagnosis patients any major surgery open biopsy significant traumatic injury within twenty eight days prior entry anticipation major surgery during other their definitive breast surgery ineligible
0, staurosporine recurrent small cell lung cancer diagnosis more four weeks since prior chemotherapy six weeks nitrosoureas mitomycin recovered
1, docetaxel patients history other malignancies except adequately treated non melanoma skin cancer solid tumours curatively treated no evidence disease greater three years
1, bevacizumab stage iva cervical cancer diagnosis treatment systemic immunostimulatory agents including but not limited interferon ifn alpha interleukin il two within six weeks five half lives drug whichever is shorter prior cycle one day one
0, assessment therapy complications noncontiguous stage ii small lymphocytic lymphoma diagnosis has internet email access indicated by logon site consent assessment
1, antibodies monoclonal colorectal neoplasms diagnosis known brain metastases uncontrolled pleural effusions
0, antibodies monoclonal stage iv squamous cell carcinoma larynx diagnosis no other uncontrolled illness
0, paclitaxel metastatic breast cancer diagnosis subjects at least one uni dimensional recist doc measurable lesion
1, bcc surgery carcinoma basal cell diagnosis patient being unable attend future follow up visits
0, erlotinib hydrochloride cytologically pathologically confirmed gallbladder carcinoma cholangiocarcinoma
1, diphosphonates solid tumor diagnosis patient unable follow comply procedures because any geographical familial social psychological reasons
0, veliparib unresectable gallbladder cancer diagnosis life expectancy greater twelve weeks
1, dli lymphoma diagnosis active infection defined positive culture if available bacteria fungus virus within three day period prior dli fever greater three within twenty four hours prior dli
1, sorafenib hepatocellular carcinoma diagnosis clinically significant gastrointestinal bleeding within four weeks prior start drug
1, vaccines cancer diagnosis patients without confirmed progressive refractory sm using standard recist criteria those confirmed progressive refractory sm using standard recist criteria but who may have available potentially curative therapeutic options will be excluded from participation this study
1, sunitinib leiomyosarcoma diagnosis prior tyrosine kinase inhibitor therapy
0, fludarabine phosphate multiple myeloma plasma cell neoplasm diagnosis negative pregnancy test
1, fludarabine refractory diffuse large cell lymphoma diagnosis hypothyroidism following hashimoto syndrome stable on hormone replacement
1, bevacizumab glioblastoma diagnosis inability comply follow up procedures
0, iodine neuroblastoma diagnosis disease evaluable by mibg scan must be present within eight weeks entry subsequent any intervening therapy
1, pembrolizumab invasive adenocarcinoma breast diagnosis supraventricular nodal arrhythmias requiring pacemaker not controlled medication
0, peginterferon alfa b lymphoma diagnosis no other concurrent investigational agents
1, dna stability analysis lung cancer diagnosis carotid artery surgery
0, mycophenolate mofetil hepatocellular carcinoma diagnosis those an ejection fraction between thirty forty will require cardiology consultation clearance transplantation
1, paclitaxel stage iii squamous cell carcinoma lip oral cavity diagnosis history inflammatory bowel disease
1, docetaxel fallopian tube cancer diagnosis laboratory testing insufficiency
0, questionnaire administration stage iii squamous cell carcinoma nasopharynx diagnosis leukocytes greater equal three zero ul
0, laboratory biomarker analysis recurrent verrucous carcinoma oral cavity diagnosis hydrastis canadensis goldenseal
0, cisplatin lung cancer diagnosis platelet count greater one hundred zero mmÂ³
0, oxaliplatin metastatic cancer diagnosis no concurrent cimetidine
0, skeletal scintigraphy breast cancer diagnosis appendix a
1, albumin bound paclitaxel recurrent ovarian cancer diagnosis muscular activities such strenuous exercise that can result significant increases plasma ck levels should be avoided whilst on sonidegib treatment
0, nintedanib peritoneal cancer diagnosis measurable detectable disease
0, esophageal stent placement esophageal cancer diagnosis life expectancy is over six months
0, methylprednisolone hemisuccinate recurrent adult hodgkin lymphoma diagnosis gated pool radionuclide scan fraction must be greater equal fifty
1, antibodies non small cell lung cancer diagnosis treatment an investigational agent within four weeks five half lives prior day one cycle one
1, carboplatin recurrent anal canal carcinoma diagnosis serious active infection requiring intravenous antibiotics at enrollment
1, levoleucovorin symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmias new york heart association class iii iv heart disease neurologic
1, cdx cdtwenty seven expressing cell malignancies example hodgkin lymphoma diagnosis autologous bone marrow transplant within one hundred days first dosing
1, valproic acid glioblastoma multiforme diagnosis patients history hemoptysis bleeding diathesis known platelet disorder coagulopathy not eligible
0, vincristine brain central nervous system tumors diagnosis sgpt less doc times upper limit normal
1, tremelimumab estrogen receptor positive tumor diagnosis patients if enrolled should not receive live vaccine during up thirty days after last dose ip
1, mek mek inhibitor oral low grade serous peritoneal cancer diagnosis additional criteria exist
1, piperacillin tazobactam drug combination hepatic stupor coma renal
0, exemestane breast cancer diagnosis no psychiatric addictive disorder that would preclude informed consent
0, immunoglobulins pre treatment tumor samples such paraffin blocks unstained slides must be available analyses
0, cyclosporins recurrent adult diffuse large cell lymphoma diagnosis hodgkin disease
0, dexamethasone acetate stage iii squamous cell carcinoma nasopharynx diagnosis adequate organ function hepatic
1, pet ct oral cancer diagnosis stage iv disease diagnosed before acquisition staging pet ct
1, immunoglobulins stage iii squamous cell carcinoma lip oral cavity diagnosis four
1, erlotinib hydrochloride carcinoma non small cell lung diagnosis have previously been treated lytwo million eight hundred seventy five thousand three hundred fifty eight any other met targeting experimental therapeutic
0, antibodies monoclonal stage iv non small cell lung cancer diagnosis must have failed greater one platinum containing chemotherapy regimen
0, interferons head neck cancer diagnosis patient characteristics
1, docetaxel breast cancer diagnosis alkaline phosphatase greater doc uln serum creatinine greater uln
0, dexamethasone lymphoma diagnosis negative pregnancy test
1, capecitabine periampullary adenocarcinoma diagnosis evidence distant metastases on imaging
0, carboplatin stage ia uterine sarcoma diagnosis creatinine less equal doc times upper limit normal uln ctcae doc grade one
0, everolimus myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis ages equal less fifty years age chronic lymphocytic leukemia cll these patients not require patient review committee approvals
0, irofulven histologically confirmed metastatic adenocarcinoma breast
0, vidarabine stage iv grade three follicular lymphoma diagnosis waldenstrom macroglobulinemia
0, bevacizumab brain tumor diagnosis pregnancy women childbearing potential men who sexually active not willing able use medically acceptable forms contraception
0, cisplatin stage iiib gallbladder cancer diagnosis arm cohort one
1, vincristine recurrent adult burkitt lymphoma diagnosis ast alt greater two times normal
1, tacrolimus stage iii small lymphocytic lymphoma diagnosis fhcrc pi must approve enrollment all patients pulmonary nodules
1, gemcitabine sarcoma soft tissue diagnosis prior chemotherapy
0, neoadjuvant therapy breast cancer diagnosis no toxicity greater grade one
0, nitrogen mustard compounds recurrent childhood hodgkin lymphoma diagnosis donor
1, nivolumab stage iv skin melanoma diagnosis subjects type diabetes mellitus residual hypothyroidism due autoimmune thyroiditis only requiring hormone replacement skin disorders such vitiligo psoriasis alopecia not requiring systemic treatment permitted enroll
0, doxorubicin childhood immunoblastic large cell lymphoma diagnosis no concurrent radiotherapy
1, tailored print plus tailored phone intervention does participant have history colorectal cancer colorectal polyp
1, mycophenolic acid recurrent childhood large cell lymphoma diagnosis females who pregnant
0, liposomal doxorubicin stage mantle cell lymphoma diagnosis breaks bcl two via cytogenetic studies or
0, cisplatin esophageal cancer diagnosis meets following criteria
0, antibodies monoclonal stage iii verrucous carcinoma larynx diagnosis no evidence active cns hemorrhage
1, alxn multiple myeloma diagnosis active autoimmune disease requiring immunosuppressive therapy
0, breast duct lavage breast cancer diagnosis not specified
1, irinotecan advanced cancer diagnosis patient has known active infection hiv hepatitis hepatitis patients not required be tested presence such viruses prior therapy on this protocol
0, antibodies monoclonal non small cell lung cancer diagnosis opatients disease progression during following platinum based adjuvant neoadjuvant chemotherapy concurrent chemoradiation nsclc eligible if less six months have elapsed between last treatment administration date recurrence
0, doxorubicin lymphoma diagnosis biologic therapy
1, cyclosporins extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis cardiac ejection fraction less thirty five ejection fraction is required if there is history anthracycline exposure history cardiac disease
1, cediranib stage iva colon cancer diagnosis patients any condition gastrointestinal tract disease resulting an inability take oral medication requirement iv alimentation active peptic ulcer disease short gut syndrome malabsorption syndrome any type total partial bowel obstruction inability tolerate oral medications that potentially impairs their ability swallow absorb excluded
0, antibodies monoclonal carcinoma squamous cell head neck diagnosis prior allogeneic stem cell transplantation is excluded
1, cyclosporins recurrent adult grade iii lymphomatoid granulomatosis diagnosis patients rapidly progressive aggressive nhl unless minimal disease state
0, antibodies monoclonal rectal adenocarcinoma diagnosis subject must not have active bleeding pathological condition that is associated high risk bleeding
1, everolimus neuroendocrine tumor grade three disease progression measured by response evaluation criteria solid tumors recist one one diagnosis hydrocortisone case adrenal pituitary insufficiency
0, fludarabine childhood immunoblastic large cell lymphoma diagnosis performance status greater eighty tju karnofsky patients greater sixty years old greater seventy patients less sixty
0, liposomal doxorubicin multiple myeloma plasma cell neoplasm diagnosis program
1, quality life assessment malignant neoplasm diagnosis any significant active medical disorder physical condition that could reasonably be expected interfere ability patient quit smoking determined by principal investigator pi
1, camptothecin glioblastoma multiforme diagnosis clinically significant non healing ulcers
0, deferasirox nodal marginal zone cell lymphoma diagnosis history drug alcohol abuse within twelve months prior enrollment
0, calcium dietary prostate cancer diagnosis patient characteristics
0, antibodies recurrent ovarian carcinoma diagnosis anc greater equal one five hundred mcl
0, romidepsin recurrent childhood medulloblastoma diagnosis at least three weeks since prior myelosuppressive chemotherapy four weeks nitrosoureas recovered
0, oxaliplatin recurrent childhood soft tissue sarcoma diagnosis no electrolyte sodium potassium bicarbonate calcium magnesium phosphate abnormality greater grade two electrolyte supplementation allowed
1, antibodies cancer kidney diagnosis new york heart association class iii iv cardiac disease
0, immunoglobulins small intestine lymphoma diagnosis patient current disease state must be one which there is no known curative therapy therapy proven prolong survival an acceptable quality life
1, pertuzumab gastroesophageal junction cancer diagnosis known brain metastases
0, cisplatin small intestine cancer diagnosis age
0, bevacizumab adult papillary meningioma diagnosis no history abdominal fistula gastrointestinal perforation within six months prior day one treatment
1, olaparib hrpos breast neoplasms diagnosis known suspected congestive heart failure greater nyha coronary heart disease angina pectoris requiring antianginal medication previous history myocardial infarction evidence transmural infarction on ecg uncontrolled poorly controlled arterial hypertension bp greater one hundred forty ninety mm hg under treatment two antihypertensive drugs rhythm abnormalities requiring permanent treatment clinically significant valvular heart disease
0, docetaxel lung cancer diagnosis not specified
0, lapatinib breast cancer diagnosis able swallow retain oral medication
1, albumin bound paclitaxel stage iia cervical cancer diagnosis patients who have significant history cardiac disease uncontrolled hypertension unstable angina congestive heart failure uncontrolled arrhythmias within six months registration
0, cortisol succinate lymphoma diagnosis must meet one following criteria
0, cytarabine lymphoma diagnosis fertile patients must use effective contraception
1, fludarabine phosphate plasma cell neoplasm diagnosis evidence hiv infection known hiv positive serology
1, itv patient concurrent malignancy history malignancy excepted adequately treated basal cell skin carcinoma cervical squamous cell carcinoma other malignancies free disease at least five years
0, docetaxel prostate cancer diagnosis prior planned ongoing bisphosphonate therapy denosumab is allowed
1, tac advanced hepatocellular carcinoma diagnosis any major surgical procedure within twenty eight days prior signing icf any transfusion treatment blood component preparation albumin preparation granulocyte colony stimulating factor csf within fourteen days prior signing icf any local therapy such alcohol injection radiofrequency ultrasound ablation intraarterial chemotherapy transcatheter arterial injection hcc performed within twenty eight days prior signing icf any investigational agent within twenty eight days prior signing icf
0, mycophenolic acid stage iv marginal zone lymphoma diagnosis cll must have either
0, antibodies recurrent non small cell lung cancer diagnosis clinically stable
0, succinylcholine stage iii pancreatic cancer diagnosis creatinine equal less doc institutional uln creatinine clearance greater equal fifty ml min calculated cockcroft gault formula
0, vorinostat stage iii grade two follicular lymphoma diagnosis chronic myelomonocytic leukemia
1, doxorubicin solid tumors diagnosis patient has evidence progressive disease while receiving iniparib
1, hormones prostate cancer diagnosis hemoglobin hb less five mmol l
0, etoposide testicular germ cell tumor diagnosis intermediate prognosis
1, pembrolizumab melanoma diagnosis this will be defined any grade four toxicity requiring treatment corticosteroids greater ten mg day prednisone equivalent dose greater twelve weeks
0, antibodies brain tumor diagnosis uncontrolled hypertension
0, methylprednisolone acetate lymphoma diagnosis unwilling undergo conventional high dose chemoradiotherapeutic conditioning prior allogeneic stem cell transplantation or
1, poly iclc stage iv uveal melanoma diagnosis note
1, erlotinib hydrochloride pancreatic cancer diagnosis because an increased risk bleeding may occur following sorafenib administration no patients will be allowed history bleeding diathesis coagulopathy
1, cisplatin prior systemic chemotherapy targeted therapy lung cancer before screening
0, bortezomib lymphoma diagnosis prior concurrent therapy
0, niacinamide recurrent childhood brain tumor diagnosis bsa greater doc mtwo at time enrollment
0, oxaliplatin resectable pancreatic carcinoma diagnosis hemoglobin greater equal nine dl
1, lapatinib erbbtwo positive stage iii breast cancer diagnosis active infection that opinion investigator would compromise patient ability tolerate therapy
0, semaxinib colorectal cancer diagnosis at least six months since prior adjuvant radioimmunotherapy radiotherapy recovered no concurrent radiotherapy surgery
1, niacinamide non small cell lung cancer diagnosis history pulmonary hemorrhage hemoptysis
0, podophyllotoxin diffuse large cell lymphoma diagnosis patients must have measurable disease defined greater equal doc cm diameter
1, estrogen antagonists postmenopausal women advanced breast cancer diagnosis patients whom one following is sole manifestation disease
0, vincristine stage iii grade three follicular lymphoma diagnosis ecog ps zero two
0, citric acid glioblastoma diagnosis total bilirubin less doc upper limit normal range uln
0, anastrozole breast cancer diagnosis tumour oestrogen receptor progesterone receptor positive greater ten cells positive
1, proteasome inhibitors melanoma diagnosis inability comply protocol specified procedures ie treatment monitoring follow up
1, niacinamide advanced cancers diagnosis known hypersensitivity thalidomide
0, temozolomide childhood germ cell tumor diagnosis at least one week since prior filgrastim csf sargramostim gm csf epoetin alfa
0, decitabine non small cell lung cancer diagnosis alt sgpt less doc times upper limit normal less five times upper limit normal subjects liver metastases
1, immunoglobulins stage iva rectal cancer diagnosis known brain metastasis note
0, antineoplaston a tumor must be at least five mm
1, mycophenolic acid stage adult lymphoblastic lymphoma diagnosis active central nervous system cns leukemia involvement at time enrollment cerebrospinal fluid greater five white blood cells wbc mm three malignant cells on cytospin
1, reolysinÂ® osteosarcoma diagnosis be on immunosuppressive therapy have known hiv infection active hepatitis c
1, ags pancreatic cancer diagnosis active acute chronic clinically significant infections including human immunodeficiency virus hiv viral hepatitis
0, cetuximab stage iva oropharyngeal squamous cell carcinoma diagnosis total bilirubin equal less two mg dl equal less three mg dl case gilbert syndrome
1, regorafenib somatostatinoma diagnosis subjects thrombotic embolic venous arterial events such cerebrovascular accident including transient ischemic attacks deep vein thrombosis pulmonary embolism within six months start treatment
0, pf lymphoma diagnosis adequate hepatic function
1, liver extracts liver cancer diagnosis patients receiving additional ablation therapies
0, hydroxyitraconazole primary prostate cancer tissue available analysis is not required inclusion onto this but is strongly encouraged
0, iodobenzylguanidine paraganglioma diagnosis all patients must have one hundred twenty threei mibg one hundred thirty onei mibg whole body scanning prior therapy
1, fluorouracil stage iiib rectal cancer diagnosis clinically significant active cardiovascular disease cerebrovascular accident myocardial infarction within six months prior randomization unstable angina congestive heart failure new york heart association class greater equal ii serious cardiac arrhythmia that is uncontrolled by medication may interfere administration treatment
0, glucuronyl glucosamine glycan sulfate breast cancer diagnosis white blood cell wbc greater doc ten nine l
0, vindesine cervical cancer diagnosis prior concurrent therapy
1, vinorelbine breast cancer diagnosis current uncontrolled severe systemic disease that could interfere intended therapy clinical significant cardiovascular disease pulmonary metabolic disease wound healing disorders severe infection heart failure ischemic heart disease
1, fentanyl cancer diagnosis known hypersensitivity drug specific contraindications drug
1, carboplatin non small cell lung cancer diagnosis two known cns metastases at time registration
0, long course fu bases radiochemotherapy rectal cancer stage iii diagnosis fit surgery
1, vaccines recurrent hepatocellular carcinoma diagnosis mental impairment that may compromise ability give informed consent comply requirements study
0, veliparib stage iv non small cell lung cancer diagnosis unable undergo mri whom mri is otherwise contraindicated presence errant metal cardiac pacemakers pain pumps other mri incompatible devices history claustrophobia anxiety related undergoing mri
1, hormones lymphoma diagnosis severe hepatic renal insufficiency
0, heparin primary brain tumor diagnosis adequate hematologic function demonstrated by laboratory values performed within fourteen days
0, vidarabine recurrent grade two follicular lymphoma diagnosis patients must have an hla identical related unrelated donor
1, flutamide prostate cancer diagnosis severe micturation symptoms
1, mycophenolic acid contiguous stage ii grade two follicular lymphoma diagnosis donor
0, thalidomide multiple myeloma diagnosis uncontrolled diabetes mellitus
0, albumin bound paclitaxel primary peritoneal carcinoma diagnosis following histologic epithelial cell types eligible
1, antibodies intraocular lymphoma diagnosis major surgical procedure laparoscopic procedure open biopsy significant traumatic injury within twenty eight days prior enrollment
1, carboplatin ovarian serous tumor diagnosis dependency on intravenous iv hydration total parenteral nutrition tpn
1, inc melanoma diagnosis lvef less fifty determined by muga scan echo
0, axitinib paraganglioma diagnosis therapeutic use low molecular weight heparin is allowed
0, dacarbazine recurrent brain tumors diagnosis bilirubin less doc times unl
0, bryostatin ovarian cancer diagnosis no concurrent steroids
0, carboplatin metastatic disease including previously untreated metastatic disease which regimen represents reasonable initial chemotherapy palliative intent metastatic gastric cancer hepatobiliary cancer cancer which no effective standard therapy exists
1, laboratory biomarker analysis splenic marginal zone lymphoma diagnosis significant uncontrolled intercurrent condition including but not limited to
1, albumin bound paclitaxel fallopian tube transitional cell carcinoma diagnosis only applies patients who elect receive bevacizumab
0, gemcitabine breast cancer
0, vidarabine stage iii small lymphocytic lymphoma diagnosis only csf mobilized pbmc will be permitted hsc source on this protocol
1, temozolomide lymphomas diagnosis history allergic reactions attributed compounds similar chemical biologic composition trcone hundred two tmz
1, dabrafenib melanoma diagnosis mek inhibitor
0, methylprednisolone small lymphocytic lymphoma diagnosis able adhere visit schedule other protocol requirements
0, ct scan adult primary hepatocellular carcinoma diagnosis diagnostic imaging abdomen utilizing either ct contrast magnetic resonance imaging mri pet ct no greater four weeks prior visit one
1, biopsy underlying disease that is known cause immunosuppression hiv cancer post organ transplantation
0, antilymphocyte serum lymphoma diagnosis left ventricular ejection fraction greater fifty
0, paclitaxel pancreatic adenocarcinoma diagnosis females child bearing potential negative serum pregnancy test within thirty days prior registration
0, inc papillary renal cell carcinoma diagnosis absolute neutrophil count anc greater equal doc ten nine without growth factor support
1, carboplatin non small cell lung cancer diagnosis patients who have received prior treatment an mtor inhibitor sirolimus temsirolimus everolimus
0, pembrolizumab triple negative breast carcinoma diagnosis if recently obtained samples unavailable an archived metastatic specimen not previously irradiated may be submitted upon agreement from principal investigator pi
1, antibodies monoclonal metastatic malignant neoplasm brain diagnosis history abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior day one
1, fludarabine mantle cell lymphoma diagnosis patients may receive prophylactic antibiotics antiviral therapy at discretion investigator
0, tamoxifen breast neoplasms diagnosis life expectancy greater six months
1, fludarabine phosphate metastatic melanoma diagnosis patients who have decreased immune competence may be less responsive experimental treatment more susceptible its toxicities
1, cetuximab colorectal cancer diagnosis patients known cerebral metastasis
1, standard laparoscopy endometrial cancer diagnosis no uterine size larger conform ten weeks gestation
1, mechlorethamine oligoastrocytoma diagnosis subjects at significant risk general anesthesia
0, antilymphocyte serum noncontiguous stage ii adult diffuse large cell lymphoma diagnosis fulfills all pulmonary cardiac renal hepatic criteria standard care matched unrelated donor mud allogeneic hct
1, albumin bound paclitaxel ovarian neoplasm diagnosis females childbearing potential who unwilling avoid pregnancy duration study
1, liposomal doxorubicin other concurrent antitumor agents
1, rituximab primary effusion lymphoma diagnosis doc
0, magnetic resonance imaging cervical cancer diagnosis hematopoietic
0, sirolimus multiple myeloma plasma cell neoplasm diagnosis no chronic phase chronic myelogenous leukemia de novo acute leukemia first remission myelodysplastic syndromes refractory anemia
0, celecoxib stage iiib breast cancer diagnosis hormone receptor status
0, cyclophosphamide breast cancer diagnosis following criteria evidence adequate hepatic function must be met based on results most recent postoperative tests performed within six weeks prior randomization
1, standard mammography tomosynthesis patients at high risk breast cancer mutations brca one breast cancer gene one brca two breast cancer gene two carriers li fraumeni history thoracic radiation will be excluded because their greater sensitivity ionizing radiation
0, interferons lymphoma diagnosis renal
1, cetuximab recurrent squamous cell carcinoma hypopharynx diagnosis patient has history cardiac dysfunction including any following
1, vidarabine adult nasal type extranodal nk cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
1, irinotecan colorectal cancer diagnosis major surgical procedure open biopsy clinically significant traumatic injury within four weeks
0, cyclophosphamide recurrent adult burkitt lymphoma diagnosis platelet count supportable greater twenty zero mm three no more one transfusion per day
1, cisplatin recurrent metastatic head neck cancer diagnosis prior systemic treatment metastatic recurrent scchn
0, antibodies monoclonal stage iiib gastric cancer diagnosis more eight weeks since prior immunotherapy recovered
1, prednisone hormone resistant prostate cancer diagnosis patients must not be planning receive any concurrent cytotoxic chemotherapy surgery radiation therapy during protocol treatment
0, methylprednisolone acetate multiple myeloma plasma cell neoplasm diagnosis performance status
1, liposomal doxorubicin recurrent childhood large cell lymphoma diagnosis growth factors that support platelet white cell number function must not have been administered within seven days prior enrollment
1, dexamethasone noncontiguous stage ii marginal zone lymphoma diagnosis patient has received rituximab therapy within six months entry into protocol
0, mechlorethamine lymphoma diagnosis pulmonary
0, rubitecan lung cancer diagnosis greater four weeks since prior chemotherapy
0, prednisolone phosphate burkitt lymphoma diagnosis pediatric all patients first complete remission not eligible
0, cyclosporins splenic marginal zone lymphoma diagnosis waldenstrom macroglobulinemia
1, fluorouracil recurrent metastatic gastric cancer diagnosis however it is allowed treatment acute allergic reactions treatment low doses methylprednisolone twentymg less equivalent drug from about six months
0, mycophenolic acid breast cancer diagnosis recent mold infection aspergillus allowed provided patient has received greater thirty days appropriate treatment infection is controlled cleared by an infectious disease specialist
0, albumin bound paclitaxel contiguous stage ii adult diffuse large cell lymphoma diagnosis patients must have histologically cytologically confirmed malignancy that is metastatic unresectable which standard curative palliative measures not exist no longer effective patient may have previously treated untreated disease
0, calcium dietary recurrent rectal cancer diagnosis absolute neutrophil count greater equal one zero per mm three
0, fludarabine recurrent childhood anaplastic large cell lymphoma diagnosis matched human leukocyte antigen hla b drbone dqbone by high resolution typing
1, stereotactic radiosurgery heent cancer diagnosis inability obtain histologic proof malignancy
1, camptothecin colon cancer diagnosis bleeding diathesis not correctable by usual forms therapy that would include medical coagulopathy but not limited administration blood products
0, mutation analysis neuroblastoma diagnosis no event greater three years follow up
1, antibodies monoclonal stage ii oral cavity squamous cell carcinoma diagnosis subjects vitiligo grave disease psoriasis not requiring systemic treatment within past two years not excluded
1, nilotinib glioma diagnosis patient received chemotherapy within four weeks six weeks nitrosourea prior entry unless disease is rapidly progressing
0, standard chemotherapy metastatic colo rectal cancer diagnosis progressive disease on within four months after ine chemotherapy kras mutant after ine chemotherapy kras wild type patients
1, endothelial growth factors recurrent fallopian tube carcinoma diagnosis concurrent use anti coagulants warfarin etc
1, mycophenolic acid noncontiguous stage ii grade two follicular lymphoma diagnosis donor
1, melphalan recurrent adult hodgkin lymphoma diagnosis patients available hla matched related donors
1, cyclophosphamide multiple myeloma diagnosis pre existent polyneuropathy grade two higher according ctcae doc
1, sirolimus stage ivb cervical cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition temsirolimus
1, everolimus recurrent adult lymphoblastic lymphoma diagnosis other concurrent chemotherapy immunotherapy radiotherapy any ancillary therapy considered investigational utilized non food drug administration fda approved indication context research investigation note
1, haploidentical bone marrow transplantation lymphoma follicular diagnosis history primary idiopathic myelofibrosis
1, cc prostate cancer diagnosis clinically significant cardiac diseases including any following
0, cytarabine primary effusion lymphoma
0, cyclophosphamide germ cell tumor
1, fludarabine stage ii non contiguous mantle cell lymphoma diagnosis karnofsky score less sixty lansky score less fifty
0, pharmacological stage iv verrucous carcinoma oral cavity diagnosis no other uncontrolled illness
1, cyclophosphamide contiguous stage ii small lymphocytic lymphoma diagnosis positive serology hepatitis hc defined positive test hcab
1, doxorubicin metastatic soft tissue sarcoma diagnosis clinically evident congestive heart failure greater class ii new york heart association nyha guidelines
1, cyclophosphamide childhood diffuse large cell lymphoma diagnosis host disease complications greater risk recurrence after autologous bmt
0, radiation therapy stage iia soft tissue sarcoma diagnosis body wall
0, liposomal doxorubicin sarcoma diagnosis wbc at least four zero mmthree platelet count at least one hundred fifty zero mmthree hepatic
1, bortezomib asymptomatic mm renal failure from unrelated causes
1, procaine stomatitis diagnosis known allergic reaction any component oral ulcer gargle forrad quadruple mixture which is composed dexamethasone gentamicin vitamin btwelve procaine severe allergic constitution
1, erlotinib hydrochloride non small cell lung cancer diagnosis peripheral neuropathy greater grade one
0, fludarabine phosphate recurrent adult burkitt lymphoma diagnosis matched related donor
0, carboplatin stage iiib gastric cancer diagnosis note
0, prednisolone hemisuccinate unspecified childhood solid tumor protocol specific diagnosis chemotherapy
0, stereotactic body radiotherapy chordoma diagnosis if chemotherapy is planned ideally it should not have been given within thirty days starting radiation should not resume until at least two weeks after completing radiation
0, surgery combined rad p gene therapy non small cell lung cancer diagnosis ecog
0, fludarabine phosphate precancerous condition diagnosis forced expiratory volume one second fev one greater thirty
1, feasibility breast cancer diagnosis history dilated cardiomyopathy congestive heart failure coronary artery disease
0, albumin bound paclitaxel neoplasms diagnosis if no bone scan within three month window is available then technetium ninety ninem naf pet bone scan will be obtained at screening within twenty eight days planned start drug
0, immunoglobulin idiotypes multiple myeloma diagnosis a
1, mycophenolic acid stage iv adult lymphoblastic lymphoma diagnosis history brain metastases
1, gemcitabine adult rhabdomyosarcoma diagnosis clinically significant gastrointestinal abnormalities that may affect absorption investigational product including but not limited to
0, methylprednisolone recurrent wilms tumor other childhood kidney tumors diagnosis mycobacterial culture
1, interleukin melanoma diagnosis age greater equal sixty years old
0, trastuzumab breast neoplasms diagnosis patients must be greater eighteen years age
1, carboplatin stage ivb uterine corpus cancer diagnosis doubling serum ca one hundred twenty five level
1, eflornithine familial adenomatous polyposis diagnosis myocardial infarction angina coronary angioplasty congestive heart failure stroke coronary bypass surgery
0, liposomal doxorubicin epstein barr virus associated non hodgkin lymphoma diagnosis serum glutamic oxaloacetic transaminase sgot less five times upper limit normal
1, modafinil carcinoma non small cell lung diagnosis received radiotherapy chemotherapy within last four weeks
1, paclitaxel stage ii breast cancer diagnosis any comorbidity condition which opinion investigator may interfere assessments procedures this protocol
0, tacrolimus neuroblastoma diagnosis not pregnant
1, tacrolimus splenic marginal zone lymphoma diagnosis patients life expectancy less six months reasons other their underlying hematologic oncologic disorder
0, carmustine brain central nervous system tumors diagnosis negative pregnancy test twenty four hours prior study
1, vidarabine contiguous stage ii grade three follicular lymphoma diagnosis poorly controlled hypertension
0, etoposide phosphate brain central nervous system tumors diagnosis no swallowing dysfunction that would preclude oral medication intake
0, antilymphocyte serum noncontiguous stage ii small lymphocytic lymphoma diagnosis related donor negative single antigen mismatch at hla b drb one unrelated donor negative single antigen mismatch at hla b positive
0, cancer prevention intervention recurrent colon cancer diagnosis karnofsky sixty one hundred
1, stemgen multiple myeloma diagnosis no history angioedema recurrent urticaria an isolated episode urticaria is not contraindication
0, topotecan adult supratentorial primitive neuroectodermal tumor pnet diagnosis doc mg dl
0, genetically engineered lymphocyte therapy stage iii grade two follicular lymphoma diagnosis less two years between last chemotherapy progression most recent progression free interval less two years
0, vorinostat recurrent adult burkitt lymphoma diagnosis complete remission is defined absence blasts peripheral circulation at time enrollment less five blasts bone marrow
1, panobinostat non hodgkin lymphoma diagnosis patients congenital qt syndrome
0, antibodies extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis mantle cell nhl
1, temozolomide glioblastoma diagnosis field risk organs iort dose greater eight gy any risk organ
1, antibodies monoclonal ovarian brenner tumor diagnosis patients known hypersensitivity chinese hamster ovary cell products other recombinant human humanized antibodies patients known allergy cremophor polysorbate eighty
0, lenalidomide plasma cell myeloma diagnosis patients must be receiving lenalidomide ten mg fifteen mg be able tolerate dose escalation twenty five mg daily
0, everolimus stage iv non small cell lung cancer diagnosis hemoglobin greater equal doc dl
0, irinotecan penile cancer diagnosis absolute neutrophil count at least two zero mm three
0, vidarabine stage iv marginal zone lymphoma diagnosis antecedent myelodysplastic syndrome secondary aml high risk cytogenetic abnormalities normal cytogenetics high risk molecular features fltthree itd mutation mixed lineage leukemia mll wildtype npmone
1, immunoglobulins malignant peritoneal neoplasm diagnosis failure fully recover from acute reversible effects prior chemotherapy regardless interval since last treatment
0, cisplatin stage ivc oral cavity verrucous carcinoma diagnosis creatinine within normal institutional limits calculated creatinine clearance greater equal sixty ml min doc three two patients levels above institutional normal using modified cockcroft gault
0, ifosfamide sts where no established grading system exists sarcoma subtypes which very indolent have an unpredictable clinical behavior patient entry requires prospective approval writing on case by case basis by coordinator this trial eortc headquarters hq
1, sorafenib tumors diagnosis diagnosis arterial venous thrombosis within six months before enrollment history bleeding diathesis
1, vardenafil dihydrochloride glioma diagnosis history allergic reaction platinum compounds mannitol
1, sleep healthy using internet shuti having medical condition other cancer that causes insomnia
1, cisplatin primary peritoneal carcinoma diagnosis renal insufficiency serum creatinine greater doc
1, erlotinib hydrochloride carcinoma non small cell lung diagnosis patients curatively treated free disease at least five years will be discussed principal investigator lkp before inclusion
1, azd reference breast cancer diagnosis any positive result on screening serum hepatitis surface antigen hbsag hepatitis antibody human immunodeficiency virus hiv antibody
1, niacinamide kidney cancer diagnosis subjects evidence current central nervous system cns metastases
0, liposomal doxorubicin endometrial cancer diagnosis absolute neutrophil count at least one five hundred mmthree
0, ganciclovir contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis organ function requirements
1, mycophenolic acid contiguous stage ii adult diffuse large cell lymphoma diagnosis patient donor infected human immunodeficiency virus hiv
1, fluciclatide injection ah f head neck cancer diagnosis subject has known diagnosis hepatitis infection
0, positron emission tomography neuroblastoma diagnosis life expectancy
1, antibodies monoclonal stage mantle cell lymphoma diagnosis bone marrow bm donors
1, prednisone recurrent prostate carcinoma diagnosis subject is on medications that lower seizure threshold cannot be discontinued during study
0, celecoxib esophageal cancer diagnosis celecoxib
0, albumin bound paclitaxel lung cancer diagnosis following subtypes eligible
0, capecitabine ovarian cancer diagnosis not specified
1, sirolimus stage iiic fallopian tube cancer diagnosis other serious illnesses serious infections requiring antibiotics bleeding disorders
0, antibodies monoclonal stage iv squamous cell carcinoma nasopharynx diagnosis risperidone
0, hydrocortisone acetate childhood burkitt lymphoma diagnosis one following fab prognostic groups
1, antibodies recurrent childhood pineoblastoma diagnosis female patients who pregnant not eligible this study
0, antibodies monoclonal colon signet ring cell adenocarcinoma diagnosis patients after menarche amenorrhea irregular cycles using contraceptive method that precludes withdrawal bleeding
1, cisplatin tumor mass greater tenmm by ct mr scan
0, cyclin dependent kinase inhibitor proteins ovarian immature teratoma diagnosis subject has adequate marrow function defined follows
0, prednisolone phosphate gestational trophoblastic tumor diagnosis biologic therapy
1, mckeown mie squamous cell esophageal carcinoma diagnosis patients concomitant hemorrhagic disease
1, vidarabine stage iii adult lymphoblastic lymphoma diagnosis lansky play performance score less fifty pediatric patients
0, antibodies monoclonal recurrent grade three follicular lymphoma diagnosis concurrent therapy zidovudine zidovudine containing regimen including combivir trizivir will be prohibited until two months following participant completion chemotherapy part this protocol use cobicistat tybost cobicistat containing single tablet regimens stribild is prohibited during concurrent chemotherapy under this protocol participants taking cobicistat cobicistat containing single table regimens must switch different agent regimen prior enrollment will remain on regimen until at least two months following treatment discontinuation cobicistat is pure potent cytochrome pfour hundred fifty family three subfamily polypeptide four cypthreeafour inhibitor has potential increase area under curve auc cypthreeafour substrates therefore both vincristine doxorubicin would have potential drug drug interaction ddi cobicistat since they cypthreeafour substrates
0, pemetrexed lung cancer diagnosis bilirubin less doc times upper limit normal uln less doc times uln patients known liver metastases
0, fludarabine lymphoma diagnosis total bilirubin less two mg dl
0, pharmacological nodal marginal zone cell lymphoma diagnosis absolute neutrophil count greater equal one five hundred ul
1, laboratory biomarker analysis nodal marginal zone cell lymphoma diagnosis left ventricular ejection fraction shortening fraction less forty
0, capecitabine colon cancer diagnosis adequate baseline bone marrow hepatic renal function defined follows
1, cholecalciferol ductal carcinoma situ diagnosis patients receiving medications that incompatible vd
1, etoposide phosphate patients unable complete pulmonary function tests due myeloma related pain fracture must have high resolution ct scan chest must also have acceptable arterial blood gases defined ptwo greater seventy
1, carmustine recurrent adult grade iii lymphomatoid granulomatosis diagnosis active infection at start lenalidomide
0, interferon alpha cervical cancer diagnosis no other concurrent immunotherapy
0, epigallocatechin gallate lung cancer diagnosis no concurrent anticoagulants such warfarin heparin
0, lu ops neuroendocrine tumors diagnosis life expectancy at least six months
0, doxorubicin ovarian serous cystadenocarcinoma diagnosis patients treating enoxaparin eligible inclusion study
0, capecitabine pancreatic cancer diagnosis surgery
1, sir sphere breast cancer metastatic liver diagnosis contraindications angiography
1, blood draw malignant neoplasms digestive organs diagnosis patients who received blood transfusions last six months
0, quality life assessment central nervous system lymphoma diagnosis remission complete remission cr partial remission pr stable disease based on clinical not necessarily radiologic assessment currently being observed no current cytotoxic chemotherapy planned patients may be on rituximab maintenance
1, levoleucovorin unresectable pancreatic carcinoma diagnosis prior neoadjuvant folfirinox
0, carboplatin one following primary tumor sites
0, antibodies monoclonal recurrent marginal zone lymphoma diagnosis toxicities from prior therapies must have resolved baseline be equal less grade two stable at least one month
0, everolimus diffuse large cell lymphoma diagnosis imaging must be completed no greater three weeks from enrollment
0, camptothecin carcinoma non small cell lung diagnosis patients treated brain metastases surgery whole stereotactic brain radiation allowed provided lesions have been stable at least two weeks patient is off steroids is on stable dose steroids
1, gemcitabine collecting duct carcinoma kidney diagnosis known hypersensitivity any component investigational drugs excipients
0, fludarabine precancerous condition diagnosis philadelphia chromosome present
1, carmustine stage iii follicular lymphoma diagnosis any history hiv one associated encephalopathy
0, cyclophosphamide stage iiic ovarian cancer diagnosis capable understanding investigative nature potential risks benefits capable providing valid informed consent
1, bortezomib multiple myeloma diagnosis any condition including presence laboratory abnormalities which places subject at unacceptable risk if he she were participate confounds ability interpret data from study
1, mycophenolic acid myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis life expectancy severely limited less two years by disease other mds aml
1, tissue biopsy bladder cancer diagnosis participants who have previously received chemotherapy part multimodal therapy
0, maleic acid stage iva thyroid gland follicular carcinoma diagnosis following groups patients eligible provided that they have new york heart association nyha class ii cardiac function on baseline echocardiogram echo multi gated acquisition scan muga
0, alvocidib stage iii small lymphocytic lymphoma diagnosis no other concurrent hormonal therapy except following
0, cyclophosphamide ovarian clear cell cystadenocarcinoma diagnosis no other severe medical psychiatric illness including but not limited following
1, immunoglobulins small intestine lymphoma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated erlotinib cetuximab
1, antibodies merkel cell carcinoma diagnosis baseline ejection fraction less fifty assessed by echocardiogram multi gated acquisition muga scan
0, interferon alpha melanoma diagnosis they should have no significant intercurrent illness such an active infection uncontrolled psychiatric illness hypercalcemia calcium greater eleven mg active gi bleeding
1, regorafenib adult angiosarcoma diagnosis prophylactic anticoagulation described below is allowed
0, imatinib mesylate stage iv marginal zone lymphoma diagnosis no concurrent combination antiretroviral therapy hiv positive patients
1, antilymphocyte serum recurrent adult lymphoblastic lymphoma diagnosis any patient who is unable provide informed consent comply requirements protocol
1, niacinamide renal cell carcinoma diagnosis john wort rifampin rifampicin
1, thalidomide non hodgkin lymphoma nhl diagnosis refractory nausea vomiting other situation that may preclude adequate absorption
0, nivolumab recurrent primary peritoneal carcinoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast equal less three uln
0, antibodies neurofibromatosis type two diagnosis urine protein
0, tacrolimus stage iv grade two follicular lymphoma diagnosis must have less five marrow blasts at time transplant
1, doxorubicin multiple myeloma relapse diagnosis patient has had prior treatment vorinostat hdac inhibitors
1, antibodies mantle cell lymphoma diagnosis patient has history gastrointestinal surgery other procedures that might opinion investigator interfere absorption swallowing drugs
1, enoxaparin lymphoma diagnosis radiation therapy month prior enrollment
1, interactive voice response ivr lung cancer diagnosis current diagnosis psychosis dementia
0, liposomal doxorubicin stage grade two follicular lymphoma diagnosis patients allowed have received radiotherapy before enrollment if radiation was given alleviate pain neurologic compromise long there remains areas measurable disease present
0, vincristine clear cell sarcoma kidney diagnosis patients must begin protocol therapy on arenthree hundred twenty one by day fourteen after surgery biopsy surgery biopsy is day zero unless medically contraindicated
0, fludarabine ovarian carcinoma diagnosis subject must be eighteen years age older
0, antibodies stage iiic breast cancer diagnosis patients must not have non healing wound fracture patients an abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior randomization not eligible
1, pharmacological stage iv small lymphocytic lymphoma diagnosis concurrent antifungal medications within past four weeks
1, tipifarnib other concurrent anticancer therapy
0, quality life assessment prostate cancer diagnosis prostate size less sixty cc by mri ct imaging
0, vidarabine recurrent grade two follicular lymphoma diagnosis informed consent
0, fludarabine clear cell carcinoma diagnosis donors
1, bb stage multiple myeloma diagnosis total bilirubin greater three times upper limit normal
1, paclitaxel invasive breast carcinoma diagnosis treatment systemic immunostimulatory agents including but not limited interferon ifn alpha interleukin il two within six weeks five half lives drug whichever is shorter prior cycle one day one
0, paclitaxel stage iiia uterine corpus cancer diagnosis entry into is limited no more eight weeks from date surgery
1, docetaxel carcinoma non small cell lung diagnosis active uncontrolled infection e
1, mycophenolate mofetil recurrent childhood grade iii lymphomatoid granulomatosis diagnosis lansky play performance score less seventy pediatric patients
0, sirolimus estrogen receptor positive breast cancer diagnosis metastatic locally recurrent disease locally recurrent disease must not be amenable resection curative intent patients who considered suitable surgical ablative techniques following potential down staging treatment not eligible
0, alemtuzumab lymphoma diagnosis disease characteristics
1, doxorubicin breast cancer diagnosis use coqten supplement use within thirty days initiating drug
1, antibodies monoclonal refractory cell non hodgkin lymphoma diagnosis patients must stop using proton pump inhibitor ppi at least four days prior first dose mlneight thousand two hundred thirty seven administration ppi while on is not permitted
0, bevacizumab gastric cancer diagnosis patient also agrees refrain from nursing during duration at least two months after is completed
1, panobinostat peripheral cell lymphoma diagnosis patients who will need valproic acid any medical condition during within five days prior first panobinostat treatment
0, doxorubicin recurrent childhood soft tissue sarcoma diagnosis ast alt less doc times uln
0, radiosensitive therapy recurrent high grade glioma diagnosis normal liver kidney bone marrow function
0, succinylcholine undifferentiated fallopian tube carcinoma diagnosis patients must be entered between one one weeks after initial surgery performed combined purpose diagnosis staging cytoreduction
1, gamma secretase inhibitor ro recurrent adult soft tissue sarcoma diagnosis indinavir nelfinavir ritonavir clarithromycin itraconazole ketoconazole nefazodone
0, dexamethasone multiple myeloma relapse diagnosis involved serum free light chain level greater ten mg dl an abnormal serum free light chain ratio or
1, n monoacetylcystine stage iva verrucous carcinoma oral cavity diagnosis greater equal grade two dry mouth prior chemoradiotherapy greater equal grade two mucositis
0, doxorubicin stage iii adult immunoblastic large cell lymphoma diagnosis ecog ps zero two
0, paclitaxel ovarian cancer diagnosis participants must have had at least one prior platinum based chemotherapeutic regimen management primary disease regimen containing carboplatin cisplatin another organoplatinum compound
0, albumin bound paclitaxel stage ii non small cell lung cancer diagnosis uncontrolled hypertension
0, cytology specimen collection procedure recurrent bladder carcinoma diagnosis platelets greater one hundred mm three
1, etoposide phosphate recurrent mantle cell lymphoma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide similar drugs
1, topotecan rectal cancer diagnosis exposure topotecan infection immunodeficiencies conditions gastrointestinal gi tract which would affect absorption medication that maintains motility gastric emptying
0, antibodies recurrent renal cell carcinoma diagnosis leukocytes greater equal three zero mcl
1, immunoglobulins recurrent salivary gland carcinoma diagnosis patients diseases which reasonable certainty not limit life expectancy twelve months less eligible assessment such concurrent illnesses should be by principal investigator
1, albumin bound paclitaxel triple negative breast cancer diagnosis prior use abraxane metastatic disease adjuvant setting
0, immunoglobulins stage ivc oropharyngeal squamous cell carcinoma diagnosis eastern cooperative oncology group ecog performance status zero one
0, laboratory biomarker analysis stage iiib rectal cancer diagnosis total bilirubin within normal institutional limits
1, ascorbic acid adenocarcinoma diagnosis patients who on following drugs cannot have substitution who decline substitution
1, cetuximab stage iva verrucous carcinoma larynx diagnosis serum calcium ionized adjusted albumin less seven mg dl doc five mmol greater one doc mg dl greater doc mmol despite intervention normalize levels
0, cisplatin untreated childhood supratentorial primitive neuroectodermal tumor diagnosis no other experimental therapy is permitted while on study
0, ultrasound imaging long term effects secondary cancer therapy children diagnosis weight less two hundred fifty pounds
1, cisplatin prior cancer chemotherapy
1, dexamethasone phosphate multiple myeloma diagnosis lvef assessed by two echocardiogram echo less fifty lower limit normal whichever is higher multiple gated acquisition scan muga less forty five lower limit normal whichever is higher
0, interleukin recurrent adult burkitt lymphoma diagnosis no prior unstable coronary artery disease
1, glycine metastatic renal cell carcinoma diagnosis last dose must be greater six weeks prior day one treatment
1, sorafenib solid tumors diagnosis prior full pelvic field radiotherapy less four weeks limited field radiotherapy less two weeks prior randomization
0, liposomal doxorubicin stage ia breast cancer diagnosis note
0, metformin stage iia prostate cancer diagnosis first two psa values along third baseline value must all be rising there must be an overall rising trajectory such that third value cannot be lower first value
0, quality life assessment psychosocial effects cancer its treatment diagnosis not specified
1, mycophenolate mofetil stage iii adult diffuse small cleaved cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml mds all cml
0, cisplatin prostate cancer diagnosis inr less doc pt ptt within normal limits
0, bortezomib extraocular extension melanoma diagnosis no other prior concurrent chemotherapy immunotherapy radiotherapy any other therapy supportive care considered investigational
1, sirolimus recurrent cervical carcinoma diagnosis failure fully recover from acute reversible effects prior chemotherapy other anti neoplastic therapy radiation therapy adverse event severity equal less grade one
0, liposomal doxorubicin neoplasms breast diagnosis recovered from acute toxicity any prior treatment exemptions
1, pharmacological recurrent breast cancer diagnosis prior thoracic radiotherapy
1, everolimus stage ia uterine corpus cancer diagnosis known pulmonary hypertension
0, poly iclc triple negative breast cancer diagnosis human immunodeficiency virus hiv
1, sirolimus recurrent pancreatic cancer diagnosis uncontrolled seizure disorder
1, vincristine sarcoma kaposi diagnosis alcohol consumption is strongly discouraged
1, vaccines stage iiia skin melanoma diagnosis known hypersensitivity sirolimus
0, everolimus stage ia ovarian cancer diagnosis patients child bearing potential must agree use acceptable contraceptive methods double barrier during treatment
0, lenalidomide multiple myeloma diagnosis following entities eligible
0, docetaxel squamous cell lung cancer diagnosis platelets greater equal one hundred zero ul
0, estrogens stage iiib breast cancer diagnosis unstable angina pectoris
1, ergocalciferols stage iv colon cancer resectable liver metastases diagnosis inability swallow pills
1, anastrozole breast cancer diagnosis presence left bundle branch block lbbb
1, gemcitabine stage ivb gallbladder cancer diagnosis patients gsixpd deficiency will be excluded view potential methemoglobinemia
1, mycophenolic acid childhood immunoblastic large cell lymphoma diagnosis patients active bacterial fungal infections unresponsive medical therapy
0, doxorubicin lymphoma diagnosis not specified
0, alvocidib stage small lymphocytic lymphoma diagnosis and at least one following
1, azacitidine neoplasms diagnosis prior chemotherapy including injectable azacitidine radiotherapy any investigational agent after last dose oral azacitidine administered part parent oral azacitidine study
0, pegaspargase cognitive side effects cancer therapy diagnosis patients must be enrolled on aalleightbone prior enrollment on aalloneone one
1, doxorubicin non hodgkin lymphomas diagnosis option primary potential curative radiation therapy
1, ondansetron solid tumor cancer diagnosis subject will not be eligible initial inclusion this if any following criteria apply will not be eligible subsequent cycles therapy if any following criteria become applicable
0, methotrexate contiguous stage ii grade two follicular lymphoma diagnosis use methotrexate tacrolimus prevention gvhd after allogeneic hct
1, pembrolizumab recurrent nasopharynx carcinoma diagnosis has received prior therapy vorinostat other epigenetic agent
0, prednisolone hemisuccinate prostatic neoplasms diagnosis informed consent
1, immunoglobulin g fallopian tube endometrioid adenocarcinoma diagnosis protein concentration mg dl creatinine mg dl patients must have upcr less doc allow participation study
0, fludarabine lymphoma diagnosis mycosis fungoides sezary syndrome
1, vidarabine stage ii multiple myeloma diagnosis infection hiv
0, alvespimycin hydrochloride stage iv squamous cell carcinoma oropharynx diagnosis qtc less four hundred fifty msec male patients four hundred seventy msec female patients
1, doxorubicin lymphoma non hodgkin diagnosis patients following excluded
1, antibodies stage iv skin melanoma diagnosis patients who have had greater twenty five their functional bone marrow irradiated not eligible this trial
0, etoposide recurrent small lymphocytic lymphoma diagnosis world health organization who classification patients malignancies must be provided
1, bevacizumab endometrial clear cell adenocarcinoma diagnosis nursing women
0, epothilones embryonal childhood rhabdomyosarcoma diagnosis erythromycin
1, alemtuzumab germ cell tumor diagnosis female only known pregnancy negative serum urine pregnancy test be conducted within seven days prior enrollment
1, antibodies monoclonal metastatic colorectal cancer diagnosis had recent major surgery within twenty eight days
0, fluorouracil stage iii childhood hepatocellular carcinoma diagnosis patients known history current evidence retinal vein occlusion rvo retinal pigment epithelial detachment rped not eligible
1, doxorubicin mtd soft tissue sarcomas diagnosis concurrent second malignancy
1, liposomal doxorubicin history another malignancy within previous five years other curatively treated non melanoma skin cancer
0, prednisolone recurrent childhood rhabdomyosarcoma diagnosis fungal culture
0, crizotinib non small cell lung cancer nsclc diagnosis patient is able swallow capsules has no surgical anatomical condition that will preclude patient from swallowing absorbing oral medications on an ongoing basis
0, sirolimus recurrent hepatocellular carcinoma diagnosis pulmonary function tests
0, doxorubicin stage iv adult hodgkin lymphoma diagnosis karnofsky performance status greater thirty given aggressiveness this disease often severely debilitated nature patients at initial presentation
0, tacrolimus stage ii contiguous adult burkitt lymphoma diagnosis donor
1, paclitaxel non small cell lung cancer diagnosis pregnancy breast feeding
1, oncolytic measles virus encoding thyroidal sodium iodide symporter primary peritoneal cavity cancer diagnosis any following prior therapies
1, laparoscopic surgery rectal cancer diagnosis distant metastasis
1, cyclosporins stage iii multiple myeloma diagnosis performance status greater two eastern cooperative oncology group ecog less fifty lansky patients less sixteen years old
0, niacinamide relapsed osteosarcoma diagnosis doc bone lesions allowed
0, niacinamide gastrointestinal carcinoid tumor diagnosis aspartate aminotransferase ast less three times uln five times uln if liver metastases present
1, liposomal doxorubicin other previous neoplasms allowed if diagnosed treated more five years before registration
0, rituximab recurrent extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis alanine aminotransferase alt aspartate aminotransferase ast equal less three uln
1, cisplatin patients prior concomitant malignant diseases other appropriately treated basal cell carcinoma skin carcinoma cervix
0, lenograstim clear cell sarcoma diagnosis creatinine clearance radioisotope glomerular filtration rate gfr seventyml min doc three two or
0, succinylcholine ovarian serous cystadenocarcinoma diagnosis patients gog performance status zero one two
1, iniparib advance solid tumors diagnosis not recovered from all previous therapies radiation surgery medications
0, vorinostat extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis refractory cytopenia multilineage dysplasia ringed sideroblasts
0, succinylcholine ovarian serous cystadenocarcinoma diagnosis creatinine no greater institutional upper limits normal three twenty nine ten
0, tacrolimus multiple myeloma plasma cell neoplasm diagnosis biologic therapy
0, pertuzumab tumor length longitudinal less ten cm radial less five cm
1, mycophenolate mofetil stage iii adult immunoblastic large cell lymphoma diagnosis prior autologous allogeneic stem cell transplant myeloablative preparative regimen if equal less eighteen years old prior myeloablative transplant within last six months
0, sirolimus stage iv skin melanoma diagnosis prior brain metastases allowed provided all following criteria met
0, immunoglobulins recurrent ovarian carcinoma diagnosis nine dl doc mmol without transfusion erythropoietin epo dependency within seven days assessment
0, docetaxel peritoneal cavity cancer diagnosis relative proportions ast alt alkaline phosphatase according one following criteria
0, albumin bound paclitaxel ovarian cancer diagnosis bilirubin less doc uln ctc grade
1, succinylcholine stage iia cervical cancer diagnosis history active clinically significant bleeding
1, irinotecan malignant gliomas diagnosis must have recovered from effects surgery
0, doxorubicin metastatic breast cancer diagnosis ecog performance status zero one
0, vidarabine stage adult lymphoblastic lymphoma diagnosis must have less five marrow blasts at time transplant
1, levoleucovorin pancreatic cancer diagnosis complete occlusion main portal vein causing portal hypertension
1, everolimus non hematologic cancers diagnosis uncontrolled severe concurrent medical condition including cardiovascular disease myocardial infarct unstable angina new york heart association nyha class ii greater congestive heart failure serious arrhythmias requiring medication treatment clinically significant pericardial disease cardiac amyloidosis transient ischemic attacks cva coronary artery other vascular stents
0, etoposide concurrent intraductal lobular carcinoma situ allowed
0, endothelial growth factors stage iiib skin melanoma diagnosis patients must have measurable disease defined at least one lesion that can be accurately measured at least one dimension longest diameter be recorded greater ten mm computed tomography ct scan clinically must be measurable calipers according recist version doc
1, vaccines stage iia lung carcinoma diagnosis concomitant systemic treatment corticosteroids anti histamine non steroidal anti inflammatory drugs aspirin greater three hundred twenty five mg specific cyclooxygenase cox two inhibitors permitted
1, ado trastuzumab emtansine breast cancer diagnosis clinically radiologically detectable metastasis mone disease
0, external beam radiation therapy stage iii cervical cancer diagnosis patient informed follow possible
1, albumin bound paclitaxel stage iva cervical cancer diagnosis any other major illness which investigator judgment will substantially increase risk associated patient participation this study
1, pazopanib non small cell lung cancer diagnosis note
0, local radiotherapy lymphomas non hodgkin diagnosis four weeks
0, thalidomide recurrent adult diffuse large cell lymphoma diagnosis fourteen days prior again within twenty four hours prescribing lenalidomide cycle one prescriptions must be filled within seven days
1, endothelial growth factors concurrent malignancies evidence active measurable disease except basal cell carcinoma skin
0, albumin bound paclitaxel stage iia breast cancer diagnosis women reproductive potential must agree use an effective non hormonal method contraception example condoms some intrauterine devices diaphragms tubal ligation vasectomized partner abstinence during therapy at least six months arm one patients at least seven months arm two patients after last dose therapy chemotherapy trastuzumab
0, histone deacetylase inhibitors recurrent adult immunoblastic large cell lymphoma diagnosis any condition including presence laboratory abnormalities that places subject at unacceptable risk if he she were participate confounds ability interpret data from study
1, placebo advanced hepatocellular carcinoma diagnosis patient has known allergy hypersensitivity tac one hundred one doxorubicin epirubicin other anthracyclines anthracenediones any components used drug formulations
1, tailored web based care program health navigationÂ® cancer related fatigue diagnosis sgot sgpt greater forty iu l
1, vidarabine stage iv adult lymphoblastic lymphoma diagnosis human immunodeficiency virus hiv positive
0, other must treat at least five new continuing patients metastatic colorectal cancer per quarter
0, cetuximab pancreatic cancer diagnosis platelet count greater one hundred zero mmÂ³
0, dutasteride localized prostate cancer diagnosis willing able provide written informed consent
0, immunoglobulins recurrent metastatic squamous cell carcinoma neck occult primary diagnosis no history coagulopathy hemorrhagic disorders
0, dexamethasone ductal breast carcinoma situ complete surgical resection negative margins
1, prednisolone development life threatening toxic conditions not manageable by symptomatic care dose reduction delay dosing
0, imatinib mesylate breast cancer diagnosis bilirubin less upper limit normal uln
0, topotecan carcinoma unknown primary diagnosis patient characteristics
0, therapeutic allogeneic lymphocytes cancer diagnosis metastatic relapsed refractory disease after prior firs negative second line standard combination chemotherapy not candidate receive such therapy
1, regorafenib sarcoma diagnosis known history concomitant malignancy likely affect life expectancy judgment investigator
0, antibodies monoclonal malignant neoplasm respiratory intrathoracic organ carcinoma diagnosis women childbearing potential also may not be breast feeding must have negative serum urine pregnancy test within seventy two hours before start treatment
0, cediranib sarcomatous mesothelioma diagnosis prior treatment platinum based chemotherapy required
1, etoposide small cell lung cancer diagnosis contraindication known hypersensitivity lmwh unfractionated heparin ufh
0, capecitabine colorectal cancer diagnosis not specified
0, cyclophosphamide childhood burkitt lymphoma diagnosis donors must be capable giving informed consent
1, paclitaxel adenosquamous lung carcinoma diagnosis severe hepatic disease defined diagnosis child pugh class hepatic disease
1, poly adp ribose polymerase inhibitors pontine glioma diagnosis platelet count greater one hundred zero mm three transfusion independent
1, azacitidine hodgkin lymphoma diagnosis any known cardiac abnormalities
0, cyclophosphamide multiple myeloma diagnosis who performance status zero
1, gemcitabine pancreatic cancer diagnosis class iii iv congestive heart failure defined by new york heart association nyha
1, alvocidib carcinoma small cell diagnosis patients who have received three more systemic cytotoxic treatment regimens will be excluded due possible cumulative marrow suppression
1, lenalidomide recurrent adult hodgkin lymphoma diagnosis history allergic reactions attributed compounds similar chemical biological composition temsirolimus lenalidomide used study
0, immunoglobulins stage iiib non small cell lung cancer diagnosis tfour lesions any size that invade mediastinum heart great vessels trachea esophagus vertebral body carina documented by greater one following methods
1, facbc pet mri a subset participants prostate cancer diagnosis any size pelvic lymphadenopathy if it is thought be contributor concurrent hydronephrosis
1, intra operative radiation therapy iort invasive ductal carcinoma diagnosis subject has known lympho vascular invasion
1, bevacizumab concurrent treatment other anti cancer therapy including other chemotherapy immunotherapy hormonal therapy radiotherapy chemoembolization targeted therapy
1, carboplatin patients following histologies endometrial cancer not eligible enrollment
0, azd neurofibroma plexiform diagnosis distinctive bony lesion dysplasia sphenoid bone dysplasia thinning long bone cortex
0, thalidomide anaplastic large cell lymphoma diagnosis not remission but less five blasts within three weeks start conditioning chemotherapy allogeneic transplantation
1, cetuximab salivary gland squamous cell carcinoma diagnosis other concurrent severe uncontrolled concomitant medical conditions active uncontrolled infection that could cause unacceptable safety risks compromise compliance protocol
1, olaparib stage iv prostate adenocarcinoma diagnosis there is no mass effect present radiologically no steroids requirement symptom control more four weeks
1, computed tomography perfusion imaging pancreatic ductal adenocarcinoma diagnosis women who pregnant intending become pregnant during study
0, bb colorectal cancer diagnosis not pregnant nursing
0, immunohistochemistry staining method head neck cancer diagnosis no anginal
0, quality life assessment myelodysplastic myeloproliferative neoplasms diagnosis disease indications hematopoietic stem cell transplantation hsct
0, hormones prostate cancer diagnosis at least four weeks since prior flutamide ketoconazole six weeks bicalutamide nilutamide
1, paclitaxel tubular breast cancer diagnosis any evidence sense motor nerve disorders
0, rituximab nodal marginal zone cell lymphoma diagnosis patients must have measurable disease defined lesions that can be accurately measured two dimensions by computed tomography ct magnetic resonance imaging mri medical photograph skin oral lesion plain ray other conventional technique greatest transverse diameter one cm greater palpable lesions both diameters greater equal two cm evaluable disease bone marrow patients must have ct chest abdomen pelvis within two days enrollment patients evidence adenopathy neck must have ct neck note
0, tacrolimus recurrent childhood small noncleaved cell lymphoma diagnosis patients must have related donor who is at least four antigen match at human leukocyte antigen hla b dr loci
0, carboplatin residual tumor diagnosis normal renal liver heart lung hematopoietic function
1, gossypol acetic acid stage adult immunoblastic large cell lymphoma diagnosis requirement routine use hematopoietic growth factors including granulocyte colony stimulating factor granulocyte macrophage colony stimulating factor interleukin eleven platelet transfusions maintain absolute neutrophil counts platelets counts above required thresholds entry use erythropoietin stimulating agents rbcs prior enrollment is allowed
1, folic acid stage iib gastric cancer diagnosis prior current pneumonitis
1, fluorouracil recurrent colon cancer diagnosis any following within three months prior inclusion
0, cyclophosphamide cancer diagnosis patient human leukocyte antigen hla typing should demonstrate hla aone restriction
0, carboplatin lung cancer diagnosis age
1, dacarbazine glioblastoma multiforme diagnosis inadequately controlled hypertension defined systolic blood pressure greater one hundred fifty diastolic blood pressure greater one hundred mmhg
1, carboplatin stage ivb verrucous carcinoma larynx diagnosis patients who have had initial surgical treatment other diagnostic biopsy primary site nodal sampling neck disease excluded
0, panobinostat recurrent colon cancer diagnosis baseline muga must demonstrate lvef greater equal lower limit institutional normal
1, cisplatin germ cell tumors diagnosis any existing co morbidity that could limit administration high dose chemotherapy
0, lenograstim lymphoma diagnosis diagnosis acquired immune deficiency syndrome
1, cisplatin stage ivb verrucous carcinoma oral cavity diagnosis previous treatment toll like receptor five tlrfive agonist
1, diphosphonates multiple myeloma bone lesions diagnosis evidence any following conditions per subject self report medical chart review
0, rituximab diffuse large cell lymphoma diagnosis fcbp must be referred qualified provider contraceptive methods if needed
1, dabrafenib any cancer without distant metastasis that has been treated successfully without evidence recurrence metastasis over three years
1, progel pleural air leak sealant lung cancer diagnosis has significant clinical disease condition
0, etoposide histologically cytologically diagnosed small cell lung cancer
0, alvocidib recurrent adult cell leukemia lymphoma diagnosis bone marrow plasmacytosis ten twenty nine marrow cellularity
1, cyclophosphamide multiple myeloma diagnosis doc grade greater two peripheral neuropathy
1, antibodies mantle cell lymphoma diagnosis john wort
0, interleukin stage multiple myeloma diagnosis eligibility vaccine preparation
1, abr tasquinimod prostate cancer diagnosis exposure ketoconazole other strong cypthreeafour inhibitors inducers intravenously orally within four days prior inclusion
0, amifostine stage iii multiple myeloma diagnosis creatinine clearance greater equal sixty cc min estimated measured
1, immunoglobulin g fallopian tube endometrioid adenocarcinoma diagnosis patients receiving concurrent immunotherapy radiotherapy
0, antibodies monoclonal recurrent melanoma diagnosis one hundred days after infusion no evidence graft versus host disease gvhd no requirement immunosuppression
0, bupivacaine patients undergo percutaneous radiofrequency ablation liver tumors
0, bevacizumab recurrent inverted papilloma paranasal sinus nasal cavity diagnosis karnofsky sixty one hundred
1, estrogens stage iv breast cancer diagnosis clinically significant electrocardiogram ecg abnormality including marked baseline prolonged qt corrected qt qtc qt interval corrected qt interval repeated demonstration qtc interval greater four hundred eighty ms family personal history long short qt syndrome brugada syndrome known history qtc prolongation torsade de pointes tdp
0, everolimus tumors diagnosis no transfusions packed red blood cells within one week starting treatment
1, immunoglobulin g lung carcinoid tumor diagnosis evidence free abdominal air not explained by paracentesis recent surgical procedures
0, iron gastric cancer diagnosis medically fit initiation palliative chemotherapy
1, etoposide phosphate small cell lung carcinoma diagnosis life threatening illness medical condition organ system dysfunction which investigator opinion could compromise subject safety interfere outcomes
1, bevacizumab soft tissue sarcoma diagnosis history stroke transient ischemic attack within six months prior enrollment
0, fludarabine mantle cell lymphoma diagnosis chronic myelogenous leukemia blast crisis
0, cytarabine recurrent follicular lymphoma diagnosis first greater relapse after initial complete remission
0, immunoglobulins adult giant cell glioblastoma diagnosis willing provide mandatory blood tissue samples correlative research purposes phase ii
1, celecoxib familial adenomatous polyposis diagnosis men greater one hundred two cm greater forty women greater eighty eight cm greater thirty five in
0, megestrol stage zero uterine corpus cancer diagnosis patients must have signed an approved informed consent authorization permitting release personal health information
0, brachytherapy breast cancer diagnosis prior concurrent therapy
1, lenalidomide noncontiguous stage ii mantle cell lymphoma diagnosis positive serology hepatitis hc defined positive test hcab
0, methylprednisolone acetate sarcoma diagnosis radiotherapy
0, fluorouracil stage iic colon cancer diagnosis within two weeks prior randomization there must be postoperative evidence adequate hepatic function bilirubin must be equal less upper limit normal uln unless patient has chronic grade one bilirubin elevation due gilbert disease similar syndrome due slow conjugation bilirubin
1, bortezomib cancer diagnosis anticoagulant use must be monitored accordance local institutional practice
0, antibodies monoclonal nonsquamous nonsmall cell neoplasm lung diagnosis absolute neutrophil count greater doc ten nine without granulocyte colony stimulating factor support within two weeks laboratory test used determine eligibility
1, lenalidomide stage ii thyroid gland papillary carcinoma diagnosis any history cerebrovascular accident cva transient ischemic attack within twelve months prior entry
0, etoposide phosphate clear cell renal cell carcinoma diagnosis collecting duct
0, oxaliplatin stage iiia gastric cancer diagnosis tone three tfour local invasion confined diaphragm pleura pericardium
1, cytarabine medulloblastoma diagnosis active infection
1, estradiol has known suspected carcinoma listed below that is excluded administration ortho novum tablet would be contraindicated
1, auranofin stage iv non small cell lung cancer diagnosis history congestive heart failure equal less three months unless ejection fraction greater forty
1, regorafenib pancreatic polypeptide tumor diagnosis patients known brain metastases should be excluded from this clinical trial
1, mycophenolate mofetil recurrent adult burkitt lymphoma diagnosis cardiac ejection fraction less forty
0, cyclophosphamide multiple myeloma plasma cell neoplasm diagnosis not meeting criteria other bmt studies
0, alvocidib adult mixed cellularity hodgkin lymphoma diagnosis ecog eastern cooperative oncology group zero two
1, melphalan non hodgkin lymphoma diagnosis significant infection uncontrolled bleeding
1, etoposide phosphate non hodgkin lymphoma diagnosis any preexisting medical condition sufficient severity prevent full compliance study
1, gemcitabine cholangiocarcinoma diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior day zero anticipation need major surgical procedure during course fine needle aspirations core biopsies within seven days prior day o
0, gemcitabine extrahepatic bile duct cancer diagnosis see disease characteristics
1, fludarabine phosphate angioimmunoblastic cell lymphoma diagnosis donor
0, podophyllotoxin aids related plasmablastic lymphoma diagnosis histologically cytologically documented activated cell like abc also known post gcb subtype
0, vidarabine recurrent marginal zone lymphoma diagnosis not eligible conventional myeloablative hct after autologous hct
0, melphalan brain central nervous system tumors diagnosis prior receiving total marrow irradiation tmi patients should have hemoglobin greater ten gm dl platelet count greater twenty zero Î¼l
1, carboplatin ovarian cancer diagnosis history abdominal fistula gi perforation intra abdominal abscess
1, lenograstim nodal marginal zone cell lymphoma diagnosis patient has an absolute neutrophil count anc less doc ten nine within fourteen days before enrollment
0, lapatinib recurrent adult primary liver cancer diagnosis patients may have received prior radiation therapy three weeks must have elapsed since completion prior radiation therapy patients must have recovered from all toxicities measurable disease must either be outside previous radiation field progressing within radiated field new lesion must be present
0, bevacizumab ovarian transitional cell carcinoma diagnosis willing return enrolling institution follow up two four weeks after treatment discontinuation
0, methylprednisolone acetate recurrent cutaneous cell non hodgkin lymphoma diagnosis karnofsky greater equal seventy ecog zero one
0, methylprednisolone hemisuccinate lymphoma diagnosis pulmonary
1, paclitaxel stage iv pancreatic cancer diagnosis known left ventricular ejection fraction lvef assessed by two dimensional two echocardiogram echo less fifty lower limit normal whichever is higher multiple gated acquisition scan muga less forty five lower limit normal whichever is higher
0, valrubicin bladder cancer diagnosis chemotherapy
0, cyclophosphamide melanoma skin diagnosis absolute neutrophil count greater one zero mm three without support filgrastim csf
1, prednisolone lymphoma large cell diffuse diagnosis contraindication any drug contained chemotherapy regimen
0, erlotinib hydrochloride lung cancer diagnosis women not breastfeeding
1, immunoglobulins adequately treated carcinoma situ without evidence disease breast cervical cancer situ
1, pemetrexed stage iiia non small cell lung cancer diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated methoxyamine
0, dexamethasone phosphate lymphoma diagnosis performance status
1, nivolumab subjects carcinomatous meningitis
0, immunoglobulins localized malignant mesothelioma diagnosis no known brain metastases
0, fludarabine phosphate lung cancer diagnosis serum creatinine less equal doc mg dl
1, cyclosporine multiple myeloma diagnosis pulmonary function
0, busulfan recurrent adult cell leukemia lymphoma diagnosis all patients acute promyelocytic leukemia first complete remission who have received retinoic acid chemotherapy not eligible
0, doxorubicin lymphoma diagnosis patient characteristics
0, nivolumab refractory malignant neoplasm diagnosis no history non malignancy acquired immune deficiency syndrome aids defining conditions other historical low cdfour positive cell counts
0, vorinostat stage iii colon cancer diagnosis negative pregnancy test
1, methylprednisolone acetate prostate cancer diagnosis e
0, sorafenib metastatic renal cell carcinoma diagnosis sexually active participants their partners must agree use medically accepted methods contraception
0, antibodies monoclonal part negative advanced solid tumors diagnosis evaluable measurable non measurable disease by recist doc criteria
0, goserelin prostate cancer diagnosis hemoglobin greater one doc dl
1, etoposide phosphate recurrent adult diffuse large cell lymphoma diagnosis any prior use lenalidomide
0, cyclosporins lymphoma diagnosis recurrent disease remission defined morphological remission bone marrow aspirate biopsy showing less five within four weeks before start treatment cytogenetic molecular remission is not required
1, cyclophosphamide noncontiguous stage ii mantle cell lymphoma diagnosis patient donor history hepatitis or positive serology consistent previous hepatitis infection patients donor who received hepatitis vaccination acceptable
1, dexamethasone phosphate multiple myeloma diagnosis within four weeks since any plasmapheresis
1, propranolol hemangioma on lip
1, thalidomide multiple myeloma diagnosis treatment corticosteroids indications other mm is permitted
0, f rgd k melanoma diagnosis subject is capable communicating personnel
1, vidarabine testicular lymphoma diagnosis patients rapidly progressive aggressive nhl unless minimal disease state
0, mitomycins transitional cell carcinoma bladder diagnosis eastern cooperative oncology group ecog performance status zero two
1, antibodies monoclonal ovarian clear cell adenocarcinoma diagnosis patients anticipation invasive procedures defined below
1, paclitaxel ovarian cancer diagnosis replacement therapy thyroxine insulin physiologic corticosteroid replacement therapy adrenal pituitary insufficiency etc
1, dexamethasone multiple myeloma diagnosis pregnant breastfeeding females
1, trastuzumab breast cancer diagnosis severe uncontrolled hypertension history congestive heart failure severe coronary arterial disease
0, cyclophosphamide multiple myeloma plasma cell neoplasm diagnosis plasma cells less thirty marrow nucleated cells marrow showing normal hematopoietic activity
1, hydroxocobalamin lung cancer diagnosis please note
0, vaccines triple negative breast carcinoma diagnosis hertwo ihc expression two positive situ hybridization non amplified
1, etoposide stage iii childhood anaplastic large cell lymphoma diagnosis john wort not eligible topical use these medications if applicable is allowed
0, bevacizumab clear cell renal cell carcinoma diagnosis women on hormone replacement therapy hrt documented serum follicle stimulating hormone fsh level greater thirty fivem iu ml
0, cisplatin regional neuroblastoma diagnosis age one less two years
1, immunoglobulin g stage iiib ovarian cancer diagnosis patients who have received prior therapy any anti vascular endothelial growth factor vegf drug including bevacizumab
0, cyclosporins recurrent mantle cell lymphoma diagnosis patients which adequate marrow biopsy specimens can not be obtained determine remission status by morphologic assessment but have fulfilled criteria remission by flow cytometry less five blasts recovery peripheral blood counts no circulating blasts may still be eligible reasonable attempts must be made obtain an adequate specimen morphologic assessment including possible repeat procedures
1, hr pem scan cancer diagnosis patient is unable undergo scanning known suspected lesion high resolution pem pet scanner due body habitus inability comply positioning requirements etc
1, everolimus recurrent adult diffuse large cell lymphoma diagnosis females who pregnant breast feeding
1, epirubicin inflammatory bilateral iv stage breast cancer
1, sirolimus cancer breast diagnosis drugs that cannot be coadministered rapamycin include but not limited to
0, bevacizumab colorectal cancer diagnosis known msi braf kras status
0, fludarabine myeloma multiple diagnosis blood related family member sibling full half offspring parent cousin niece nephew aunt uncle grandparent
0, cyclophosphamide other aggressive non dlbcl non burkitt non hodgkin cell lymphoma variants defined by two thousand eight world health organization who classification including rare cdtwenty negative cell lymphomas plasmablastic lymphoma primary effusion lymphoma also eligible grade threeb follicular lymphoma is also eligible long one above risk criteria is met
1, maleic acid recurrent adult immunoblastic large cell lymphoma diagnosis history cva within six months
1, vidarabine stage childhood large cell lymphoma diagnosis donor
0, staurosporine recurrent metastatic squamous neck cancer occult primary diagnosis more twelve weeks
0, metronidazole testicular germ cell tumor diagnosis hormone receptor status
1, trastuzumab stage iia breast cancer diagnosis ihc staining intensity
1, protein expression analysis adult anaplastic oligoastrocytoma diagnosis history signs active coronary artery disease without angina pectoris
0, cisplatin cancer diagnosis child bearing potential
1, bevacizumab breast cancer diagnosis history another pathology that may affect development protocol interpretation results
1, folic acid stage ivb colorectal cancer diagnosis disease is well controlled at baseline only requiring low potency topical steroids hydrocortisone doc hydrocortisone butyrate doc fluocinolone doc one desonide doc five alclometasone dipropionate doc five
1, bevacizumab vestibular schwannoma diagnosis prophylactic use anticoagulants is allowed warfarin one mg qd catheter prophylaxis prophylactic low molecular weight heparin enoxaparin fortymg qdzero
1, bendamustine hydrochloride adult lymphocyte depletion hodgkin lymphoma diagnosis history abdominal fistula gastrointestinal perforation equal less six months prior treatment drugs
1, vidarabine stage iii childhood anaplastic large cell lymphoma diagnosis age less twelve years
0, erlotinib hydrochloride recurrent childhood medulloblastoma diagnosis no concurrent htwo blockers
1, everolimus recurrent prostate carcinoma diagnosis immunosuppressive agents within three weeks before treatment nab rapamycin except corticosteroids used antiemetics
1, itraconazole prostate cancer diagnosis prolonged corrected qt interval greater four hundred fifty msec on electrocardiography
0, immunoglobulin g patients lymphoid leukemias lymphomas not easily classified above categories will be eligible providing they have failed standard therapy not eligible have refused bone marrow transplantation
1, methotrexate primary non hodgkin lymphoma central nervous system diagnosis cardiac ejection fraction less fifty uncontrolled malign arrhythmia
0, methotrexate nonmalignant neoplasm diagnosis ast less three times upper limit normal
0, cyclophosphamide b cell lymphoma unclassifiable features intermediate between diffuse large cell lymphoma burkitt lymphoma diagnosis thirteen thousand two hundred seventy seven who collected autologous cells coh irb protocol no
1, tacrolimus stage iii childhood anaplastic large cell lymphoma diagnosis liver function abnormalities
0, dacarbazine neuroblastoma diagnosis patients previously treated only one two drugs eligible
1, antibodies stage iiib primary peritoneal cancer diagnosis patients acute hepatitis active infection that requires parenteral antibiotics
1, tak advanced solid tumor lymphoma malignancies diagnosis escalation cohort expansion cohorts excluding ptld autologous stem cell transplant within six months before day one cycle one prior allogeneic stem cell transplant at any time
0, lenalidomide stage marginal zone lymphoma diagnosis received high dose chemotherapy autologous stem cell transplantation asct from forty two one hundred twenty eight days before enrollment stable disease partial response complete response following asct
1, r chop diffuse large cell lymphoma diagnosis if hbsag positive should check hbv dna dna positive patients cannot be enrolled
1, iodobenzylguanidine mibg avid tumors diagnosis pregnancy breast feeding
1, cyclophosphamide diffuse large cell lymphoma diagnosis patients who did not conform above criteria
1, dexamethasone acetate ovarian neoplasm diagnosis prior use must be greater one month vpa
0, lenalidomide pancreatic cancer diagnosis subjects must be able adhere visit schedule other protocol requirements
0, antibodies monoclonal stage iv squamous cell carcinoma lip oral cavity diagnosis more twenty eight days since prior major surgery open biopsy
0, trastuzumab recurrent breast cancer diagnosis fasting plasma glucose fpg less one hundred forty mg dl doc mmol l
1, immunoglobulins stage iva uterine corpus cancer diagnosis history cerebrovascular accident cva stroke transient ischemic attack tia subarachnoid hemorrhage within six months first date therapy
1, fluorouracil stage iia pancreatic cancer diagnosis carbamazepine phenobarbital
1, fluoroquinolones refractory solid tumors diagnosis subjects history gastrointestinal surgery hepatectomy nephrotomy digestive organ resection etc
0, carboplatin stage ivb major salivary gland carcinoma diagnosis patients who meet following criteria will be excluded
0, beclomethasone contiguous stage ii adult diffuse large cell lymphoma diagnosis pregnancy breast feeding
1, antibodies monoclonal recurrent adult lymphoblastic lymphoma diagnosis active infection history opportunistic infections
1, vaccines infections papillomavirus diagnosis hypersensitivity latex
1, paclitaxel recurrent platinum resistant ovarian cancer diagnosis qtcf interval greater four hundred seventy msecs
1, decision aid women who have been previously diagnosed breast cancer have tested positive breast cancer gene will not be included
1, melphalan recurrent grade two follicular lymphoma diagnosis left ventricular ejection fraction lvef less fifty coronary artery disease requiring treatment
1, vaccines stage ic fallopian tube cancer diagnosis concomitant systemic treatment corticosteroids anti histamine non steroidal anti inflammatory drugs other platelet inhibitory agents
1, dexamethasone breast cancer diagnosis asa class iv patients
1, niacinamide kidney cancer diagnosis because patients immune deficiency at increased risk lethal infections when treated marrow suppressive therapy hiv positive patients receiving combination anti retroviral therapy excluded
0, gemcitabine neoplasms ovarian diagnosis at least four weeks since last surgery radiation therapy
0, immunoglobulins contiguous stage ii grade two follicular lymphoma diagnosis absolute neutrophil count greater equal one five hundred mm three
0, cyclophosphamide precancerous condition diagnosis failed conventional therapy
1, alemtuzumab recurrent adult immunoblastic large cell lymphoma diagnosis donor is hiv positive has medical condition that would result increased risk filgrastim csf mobilization harvest pbsc
0, irinotecan gliosarcoma diagnosis active connective tissue disorders such lupus scleroderma that opinion treating physician may put patient at high risk radiation toxicity
1, carboplatin stage iv fallopian tube cancer diagnosis stage not greater b no more superficial myometrial invasion without vascular lymphatic invasion no poorly differentiated subtypes including papillary serous clear cell other figo grade three lesions
0, interleukin recurrent adult immunoblastic large cell lymphoma diagnosis note
0, everolimus sarcoma diagnosis patients their legal guardian must sign an informed consent
1, oxaliplatin colorectal cancer diagnosis patients will be excluded from any following reasons
0, cyclosporins recurrent marginal zone lymphoma diagnosis fhcrc only
0, dacarbazine adult mixed glioma diagnosis more twenty eight days since prior no concurrent investigational agents
0, etoposide embryonal botryoid childhood rhabdomyosarcoma diagnosis negative pregnancy test
0, levoleucovorin stage iib colon cancer diagnosis eligible patients reproductive potential both sexes must agree use an accepted effective method contraceptive during therapy at least three months after completion bevacizumab women must not be pregnant breast feeding all females childbearing potential must have serum pregnancy test rule out pregnancy within two weeks prior step two randomization
0, cyclosporins retinoblastoma diagnosis renal
0, mycophenolate mofetil recurrent grade three follicular lymphoma diagnosis myelofibrosis cmml
0, alvocidib extrapulmonary small cell carcinoma allowed
0, everolimus refractory hodgkin lymphoma diagnosis patients onest chronic phase cpone must have failed be intolerant tyrosine kinase inhibitors tki patients beyond cpone will be accepted if they have less five marrow blasts at time transplant
1, carboxymethylcellulose sodium glioblastoma multiforme diagnosis this includes inflammatory bowel disease ulcerative colitis crohn disease systemic vasculitis scleroderma psoriasis multiple sclerosis hemolytic anemia immune mediated thrombocytopenia rheumatoid arthritis systemic lupus erythematosus sjogren syndrome sarcoidosis other rheumatologic disease any other medical condition use medication which might make it difficult patient complete full course treatments generate an immune response vaccines
0, cetuximab stage iva squamous cell carcinoma paranasal sinus nasal cavity diagnosis locally advanced recurrent no longer amenable local surgical radiation therapy or
1, paclitaxel hertwo negative breast cancer diagnosis patients hypertension that is well controlled on medication eligible
0, carmustine melanoma skin diagnosis hematopoietic
0, paclitaxel primary peritoneal carcinoma
0, immunoglobulins stage iiic fallopian tube cancer diagnosis activated prothrombin time aptt equal less doc uln
0, topotecan esophageal cancer diagnosis prior treatment doxorubicin is permitted if total dose was three hundred fifty mg mtwo less
1, immunoglobulins stage ivb colorectal cancer diagnosis other types vaccines including inactivated killed toxoid inactivated toxoid subunit conjugate all permitted at any time
0, immunoglobulins adenocarcinoma colon diagnosis no prior allergic reaction known sensitivity chimerized murine monoclonal antibody therapy
0, cilengitide childhood grade iii meningioma diagnosis cilengitide was teratogenic when tested animals such female patients childbearing potential must have negative serum urine pregnancy test prior entry female patients must avoid breast feeding while on study
0, aldesleukin stage iv breast cancer diagnosis leptomeningeal disease
1, pain symptom questionnaire advanced cancers diagnosis one patients significant pulmonary dysfunction large intracranial metastases significant thrombocytopenia platelet count refractory transfusion
1, mycophenolic acid recurrent grade two follicular lymphoma diagnosis donor
1, irinotecan gastric adenocarcinoma diagnosis gilbert disease
1, everolimus unstable angina pectoris symptomatic congestive heart failure myocardial infarction within six months start drug serious uncontrolled cardiac arrhythmia any other clinically significant cardiac disease
0, vidarabine recurrent adult diffuse small cleaved cell lymphoma diagnosis best available matches hla class hla b allele matched donors allowing any one two drbone dqbone antigen allele mismatch
1, fludarabine stage childhood small noncleaved cell lymphoma diagnosis patients greater grade ii hypertension by common toxicity criteria ctc
0, placebo cancer diagnosis not specified renal
0, antibodies monoclonal ovarian seromucinous carcinoma diagnosis suitably recovered from prior localized therapy opinion investigator
1, docetaxel prostate cancer diagnosis severe active co morbidity defined follows active co morbidity defined follows
0, tamoxifen stage iia breast cancer diagnosis willing able sign an informed consent
1, imatinib mesylate prostate cancer diagnosis patient any significant history non compliance medical regimens inability grant reliable informed consent
1, methotrexate recurrent mantle cell lymphoma diagnosis twelve pediatric
1, oxaliplatin ovarian cancer diagnosis positive human immunodeficiency virus hiv hepatitis hepatitis b
1, tacrolimus childhood diffuse large cell lymphoma diagnosis eligible high priority curative autologous transplant
0, tipifarnib myelodysplastic myeloproliferative neoplasms diagnosis no other concurrent severe disease that would preclude compliance
1, ceritinib head neck cancer diagnosis condom is required be used also by vasectomized men order prevent delivery drug via seminal fluid
1, androgens prostatic neoplasms diagnosis active medical problems that interfere arestm reading use device
0, gemcitabine biliary cancer diagnosis measurable disease
1, prednisone sarcoma diagnosis effects upon breast milk also unknown may potentially be harmful infant
0, irinotecan stage iv gastric cancer diagnosis estrogen receptor negative
1, liposomal doxorubicin tumors breast diagnosis known human immunodeficiency virus hiv infection chronic hepatitis c
1, part dose expansion duvortuxizumab precursor cell lymphoblastic leukemia lymphoma diagnosis prior treatment therapeutic agent targeting cdnineteen cdthree
1, arginine butyrate tumor impinging on an organ anatomical structure deemed critical by investigator
0, cisplatin extragonadal germ cell tumor diagnosis retroperitoneum
0, cyclosporins lymphoma diagnosis patient characteristics
0, antibodies recurrent adenoid cystic carcinoma oral cavity diagnosis no other uncontrolled illness
1, dexamethasone t cell lymphoma diagnosis active uncontrolled infection viral bacterial fungal infection
0, screening method stage iii vulvar cancer diagnosis hiv positive human immunodeficiency virus hiv negative women will be enrolled hiv testing will not be performed part study
1, vidarabine stage iv renal cell cancer diagnosis fungal infections radiological progression after receipt amphotericin active triazole greater one month
1, pharmacological pancreatic polypeptide tumor diagnosis history known active diverticulitis within past three months
0, antibodies stage iv squamous cell carcinoma larynx diagnosis eastern cooperative oncology group ecog performance status equal less two karnofsky greater equal sixty
1, maleic acid stage iv adult diffuse small cleaved cell lymphoma diagnosis clinically significant peripheral vascular disease
0, carboplatin extragonadal germ cell tumor diagnosis total bilirubin less doc times uln
0, immunoglobulins stage iii verrucous carcinoma larynx diagnosis verapamil
1, immunoglobulin fc fragments recurrent fallopian tube carcinoma diagnosis platelet function abnormality
1, mitogens stage iii adult hodgkin lymphoma diagnosis any prior local irradiation field that included thymus total body irradiation is allowed
1, methylprednisolone prostate cancer diagnosis prior surgery less four weeks registration study
0, ethiodized oil diagnosis hepatocellular carcinoma hcc
1, immunoglobulins stage iva oropharyngeal squamous cell carcinoma diagnosis any condition that opinion investigator would interfere evaluation treatment interpretation patient safety results
1, sirolimus stage iic fallopian tube cancer diagnosis any condition which investigator opinion deems patient an unsuitable candidate receive drug any significant medical illness abnormal laboratory finding that would investigator judgment increase subject risk by participating this study
1, temozolomide carcinoma squamous cell diagnosis subject is situation condition that opinion investigator may interfere optimal participation study
1, immunoglobulins recurrent prostate cancer diagnosis prisoners patients who compulsorily detained involuntarily incarcerated treatment either psychiatric physical infectious illness
0, fludarabine phosphate stage iv marginal zone lymphoma diagnosis no more six prior courses fludarabine
0, fludarabine intraocular lymphoma diagnosis patients will be accepted beyond first clinical progression cpone if they have received previous myelosuppressive chemotherapy hct have less five marrow blasts at time transplant
1, prolactin release inhibiting factors metastatic hormone sensitive prostate cancer diagnosis subject received treatment estrogens cyprotoerone acetate androgens within four weeks prior day one
1, tenovus cancer choir cancer diagnosis participants who pregnant
1, methotrexate breast cancer diagnosis lack consent after informing patient
1, romidepsin recurrent adult lymphoblastic lymphoma diagnosis st
1, temozolomide unspecified adult solid tumor diagnosis concurrent disease condition that would interfere participation safety such as
1, liposomal doxorubicin unspecified adult solid tumor protocol specific diagnosis patients known brain metastases should be excluded from this clinical trial because their poor prognosis because they often develop progressive neurologic dysfunction that would confound evaluation neurologic other adverse events
0, doxorubicin adequate bone marrow reserve defined an absolute peripheral granulocyte count greater equal one thousand five hundred mmthree platelet count greater equal seventy five zero mmthree unless bone marrow infiltrated metastatic ewing sarcoma anc greater equal five hundred platelet greater equal fifty zero mmthree
0, tacrolimus contiguous stage ii grade one follicular lymphoma diagnosis pregnancy breast feeding
1, educational intervention recurrent breast cancer diagnosis subnormal intellectual potential diagnosis mental retardation
0, niacinamide stage iii renal cell cancer diagnosis scans must be obtained within four weeks randomization changes on these scans that felt be post surgical must be documented
0, docetaxel lung cancer diagnosis surgery
1, aldesleukin metastatic pancreatic cancer diagnosis women child bearing potential who pregnant breastfeeding because potentially dangerous effects treatment on fetus infant
1, bb stage iii adult lymphoblastic lymphoma diagnosis breakpoint cluster region abelson positive bcr abl positive patients will be excluded from study
1, camptothecin solid tumors diagnosis presence serious cardiac congestive heart failure angina pectoris myocardial infarction within one year prior entry uncontrolled hypertension arrhythmia neurological psychiatric disorder
1, fluorodeoxyglucose f cancer cervix diagnosis o previous treatment pregnancy
1, memantine brain cancer diagnosis patients must not be pregnant breast feeding must agree practice adequate contraception acceptable forms birth control include condom spermicide diaphragm spermicide non barrier contraception such tubal ligation vasectomy oral contraceptives implanted levonorgestrel vaginal hormonal contraceptive ring
1, cd cart lymphoma cell diagnosis diagnosis classification undefined
1, dacarbazine pancreatic cell carcinoma diagnosis myocardial infarction
1, vincristine aids related non hodgkin lymphoma diagnosis patients may not be receiving any other investigational agents concurrent biological chemotherapy radiation therapy
0, bevacizumab metastatic pancreatic cancer diagnosis patient must have measurable disease
0, albumin bound paclitaxel stage iiib breast cancer diagnosis absolute neutrophil count anc greater equal one zero ul
1, external beam radiation prostate cancer diagnosis patients pacemakers cerebral aneurysm clips shrapnel injury implantable electronic devices
1, dacarbazine situ cervical carcinoma basal cell skin carcinoma accepted
0, indinavir sarcoma diagnosis hepatic
0, conventional surgery adrenocortical carcinoma diagnosis creatinine less doc mg dl
0, antibodies bispecific malignant ovarian clear cell tumor diagnosis each patient must be aware nature her disease process must willingly consent treatment after being informed alternatives potential benefits side effects risks eligibility testing that is considered standard care may be done prior informed consent but no immunotherapy related procedures testing may occur without informed consent
0, sirolimus stage marginal zone lymphoma diagnosis have seventeenp deletion cytogenetic abnormality patients should have received induction chemotherapy but could be transplanted onest cr
0, methylprednisolone acetate stage iii childhood large cell lymphoma diagnosis clinical spinal cord compression
1, liposomal doxorubicin stage iv mantle cell lymphoma diagnosis chronic current infectious disease requiring systemic antibiotics antifungal antiviral treatment such but not limited chronic renal infection chronic chest infection bronchiectasis tuberculosis active hepatitis c
0, antilymphocyte serum lymphoma diagnosis platelet count less twenty zero mm three
1, vaccines breast neoplasms diagnosis previously resected brain metastases unless ct mri scan brain shows no metastasis within one month receiving dpx nine hundred seven
0, immunoglobulins adenocarcinoma colon diagnosis platelet count greater equal one hundred zero mcl
1, immunoglobulins malignant glioma diagnosis mean qt interval corrected heart rate qtc greater equal four hundred seventy ms calculated from an electrocardiograms ecgs using bazett correction if first ecg is abnormal then mean will be calculated from three consecutive ecgs taken two five minutes apart please contact pi further clarification
1, fludarabine adult nasal type extranodal nk cell lymphoma diagnosis donors
0, poly iclc smoldering multiple myeloma diagnosis abnormal serum flc ratio doc negative doc five
0, paclitaxel ovarian cancer diagnosis pretreatment serum hcg five zero five zero iu l
1, camptothecin metastatic breast cancer diagnosis has received organ allograft other corneal bone skin
1, carboplatin carcinoma breast stage iv diagnosis has had prior chemotherapy targeted small molecule therapy radiation therapy within two weeks prior day one who has not recovered less grade one at baseline from adverse events due previously administered agent
0, pharmacodynamic studies stage iii adult diffuse small cleaved cell lymphoma diagnosis patients their legal representatives must be able read understand provide informed consent participate trial
0, bortezomib recurrent adult diffuse mixed cell lymphoma diagnosis no concurrent radiotherapy
1, dexamethasone acetate noncontiguous stage ii grade one follicular lymphoma diagnosis patients active hepatitis virus hbv infection hepatitis hepatitis positive serology
0, immunoglobulins noncontiguous stage ii small lymphocytic lymphoma diagnosis no prior decompensated congestive heart failure unstable angina myocardial infarction within past six months not corrected by percutaneous transluminal coronary angioplasty surgery
0, recombinant ephb hsa fusion protein stage prostate cancer diagnosis serum creatinine less doc uln
0, radiation therapy stage iii adult soft tissue sarcoma diagnosis total bilirubin equal less doc times upper limit normal
0, carboplatin head neck cancer diagnosis clinical stage iii ivb ttwo tfour nzero nthree mzero disease
1, levoleucovorin recurrent colon cancer diagnosis unwillingness participate inability comply protocol duration study
1, therapeutic conventional surgery recurrent breast cancer diagnosis patient has evidence distant metastases
1, cisplatin solid tumors diagnosis participant has history suggestive li fraumeni syndrome
1, exercise intervention fallopian tube endometrioid adenocarcinoma diagnosis patients who have had surgery weight loss
0, etoposide multiple myeloma plasma cell neoplasm diagnosis first complete remission without appropriate allogeneic donor
0, obinutuzumab recurrent small lymphocytic lymphoma diagnosis grades one threea
0, bortezomib childhood choroid plexus tumor diagnosis no known curative therapy therapy proven prolong survival an acceptable quality life
1, albumin bound paclitaxel stage iiib fallopian tube cancer diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior first date bevacizumab therapy cycle two
1, bevacizumab cervical adenosquamous carcinoma diagnosis myocardial infarction unstable angina equal less six months prior registration
1, clonidine breast cancer diagnosis if patients have been off these one month then they eligible
0, lenalidomide lymphoma diagnosis females these restrictions apply at least four weeks before treatment during period therapy one month after last dose drug
0, injection hx cancer diagnosis capable complying procedures
1, sunitinib metastatic renal cell carcinoma diagnosis patient included another clinical trial except supportive care trials
1, everolimus extra adrenal paraganglioma diagnosis prior chemotherapy radiation therapy surgery within four weeks prior entry except palliative radiotherapy non target lesions within two weeks prior entry
1, etoposide recurrent grade one follicular lymphoma diagnosis previous systemic chemotherapy immunotherapy within three weeks before entry
0, oxaliplatin gastric cancer diagnosis patients must have normal organ marrow function defined below
1, poly adp ribose polymerase inhibitors pontine glioma diagnosis age greater fifteen years
0, temozolomide recurrent childhood brain stem glioma diagnosis patients who have had prior radiation must have had their last fraction of
0, cisplatin hepatosplenic gamma delta cell lymphoma diagnosis isolated hyperbilirubinaemia due gilbert disease is acceptable
0, albumin bound paclitaxel lung cancer diagnosis age
1, rituximab anaplastic large cell lymphoma diagnosis known hypersensitivity thalidomide
1, saracatinib adenocarcinoma stomach diagnosis negative pregnancy test
0, oxaliplatin adult primary cholangiocellular carcinoma diagnosis fertile patients must use adequate contraception hormonal barrier method birth control abstinence before during treatment
0, fludarabine metastatic cancer diagnosis serology
1, l malignant melanoma diagnosis cytotoxic chemotherapy radiation treatment within three weeks prior initiation
1, fludarabine phosphate stage iii adult burkitt lymphoma diagnosis current serious systemic illness that would result increased risk csf mobilization harvest peripheral blood stem cells pbsc
1, vaccines human papillomavirus infection diagnosis currently user illegal drugs an alcohol abuser
0, mitogens head neck cancer diagnosis at least four weeks since prior biologic therapy chemotherapy
1, antibodies extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis history inflammatory bowel disease crohn disease ulcerative colitis celiac disease other chronic gastrointestinal conditions associated diarrhea current acute colitis any origin
1, cyclosporins recurrent small lymphocytic lymphoma diagnosis active central nervous system cns leukemia involvement at time enrollment cerebrospinal fluid greater five white blood cells wbc mm three malignant cells on cytospin
1, neurologic evaluation hodgkin lymphoma diagnosis history congenital heart disease reported literature be associated neurocognitive status determined by principal investigators
1, bendamustine hydrochloride receiving any other investigational agent concurrently which would be considered treatment primary neoplasm
1, cortisone acetate cognitive side effects cancer therapy diagnosis patients bcr ablone fusion not eligible post induction therapy on this but may be eligible enroll successor children oncology group cog philadelphia positive ph positive all trial by day one induction
0, vincristine lymphoma diagnosis patient characteristics
0, ivac w bre uid breast cancer triple negative breast cancer tnbc diagnosis haemoglobin greater ten dl
0, doxorubicin lymphoma diagnosis ast alt no greater two times uln
1, paclitaxel metastatic breast cancer diagnosis pregnancy breast feeding
1, ketoconazole recurrent neuroblastoma diagnosis steroids routine metabolic deficiency states allowed
0, cyberknife stereotactic radiosurgery prostatic cancer diagnosis patients belonging one following risk categories
1, etoposide phosphate non hodgkin lymphoma diagnosis known cns disease
0, belinostat tumor diagnosis signed written institutional review board irb approved informed consent
0, gene expression analysis hereditary multiple melanoma diagnosis patient characteristics
1, etoposide stage iv aids related lymphoma diagnosis active infection requiring systemic antibiotic therapy antibacterial antifungal antiviral agents excluding hiv
0, fludarabine melanoma diagnosis any patient receiving il two must sign durable power attorney
0, paclitaxel adenocarcinoma gastroesophageal junction diagnosis female patients childbearing potential must be willing use two methods birth control be surgically sterile abstain from heterosexual activity course through two days after last dose medication
1, cyclosporine recurrent small lymphocytic lymphoma diagnosis donor
0, methotrexate multiple myeloma plasma cell neoplasm diagnosis no psychosocial conditions that would preclude no uncontrolled diabetes mellitus no uncontrolled thyroid disease no active serious infections hiv negative not pregnant nursing negative pregnancy test
0, therapeutic autologous lymphocytes peritoneal cavity cancer diagnosis performance status
0, aldesleukin melanoma diagnosis normal total bilirubin except patients liver metastases which total bilirubin less equal doc uln will be permitted patients gilbert syndrome must have total bilirubin less that doc mg dl
1, sorafenib hepatocellular carcinoma hcc diagnosis positive serum pregnancy test human chorionic gonadotropin within seven days prior enrollment unwilling unable undergo hormonal suppression avoid menstruation during treatment
1, iron hereditary haemochromatosis diagnosis normal sf sf greater one thousandÂµg l
0, vitamin b complex malignant mesothelioma diagnosis platelet count greater one hundred zero mm three
1, akt inhibitor mk endometrial clear cell adenocarcinoma diagnosis hgbaonec greater doc fasting glucose greater one mg dl will exclude patients from entry on patients requiring insulin control their hyperglycemia excluded from entry on this study
0, irinotecan recurrent nasopharyngeal cancer diagnosis able tolerate enteral medications cefixime cefpodoxime loperamide
1, pf dacomitinib glioblastoma diagnosis congestive heart failure previous six months
1, fulvestrant stage iiia breast cancer diagnosis uncontrolled central nervous system metastases
1, capecitabine squamous carcinoma esophagus diagnosis parallel treatment another clinical prior participation this study
1, norethindrone acetate ethinyl estradiol ferrous fumarate drug combination cancer diagnosis has bazett corrected qt qtcb interval greater equal four hundred eighty milliseconds msec at screening
1, laboratory biomarker analysis refractory brain neoplasm diagnosis small molecule cell cycle inhibitors equal less two weeks prior registration
1, docetaxel mouth neoplasms diagnosis pregnancy confirmed by serum urine hcg lactation period
1, tacrolimus recurrent adult hodgkin lymphoma diagnosis adult
0, antibodies lung cancer diagnosis at least three years since prior chemotherapy except topical therapy
0, antibodies monoclonal recurrent fallopian tube carcinoma diagnosis potassium within normal reference range laboratory correction supplements is acceptable
0, vaccines noncontiguous stage ii adult diffuse large cell lymphoma diagnosis use alemtuzumab immunosuppression is not permitted this study
0, niacinamide breast cancer diagnosis platelet count greater one hundred zero mmÂ³
1, o benzylguanine hepatosplenic cell lymphoma diagnosis patients who hepatitis virus hcv antibody positive hepatitis virus hbv surface antigen positive must be free clinical evidence cirrhosis that would otherwise make them ineligible hct determined by principal investigator consultation gastrointestinal service patients hbv ongoing evidence viral replication may require therapy prior receiving high dose chemotherapy
1, asparaginase pancreatic adenocarcinoma metastatic diagnosis replacement low molecular weight heparin treatment if required
0, bortezomib ovarian transitional cell carcinoma diagnosis recovery from effects recent surgery radiotherapy chemotherapy
0, endothelial growth factors pancreatic gastrinoma diagnosis lesions that can be accurately measured at least one dimension longest diameter be recorded greater equal two cm conventional techniques greater equal one cm spiral computed tomography ct scan
0, docetaxel breast cancer diagnosis such case hormonal therapy must stop at before randomization be re started if indicated following chemotherapy
0, mitogens rhabdoid tumor diagnosis doc mg dl female serum creatinine
0, mycophenolic acid recurrent grade three follicular lymphoma diagnosis acute lymphoblastic leukemia all nine twenty two elevenqtwothree abnormality early relapse less five marrow blasts crtwo greater
0, bn breast cancer diagnosis postmenopausal defined as
0, dacarbazine brain central nervous system tumors diagnosis no ischemic heart disease within past twelve months
1, trametinib stage iv pancreatic cancer diagnosis any major surgery extensive radiotherapy greater fifteen days treatment chemotherapy delayed toxicity biologic therapy immunotherapy within twenty one days prior first dose treatment daily weekly chemotherapy without potential delayed toxicity within fourteen days prior first dose treatment
0, tacrolimus recurrent adult diffuse mixed cell lymphoma diagnosis refractory anemia excess blasts two ten two blasts
0, stereotactic radiosurgery adult giant cell glioblastoma diagnosis prior treatment fractionated radiation therapy up sixtygy is an eligibility criterion however there should not have been second course fractionated radiotherapy supratentorial area
1, thalidomide stage iva rectal cancer diagnosis patients recent history deep vein thrombosis dvt pulmonary embolism pe requiring therapy within three months
1, survey administration hereditary ovarian carcinoma diagnosis previous participation gcra
0, rituximab multiple myeloma plasma cell neoplasm diagnosis received prior alkylating agen negative thalidomid negative corticosteroi negative bortezomib containing regimens relapsed after one year treatment ineligible receive such therapies due comorbidities allergies
0, aminopterin lymphoma diagnosis chemotherapy
1, fulvestrant breast cancer diagnosis platelet count less seventy five zero
1, albumin bound paclitaxel stage iv follicular thyroid cancer diagnosis clinically significant gastrointestinal bleeding uncontrolled peptic ulcer disease
0, liposomal doxorubicin epithelioid sarcoma diagnosis karnofsky performance status score greater equal seventy patients greater sixteen years age
1, tretinoin neuroendocrine tumor diagnosis pregnancy breast feeding
0, docetaxel gastric cancer diagnosis no severe functional damage major organ no uncontrolled severe cardiopulmonary concurrent system disease
1, bendamustine hydrochloride splenic marginal zone lymphoma diagnosis requirement immediate palliative treatment any kind including surgery
1, antibodies monoclonal lymphoma non hodgkin diagnosis patients history other malignancies during past three years
1, bevacizumab locally recurrent metastatic breast cancer diagnosis pregnant ie positive beta human chorionic gonadotropin test is breast feeding
1, mitomycins cancer diagnosis serum albumin level less three dl
1, fludarabine indolent non hodgkin lymphoma diagnosis patients serologic evidence prior exposure eligible
0, we want know campaign patient survey at time points cancer survivors
1, vorinostat non small cell lung cancer diagnosis prior exposure any hdac inhibitors within previous thirty days
1, erythromycin ethylsuccinate ileo anal pouch without adenomas
1, androgens prostate neoplasms diagnosis patients who taking drugs herbal supplements which affect androgen metabolism spironolactone aprepitant bexarotene clarithromycin itraconazole ketoconazole st
0, antibodies monoclonal stage iv skin melanoma diagnosis fertile patients must use effective contraception
1, bb lymphoma cell cutaneous diagnosis an ecg recorded at screening showing evidence cardiac ischemia st depression greater two mm measured from isoelectric line st segment
0, temozolomide solid tumors diagnosis all patients greater eighteen years age must sign written informed consent
1, bevacizumab undifferentiated ovarian carcinoma diagnosis patients history evidence upon physical examination major central nervous system cns disease example
1, dasatinib non small cell lung carcinoma diagnosis patients currently taking drugs that generally accepted have risk causing torsades de pointes including
1, fludarabine phosphate small intestine lymphoma diagnosis patient has fungal infection radiological progression after receipt amphotericin active triazole greater one month
1, diphosphonates breast cancer diagnosis known hypersensitivity zometa zoledronic acid other bisphosphonates
1, erlotinib hydrochloride stage iv breast cancer diagnosis human immunodeficiency virus hiv positive patients receiving combination anti retroviral therapy excluded from study
1, antibodies monoclonal recurrent adult immunoblastic large cell lymphoma diagnosis pregnant breast feeding females lactating females must agree not breast feed while taking lenalidomide
1, lenalidomide recurrent adult diffuse small cleaved cell lymphoma diagnosis modafinil provigil
1, cisplatin non small cell lung cancer diagnosis women child bearing age unable unwilling take effective contraceptive measures
0, cyclophosphamide contiguous stage ii adult diffuse large cell lymphoma diagnosis cdfour count must be greater equal one hundred mm three
1, idelalisib recurrent extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis patients active hepatitis defined by hepatitis surface antigen positivity core antibody positivity presence hepatitis deoxyribonucleic acid dna not eligible this patients positive hepatitis core antibody but negative hepatitis dna may participate but must have hepatitis serologies hepatitis dna monitored periodically by treating physician
1, oxaliplatin stage iiia gastric cancer diagnosis neuropathy grade two greater by nci ctcae doc
1, sar neoplasm malignant diagnosis mean qtc interval greater four hundred seventy msec using qtcf formula any clinically significant qtc prolongation history torsade de pointes malignant arrhythmias conduction disturbances
0, carboplatin stage iv non small cell lung cancer diagnosis eastern cooperative oncology group ecog performance status zero one
0, cyclosporine stage iv adult hodgkin lymphoma diagnosis disease is completely absent no relapse occurred prior preparative regimen requires all following
0, rosiglitazone breast cancer diagnosis prior exemestane metformin rosiglitazone is allowed if taken longer seven days prior enrollment
1, bevacizumab cervical cancer diagnosis patients proteinuria
1, poly adp ribose polymerase inhibitors childhood mixed glioma diagnosis patients any clinically significant unrelated systemic illness serious infections significant cardiac pulmonary hepatic other organ dysfunction that would compromise patient ability tolerate protocol therapy would likely interfere procedures results
0, cisplatin non small cell lung cancer diagnosis age eighteen seventy five ecog less two lose weight less ten during six months
1, vinblastine stage iv melanoma diagnosis trimethoprim sulfamethoxazole bactrim
0, immunoglobulins recurrent melanoma diagnosis no known esophageal varices
1, everolimus recurrent solid neoplasm diagnosis patients who have received prior solid organ transplantation not eligible
0, everolimus solid tumors diagnosis anc greater one thousand mmthree platelets greater seventy five zero mmthree hemoglobin greater ninety l
1, mechlorethamine non hodgkin lymphoma diagnosis history central nervous system cns disease
0, antibodies monoclonal melanoma skin diagnosis ejection fraction greater forty five by echocardiogram thallium stress test patients greater fifty years age who have history cardiovascular disease
0, pharmacological stage iv colon cancer diagnosis no poorly controlled angina
0, vitamins stage iiia non small cell lung cancer diagnosis patient must be willing able sign informed consent prior start trial
0, antibodies recurrent grade one follicular lymphoma diagnosis has not been naturally postmenopausal at least one consecutive months has had menses at any time preceding one consecutive months
1, vidarabine refractory multiple myeloma diagnosis donor
1, mycophenolic acid stage iii adult diffuse small cleaved cell lymphoma diagnosis lansky play performance score less sixty pediatric patients
0, fludarabine phosphate multiple myeloma plasma cell neoplasm diagnosis no unstable angina within past six months
0, interferon alpha recurrent gastrointestinal carcinoid tumor diagnosis no concurrent immunotherapy
1, taxane breast cancer diagnosis other neurological diseases such multiple sclerosis
0, bortezomib multiple myeloma plasma cell neoplasm diagnosis prior concurrent therapy
1, fludarabine phosphate childhood grade iii lymphomatoid granulomatosis diagnosis patients renal failure eligible however patients renal compromise serum creatinine greater doc will likely have further compromise renal function may require hemodialysis which may be permanent due need maintain adequate serum cyclosporine levels
0, ifosfamide germ cell tumors diagnosis disease status at enrollment
0, tacrolimus recurrent grade three follicular lymphoma diagnosis diffusing capacity lung carbon monoxide dlco forced expiratory volume one second fevone forced vital capacity fvc greater fifty predicted corrected hemoglobin
0, bevacizumab lung cancer diagnosis patient characteristics
1, levoleucovorin adenocarcinoma esophagogastric junction diagnosis brain metastases
1, dacarbazine gliosarcoma diagnosis active infection requiring iv antibiotics
1, immunoglobulins one presence hemosiderin two resolving hemorrhagic changes related surgery three presence punctate hemorrhage tumor
0, questionnaire administration recurrent ovarian carcinoma diagnosis patients not on chemotherapy also eligible not required have recist criteria
0, immunoglobulins brenner tumor diagnosis no concurrent amifostine other protective agents
1, cetuximab head neck cancer diagnosis pleural pericardial effusion any grade
1, etoposide phosphate recurrent childhood anaplastic large cell lymphoma diagnosis patients who have not recovered from adverse events due agents administered more four weeks earlier or
1, immunoglobulin g prostate adenocarcinoma diagnosis any other medical intervention condition which opinion pi treating physician could compromise patient safety adherence requirements including biopsies leukapheresis procedures over primary three six month treatment period
1, bevacizumab recurrent breast carcinoma diagnosis patients recent within six months arterial thrombotic events including transient ischemic attack tia cerebrovascular accident cva unstable angina myocardial infarction mi clinically significant peripheral artery disease
0, dexamethasone phosphate lymphoma diagnosis no other uncontrolled clinically significant confounding medical condition within past thirty days
1, bortezomib cervical cancer diagnosis patient has hypersensitivity bortezomib boron mannitol
0, prednisolone phosphate multiple myeloma plasma cell neoplasm diagnosis renal
0, biological therapy recurrent mantle cell lymphoma diagnosis no concurrent antibiotics antifungals antivirals
0, cetuximab colorectal cancer diagnosis at least thirty days since prior investigational agents
0, imatinib mesylate nodal marginal zone cell lymphoma diagnosis see disease characteristics
0, methylprednisolone hemisuccinate lymphoma diagnosis pulmonary
1, carmustine stage iv mantle cell lymphoma diagnosis inability collect adequate stem cells
0, levoleucovorin stage iva rectal cancer diagnosis hemoglobin greater equal nineg dl
1, antibodies recurrent adult diffuse large cell lymphoma diagnosis concomitant therapy any following
0, laboratory biomarker analysis stage iii grade three follicular lymphoma diagnosis no uncontrolled dysrhythmia requiring medication
0, thalidomide burkitt lymphoma bl diagnosis following effective methods contraception
1, alemtuzumab recurrent childhood lymphoblastic lymphoma diagnosis patient has central nervous system cns involvement disease refractory intrathecal chemotherapy
0, lenograstim recurrent adult diffuse small cleaved cell lymphoma diagnosis total bilirubin less doc times upper limit normal
0, albumin bound paclitaxel lung adenocarcinoma diagnosis patient must have measurable stage iv disease includes monea moneb stages recurrent disease according seventh edition tnm classification system
0, plastic stent cholangiocarcinoma extrahepatic bile duct diagnosis accept informed consent
1, aldesleukin stage iv melanoma diagnosis have positive pregnancy test at baseline or
1, antibodies stage iii squamous cell carcinoma oropharynx diagnosis sodium less one hundred thirty mmol greater one hundred fifty five mmol despite intervention normalize levels
0, bevacizumab metastatic breast cancer diagnosis urine dipstick proteinuria less equal one
1, rituximab stage iii marginal zone lymphoma diagnosis no current malignancy
1, bb recurrent mantle cell lymphoma diagnosis patients known positive human immunodeficiency virus hiv infectious hepatitis type c
1, carmustine glioblastoma diagnosis lung function
0, albumin bound paclitaxel tubular breast cancer stage ii diagnosis hemoglobin greater ten dl greater doc mmol hepatic function
1, cortisone recurrent lymphoblastic leukemia lymphoma diagnosis routine systemic maintenance therapy abelson murine leukemia viral oncogene homolog one abl kinase inhibitor methotrexate six mercaptopurine vincristine etc
1, mg kg Î± tea metastatic sarcoma diagnosis patients brain metastases who have been treated surgery gamma knife radiosurgery radiation no radiographic progression at least four weeks off steroids eligible
1, lapatinib known endobronchial lesions involvement large pulmonary vessels by tumor
0, cisplatin bladder cancer diagnosis required initial laboratory values
1, rituximab stage iii small lymphocytic lymphoma diagnosis infection human immunodeficiency virus hiv
1, experimental arm primary extranodal stomach dlbcl
0, docetaxel non small cell lung cancer diagnosis absolute neutrophil count greater doc one hundred nine plateletgreater one hundred one hundred nine hÃ©moglobine greater equal nine five dl
1, cyclosporine unspecified childhood solid tumor protocol specific diagnosis positive serology toxoplasma gondii on treatment evidence active infection
0, vidarabine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis louis cord blood bank any established registered international blood marrow banks
0, antibodies monoclonal unspecified childhood solid tumor protocol specific diagnosis patient characteristics
0, epothilones recurrent prostate cancer diagnosis creatinine less doc times uln
0, etoposide phosphate lung cancer diagnosis measurable evaluable disease outside area prior surgical resection
1, quality life assessment stage iii mucoepidermoid carcinoma oral cavity diagnosis unexplained fever untreated active infection
1, egd eus patients known chronic pancreatitis were excluded from cancer group
0, educational intervention unspecified adult solid tumor protocol specific diagnosis disease characteristics
0, pazopanib hydrochloride recurrent leiomyosarcoma diagnosis prolongation corrected qt interval via fridericia formula qtcf greater four hundred eighty msec
0, everolimus brain central nervous system tumors diagnosis pimozide
1, mogamulizumab solid tumor diagnosis subject who has undergone major surgical procedure defined by investigator within twenty eight days prior first dose khktwo thousand four hundred fifty five is still recovering from prior surgery
0, fulvestrant females eighteen years old greater histologically cytologically confirmed diagnosis advanced metastatic adenocarcinoma breast
1, cediranib recurrent breast cancer diagnosis patients known brain metastases should be excluded from this clinical trial because their poor prognosis because they often develop progressive neurologic dysfunction that would confound evaluation neurologic other adverse events head ct mri must be performed at baseline
0, paclitaxel non small cell lung cancer nsclc diagnosis platelet count greater ten doc zero mmthree
1, prednisone prostate cancer diagnosis history pituitary dysfunction
0, antibodies monoclonal stage ivc inverted papilloma paranasal sinus nasal cavity diagnosis life expectancy greater three months
1, chenodeoxycholic acid small cell lung cancer diagnosis decision unsuitableness by principal investigator physician charge
0, podophyllotoxin childhood alveolar rhabdomyosarcoma diagnosis doc mg dl males doc mg dl females patients thirteen fifteen years age
0, bleomycin childhood mixed cellularity classical hodgkin lymphoma diagnosis surgically staged patients must also have presurgical staging
0, cyclophosphamide recurrent mantle cell lymphoma diagnosis alanine aminotransferase alt serum glutamic pyruvate transaminase sgpt equal less doc upper limit normal
0, sunitinib stage iiib fallopian tube cancer diagnosis patients may have had up one prior hormonal treatment metastatic disease patients must be at least twenty eight days since last dose hormonal therapy
0, albumin bound paclitaxel ovarian cancer diagnosis disease characteristics
0, cisplatin stage iva oral cavity squamous cell carcinoma diagnosis examination by an ear nose throat ent head neck surgeon
1, succinylcholine solid neoplasm diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated trcone hundred two
0, etoposide neuroblastoma diagnosis no concurrent illness that would obscure toxicity dangerously alter drug metabolism
1, antibodies synchronous previous contralateral invasive breast cancer patients synchronous previous contralateral ductal carcinoma situ dcis lobular carcinoma situ lcis eligible
1, testosterone cancer prostate diagnosis hematological parameters hematocrit hemoglobin outside twenty upper lower limits normal at screening
0, everolimus renal pelvis cancer diagnosis calculated creatinine clearance equal ninety eight
0, fludarabine childhood diffuse large cell lymphoma diagnosis secondary mds any ipss scores
0, ultrasound imaging unspecified childhood solid tumor protocol specific diagnosis scheduled receive chemotherapeutic agents known be associated ovarian failure including any following
1, cetuximab past current history neoplasm oher squamous cell carcinoma head neck
1, mitomycins metastatic breast cancer diagnosis mean resting qt interval corrected heart rate qtc greater four hundred seventy ms calculated from three consecutive ecgs using bazett correction
0, testosterone enanthate brain central nervous system tumors diagnosis hypogonadal defined serum testosterone level less three hundred fifty ng dl
0, sirolimus recurrent renal cell cancer diagnosis hemoglobin greater equal doc dl
0, etoposide lymphoma large cell diffuse diagnosis ecog performance status zero two
1, flourescein glioblastoma multiforme diagnosis contraindication flourescein
0, docetaxel fallopian tube cancer diagnosis uncontrolled hypertension systolic blood pressure bp greater one hundred forty mm hg diastolic bp greater ninety mm hg within past twenty eight days
0, fludarabine phosphate lymphoma diagnosis no requirement o two
1, isophosphamide mustard stage iv childhood anaplastic large cell lymphoma diagnosis patients central nervous system cns disease not eligible
1, osi resected basal cell squamous cell carcinoma skin cured situ cervical carcinoma cured ductal carcinoma situ breast cured superficial bladder cancer
1, broccoli sprout extract recurrent bladder cancer diagnosis poor medical risk opinion treating oncologist due non malignant systemic disease
0, etoposide phosphate stage iiia non small cell lung cancer diagnosis magnetic resonance imaging mri scan contrast brain preferred ct scan brain contrast within sixty days prior registration
0, epirubicin gastric cancer diagnosis any patient history ischaemic heart disease abnormal ecg who is over sixty years age should have pre treatment evaluation cardiac function multigated acquisition muga scan echocardiogram
0, carboplatin ovarian cancer diagnosis patient characteristics
1, prophylactic donor leukocyte infusions multiple myeloma diagnosis medical psychological conditions that would make donor unlikely tolerate csf injections leukapheresis
0, cisplatin stage iv bladder cancer diagnosis patients that have had surgical resection prior enrollment residual unresected disease measurable unmeasurable must be evident on post surgical scans
0, romidepsin recurrent childhood ependymoma diagnosis performance status
0, laboratory biomarker analysis recurrent synovial sarcoma diagnosis histologic cohort one
0, allopurinol multiple myeloma diagnosis active disease requiring treatment
0, tak dose escalation cohorts cancer diagnosis serum creatinine less doc times upper limit standard value each institution
1, cyclosporins noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis donor
0, albumin bound paclitaxel recurrent endometrial carcinoma diagnosis fasting triglycerides equal less doc six mmol l
1, radiofrequency ablation lung cancer diagnosis other antineoplastic interventional radiology techniques
0, carbon ion radiotherapy recurrent rectal cancer diagnosis ability subject understand character individual consequences clinical trial
1, vinorelbine any clinically significant gastrointestinal abnormalities that may alter absorption such malabsorption syndrome major resection stomach bowels consult gsk medical monitor if uncertain about eligibility
0, antibodies monoclonal gliosarcoma diagnosis activated partial thromboplastin time aptt partial thromboplastin time ptt equal less doc institutional upper limit normal
0, vitamins stage iv pancreatic cancer diagnosis laboratory values that would not prevent patient from receiving chemotherapy determined by pi oncologist
1, vincristine chemotherapy radiotherapy prior administration first dose treatment retinoblastoma other tumor types
0, immunoglobulin g stage iib fallopian tube cancer diagnosis patients suboptimal disease stage iv will not be eligible april one oneone they should be enrolled on gog two hundred sixty two three one oneone
0, sorafenib metastatic renal cell carcinoma diagnosis patients must have received one only one prior vegf targeted therapy one only one prior mtor inhibitor therapy metastatic setting
0, staurosporine lymphoma diagnosis disease characteristics
1, interferons concurrent neoplasms other basal cell carcinoma skin
1, trametinib tumor biopsy sequencing
0, cisplatin carcinoma small cell diagnosis ecog performance status zero two those performance status two must have been stable no deterioration over previous two weeks
1, pertuzumab concomitant malignancies previous malignancies within last five years except adequately treated basal squamous cell carcinoma skin carcinoma situ cervix
1, laboratory biomarker analysis recurrent adult brain tumor diagnosis patients clinically important history liver disease including viral other hepatitis cirrhosis ineligible
0, bevacizumab adult primary hepatocellular carcinoma diagnosis no encephalopathy
0, acetylcysteine recurrent squamous cell carcinoma larynx diagnosis initiation investigational agent equal less three days after initiation radiotherapy
0, razoxane recurrent childhood lymphoblastic lymphoma diagnosis patients leukemia must have greater twenty five blasts on bone marrow aspirate be eligible
0, romidepsin stage iii cutaneous cell non hodgkin lymphoma diagnosis transformed mycosis fungoides
0, gemcitabine pancreatic cancer diagnosis they will have undergone staging physical examination chest ray contrast enhanced ct mri if ct contraindicated angiogram determine resectability
1, bcg vaccine neoplasms diagnosis partial cystectomy
1, cediranib ovarian mucinous adenocarcinoma diagnosis history myocardial infarction within six twelve months patients history myocardial infarction within six months excluded from study
0, dacarbazine glioblastoma multiforme diagnosis continued patients prior therapy that included interstitial brachytherapy stereotactic radiosurgery must have reasonable confirmation true progressive disease rather radiation necrosis determined by treating physician neuro radiologist example through mri magnetic resonance mr spectroscopy pet scan brain
0, vidarabine recurrent marginal zone lymphoma diagnosis performance status greater eighty tju karnofsky patients greater sixty years old greater seventy patients less sixty years old
0, antibodies stage iiic skin melanoma diagnosis multiple deposits that can be biopsied excised individually on different dates measured follows
1, oxaliplatin colon cancer diagnosis uncontrolled hypertension
1, succinylcholine stage iv ovarian cancer diagnosis no poorly differentiated subtypes including papillary serous clear cell other international federation gynecology obstetrics figo grade three lesions
1, temozolomide gliosarcoma diagnosis prior radiotherapy head neck overlap radiation fields
0, lenograstim lymphoma diagnosis not specified
1, mycophenolic acid splenic marginal zone lymphoma diagnosis diffusing capacity lung carbon monoxide dlco less thirty total lung capacity tlc less thirty forced expiratory volume one second fevone less thirty receiving supplementary continuous oxygen fhcrc principal investigator pi must approve enrollment all patients pulmonary nodules
0, epithelial cell adhesion molecule epcam ferrofluid colorectal cancer diagnosis age greater eighteen years
0, chp her chp ny eso histological confirmation cancer
1, gossypol acetic acid stage iii grade three follicular lymphoma diagnosis any prior use racemic gossypol at one hundred one
1, fludarabine phosphate metastatic melanoma that express mage athree hla aone antigen diagnosis patients who have decreased immune competence may be less responsive experimental treatment more susceptible its toxicities
0, fludarabine anaplastic large cell lymphoma diagnosis nine nine twenty two complex karyotypes greater equal three abnormalities complete remission cr one
0, fludarabine recurrent childhood lymphoblastic lymphoma diagnosis donors who have poor peripheral venous access may require central venous line placement stem cell apheresis
1, immunoglobulin g stage iia ovarian cancer diagnosis patients taking warfarin
0, mycophenolate mofetil childhood immunoblastic large cell lymphoma diagnosis creatinine clearance greater sixty ml min
1, paclitaxel endometrial clear cell carcinoma diagnosis pregnancy breastfeeding
1, mesna sarcoma diagnosis patient has known hypersensitivity administration any prescribed oral intravenous medication metabolite including but not limited history hypersensitivity drugs their components severe renal impairment severe bone marrow suppression systemic infection
0, everolimus childhood neurofibrosarcoma diagnosis serum cholesterol levels must be less grade two less three hundred mg dl serum triglyceride levels must be less grade two less doc times uln
0, gamma secretase inhibitor ro adult fibrosarcoma diagnosis female patients childbearing potential defined follows
1, doxorubicin stage ii breast cancer diagnosis history abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior enrollment
0, sirolimus estrogen receptor er negative positive lymph nodes er negative negative nodes if tumor greater two cm er positive positive lymph nodes er positive negative lymph nodes tumor greater five cm
0, antilymphocyte serum marginal zone cell lymphoma diagnosis age performance status graft criteria
1, positron emission tomography stage iv prostate cancer diagnosis myocardial infarction
1, everolimus large cell lymphoma diagnosis known cause harm fetus
0, methotrexate recurrent grade three follicular lymphoma diagnosis donor must be healthy have non reactive test results all infectious disease assays required by state federal regulations donors who screen seropositive hepatitis an syphilis must be cleared by infectious disease consultation donor
1, bb prior history malignancies other multiple myeloma unless patient has been free disease greater three years
1, laboratory biomarker analysis stage iv fallopian tube cancer diagnosis known human immunodeficiency virus hiv other history immunodeficiency disorder
1, akt inhibitor mk recurrent adult cell leukemia lymphoma diagnosis known active viral hepatitis
0, lenalidomide recurrent small lymphocytic lymphoma diagnosis glomerular filtration rate gfr greater equal thirty ml min doc three two cockcroft gault
1, succinylcholine prostatic neoplasms diagnosis lymphadenopathy lymph nodes exceeding three cm short axis diameter
0, thalidomide squamous cell carcinoma metastatic neck occult primary diagnosis absolute neutrophil count greater one five hundred mcl
0, antibodies bispecific siewert type iii adenocarcinoma esophagogastric junction peritoneal carcinomatosis diagnosis total bilirubin less one five times upper limit normal
0, niacinamide stage iib pancreatic cancer diagnosis women childbearing potential men must agree use medically accepted form birth control during treatment two months following completion treatment
1, antibodies monoclonal syringoma chondroid diagnosis addition all wocbp should be instructed contact investigator immediately if they suspect they might be pregnant missed late menstrual period at any time during participation
0, curcumin stage zero breast cancer diagnosis whole breast
0, trastuzumab her two overexpressing breast cancer
1, mitogens nodal marginal zone cell lymphoma diagnosis any infection that is not improving during appropriate treatment
1, docetaxel breast cancer diagnosis patients must not have received radiotherapy treatment metastatic locally recurrent advanced disease other relief pain progressing metastatic bone lesions brain metastases
0, temozolomide stage iv non small cell lung cancer diagnosis alkaline phosphatase less two times uln unless due elevated bone metastases
1, interferons carcinoma renal cell diagnosis concomitant rifampicin st
1, flutamide prostate cancer diagnosis prior history malignancy
0, nivolumab melanoma diagnosis age greater eighteen years old
1, mycophenolate mofetil lymphoma non hodgkin diagnosis life expectancy severely limited by diseases other disease indication transplant
0, busulfan multiple myeloma diagnosis more four weeks since prior chemotherapy
1, albumin bound paclitaxel uterine cervical cancer diagnosis drug allergy
0, laboratory biomarker analysis stage iv skin melanoma diagnosis stage iv stage iii disease not potentially curable surgery
1, antibodies recurrent adult immunoblastic large cell lymphoma diagnosis circulating human anti mouse antibody hama be determined before each infusion
0, fulvestrant breast cancer diagnosis patients must be post menopausal based on either history an oophorectomy at lease one year amenorrhea
1, rectal spacer very high risk prostate cancer tthreeb tfour on clinical exam primary gleason pattern five greater four cores gleason score eight ten
1, antibodies monoclonal non squamous non small cell lung cancer diagnosis pregnant lactating women
0, albumin bound paclitaxel human epidermal growth factor two negative carcinoma breast diagnosis patients without such history required have baseline ophthalmologic exam part screening must not have evidence retinal neovascularization macular edema macular degeneration on screening exam order be eligible
1, folic acid human mammary carcinoma diagnosis have previously received pralatrexate
1, pci diffuse large cell lymphoma diagnosis treatment group two
1, temozolomide tumor bleeding
0, cyclophosphamide cutaneous cell non hodgkin lymphoma diagnosis patients must be htlv iii hiv anti body negative
1, topotecan ovarian cancer diagnosis received prior treatment camptothecin topotecan cpt eleven investigational camptothecins
0, mechlorethamine recurrent small lymphocytic lymphoma diagnosis marrow is preferred source stem cells from hla haploidentical donor however pbmc could be used stem cell source after clearance fhcrc principal investigator case difficulties contraindications bone marrow harvest from donor
0, entinostat recurrent colon cancer diagnosis not candidate curative resection
1, cabozantinib s malate recurrent osteosarcoma diagnosis abdominal fistula
1, mycophenolic acid stage iii childhood small noncleaved cell lymphoma diagnosis fungal pneumonia radiological progression after receipt amphotericin formulation mold active azoles greater one month
1, bevacizumab patients currently receiving anticancer therapies who have received anticancer therapies within three weeks start drug patients receiving prior treatment investigational drugs four weeks start drug
0, oxaliplatin peritoneal neoplasms diagnosis inclusion women minorities
0, erlotinib hydrochloride metastatic colorectal cancer diagnosis effects pemetrexed erlotinib on developing human fetus at recommended therapeutic dose unknown
0, gemcitabine gastric cancer diagnosis prior gemcitabine hydrochloride allowed
1, nimorazole locally advanced head neck hpv negative squamous cell cancers diagnosis male subjects not willing use condoms throughout drug therapy six months after cessation therapy if their partner is childbearing potential has no contraception
0, adjuvant therapy metastatic cancer diagnosis not specified
1, carboplatin non small cell lung cancer diagnosis recent current use inhaled steroids is not exclusionary
1, everolimus colon cancer diagnosis current drug alcohol abuse history drug alcohol abuse within past two years
0, carboplatin brain central nervous system tumors diagnosis concurrent physiologic stress doses steroids allowed endocrine deficiencies
0, amifostine gestational trophoblastic tumor diagnosis no other possible causes neuropathy alcoholism diabetes peripheral vascular disease
1, therasphereÂ® neoplasms diagnosis uncorrected platelet count less equal seventy five zero ul
1, cyclosporine adult nasal type extranodal nk cell lymphoma diagnosis donors who hiv positive medical conditions that would result increased risk granulocyte colony stimulating factor csf mobilization harvest peripheral blood stem cell pbsc
1, sunitinib stage iii renal cell cancer diagnosis patients may not be receiving any other investigational agents
0, magnetic resonance imaging refractory brain neoplasm diagnosis research participant does not have uncontrolled seizure activity following surgery prior starting first cell dose
1, erlotinib hydrochloride non small cell lung cancer nsclc stage iv diagnosis clinically significant resting bradycardia
1, tacrolimus refractory multiple myeloma diagnosis female patients who pregnant breastfeeding
0, doxorubicin stage iii adult diffuse large cell lymphoma diagnosis patients clinically significant peripheral vascular disease serious non healing wound ulcer bone fracture bleeding diathesis coagulopathy ineligible
0, methylprednisolone hemisuccinate recurrent adult non hodgkin lymphoma diagnosis patients undergoing transplant early relapse eligible transplant first second relapse only
0, irinotecan glioblastoma diagnosis kps greater seventy
1, radiopharmaceuticals primary diagnosis glioblastoma
0, paclitaxel primary peritoneal cancer diagnosis bone marrow function
1, etoposide phosphate mantle cell lymphoma diagnosis female patients who lactating have positive serum pregnancy test during screening period positive urine pregnancy test on day one before first dose drug if applicable
0, antibodies recurrent adult burkitt lymphoma diagnosis bilirubin less doc mg dl
0, dexamethasone lymphoma large cell diffuse diagnosis computed tomography ct involvement two more clearly demarcated lesions long axis greater doc centimeters cm short axis greater doc cm one clearly demarcated lesion long axis greater doc cm short axis greater doc cm
1, prednisolone hemisuccinate prior malignancy except adequately treated basal cell squamous cell skin cancer situ cervical cancer other cancer five year disease free status
0, bleomycin lymphoma diagnosis stage ii disease
0, bleomycin head neck cancer diagnosis men women childbearing potential must use physician approved contraceptive methods seven days following bleomycin ept
0, laboratory biomarker analysis stage iii lymphoepithelioma nasopharynx diagnosis no other uncontrolled illness
0, questionnaire administration ductal breast carcinoma situ diagnosis able read understand english spanish participate patient teaching
0, albumin bound paclitaxel bronchoalveolar cell lung cancer diagnosis no mone disease
1, fludarabine malt lymphoma diagnosis prior treatment within last three weeks
0, niacinamide adult hepatocellular carcinoma diagnosis concomitant treatment rifampin st john wort is not allowed patients should discontinue these drugs at least four weeks prior registration
0, cyclophosphamide angioimmunoblastic cell lymphoma diagnosis serum bilirubin less doc upper limit normal uln alanine transaminase aspartate transaminase alt ast less doc uln alp less threex uln absence liver metastases
1, oxaliplatin stage iiib colon cancer diagnosis amiodarone equal less one hundred eighty days prior start treatment
0, dacarbazine glioblastoma multiforme diagnosis patients prior therapy that included interstitial brachytherapy gliadel wafer stereotactic radiosurgery must have confirmation progressive disease rather radiation necrosis by pet scanning thallium scanning mri spectroscopy surgical documentation
0, dabrafenib melanoma diagnosis ct preferred all lesions where possible
0, topotecan neuroblastoma diagnosis see disease characteristics
1, hydrocortisone breast cancer diagnosis anti inflammatory medications statins cholesterol medication
1, r ceop diffuse large cell lymphoma diagnosis active infectious disease requiring general antibiotics anti fungal anti virus therapy
0, fludarabine refractory multiple myeloma diagnosis age
1, niacinamide hepatocellular carcinoma diagnosis participation another clinical trial any investigational drug
0, ascorbic acid subject has metastatic prostate cancer documented by positive bone scan metastatic lesions on computed tomography ct magnetic resonance imaging mri scan
0, etoposide phosphate stage iv grade two follicular lymphoma diagnosis serum creatinine less doc mg dl calculated creatinine clearance greater fiftyml min
1, bevacizumab neoplasm cardioesophageal junction diagnosis serious non healing wound ulcer bone fracture
0, bortezomib fallopian tube cancer diagnosis at least two weeks since prior major surgery
1, mitoxantrone recurrent childhood lymphoblastic lymphoma diagnosis stem cell infusion
1, targomirs non small cell lung cancer diagnosis renal failure requiring hemo peritoneal dialysis
1, paclitaxel lung cancer diagnosis other severe acute chronic medical psychiatric condition laboratory abnormality that may increase risk associated participation may interfere interpretation results
0, cyclophosphamide breast cancer diagnosis count greater doc one hundred nine platelets greater one hundred one hundred nine l
0, mycophenolic acid angioimmunoblastic cell lymphoma diagnosis donor must have adequate veins leukapheresis agree placement central venous catheter femoral subclavian
0, etoposide b cell lymphoma unclassifiable features intermediate between diffuse large cell lymphoma burkitt lymphoma diagnosis karnofsky performance status kps greater equal seventy
1, carboxymethylcellulose sodium melanoma diagnosis participation any other clinical trial involving another investigational agent within four weeks prior first dose agent
1, jm lymphoma diagnosis acute infection unexplained fever greater thirty eight c
1, camptothecin adenocarcinoma rectum diagnosis patients known gilbert disease may have excessive cpt eleven induced toxicity
1, docetaxel lung cancer diagnosis active infection fever greater three doc within past three days
1, colonoscopy colorectal cancer diagnosis patients who did not consent research
0, isophosphamide mustard recurrent childhood anaplastic large cell lymphoma diagnosis cdthirty positive disease
0, busulfan diffuse large cell lymphoma diagnosis written informed consent obtained according international guidelines local laws by patient authorized legal representative case patient is temporarily legally not competent due his her disease
1, cyclophosphamide recurrent adult grade iii lymphomatoid granulomatosis diagnosis human immunodeficiency virus hiv positive patients
0, sirolimus adult giant cell glioblastoma diagnosis baseline mri ct scan prior registration patients phase ii component who not participating pre operative component should be on steroid dose that has been stable at least five days prior scan if steroid dose is increased between date imaging registration new baseline mr ct is required
0, hydroxychloroquine small cell lung cancer diagnosis able swallow medication
1, androgens prostate cancer diagnosis one history androgen ablation therapy within past year date consent
0, antibodies monoclonal renal cell carcinoma rcc diagnosis surgery requiring local epidural anesthesia must be completed at least seventy two hours before drug administration
0, cediranib childhood infratentorial ependymoma diagnosis more one weeks since prior investigational biologic agents
1, bb multiple myeloma diagnosis subjects will not continue treatment at discretion physician if any following criteria occurred during treatment cc five thousand thirteen mm twenty one during screening phase
1, vitamin b cutaneous cell lymphoma diagnosis use oral retinoids within four weeks treatment high dose vitamin a
1, dacarbazine adult anaplastic astrocytoma diagnosis patients should not have taken valproic acid another histone deacetylase inhibitor at least two weeks prior enrollment
0, antibodies monoclonal adenocarcinoma rectum diagnosis see disease characteristics
1, vitamin k neoplasms diagnosis participation another investigational drug trial within thirty days prior day one five times half life drug whichever is longer exposure more three new investigational agents within one months prior day one
0, cisplatin sarcoma diagnosis no prior anthracycline cisplatin
1, camptothecin concurrent anticancer hormonal therapy
0, fludarabine phosphate testicular lymphoma diagnosis crone high risk cytogenetics nine twenty two four oneone hypodiploid less fourfive chromosomes pediatric patients nine twenty two eight onefour four oneone one onenine adult patients greater four wk achieve crone greater equal crtwo patients should have less five marrow blasts at time transplant
1, panobinostat metastatic melanoma diagnosis male patients whose sexual partners wocbp not using double method contraception during three months after end treatment
1, thalidomide multiple myeloma diagnosis serum alanine aminotransferase alt greater doc uln
0, tetrathiomolybdate breast cancer diagnosis patients must be on stable medical therapy at least two weeks if they being treated medically their peripheral neuropathy
0, fludarabine stage ii childhood large cell lymphoma diagnosis must have less five blasts at time transplant
1, immunoglobulins ovarian clear cell adenocarcinoma diagnosis patients who require drainage gastrostomy tube
0, antibodies monoclonal colorectal cancer diagnosis patients must have normal organ marrow function
0, cyclophosphamide lymphoma diagnosis ecog performance status zero two
0, cyclophosphamide recurrent adult grade iii lymphomatoid granulomatosis diagnosis crtwo
0, prednisolone acetate peritoneal neoplasms diagnosis no radio chemotherapy planned at inclusion within two weeks following inclusion
0, pertuzumab tumors diagnosis ii
0, prednisolone phosphate stage iii childhood large cell lymphoma diagnosis clinical spinal cord compression
0, sirolimus chronic lymphocytic leukemia hodgkin lymphoma non hodgkin lymphoma excluded these malignancies may express il two receptor pose potential growth signal any present disease
0, lenalidomide angioimmunoblastic cell lymphoma diagnosis not pregnant nursing
0, stem cell transplantation lymphoma diagnosis acute hybrid leukemia including mixed lineage biphenotypic undifferentiated aul
0, methotrexate lymphoma diagnosis platelet count at least one hundred zero mm three
0, doxorubicin recurrent fallopian tube cancer diagnosis alkaline phosphatase equal less doc uln
0, antibodies monoclonal testicular choriocarcinoma yolk sac tumor diagnosis life expectancy
1, bevacizumab glioblastoma multiforme diagnosis patients known autoimmune thyroid disease positive anti tpo antibodies anti thyroid peroxidase at time screening
0, musculoskeletal complications management prevention stage iii ovarian germ cell tumor diagnosis meet eligibility criteria first allogeneic hct scheduled undergo allogeneic hct
1, antibodies monoclonal recurrent diffuse large cell lymphoma diagnosis history solid organ transplantation
1, lapatinib colorectal cancer diagnosis serious cardiac arrhythmia requiring medication
0, tacrolimus stage iv grade two follicular lymphoma diagnosis partial cytogenetic remission
0, cetuximab metastatic colorectal cancer diagnosis absolute neutrophil count greater one five hundred Âµl
1, niacinamide therapy breast cancer four weeks preceding therapy start
0, fluorouracil recurrent malignant extragonadal non seminomatous germ cell tumor diagnosis coronary peripheral artery bypass graft
1, immunoglobulins anaplastic large cell lymphoma diagnosis patients may not be receiving any other investigational agents
0, succinylcholine stage iv breast cancer diagnosis patients must also meet at least one following criteria
0, morphine brain central nervous system tumors diagnosis dose expected remain stable until after first week opioid rotation on study
0, carboplatin recurrent ovarian carcinoma diagnosis negative serum pregnancy test result females child bearing potential
1, albumin bound paclitaxel carcinoma non small cell lung diagnosis qtc fridericia correction that is unmeasurable greater four hundred eighty msec on screening ecg
1, placebo comparator leukemia any form lymphoma multiple myeloma
0, albumin bound paclitaxel stage ii breast cancer diagnosis not pregnant nursing
1, bevacizumab solid tumors diagnosis history abdominal fistula major surgery bowel obstruction intra abdominal abscesses within twenty eight days will be excluded
0, carboplatin breast cancer diagnosis leukocytes greater three zero mcl
0, hydroxyflutamide prostate cancer diagnosis negative dipstick bacteriuria
0, endothelial growth factors colorectal adenocarcinoma diagnosis patients documented liver metastases ast alt must be equal less five uln
0, immunoglobulins recurrent small lymphocytic lymphoma diagnosis no history erythema multiforme toxic epidermal necrolysis stevens johnson syndrome
0, isophosphamide mustard undifferentiated embryonal sarcoma diagnosis absolute neutrophil count greater equal one thousand five hundred ul note
0, mycophenolic acid lymphoma diagnosis children less equal seven years age who unable perform pft oxygen saturation greater equal ninety two on room air by pulse oximetry
0, mycophenolate mofetil stage iv grade three follicular lymphoma diagnosis acute myeloid leukemia aml
1, lomustine glioblastoma diagnosis concomitant treatment yellow fever vaccine
1, leucovorin stage iva colon cancer diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated on this study
1, bevacizumab high grade gliomas diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior day one therapy
0, everolimus bladder cancer diagnosis note
1, olaparib ovarian cancer diagnosis patients known brain metastases diagnosed within one year should be excluded from this clinical trail because their poor prognosis because they often develop progressive neurological dysfunction that would confound evaluation neurologic other adverse events
1, hormones breast cancer diagnosis arm three
1, tremelimumab uncontrolled intercurrent illness including but not limited ongoing active infection symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmia psychiatric illness social situations that would limit compliance requirements
1, gemcitabine malignant solid tumor diagnosis have coronary artery disease uncontrolled congestive heart failure
1, immunoglobulin g ovarian seromucinous carcinoma diagnosis invasive procedures defined follows
0, mycophenolate mofetil stage ii contiguous adult diffuse mixed cell lymphoma diagnosis donors excluded when preexisting immunoreactivity is identified that would jeopardize donor hematopoietic cell engraftment this determination is based on standard practice individual institution recommended procedure patients ten ten hla allele level phenotypic match is obtain panel reactive antibody pra screens class class ii antigens all patients before hct if pra shows greater ten activity then flow cytometric cell cytotoxic cross matches should be obtained donor should be excluded if any cytotoxic cross match assays positive those patients an hla class allele mismatch flow cytometric cell cytotoxic cross matches should be obtained regardless pra results positive anti donor cytotoxic crossmatch is an absolute donor exclusion
0, vitamins lung cancer diagnosis bilirubin less doc mg dl
0, etoposide phosphate lung cancer diagnosis not specified chemotherapy
0, clinical observation neuroblastoma diagnosis stage three
1, trastuzumab breast cancer diagnosis you can then decide if you wish participate
0, laboratory biomarker analysis recurrent adult lymphoblastic lymphoma diagnosis research participant has an indication be considered autologous stem cell transplantation
0, histone deacetylase inhibitors recurrent grade three follicular lymphoma diagnosis no prior oral isotretinoin
0, vaccines pancreatic acinar cell carcinoma diagnosis absolute neutrophil count greater equal one five hundred mcl
1, bortezomib multiple myeloma diagnosis other medications severe acute chronic medical psychiatric condition laboratory abnormality that may increase risk associated participation drug administration may interfere interpretation results judgment investigator would make subject inappropriate entry into this study
1, artesunate locally advanced breast cancer diagnosis concurrent intake supplements any other medication unapproved efficacy vitamins minerals others otc
1, bevacizumab signet ring adenocarcinoma rectum diagnosis patients only non measurable disease defined all other lesions including small lesions longest diameter less twenty mm conventional techniques less ten mm spiral ct scan truly non measurable lesions which include following
0, niacinamide non small cell lung cancer diagnosis at this body surface area maximum dosing oral vinorelbine at one hundred twenty mg week is equivalent eighty six mg mtwo week patient bsa doc mtwo
1, erlotinib hydrochloride liver carcinoma diagnosis inadequate organ function
0, afatinib carcinoma non small cell lung diagnosis male female patients age greater equal eighteen years
0, thalidomide intraocular melanoma diagnosis other
0, irinotecan colorectal cancer diagnosis braf inhibitor including but not limited vemurafenib dabrafenib regorafenib is not considered braf inhibitor purpose determining trial eligibility
0, albumin bound paclitaxel ovarian neoplasm diagnosis patients must be recovered from initial surgery must enter this no later twelve weeks after such surgery
0, gemcitabine recurrent breast cancer diagnosis see disease characteristics
0, bevacizumab new areas tumor outside original radiotherapy fields determined by investigator or
0, etoposide phosphate testicular germ cell tumor diagnosis anc greater one zero Î¼l
1, ramucirumab metastatic gastric cancer diagnosis participant has received prior therapy an agent that directly inhibits vascular endothelial growth factor vegf including bevacizumab vascular endothelial growth factor receptor two vegfr two activity any antiangiogenic agent
1, dasatinib prostate cancer diagnosis history clinically significant ventricular arrhythmias ventricular tachycardia ventricular fibrillation torsades de pointes
0, irinotecan recurrent childhood pineoblastoma diagnosis must not have received within three weeks entry onto this six weeks if prior nitrosourea
1, albumin bound paclitaxel refractory cancer diagnosis resting ecg measurable qtcf greater four hundred seventy msec on two more time points within two hour period family history long qt syndrome
1, albumin bound paclitaxel breast cancer diagnosis known metastatic disease
0, vidarabine hepatosplenic cell lymphoma diagnosis must have received prior chemotherapy consolidation chemotherapy by autografting prior nonmyeloablative hct is permitted
0, isophosphamide mustard metastatic osteosarcoma diagnosis creatinine based on age follows
0, etanidazole adult ependymoblastoma diagnosis bilirubin less doc mg dl
1, fluorouracil extrahepatic bile duct cancer diagnosis no prior radiotherapy greater twenty five bone marrow
0, dabrafenib melanoma diagnosis ecog performance status zero one
0, temozolomide patients must have had histologic verification malignancy at original diagnosis relapse except patients intrinsic brain stem tumors patients optic pathway gliomas patients pineal tumors elevations serum cerebrospinal fluid csf alpha fetoprotein beta human chorionic gonadotropin hcg
1, tacrolimus refractory multiple myeloma diagnosis calculated creatinine clearance less forty cc min by modified cockroft gault formula adults schwartz formula pediatrics
0, erlotinib hydrochloride stage iv squamous cell carcinoma lip oral cavity diagnosis no prior corneal abnormalities dry eye syndrome sjogren syndrome
1, sipuleucel t prostate cancer diagnosis any previous treatment ipilimumab yervoy tm mdx ten mdx one hundred one denosumab xgeva tm
1, antibodies monoclonal malignant sweat gland neoplasm diagnosis primary immunodeficiency state such severe combined immunodeficiency disease
0, angiotensin i unspecified adult solid tumor protocol specific diagnosis bone lesions
1, gefitinib any other malignancy within last five years except cured basal cell cancer skin cured cancer situ cervix
1, niacinamide refractory solid tumors diagnosis current scans
1, bgt solid tumor diagnosis no acute chronic liver disease
1, cyclosporine recurrent marginal zone lymphoma diagnosis positive crossmatch between donor recipient
1, lapatinib neoplasms breast diagnosis clinically significant active cardiovascular disease including cerebrovascular accident less six months before enrolment myocardial infarction less six months before enrolment unstable angina new york heart association nyha greater grade two congestive heart failure serious cardiac arrhythmia requiring medication during that might interfere regularity treatment not controlled by medication
1, interleukin recurrent esophageal cancer diagnosis serious concurrent infection requiring intravenous antibiotic therapy
0, immunoglobulins stage ii diffuse large cell lymphoma diagnosis patients may have received other monoclonal immunotherapy radiation therapy bortezomib
0, albumin bound paclitaxel recurrent melanoma diagnosis prior radiation therapy is allowed however if radiation has been administered lesion there must be radiographic evidence progression that lesion order that lesion constitute measurable disease be included measured target lesions
1, temozolomide who grade ii astrocytomas diagnosis positive serological test results hepatitis b
0, bevacizumab peritoneal carcinoma diagnosis previously untreated patients who have achieved at least partial response platinum based chemotherapy but experience relapse within period six months its conclusion
0, tamoxifen breast cancer diagnosis other
1, fludarabine phosphate splenic marginal zone lymphoma diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvate transaminase sgpt greater equal three upper limit normal
1, hormonal function measurement testicular neoplasms diagnosis inability answer questionnaires
1, niacinamide hepatocellular carcinoma diagnosis active clinically serious infection greater ctcae grade two
0, sbrt pancreatic cancer diagnosis diagnosis
1, epoetin alfa lymphoblastic lymphoma
0, pemetrexed carcinoma non small cell lung diagnosis ecog ps zero two
1, immunoglobulins stage iv nasopharyngeal keratinizing squamous cell carcinoma diagnosis use strong inhibitors inducers cypthreeafour is not permitted
1, carboplatin ewings sarcoma diagnosis relapsed disease
0, taxane breast cancer diagnosis demonstrate adequate organ function obtained within fourteen days prior randomization analyzed by central laboratory
1, cyclophosphamide burkitt lymphoma diagnosis st
1, antibodies monoclonal splenic marginal zone lymphoma diagnosis prior chemotherapy prior radiation therapy other malignancies
0, irinotecan diagnosed histologicall negative cytologically confirmed metastatic adenocarcinoma colon rectum
0, placebo carcinoma renal cell diagnosis adequate renal function
1, isophosphamide mustard low grade myofibroblastic sarcoma diagnosis patients body surface area less doc two not eligible
1, vaccines recurrent grade three follicular lymphoma diagnosis experience graft failure absolute neutrophil count less five hundred mm three
1, ifosfamide malignant cutaneous granular cell tumor diagnosis cypthreeafour inducers
0, etoposide lymphoma diagnosis life expectancy
0, fludarabine recurrent adult lymphoblastic lymphoma diagnosis mds lower ipss scores int one less severe clinical features such severe neutropenia thrombocytopenia high risk chromosome abnormalities such monosomy seven
0, iodine i lung cancer diagnosis patient characteristics
1, regorafenib adenocarcinoma rectum diagnosis known history human immunodeficiency virus hiv infection current chronic active hepatitis infection requiring treatment antiviral therapy
1, vitamin b complex family member has history colorectal adenoma adenocarcinoma diagnosis lipid lowering medications following exceptions
1, tacrolimus stage ii grade two non contiguous follicular lymphoma diagnosis donor
0, pemetrexed non small cell lung cancer diagnosis phase one
1, zoledronic acid uterine cervical neoplasms diagnosis patients denovo osteoporosis also excluded
0, tamoxifen stage iib breast cancer diagnosis patient must have signed dated an institutional review board irb approved consent form that conforms federal institutional guidelines
1, fludarabine phosphate stage iv grade three follicular lymphoma diagnosis presence uncontrolled psychiatric disorder
1, antilymphocyte serum blood cancer diagnosis ejection fraction less thirty uncontrolled cardiac failure
1, trastuzumab breast cancer diagnosis prior treatment hspninety inhibitors
1, antibodies monoclonal patients known symptomatic brain metastases requiring steroids
1, vincristine childhood burkitt lymphoma diagnosis patients who opinion investigator may not be able comply safety monitoring requirements not eligible
1, immunoglobulins refractory cell non hodgkin lymphoma diagnosis circulating human anti mouse antibody hama be determined before each infusion
0, bevacizumab stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis negative pregnancy test
0, bevacizumab carcinoma diagnosis transaminases sgot sgpt must be less threex institutional upper limit normal uln
0, etoposide precancerous condition diagnosis chronic lymphocytic leukemia cr pr two greater
1, triptorelin pamoate prostate adenocarcinoma diagnosis unstable angina congestive heart failure requiring hospitalization within last six months
0, imatinib mesylate unspecified adult solid tumor protocol specific diagnosis fertile patients must use effective barrier contraception during three months after participation
1, immunoglobulins tumors metastatic brain diagnosis any non oncology vaccine therapy used prevention infectious diseases up one month before after any dose ipilimumab
1, capecitabine rectal cancer diagnosis prior severe infusion reaction monoclonal antibody
1, vaccines lung cancer diagnosis pregnancy breast feeding
0, melphalan multiple myeloma plasma cell neoplasm diagnosis no new york heart association class iii congestive heart failure
1, carboplatin stage iii follicular thyroid cancer diagnosis concurrent use systemic corticosteroids
0, prednisolone recurrent adult grade iii lymphomatoid granulomatosis diagnosis patients treated previously radiation therapy excess one thousand cgy rads any thoracic abdominal port excess three thousand cgy rads cranial spinal ports who not eligible other protocols eligible this study
0, hormones stage iv prostate cancer diagnosis received greater three prior courses paclitaxe negative docetaxel based therapy disease progression documented during therapy after cessation therapy
0, fluorouracil mucinous adenocarcinoma rectum diagnosis platelet count greater equal one hundred zero ul
1, bortezomib multiple myeloma diagnosis pregnancy testing was not required post menopausal surgically sterilized women
0, bevacizumab stage iv major salivary gland carcinoma diagnosis patients should not have prior history serious human anti human antibody haha reaction patients known hypersensitivity chinese hamster ovary cell products other recombinant human antibodies not eligible
0, etoposide sarcoma diagnosis patient characteristics
1, bb ovarian cancer diagnosis prior carboplatin cisplatin hypersensitivity reaction
0, thalidomide peripheral cell lymphoma diagnosis fourteen days again within twenty four hours prior prescribing lenalidomide cycle one prescriptions must be filled within seven days must either commit continued abstinence from heterosexual intercourse begin two acceptable methods birth control one highly effective method one additional effective method at same time at least twenty eight days before she starts taking lenalidomide fcbp must also agree ongoing pregnancy testing men must agree use latex condom during sexual contact fcbp even if they have had successful vasectomy
0, bevacizumab breast cancer diagnosis who performance status zero one
1, paclitaxel non squamous non small cell lung cancer diagnosis squamous cell small cell mixed histology
1, aldesleukin stage iiib skin melanoma diagnosis clinically significant psychiatric disease which opinion pi sub investigator would render immunotherapy its potential sequelae unsafe compliance procedural requirements unlikely
1, tacrolimus recurrent grade one follicular lymphoma diagnosis seropositive human immunodeficiency virus hiv
1, melphalan lymphoma diagnosis patients active hepatitis either active carrier hbsag positive viremic hbv dna greater equal ten zero copies ml greater equal two zero iu ml
1, cyclophosphamide contiguous stage ii mantle cell lymphoma diagnosis known hiv positive status
0, metronidazole salivary gland adenocarcinoma diagnosis scleroderma
1, vaccines bone sarcoma diagnosis any serious uncontrolled medical psychiatric condition that opinion investigator makes patient not able participate study
0, interferons histologically confirmed metastatic melanoma
1, immunoglobulins stage iii squamous cell carcinoma lip oral cavity diagnosis major active psychiatric disorders which would limit compliance
1, vitamins prostate cancer diagnosis history sarcoidosis
1, tmx non muscle invasive bladder cancer diagnosis hemoglobin less doc dl
0, antibodies monoclonal endometrial transitional cell carcinoma diagnosis total bilirubin equal less doc mg dl direct bilirubin equal less doc mg dl
0, rituximab lymphoma diagnosis transaminases less two times normal
0, capecitabine gastric cancer diagnosis bone marrow
1, cyclosporine anaplastic large cell lymphoma diagnosis donor
1, rituximab non hodgkin lymphoma diagnosis pregnancy testing is not required post menopausal surgically sterilized women
0, sirolimus pancreatic neuroendocrine cancer diagnosis planned initiation active therapy everolimus sunitinib traditional cytotoxic chemotherapy
1, stereotactic body radiation therapy primary tumor any stage within touching zone proximal bronchial tree note
1, trametinib stage iiic rectal cancer diagnosis history current evidence risk retinal vein occlusion rvo central serous retinopathy csr
0, alovudine stage iv breast cancer diagnosis no prior therapy veliparib metastatic disease will be allowed
1, docetaxel stage iv bladder cancer diagnosis potassium less institutional normal level despite supplementation serum calcium ionized adjusted albumin magnesium below lower limits normal despite supplementation
0, estradiol stage iv lung cancer diagnosis patients without an egfr mutation must have received one two lines chemotherapy beforehand
1, paclitaxel urinary bladder neoplasms diagnosis liver metastases serum albumin less three dl
1, letrozole endometrial cancer diagnosis history cerebral vascular accident transient ischemic attack subarachnoid hemorrhage within past three months
0, antibodies stage iii verrucous carcinoma oral cavity diagnosis coronary peripheral artery bypass graft stenting within past twelve months
1, cetuximab metastatic colorectal cancer diagnosis diagnosis suspicion brain leptomeningeal metastases
0, epothilones breast cancer diagnosis aspartate aminotransferase ast less doc uln
1, cyclophosphamide stage iib breast cancer diagnosis active cardiac disease
0, oxaliplatin carcinoma non small cell lung diagnosis adequate kidney function serum creatinine less doc upper limit normal uln
0, sunitinib stage iv verrucous carcinoma oral cavity diagnosis ast alt less doc times uln
1, sirolimus malabsorption syndrome disease significantly affecting gastrointestinal function resection stomach small bowel
1, clofarabine lymphoblastic lymphoma diagnosis patients who receive other chemotherapy
1, treosulfan asymptomatic metastatic lesions whose further growth would likely cause functional deficits intractable pain should be considered loco regional therapy prior enrolment
0, cisplatin head neck cancer diagnosis radiotherapy
1, trastuzumab breast cancer diagnosis patients new york heart association class ii greater congestive heart failure
0, everolimus refractory relapsed osteosarcoma diagnosis neutrophil count greater doc zero mmÂ³ platelets greater ten doc zero mmÂ³ hemoglobin greater doc mg dl
1, cetuximab stage ivc laryngeal squamous cell carcinoma diagnosis use strong inhibitors inducers cypthreeafour is not permitted
0, everolimus breast cancer diagnosis ecog performance status zero
1, epirubicin breast neoplasms diagnosis concomitant treatment corticosteroids used reasons other premedication however patients receiving chronic treatment corticosteroids greater six months at low dose less twenty mg methylprednisolone equivalent dose other corticosteroids whichever reason eligible
1, mifepristone stage iiic breast cancer diagnosis patients must have one week washout period from prior hormonal therapy testosterone estrogen progestin gonadotropin releasing hormone antagonist
1, lenalidomide stage iii grade one follicular lymphoma diagnosis inability comply follow up testing procedures
0, antibodies monoclonal non hodgkin lymphoma diagnosis patients must have karnofsky performance status at least sixty an anticipated survival at least three months
1, pemetrexed lung cancer non small cell diagnosis clinically significant gastrointestinal abnormalities which might interfere oral dosing including but not limited to
0, lenograstim recurrent neuroblastoma diagnosis no concurrent hydroxyurea
1, doxorubicin recurrent primary peritoneal carcinoma diagnosis patients who require parental hydration nutrition
1, pazopanib ovarian cancer diagnosis corrected qt interval qtc greater four hundred eighty msecs using bazett formula
1, sorafenib lymphomas diagnosis previous mediastinal radiotherapy
0, epigallocatechin gallate unspecified adult solid tumor protocol specific diagnosis cardiovascular
0, silicon non melanomatous skin cancer diagnosis no concurrent chemotherapy
0, albumin bound paclitaxel metastatic transitional cell cancer renal pelvis ureter diagnosis granulocyte count greater equal one five hundred mm three
0, monosialotetrahexosylganglioside sodium colorectal cancer diagnosis should have target lesions non target lesions
1, erlotinib hydrochloride pancreatic adenocarcinoma diagnosis chronic diarrhea
0, docetaxel first line treatment patients non resectable gastric cancer cancer esophagus diagnosis neutrophils greater one five one platelets greater one one l
1, cyclophosphamide malignant neoplasm female breast diagnosis women childbearing potential either positive no pregnancy test at baseline
0, r blocks lymphoma non hodgkin diagnosis up eighteen years age
1, paclitaxel stage iv squamous cell carcinoma nasopharynx diagnosis prior therapy herceptin
0, cyclophosphamide malignant rhabdoid tumor diagnosis at least three half lives must have elapsed since prior therapy that included monoclonal antibody see appendix i
0, email coaching ovarian cancer diagnosis less two days fifteen minutes more resistance training per week
1, x suit nir covered biliary stent biliary tract cancer diagnosis presence any esophageal duodenal stent
1, methotrexate stage iv childhood anaplastic large cell lymphoma diagnosis lactating females not eligible unless they have agreed not breastfeed their infants
0, pharmacological stage iii mucoepidermoid carcinoma oral cavity diagnosis platelet count greater equal one hundred zero mm three
1, bupivacaine rectum cancer diagnosis subjects inflammatory bowel disease active colitis pre existing intra abdominal inflammation
1, sirolimus mantle cell lymphoma refractory diagnosis left ventricular ejection fraction less forty five calculated by echocardiographic scintigraphic method
0, cisplatin head cancer diagnosis no more six seven weeks minimum three weeks should have elapsed between surgery initiation radiation
0, visual examination head neck cancer diagnosis written informed consent
0, interferons unspecified childhood solid tumor protocol specific diagnosis age
1, leuprolide prostate cancer diagnosis serious hypertension not controlled by appropriate treatment
1, bb multiple myeloma diagnosis active hepatitis infection
0, leuprolide prostate cancer diagnosis surgery
0, leucovorin stage iia rectal cancer diagnosis group ii
0, fluorouracil stage iiic colon cancer diagnosis patients who known have lynch syndrome have been found carry specific mutation an mmr gene mlhone mshtwo mshsix pmstwo eligible participate
0, vatalanib uncontrolled intercurrent illness including not limited ongoing uncontrolled infection symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmia uncontrolled high blood pressure history labile hypertension history poor compliance an antihypertensive regimen myocardial infarction less equal six months prior registration uncontrolled diabetes interstitial pneumonia extensive symptomatic interstitial fibrosis lung chronic liver disease psychiatric illness social situations that limits compliance requirements
0, dexamethasone refractory multiple myeloma diagnosis total bilirubin less two mg dl
1, bevacizumab glioblastoma diagnosis pregnant lactating
0, ferrosoferric oxide breast cancer diagnosis surgery
1, methylprednisolone hemisuccinate concurrent use other anti cancer agents treatments
1, bevacizumab lung cancer diagnosis use anti coagulant agents including warfarin heparin aspirin nsaids
1, carboplatin stage iv esophageal cancer diagnosis prior therapy herceptin
0, capecitabine metastatic colorectal cancer diagnosis performance status greater equal two
0, albumin bound paclitaxel advanced cancers diagnosis negative serum pregnancy test women childbearing potential within seven days first dose treatment patients child bearing potential must agree use effective contraception during after three months post dose
0, leucovorin stage iv colon cancer diagnosis platelet count at least one hundred zero mm three
0, food intake modification carcinoma non small cell lung diagnosis ability give written informed consent
0, reverse transcriptase inhibitors kaposi sarcoma diagnosis condoms male female iud hormone based therapy contraceptive pills norplant depo provera
0, everolimus stage iiib endometrial carcinoma diagnosis fasting triglycerides equal less doc six mmol l
0, carboplatin recurrent bladder cancer diagnosis neutrophilsgreater doc one hundred nine l
1, vincristine stage adult lymphoblastic lymphoma diagnosis use any other experimental drug therapy within fourteen days baseline
0, antibodies monoclonal neoplasm metastasis diagnosis total testosterone less fifty ng dl except patients prior orchiectomy where testosterone does not need be measured
0, fluorouracil esophageal cancer diagnosis not specified chemotherapy
1, albumin bound paclitaxel thyroid gland undifferentiated anaplastic carcinoma diagnosis pregnancy women childbearing potential men who sexually active not willing able use medically acceptable forms contraception
1, midazolam solid tumor diagnosis participant has received another investigational agent within twenty eight days first dose drug
1, pemetrexed stage iiia non small cell lung cancer diagnosis bone lesions
0, antibodies monoclonal advanced cancers diagnosis there is no limit on number prior treatment regimens
0, bb multiple myeloma diagnosis must agree use condom during sexual contact fcbp throughout drug therapy during any dose interruption one week after discontinuation therapy
1, fludarabine phosphate noncontiguous stage ii grade one follicular lymphoma diagnosis life expectancy severely limited by diseases other malignancy
0, cisplatin ovarian cancer diagnosis prior concurrent therapy
0, itreg multiple myeloma diagnosis renal
0, fludarabine phosphate splenic marginal zone lymphoma diagnosis karnofsky score greater equal seventy adults lansky score greater equal fifty pediatrics
0, antibodies stage ivb colorectal cancer diagnosis hemoglobin must be greater equal ten dl
0, veliparib head neck squamous cell carcinoma diagnosis patients history allergic reactions attributed compounds similar chemical biologic composition abt eight hundred eighty eight other agents used including cremophor carboplatin paclitaxel cisplatin five fluorouracil hydroxyurea any compounds similar chemical biologic composition not eligible
0, isophosphamide mustard seminoma diagnosis minimum three weeks after last day start previous chemotherapy regimen before first day chemotherapy on protocol
0, sirolimus adult gliosarcoma diagnosis no prior erlotinib hydrochloride aeeseven hundred eighty eight other epidermal growth factor receptor targeting agents phase ii patients receiving sorafenib erlotinib hydrochloride
1, immunoglobulins stage iv adenoid cystic carcinoma oral cavity diagnosis history allergic reactions attributed compounds similar chemical biologic composition cetuximab
1, paclitaxel recurrent adult diffuse large cell lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition at one hundred one other agents used study
1, oxaliplatin colorectal cancer diagnosis non measurable lesion only disease evidence
1, oxaliplatin metastatic colorectal cancer diagnosis bowel obstruction
1, n monoacetylcystine stage iii squamous cell carcinoma nasopharynx diagnosis any following
1, azd ovarian cancer diagnosis hiv positive patients history hepatitis current chronic active hepatitis
0, paclitaxel advanced non small cell lung cancer diagnosis eastern cooperative oncology group ecog performance status zero two
1, doxorubicin mantle cell lymphoma diagnosis women who pregnant lactating
1, capecitabine other prior malignancies except treated situ carcinoma cervix tumours skin without indication melanoma ten years tumourfree
1, cytarabine lymphoma diagnosis presence human anti zevalin antibody haza
0, histone deacetylase inhibitors small cell lung carcinoma diagnosis adequate haematological function
1, antibodies monoclonal multiple myeloma diagnosis participant has any concurrent medical psychiatric condition disease example active systemic infection uncontrolled diabetes acute diffuse infiltrative pulmonary disease that is likely interfere procedures results that opinion investigator would constitute hazard participating this study
1, bortezomib recurrent mantle cell lymphoma diagnosis significant concurrent uncontrolled medical condition including but not limited renal hepatic gastrointestinal endocrine pulmonary neurological cerebral psychiatric disease which opinion investigator may represent risk patient
0, cyclophosphamide non hodgkins lymphoma diagnosis any patient unable tolerate consolidation maintenance chemotherapy would have been deemed appropriate by treating physician
0, citric acid solid tumor diagnosis consent form must be signed prior conduct any trial specific procedure
0, laboratory biomarker analysis recurrent childhood brain tumor diagnosis patients will be eligible this even if they receiving anti convulsants
0, laboratory biomarker analysis stage ib non small cell lung cancer diagnosis can be receiving any type treatment chemotherapy radiation therapy both neither eligible
1, niacinamide adult primary hepatocellular carcinoma diagnosis uncontrolled hypertension defined systolic blood pressure greater one hundred forty mmhg diastolic pressure greater ninety mmhg despite optimal medical management
0, paclitaxel ovarian embryonal carcinoma diagnosis absolute neutrophil count greater seven hundred fifty mmÂ³
1, melphalan recurrent childhood small noncleaved cell lymphoma diagnosis patients who opinion treating physician unlikely comply restrictions allogeneic stem cell transplantation based on formal psychosocial screening
1, albumin bound paclitaxel epithelial ovarian cancer diagnosis prior history hypertensive crisis hypertensive encephalopathy
1, aminolevulinic acid non melanoma skin cancer diagnosis use following medications
1, androgens metastatic breast cancer diagnosis female patients who both lactating breastfeeding have positive serum pregnancy test during screening period
0, cytarabine recurrent childhood anaplastic large cell lymphoma diagnosis fertile patients must use effective contraception during greater three months after completion treatment
1, epacadostat stage iii fallopian tube cancer diagnosis patients who had within past six months cardiovascular accident cva at risk arterial thrombus such severe peripheral vascular disease pvd carotid artery disease cad
1, etoposide phosphate recurrent burkitt lymphoma diagnosis dementia any kind
1, vincristine lymphoma large cell diffuse diagnosis serious medical psychiatric illness likely affect participation that may compromise ability give informed consent
1, gemcitabine uterine corpus leiomyosarcoma diagnosis patients who have had prior therapy gemcitabine docetaxel
1, vinblastine precancerous condition diagnosis patients must have had their last dose radiation therapy at least six weeks prior entry their last dose chemotherapy at least four weeks prior entry
1, capecitabine breast cancer diagnosis radiation therapy less fourteen days prior enrollment
1, vidarabine recurrent childhood lymphoblastic lymphoma diagnosis donor
1, sunitinib stage iiic breast cancer diagnosis have clinical diagnosis congestive heart failure angina pectoris any following within six months prior drug administration
1, immunosuppressive agents stage iii adult immunoblastic large cell lymphoma diagnosis presence active central nervous system cns disease history adequately treated cns disease is acceptable
0, cyclosporine patients clinical laboratory evidence liver disease would be evaluated cause liver disease its clinical severity terms liver function degree portal hypertension patients will be excluded if they found have fulminant liver failure cirrhosis liver evidence portal hypertension alcoholic hepatitis esophageal varices history bleeding esophageal varices hepatic encephalopathy uncorrectable hepatic synthetic dysfunction evinced by prolongation prothrombin time ascites related portal hypertension bridging fibrosis bacterial fungal liver abscess biliary obstruction chronic viral hepatitis total serum bilirubin greater three mg dl symptomatic biliary disease
1, pemetrexed confirmed presence cns tumor involvement
0, pharmacological recurrent colon cancer diagnosis more four weeks since prior radiotherapy
1, vemurafenib melanoma diagnosis ocular
1, sorafenib bladder cancer diagnosis serious non healing wound ulcer bone fracture
1, sirolimus stage iv childhood lymphoblastic lymphoma diagnosis active bacterial fungal infections unresponsive medical therapy
1, radiotherapy followed by chemotherapy extranodal natural killer cell lymphoma nasal type diagnosis abnormal coagulation function
0, carboplatin ovarian cancer diagnosis see disease characteristics
0, fludarabine lymphoma diagnosis lvef at least forty by muga echocardiogram
0, albumin bound paclitaxel fallopian tube cancer diagnosis participants must have normal organ marrow function defined below
1, dexamethasone acetate multiple myeloma diagnosis any other cardiac condition that opinion treatment physician would make this protocol unreasonably hazardous patient
1, etoposide neuroblastoma diagnosis evidence any significant clinical disorder laboratory finding that makes it undesirable subject participate trial
0, albumin bound paclitaxel ovarian cancer diagnosis poorly controlled seizures
1, paclitaxel pancreatic adenocarcinoma diagnosis pre existing grade two greater neuropathy
1, darbepoetin alfa cancer diagnosis active bleeding
1, degarelix prostate cancer diagnosis hypersensitivity towards any component fetwo hundred thousand four hundred eighty six
0, vidarabine stage iii marginal zone lymphoma diagnosis no more three prior treatments disease not including steroids alone
1, dexamethasone phosphate refractory plasma cell myeloma diagnosis telithromycin
1, lenalidomide follicular lymphoma diagnosis pregnant lactating females
0, rituximab extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis understand voluntarily sign an informed consent form
1, immunoglobulins cancer diagnosis patients known be serologically positive hepatitis hepatitis human immunodeficiency virus hiv
1, lenograstim diffuse large cell lymphoma diagnosis hbv positivity
0, methylprednisolone acetate recurrent cutaneous cell non hodgkin lymphoma diagnosis acute non lymphocytic leukemia fab types mone mseven first second remission early first second bone marrow relapse greater one marrow blasts no circulating peripheral blasts
0, bevacizumab undifferentiated ovarian carcinoma diagnosis serum glutamic oxaloacetic transaminase sgot aspartate aminotransferase ast less equal three uln ctep ctcae version doc grade one
1, lenalidomide plasma cell myeloma diagnosis participation other clinical trials including those other investigational agents not included this trial within thirty days start this trial throughout duration this trial
1, prostate pelvis imrt prostate cancer diagnosis life expectancy less five years
1, mycophenolate mofetil childhood nasal type extranodal nk cell lymphoma diagnosis forty kidneys
0, albumin bound paclitaxel lung cancer diagnosis prior concurrent therapy
0, bb myeloma diagnosis lambda light chain ratio
0, dexamethasone acetate extramedullary plasmacytoma diagnosis measurable disease such protein objective measurable emp
1, immunoglobulins recurrent primary peritoneal carcinoma diagnosis history severe allergic anaphylactic other hypersensitivity reactions chimeric humanized antibodies fusion proteins
0, fosfestrol prostate cancer diagnosis no previous thromboembolic disease including stroke venous arterial thrombosis myocardial infarction ongoing angina pectoris
0, antibodies lymphoma non hodgkin diagnosis patients must have previously responded duration response at least three months iodine onethreeone anti bone antibody therapy
0, hypofractionated image guided intensity modulated external beam radiation adenocarcinoma diagnosis gleason score equal seven or
1, leuprolide prostatic adenocarcinoma diagnosis active infection within one week registration
1, liposomal doxorubicin metastatic undifferentiated pleomorphic sarcoma diagnosis at least three half lives since last dose prior first dose ribociclib exception
0, fludarabine phosphate recurrent lymphoplasmacytic lymphoma diagnosis not requiring supplemental oxygen mechanical ventilation oxygen saturation ninety higher on room air
0, questionniares childhood cancer diagnosis currently fifteen years older
1, carboplatin recurrent colon cancer diagnosis pregnant nursing women
0, hpph tumors can be primary recurrent stage zero nzerom any
0, temozolomide brain central nervous system tumors diagnosis karnofsky performance status seventy one hundred
0, computed tomography unspecified adult solid tumor protocol specific diagnosis less six lesions
0, fludarabine skin cancer diagnosis oxygen saturation greater equal ninety on room air
1, fluorouracil metastatic colorectal cancer diagnosis pregnant breast feeding subjects
1, gemcitabine pancreatic adenocarcinoma diagnosis subjects plastic biliary stents will be excluded metal biliary stents allowed will not be excluded
0, bevacizumab liver neoplasms diagnosis eighteen eighty years
0, sirolimus ovarian serous surface papillary adenocarcinoma diagnosis hcc confirmed by biopsy diagnosed by clinical radiologic criteria all following criteria must be met biopsy is required
0, immunoglobulins recurrent adult lymphoblastic lymphoma diagnosis chronic lymphocytic leukemia cll
0, metronidazole recurrent ovarian epithelial cancer diagnosis serum glutamic oxaloacetic transaminase sgot aspartate aminotransferase ast serum glutamic pyruvic transaminase sgpt alanine aminotransferase alt equal less three uln
1, quality life assessment multiple myeloma diagnosis is hearing impaired degree that they unable hear instructions via phone
1, busulfan symptomatic ischemic heart disease
1, thalidomide prior malignancies within past three years exception adequately treated basal cell squamous cell skin cancer thyroid cancer carcinoma situ cervix breast prostate cancer gleason grade six less stable prostate specific antigen psa levels
0, gemcitabine pancreatic cancer diagnosis clearance period from prior therapy more four weeks
1, docetaxel tongue cancer diagnosis severe active co morbidity defined follows
1, o benzylguanine aids related immunoblastic large cell lymphoma diagnosis patients who hepatitis virus hcv antibody positive hepatitis virus hbv surface antigen positive must be free clinical evidence cirrhosis that would otherwise make them ineligible hct determined by principal investigator consultation gastrointestinal service patients hbv ongoing evidence viral replication may require therapy prior receiving high dose chemotherapy
0, prednisone lymphoma diagnosis at least six months hematopoietic
1, questionnaire administration recurrent squamous cell carcinoma larynx diagnosis at discretion physician
0, fludarabine phosphate angioimmunoblastic cell lymphoma diagnosis human leukocyte antigen hla genotypically phenotypically identical related donor
0, sirolimus stage iii multiple myeloma diagnosis ast alt equal less doc times upper limit normal uln
1, lde metastatic colorectal cancer diagnosis added homicidal ideation risk doing harm self others patients active severe personality disorders defined according ds negative iv diagnostic statistical manual mental disorders fourth edition not eligible
0, keyhole limpet hemocyanin bladder cancer diagnosis karnofsky sixty one hundred
0, docetaxel breast cancer diagnosis unstable angina pectoris
0, temozolomide malignant glioma diagnosis pregnant breast feeding
1, dexamethasone stage iiic fallopian tube cancer diagnosis patients clinical symptoms signs gastrointestinal obstruction those who require parenteral hydration nutrition patients history current diagnosis inflammatory bowel disease not eligible
1, thalidomide lymphoma diagnosis history stroke intracranial hemorrhage within six months prior entry
1, d crt photon apbi breast cancer diagnosis active connective tissue disease
0, albumin bound paclitaxel histologic confirmation original primary tumor is required
1, fludarabine phosphate extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis cardiac
0, dacarbazine glioblastoma diagnosis karnofsky performance status greater seventy
1, trastuzumab recurrent breast carcinoma diagnosis angina pectoris that requires current use anti anginal medication
1, cisplatin small cell lung cancer diagnosis patients should not participate other investigational agent while taking part this trial
1, antibodies recurrent lip oral cavity squamous cell carcinoma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated either agent
1, curative resection pringle manoeuvre preoperative anti cancer therapy
1, lapatinib malignant solid neoplasms diagnosis active clinically serious bacterial fungal infection
1, clopidogrel breast neoplasms diagnosis patients serious bleeding disorder that make them inappropriate candidates nsaid therapy
1, dalteparin myeloma diagnosis ecog greater two
0, thalidomide recurrent adult lymphoblastic lymphoma diagnosis calculated creatinine clearance greater equal fifty ml min using cockcroft gault formula
0, calcium dietary metastatic cancer diagnosis concurrent targeted therapy agents bevacizumab cetuximab allowed
1, bortezomib intraocular lymphoma diagnosis patient has greater equal grade two peripheral neuropathy within fourteen days before enrollment
1, bevacizumab early endometrial carcinoma specified below
0, educational control breast cancer diagnosis age greater twenty one years
1, paclitaxel insulinoma diagnosis pregnant nursing women
0, methylprednisolone lymphoma diagnosis prior concurrent therapy
0, bortezomib mantle cell lymphoma diagnosis female subject is either post menopausal at least one year before screening visit surgically sterilized if they childbearing potential agree practice two effective methods birth control at same time hormonal contraceptive intra uterine device diaphragm spermicide condom spermicide abstinence from time signing informed consent through thirty days after last dose treatment agree completely abstain from heterosexual intercourse
0, estradiol stage iiic breast cancer diagnosis pleural pericardial effusion
0, fluorouracil unspecified adult solid tumor protocol specific diagnosis performance status zero two eastern cooperative oncology group ecog
0, cyclophosphamide rhabdoid tumor diagnosis agents that have known adverse events occurring beyond seven days after administration this period must be extended beyond time during which adverse events known occur
1, busulfan non hodgkin lymphoma diagnosis any preexisting medical condition sufficient severity prevent full compliance study
1, rituximab marginal lymphoma diagnosis male subjects who not agree use an acceptable method contraception duration study
0, aldesleukin metastatic melanoma diagnosis willing sign durable power attorney
0, cyclosporins noncontiguous stage ii mantle cell lymphoma diagnosis recipient has achieved second subsequent complete response but has persistent radiographic abnormalities unknown significance
0, dexamethasone acetate multiple myeloma diagnosis neutrophils greater twoxone hundred nine hemoglobin greater ten dl platelets greater ten xone hundred nine l
1, bevacizumab liver cancer diagnosis history aneurysms strokes transient ischemic attacks arteriovenous malformations within six months
1, specimen ultra high field mri bladder cancer diagnosis no allergy contrast agents
1, antibodies monoclonal ovarian seromucinous carcinoma diagnosis patients who have received prior abt eight hundred eighty eight any other poly adenosine diphosphate adp
0, paclitaxel medulloblastoma diagnosis central nervous system
0, camptothecin stage iv gastric cancer diagnosis no myocardial infarction within past six months
0, sargramostim sarcoma diagnosis surgery
0, antilymphocyte serum first remission lymphoblastic lymphoma small non cleaved cell lymphoma mantle cell lymphoma
1, poly i c stage iiib skin melanoma diagnosis immunosuppressive therapy within thirty days prior initiation protocol therapy
0, lapatinib ovarian cancer diagnosis john wort
0, camptothecin recurrent cervical cancer diagnosis estrogen receptor negative
1, gemcitabine gallbladder cancer diagnosis inadequate end organ function evidence severe uncontrolled systemic disease any concurrent condition which investigator opinion makes it undesirable patient participate trial which would jeopardize compliance wit
0, antibodies monoclonal recurrent adrenal cortex carcinoma diagnosis patients must have measurable disease according standard recist version doc ct scans magnetic resonance imaging mris used assess measurable disease must have been completed within twenty eight days prior registration
0, liposomal doxorubicin multiple myeloma plasma cell neoplasm diagnosis not specified
0, endothelial growth factors stage iii basal cell carcinoma lip diagnosis platelet count at least one hundred zero mm three
0, sirolimus renal transplant patients at high risk skin cancer diagnosis minimum period six month after renal transplantation
1, cyclosporins childhood nasal type extranodal nk cell lymphoma diagnosis patient has an identical related bone marrow donor six six hla identical matched unrelated donor
1, busulfan recurrent grade one follicular lymphoma diagnosis patient has an identical related bone marrow donor six six hla identical matched unrelated donor
0, methylprednisolone acetate lymphoma diagnosis myelodysplastic syndromes meeting any following criteria
0, immunoglobulins stage iib pancreatic cancer diagnosis platelets greater equal one hundred zero Î¼l
1, adjuvants immunologic stage iv renal cell cancer diagnosis participation other clinical studies during this clinical study
0, fluorodeoxyglucose f prostate cancer diagnosis chemotherapy
0, taxane triple negative breast cancer diagnosis prior treatment any these agents is not required if agents contraindicated prospective subject documented her medical history
1, bevacizumab childhood immunoblastic large cell lymphoma diagnosis qtc prolongation greater five hundredmsec other significant ecg abnormality noted within fourteen days registration
0, doxorubicin stage iiia hodgkin lymphoma diagnosis documentation receipt antiretroviral therapy art by licensed health care provider
1, laboratory biomarker analysis recurrent breast cancer diagnosis clinically significant pulmonary dysfunction cardiomyopathy any history clinically significant congestive heart failure chf unstable angina pectoris cardiac arrhythmia
0, bortezomib recurrent grade one follicular lymphoma diagnosis lymph node biopsy must be done equal less twenty eight days prior registration if used an eligibility criterion entry
1, oxaliplatin pancreatic ductal adenocarcinoma diagnosis history abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior day zero
0, dacarbazine stage iv skin melanoma diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum glutamate pyruvate transaminase sgpt equal less three institutional upper limit normal
1, adenosine liver tumors diagnosis iv
1, rituximab lymphoma diagnosis patients grade greater equal three non hematologic toxicity from previous therapy that has not resolved less equal grade one
1, sunitinib breast cancer diagnosis active infection that opinion investigator would compromise patient ability tolerate therapy
0, tanespimycin recurrent small lymphocytic lymphoma diagnosis no serious ventricular arrhythmia ventricular tachycardia vt ventricular fibrillation vf greater equal three beats row
1, antibodies monoclonal ovarian serous adenocarcinoma diagnosis stage not greater b no more superficial myometrial invasion without vascular lymphatic invasion no poorly differentiated subtypes including papillary serous clear cell other figo grade three lesions
1, bb brain neoplasms diagnosis disease treatment history
0, oxaliplatin stage iiia colon cancer diagnosis serum hepatitis virus hbv dna twenty zero iu ml one hundred five copies ml lower values two zero twenty zero iu ml one hundred four one hundred five copies ml often seen hepatitis virus antigen hbeag negative chronic hepatitis b
0, antilymphocyte serum multiple myeloma diagnosis pulmonary
1, bortezomib multiple myeloma diagnosis poems syndrome plasma cell dyscrasia polyneuropathy organomegaly endocrinopathy monoclonal protein protein skin changes
0, acetylcysteine melanoma skin diagnosis closed accrual three seven two thousand one measurable evaluable disease required
1, carboplatin history other malignancy except adequately treated basal cell squamous cell skin cancer carcinoma situ cervix radically treated prostatic carcinoma good prognostic gleason equal six
1, fluorouracil metastatic colorectal cancer diagnosis active infection requiring parenteral antibiotics
0, penicillanic acid multiple myeloma plasma cell neoplasm diagnosis no known allergy piperacillin tazobactam vancomycin no history immediate accelerated reaction beta lactam antibiotics no prior inclusion this no catheter related infection no known hiv infection not pregnant nursing
1, antibodies monoclonal stage iia breast cancer diagnosis valvular disease documented compromise cardiac function and
1, everolimus recurrent verrucous carcinoma oral cavity diagnosis patients may not have received prior cetuximab therapy
1, leucovorin stage iiia gastric cancer diagnosis active infection other serious underlying medical condition which would impair ability patient receive planned treatment
0, dexamethasone multiple myeloma plasma cell neoplasm diagnosis ineligible stem cell transplantation due any following
0, liposomal doxorubicin metastatic breast cancer diagnosis sgot sgpt ast alt less doc uln
0, pemetrexed carcinoma non small cell lung diagnosis event limited tissue availability stains will be prioritized follows
0, methotrexate lymphoma diagnosis disease characteristics
0, epoetin alfa unspecified adult solid tumor protocol specific diagnosis no active bleeding
0, cisplatin head neck cancer diagnosis see disease characteristics
0, everolimus recurrent adult soft tissue sarcoma diagnosis patients may have received prior therapy oral tyrosine kinase inhibitors other similar agents at least seven days must have elapsed since completion therapy biologic agent all toxicities must have resolved less grade two prior enrollment
0, nintedanib peritoneal cancer diagnosis bilirubin should be normal limits ctcae doc grade one
1, high dose rate brachytherapy stage ib breast cancer diagnosis any dosimetric treatment criteria defined have not been met patients who become ineligible due inability meet dosimetric criteria should not receive treatment defined this protocol will come off any subsequent adjuvant radiation will be delivered at discretion treating physician
0, carboplatin brain tumor diagnosis other
1, immunoglobulin g recurrent childhood pineoblastoma diagnosis patients must not have history abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior entry
0, antineoplaston as brain central nervous system tumors diagnosis age
0, cognitive behavioral therapy hypnosis group breast cancer diagnosis min
1, camptothecin carcinoma non small cell lung diagnosis platelets less one hundred zero mmthree
0, temozolomide adult giant cell glioblastoma diagnosis karnofsky performance status greater equal sixty
0, mycophenolate mofetil recurrent grade three follicular lymphoma diagnosis low grade nh negative less six months duration complete response cr between courses conventional therapy
1, immunoglobulins recurrent grade two follicular lymphoma diagnosis have positive pregnancy test at baseline or
1, liposomal doxorubicin ovarian endometrioid tumor diagnosis patients may not be receiving any medication that may markedly affect renal function vancomycin amphotericin pentamidine
1, etoposide phosphate recurrent childhood small noncleaved cell lymphoma diagnosis estimated risk graft vs
0, sucralfate patients head neck cancer receive chemo radiation tube
0, plasminogen breast cancer diagnosis axillary lymph nodes tumour free node negative disease
0, liposomal doxorubicin contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis patients allowed have received radiotherapy before enrollment if radiation was given alleviate pain neurologic compromise long there remains areas measurable disease present
0, sirolimus stage iiia fallopian tube cancer diagnosis absolute neutrophil count anc greater equal one thousand five hundred mm three
0, antibodies monoclonal small lymphocytic lymphoma diagnosis note
0, doxorubicin nodal marginal zone cell lymphoma diagnosis ecog ps zero two
0, antibodies monoclonal multiple myeloma diagnosis patients must have clearly detectable quantifiable monoclonal component value
0, gemcitabine histologically cytologically confirmed carcinoma arising from pancreas
1, epirubicin history any prior ips negative contralateral invasive breast cancer
1, pemetrexed has known active central nervous system cns metastases carcinomatous meningitis
0, pembrolizumab lung cancer diagnosis subjects childbearing potential those who have not been surgically sterilized have not been free from menses greater one year
1, tacrolimus bone marrow biopsy sole diagnostic means follicular lymphoma
1, paclitaxel subjects diagnosis epithelial ovarian fallopian tube peritoneal cancers low malignant potential borderline carcinomas
0, octreotide somatostatin producing neuroendocrine tumor diagnosis patient has an range inr between two three on stable no change two weeks prior registration dose oral anticoagulant on stable no change prior two weeks dose low molecular weight heparin
1, capecitabine advanced pancreatic carcinoma diagnosis also not will be excluded patients who had previously received preoperative neoadjuvant treatment localized disease chemotherapy radiotherapy
0, antibodies stage iv grade three follicular lymphoma diagnosis total bilirubin equal less doc mg dl
1, cytarabine lymphoma diagnosis age less twelve years age greater thirty years
1, alisertib malignant neoplasms lip oral cavity pharynx diagnosis female subject who is pregnant breast feeding
0, aldesleukin melanoma diagnosis before treatment starts at each visit patient will be asked complete two quality life questionnaires
1, selenium stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis evidence any other significant medical disorder laboratory finding that opinion investigator compromises subject safety during study
0, prednisone stage ii contiguous adult diffuse large cell lymphoma diagnosis age adjusted international prognostic index ipi score
0, tamoxifen breast cancer diagnosis disease characteristics
1, bortezomib brain central nervous system tumors diagnosis any following conditions
1, lumpectomy breast neoplasm diagnosis have prosthesis implant operative breast
1, lum imaging device pancreatic cancer diagnosis pregnant women lactating women
0, bevacizumab stage iiia non small cell lung cancer diagnosis measurable nonmeasurable disease by ct scan mri
1, oxaliplatin stage ii gastric cancer diagnosis peripheral neuropathy greater equal grade two
0, sirolimus adult glioblastoma diagnosis disease progression after initial therapy radiotherapy without chemotherapy if used initial therapy
0, antibodies monoclonal sarcoma diagnosis both pediatric adult patients any age eligible
1, laboratory biomarker analysis recurrent childhood pilocytic astrocytoma diagnosis hypothalamus vs
0, radiotherapy malignant glioma diagnosis age greater equal seventy years
1, irinotecan lung cancer diagnosis history heart attack within six months
1, irinotecan stage iiic colon cancer diagnosis refer world health organization who international society hypertension ish guidelines
0, celecoxib melanoma diagnosis patients active disease outside thorax may be eligible once extrathoracic disease is definitively treated by local modalities such radiation surgery radiofrequency ablation
0, topotecan metastatic small cell lung cancer diagnosis ecog ps zero two
1, broccoli sprout extract chemotherapy surgery excluding transurethral resection bladder tumor turbt bcg radiotherapy prior four weeks six weeks mitomycin interferon
0, carmustine recurrent adult diffuse small cleaved cell lymphoma diagnosis primary previously treated
0, clinical psychosocial phone calls non metastatic patients rectal cancer diagnosis patient adequate hematopoietic hepatic cardiac functions according investigator
0, antibodies monoclonal recurrent squamous cell lung carcinoma diagnosis patients must have zubrod performance status zero one documented within twenty eight days prior screening pre screening registration
0, methylprednisolone hemisuccinate recurrent adult diffuse mixed cell lymphoma diagnosis all patients acute promyelocytic leukemia first complete remission who have received retinoic acid chemotherapy not eligible
1, olaparib tumors diagnosis thus surgical procedures standard care not part trial participation
1, bevacizumab multiple myeloma diagnosis permanent sensory loss that interferes function
1, goserelin symptomatic brain other cns metastases
0, saracatinib stage iva thymoma diagnosis urine protein
0, vidarabine recurrent small lymphocytic lymphoma diagnosis patients eligible this trial will have high risk diseases that include but not limited to
0, cetuximab stage iv non small cell lung cancer diagnosis stage iv disease includes monea moneb
0, cytology specimen collection procedure stage renal cell cancer diagnosis aspartate aminotransferase ast equal less doc uln
1, everolimus hepatocellular carcinoma diagnosis patients any evidence extrahepatic hcc metastasis
1, trastuzumab concurrent endocrine antitumor therapy
0, standard postoperative care tumors diagnosis neck dissection
1, epirubicin advanced hepatocellular carcinoma diagnosis liver function is childs pugh c
0, paclitaxel metastatic breast cancer diagnosis ast less doc uln bilirubin less doc uln anc greater one five hundred ul platelet count greater one zero ul normal pt ptt
0, niacinamide non squamous cell lung cancer diagnosis hepatic function requirements
1, antibodies monoclonal stage iv colorectal cancer diagnosis uncontrolled high blood pressure defined systolic blood pressure bp greater one hundred sixty mmhg diastolic bp one hundred mmhg without anti hypertensive medication patients initial bp elevations eligible if initiation adjustment bp medication lowers pressure meet entry criteria
0, carbon ion radiotherapy histologically confirmed atypical meningioma
1, bortezomib multiple myeloma diagnosis exceptions include following
0, thalidomide lymphoma diagnosis no hairy cell leukemia
0, dasatinib stage iii cutaneous cell non hodgkin lymphoma diagnosis patients must not be taking therapeutic doses anticoagulants low dose warfarin port prophylaxis is permitted
1, antibodies monoclonal stage ib pancreatic cancer diagnosis antimycobacterial
1, antibodies monoclonal plasma cell neoplasm diagnosis skin condition likely interfere ecg electrode placement breast implant thoracic surgery
1, cisplatin carcinoma hepatocellular diagnosis serious cardiac arrhythmia
0, protein expression analysis patients low stage international neuroblastoma staging system inss stage one two neuroblastoma nbl
0, hmn labetuzumab colorectal cancer diagnosis hematopoietic
1, antilymphocyte serum cancer diagnosis uncontrolled active infection defined more one week no response appropriately chosen antibiotics
0, antibodies stage iiib non small cell lung cancer diagnosis concurrent full dose anticoagulants allowed provided following criteria met part two only
0, docetaxel ovarian cancer diagnosis hepatic
1, sirolimus unspecified adult solid tumor protocol specific diagnosis patients who currently receiving rapamycin rap rapamune sirolimus therapy excluded from due possibility overdosing cci seven hundred seventy nine is metabolized into sirolimus
0, citric acid hormone sensitive breast cancer defined greater ten estrogen receptor greater ten progesterone receptor positivity by immunohistochemistry
1, aminolevulinic acid carcinoma basal cell diagnosis xeroderma pigmentosum
1, gemcitabine adult angiosarcoma diagnosis myocardial infarction
0, cyclophosphamide breast cancer diagnosis an estimated life expectancy at least twelve months
0, dacarbazine adult ependymoblastoma diagnosis patient agrees use an effective method contraception hormonal two barrier methods while on at least three months following plerixafor infusion
0, bevacizumab malignant gliomas diagnosis women child bearing potential men must agree use adequate contraception hormonal barrier method birth control abstinence prior entry duration participation
1, mtc prgd breast cancer diagnosis efficacy evaluation group
1, fludarabine phosphate recurrent adult diffuse small cleaved cell lymphoma diagnosis donor
1, irinotecan head neck cancer diagnosis patients who completed neoadjuvant concurrent adjuvant chemotherapy greater three months prior recurrence will be considered chemotherapy naive
1, pembrolizumab stage iv esophageal adenocarcinoma diagnosis known history any evidence active non infectious pneumonitis
1, cabozantinib uterine sarcoma diagnosis patients who have suffered cerebrovascular accident at any time past patients who have suffered transient ischemic attack past six months patients who have suffered deep venous thrombosis dvt pulmonary embolism past six months
0, imatinib mesylate primary peritoneal cavity cancer diagnosis recurrent persistent disease
0, antibodies small intestine lymphoma diagnosis on ecg
1, folic acid colorectal cancer diagnosis female patients who pregnant lactating men women reproductive potential not willing employ an effective method birth control during treatment three weeks after discontinuing treatment
1, melphalan multiple myeloma diagnosis female patients who pregnant breast feeding
0, hydrocortisone acetate stage iv adult lymphoblastic lymphoma diagnosis all patients must be enrolled on project every child apecfourteenbone prior treatment enrollment on aallone one
0, bb advanced metastatic cutaneous acral mucosal melanoma
1, mycophenolic acid stage grade two follicular lymphoma diagnosis treatment rituximab any reason two months preceding hct
0, methotrexate childhood immunoblastic large cell lymphoma diagnosis absolute neutrophil count greater one zero mm three
1, vorinostat stage iii grade three follicular lymphoma diagnosis patients evidence human immunodeficiency virus hiv seropositivity positive polymerase chain reaction pcr assay human lymphotropic virus htlv one htlvtwo seropositivity safety allogeneic hsct is not yet well established this population
1, antilymphocyte serum recurrent adult grade iii lymphomatoid granulomatosis diagnosis small bowel any volume forty six gy
1, albumin bound paclitaxel inflammatory breast cancer diagnosis known suspected congestive heart failure greater nyha coronary heart disease angina pectoris requiring antianginal medication previous history myocardial infarction evidence transmural infarction on ecg uncontrolled poorly controlled arterial hypertension bp greater one hundred sixty ninety mm hg under treatment two antihypertensive drugs rhythm abnormalities requiring permanent treatment clinically significant valvular heart disease
0, carboplatin head neck cancer diagnosis patients must have normal cardiac function lvef assessed by muga echo clinically satisfactory twelve lead ecg
1, bb multiple myeloma diagnosis unable take corticotherapy at entry
0, paclitaxel recurrent uterine corpus cancer diagnosis neuropathy sensory motor nci ctcae grade equal less two
0, mycophenolic acid natural killer cell lymphoblastic leukemia lymphoma diagnosis first relapse less twenty five blasts bone marrow
1, cyclophosphamide noncontiguous stage ii adult burkitt lymphoma diagnosis consenting five six six six hla matched related donor available
1, mycophenolic acid recurrent childhood anaplastic large cell lymphoma diagnosis identical twin
1, trastuzumab stage ivb vulvar cancer diagnosis brain central nervous system metastasis at entry
0, docetaxel thorax respiratory cancer diagnosis sirolimus
0, patients undergo cvats lobectomy non small cell lung cancer stage diagnosis sufficient organ functions
0, doxorubicin ovarian cancer diagnosis bilirubin no greater doc times normal sgot sgpt ggt no greater doc times normal alkaline phosphatase no greater doc times normal no acute hepatitis renal
0, fluorodeoxyglucose f stage iv verrucous carcinoma oral cavity diagnosis hemoglobin greater doc dl based upon cbc differential obtained within two weeks prior registration on study
0, vincristine lymphoma diagnosis not pregnant nursing
1, tesla magnetic resonance imaging stage adult primary liver cancer bclc diagnosis cerebral aneurysm clips biopsy marker clips
0, rituximab recurrent grade one follicular lymphoma diagnosis calculated creatinine clearance greater equal fifty ml min using cockcroft gault formula
0, albumin bound paclitaxel childhood malignant ovarian germ cell tumor diagnosis doc mg dl two less six years age
1, lenalidomide stage ivb oral cavity verrucous carcinoma diagnosis patients may not be receiving any other investigational agents
0, quinacrine prostatic cancer diagnosis serum creatinine less doc mg dl
0, tacrolimus noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis low grade nh negative less six months duration complete response cr between courses conventional therapy
1, carboplatin noncontiguous stage ii grade two follicular lymphoma diagnosis any prior use racemic gossypol at one hundred one
1, albumin bound paclitaxel stage iiic ovarian cancer diagnosis patients major surgical procedure anticipated during course this includes but is not limited to
0, fulvestrant progesterone receptor positive breast cancer diagnosis fasting serum cholesterol less three hundred mg dl less doc five mmol fasting triglycerides less doc uln note
1, antibodies monoclonal refractory diffuse large cell lymphoma diagnosis patients who have had chemotherapy radiotherapy equal less twenty one days equal less six weeks monoclonal antibodies prior first administration treatment those who have not recovered from adverse events due agents administered more four weeks earlier
1, sirolimus adult solid neoplasm diagnosis patients who receiving any other investigational agents
1, trastuzumab breast neoplasms diagnosis evidence severe uncontrolled systemic diseases unstable uncompensated respiratory hepatic renal cardiac disease
1, endoscopic snare papillectomy tumor size greater fourcm
0, vincristine brain central nervous system tumors diagnosis not specified
0, px glioblastoma diagnosis targeted therapy
1, lde gastroesophageal junction cancer diagnosis istory hypersensitivity ldetwo hundred twenty five bkmone hundred twenty drugs similar chemical classes
0, vidarabine stage iv adult burkitt lymphoma diagnosis primary allogeneic hematopoietic stem cell transplantation hsct is appropriate selected patients severe aplastic anemia however patients aplastic anemia must have failed at least one cycle standard immunosuppressive therapy calcineurin inhibitor plus anti thymocyte globulin atg if fully matched donor is not available
0, cyclosporine lysosomal storage disease diagnosis other metabolic disorders including but not limited cell disease that deemed be high risk poor outcome standard transplant regimen due anticipated toxicity based on experience gained at university minnesota other centers
0, dexamethasone acetate multiple myeloma diagnosis if menstrual cycles irregular pregnancy testing must occur weekly first twenty eight days then every fourteen days while on at discontinuation at days fourteen twenty eight following drug discontinuation
1, ifosfamide pancreatic cancer diagnosis active clinically significant infection requiring antibiotics
0, lenograstim recurrent adult burkitt lymphoma diagnosis negative human immunodeficiency virus hiv
1, pembrolizumab non small cell lung cancer diagnosis has active autoimmune disease that has required systemic treatment past two years
1, hand function balance tests breast cancer diagnosis although acupuncture is minimally invasive procedure patients will be excluded if there is an indication infection
0, paclitaxel malignant ovarian mixed epithelial tumor diagnosis no patients known chronic active hepatitis
1, gemcitabine lung cancer non small cell diagnosis clinically significant gastrointestinal abnormalities which might interfere oral dosing
1, calcitriol non small cell lung cancer diagnosis any unresolved toxicity nci ctcae version doc greater two please see appendix link
1, biospecimen collection urethral cancer diagnosis affected by dementia altered mental status any psychiatric co morbid condition that would prohibit understanding rendering informed consent determined by treating physician
0, endothelial growth factors stage iv ovarian cancer diagnosis patients must be entered between one one weeks after initial surgery performed combined purpose diagnosis staging cytoreduction
0, albumin bound paclitaxel stage iv breast cancer diagnosis biopsies may be done local anesthesia intravenous conscious sedation according standard institutional guidelines
0, paclitaxel lung cancer diagnosis ecog zero one or
1, bupivacaine colonic cancer diagnosis previous major abdominal surgery
1, rifampin history is clinically suspicious cancer related central nervous system cns disease
0, saracatinib adenocarcinoma pancreas diagnosis more seven days since prior no concurrent cytochrome pfour hundred fifty threeafour cypthreeafour active agents
1, autologous human tumor derived hsppc renal cell carcinoma diagnosis adequate cardiac function
0, isophosphamide mustard alveolar soft part sarcoma diagnosis sufficient tissue blood must be available submit required biology studies
0, morphine brain central nervous system tumors diagnosis no concurrent methadone maintenance therapy opioid addiction
0, fludarabine stage adult diffuse large cell lymphoma diagnosis chronic lymphocytic leukemia cll
1, mycophenolate mofetil stage iv adult immunoblastic large cell lymphoma diagnosis donor
0, trastuzumab breast cancer diagnosis unstable angina pectoris
0, carboplatin pancreatic cancer diagnosis part b
0, cortisol succinate central nervous system tumor pediatric diagnosis radiotherapy
1, pembrolizumab stage iv esophageal squamous cell carcinoma diagnosis subjects equal less grade two neuropathy an exception this criterion may qualify study
0, endothelial growth factors if original histology was grade three glioma subsequent histological diagnosis one these diseases is allowed provided no prior diagnosis grade two glioma
1, cyclophosphamide recurrent adult soft tissue sarcoma diagnosis patients embryonal histology stage clinical group one at initial disease presentation who present local regional recurrence ineligible
0, pharmacological childhood choroid plexus tumor diagnosis karnofsky performance score ps sixty one hundred greater ten years age lansky ps sixty one hundred less ten years age
0, vaccines head neck cancer diagnosis laboratory values obtained less thirtydays prior registration
0, antibodies monoclonal stage iv major salivary gland carcinoma diagnosis patients must have recovered grade one better from any acute effects prior surgery chemotherapy radiation therapy should be greater four weeks post surgery chronic late xerostomia speech swallowing abnormalities resulting from prior radiation surgery permitted if nutritional status is stable
0, fluorodeoxyglucose f lung cancer diagnosis patient characteristics
0, albumin bound paclitaxel metastases neoplasm diagnosis more two weeks since prior radiation therapy
1, vidarabine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis patients known hypersensitivity fludarabine history purine analog associated autoimmune hemolytic anemia idiopathic thrombocytopenic purpura
1, mycophenolate mofetil childhood immunoblastic large cell lymphoma diagnosis current serious systemic illness
0, fludarabine b cell lymphoma diagnosis fevone fvc at least forty predicted
0, antibodies monoclonal adenocarcinoma colon diagnosis no proteinuria secondary nephropathy
1, dexamethasone acetate multiple myeloma diagnosis participation an investigational therapeutic within one month prior day one
1, albumin bound paclitaxel patients who have completed lumpectomy segmental mastectomy modified radical mastectomy therefore no longer have any measurable cancer left their breast not eligible
1, immunoglobulin g stage iib fallopian tube cancer diagnosis patients ctcae grade two greater peripheral vascular disease at least brief less two hours episodes ischemia managed non surgically without permanent deficit
1, pertuzumab hertwo positive breast cancer diagnosis pregnant lactating women
1, everolimus breast cancer diagnosis dillapiol
1, doxorubicin malignant neoplasm breast diagnosis prior treatment caelyx lapatinib
0, antibodies brain neoplasm diagnosis karnofsky performance status at least seventy eastern cooperative oncology group ecog zubrod level one
1, camptothecin cholangiocarcinoma gallbladder diagnosis pregnancy breastfeeding
0, doxorubicin recurrent prostate cancer diagnosis major surgery within last two weeks
0, bevacizumab recurrent squamous cell carcinoma oropharynx diagnosis recurrent disease
1, methylprednisolone acetate nodal marginal zone cell lymphoma diagnosis any patient who is unable provide informed consent comply requirements protocol
0, fludarabine phosphate recurrent childhood small noncleaved cell lymphoma diagnosis lymphoproliferative disease
0, fluorouracil stage iv rectal cancer diagnosis baseline ekg qtc prolongation that is grade two higher by ctcae version doc
0, estradiol stage iiia breast cancer diagnosis no prior allogeneic bone marrow organ transplantation
1, anticoagulants lymphoma diagnosis prior history documented dvt pe past three months
1, oxaliplatin gastric cancer diagnosis hypersensitivity five fu leucovorin oxaliplatin docetaxel
1, vidarabine childhood diffuse large cell lymphoma diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvate transaminase sgpt greater equal three upper limit normal
1, mycophenolate mofetil recurrent grade one follicular lymphoma diagnosis current serious systemic illness
1, trametinib colorectal cancer diagnosis retinal degenerative disease hereditary retinal degeneration age related macular degeneration history uveitis retinal vein occlusion central serous retinopathy retinal detachment
0, antibodies monoclonal recurrent metastatic squamous neck cancer occult primary diagnosis female subjects reproductive potential
1, antibodies monoclonal stage iv primary peritoneal cancer diagnosis evidence bleeding diathesis coagulopathy
1, carboplatin ovarian cancer diagnosis inadequately controlled hypertension
0, immunoglobulins recurrent colon cancer diagnosis prior radiotherapy is allowed provided at least twenty eight days have elapsed since last treatment all adverse events related radiation therapy must be resolved
1, paclitaxel fallopian tube carcinoma diagnosis active peptic ulcer disease inflammatory bowel disease ulcerative colitis other gastrointestinal condition increased risk perforation history abdominal fistula gastrointestinal perforation intra abdominal abscess within four weeks prior administration first dose drug
0, il rÎ± specific hinge optimized bb costimulatory car truncated cd expressing t lymphocytes recurrent brain neoplasm diagnosis platelet count must be greater equal one hundred zero however if platelet level is between seventy five zero ninety nine zero then cell infusion may proceed after platelet transfusion is given post transfusion platelet count is greater equal one hundred zero
1, antibodies monoclonal non small cell lung cancer diagnosis positive human immunodeficiency virus hiv hepatitis c
1, methotrexate high grade osteosarcoma diagnosis variation above twenty recommended dose without justification
1, indocyanine green stage ii renal cell cancer diagnosis subject has previous history adverse reaction allergy icg iodine shellfish iodine dyes
1, laboratory biomarker analysis stage iv prostate cancer diagnosis subject is unable unwilling abide by protocol cooperate fully investigator designee
1, immunoglobulins stage iiia ovarian cancer diagnosis patients clinically significant proteinuria urine protein should be screened by urine protein creatinine ratio upcr patients must have upcr less doc allow participation study
0, azacitidine prostate cancer diagnosis patient had karnofsky performance status kps at least seventy eastern cooperative oncology group ecog performance status score zero two
1, sirolimus stage iiia ovarian epithelial cancer diagnosis known pulmonary hypertension
1, modafinil malignant melanoma diagnosis history pneumonitis interstitial lung disease
1, vinorelbine cancer lung diagnosis white blood cells wbc less three zero mmÂ³
1, lenograstim patients will be ineligible if they have advanced myeloma refractory unresponsive salvage chemotherapy regimens
1, testosterone prostate cancer diagnosis osseous metastatic disease imminent risk at discretion treating physician pathologic fracture cord compression patients known spinal metastasis raising concern cord compression mri spine should be performed rule out epidural disease
1, bevacizumab metastatic melanoma diagnosis clinically significant stroke transient ischemic attack tia equal less six months prior registration randomization seizures not controlled standard medical therapy
1, nivolumab solid tumors diagnosis history bleeding diathesis within last six months
0, dacarbazine brain central nervous system tumors diagnosis concurrent anticonvulsants allowed
0, bevacizumab breast cancer diagnosis patients ast alkaline phosphatase greater uln eligible inclusion if liver imaging computed tomography ct mri pet scan does not demonstrate metastatic disease adequate hepatic function
1, palbociclib cancer diagnosis consult glaxosmithkline gsk medical monitor if unsure whether second malignancies meet requirements specified above
1, albumin bound paclitaxel endometrial cancer diagnosis significant cardiovascular diseases uncontrolled hypertension unstable angina history infarction within past twelve months prior start treatment congestive heart failure greater nyha ii serious cardiac arrhythmia pericardial effusion see appendix twelve
0, abt neuroblastoma diagnosis not specified
1, radium prostate cancer diagnosis has received an investigational therapeutic drug within last four weeks prior start treatment is scheduled receive one during treatment period
0, pemetrexed unspecified adult solid tumor protocol specific diagnosis patients must be eighteen years age older
0, pn only colorectal cancer diagnosis substance dependence alcohol drugs within past twelve months
0, dinaciclib stage iv skin melanoma diagnosis at least twenty eight days since prior systemic chemotherapy
1, dexamethasone phosphate prior current systemic therapy multiple myeloma including steroids except emergency use four day block dexamethasone before randomization maximum total dose allowed one hundred sixty mg
0, cyclophosphamide diffuse large cell lymphoma diagnosis age adjusted international prognostic index ipi score zero one
1, vidarabine stage iv childhood lymphoblastic lymphoma diagnosis females who pregnant
0, oxaliplatin unspecified childhood solid tumor protocol specific diagnosis see biologic therapy
1, etoposide other malignancy except adequately treated basal cell squamous cell skin cancer carcinoma situ cervix adequately treated stage ii cancer complete remission any other cancer which patient has been disease free five years
1, sirolimus stage iii adult soft tissue sarcoma diagnosis patients hyperglycemia defined fasting serum glucose above one hundred twenty mg dl those patients already on oral anti diabetic insulin therapy
1, quality life assessment recurrent small lymphocytic lymphoma diagnosis patients life threatening illness medical condition organ system dysfunction which investigator opinion could compromise subject safety interfere absorption metabolism pci thirty two thousand seven hundred sixty five po put outcomes at undue risk
1, desipramine cancer diagnosis have known allergy gemcitabine pemetrexed desipramine lytwo million six hundred three thousand six hundred eighteen any ingredient gemcitabine pemetrexed desipramine lytwo million six hundred three thousand six hundred eighteen like captisol
1, sirolimus lymphoma diagnosis note
1, romidepsin relapsed refractory cell lymphomas diagnosis subjects positive hep serology
0, vidarabine hepatosplenic cell lymphoma diagnosis donor
1, cediranib recurrent fallopian tube carcinoma diagnosis participants receiving any medications substances that strong inhibitors inducers cytochrome pfour hundred fifty family three subfamily polypeptide four cypthreeafour moderate inhibitors cypthreeafour ineligible dihydropyridine calcium channel blockers permitted management hypertension
0, metformin large cell lung carcinoma diagnosis women childbearing potential serum pregnancy test within seventy two hours prior registration
0, histone deacetylase inhibitors angioimmunoblastic cell lymphoma diagnosis no prior oral isotretinoin
1, lenograstim lymphoma diagnosis aspartate aminotransferase ast alanine aminotransferase alt greater equal doc upper limit normal total bilirubin greater equal doc upper limit normal
1, cyclophosphamide cervix cancer diagnosis lvef by muga ultrasound must be greater fifty should be performed within twenty eight days prior enrolment
1, fluorouracil elderly metastatic colorectal cancer patients diagnosis previous treatment egfr inhibitors
1, cyclosporine recurrent small lymphocytic lymphoma diagnosis infection hiv
1, sirolimus resectable hepatocellular carcinoma diagnosis other serious illnesses serious infections requiring antibiotics bleeding disorders
0, sirolimus refractory solid tumors children diagnosis total bilirubine equal less doc uln
1, endothelial growth factors primary peritoneal serous adenocarcinoma diagnosis active infection requiring parenteral antibiotics
1, pembrolizumab ovarian cancer diagnosis history severe hypersensitivity reactions immune related adverse events other monoclonal antibodies
0, dacarbazine recurrent childhood subependymal giant cell astrocytoma diagnosis serum albumin greater two dl
1, capecitabine metastatic colorectal cancer diagnosis known clinically suspected brain metastases
1, methotrexate stage iv adult immunoblastic large cell lymphoma diagnosis pregnant women excluded from this because vorinostat is histone deacetylase inhibitor agent potential teratogenic abortifacient effects because there is an unknown but potential risk adverse events nursing infants secondary treatment mother vorinostat breastfeeding should be discontinued if mother is treated vorinostat
0, paclitaxel stage iv non small cell lung cancer diagnosis serum creatinine equal less doc uln calculated creatinine clearance greater equal fifty ml min by cockroft gault formula
1, etoposide stage iii grade three follicular lymphoma diagnosis chemosensitive nhl except patients receiving greater equal three prior chemotherapy regimens patients having transformed nhl ptcl mcl alcl alk neg
0, bexarotene lymphoma diagnosis karnofsky sixty one hundred
0, thinstrand prostate cancer diagnosis greater equal forty years age
0, antilymphocyte serum diffuse large cell lymphoma
1, questionnaire administration contiguous stage ii grade one follicular lymphoma diagnosis patients who have received gonadotropin release hormone agonist antagonist lupron prior entry not eligible
1, endothelial growth factors glioblastoma diagnosis history oxalate nephrolithiasis urine oxalate greater sixty mg dl
0, hydroxystaurosporine stage iv lymphoepithelioma oropharynx diagnosis karnofsky sixty one hundred
1, bortezomib multiple myeloma diagnosis patient serious medical psychiatric illness likely interfere participation on this clinical study
0, endothelial growth factors stage iia fallopian tube cancer diagnosis patients this trial may receive ovarian estrogen positive
1, sirolimus stage iii childhood burkitt lymphoma diagnosis donor
1, bcg vaccine recurrent bladder carcinoma diagnosis patients who have diagnosis immunodeficiency per pi discretion who have received treatment systemic immunosuppressive medications including but not limited prednisone cyclophosphamide azathioprine methotrexate thalidomide anti tnf agents within two weeks prior registration not eligible
0, hormones prostate cancer diagnosis surgery
0, histone deacetylase inhibitors breast cancer diagnosis ability provide written informed consent obtained prior participation any related procedures being performed
0, panobinostat nodal lymphoma diagnosis serum potassium magnesium phosphorus sodium total calcium corrected serum albumin ionized calcium within normal limits
1, vaccines recurrent fallopian tube carcinoma diagnosis patients history immunodeficiency including organ grafts human immunodeficiency virus hiv will not be eligible
1, fludarabine phosphate stage iv renal cell cancer diagnosis fertile men women unwilling use contraceptive techniques during twelve months following treatment
0, bortezomib multiple myeloma diagnosis written informed consent accordance federal local institutional guidelines
1, levoleucovorin advanced cancers diagnosis patients already uncompensated liver failure child pugh liver classification c
1, antibodies monoclonal recurrent melanoma diagnosis patients who have received prior anti pdone directed therapy monoclonal antibody mab small molecule not eligible
0, methotrexate breast cancer diagnosis prior concurrent therapy
0, fluorouracil stage ivb laryngeal verrucous carcinoma diagnosis patients should not have history thrombosis pulmonary embolism deep venous thrombosis currently requiring therapeutic anticoagulation prophylactic use warfarin one mg per day is allowed international normalized ratio inr should be less doc at registration
1, buparlisib nevoid basal cell carcinoma syndrome diagnosis patients who currently receiving treatment medication known risk prolong qt interval inducing torsades de pointes treatment cannot either be discontinued switched different medication prior starting drug
1, lenograstim multiple myeloma diagnosis current anticipated use other investigational agents
1, entinostat stage iv breast cancer diagnosis patients brain metastases must have stable neurologic status magnetic resonance imaging mri imaging following local therapy surgery radiation at least four weeks no dexamethasone requirement stable low dose dexamethasone allowed at discretion chair patients leptomeningeal disease not eligible
1, fondaparinux esophageal neoplasms diagnosis severe renal liver disfunction
1, capecitabine stage ii breast cancer diagnosis any other life threatening illness serious uncontrolled concurrent infection clinically significant cardiac disease
0, alvocidib recurrent childhood small noncleaved cell lymphoma diagnosis at least two months
0, vinorelbine recurrent non small cell lung cancer diagnosis men women reproductive potential may not participate unless they have agreed use an effective contraceptive method while on study
0, azacitidine stage iv mantle cell lymphoma diagnosis confirmed relapsed refractory acute myeloid leukemia aml acute lymphoblastic leukemia all chronic myelogenous leukemia blast crisis cml bc
1, sunitinib renal cell cancer diagnosis vaccination within four weeks first dose avelumab while on trial is prohibited except administration inactivated vaccines example inactivated influenza vaccines
1, metformin recurrent plasma cell myeloma diagnosis non hematologic malignancy within past three years aside from following exceptions
0, cisplatin esophageal cancer diagnosis sulindac
1, doxorubicin breast cancer diagnosis known hiv positive individuals on combination antiretroviral therapy
1, antibodies gastrointestinal cancer metastatic diagnosis anc less equal one thousand
0, prednisolone hemisuccinate recurrent childhood large cell lymphoma diagnosis al negative relapse persistent disease less twenty bone marrow blasts
1, cetuximab stage iv esophageal cancer diagnosis abnormalities cornea based on history dry eye syndrome sjogren syndrome congenital abnormality fuch dystrophy abnormal slit lamp examination using vital dye fluorescein bengal rose an abnormal corneal sensitivity test schirmer test similar tear production test
1, immunoglobulins multiple myeloma diagnosis primary associated amyloidosis
1, financial incentive increase ambulation bladder cancer diagnosis plan cystectomy without cutaneous ureterostomies without bowel diversion
0, tacrolimus recurrent childhood grade iii lymphomatoid granulomatosis diagnosis patients renal failure eligible however patients renal compromise serum creatinine greater doc will likely have further compromise renal function may require hemodialysis which may be permanent due need maintain adequate serum tacrolimus levels
0, pt injection non small cell lung carcinoma diagnosis histologically cytologically confirmed nsclc which is stage iii stage iv recurrent disease failed therapy standard first line phase ii well second line chemotherapy regimen phase be intolerant standard chemotherapy
0, cyclophosphamide contiguous stage ii grade three follicular lymphoma diagnosis adequately matched unrelated donor available
1, vitamins advanced intrahepatic cholangiocarcinoma diagnosis known hypersensitivity vitamin five fluorouracil mitomycin c
1, vemurafenib stage iiib melanoma diagnosis any other signs indicative pulmonary hemorrhage within three months before first dose treatment
1, belinostat lymphomas diagnosis marked baseline prolongation qt qtc interval repeated demonstration qtc interval greater four hundred fifty msec long qt syndrome required use concomitant medication that may cause torsades de pointes
1, gsk any major surgery radiotherapy immunotherapy within four weeks prior first dose drug palliative radiotherapy single symptomatic lesion within two weeks prior first dose drugs
0, cisplatin stage iva squamous cell carcinoma larynx diagnosis neck computed tomography ct contrast ct positron emission tomography pet contrast an magnetic resonance imaging mri neck tone gadolinium ttwo within eighty four days prior surgery note
0, angiogenesis modulating agents digestive system neoplasms diagnosis ecog performance status zero one
0, antibodies monoclonal recurrent ovarian carcinoma diagnosis must have archival tissue available baseline pd lone assessment
0, cyclophosphamide recurrent grade two follicular lymphoma diagnosis patients who less two days more eighty days after pbsct will not be registered randomization
1, calcitriol non small cell lung cancer diagnosis patients iiib nsclc who eligible definitive chemoradiation
1, albumin bound paclitaxel stage iiib breast cancer diagnosis patients controlled type one diabetes mellitus on stable insulin regimen may be eligible
1, antibodies monoclonal rectal mucinous adenocarcinoma diagnosis patients malabsorption syndrome other condition that would interfere intestinal absorption patients must be able swallow tablets
1, tisotumab vedotin humax tf adc esophagus cancer diagnosis known past current coagulation defects
1, antibodies stage iva lip oral cavity squamous cell carcinoma diagnosis patient confirmed history interstitial lung disease
0, mango juice recurrent bladder cancer diagnosis eastern oncology group ecog performance status zero two
1, niacinamide head neck cancer diagnosis thrombotic embolic events such cerebrovascular accident deep vein thrombosis pulmonary embolism
1, cisplatin lung neoplasm malignant diagnosis patients medical conditions that only manifestation is hydrothorax ascites bone lesions other unmeasurable diseases
1, thalidomide refractory mantle cell lymphoma diagnosis medications risk causing torsades de pointes not permitted although concomitant treatment corrected qt qtc prolonging agents is not strictly prohibited these agents should be avoided whenever possible an alternative non qtc prolonging drug should be substituted if possible
1, albumin bound paclitaxel contiguous stage ii grade two follicular lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition at one hundred one other agents used study
0, loxo thyroid neoplasms diagnosis locally advanced metastatic malignancy an ntrkone ntrktwo ntrkthree gene fusion identified through molecular assays routinely performed at clia other similarly certified laboratories
0, prednisolone phosphate lymphoma diagnosis no concurrent serious uncontrolled infection
1, a non hodgkin lymphoma diagnosis proven active central nervous system cns disease
1, sirolimus stage iiia fallopian tube cancer diagnosis metastatic disease central nervous system which other therapeutic options including radiotherapy may be available
0, immunoglobulin g stage iiib primary peritoneal cancer diagnosis an approved informed consent authorization permitting release personal health information must be signed by patient guardian
1, antibodies monoclonal transformed recurrent non hodgkin lymphoma diagnosis other active malignancy equal less three years prior registration exceptions
0, carmustine primary glioblastoma multiforme diagnosis mri ct without contrast within thirty days entry
0, misonidazole stage iii non small cell lung cancer diagnosis patient must provide specific informed consent prior entry
0, etoposide phosphate stage iiia non small cell lung cancer diagnosis see disease characteristics
1, nitrogen mustard compounds mantle cell lymphoma diagnosis grade two peripheral neuropathy within fourteen days before beginning maintenance therapy
0, idelalisib cll patients symptomatic disease that mandates treatment defined by international workshop on chronic lymphocytic lymphoma iwcll two thousand eight criteria
0, veliparib stage iiia breast cancer diagnosis written informed consent must be obtained prior any related procedures
1, cyclosporine refractory plasma cell myeloma diagnosis age less twelve years
0, etoposide stage iv small lymphocytic lymphoma diagnosis able adhere visit schedule other protocol requirements
1, vaccines ovarian cancer diagnosis patients known allergy cisplatin chemotherapy
1, poly iclc stage iiib uveal melanoma diagnosis following will not be exclusionary
0, temozolomide glioma diagnosis patients must have fully recovered from acute toxic effects all prior chemotherapy immunotherapy radiotherapy prior entering this study
0, paclitaxel at least one radiographically measurable assessable lesion on chest cg according recist doc response evaluation criteria solid tumors regional lymph node metastases may also be measured assessed by imaging mediastinal lymph nodes
1, temozolomide recurrent childhood brain tumor diagnosis creatinine clearance radioisotope gfr greater seventy ml min doc threem two serum creatinine based on age follows
1, bendamustine hydrochloride mantle cell lymphoma diagnosis patients serious digestive symptoms nausea vomiting diarrhea
0, alemtuzumab myelodysplastic myeloproliferative neoplasms diagnosis negative pregnancy test
1, nivolumab cancer diagnosis ii
0, lapatinib hertwo negative metastatic breast cancer diagnosis absolute neutrophil count greater one thousand five hundred Âµl
0, recombinant human mannose binding lectin lymphoma diagnosis investigational use an fda approved drug allowed
1, laboratory biomarker analysis stage iv primary peritoneal cavity cancer diagnosis active smokers those who have smoked equal less thirty days prior registration patients unwilling unable refrain completely from smoking while on study
1, doxorubicin myeloma proteins diagnosis prior local radiotherapy within one week treatment
1, antibodies monoclonal anaplastic large cell lymphoma diagnosis patients who homozygous at mismatched major histocompatibility complex mhc class locus
1, antibodies monoclonal rectal adenocarcinoma diagnosis history inflammatory bowel disease
1, decitabine breast cancer diagnosis patients known hypersensitivity any components decitabine lbhfive hundred eighty nine
1, olaparib recurrent glioblastoma diagnosis participants may not have had prior use parp inhibitors patients may not have received prior treatment affecting vegf pathway recurrent setting including but not limited thalidomide bevacizumab sunitinib sorafenib
0, tki neoplasms by site diagnosis patients previously treated one two systemic lines
1, vilaprisan bay leiomyoma diagnosis abuse alcohol drugs medicines laxatives
1, pentamidine non small cell lung cancer diagnosis hemoglobin less one hundred l
1, irinotecan recurrent colon carcinoma diagnosis any hemorrhage bleeding event greater grade three equal less four weeks prior registration
0, antibodies advanced cancers diagnosis if bilirubin is greater equal five mg dl fluorouracil fivefu dose will be omitted
0, ramucirumab adenocarcinoma diagnosis participant must have adequate coagulation function defined by international normalized ratio inr less doc partial thromboplastin time ptt less five seconds above uln unless receiving anticoagulation therapy
0, gemcitabine pancreatic cancer stage iva diagnosis life expectancy greater two months
1, etoposide phosphate recurrent adult diffuse small cleaved cell lymphoma diagnosis circulating anti mouse antibody hama
0, ado trastuzumab emtansine breast cancer diagnosis adequately excised
1, succinylcholine neoplasm metastasis diagnosis is pregnant lactating
0, doxorubicin stage iii bladder cancer diagnosis wbc at least three five hundred mm three
0, flow cytometry cancer diagnosis recipient an allogeneic stem cell transplantation
1, naltrexone lobular carcinoma diagnosis participants using other contraindicated medications thioridazine yohimbine
1, bi chemotherapy immunotherapy radiotherapy biological therapies including trastuzumab molecular targeted hormone therapy breast cancer within two weeks starting trial medication excluding luteinizing hormone releasing hormone lhrh agonists prostate cancer bisphosphonates treatment other investigational drugs
1, fludarabine phosphate stage iv grade one follicular lymphoma diagnosis donors who hiv positive medical conditions that would result increased risk csf mobilization harvest pbmc
1, vorinostat adult mixed glioma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated vorinostat saha potential risks may also apply temozolomide
1, cisplatin nasopharyngeal cancer diagnosis inducers cypthreeafour prohibited beginning at least fourteen four days prior administration first dose medication duration study
0, antibodies inflammatory breast cancer diagnosis see disease characteristics
1, antibodies monoclonal patient is receiving plans receive an anti cancer therapy during exception patients receiving chronic luteinizing hormone releasing hormone lhrh agonists
0, antibodies lung cancer diagnosis prior therapy chemotherapy immunotherapy radiotherapy must be completed at least two weeks prior infusion radiolabeled antibody
1, thalidomide childhood grade ii meningioma diagnosis patients any significant medical illnesses that investigator opinion cannot be adequately controlled appropriate therapy would compromise patient ability tolerate this therapy
0, thalidomide lung cancer diagnosis no prior chemotherapy
1, liposomal doxorubicin inflammatory breast cancer diagnosis inadequate general condition not fit dose dense dose intensified anthracycline taxane targeted agents based chemotherapy
0, veliparib stage iiic colon cancer diagnosis prior experimental non food drug administration fda approved therapies immunotherapies allowed patients must not have received these therapies four weeks prior initiation treatment must have full recovery from any acute effects these therapies
1, oxaliplatin fallopian tube carcinoma diagnosis prior treatment more three three lines chemotherapy including adjuvant chemotherapy
1, docetaxel lung cancer diagnosis female who is pregnant lactating serum pregnancy test is required all female patients childbearing potential
1, romidepsin peripheral cell lymphoma diagnosis patients diagnosis any following not eligible
0, acetylcysteine malignant ovarian serous tumor diagnosis patients must have signed an approved informed consent authorization permitting release personal health information
0, cervical cancer screening diagnosis ovarian cancer
1, etoposide phosphate lymphoma diagnosis hiv infection treatment may result progression hiv other viral infections
0, panobinostat recurrent grade one follicular lymphoma diagnosis life expectancy greater equal one weeks
0, lenograstim hepatoblastoma diagnosis extragonadal primary site
1, antibodies adenocarcinoma gastroesophageal junction diagnosis history allergic reactions attributed compounds similar chemical biologic composition olaparib ramucirumab
0, tamoxifen breast cancer diagnosis participants must have at least four week washout period prior day one run if any these have been used
1, gemcitabine lymphoma cell cutaneous diagnosis impaired cardiac function clinically significant cardiac disease including any following
1, saracatinib stage ivb squamous cell carcinoma oropharynx diagnosis uncontrolled intercurrent illness including but not limited ongoing active infection psychiatric illness social situations that would limit compliance requirements
1, oxaliplatin stage iiia gastric cancer diagnosis respiratory condition that required any oxygen supplementation equal less six months prior registration
0, sunitinib prostate cancer diagnosis metastatic locally recurrent disease not curable standard therapy
1, pemetrexed non small cell lung cancer diagnosis have received recent yellow fever vaccination within twenty eight days enrollment receiving concurrent yellow fever vaccination
1, antibodies monoclonal endometrial transitional cell carcinoma diagnosis clinically significant peripheral vascular disease
1, becatecarin stage iiib breast cancer diagnosis patients only non measurable disease defined all other lesions including small lesions longest diameter less ten mm conventional techniques truly non measurable lesions which include following
0, albumin bound paclitaxel breast cancer diagnosis wbc at least three five hundred mmthree platelet count at least one hundred zero mmthree hepatic
0, docetaxel at least three weeks since prior biologic immunologic therapy malignant tumor
1, regorafenib rectal adenocarcinoma diagnosis substance abuse medical psychological social conditions that may interfere subject participation evaluation results
0, nivolumab spiradenocarcinoma diagnosis prothrombin time pt international normalized ratio inr partial thromboplastin time ptt equal less doc institutional unl unless subject is on anticoagulant therapy if subject is receiving anticoagulant therapy pt activated ptt aptt must be within therapeutic range intended use anticoagulants
1, melatonin advanced cancers diagnosis patients greater two hours direct exposure outdoor natural light per day by interview coordinator
1, lenalidomide stage iv marginal zone lymphoma diagnosis any other condition not defined above including presence laboratory abnormalities which opinion investigator would place subject at unacceptable risk if he she were participate would confound ability interpret data from study
1, paclitaxel patients history another primary malignancy less five years exception non melanoma skin cancer cervical cancer situ
0, laboratory biomarker analysis stage iv ovarian cancer diagnosis tissue obtained during prior optimal suboptimal cytoreductive surgery
0, docetaxel breast cancer diagnosis not specified
1, autologous anti cd car bb cd zeta egfrt expressing t lymphocytes recurrent small lymphocytic lymphoma diagnosis patients clinically significant pulmonary dysfunction determined by medical history physical exam should undergo pulmonary function testing those forced expiratory volume one second fevone less fifty predicted will be excluded
0, bb all previous cancer chemotherapy bisphosphonates not included including surgery must have been discontinued greater two weeks prior first dose drug
0, immunoglobulin g human papillomavirus infection diagnosis aspartate aminotransferase ast alanine aminotransferase alt equal less doc uln
1, cyclophosphamide recurrent ovarian carcinoma diagnosis has known history active bacillus tuberculosis tb
1, sorafenib advanced solid tumors diagnosis significant gastrointestinal disorder opinion investigator could interfere absorption arq one hundred ninety seven sorafenib significant uncontrolled inflammatory bowel disease extensive small bowel resection
0, everolimus stage iv ovarian cancer diagnosis serum glutamic oxaloacetic transaminase sgot aspartate aminotransferase ast equal less doc uln equal less five uln if liver metastasis is present patient is hcc cohort
1, docetaxel bladder cancer diagnosis any patients judged by investigator be unfit participate study
1, irinotecan prior second line chemotherapy regimens colorectal cancer
0, paclitaxel cervical cancer diagnosis partial thromboplastin time less doc times control
1, prednisone previously treated ketoconazole prostate cancer greater seven days
0, doxorubicin malignant fibrous histiocytoma
1, sirolimus solid tumors diagnosis sexually active male pre menopausal female subjects their partners unless they agree use adequate contraceptive measures while on thirty days after last dose drug
0, laboratory biomarker analysis stage iv melanoma diagnosis not pregnant nursing
1, fludarabine recurrent grade three follicular lymphoma diagnosis life expectancy severely limited by diseases other malignancy
0, exercise diet colorectal cancer diagnosis age eighteen years age older
1, enzastaurin ly monohydronchloride glioma diagnosis no concurrent use other standard chemotherapeutics investigative agents
1, mannitol central nervous system lymphoma diagnosis prior cranial spinal radiotherapy
1, mycophenolate mofetil recurrent childhood non hodgkin lymphoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast greater two uln
1, vidarabine recurrent diffuse large cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
1, podophyllotoxin glioblastoma diagnosis purposes this wocbp include any female who has experienced menarche who has not undergone tubal ligation who is not postmenopausal
0, histone deacetylase inhibitors recurrent cutaneous cell non hodgkin lymphoma diagnosis life expectancy greater twelve weeks
0, hormones symptomatic congestive heart failure
1, otx mk castrate resistant prostate cancer crpc diagnosis concomitant therapy strong cypthreeafour interfering drugs
0, computerized working memory training program control brain tumor diagnosis fully evaluable psychological testing results including iq greater equal seventy
0, oxaliplatin gastric cancer diagnosis at least one uni dimensionally measurable lesion by recist criteria ver doc
0, bevacizumab pancreatic polypeptide tumor diagnosis fasting serum cholesterol equal less three hundred fifty mg dl equal less doc mmol l
1, fludarabine phosphate noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis donor
0, trioxsalen metastatic cancer diagnosis see disease characteristics
0, folic acid metastatic colorectal cancer diagnosis serum creatinine level less doc mg dl glomerular filtration rategreater fifty ml min by cockroft gault formula
1, antibodies monoclonal stage iva squamous cell carcinoma lip oral cavity diagnosis patients who have received any continuous intermittent small molecule therapeutics excluding monoclonal antibodies equal less five effective half lives prior starting drug who have not recovered from side effects such therapy typically greater equal two week interval since completion prior therapy is recommended four weeks monoclonal antibodies
0, vaccines breast cancer diagnosis more four weeks since prior parenteral oral inhaled corticosteroids
0, rituximab lymphoplasmacytic lymphoma diagnosis minimum any one following constitutional symptoms
0, dexamethasone phosphate such dysfunction is sufficient support classification myeloma if proven be myeloma related
0, carboplatin ovarian undifferentiated adenocarcinoma diagnosis platelets greater equal one hundred zero mcl
0, liposomal doxorubicin leiomyosarcoma diagnosis high risk uterine lms figo stage ii
0, gemcitabine stage iii pancreatic cancer diagnosis total bilirubin equal less doc uln
0, albumin bound paclitaxel carcinoma non small cell lung diagnosis radiographically documented measurable disease defined by presence greater one radiographically documented measurable lesion
1, everolimus b cell lymphoma diagnosis patients active infections requiring intravenous iv antibiotic antiviral therapy not eligible entry onto until resolution infection patients on prophylactic antibiotics antifungals antivirals acceptable
1, pembrolizumab refractory mantle cell lymphoma diagnosis has undergone prior allogeneic hematopoietic stem cell transplantation within last five years
0, lenalidomide extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis any current infection requiring use antibiotic antiviral antifungal medication
1, paclitaxel history congestive heart failure uncontrolled symptomatic angina pectoris arrhythmia myocardial infarction poorly controlled hypertension systolic bp greater one hundred eighty mmhg diastolic bp greater one hundred mmhg
1, ascorbic acid prostate cancer diagnosis subject has corrected qt interval calculated by fridericia formula qtcf greater five hundred ms within twenty eight days before randomization
0, isis ovarian cancer diagnosis prior concurrent therapy
1, saline leiomyoma diagnosis unevaluated gynecologic abnormalities unexplained vaginal bleeding cervical dysplasia abnormal adnexal ovarian mass
1, vismodegib basal cell carcinoma diagnosis have received following treatments bcc treatment area within designated time period before treatment initiation
1, mycophenolate mofetil stage iv adult burkitt lymphoma diagnosis cross match positive recipient
0, lapatinib unresectable extrahepatic bile duct cancer diagnosis erythromycin
1, allogeneic cytomegalovirus specific cytotoxic t lymphocytes recurrent adult immunoblastic large cell lymphoma diagnosis donor
1, intraoperative radiation therapy breast cancer diagnosis prior concurrent therapy
0, laboratory biomarker analysis stage iii marginal zone lymphoma diagnosis at least four weeks since prior chemotherapy six weeks nitrosoureas mitomycin recovered
0, diindolylmethane stage ii prostate cancer diagnosis broccoli cauliflower brussels sprouts cabbage arugula watercress bok choy turnip greens mustard greens collard greens rutabaga napa chinese cabbage radishes turnips kohlrabi kale
1, bb peripheral neuropathy national cancer institute nci grade greater two annex five
0, n monoacetylcystine melanoma skin diagnosis biologic therapy
1, veliparib stage iva thyroid gland medullary carcinoma diagnosis patients uncontrolled seizures any neurological conditions resulting increased risk seizures not eligible entry
0, tamoxifen fallopian tube cancer diagnosis no grade two greater sensory motor neuropathy
0, semaxinib breast cancer diagnosis hematopoietic
1, fludarabine breast cancer diagnosis life expectancy is severely limited by concomitant illness
0, irinotecan lung cancer
1, dacarbazine recurrent childhood central nervous system neoplasm diagnosis part phase two
0, prednisolone phosphate gestational trophoblastic tumor diagnosis grade iib iv disease
1, n monoacetylcystine stage ivc mucoepidermoid carcinoma oral cavity diagnosis previous receipt head neck irradiation
1, i l sip radioimmunotherapy rit combination external beam radiotherapy ebrt concurrent chemotherapy non small cell lung cancer diagnosis presence active infections requiring antibimicrobial therapy other severe concurrent disease which opinion investigator would place patient at undue risk interfere study
1, bevacizumab advanced gastric cancer diagnosis evidence gastrointestinal bleeding
0, ds solid tumors diagnosis previous treatment single agent therapy erlotinib gefitinib afatinib others
1, cetuximab stage ivb laryngeal squamous cell carcinoma diagnosis patients who receiving any other investigational agents
0, cisplatin sarcoma diagnosis ejection fraction within institutional normal limits pulmonary
1, irinotecan melanoma diagnosis history copd other chronic pulmonary disease pft indicating an fevone less thirty dlco less forty predicted age
1, allopurinol lymphoblastic lymphoma diagnosis stable disease is acceptable move forward provided it is non bulky
0, etoposide stage iii non small cell lung cancer diagnosis ntwo disease must be documented by either biopsy fluorodeoxyglucose positron emission tomography pet ct scan if nodes more two cm
0, vaccines prostate cancer diagnosis patient characteristics
0, docetaxel pancreatic cancer diagnosis hemoglobin greater doc dl
1, bevacizumab stage iiic colon cancer diagnosis unstable angina within twelve months before entry and
1, levoleucovorin stage iii childhood lymphoblastic lymphoma diagnosis participation clinical trials other investigational agents not included this trial within fourteen days start this trial within thirty days any dose bortezomib
0, immunoglobulins stage iv squamous cell carcinoma lip oral cavity diagnosis no other concurrent investigational agents
1, thalidomide central nervous system lymphoma diagnosis any severe uncontrolled medical conditions other conditions that treating physician opinion could adversely impact their ability participate study
0, edotreotide neuroblastoma diagnosis other
0, sorafenib liver cancer diagnosis qtc greater four hundred fifty msec on screening ecg
1, docetaxel breast cancer diagnosis participant has history uncontrolled hereditary acquired bleeding thrombotic disorders
0, thalidomide stage iii multiple myeloma diagnosis less eighteen months since diagnosis
0, irinotecan brain cancer diagnosis hematocrit greater twenty nine absolute neutrophil count anc greater one five hundred cells platelets greater one zero cells l
0, poly iclc triple negative breast cancer diagnosis wbc greater three zero Î¼l
1, therapeutic autologous dendritic cells brain central nervous system tumors diagnosis pregnant nursing
0, sorafenib liver cancer diagnosis absolute neutrophil count anc greater one thousand two hundred mm three
0, docetaxel stage ivb oropharyngeal squamous cell carcinoma diagnosis ability complete questionnaire by themselves assistance
1, ramucirumab gastroesophageal junction adenocarcinoma diagnosis have history gi perforation fistulae within six months prior randomization
0, docetaxel bladder cancer diagnosis at least three months hematopoietic
0, vorinostat small intestine lymphoma diagnosis karnofsky greater equal seventy
0, endothelial growth factors recurrent adult brain neoplasm diagnosis phase ii only prior exposure bevacizumab is not allowed
0, cyclosporins recurrent adult grade iii lymphomatoid granulomatosis diagnosis patient must have adequate insurance cover cost transplant hospitalization
1, levoleucovorin pancreatic adenocarcinoma diagnosis pregnancy breastfeeding
1, niacinamide metastatic breast cancer diagnosis including transient ischemic attacks within past six months
0, methotrexate patients must have no prior radiation therapy greater equal twenty five bone marrow other diseases prior systemic anthracycline therapy prior intravesical anthracycline therapy non muscle invasive urothelial carcinoma bladder is permitted
0, antibodies monoclonal stage iiib ovarian cancer diagnosis patients their partners should be practicing an effective form contraception during at least three months following last dose this combined therapy
0, immunoglobulins adenocarcinoma esophagus diagnosis no portion lesion may be within five cm cricopharyngeus
1, tmx carcinoma situ diagnosis patient has received radiation therapy pelvis within twelve months before first drug treatment
1, standard follow up care vulvar cancer diagnosis planned surgery urinary incontinence next three months
1, pembrolizumab stage iiib skin melanoma diagnosis has history current evidence any condition therapy laboratory abnormality that might confound results trial interfere subject participation full duration trial is not best interest subject participate opinion treating investigator
0, antibodies monoclonal recurrent gastric cancer diagnosis no prior chemotherapy metastatic disease
0, alvocidib malignant neoplasm diagnosis bilirubin equal less doc mg dl
1, antibodies monoclonal stage iv squamous cell carcinoma hypopharynx diagnosis known human immunodeficiency virus hiv positive patients ineligible because these patients at increased risk lethal infections when treated marrow suppressive therapy potential pharmacokinetic interaction between antiretroviral therapy investigational agents
0, erlotinib hydrochloride adult diffuse astrocytoma diagnosis anal
0, biological therapy stage iii mantle cell lymphoma diagnosis no concurrent antineoplastic agent
1, tacrolimus stage iv childhood anaplastic large cell lymphoma diagnosis donor
0, succinylcholine patients stage iiia stage iiic positive cytologic washings ascites adnexal spread serosal involvement stage iv by virtue intraperitoneal disease spread histologically confirmed endometrial cancer endometrioid serous clear cell squamous adenosquamous undifferentiated mixed histologies
0, cadexomer iodine stage ivb thyroid gland papillary carcinoma diagnosis left ventricular ejection fraction greater equal institutional lower limit normal lln by echocardiogram echo multi gated acquisition scan muga
1, doxorubicin breast cancer diagnosis exception
0, everolimus childhood solid tumor diagnosis serum albumin two dl
0, mycophenolic acid recurrent cutaneous cell non hodgkin lymphoma diagnosis patients less sixty six years age other diseases treatable by allogeneic bone marrow transplant bmt whom through pre existing chronic disease affecting kidneys liver lungs heart considered be at high risk regimen related toxicity using standard high dose regimens autografting must also be contraindicated these patients they must be approved this protocol by both pcc by principal investigator following diseases likely candidates but other less common diseases may be considered approved by pcc
0, mycophenolate mofetil lymphoma diagnosis not pregnant
0, alpha tocopherol pancreatic neoplasms diagnosis patient has capability understanding informed consent document has signed informed consent document
1, sentinel lymph node mapping gynecologic cancer diagnosis medical co morbidities making surgery unsafe determined by primary treating physician
0, ethiodized oil unresectable non metastatic hepatocellular carcinoma diagnosis lvef by muga scan us greater fifty
0, vincristine metastatic ewing sarcoma diagnosis age less six months
1, cisplatin stage iii pancreatic cancer diagnosis ongoing gi adverse events greater grade two nausea vomiting diarrhea at start study
1, vidarabine childhood nasal type extranodal nk cell lymphoma diagnosis any vertebral instability
1, mycophenolate mofetil stage multiple myeloma diagnosis pregnancy
1, pembrolizumab metastatic cancers diagnosis systemic steroids administered specifically premedication chemotherapy infusion radiotherapy allowed
0, modafinil nervous system tumors diagnosis ongoing active infection
0, mycophenolic acid plasma cell neoplasm diagnosis hematopoietic
1, gemcitabine pancreatic cancer diagnosis female patients child bearing age not using adequate contraception oral subcutaneous contraceptives intrauterine pessary iup condoms
1, thalidomide recurrent laryngeal verrucous carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition lenalidomide cetuximab other agents used study
0, tacrolimus recurrent adult lymphoblastic lymphoma diagnosis complete remission
1, antibodies monoclonal lung cancer diagnosis major surgical procedure within twenty eight days prior treatment start anticipation need major surgical procedure during course ebus mediastinoscopy vats not considered major surgical procedures
1, otx mk diffuse large cell lymphoma diagnosis chronic graft versus host disease gvhd on immunosuppressive therapy control gvhd
0, mitomycin metastatic colorectal cancer mcrc diagnosis clinical decision made initiate treatment capecitabine prior enrollment study
1, everolimus stage iv breast cancer diagnosis john wort these may decrease temsirolimus levels use agents that potently inhibit cypthreea hence may raise temsirolimus levels such ketoconazole is discouraged but not specifically prohibited cci seven hundred seventy nine can inhibit cytochrome pfour hundred fifty family two subfamily polypeptide six cyptwodsix may decrease metabolism increase drug levels drugs that substrates cyptwodsix such codeine appropriateness use such agents is left physician discretion if there is any doubt about eligibility based on concomitant medication chair dr fleming should be contacted all concomitant medications must be recorded
0, peginterferon alfa a evidence any other liver disease including hepatitis hepatitis delta alcoholic liver disease primary biliary cirrhosis sclerosing cholangitis autoimmune hepatitis hemochromatosis alpha one antitrypsin deficiency wilson disease
1, fludarabine phosphate recurrent adult cell leukemia lymphoma diagnosis thirty six whole brain
1, albumin bound paclitaxel non small cell lung cancer diagnosis receiving therapeutic anticoagulation warfarin low molecular weight heparin similar agents
0, sirolimus breast cancer recurrent diagnosis age less fifty five years one year more amenorrhea postmenopausal levels follicle stimulating hormone fsh luteinizing hormone lh per local institutional standards
0, tumor infiltrating lymphocytes metastatic melanoma diagnosis total bilirubin less equal two mg dl except patients gilbert syndrome who must have total bilirubin less three mg dl
1, bevacizumab high grade glioma diagnosis any disease condition that contraindicates use medication treatment places child at an unacceptable risk experiencing treatment related complications
0, medi gastrointestinal adenocarcinomas diagnosis body weight greater forty five kg
0, antibodies monoclonal recurrent childhood grade iii lymphomatoid granulomatosis diagnosis patients known bone marrow metastatic disease
1, antibodies monoclonal ovarian serous surface papillary adenocarcinoma diagnosis prior use bevacizumab is not allowed any cohort
1, mycophenolate mofetil recurrent cutaneous cell non hodgkin lymphoma diagnosis hiv positive
1, paclitaxel stage iii adrenocortical carcinoma diagnosis surgery radiotherapy chemotherapy hormonal therapy during three weeks prior initiation therapy
0, cx oral formulation breast cancer diagnosis anc greater one thousand five hundred cells mmthree platelet count greater one hundred zero cells mmthree hemoglobin greater nine gm l
0, breast cancer surgery breast cancer diagnosis performance status who less one
0, liposomal doxorubicin primary peritoneal cavity cancer diagnosis creatinine clearance greater fifty ml min
0, prednisone lymphoma diagnosis sixty over note
0, liposomal doxorubicin grade threeb follicular lymphoma diagnosis have performance status zero one on eastern cooperative oncology group ecog performance scale ps ecog ps two if related dlbcl associated manifestations
0, sargramostim lung cancer diagnosis more four weeks since prior immunotherapy
0, albumin bound paclitaxel recurrent salivary gland cancer diagnosis eastern cooperative oncology group ecog performance status zero one
0, cyclosporine stage iii small lymphocytic lymphoma diagnosis peripheral blood stem cells will be collected from donors greater twelve years age
0, antibodies neuroblastoma diagnosis eligible nk donor
0, paclitaxel stage iib non small cell lung cancer diagnosis maximum dose greater sixty six gy allowed only one lobar bronchus
1, levoleucovorin stage iia gastric cancer diagnosis known hypersensitivity any component bevacizumab
1, albumin bound paclitaxel this exception does not include carcinomatous meningitis which is excluded regardless clinical stability
0, g an oncolytic virus glioma diagnosis phase ii
0, etoposide stage iiib non small cell lung cancer diagnosis absolute neutrophil count greater doc ten nine l
0, questionnaires rectal cancer diagnosis clinical stage ii iii iucc tnm classification two thousand two
1, levoleucovorin mixed adenocarcinoma stomach diagnosis patients greater equal grade two neuropathy not eligible
1, cyclophosphamide lymphoma diagnosis any experimental therapy past thirty days
1, pomalidomide myeloma diagnosis major surgery within twenty one days prior signing consent
0, cisplatin head neck cancer diagnosis pilocarpine hydrochloride
1, antibodies testicular lymphoma diagnosis men women childbearing potential who unwilling employ adequate contraception condoms diaphragm birth control pills injections intrauterine device iud abstinence etc
0, gemcitabine patients must have advanced recurrent uterine leiomyosarcoma documented disease progression histologic confirmation original primary tumor is required
1, cytarabine stage iv childhood lymphoblastic lymphoma diagnosis patients who pregnant pregnancy test is required female patients childbearing potential
0, oxaliplatin colorectal carcinoma diagnosis participant has adequate hematologic function evidenced by an absolute neutrophil count anc greater one thousand five hundred microliter Î¼l hemoglobin greater ten grams deciliter dl platelets greater ten zero Î¼l
0, gemcitabine recurrent uterine corpus sarcoma diagnosis creatinine less doc times uln
1, antibodies monoclonal stage iv marginal zone lymphoma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide similar drugs
1, cyclophosphamide breast cancer diagnosis this treatment should be stopped at least fifteen days before entry
1, laboratory biomarker analysis stage iiic ovarian cancer diagnosis pregnancy nursing unwilling take adequate birth control during therapy note
1, fosaprepitant lymphoma non hodgkin diagnosis previous adverse reaction standard anti emetics proposed study
0, floxuridine cancer diagnosis patient characteristics
0, sorafenib renal cell carcinoma diagnosis minimum five predicted half lives agent must have elapsed between end treatment registration on when half lives not available principle two weeks once daily medications three weeks agents given less frequently will be adopted but discussion principal investigator is recommended
1, epothilones colon cancer diagnosis neuropathy grade one
0, antineoplaston therapy atengenal astugenal tumor must be at least five mm size
0, epirubicin inflammatory breast cancer diagnosis all patients must have bilateral mammography breast ultrasound twenty one days breast mri optional
1, mc autologous pbmcs gm csf fallopian tube carcinoma diagnosis active central nervous system metastases at time treatment
1, cytarabine stage iv grade one follicular lymphoma diagnosis active infection at start lenalidomide
0, topotecan ewing sarcoma bone diagnosis absolute granulocyte count greater equal seven hundred fifty ul
1, poly iclc primary peritoneal cancer diagnosis subject has chronic acute hepatitis infection
0, doxorubicin hepatocellular carcinoma diagnosis patients may not have been previously treated sorafenib chemoembolization radioembolization systemic chemotherapy cytotoxic agents molecularly targeted agents
1, cyclosporins myelodysplastic myeloproliferative neoplasm diagnosis not eligible autologous hct not eligible high dose allogeneic hct after failed autologous hct
0, docetaxel metastatic cancer diagnosis radiotherapy
0, lomustine glioblastoma diagnosis ability comply follow up procedures
1, dihematoporphyrin ether non small cell lung cancer diagnosis subjects who would likely need second pdt course within ninety days
1, fluorouracil anal cancer diagnosis eighteen live vaccines within thirty days prior first dose trial treatment while participating trial
0, gemcitabine adult lymphocyte depletion hodgkin lymphoma diagnosis measurable disease must be present either on physical examination imaging studies non measurable disease alone is not acceptable
1, fludarabine phosphate stage iv adult diffuse large cell lymphoma diagnosis presence uncontrolled psychiatric disorder
0, vincristine stage ii contiguous mantle cell lymphoma diagnosis one total bilirubin equal less two upper limit normal two aspartate aminotransferase ast equal less three upper limit normal three liver biopsy pathology demonstrates equal less grade two fibrosis no cirrhosis
1, fludarabine noncontiguous stage ii adult diffuse mixed cell lymphoma diagnosis donor
1, azacitidine vsix hundredebraf mutated metastatic melanoma diagnosis no measurable disease pregnant breast feeding women wocbp not willing use double barrier method contraception during three months after end treatment
1, sirolimus malignant peripheral nerve sheath tumors diagnosis patients known hypersensitivity rapamycins
0, vaccines neoplasms prostate diagnosis creatinine doc uln
1, simvastatin adenocarcinoma rectum diagnosis prior statins therapy within one year from date entry
0, liposomal doxorubicin stage ii contiguous adult lymphoblastic lymphoma diagnosis prior therapy restrictions
0, etc solid tumors diagnosis radiologically confirmed disease progression
0, this group patients will be exposed multimedia newly diagnosed breast cancer patients
0, cyclosporine refractory multiple myeloma diagnosis must have suitable matched sibling matched unrelated donor stem cell source
0, dacarbazine unspecified adult solid tumor protocol specific diagnosis negative pregnancy test
0, laboratory biomarker analysis stage iiia ovarian cancer diagnosis evaluable patients must have had measurable nonmeasurable disease
0, erlotinib hydrochloride stage iv adenoid cystic carcinoma oral cavity diagnosis metastatic unresectable disease
1, fludarabine refractory multiple myeloma diagnosis small bowel any volume forty six gy
0, antibodies monoclonal non squamous non small cell lung cancer diagnosis eastern cooperative oncology group ecog performance status less two
0, iodine hepatocellular carcinoma diagnosis two child pugh classification grade b
0, ifosfamide extraskeletal osteosarcoma diagnosis platelet count greater equal one hundred zero ul note
0, pharmacological women childbearing potential men must use two forms contraception barrier contraception one other method contraception starting prior entry duration participation at least twelve months post treatment should woman become pregnant suspect she is pregnant while she her partner participating this twelve months after participation patient should inform treating physician immediately
0, pazopanib hydrochloride lung cancer diagnosis egfr wild type unknown known egfr mutations not eligible
1, dexamethasone peripheral cholangiocarcinoma diagnosis hepatic encephalopathy
0, pain therapy breast cancer diagnosis no sudden swelling ankles hands face
0, aminolevulinic acid glioblastoma diagnosis ii
0, anastrozole breast cancer diagnosis one at time period between two months prior one month after beginning their anastrozole treatment cohort one two patients within positive
1, ketoprofen unspecified adult solid tumor protocol specific diagnosis persons not competent consent
1, regorafenib active cholangiocarcinoma diagnosis active chronic hepatitis need antiviral treatment
1, paclitaxel breast cancer diagnosis definitive evidence metastatic disease exception axillary lymph nodes mammary nodes
0, antibodies monoclonal stage iva verrucous carcinoma larynx diagnosis alanine aminotransferase alt aspartate aminotransferase ast within doc normal range equal less doc upper limit normal uln if liver metastases present
0, liposomal doxorubicin long term effects secondary cancer therapy adults diagnosis able read speak english
1, etoposide phosphate non small cell lung cancer diagnosis rpggreater one doc mmol blood fasting sugar bfs less doc mmol patient also be enrolled
1, vitamin d concurrent use other anti cancer therapy including chemotherapy agents targeted agents biological agents immunotherapy investigational agents not otherwise specified this protocol
1, antibodies recurrent nasopharyngeal keratinizing squamous cell carcinoma diagnosis patients known active brain metastases should be excluded from this clinical trial patients treated brain metastases stable greater equal twelve weeks eligible
1, niacinamide liver neoplasms diagnosis patients known brain metastases will be excluded from this clinical trial because their poor prognosis because they often develop progressive neurologic dysfunction that would confound evaluation neurologic other adverse events
0, ispinesib recurrent childhood large cell lymphoma diagnosis no greater doc mg dl eleven fifteen years age
1, bortezomib multiple myeloma diagnosis poorly controlled hypertension diabetes mellitus other serious medical illness psychiatric illness that could potentially interfere completion treatment according this protocol
1, docetaxel patient has received prior chemotherapy head neck cancer
0, irinotecan recurrent gastrointestinal carcinoid tumor diagnosis more four weeks since prior chemotherapy six weeks nitrosoureas mitomycin recovered
1, lenograstim stage adult diffuse mixed cell lymphoma diagnosis an acute medical condition resulting from prior chemotherapy
1, panobinostat recurrent colon cancer diagnosis uncontrolled hypertension
1, mycophenolate mofetil myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis human immunodeficiency virus hiv positive patients
0, epirubicin ovarian cancer diagnosis chemotherapy
1, niacinamide pancreatic cancer diagnosis pemetrexed cisplatin sorafenib pregnancy category d
1, carboplatin retinoblastoma diagnosis concomitant medications
1, immunoglobulin g stage iiib uterine corpus cancer diagnosis history cerebrovascular accident cva stroke transient ischemic attack tia subarachnoid hemorrhage within six months first date therapy
1, cisplatin ampullary cancer diagnosis evidence significant clinical disorder laboratory finding which opinion investigator makes it undesirable patient participate trial
0, sulfamethoxazole multiple myeloma plasma cell neoplasm diagnosis no alcohol dependency
0, bb refractory multiple myeloma diagnosis lenalidomide dose may have been escalated fifteen mg qd after two cycles if participant was not responding treatment was tolerating treatment
0, hpph stage ii lymphoepithelioma nasopharynx diagnosis no radiation therapy chemotherapy other biological therapy at least thirty days prior pdt
0, dexamethasone lymphoma diagnosis not specified hepatic
1, immunoglobulins uterine corpus carcinosarcoma diagnosis men women childbearing potential who unwilling employ adequate contraception
0, immunoglobulins stage iii marginal zone lymphoma diagnosis patients must be not eligible conventional transplants must have disease expected be stable at least one hundred days without chemotherapy patients hematologic malignancies treatable hematopoietic stem cell transplant hsct b cell malignancy except those treatable autologous transplant will be included
1, wild type reovirus recurrent childhood anaplastic oligodendroglioma diagnosis nitrosoureas mitomycin equal less six weeks registration
0, folic acid advanced non small cell lung cancer nsclc diagnosis patients must have ability sign an approved informed consent form icf
1, cyclophosphamide stage ib breast cancer diagnosis cardiac disease history active disease that would preclude use drugs included treatment regimens this includes but is not confined to
1, vinorelbine mesothelioma diagnosis yellow fever vaccine within thirty days consent
0, etoposide phosphate lymphoma diagnosis chemotherapy
0, bevacizumab stage iia breast cancer diagnosis no baseline neuropathy grade greater equal two
0, lenalidomide recurrent burkitt lymphoma diagnosis unless related bone marrow involvement disease which case platelets must be greater equal fifty zero mm three
1, fluorodeoxyglucose f recurrent breast cancer diagnosis type diabetes mellitus patients type ii diabetes mellitus will be included long their glucose can be controlled under two hundred mg dl
0, thalidomide stage ivc lip oral cavity squamous cell carcinoma diagnosis females childbearing potential fcbp must have negative serum urine pregnancy test sensitivity at least twenty five miu ml within ten
0, succinylcholine hepatocellular carcinoma diagnosis magnetic resonance imaging mri computerized tomography ct consistent liver cirrhosis at least one solid liver lesion greater two cm early enhancement delayed enhancement washout regardless alpha feto protein levels afp
1, albumin bound paclitaxel recurrent primary peritoneal carcinoma diagnosis myocardial infarction unstable angina equal less six months prior registration
0, fluorouracil recurrent lymphoepithelioma oropharynx diagnosis no significant ongoing active infection
1, vidarabine clear cell renal cell carcinoma diagnosis any vertebral instability
1, cyclophosphamide recurrent pleural malignant mesothelioma diagnosis exclusions leukapheresis procedure this can be performed at later time symptoms resolve
1, doxorubicin triple negative breast carcinoma diagnosis pregnancy testing according institutional standards women childbearing potential must be performed within two weeks prior randomization
1, lenalidomide recurrent oral cavity verrucous carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition lenalidomide cetuximab other agents used study
1, lenalidomide adult grade iii lymphomatoid granulomatosis diagnosis residual grade three grade four non hematologic toxicity after asct
1, antibodies monoclonal recurrent small lymphocytic lymphoma diagnosis age less twelve years
0, mycophenolic acid refractory multiple myeloma diagnosis dlco diffusing capacity lung carbon monoxide greater fifty predicted corrected hemoglobin
1, letrozole breast cancer diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior day zero anticipation need major surgical procedure during course study
1, cyclosporine recurrent marginal zone lymphoma diagnosis donor
0, antibodies monoclonal high risk non muscle invasive bladder cancer diagnosis life expectancy more equal greater equal twelve weeks
1, curcumin pancreatic cancer diagnosis prior radiation
0, leucovorin childhood central nervous system mixed germ cell tumor diagnosis patients requiring steroids should be on stable decreasing dose greater seven days prior entry must not be on more four mg dexamethasone equivalent per day
1, management therapy complications stage iii malignant testicular germ cell tumor diagnosis currently treated therapeutic dose anti coagulation recent pulmonary embolism deep vein thrombosis
1, antibodies recurrent pancreatic neuroendocrine carcinoma diagnosis known hypersensitivity other recombinant human antibodies chinese hamster ovary cell products
0, aromatase inhibitors breast cancer diagnosis treatmen negative ai clinically indicated ai may be anastrozole exemestane letrozole
1, cisplatin nasal nasal type nk cell lymphoma diagnosis evidence cns metastasis
0, antibodies monoclonal infiltrating bladder urothelial carcinoma associated urethral carcinoma diagnosis purposes this radiosensitizing single agent chemotherapy is not considered prior systemic therapy
1, leuprolide prostate cancer diagnosis known hypersensitivity any leuteinizing hormone releasing hormone lhrh agonist
0, dasatinib signet ring adenocarcinoma rectum diagnosis creatinine equal less doc institutional uln
1, dexamethasone acetate recurrent plasma cell myeloma diagnosis known hepatitis surface antigen positive status known suspected active hepatitis infection
1, subjects mailed informational educational materials abnormal breast cancer screening tests diagnosis living nursing home
0, fludarabine unspecified adult solid tumor protocol specific diagnosis white blood cell wbc greater three zero mm three
0, temozolomide adult giant cell glioblastoma diagnosis no other concurrent chemotherapy agents investigational agents biologic therapy
0, immunoglobulins recurrent adult liver carcinoma diagnosis hepatic artery embolization
0, mycophenolic acid stage iii adult lymphoblastic lymphoma diagnosis written informed consent written informed consent unrelated donor is required participate optional studies
0, pharmacological childhood central nervous system germ cell tumor diagnosis negative pregnancy test
0, laboratory biomarker analysis unspecified adult solid tumor protocol specific diagnosis patients must be english proficient patients who speak english second language eligible
1, antibodies monoclonal recurrent gastrointestinal carcinoid tumor diagnosis abnormalities cornea based on history dry eye syndrome sjogren syndrome congenital abnormality fuch dystrophy abnormal slit lamp examination using vital dye fluorescein bengal rose an abnormal corneal sensitivity test schirmer test similar tear production test
0, cabozantinib glioblastoma multiforme diagnosis adequate liver function defined as
0, dendritic cells dcvac pca prostate cancer diagnosis post radical prostatectomy
0, sorafenib metastatic gastrointestinal carcinoid tumor diagnosis at least three weeks since prior radiotherapy
0, clofarabine patients organ confined prostate cancer no evidence recurrent progressive disease based on prostate specific antigen values also eligible this if hormonal therapy has been initiated radical prostatectomy has been performed
1, olaparib recurrent platinum resistant ovarian cancer diagnosis history intra abdominal abscess within three months prior starting treatment
1, pharmacological stage iv squamous cell carcinoma lip oral cavity diagnosis inducers cypthreeafour
0, paclitaxel advanced metastatic non small cell lung cancer diagnosis karnofsky performance status seventy one hundred
0, cetuximab tongue cancer diagnosis measurable disease defined greater one unidimensionally measurable lesion greater twenty mm by conventional techniques greater one mm by ct scan
1, tacrolimus stage adult diffuse small cleaved cell lymphoma diagnosis patients active bacterial fungal infections unresponsive medical therapy
1, bnc combination folfiri colorectal cancer diagnosis note
1, immunoglobulin g recurrent ovarian carcinoma diagnosis history inflammatory bowel disease requiring ongoing therapy
0, melphalan non hodgkin lymphoma diagnosis autologous graft minimum greater equal doc ten six cdthirty four positive cells kg not cdthirty four selected
1, antibodies stage iib ovarian cancer diagnosis protein concentration mg dl creatinine mg dl patients must have upcr less doc allow participation study
1, phosphoramide mustards neuroendocrine tumors diagnosis coronary peripheral artery bypass graft
1, brivanib alaninate endometrial squamous cell carcinoma diagnosis patients that on required chronic anti platelet therapy aspirin greater three hundred mg day clopidogrel greater equal seventy five mg day
0, laboratory biomarker analysis adequately treated non melanoma skin cancer lentigo maligna without evidence disease
0, albumin bound paclitaxel ovarian serous cystadenocarcinoma diagnosis patients following histologic epithelial cell types eligible
1, sirolimus stage ib breast cancer diagnosis known hypersensitivity sirolimus
1, niacinamide bclc stage adult hepatocellular carcinoma diagnosis active bleeding during last thirty days prior cycle one treatment including variceal bleeding esophageal varices should be treated according standard practice ligation banding procedure completed thirty days prior cycle one treatment
0, levoleucovorin stage iii colon cancer diagnosis bilirubin less doc times upper limit normal uln
0, antibodies colorectal cancer diagnosis no cns metastases
1, camptothecin first line metastatic colorectal cancer diagnosis patients chronic inflammatory bowel disease bowel obstruction
1, standard salvage radiation treatment ssrt prostate cancer diagnosis prior androgen deprivation therapy is not permitted if it was within six months previous signing consent form
0, imatinib mesylate kidney cancer diagnosis life expectancy greater three months
1, melphalan stage iv grade one follicular lymphoma diagnosis human immunodeficiency virus hiv positive
1, o benzylguanine other concurrent anticancer investigational drugs
1, bortezomib recurrent adult immunoblastic large cell lymphoma diagnosis patient has greater equal grade two peripheral neuropathy within fourteen days before enrollment
0, ner enema colorectal cancer diagnosis non smokers from three months before enema administration duration clinical investigation
1, mycophenolic acid stage iv adult diffuse large cell lymphoma diagnosis patients poorly controlled hypertension on multiple antihypertensives
1, diphosphonates lymphoma diagnosis primary hyperparathyroidism
1, cytarabine adult diffuse large cell lymphoma diagnosis serious medical psychiatric illness likely interfere participation this clinical study
0, cyclosporins secondary central nervous system hodgkin lymphoma diagnosis karnofsky greater equal seventy
0, bowel obstruction management extrahepatic bile duct cancer diagnosis ecog zero three
0, vaccines extensive stage small cell lung cancer diagnosis recovered from prior therapy
0, methotrexate stage ii non contiguous adult lymphoblastic lymphoma diagnosis all
1, fluorodeoxyglucose f stage iv adult soft tissue sarcoma diagnosis inflammatory bowel disease ulcerative colitis crohn disease other gastrointestinal conditions increased risk perforation
0, levoleucovorin colorectal cancer diagnosis eighteen over
0, entinostat unspecified adult solid tumor protocol specific diagnosis evaluable measurable disease
1, irradiation breast cancer diagnosis mastectomy axillary homolateral lymph node dissection
1, dabrafenib braf mutant melanoma diagnosis use other prohibited medications within five half lives fourteen days prior first dose drugs requires any these medications while receiving medication on this pregnant lactating female
1, azacitidine stage iiic breast cancer diagnosis hormone therapy less three weeks prior registration
0, dihydroxyphenylalanine recurrent adult brain tumor diagnosis provides written informed consent
0, antibodies monoclonal non small cell lung cancer diagnosis adequate organ system function within fourteen days registration
0, liposomal doxorubicin histologically confirmed hepatocellular carcinoma hcc family tumors by percutaneous needle biopsy unless primary tumor resection is attempted
0, mycophenolate mofetil stage ii childhood lymphoblastic lymphoma diagnosis acute myeloid leukemia
0, pharmacological stage iv thyroid gland papillary carcinoma diagnosis anc greater one five hundred Âµl
1, tetrathiomolybdate multiple myeloma diagnosis inability swallow medication capsules
0, cisplatin carcinoma non small cell lung diagnosis prior concurrent therapy
0, ifosfamide recurrent cutaneous cell non hodgkin lymphoma diagnosis echocardiogram ekg normal
0, doxorubicin neoplasm metastasis diagnosis radiation
0, albumin bound paclitaxel stage ib breast cancer diagnosis if pathologic nodal staging based on sentinel lymphadenectomy is pnzero pnoneb
0, pazopanib hydrochloride recurrent squamous cell carcinoma nasopharynx diagnosis stage iv recurrent disease
0, aslan gastric neoplasms diagnosis male female patients twenty one years age older at time written informed consent is obtained
1, liposomal doxorubicin stage iii mantle cell lymphoma diagnosis positive serology hepatitis hb defined positive test hbsag addition if negative hbsag but hbcab positive regardless hbsab status hepatitis dna test will be performed if positive patient will be excluded
1, dexrazoxane small intestine lymphoma diagnosis growth factors that support platelet white cell number function must not have been administered within seven days prior enrollment
1, antibodies monoclonal stage iiic ovarian cancer diagnosis prior therapy vascular endothelial growth factor receptor vegfr targeting agents mammalian target rapamycin mtor inhibitors except hcc islet cell single agent bevacizumab alone cohort where prior mtor inhibitor is allowed note
1, fludarabine phosphate contiguous stage ii marginal zone lymphoma diagnosis poorly controlled hypertension
1, immunoglobulins kidney cancer diagnosis refusal inability use effective means contraception men women childbearing potential
1, albumin bound paclitaxel breast cancer diagnosis patients neurological symptoms must undergo ct scan mri brain exclude brain metastasis
1, vincristine burkitt lymphoma diagnosis prior administration an aurora kinase targeted agent including alisertib
1, vidarabine lymphoma diagnosis pregnant breast feeding
1, albumin bound paclitaxel lung cancer diagnosis thoracentesis paracentesis port placement laparoscopy thorascopy tube thoracostomy bronchoscopy endoscopic ultrasonographic procedures mediastinoscopy skin biopsies incisional biopsies imaging guided biopsy diagnostic purposes routine dental procedures
0, cyclosporine stage adult immunoblastic large cell lymphoma diagnosis donor
1, immunoglobulins undifferentiated fallopian tube carcinoma diagnosis myocardial infarction unstable angina less six months prior registration
0, sirolimus metastatic gastric cancer diagnosis patients cns metastasis must have stable neurologic function without evidence cns progression within eight weeks
1, antibodies monoclonal non small cell lung cancer diagnosis severe infections within four weeks prior day one cycle one
0, fludarabine anaplastic large cell lymphoma diagnosis best available match is hla class ii drbone dqbone matched donor incompatible any single serologically detectable class hla b mismatch one additional allele level class mismatch is allowed any combination two allele level mismatches if typed at molecular level
1, veliparib childhood grade meningioma diagnosis total bilirubin sum conjugated positive unconjugated less doc times institutional upper limit normal uln age
0, carboplatin adult anaplastic astrocytoma diagnosis women child bearing years must have negative pregnancy test serum urine within one week entry men women reproductive potential must agree use an effective contraceptive method including one following
0, temozolomide metastatic cancer diagnosis hematopoietic
1, cyclophosphamide melanoma diagnosis pregnant lactating women will be excluded due unknown potentially harmful effects immune response ct antigens stem cell proteins that may be expressed placenta fetus neonates
1, dexamethasone acetate lymphoblastic lymphoma diagnosis inability unwillingness research participant legal guardian representative give written informed consent
1, lenalidomide multiple myeloma diagnosis evidence al amyloid light chain amyloidosis
1, tacrolimus non hodgkin lymphoma diagnosis serum bilirubin greater doc mg dl except case gilbert syndrome hemolytic anemia which bilirubin can be elevated greater doc mg dl
1, mg kg humanized anti pd mab head neck squamous cell carcinoma diagnosis hiv positive
1, etoposide phosphate b cell lymphoma unclassifiable features intermediate between diffuse large cell lymphoma burkitt lymphoma diagnosis those evidence exposure hepatitis virus hbv may enroll so long hbv viral load is negative subject is willing able take appropriate antiviral prophylaxis prevent reactivation
1, computed tomography radiotherapy equal less four weeks failure fully recover from acute reversible effects prior anti cancer therapy regardless interval since last treatment note
0, antiviral agents stage grade one follicular lymphoma diagnosis hematologic malignancies disorders including aplastic anemia myelodysplastic syndrome
1, irinotecan adult glioblastoma diagnosis prospective participants who opinion investigator may not be able comply all procedures including compliance issues related feasibility logistics
0, doxorubicin myelodysplastic myeloproliferative neoplasms diagnosis inv three three three
1, gemcitabine recurrent fallopian tube carcinoma diagnosis patients known be hiv positive but without clinical evidence an immunocompromised state eligible this trial
1, musculoskeletal complications management prevention noncontiguous stage ii adult diffuse large cell lymphoma diagnosis doc
1, interleukin wash out period less five times half life previous anti cancer treatment before entry except if previous chemotherapy treatment before entry
0, sirolimus stage iv melanoma diagnosis no prior radiotherapy greater twenty five bone marrow
1, paclitaxel any ongoing toxicity from prior anti cancer therapy that is greater grade one that is progressing severity
1, immunoglobulins ovarian seromucinous carcinoma diagnosis patients concurrent severe medical problems unrelated malignancy that would significantly limit full compliance expose patient extreme risk decreased life expectancy
0, methotrexate stage iii adult lymphoblastic lymphoma diagnosis inclusion
1, folic acid stage ia pancreatic cancer diagnosis patients receiving following drugs that contraindicated nelfinavir nfv viracept will be excluded if they cannot be change discontinued drugs that should not be coadministered viracept
1, antibodies monoclonal history seizure known condition that may pre dispose seizure including but not limited prior stroke loss consciousness within one year prior randomization brain arteriovenous malformation intracranial masses such schwannomas meningiomas that causing edema mass effect
1, albumin bound paclitaxel pancreatic cancer diagnosis this includes gemcitabine capecitabine five fu abraxane
0, immunoglobulins metastatic cancer diagnosis negative pregnancy test
1, gossypol stage grade one follicular lymphoma diagnosis failure recover fully judged by investigator from prior surgical procedures failure recover from adverse events due agents administered more four weeks earlier
1, maleic acid fallopian tube clear cell adenocarcinoma diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin starting treatment those who have not recovered from adverse events due agents administered more four weeks earlier patients may not have had hormonal therapy within two weeks prior entering patients receiving raloxifene bone health per food drug administration fda indication may remain on raloxifene absent other drug interactions
0, tacrolimus noncontiguous stage ii grade two follicular lymphoma diagnosis complete remission is defined absence blasts peripheral circulation at time enrollment less five blasts bone marrow
0, nv colorectal cancer diagnosis transaminases no greater three times upper limit normal
0, liposomal doxorubicin stage ii renal cell cancer diagnosis oncocytoid
0, denileukin diftitox lymphoma diagnosis creatinine less doc mg dl cardiovascular
1, antibodies monoclonal refractory small lymphocytic lymphoma diagnosis pregnant breastfeeding women excluded from this breastfeeding should be discontinued if mother is treated ibrutinib
1, poly adp ribose polymerase inhibitors medulloblastoma diagnosis documented within fourteen days registration within seven days starting treatment
1, bevacizumab prior radiotherapy chemotherapy brain tumor
0, fluorouracil recurrent rectal cancer diagnosis creatinine within normal institutional limits
1, rituximab high grade cell lymphoma diagnosis patients child pugh hepatic impairment
0, busulfan nodal marginal zone cell lymphoma diagnosis gated pool radionuclide scan fraction must be greater equal fifty
1, mycophenolic acid recurrent childhood small noncleaved cell lymphoma diagnosis thirty
1, albumin bound paclitaxel breast adenocarcinoma diagnosis known active human immunodeficiency virus hiv
1, antibodies monoclonal stage iv hypopharyngeal squamous cell carcinoma diagnosis patients who have had chemotherapy radiotherapy within two weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more two weeks earlier
1, edotreotide adult anaplastic ependymoma diagnosis presence pacemakers aneurysm clips artificial heart valves ear implants metal fragments foreign objects eyes skin body that would preclude obtaining an mri part initial evaluation
0, docetaxel breast cancer diagnosis age
0, docetaxel progression non small cell lung cancer diagnosis patients may not be eligible other curative intent treatment surgical resection
0, vaccines stage iiic breast cancer diagnosis urine dipstick proteinuria less two positive urine protein creatinine upc ratio equal less doc note
1, albumin bound paclitaxel stage iiib ovarian cancer diagnosis patients history cerebrovascular accident cva stroke transient ischemic attack tia subarachnoid hemorrhage within six months first date treatment on this ineligible
0, camptothecin stage iv breast cancer diagnosis wbc at least three zero mm three
1, liposomal doxorubicin primary peritoneal serous adenocarcinoma diagnosis history tuberculosis history purified protein derivative ppd positivity
0, camptothecin colorectal cancer diagnosis imidazole antibiotics clotrimazole
1, paclitaxel ovarian cancer diagnosis known clinically significant gastrointestinal disease including but not limited inflammatory bowel disease
0, carboplatin breast cancer diagnosis disease characteristics
0, interferon alpha colorectal neoplasms diagnosis renal
0, ifosfamide lymphoma diagnosis not specified
0, cortisone acetate refractory lymphoblastic lymphoma diagnosis note
0, temozolomide ependymoma diagnosis dose must be stable range decreasing at least fourteen days
0, rituximab non hodgkin lymphomas diagnosis fasting serum cholesterol less doc five mmol fasting triglycerides less doc uln
0, bevacizumab localized unresectable adult primary liver cancer diagnosis ptt less four seconds above uln
0, irinotecan stage ivb rectal cancer diagnosis no significant traumatic injury within past twenty eight days
0, counseling intervention breast cancer diagnosis must not be undergoing active treatment
0, muromonab cd brain central nervous system tumors diagnosis hematopoietic
0, dacarbazine adult gliosarcoma diagnosis hemoglobin greater equal one doc dl note
1, iodine anti b antibody non hodgkin lymphoma diagnosis patients progressive disease within one year irradiation arising field that has been previously irradiated more three thousand five hundred cgy
1, oxaliplatin colon cancer diagnosis signed informed consent
1, liposomal doxorubicin advanced recurrent breast cancer diagnosis substance abuse medical psychological social conditions that may interfere patients participation evaluation results
1, oxaliplatin recurrent childhood large cell lymphoma diagnosis no prior oxaliplatin
1, vb differential thyroid cancer diagnosis history abdominal fistula gastro intestinal perforation active diverticulitis intra abdominal abscess gastro intestinal tract bleeding within six months dosing
1, immunoglobulins childhood rhabdomyosarcoma mixed embryonal alveolar features diagnosis female patients childbearing potential not eligible unless negative pregnancy test result has been obtained
1, immunoglobulin g undifferentiated ovarian carcinoma diagnosis patients who have received prior therapy any anti vascular endothelial growth factor vegf drug including bevacizumab
1, bevacizumab astrocytoma oligoastrocytoma mixed diagnosis patient must not require sedation imaging purposes
0, mycophenolate mofetil splenic marginal zone lymphoma diagnosis donor must consent filgrastim csf administration leukapheresis
1, rituximab stage adult diffuse mixed cell lymphoma diagnosis transfusion requirement red blood cells platelets within fourteen days prior baseline
1, metformin colon cancer diagnosis blood glucose using point care test less seventymg dl
0, sunitinib stage ivb uterine corpus cancer diagnosis eligible patients may have received no more one prior cytotoxic chemotherapy regimen recurrent locally advanced metastatic disease if prior chemotherapy was an anthracycline they may have received no more six cycles less four hundred fifty mg two doxorubicin patients must have completed any previous chemotherapy minimum four weeks six weeks if regimen contained carmustine bcnu mitomycin prior registration prior investigational treatment is permissible long such treatment completed four weeks prior registration
1, mycophenolate mofetil recurrent small lymphocytic lymphoma diagnosis donors who hiv positive medical conditions that would result increased risk csf mobilization harvest pbmc
1, vidarabine stage adult cell leukemia lymphoma diagnosis eligible high priority curative autologous transplant
1, ganetespib stage ii laryngeal squamous cell carcinoma diagnosis use these medications treatment hypertension is allowed
1, antibodies recurrent adult cell leukemia lymphoma diagnosis patients clinically significant cardiovascular disease
0, vidarabine chemotherapy sensitive lymphoma diagnosis diffusing capacity lungs carbon monoxide dlco forced expiratory volume fevone forced vital capacity fvc greater fifty predicted by pulmonary function tests pfts
0, bortezomib recurrent adult cell leukemia lymphoma diagnosis histologically cytologically confirmed diagnosis one following hematologic malignancies
1, fludarabine phosphate recurrent mantle cell lymphoma diagnosis serum glutamate pyruvate transaminase sgpt serum glutamic oxaloacetic transaminase sgot fourx upper limit normal
0, leucovorin stage iii rectal cancer diagnosis alkaline phosphatase ap less doc times upper limit normal uln aspartate aminotransferase ast less doc times uln
0, laboratory biomarker analysis unspecified adult solid tumor protocol specific diagnosis no more three prior regimens metastatic disease
1, mycophenolate mofetil recurrent adult grade iii lymphomatoid granulomatosis diagnosis patients who human immunodeficiency virus hiv positive
1, mailing completed kits processing colorectal cancer diagnosis patient
1, immunoglobulins stage iib fallopian tube cancer diagnosis new york heart association nyha class ii higher congestive heart failure
0, acetylcarnitine ovarian clear cell cystadenocarcinoma diagnosis duloxetine cymbalta
1, dexamethasone multiple myeloma diagnosis patients who require vitamin antagonists except low dose inr less two five
0, maleic acid clear cell renal cell carcinoma diagnosis no concurrent hematopoietic growth factors except epoetin alfa bisphosphonates
1, fludarabine phosphate recurrent childhood anaplastic large cell lymphoma diagnosis donors who hiv positive medical conditions that would result increased risk granulocyte colony stimulating factor csf mobilization harvest peripheral blood stem cell pbsc
0, carboplatin more four weeks since prior no other concurrent anticancer therapies including chemotherapy radiotherapy antibody based therapy
1, anastrozole stage iib breast cancer diagnosis radiation therapy
0, gemcitabine prostate cancer diagnosis performance status
0, cyclosporins refractory multiple myeloma diagnosis patients treated previously radiation therapy excess one thousand cgy rads any thoracic abdominal port excess three thousand cgy rads cranial spinal ports who not eligible other protocols eligible this study
0, itraconazole advanced solid tumors diagnosis agree practice true abstinence when this is line preferred usual lifestyle participant
1, bevacizumab colorectal cancer diagnosis fine needle aspirations core biopsies within seven days prior day zero
0, stereotactic radiosurgery adult brain stem glioma diagnosis life expectancy greater two months
1, cetuximab stage iv squamous cell carcinoma nasopharynx diagnosis cardiac disease
1, cetuximab colorectal cancer diagnosis following laboratory results
0, boronophenylalanine fructose complex metastatic cancer diagnosis hepatic
1, rituximab contiguous stage ii adult diffuse large cell lymphoma diagnosis known hypersensitivity lenalidomide thalidomide
1, qualitative information sheet colorectal cancer diagnosis no telephone number
0, lenalidomide stage thyroid gland papillary carcinoma diagnosis females childbearing potential fcbp must have negative serum urine pregnancy test sensitivity at least twenty five miu ml within ten fourteen days prior again within twenty four hours starting lenalidomide must either commit continued abstinence from heterosexual intercourse begin two acceptable methods birth control one highly effective method one additional effective method at same time at least twenty eight days before she starts taking lenalidomide fcbp must also agree ongoing pregnancy testing men must agree use latex condom during sexual contact fcbp even if they have had successful vasectomy all patients must be counseled at minimum every twenty eight days about pregnancy precautions risks fetal exposure
0, lenalidomide angioimmunoblastic cell lymphoma diagnosis patients feeding tubes
1, sirolimus patients squamous non small cell lung cancer nsclc
0, doxorubicin tumor size at least eight cm diameter
1, vidarabine renal cell cancer diagnosis multiple brain metastasis
1, erlotinib hydrochloride advanced solid tumors diagnosis renal function follows
0, laboratory biomarker analysis recurrent adult burkitt lymphoma diagnosis myelodysplastic syndromes five more blasts
1, melphalan refractory hodgkin lymphoma diagnosis known human immunodeficiency virus hiv seropositivity
1, laboratory biomarker analysis stage iv non small cell lung cancer diagnosis patients who human immunodeficiency virus hiv seropositive
1, ixazomib multiple myeloma diagnosis patients who have any debilitating medical psychiatric illness which would preclude their giving informed consent their receiving optimal treatment follow up
0, erlotinib hydrochloride tumors metastatic brain diagnosis zubrod zero one
0, photodynamic therapy recurrent squamous cell carcinoma larynx diagnosis no radiation therapy chemotherapy other biological therapy at least thirty days prior pdt
1, vidarabine recurrent childhood anaplastic large cell lymphoma diagnosis patient has poorly controlled hypertension on multiple antihypertensives
1, antibodies monoclonal stage iiib breast cancer diagnosis patients controlled type one diabetes mellitus on stable insulin regimen may be eligible
0, cisplatin cervical cancer diagnosis see disease characteristics
0, cyclophosphamide breast cancer diagnosis laboratory results within fourteen days prior randomization
0, vorinostat stage iiic breast cancer diagnosis ast alt equal less two times upper limit normal
0, gemcitabine advanced non small cell lung cancer diagnosis negative history allergy non steroidal anti inflammatory sulphonamide drugs
1, cetuximab stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
1, albumin bound paclitaxel cervix carcinoma recurrent diagnosis patients serum creatinine level more doc mg dl but less doc mg dl eligible if creatinine clearance is seventy ml min were eligible if creatinine clearance determination was more fifty ml min
0, sunitinib adult anaplastic astrocytoma diagnosis phenobarbital
1, sunitinib ciliary body choroid melanoma small size diagnosis unable render informed consent follow protocol requirements
0, l glutamine placebo cancer related problem condition diagnosis other
0, methylprednisolone acetate diffuse large cell lymphoma diagnosis accept use latex condom during any sexual relations women childbearing potential even if they have had vasectomy while participating this during dose interruptions after discontinuation treatment
1, busulfan mantle cell lymphoma diagnosis typing hla class ii drbone will be based on pcr sequence specific oligonucleotide primers ssop
0, gen epithelial ovarian cancer diagnosis ii
0, dexamethasone phosphate mantle cell lymphoma diagnosis past documentation cdtwenty antigen expression is admissible
0, bortezomib multiple myeloma diagnosis agree completely abstain from heterosexual intercourse and
0, octreotide neuroblastoma diagnosis signed informed consent
0, cediranib advanced malignant mesothelioma diagnosis wbc greater equal three zero mm three
1, bb multiple myeloma diagnosis patients history treatment clinically significant ventricular cardiac arrhythmias
1, pembrolizumab refractory cell non hodgkin lymphoma diagnosis note
1, cyclosporins recurrent childhood anaplastic large cell lymphoma diagnosis cardiac ejection fraction less thirty five ejection fraction is required if there is history anthracycline exposure history cardiac disease
1, antibodies monoclonal non hodgkin lymphomas diagnosis positive serology hepatitis hc defined positive test hcab which case reflexively perform hc riba immunoblot assay on same sample confirm result
0, temozolomide childhood grade iii meningioma diagnosis not pregnant nursing
1, gemcitabine renal cell carcinoma diagnosis nct ctcae grade three higher hemorrhage within four weeks starting treatment
1, poly adp ribose polymerase inhibitors ependymoma diagnosis renal
0, educational intervention stage iiib ovarian cancer diagnosis patients must have completed all primary chemotherapy consolidation therapy if administered at least six weeks no more six months two weeks prior enrollment must be complete remission consolidation therapy is defined any chemotherapy biological therapy used patient who has completed at least four courses primary chemotherapy had documented complete remission prior initiation such chemotherapy chemo biological therapy
0, prednisolone phosphate lymphoma non hodgkin diagnosis refractory first line chemotherapy relapsed
0, albumin bound paclitaxel stage iva verrucous carcinoma larynx diagnosis women childbearing potential male participants counseled on birth control must agree use medically effective means birth control throughout their participation treatment phase until at least sixty days following last treatment
0, isophosphamide mustard recurrent refractory childhood hodgkin lymphoma diagnosis ns cellular phase
0, anti cd car vector transduced t cells recurrent grade three follicular lymphoma diagnosis cll
1, antibodies monoclonal contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis donor
1, antibodies monoclonal stage ivb oropharyngeal squamous cell carcinoma diagnosis patients who receiving any other investigational agents
1, cabozantinib s malate metastatic malignant neoplasm diagnosis participant has prothrombin time pt international normalized ratio inr partial thromboplastin time ptt test greater equal doc laboratory uln within seven days before first dose treatment
0, blood collection hormonal status analysis breast cancer diagnosis signature icf
0, antibodies monoclonal brain central nervous system tumors diagnosis renal
1, mycophenolate mofetil lymphoma cell diagnosis patients secondary acute myeloid leukemia arising from myeloproliferative disease including chronic myelomonocytic leukemia cmml evidence active myeloproliferative features myelofibrosis background
1, sorafenib hepatocellular cancer diagnosis patients who have had chemotherapy large field radiotherapy major surgery must wait four weeks prior entering two weeks is sufficient targeted systemic therapy provided toxicity has recovered less equal grade one
0, autologous cd car cd cd zeta egfrt expressing tcm enriched t cells recurrent small lymphocytic lymphoma diagnosis total bilirubin equal less doc
0, succinylcholine stage ii bladder urothelial carcinoma diagnosis be candidate radical cystectomy
1, aminopurine stage ii childhood lymphoblastic lymphoma diagnosis uncontrolled seizure disorder
1, niacinamide carcinoma diagnosis pulmonary hemorrhage bleeding event greater equal ctcae grade two within four weeks prior first dose drug
0, antibodies stage iiic primary peritoneal cancer diagnosis patients must be greater equal four weeks from treatment show progressive disease liver after regional therapy must have measurable disease outside liver
0, oxaliplatin stage iiia rectal cancer diagnosis group ii
0, atengenal mixed gliomas diagnosis fertile patients must use effective contraception during four weeks after study
0, docetaxel stage iii ovarian epithelial cancer diagnosis alkaline phosphatase less doc times normal
0, autologous hematopoietic stem cell transplantation recurrent marginal zone lymphoma diagnosis patient evaluation selection deferral hematopoietic cell transplantation hct
0, fluorouracil liver cancer diagnosis negative pregnancy test
1, bbi any known symptomatic untreated brain metastases requiring increase steroid dose within two weeks prior starting on study
1, etoposide phosphate recurrent grade one follicular lymphoma diagnosis patients who have not recovered from adverse events due agents administered more four weeks earlier or
0, hydroxystaurosporine recurrent esthesioneuroblastoma paranasal sinus nasal cavity diagnosis more four weeks since prior radiotherapy recovered
1, gemcitabine pancreatic cancer diagnosis concurrent serious systemic disorders that incompatible participation
1, liposomal doxorubicin metastatic fibrosarcoma diagnosis known hypersensitivity any excipients ribociclib doxorubicin
0, cortisone acetate stage childhood hodgkin lymphoma diagnosis creatinine no greater doc times normal
0, interferon alpha ocular melanoma
1, enalaprilat cancer diagnosis heart rateless fifty bpm
1, etoposide stage iv grade two follicular lymphoma diagnosis prior entry any electrocardiogram ecg abnormality at screening has be documented by investigator not medically relevant
1, doxorubicin recurrent primary peritoneal carcinoma diagnosis extensive abdominal surgery if it includes enterotomy ies equal less three weeks prior entry note
0, anastrozole invasive ductal breast carcinoma diagnosis two positive by ihc ish ratio hertwo gene copy chromosome seventeen less two
0, albumin bound paclitaxel regional transitional cell cancer renal pelvis ureter diagnosis prior intravesicular chemotherapy allowed
1, vaccines esophageal cancer diagnosis participation any other clinical trial involving another investigational agent within four weeks prior first dosing
0, interferon alpha kidney cancer diagnosis prior concurrent therapy
0, staurosporine recurrent ovarian epithelial cancer diagnosis performance status
1, antibodies advanced cancer diagnosis new york heart association class chf score greater ii
0, etoposide refractory small lymphocytic lymphoma diagnosis previously collected pbmc may be used
1, pancrelipase pancreatic cancer diagnosis no other concurrent investigational agent
0, rituximab recurrent adult diffuse large cell lymphoma diagnosis age adjusted international prognostic index ipi score
0, sirolimus estrogen receptor positive breast cancer diagnosis any number lines hormonal therapy before after ai therapy is allowed
0, antibodies monoclonal stage iv salivary gland cancer diagnosis eastern cooperative oncology group ecog zero
1, albumin bound paclitaxel metastatic breast cancer diagnosis pre existing peripheral neuropathy greater grade one
1, picoplatin head neck cancer diagnosis active inflammatory bowel disease gastritis ulcers gastrointestinal rectal bleeding
1, dihydroxyphenylalanine cancer high grace glioma diagnosis subject exceeds weight limit pet scanner bed twenty doc kg
0, cediranib localized unresectable adult primary liver cancer diagnosis bilirubin less three times upper limit normal uln
1, paclitaxel pancreatic cancer diagnosis age less eighteen years old
0, bb smoldering multiple myeloma diagnosis serum protein three dl greater
1, albumin bound paclitaxel metastatic pancreatic ductal adenocarcinoma diagnosis uncontrolled electrolyte disorders
0, cyclosporins stage marginal zone lymphoma diagnosis increasing splenomegaly
1, sirolimus solid tumor diagnosis new brain metastases spinal cord compression leptomeningeal metastases on screening ct scan mri
0, prednisolone history cancer including solid tumors hematologic malignancies except basal cell squamous cell carcinoma skin that have been excised cured
0, flow cytometry breast cancer diagnosis menopausal status not specified
1, radiation astrocytoma grade iv diagnosis pregnant breast feeding females excluded due potential mutagenic effects on developing fetus newborn
0, vorinostat unspecified adult solid tumor protocol specific diagnosis negative pregnancy test
0, dexamethasone smoldering myeloma diagnosis anemia hb twog dl below lower limit normal less teng dl
1, tacrolimus contiguous stage ii adult immunoblastic large cell lymphoma diagnosis poorly controlled hypertension
0, cilengitide childhood high grade cerebellar astrocytoma diagnosis absolute neutrophil count anc greater equal one zero Î¼l
1, birinapant tl fallopian tube neoplasms diagnosis no concomitant use complementary alternative medication other agents investigational therapeutic agents will be allowed without approval principal investigator pi associate investigator ai
1, cyclosporins stage iii adult diffuse mixed cell lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
1, lenvatinib stage iva differentiated thyroid gland carcinoma diagnosis new york heart association congestive heart failure grade ii above unstable angina myocardial infarction within past six months serious cardiac arrhythmia associated significant cardiovascular impairment within past six months ejection fraction ef by multi gated acquisition muga echo should not be less institutional lower limit normal
0, leucovorin stage iii colon cancer diagnosis no evidence residual involved lymph node disease
0, antibodies monoclonal prostatic neoplasms diagnosis progressive hormone refractory disease after orchiectomy gonadotropin releasing hormone analog anti androgen treatment within twelve months screening based on one following
1, bevacizumab fallopian tube clear cell adenocarcinoma diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior first date bevacizumab therapy cycle two
0, bortezomib multiple myeloma diagnosis negative pregnancy test at inclusion if applicable
1, cyclophosphamide stage iii adult diffuse mixed cell lymphoma diagnosis use any other experimental drug within twenty eight days baseline
1, analgesics opioid cancer diagnosis taking opioids management drug addiction
0, trastuzumab metastatic breast cancer diagnosis ast alt less doc uln less doc uln if patient has liver metastases
0, mycophenolate mofetil stage mantle cell lymphoma diagnosis patients primary refractory relapsed disease not eligible an autologous transplant
0, prednisone stage ivb hodgkin lymphoma diagnosis creatinine clearance radioisotope glomerular filtration rate gfr greater equal seventy ml min doc three two serum creatinine based on age gender follows
0, leucovorin colorectal cancer diagnosis patient characteristics
1, bms dose escalation advanced cancer diagnosis currently on anti platelet anti coagulation therapy
1, pembrolizumab stage iiia skin melanoma diagnosis note
0, sirolimus recurrent endometrial carcinoma diagnosis no uncontrolled concurrent illness including but not limited any following
1, albumin bound paclitaxel stage iiia uterine sarcoma diagnosis patient has severe uncontrolled concurrent medical disease uncontrolled diabetes unstable angina myocardial infarction within six months congestive heart failure etc
1, sirolimus succinate dehydrogenase sdh deficient gastrointestinal stromal tumors gist diagnosis active infection requiring within two weeks prior first dose drug
1, intensity modulated radiation therapy recurrent childhood rhabdomyosarcoma diagnosis patients who have prior history radiation therapy thorax adjacent regions cannot be entered on this protocol
1, lenalidomide refractory follicular lymphoma diagnosis pregnant lactating intending become pregnant during study
1, dexamethasone phosphate plasma cell myeloma diagnosis other concurrent chemotherapy any ancillary therapy considered investigational note
1, th tumors diagnosis patients who have exhibited allergic reactions similar structural compound biological agent formulation containing solutol propylene glycol
0, fludarabine phosphate diffuse large cell lymphoma diagnosis platelet count greater equal fifty zero mm three
1, oxaliplatin stage iia rectal cancer diagnosis evidence any other disease neurological metabolic dysfunction physical examination finding laboratory finding giving reasonable suspicion disease condition that contraindicates use bevacizumab puts patient at high risk treatment related complications
1, dexamethasone multiple myeloma diagnosis has received live vaccine within thirty days prior first dose trial treatment
1, gsk a melanoma diagnosis patient is known be positive human immunodeficiency virus hiv has another confirmed suspected immunosuppressive immunodeficient condition
0, prednisolone phosphate multiple myeloma plasma cell neoplasm diagnosis creatinine clearance greater forty five ml min
0, laboratory biomarker analysis recurrent liposarcoma diagnosis according current guidelines patients must be able take oral medication maintain fast required approximately one hour before two hours after mlneight thousand two hundred thirty seven administration
1, albumin bound paclitaxel head neck neoplasms diagnosis snc metastasis
0, acalabrutinib small lymphocytic lymphoma diagnosis willing able participate all required evaluations procedures this protocol including swallowing capsules without difficulty serial biopsies
0, levamisole colorectal cancer diagnosis life expectancy
0, gemcitabine malignant neoplasmas diagnosis patients histologically confirmed solid malignancy which standard curative palliative measures not exist no longer effective patients clinical rationale gemcitabine based therapy
1, bevacizumab non small cell lung cancer diagnosis any serious uncontrolled comorbidity on investigator judgment
0, debio cancer diagnosis age greater eighteen years
0, general health education control cervical carcinoma diagnosis possessing functional telephone home on person
0, prednisolone hemisuccinate hemangioma diagnosis children age zero six months old
0, sirolimus advanced cancer diagnosis patients should be at least four weeks from last day therapeutic radiation cytotoxic chemotherapy from antibody therapy at least five half lives from non cytotoxic targeted biologic therapy
0, mycophenolic acid recurrent grade three follicular lymphoma diagnosis life threatening cytopenia red cell platelet transfusion dependence
1, goserelin evidence inflammatory cancer clinical presentation skin erythema involving more one third breast pathological evidence dermal lymphatic involvement
1, veratrum alkaloids adenocarcinoma diagnosis presence active infection requiring systemic use antibiotics within seventy two hours treatment
1, capecitabine colorectal cancer diagnosis existing uncontrolled coagulopathy
0, mycophenolate mofetil follicular lymphoma diagnosis adults creatinine greater doc mg dl history renal dysfunction must have estimated glomerular filtration rate gfr greater forty ml min
1, afatinib bibw carcinoma non small cell lung diagnosis more two prior cytotoxic chemotherapy treatment regimens relapsed metastatic disease
0, bryostatin stage iv pancreatic cancer diagnosis platelets greater one hundred fifty zero mm three
0, antibodies small intestine cancer diagnosis mycosis fungoides
0, immunoglobulins recurrent squamous cell carcinoma nasopharynx diagnosis more four weeks since prior radiotherapy
1, fludarabine lymphoma diagnosis prior allogeneic hematopoietic stem cell transplant
0, pertuzumab stage iv colon cancer diagnosis congestive heart failure cardiac dysfunction cardiomyopathy requiring medication treatment
0, methyltestosterone cancer survivor diagnosis no prior testosterone
1, cyclophosphamide recurrent marginal zone lymphoma diagnosis patients who have had major surgical procedures significant traumatic injury within twenty eight days prior treatment
1, albumin bound paclitaxel stage iiib non small cell lung cancer diagnosis unstable angina
0, methotrexate stage iii adult diffuse mixed cell lymphoma diagnosis body weight less thirty five kg lower dose formulations not available subjects lower body weight
0, antibodies lung cancer diagnosis must have evidence carcinoembryonic antigen cea production expression documented by one following
1, succinylcholine breast neoplasms diagnosis known presence osteonecrosis jaw
0, immunotoxins ovarian cancer diagnosis at least four weeks since prior therapy recovered
0, albumin bound paclitaxel stage iv non small cell lung cancer diagnosis pleural pericardial effusion
1, cesium head neck squamous cell carcinoma diagnosis patients deemed be high risk by pre admission testing cpm by preoperative risk assessment by hospitalist perioperative complications
0, somatostatin histologically confirmed low grade neuroendocrine tumors
1, fludarabine phosphate anaplastic large cell lymphoma diagnosis patients rapidly progressive intermediate high grade nhl
1, docetaxel non small cell lung carcinoma diagnosis hematologic malignancies
1, mycophenolate mofetil stage childhood anaplastic large cell lymphoma diagnosis patient rapidly progressive aggressive nhl unless minimal disease state
1, albumin bound paclitaxel fallopian tube cancer diagnosis any uncontrolled concurrent illness history any medical condition that may interfere interpretation results
1, cetuximab basaloid squamous cell carcinoma diagnosis prior therapeutic radiation head neck
1, antibodies monoclonal receiving any other investigational agent which would be considered treatment primary neoplasm patients must be greater equal two weeks from prior anti lymphoma therapy use steroids rituximab up one week prior registration management symptoms is allowed
0, bb plasma cell myeloma diagnosis hemodynamically stable systolic blood pressure greater ninety mm hg lying position within past forty two days
1, natural killer nk cells plasma cell myeloma diagnosis recipients previous allogeneic transplants who have rash involving more ten body surface area attributed graft versus host disease gvhd greater grade one gvhd skin
1, cyclosporine hodgkin lymphoma diagnosis karnofsky performance status less seventy at time registration
1, fluorouracil signet ring adenocarcinoma rectum diagnosis known positivity human immunodeficiency virus hiv
0, dexamethasone acetate solid tumor cancer diagnosis oral contraceptives oral injectable implantable double barrier method contraception consisting spermicide either condom diaphragm period after trial account potential drug interaction minimum six weeks
1, capecitabine significant medical disease other gastric cancer including but not limited uncontrolled diabetes mellitus active angina heart failure uncontrolled hypertension an active psychiatric condition that would prevent consistent compliant participation study
1, erlotinib hydrochloride histologically cytologically documented solid tumors diagnosis evidence active bleeding bleeding diathesis
1, fludarabine stage childhood hodgkin lymphoma diagnosis donor
1, doxorubicin sarcoma breast cancer lung carcinomas gynecological cancer amenable anthracycline therapy diagnosis definition effective contraception will be based on guidelines ich mthree revtwo
1, carboplatin non small cell lung carcinoma diagnosis received prior systemic cytotoxic chemotherapy biological therapy major surgery within three weeks first dose drug received thoracic radiation therapy greater three gray gy within six months first dose drug
0, individualized dose escalation stage iii non small cell lung cancer diagnosis irresectable disease assessed by multidisciplinary team patient refusing surgery
0, ifosfamide teratoma diagnosis not specified
1, everolimus regional digestive system neuroendocrine tumor gone diagnosis men women childbearing potential their sexual partners who unwilling employ adequate contraception diaphragm birth control pills injections intrauterine device iud surgical sterilization subcutaneous implants abstinence etc
0, docetaxel uterine neoplasm diagnosis adequate liver function
1, acetylcysteine stage ivb basal cell carcinoma lip diagnosis co morbid systemic illnesses other severe concurrent disease which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety toxicity prescribed regimens
0, lenograstim precursor cell lymphoblastic leukemia lymphoma diagnosis hepatic infiltration biliary obstruction due leukemia
1, vaccines other malignancy within past five years except nonmelanomatous skin cancer superficial bladder cancer carcinoma situ cervix
1, carboplatin endometrial adenosquamous carcinoma diagnosis aortic aneurysm history aortic dissection
1, prednisolone phosphate peripheral cell lymphoma unspecified diagnosis hepatitis virus surface antigen positive
1, prednisone stage iv adult diffuse large cell lymphoma diagnosis inability comply follow up testing procedures
1, vandetanib lip oral cavity squamous cell carcinoma diagnosis hypertension not controlled by medical therapy systolic blood pressure greater one hundred sixty mm mercury hg diastolic blood pressure greater one hundred mm hg
0, cisplatin gastric cancer diagnosis tnm
0, etoposide rhabdomyosarcoma diagnosis development new enlarging lesions setting persistently elevated hcg afp even if hcg afp not continuing increase
1, everolimus gliosarcoma diagnosis pts unwilling unable comply protocol
0, endothelial growth factors myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis ast alt less doc uln
0, irinotecan pancreatic cancer non resectable diagnosis age greater equal eighteen years
1, pharmacological recurrent breast carcinoma diagnosis chemotherapy equal less three weeks
1, veliparib recurrent fallopian tube carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition abt eight hundred eighty eight other agents used this study
0, pharmacological recurrent basal cell carcinoma lip diagnosis no increase biochemical markers carcinoembryonic antigen ca fifteen three symptoms sole evidence disease progression
0, laboratory biomarker analysis stage iv basal cell carcinoma lip diagnosis patients who received an antiandrogen part first line hormonal therapy must show disease progression after discontinuing treatment
1, alemtuzumab solid tumor diagnosis ventilatory failure
0, fludarabine childhood diffuse large cell lymphoma diagnosis mantle cell nhl may be treated first complete response cr diagnostic lumbar puncture lp required pretransplant
0, thalidomide stage ii grade two non contiguous follicular lymphoma diagnosis institutional flow cytometry immunohistochemistry must confirm cluster differentiation two cdtwo antigen expression
0, dacarbazine refractory central nervous system neoplasm diagnosis irinotecan temozolomide mammalian target rapamycin mtor inhibitor exposure
0, liposomal doxorubicin rhabdoid tumor kidney diagnosis female patients childbearing age must have negative pregnancy test
1, cyclophosphamide esophageal cancer diagnosis doc
0, calcium carbonate metastatic colorectal cancer diagnosis kras braf status
0, antibodies monoclonal colorectal cancer diagnosis patients history allergic reactions attributed compounds similar chemical biologic composition medifour thousand seven hundred thirty six olaparib cediranib other humanized monoclonal antibodies history anaphylaxis angioedema laryngeal edema serum sickness uncontrolled asthma not eligible
1, quality life assessment recurrent ovarian epithelial cancer diagnosis residence greater seventy miles from research site
0, icotinib adenosquamous cell lung cancer diagnosis patient who can start investigational therapy within three six weeks after complete resection
0, paclitaxel lung cancer diagnosis not specified hepatic
1, dacarbazine anaplastic oligoastrocytoma diagnosis anuria dehydration severe pulmonary congestion pulmonary edema fixed low cardiac input since all conditions which osmotic diuresis contraindicated ascorbic acid has high osmolarity
1, fluorouracil gastric adenocarcinoma peritoneal carcinomatosis diagnosis excluded therapies medications previous concomitant
0, succinylcholine recurrent non small cell lung carcinoma diagnosis histologically cytologically confirmed diagnosis solid malignancy
0, carboplatin small cell lung carcinoma diagnosis histologically cytologically confirmed extensive disease sclc
1, cediranib metastatic prostate carcinoma diagnosis patients may not have current signs symptoms bowel obstruction within one month prior starting drugs except if it was temporary incident improved within less twenty four hrs medical management
1, sorafenib kidney cancer diagnosis cerebrovascular accident within twelve months
0, ropidoxuridine stage iva colon cancer diagnosis total bilirubin within normal institutional limits
0, vidarabine burkitt lymphoma diagnosis all patients must be cr defined by less five blasts by morphology flow cytometry representative bone marrow sample cellularity greater equal onefive age patients who not have high risk disease high risk crone greater one cycle obtain cr greater equal crtwo must be discussed pi prior enrollment at patient care conference equivalent group such pediatric leukemia board an alternative
1, albumin bound paclitaxel ovarian clear cell adenocarcinoma diagnosis immuno compromised patients patients known be human immunodeficiency virus hiv positive currently receiving antiretroviral therapy note
1, ferrosoferric oxide stage iiic esophageal cancer diagnosis subjects known hepatic insufficiency cirrhosis
1, trametinib endometrial serous adenocarcinoma diagnosis alfentanil fentanyl
1, lenograstim stage ib breast cancer diagnosis myocardial infarction documented clinical diagnosis by ekg any other test
1, paclitaxel noncontiguous stage ii grade one follicular lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition at one one other agents used study
0, opb solid tumors diagnosis life expectancy greater three months following trial entry
0, doxorubicin stage iii uterine corpus cancer diagnosis no prior chemotherapy
1, cortisone recurrent grade three follicular lymphoma diagnosis unable comply requirements protocol unable provide adequate informed consent opinion principal investigator
1, albumin bound paclitaxel metastatic pancreatic cancer diagnosis previous radiotherapy measurable lesions
1, letrozole recurrent ovarian carcinoma diagnosis patient is currently receiving any following medications cannot be discontinued equal less seven days prior starting drug
1, pharmacological endometrial mixed adenocarcinoma diagnosis serious non healing wound ulcer bone fracture within twenty eight days before first dose treatment
1, poly iclc ocular melanoma extraocular extension diagnosis following will not be exclusionary
0, rituximab extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis bi dimensionally measurable disease at least one cm
0, gemcitabine fallopian tube cancer diagnosis have negative pregnancy test if participant is child bearing potential must use birth control while on three months after stopping drug
1, bevacizumab ovarian carcinosarcoma diagnosis prior liver transplant evidence recurrent metastatic disease
0, falimarev colorectal cancer diagnosis prior concurrent therapy
1, everolimus medically significant symptomatic bradycardia
1, mycophenolate mofetil anaplastic large cell lymphoma diagnosis serum glutamate pyruvate transaminase sgpt serum glutamic oxaloacetic transaminase sgot four upper limit normal
0, dexamethasone phosphate stage iii multiple myeloma diagnosis upep on twenty four hour collection is required no substitute method is acceptable urine must be followed monthly if baseline urine spike is greater equal two hundred mg twenty four hr please note that if both serum urine components present both must be followed order evaluate response
0, gene expression analysis multiple myeloma plasma cell neoplasm diagnosis see disease characteristics
1, estradiol presence symptomatic metastatic disease risk spinal cord compression urinary obstruction
1, rituximab stage iii adult diffuse mixed cell lymphoma diagnosis residual grade three grade four non hematologic toxicity after asct
1, stereotactic body radiation therapy stage iva oropharyngeal squamous cell carcinoma diagnosis patients prior history head neck radiotherapy greater forty gy significant areas anticipated overlap
0, cyclophosphamide breast cancer diagnosis not specified other
0, chemoradiation adenosquamous carcinoma diagnosis age greater equal eighteen years old
0, carboplatin stage iiic ovarian cancer diagnosis absolute neutrophil count anc greater equal one five hundred mcl equivalent common terminology criteria adverse events doc ctcae grade one this anc cannot have been induced supported by granulocyte colony stimulating factors
1, metformin stage ivc oral cavity squamous cell carcinoma diagnosis participants is taking another investigational agent
1, antibodies monoclonal pancreatic polypeptide tumor diagnosis current therapy cytochrome pfour hundred fifty threeafour cypthreeafour inhibitor inducer note
1, ibrutinib recurrent small lymphocytic lymphoma diagnosis opportunistic infection within sixty days prior enrollment
1, doxorubicin prior therapy lymphoma
0, vincristine stage iv aids related lymphoma diagnosis participants must have fifteen blank unstained slides diagnostic tissue block must be available central pathology review by amc core pathology laboratory
0, antibodies neuroblastoma diagnosis cerebrospinal fluid leptomeningeal disease that is refractory conventional therapy which no conventional therapy exists
1, paclitaxel metastatic breast cancer diagnosis patient was enrolled different clinical which investigational procedures were performed investigational therapies were administered
1, bevacizumab anal colon rectal cancers diagnosis congenital long qt syndrome onest degree relative unexplained sudden death under forty years age
1, dacarbazine glioblastoma diagnosis known human immunodeficiency virus hiv infection chronic hepatitis c
0, dexamethasone recurrent grade one follicular lymphoma diagnosis note
1, temozolomide recurrent childhood medulloblastoma diagnosis one mg dl maximum serum creatinine
1, antibodies stage ic ovarian cancer diagnosis patients known hypersensitivity chinese hamster cell products other recombinant human humanized antibodies
0, antibodies cognitive side effects cancer therapy diagnosis systolic blood pressure equal less one hundred sixty mg hg diastolic pressure equal less ninety mm hg within fourteen days prior step two registration
0, albumin bound paclitaxel undifferentiated ovarian carcinoma diagnosis serum glutamic oxaloacetic transaminase sgot equal less doc times uln ctcae doc grade one
1, sirolimus recurrent bladder carcinoma diagnosis co morbid systemic illnesses other severe concurrent disease which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety toxicity prescribed regimens
0, methylprednisolone acetate ovarian cancer diagnosis has undergone allogeneic hsct myeloablative conditioning
1, choline prostate cancer diagnosis patients who less six weeks post operative greenfield filter placement
0, albumin bound paclitaxel recurrent endometrial carcinoma diagnosis karnofsky seventy one hundred
1, sunitinib stage iiia intraocular melanoma diagnosis current evidence hematemesis melena gross hematuria
1, everolimus ovarian serous surface papillary adenocarcinoma diagnosis known brain metastasis
0, immunoglobulin g stage iv fallopian tube cancer diagnosis all patients enrolled into gog two hundred sixty two at sites where acrin six thousand six hundred ninety five is open will be enrolled advanced imaging protocol patients receiving adjuvant neoadjuvant chemotherapy eligible acrin six thousand six hundred ninety five following sentence does not apply those patients entered after two eight two thousand twelve
0, cisplatin unspecified adult solid tumor protocol specific diagnosis chemotherapy
1, cyclosporine recurrent grade three follicular lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
0, patientslikeme plm breast cancer stage diagnosis having computer is not required
0, nivolumab advanced cancer diagnosis have recovered from acute toxicities prior treatment
0, abemaciclib rhabdomyosarcoma recurrent refractory diagnosis abstinence non sexually active child will be sufficient birth control
1, estrogens conjugated usp metastatic hormone sensitive prostate cancer diagnosis subject received bisphosphonates denosumab within two weeks prior day one unless administered at stable dose treat diagnosed osteoporosis
1, niacinamide giant cell glioblastoma diagnosis subjects must not be receiving any other investigational agents
1, albumin bound paclitaxel ovarian cancer diagnosis major surgery within fourteen days before first dose drug
0, fludarabine diffuse large cell lymphoma diagnosis intermediate one int one per international prognostic scoring system ipss after greater equal one prior cycle induction chemotherapy must have less five marrow blasts at time transplant
1, antibodies signet ring adenocarcinoma rectum diagnosis history allergic reactions attributed compounds similar chemical biologic composition cetuximab dasatinib
0, mycophenolate mofetil refractory plasma cell myeloma diagnosis refractory relapsed disease after standard chemotherapy
1, tacrolimus lymphoma large cell diffuse diagnosis active central nervous system cns involvement by malignant cells
0, dacarbazine recurrent ewing sarcoma peripheral primitive neuroectodermal tumor diagnosis patients who have previously been exposed parp inhibitor not eligible
1, antibodies recurrent squamous cell carcinoma hypopharynx diagnosis thrombotic embolic events such cerebrovascular accident including transient ischemic attacks within past six months
0, fludarabine myeloma diagnosis all patients cml chronic failed interferon gleevec accelerated phase
1, cetuximab brain neoplasm diagnosis pregnant breastfeeding
0, mycophenolate mofetil noncontiguous stage ii grade one follicular lymphoma diagnosis donor
0, aldesleukin breast cancer diagnosis ppd
0, paclitaxel stage iiib non small cell lung cancer diagnosis no grade two greater peripheral neuropathy unless secondary mechanical etiology
1, mannitol recurrent childhood pineoblastoma diagnosis subjects uncontrolled over last thirty days clinically significant confounding medical conditions
1, medroxyprogesterone acetate advanced persistent recurrent endometrial cancer diagnosis patients who plan receive live attenuated vaccines within one week start everolimus during study
1, gemcitabine non small cell lung cancer diagnosis has current clinically relevant coronary artery disease uncontrolled congestive heart failure
1, busulfan contiguous stage ii adult immunoblastic large cell lymphoma diagnosis patient donor history hepatitis or positive serology consistent previous hepatitis infection patients donor who received hepatitis vaccination acceptable
0, aldesleukin lymphoma diagnosis no active hepatitis infection
1, sirolimus astrocytoma diagnosis if otwo saturation is less eighty eight at rest further pulmonary function tests pfts should be ordered confirm normal pulmonary function eligibility
0, bb multiple myeloma diagnosis serum proteingreater doc fiveg dl urine proteingreater two hundredmg twenty fourh
0, thalidomide disease free prior malignancies greater equal five years exception currently treated basal cell squamous cell carcinoma skin carcinoma insitu cervix breast
0, akt inhibitor mk advanced adult hepatocellular carcinoma diagnosis local ablative therapy such radiofrequency ablation cryotherapy must have been completed more two weeks prior entry
0, paclitaxel bladder cancer diagnosis who zero one
1, paclitaxel ovarian cancer diagnosis proteinuria greater two positive on urinalysis
0, ketogenic diet carcinoma non small cell lung diagnosis hypertensive medication should be initiated increased optimal blood pressure control according standard public health guidelines prior starting ketogenic diet
1, narrow band imaging colorectal neoplasms hereditary nonpolyposis diagnosis pregnant patients
0, cytogenetic analysis precancerous condition diagnosis prior concurrent bisphosphonates allowed
0, dexamethasone acetate refractory plasma cell neoplasm diagnosis surgery
1, antibodies monoclonal recurrent renal cell carcinoma diagnosis serious non healing wound ulcer bone fracture history abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior day one
0, calcitriol solid tumor diagnosis subjects that have previously lost their hair may enroll if they currently have grade zero one alopecia
1, laboratory biomarker analysis uncontrolled illness including but not limited ongoing active infection symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmia psychiatric illness social situations that would limit compliance requirements within six months enrollment
0, bleomycin testicular germ cell tumor diagnosis glomerular filtration rate greater fifty ml min
1, vatalanib breast neoplasms diagnosis chronic renal disease
0, dexamethasone neuroblastoma diagnosis not pregnant nursing
1, etoposide childhood diffuse large cell lymphoma diagnosis total cd thirty four positive greater equal two ten six kg if unable collect this dose total nucleated cell bone marrow dose greater equal x ten eight kg
0, oxaliplatin pancreatic cancer diagnosis inr two three
0, romidepsin adenocarcinoma stomach diagnosis at least one unidimensionally measurable lesion greater twenty mm by conventional techniques greater one mm by spiral ct scan
1, oxaliplatin stage iiic colon cancer diagnosis subject must have an range inr usually between two three on stable dose warfarin
1, rituximab non hodgkin lymphoma diagnosis receipt extensive radiation therapy systemic chemotherapy other antineoplastic therapy within four weeks before enrollment
1, ixazomib recurrent extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis known central nervous system involvement
0, pharmacological recurrent childhood brain tumor diagnosis radiographically documented measurable disease
0, romidepsin insulinoma diagnosis more four weeks since prior chemotherapy
0, etoposide phosphate stage fours neuroblastoma diagnosis age one month less six months
0, fludarabine phosphate breast cancer diagnosis serum bilirubin less doc times upper limit normal uln
1, antibodies monoclonal colorectal neoplasm diagnosis patient is less five years free another primary malignancy except
0, irinotecan adenocarcinoma colon diagnosis no evidence residual involved lymph node disease
1, cetuximab recurrent rectal cancer diagnosis any continuous dosing daily dosing every other day dosing monday wednesday friday dosing weekly etc
0, mitogens melanoma diagnosis laboratory
1, palbociclib carcinoma squamous cell head neck diagnosis prior treatment cetuximab
1, oxaliplatin stage iva colon cancer diagnosis known hypersensitivity bgjthree hundred ninety eight fluorouracil oxaliplatin irinotecan any excipients
0, carboplatin intraocular lymphoma diagnosis patients must have ct chest abdomen pelvis within twenty eight days enrollment patients evidence adenopathy neck must have ct neck
1, bb squamous cell carcinoma skin
0, bicalutamide non castrate metastatic prostate cancer diagnosis serum bilirubin within normal range less doc uln if liver metastases present total bilirubin less doc uln direct bilirubin within normal range patients well documented gilbert syndrome
0, bortezomib ovarian brenner tumor diagnosis alkaline phosphatase less equal doc uln per nci ctcae version four grade one
0, paclitaxel melanoma diagnosis patients must meet all following criteria be enrolled study
1, antibodies monoclonal sarcoma diagnosis participation any other clinical trial involving another investigational agent within four weeks prior day one study
0, alvocidib recurrent grade three follicular lymphoma diagnosis ineligible potentially curative autologous stem cell transplantation
0, vaccines liver cancer diagnosis no high serum titer neutralizing anti adenoviral antibodies
0, etoposide extragonadal germ cell tumor diagnosis neutrophil count at least one five hundred mmthree
1, pci sll small lymphocytic lymphoma diagnosis hiv infection
1, bevacizumab tubular breast cancer stage iii diagnosis chronic corticosteroids unless initiated greater six months prior entry at low dose less ten mg methylprednisolone equivalent
1, mycophenolate mofetil recurrent adult diffuse small cleaved cell lymphoma diagnosis presence active serious infection mucormycosis uncontrolled aspergillosis tuberculosis
1, propranolol clinical radiological evidence laboratory pathology report not completely resectedmelanoma
1, niacinamide recurrent adult brain neoplasm diagnosis seizure disorder necessitating use enzyme inducing antiepileptic drugs eiaeds efforts may be made by treating physician change antiepileptic drug from another agent valproic acid non eiaed prior excluding patient from study
1, methylphenidate gastrointestinal cancer diagnosis john wort including dhea same ginkgo ginseng st
1, antibodies monoclonal recurrent esophageal cancer diagnosis major surgery significant traumatic injury occurring within twenty one days prior treatment
0, methylprednisolone lymphoma diagnosis combined immune deficiencies including but not limited to
0, prednisolone phosphate ast alt less doc times uln unless due lymphoma
1, cisplatin stage ivb oropharyngeal squamous cell carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition vx nine hundred seventy cisplatin
0, camptothecin esophageal cancer diagnosis prior concurrent therapy
0, liposomal doxorubicin hertwo negative breast cancer diagnosis women child bearing potential must have negative pregnancy test within seven days initiating no childbearing potential is defined age fifty five years older no menses two years any age surgical removal uterus both ovaries
0, questionnaire administration stage iiia rectal cancer diagnosis patients must be deemed eligible systemic chemotherapy folfoxsix positive
0, erlotinib hydrochloride breast cancer diagnosis no unstable angina pectoris
0, trebananib ovarian cancer diagnosis common terminology criteria adverse events ctcae version doc peripheral neuropathy greater grade two
1, antibodies ovarian seromucinous carcinoma diagnosis no poorly differentiated subtypes including papillary serous clear cell other international federation gynecology obstetrics figo grade three lesions
0, trastuzumab stage ib breast cancer diagnosis patients alkaline phosphatase that is greater uln but equal less doc uln unexplained bone pain eligible inclusion if bone scan pet ct scan pet scan performed within ninety days prior randomization does not demonstrate metastatic disease
0, dacarbazine lymphoma diagnosis no other concurrent chemotherapy
0, tacrolimus contiguous stage ii small lymphocytic lymphoma diagnosis stable not hematologic remission
1, part jnj adenocarcinoma diagnosis presence any medical condition that requires intact wound healing capacity is expected endanger participant safety if wound healing capacity would be severely reduced during administration investigational agent
1, sirolimus squamous cell skin carcinoma diagnosis inability give informed consent
0, immunoglobulins other adenocarcinoma variant
0, docetaxel unspecified carcinoma
1, fludarabine phosphate recurrent grade two follicular lymphoma diagnosis addition cytotoxic agents cytoreduction exception hydroxyurea imatinib mesylate will not be allowed within two weeks initiation conditioning
0, afuresertib gc fasted state cancer diagnosis male subjects female partners child bearing potential must agree use one acceptable contraception methods
0, antineoplaston a ovarian cancer diagnosis no other concurrent antineoplastic agents
0, interleukin transitional cell carcinoma bladder diagnosis subjects both females males reproductive potential must agree use effective contraceptive measures duration study
0, etoposide phosphate desmoplastic small round cell tumor diagnosis metastatic disease must be biopsy proven pelvic primary greater fourteen years age at time diagnosis
1, tacrolimus lymphoma diagnosis failure demonstrate adequate compliance medical therapy follow up
0, calcium heparin a procedure code cancer related surgery during index hospitalization
0, thalidomide ds stage ii plasma cell myeloma diagnosis patients must not have uncontrolled active infection requiring intravenous antibiotics new york heart association nyha class iii class iv heart failure myocardial infarction within last six months history treatment clinically significant ventricular cardiac arrhythmias poorly controlled hypertension poorly controlled diabetes mellitus patients must have undergone an electrocardiogram ekg within twenty eight days prior registration
0, everolimus history malignancy within last five years except localized treated skin cancer treated without evident relapse
1, vaccines stage iiib breast cancer diagnosis known hypersensitivity reaction gm csf
1, lenvatinib advanced solid tumors diagnosis history congestive heart failure greater new york heart association nyha class ii unstable angina myocardial infarction stroke within six months first dose drug cardiac arrhythmia requiring medical treatment
1, sorafenib metastatic renal cell cancer diagnosis operation last three months
1, tamoxifen breast cancer diagnosis life expectancy less two years acutely ill delirious
1, mycophenolic acid recurrent adult grade iii lymphomatoid granulomatosis diagnosis donor
0, cetuximab stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis risperidone
1, lenograstim myeloma diagnosis known human immunodeficiency virus infection
1, prednisone multiple myeloma diagnosis subjects who didn achieve partial response better after getting at least six cycles melphalan prednisone velcade at end melphalan prednisone velcade whatever overall response not eligible
1, sirolimus risk factors torsades de pointes such hypokalemia hypomagnesemia cardiac failure clinically significant symptomatic bradycardia high grade atrioventricular av block
0, akt inhibitor mk childhood immunoblastic large cell lymphoma diagnosis nervous system disorders common terminology criteria adverse events ctcae vfour resulting from prior therapy must be equal less grade two
0, isophosphamide mustard advanced solid tumors diagnosis measurable non measurable disease by recist version doc
1, bortezomib multiple myeloma diagnosis pregnant lactating women women childbearing potential not employing adequate contraception
1, etoposide stage adult diffuse small cleaved cell lymphoma diagnosis positive serology because prior vaccination is allowed
1, oxaliplatin colorectal cancer diagnosis fresh bleeding from gastrointestinal tract
0, antibodies recurrent melanoma diagnosis bilirubin equal less doc times upper limit normal uln
1, rituximab brain neoplasm diagnosis ocular involvement will not exclude
1, antibodies stage iiic uterine sarcoma diagnosis patients anticipation invasive procedures defined below
0, immunoglobulins recurrent colon cancer diagnosis patients fractures secondary metastatic disease eligible after appropriate radiotherapy
0, vorinostat recurrent marginal zone lymphoma diagnosis serum creatinine equal less doc mg dl
0, paclitaxel recurrent endometrial cancer diagnosis adequate bone marrow function shown by
0, liposomal doxorubicin newly diagnosed cell non hodgkin lymphoma revised european american lymphoma real categories ii nine ten eleven
1, antibodies monoclonal stage iib breast cancer diagnosis pregnancy lactation at time entry note
0, interleukin stage cutaneous cell non hodgkin lymphoma diagnosis at least three weeks since prior topical chemotherapy
0, isophosphamide mustard fibrohistiocytic neoplasm diagnosis ineligible sites
0, immunoglobulins childhood cerebral anaplastic astrocytoma diagnosis doc mg dl six less ten years age
0, irinotecan stage ivb rectal cancer diagnosis not pregnant nursing
1, pembrolizumab glioma diagnosis evidence active non infectious pneumonitis history interstitial lung disease
0, mycophenolic acid stage grade two follicular lymphoma diagnosis patients equal less fifty years age who have received previous high dose transplantation not require patient review committee approvals all children less two years must be discussed fhcrc principal investigator pi brenda sandmaier md two six million six hundred seventy four thousand nine hundred sixty one prior registration
0, bryostatin unspecified adult solid tumor protocol specific diagnosis creatinine no greater doc mg dl creatinine clearance at least sixty ml min cardiovascular
1, ispinesib stage ivb colon cancer diagnosis prohibited medications sb seven hundred fifteen thousand nine hundred ninety two is moderate significant vitro inhibitor cypthreeafour following lists medications substances moderate significant inhibitors inducers cypthreeafour that if administered concomitantly sb seven hundred fifteen thousand nine hundred ninety two may alter drug exposure use these medications substances within four days greater six months amiodarone prior administration first dose sb seven hundred fifteen thousand nine hundred ninety two through discontinuation from is prohibited
1, fludarabine stage childhood lymphoblastic lymphoma diagnosis acute leukemia relapse greater equal five marrow blasts by morphology
0, panobinostat adult mixed cellularity hodgkin lymphoma diagnosis baseline multi gated acquisition muga echocardiogram echo must demonstrate left ventricular ejection fraction lvef greater equal forty five
0, antibodies monoclonal melanoma diagnosis five prior systemic regimens
0, akt inhibitor mk secondary central nervous system non hodgkin lymphoma diagnosis ecog performance status less two karnofsky greater sixty
0, etoposide pulmonary neoplasms diagnosis age greater eighteen years
1, carboplatin prior chemotherapy biological therapy radiation therapy other investigational anticancer therapy not including palliative radiotherapy at focal sites within twenty one days prior first dose trial treatment phase oneb only
1, capecitabine metastatic breast cancer diagnosis concurrent treatment other experimental drugs participation another clinical trial any investigational drug within thirty days prior entry
0, alemtuzumab childhood burkitt lymphoma diagnosis mantle cell nhl
0, aminolevulinic acid benign neoplasms brain diagnosis total bilirubin below upper limit normal
0, mitomycins metastatic cancer diagnosis no severe allergy intolerance contrast media narcotics sedatives atropine
1, trastuzumab gastroesophageal junction cancer diagnosis cirrhosis at level child pugh worse or
0, dexamethasone acetate this protocol defines female childbearing potential sexually mature woman who
1, buserelin non castrate metastatic prostate cancer diagnosis documented cardiomyopathy
0, physician behavior related patient preference survey lung cancer diagnosis any attending radiation oncologist whose patient is enrolled this study
0, fluorouracil breast cancer diagnosis cerebrovascular accident within past six months
0, lenograstim ovarian cancer diagnosis life expectancy greater six months
1, mycophenolate mofetil splenic marginal zone lymphoma diagnosis patient unable give informed consent
1, vincristine stage iv grade three follicular lymphoma diagnosis unable comply requirements protocol unable provide adequate informed consent opinion principal investigator
1, chinese acupuncture ovarian neoplasms diagnosis enrollment other research studies
1, entecavir hepatocellular carcinoma diagnosis any other hemorrhage bleeding event greater ctcae grade three within four weeks entry
0, androgens prostatic neoplasms diagnosis three patients prostate place psa must be elevated biopsy proven disease not candidates local therapy
1, cyclophosphamide childhood nasal type extranodal nk cell lymphoma diagnosis women childbearing potential who pregnant beta hcg positive breast feeding
1, gemcitabine advanced cancer diagnosis subjects should not take proton pump inhibitors htwo antagonists
1, dacarbazine small cell lung cancer diagnosis azole antifungals
0, fluorouracil carcinoma unknown primary diagnosis eligible peg gastrostomy other
0, ifosfamide metastatic ewing sarcoma peripheral primitive neuroectodermal tumor diagnosis if random glucose is elevated fasting glucose must be within normal range
1, endothelial growth factors stage iiic primary peritoneal cancer diagnosis patients on anticoagulant therapy
1, albumin bound paclitaxel tumor diagnosis prolongation corrected qt interval qtc greater four hundred eighty msecs
0, fluorouracil esophageal cancer diagnosis patients lymph node metastases levels fifteen twenty predominantly celiac axis paracardial nodes less doc cm by ct
1, dasatinib brain central nervous system tumors diagnosis enzyme inducing anti convulsants eiacs note
0, radiation therapy vulvar cancer diagnosis see general eligibility criteria
1, trastuzumab cancer breast diagnosis know be hiv positive
1, tocotrienols ovarian cancer diagnosis pregnant breast feeding patients
0, dasatinib history significant bleeding disorder unrelated cancer including
1, sirolimus stage ii small lymphocytic lymphoma diagnosis active bacterial fungal infections unresponsive medical therapy
1, doxorubicin ovarian cancer diagnosis serum total bilirubin greater doc mg dl twenty mmol l
1, laboratory biomarker analysis childhood solid neoplasm diagnosis patients who receiving cyclosporine tacrolimus other agents prevent graft versus host disease post bone marrow transplant not eligible this trial
1, fluorouracil digestive system neoplasms diagnosis current recent within one year thromboembolism cerebrovascular disease
1, fludarabine melanoma diagnosis has an active autoimmune disease requiring systemic treatment within past three months documented history clinically severe autoimmune disease
1, antibodies liver cancer diagnosis continuation seventeen if varices identified that require intervention banding that patient will not be eligible trial until varices have been adequately treated
1, levoleucovorin cognitive side effects cancer therapy diagnosis lactating females not eligible unless they have agreed not breastfeed their infant
0, oxaliplatin peritoneal neoplasms diagnosis normal bone marrow function hb greater doc mmol absolute neutrophil count greater doc one hundred nine platelet count greater one hundred one hundred nine renal function serum creatinine less doc uln creatinine clearance cockroft formula greater thirty ml min determined less three months prior randomisation
1, androgens prostate cancer diagnosis clinically significant cardiac failure requiring treatment nyha ii iv
1, pharmacological metastatic endometrioid adenocarcinoma diagnosis thromboembolic event requiring therapeutic anticoagulation note
1, oxycodone cancer diagnosis any situation where opioids contraindicated
1, zoledronic acid lung cancer diagnosis history allergic reactions bisphosphonates
1, laboratory biomarker analysis recurrent ewing sarcoma diagnosis patients requiring corticosteroids who have not been on stable decreasing dose corticosteroid seven days prior enrollment not eligible if used modify immune adverse events related prior therapy greater equal fourteen days must have elapsed since last dose corticosteroid
1, everolimus stage iiia primary peritoneal cancer diagnosis note
0, prednisone hepatocellular carcinoma fibrolamellar variant diagnosis pretransplant alpha fetoprotein afp level less four hundred
1, nicotine stage ia non small cell lung cancer diagnosis patient is pregnant breastfeeding patient has unstable cardiac disease within past month defined unstable angina myocardial infarction serious arrhythmias any cardiac intervention procedure patient is currently taking chantix patient does not have regular access phone receive calls from quitline
0, temozolomide brain central nervous system tumors diagnosis chronic obstructive pulmonary disease exacerbation other respiratory illness requiring hospitalization precluding therapy at time registration
0, alvocidib stage iv pancreatic cancer diagnosis no prior docetaxel flavopiridol
0, gen fallopian tube cancer diagnosis neurologic function
1, tamoxifen progesterone receptor negative breast cancer diagnosis patients clinically significant pulmonary disease diffusion capacity corrected less sixty predicted patients pulmonary problems should be evaluated appropriate pulmonary studies consult
1, immunoglobulins stage iv squamous cell carcinoma lip oral cavity diagnosis abnormalities cornea based on history dry eye syndrome sjogren syndrome congenital abnormality fuch dystrophy abnormal slit lamp examination using vital dye fluorescein bengal rose an abnormal corneal sensitivity test schirmer test similar tear production test
0, fludarabine follicular lymphoma diagnosis if patient is younger eighteen years age they have reached age assent then they must have completed local institutional review board irb assent process
0, prednisone lymphoma diagnosis see disease characteristics
1, bevacizumab glioblastoma multiforme diagnosis topical inhaled steroids allowed
1, sentinel lymph node dissection patient has had any type solid tumor hematologic malignancy during past five years
1, carboplatin tumor infiltration into tracheobronchial system
0, quality life assessment invasive ductal breast carcinoma diagnosis women childbearing potential must be non pregnant non lactating willing use medically acceptable form contraception during radiation therapy
0, pembrolizumab recurrent splenic marginal zone lymphoma diagnosis absolute neutrophil count greater equal doc ten nine l
0, carboplatin non small cell lung cancer diagnosis performance status zero one on ecog performance status scale
0, antibodies monoclonal peritoneal neoplasms diagnosis life expectancy greater twelve weeks
1, vaccines anaplastic oligodendroglioma diagnosis hla two hla three negative
1, fludarabine phosphate stage ii grade two contiguous follicular lymphoma diagnosis donor centers who will exclusively donate marrow
0, vaccines mixed adenocarcinoma stomach diagnosis ast alt less three times uln
0, temozolomide adult giant cell glioblastoma diagnosis no other concurrent investigational agents
1, cyclophosphamide carcinoma non small cell lung diagnosis patient has diarrhoea grade greater two
1, niacinamide prostate cancer diagnosis any condition that impairs patient ability swallow whole pills
0, paclitaxel stage iiib primary peritoneal cavity cancer diagnosis patients who platinum sensitive platinum resistant
1, romidepsin recurrent grade three follicular lymphoma diagnosis telaprevir incivek
0, razoxane refractory childhood hodgkin lymphoma diagnosis stratum i
0, albumin bound paclitaxel peritoneal cavity cancer diagnosis chemotherapy
0, pf glioblastoma diagnosis stable dose corticosteroids greater equal five days prior baseline magnetic resonance imaging mri
1, immunoglobulin g recurrent primary peritoneal carcinoma diagnosis myocardial infarction unstable angina within six months prior enrollment
0, immunoglobulin g childhood oligodendroglioma diagnosis karnofsky performance status ps fifty one hundred greater sixteen years age lansky ps fifty one hundred less sixteen years age
1, antibodies renal cell carcinoma diagnosis patients history myocardial infarction transient ischemic attack tia stroke pulmonary embolism history deep vein thrombosis within preceding twelve months
0, paclitaxel must have undergone staging exploratory laparotomy tumor debulking within past seventy days
0, oxaliplatin recurrent gastric carcinoma diagnosis serum creatinine equal less institutional upper limit normal uln
1, everolimus stage ivb laryngeal squamous cell carcinoma diagnosis patients diseases which reasonable certainty not limit life expectancy twelve months less eligible assessment such concurrent illnesses should be by principal investigator
0, gemcitabine endometrial adenosquamous carcinoma diagnosis measurable disease defined greater one lesion that can be accurately measured greater one dimension greater twenty mm by conventional techniques including palpation plain ray ct scan mri greater one mm by spiral ct scan
1, cetuximab stage iva laryngeal verrucous carcinoma diagnosis patients known active brain metastases should be excluded from this clinical trial patients treated brain metastases stable greater equal twelve weeks eligible
1, clarithromycin refractory plasma cell myeloma diagnosis patients history prior transplant treatment combination therapy lenalidomide biaxin steroid without response
1, lenalidomide lymphoma mucosa associated lymphoid tissue malt diagnosis major surgery other diagnostic surgery within last four weeks
1, lenvatinib metastatic renal cell carcinoma diagnosis subjects who have completed local therapy have discontinued use steroids this indication at least four weeks prior commencing treatment whom stability has been proven by at least two ct mri scans obtained at least four weeks apart eligible phase oneb only
1, bleomycin lymphoma non hodgkin diagnosis prior medication
0, belinostat recurrent grade one follicular lymphoma diagnosis at least two weeks since prior valproic acid any other histone deacetylase inhibitor
1, laboratory biomarker analysis recurrent adrenal gland pheochromocytoma diagnosis history familial qtc prolongation syndrome
1, cyclosporins refractory plasma cell myeloma diagnosis life expectancy severely limited by disease other malignancy
0, falimarev colorectal cancer diagnosis no allergy untoward reaction sargramostim gm csf
1, laboratory biomarker analysis stage iiib ovarian cancer diagnosis any underlying medical psychiatric condition which opinion investigator will make administration incbtwenty four thousand three hundred sixty hazardous obscure interpretation adverse events
1, temozolomide glioblastoma diagnosis known allergy medication
1, enalapril untreated phaeochromocytoma
1, talimogene laherparepvec unresected stage iiib ivmonec melanoma diagnosis bone metastases
1, entolimod unspecified adult solid tumor protocol specific diagnosis topical applications rash inhaled sprays obstructive airways diseases eye drops local injections intra articular allowed
1, thalidomide recurrent childhood pilocytic astrocytoma diagnosis male condom
0, sirolimus somatostatin producing neuroendocrine tumor diagnosis patients may have received prior systemic anti neoplastic therapy except prior mammalian target rapamycin mtor inhibitors agents targeting insulin like growth factor one receptor igfoner there no limitations on number prior regimens at least twenty eight days must have elapsed since last treatment
1, metronidazole uncontrolled intercurrent illness including but not limited ongoing active infection symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmia psychiatric illness social situations that would limit compliance requirements because recently recognized risk cardiac inflammation after vaccinia patients clinically significant cardiomyopathy excluded patients must have recovered from any intercurrent illness any acute toxicity related prior therapy surgery radiation
0, gemcitabine unresectable pancreatic carcinoma diagnosis participation imaging research studies patients must meet additional following criteria
0, pemetrexed lung cancer diagnosis chemotherapy
0, carboplatin breast cancer diagnosis creatinine clearance at least sixty ml min
0, cyclophosphamide early stage breast cancer diagnosis measurable disease
0, iron lymphoma diagnosis see disease characteristics
0, doxorubicin recurrent refractory childhood hodgkin lymphoma diagnosis patient current disease state must be one which there is no known curative therapy therapy proven prolong survival an acceptable quality life
0, cyclophosphamide lymphoma patients permitted
0, strengthening osteosarcoma diagnosis patient is newly diagnosed le malignancy shown by biopsy
0, decitabine zero equal low one equal intermediate two equal high symptomatic splenomegaly greater equal onezerocm below left mid costal margin
0, bb aggressive marginal zone lymphoma mzl diagnosis ecog zero two
1, sirolimus sporadic angiomyolipomas amls diagnosis history human immunodeficiency virus hiv infection hepatitis screening all three is mandatory prior prior hepatitis infection
0, ado trastuzumab emtansine wilms tumor diagnosis note
0, cisplatin esophageal squamous cell cancer diagnosis wbc greater four zero mmthree absolute neutrophil count greater zero mmthree platelet greater one hundred zero mmthree hb greater teng dl within four days before enrollment alt ast less doc times uln less five times uln patients liver metastases bilirubin level less doc times uln serum akp less doc times uln serum creatinine less doc times uln
0, everolimus hertwo neu over expressing locally advanced breast cancer diagnosis patients measurable disease per recist criteria
1, antibodies stage iii grade one follicular lymphoma diagnosis clinically active hepatitis b infections note
0, liver extracts neoplasm metastasis diagnosis at least thirty days must have elapsed since completion any prior antineoplastic therapy patient must have recovered from acute side effects before day zero
1, podophyllotoxin refractory plasma cell myeloma diagnosis corrected diffusion capacity lungs carbon monoxide dlco less fifty predicted forced expiratory volume one second fevone less fifty predicted receiving supplementary continuous oxygen fhcrc principal investigator pi must approve enrollment all patients pulmonary nodules
1, letrozole recurrent ovarian germ cell tumor diagnosis history non compliance medical regimens who considered potentially unreliable will not be able complete entire study
0, vaccines lung cancer diagnosis negative pregnancy test
0, cabozantinib s malate stage ivc thyroid gland follicular carcinoma diagnosis serum phosphorus calcium magnesium potassium greater equal lln
1, paclitaxel ovarian cancer diagnosis patient has appropriate post vasectomy documentation absence sperm ejaculate
1, phosphoramide mustards kidney cancer diagnosis any following because this involves an investigational agent whose genotoxic mutagenic teratogenic effects on developing fetus newborn unknown
0, mesna lung cancer diagnosis see disease characteristics
1, interleukin stage iv gastric cancer diagnosis known seropositive hiv antibody
1, capecitabine metastatic oesophageal cancers diagnosis pregnant women lactation refusal use adequate contraceptive measures hormonal barrier method birth control abstinence
0, cediranib adult gliosarcoma diagnosis use transfusion other intervention achieve hemoglobin hgb greater equal one doc dl is acceptable
0, nivolumab stage iii skin cancer diagnosis serum total bilirubin equal less doc institutional upper limit normal uln patients gilbert syndrome total bilirubin less doc mg dl
0, alvocidib histologically confirmed relapsed refractory solid tumor lymphoma including
0, etoposide breast cancer diagnosis brain
0, tacrolimus recurrent grade one follicular lymphoma diagnosis subjects must be ineligible unable receive conventional myeloablative transplantation
0, sunitinib recurrent small lymphocytic lymphoma diagnosis exclusively kappa lambda light chains
1, hs solid tumor adult diagnosis obvious neurological mental disorder
0, alemtuzumab recurrent adult diffuse large cell lymphoma diagnosis must have less five marrow blasts at time transplant
1, etoposide phosphate medulloblastoma diagnosis concomitant enrollment on clinical such cog that does not allow co enrollment on this standard care protocol arm only
1, mannitol neoplasm supratentorial diagnosis known renal failure
0, camptothecin primary peritoneal carcinoma diagnosis performance status
1, aeg advanced cancer diagnosis major thoracic abdominal surgery preceding four weeks
1, lapatinib patients history other active malignancy past five years exception adequately treated cervical carcinoma situ non melanomatous skin cancers excluded
0, bortezomib stage iv follicular thyroid cancer diagnosis negative pregnancy test
1, immunoglobulin g patients history evidence upon physical examination central nervous system cns disease including primary brain tumor seizures history seizures any cns metastases ineligible
0, antibodies monoclonal disseminated neuroblastoma diagnosis at least fifty donor chimerism cell lineage full greater ninety donor chimerism unseparated blood on last assessment within three months before entry
1, bortezomib prior therapy pomalidomide containing regimen
1, bb plasmacytoma diagnosis previously treated patients group two
1, antibodies monoclonal a ongoing planned administration anti cancer therapies other those specified this study
0, fludarabine refractory plasma cell myeloma diagnosis bone marrow cellularity greater equal fifty age defined normal values by core biopsy cellularity must be evaluated within ninety days dosimetry infusion at least twenty one days after receiving any cytoreductive myelosuppressive chemotherapy
0, nivolumab nonsmall cell lung cancer diagnosis non pregnant non nursing
0, estrogens stage iib breast cancer diagnosis since pre entry lvef serves baseline comparing subsequent lvef assessments it is critical that this baseline be an accurate assessment if baseline lvef is greater sixty five investigator is encouraged have accuracy initial lvef result confirmed repeat test if accuracy is uncertain
1, liposomal doxorubicin mixed oligoastrocytoma diagnosis known history hiv autoimmune diseases requiring immunosuppressant drugs
1, newsletters cancer diagnosis another person same household is enrolled study
1, lenalidomide refractory small lymphocytic lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition ibrutinib
1, laboratory biomarker analysis unspecified adult solid tumor protocol specific diagnosis females childbearing potential must have negative serum pregnancy test equal less seven days prior registration
1, cisplatin stage iiib fallopian tube cancer diagnosis patients history evidence upon physical examination major central nervous system cns disease example
0, etoposide phosphate recurrent lymphoplasmacytic lymphoma diagnosis kps greater equal seventy
0, poly i c primary peritoneal cancer diagnosis serum creatinine less doc mg dl
1, calcium dietary non small cell lung cancer diagnosis receiving dialysis renal failure
0, immunoglobulins brain cancer diagnosis patients on following medications will be included
0, prednisone multiple myeloma diagnosis patient has given voluntary written informed consent before performance any related procedure not part normal medical care understanding that consent may be withdrawn by patient at any time without prejudice their future medical care
0, amonafide prostate cancer diagnosis no other prior malignancy is allowed except following
0, irinotecan esophageal cancer diagnosis bone lesions
1, lenalidomide multiple myeloma diagnosis patients renal insufficiency requiring hemodialysis
1, docetaxel non small cell lung cancer diagnosis tendency hemorrhage
1, bb peripheral cholangiocarcinoma diagnosis prior treatment hai chemotherapy
0, paclitaxel unresectable pancreatic carcinoma diagnosis phase study
1, cediranib stage iva pancreatic cancer diagnosis patients should not have received any other investigational agents within past four weeks
0, pembrolizumab melanoma diagnosis have performance status zero one on ecog performance scale
0, etoposide recurrent adult diffuse small cleaved cell lymphoma diagnosis patients who less twenty eight days more eighty days after pbsct will not be registered randomization
0, reverse transcriptase polymerase chain reaction stage iv adult diffuse large cell lymphoma diagnosis at least two prior combination chemotherapy regimens not including single agent monoclonal antibody rituxan therapy
1, immunoglobulin g primary peritoneal high grade serous adenocarcinoma diagnosis history severe allergic anaphylactic other hypersensitivity reactions chimeric humanized antibodies fusion proteins
0, thiotepa recurrent grade one follicular lymphoma diagnosis acute myeloid leukemia aml
0, paclitaxel stage ib breast cancer diagnosis surgery chemotherapy hormones biologics radiation
0, ibrutinib rice diffuse large cell lymphoma recurrent diagnosis serum creatinine less two uln estimated glomerular filtration rate cockroft gault greater forty ml min doc threemtwo
1, ceritinib systemic anaplastic large cell lymphoma diagnosis history documented congestive heart failure new york heart association functional classification iii iv
0, fluorouracil recurrent colon cancer diagnosis no uncontrolled colonic small bowel disorders greater three loose stools daily
1, capecitabine recurrent adult diffuse large cell lymphoma diagnosis patients who serologically positive hepatitis b or have history liver disease other forms hepatitis cirrhosis ineligible
0, vaccines ovarian cancer diagnosis hematocrit greater twenty five
0, cyclosporins stage ii adult hodgkin lymphoma diagnosis donor recipient must have human leukocyte antigen hla eight eight allelic match at hla b drbone high resolution typing is required all alleles
1, razoxane childhood immunoblastic large cell lymphoma diagnosis patients requiring corticosteroids who have not been on stable decreasing dose corticosteroid prior seven days
0, vinblastine medulloblastomas diagnosis score lansky greater thirty world health organization who score less two
1, cyclosporine testicular lymphoma diagnosis patients rapidly progressive high grade nhl
0, capecitabine breast cancer diagnosis no diabetes current history delayed wound healing skin ulcers
0, cyclophosphamide melanoma skin diagnosis lymphocyte count greater five hundred mm three
1, midazolam non small cell lung cancer nsclc diagnosis rptwod cohort subjects
1, cyclosporins stage iii adult lymphoblastic lymphoma diagnosis marrow donors
0, poly adp ribose polymerase inhibitors pontine glioma diagnosis greater equal six months since allogeneic stem cell transplant prior registration
0, emtricitabine kaposi sarcoma diagnosis hiv one infection
1, cetuximab metastatic colorectal cancer diagnosis known uncontrolled cns metastases
0, cyclophosphamide multiple myeloma plasma cell neoplasm diagnosis creatinine clearance greater forty ml min
0, dacarbazine recurrent brain tumors diagnosis no overt cardiovascular disease
1, erlotinib hydrochloride advanced malignant aerodigestive tract tumor lung head neck esophagus diagnosis transaminase sgot sgpt greater doc upper limit normal uln greater five uln if known liver metastases
0, lapatinib prostate cancer diagnosis six month life expectancy
1, stress cardiac mri contraindication mri pacemakers defibrillators aneurysm clips other implanted ferromagnetic objects gadolinium known hypersensitivity gadolinium advanced renal insufficiency defined by glomerular filtration rate less thirty ml min doc threem two
1, immunoglobulins recurrent colorectal carcinoma diagnosis has active autoimmune disease that has required systemic treatment past two years use disease modifying agents corticosteroids immunosuppressive drugs replacement therapy thyroxine insulin physiologic corticosteroid replacement therapy adrenal pituitary insufficiency is not considered form systemic treatment
0, immunoglobulins clear cell renal cell carcinoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast equal less uln
0, irinotecan recurrent childhood medulloblastoma diagnosis doc mg dl male patients aged greater equal sixteen years
1, carboplatin lymphoma diagnosis serious non healing wound ulcer bone fracture
1, nelfinavir non hodgkin lymphoma diagnosis acute active infection within fourteen days enrollment
1, sirolimus undifferentiated ovarian carcinoma diagnosis history non compliance medical regimens who considered potentially unreliable will not be able complete entire study
0, rituximab stage small lymphocytic lymphoma diagnosis fevers greater ten doc night sweats greater two weeks without evidence infection
1, fludarabine phosphate stage small lymphocytic lymphoma diagnosis diffusion capacity carbon monoxide dlco less forty total lung capacity tlc less forty forced expiratory volume one second fevone less forty receiving supplementary continuous oxygen
0, temozolomide central nervous system tumor pediatric diagnosis renal
1, dacarbazine neoplasm metastasis diagnosis history allergic reactions attributed compounds similar chemical biologic composition erlotinib temozolomide
0, lenalidomide adult lymphocyte depletion hodgkin lymphoma diagnosis eastern cooperative oncology group ecog performance status zero two
1, megestrol acetate stage ia endometrial carcinoma diagnosis mri evidence deep myometrial extrauterine spread
1, vitamin e cancer diagnosis cild is receiving head neck irradiation
1, cyclosporins recurrent small lymphocytic lymphoma diagnosis prior autologous hematopoietic stem cell transplant
1, vidarabine stage iv grade three follicular lymphoma diagnosis patient rapidly progressive aggressive nhl unless minimal disease state
0, thiotepa central nervous system tumors diagnosis surgery
0, progesterone breast cancer diagnosis life expectancy
0, albumin bound paclitaxel endometrial neoplasms diagnosis ability swallow oral medications willingness perform mucositis prophylaxis suitable venous access required blood sampling
0, immunoglobulins large cell lung cancer diagnosis more seven days since prior fna cnb mediastinoscopy
1, melphalan adult medulloblastoma diagnosis subjects who have contraindications carboplatin melphalan sts
0, antibodies monoclonal stage squamous cell carcinoma larynx diagnosis clinically significant peripheral vascular disease
0, gemcitabine stage iii intrahepatic cholangiocarcinoma diagnosis aspartate transaminase ast equal less five uln
1, paclitaxel ovarian cancer diagnosis known history human immunodeficiency virus hiv hiv one two antibodies
1, doxorubicin liver cancer diagnosis other based on judgment investigator
1, sorafenib stage iva squamous cell carcinoma paranasal sinus nasal cavity diagnosis known suspected allergy sorafenib any agent given course this trial
1, vaccines recurrent melanoma diagnosis patients who have had chemotherapy biological radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
0, immunoglobulin g stage ivc laryngeal squamous cell carcinoma diagnosis no prior chemotherapy biologic molecular targeted therapy recurrent metastatic scchn
1, immunoglobulins recurrent ovarian carcinoma diagnosis history myocardial infarction within six months
1, maytansine recurrent breast cancer diagnosis note
1, interleukin unresectable extrahepatic bile duct cancer diagnosis known seropositive hepatitis surface antigen
1, selenium stage iii squamous cell carcinoma lip oral cavity diagnosis prior chemotherapy radiotherapy hnscc any prior radiotherapy that would compromise delivery radical dose hnscc
1, pemetrexed documented symptomatic brain metastases progression requiring corticosteroids associated leptomeningeal involvement
0, cyclophosphamide melanoma diagnosis patients surgically resected brain metastases eligible
1, coal tar cancer diagnosis patients be treated regimen containing capecitabine
1, nivolumab recurrent non small cell lung carcinoma diagnosis cervical intra epithelial neoplasia
1, antibodies monoclonal history physical evidence cns disease including primary metastatic brain tumor
1, thoracic radiotherapy uncontrolled pleural effusion which may intervene radiotherapy primary tumor lung
0, liposomal doxorubicin lymphoma diagnosis pulmonary
1, antibodies monoclonal squamous non small cell lung cancer diagnosis history autoimmune disease except controlled treated hypothyroidism type diabetes
1, henatinib advanced solid cancer diagnosis other serious illness condition
1, mercaptopurine evidence current uncontrolled cardiovascular conditions including uncontrolled hypertension uncontrolled cardiac arrhythmias symptomatic congestive heart failure unstable angina myocardial infarction within past six months
1, carboplatin adenocarcinoma diagnosis subject has an active uncontrolled bacterial viral fungal infection requiring systemic therapy defined ongoing signs symptoms related infection without improvement despite appropriate antibiotics antiviral therapy other treatment
0, antibodies squamous cell lung cancer diagnosis active peptic ulcer disease
1, id lv melanoma currently enrolling diagnosis active tuberculosis recent less two week ago clinically significant infection evidence active hepatitis hepatitis hiv infection
0, bicalutamide breast cancer diagnosis platelet count greater one hundred one hundred nine l
1, navitoclax peripheral cell lymphoma diagnosis ponea oneb only
1, eflornithine familial adenomatous polyposis diagnosis fasting glucose greater one hundred ten mg dl greater doc mmol l
0, fludarabine phosphate nonmalignant neoplasm diagnosis myelofibrosis
1, formyltetrahydrofolates rectum cancer diagnosis pregnant breastfeeding
0, belinostat recurrent adult hodgkin lymphoma diagnosis platelets greater equal seventy five zero mcl
1, anastrozole breast neoplasms diagnosis medical psychiatric condition which may preclude protocol compliance
0, antibodies monoclonal salivary gland squamous cell carcinoma diagnosis eastern cooperative oncology group ecog performance status zero one
0, albumin bound paclitaxel breast carcinoma diagnosis radiation therapy is allowed provided last dose is given greater equal three weeks prior randomization
0, fluorouracil head neck neoplasms diagnosis oral cavity oropharynx hypopharyx larynx presenting locally recurrent metastatic disease at least one unidimensionally bidimensionally measurable lesion
0, irinotecan ganglioneuroblastoma diagnosis patients must not have received long acting myeloid growth factors neulasta within fourteen days entry on this seven days must have elapsed since administration short acting myeloid growth factor
0, levoleucovorin stage iii pancreatic cancer diagnosis if patient has biliary obstruction biliary decompression will be required either endoscopic placement biliary stent seven french greater percutaneous transhepatic drainage acceptable once biliary drainage has been established institution gemcitabine therapy may proceed when total bilirubin falls below doc mg dl
0, docetaxel breast cancer diagnosis eligibility must be based on most recent postoperative test result performed within six weeks prior randomization
0, bortezomib recurrent salivary gland cancer diagnosis idarubicin
1, tailored exercise prescription breast cancer diagnosis any unstable uncontrolled cardiopulmonary illness
0, adjuvants immunologic stage iiia primary peritoneal cancer diagnosis magnetic resonance imaging mri ct positive positron emission tomography pet image if performed will not exclude patient if other criteria met anatomical imaging is negative
1, taxane breast cancer diagnosis patients who pregnant breastfeeding
1, dacarbazine astrocytoma grade iv diagnosis chronic obstructive pulmonary disease exacerbation other respiratory illness requiring hospitalization precluding therapy
1, paclitaxel endometrial adenosquamous carcinoma diagnosis ctcae grade two greater peripheral vascular disease
1, letrozole previous current malignancies at other sites within last five years exception adequately treated cone biopsied situ carcinoma cervix uteri basal squamous cell carcinoma skin
1, mitomycins urothelial carcinoma bladder diagnosis any component small cell histology
1, intensity modulated radiotherapy treatment non small cell lung cancer diagnosis patients suitable standard concurrent ctrt
1, fluorouracil stage iiib gastric cancer diagnosis celiac adenopathy greater equal two cm size
1, carboplatin breast cancer diagnosis history any arterial thrombotic event within twelve months before randomization
0, dexamethasone acetate multiple myeloma diagnosis pt ptt less doc upper limits normal uln
0, sirolimus histologic proof neuroblastoma positive bone marrow tumor cells increased urine catecholamines
1, angiogenesis inhibitors renal cell carcinoma diagnosis subject is known have history hype negative hypo coagulation syndromes resulting prolongation bleeding parameters
1, cetuximab recurrent pancreatic cancer diagnosis gastrointestinal tract disease resulting an inability take oral medication requirement iv alimentation prior surgical procedures affecting absorption active peptic ulcer disease
0, cytarabine mature cell lymphoma
1, scar technique colonic adenoma diagnosis pregnancy
0, everolimus recurrent small cell lung carcinoma diagnosis willing provide tissue samples correlative research purposes
1, antilymphocyte serum lymphoma diagnosis active hepatitis either active carrier hbsag positive viremic hbv dna greater equal ten zero copies ml greater equal two zero iu ml
1, liver extracts bile duct cancer diagnosis prior biliary resection attempted resection
1, vaccines carcinoma advanced metastatic diagnosis patients known brain metastases unless treated stable greater two months
0, etoposide anaplastic large cell lymphoma alk positive diagnosis ejection fraction greater equal fifty by radionuclide angiogram
1, gemcitabine prior neo adjuvant treatment radiation therapy systemic therapy pancreatic adenocarcinoma
0, antibodies stage iva nasal cavity paranasal sinus squamous cell carcinoma diagnosis absolute neutrophil count greater one five hundred mcl
0, mycophenolate mofetil lymphoma diagnosis d
0, sargramostim unspecified adult solid tumor protocol specific diagnosis no untreated unstable brain metastases
1, bevacizumab primary peritoneal high grade serous adenocarcinoma diagnosis baseline ejection fraction equal less fifty assessed by echocardiogram multi gated acquisition muga
1, gauge needle pancreatic neoplasms diagnosis age less nineteen years
1, nivolumab advanced melanoma diagnosis history any hepatitis
0, mycophenolate mofetil stage iii mantle cell lymphoma diagnosis low grade nh negative less six months duration complete response cr between courses conventional therapy
0, immunoglobulins hertwo positive breast cancer diagnosis bilirubin within normal limits within ninety days prior registration
1, dynamic contrast enhanced magnetic resonance imaging recurrent renal cell cancer diagnosis history cerebrovascular accident including transient ischemic attack tia pulmonary embolism untreated deep venous thrombosis dvt within past six months note
0, cephalosporins small lymphocytic lymphoma diagnosis absolute neutrophil count less five hundred cells mm three less one thousand cells mm three predicted decrease less five hundred cells mm three
0, cyclosporine adult grade iii lymphomatoid granulomatosis diagnosis pbmc only will be permitted hsc source on this protocol
0, albumin bound paclitaxel ovarian serous cystadenocarcinoma diagnosis no poorly differentiated subtypes grade three clear cell papillary serous
1, sirolimus stage iiia breast cancer diagnosis chronic treatment systemic steroids another immunosuppressive agent use steroids part management everolimus toxicities will be allowed
0, epothilone b localized unresectable adult primary liver cancer diagnosis no prior allergic hypersensitivity reaction attributed compounds containing cremophor el paclitaxel compounds similar chemical biological composition bms two hundred forty seven thousand five hundred fifty
0, maleic acid stage iiic skin melanoma diagnosis women who have had tubal ligation
1, fludarabine stage iii marginal zone lymphoma diagnosis patients who homozygous at mismatched major histocompatibility complex mhc class locus
1, sorafenib carcinoma hepatocellular diagnosis subject has any significant medical condition laboratory abnormality psychiatric illness that would prevent subject from participating study
0, antibodies monoclonal recurrent midline lethal granuloma paranasal sinus nasal cavity diagnosis no hemoptysis at least one tablespoon
1, letrozole cancer breast diagnosis clinically significant history liver disease
1, bortezomib multiple myeloma diagnosis severe cardiac dysfunction nyha classification ii iv
0, cortisol succinate colorectal cancer diagnosis patients who have failed first line treatment containing fluoropyrimidine oxaliplatin based chemotherapy without bevacizumab mcrc
1, gemcitabine primary peritoneal cancer diagnosis serious comorbidities determined by investigator such but not limited active congestive heart failure recent myocardial infarction active infection
1, etoposide phosphate lymphoma diagnosis active cns involvement by malignancy
1, paclitaxel breast cancer diagnosis active infection
0, rituximab lymphoma diagnosis lymphoplasmacytoid
1, thalidomide lymphoma non hodgkin diagnosis any clinically significant comorbidities such uncontrolled pulmonary disease known impaired cardiac function clinically significant cardiac disease specified below active cns disease active infection any other condition that could compromise participant participation study
0, mycophenolate mofetil stage iii adult burkitt lymphoma diagnosis myelodysplastic syndromes mds greater int one per ipss after greater equal one prior cycle induction chemotherapy should have less five marrow blasts at time transplant
0, vidarabine noncontiguous stage ii adult lymphoblastic lymphoma diagnosis myelodysplasia mds
0, doxorubicin stage ia breast cancer diagnosis if ihc staining intensity is reported range zero one positive one positive two positive higher intensity score range should be used determine eligibility
0, irinotecan head neck cancer diagnosis more three months since prior biologic therapy
0, sirolimus pancreatic polypeptide tumor diagnosis hepatic artery embolization
0, gemcitabine metastatic cancer diagnosis karnofsky performance status fifty one hundred
0, belinostat fallopian tube cancer diagnosis patients must have signed an approved informed consent authorization permitting release personal health information
1, fludarabine phosphate noncontiguous stage ii grade two follicular lymphoma diagnosis female patients who pregnant breastfeeding
0, cyclophosphamide splenic marginal zone lymphoma diagnosis patients must be willing use contraception if they have childbearing potential
1, hydroxyurea glioblastoma diagnosis previous enrollment randomization treatment present study
1, everolimus recurrent grade one follicular lymphoma diagnosis addition cytotoxic agents cytoreduction exception tyrosine kinase inhibitors such imatinib cytokine therapy hydroxyurea low dose cytarabine chlorambucil rituxan will not be allowed within three weeks initiation conditioning
1, doxorubicin known central nervous system involvement by lymphoma
1, veliparib recurrent solid neoplasm diagnosis eligibility subjects receiving any medicat
1, trametinib metastatic malignant neoplasm liver diagnosis concurrent treatment bisphosphonates is permitted however treatment must be initiated prior first dose therapy prophylactic use bisphosphonates patients without bone disease is not permitted except treatment osteoporosis
0, paclitaxel non small cell lung cancer diagnosis at least eighteen years age
1, antibodies stage iia ovarian cancer diagnosis patients major surgical procedure anticipated during course this includes but is not limited to
0, niacinamide stage iva squamous cell carcinoma oropharynx diagnosis surgery must have been completed at least twenty eight days prior registration all complications adverse events must have been resolved
0, cyclophosphamide peripheral cell lymphoma diagnosis contraindication any required concomitant drugs supportive treatments including hypersensitivity all anticoagulation antiplatelet options antiviral drugs intolerance hydration due preexisting pulmonary cardiac impairment
1, antibodies monoclonal metastatic malignant neoplasm spine diagnosis patients both brain spine metastases will be excluded from trial
0, liposomal doxorubicin node negative primary tumor greater doc cm tonec tthree
1, vidarabine recurrent indolent adult non hodgkin lymphoma diagnosis patients available hla matched related donors
1, albumin bound paclitaxel adenocarcinoma diagnosis pregnancy positive serum pregnancy test lactation
0, mycophenolic acid anaplastic large cell lymphoma diagnosis there is likelihood rapid disease progression while hla typing results preliminary search donor pool suggests that ten ten hla b drbone dqbone matched unrelated donor will not be found
1, bevacizumab colorectal cancer diagnosis history prior concurrent central nervous system cns metastases
1, pioglitazone squamous cell lung cancer diagnosis stereotactic radiation whole brain radiation within twenty eight days prior cycle one day one
1, liposomal doxorubicin lymphoma cell diagnosis subjects prior diagnosis malignancy more ten years may be entered into at discretion principal investigator
1, mycophenolic acid recurrent childhood lymphoblastic lymphoma diagnosis patient has following organ dysfunction
1, secretin cellular diagnosis pancreatic cancer diagnosis presence pace makers aneurysm clips artificial heart valves ear implants metal fragments foreign objects eyes skin body
1, pelvic floor muscle training prostate cancer diagnosis less one week before surgery
0, bevacizumab head neck cancer diagnosis measurable disease is not required
1, cetuximab recurrent laryngeal verrucous carcinoma diagnosis patients history toxicity greater equal grade three prior egfr directed therapy
0, etoposide breast cancer diagnosis not specified note
1, fludarabine phosphate aids related diffuse mixed cell lymphoma diagnosis positive serology toxoplasma gondii on treatment evidence active infection
0, gemcitabine er pgr negative poor allred score less three eight hertwo negative breast cancer
1, thoracotomy malignant tumor history within past five years except following conditions
1, azacitidine melanoma diagnosis patients thyroid dysfunction not responsive therapy
1, cisplatin cancer head diagnosis minimum sensitivity pregnancy test must be twenty five iu equivalent units hcg
0, rituximab stage iii grade one follicular lymphoma diagnosis platelet count at least fifty zero mm three
1, everolimus cervical adenosquamous carcinoma diagnosis serious illness medical condition which would not permit patient be managed according protocol including but not limited to
0, antibodies stage iv grade three follicular lymphoma diagnosis platelets greater equal fifty zero mcl
1, ketoprofen uterine cervical cancer diagnosis severe renal insufficiency
0, jm stage ii multiple myeloma diagnosis platelet greater equal seventy five thousand ul
1, paclitaxel insulinoma diagnosis exposure any investigational drug within three weeks prior start dosing
1, antibodies stage iv squamous cell carcinoma nasopharynx diagnosis all wocbp must have negative pregnancy test equal less seven days prior registration if pregnancy test is positive patient must not receive investigational product must not be enrolled study
1, antibodies monoclonal ovarian cancer diagnosis if cardiac function assessment is clinically indicated performed
0, levoleucovorin recurrent extrahepatic bile duct carcinoma diagnosis myocardial infarction within past six months uncontrolled angina within past six months class ii iv new york heart association nyha congestive heart failure grade three cardiac valve dysfunction cardiac arrhythmia not controlled by medication history stroke transient ischemic attack within six months history arterial thrombotic event ate any type past six months treatment refractory hypertension defined blood pressure systolic greater one hundred forty mmhg diastolic greater ninety mmhg which cannot be controlled anti hypertensive therapy known intra cardiac defibrillators known cardiac metastases
0, tacrolimus multiple myeloma plasma cell neoplasm diagnosis not pregnant nursing
1, irinotecan fallopian tube cancer diagnosis history myocardial infarction unstable angina within six months prior day one
1, mycophenolic acid cutaneous cell non hodgkin lymphoma diagnosis patient has fungal infection radiological progression after receipt amphotericin active triazole greater one month
1, antibodies monoclonal advanced cancer diagnosis pregnant lactating women
0, albumin bound paclitaxel ovarian neoplasm diagnosis participants who undergo primary cytoreductive surgery must be entered between one one weeks after surgery
1, niacinamide stage ivc verrucous carcinoma oral cavity diagnosis any condition which investigator opinion makes subject unsuitable trial participation
1, sirolimus clear cell metastatic renal cell carcinoma diagnosis uncontrolled hypertension defined systolic blood pressure greater one hundred fifty mmhg diastolic pressure greater ninety mmhg despite optimal medical treatment
0, bortezomib stage iii adult hodgkin lymphoma diagnosis no dexamethasone aprepitant an antiemetic
1, antibodies monoclonal stage ia breast cancer diagnosis history cardiac disease
0, fluorouracil unspecified adult solid tumor protocol specific diagnosis rales pulmonary infiltrates hypoxia tachypnea
0, temozolomide recurrent childhood rhabdomyosarcoma diagnosis platelet count greater one hundred zero mm three transfusion independent
1, fludarabine uncontrolled symptomatic congestive heart failure
0, rituximab stage mantle cell lymphoma diagnosis received high dose chemotherapy autologous stem cell transplantation asct from forty two one hundred twenty eight days before enrollment stable disease partial response complete response following asct
0, dexamethasone multiple myeloma diagnosis current use oral corticosteroids exception inhaled topical steroids
1, androgens prostate cancer diagnosis patient already on adt
1, paclitaxel prior treatment breast cancer
1, albumin bound paclitaxel neoplasms diagnosis significant uncontrolled intercurrent illness
0, fluorouracil stage ii pancreatic cancer diagnosis registration eligibility criteria
0, rituximab lymphoma non hodgkin diagnosis last rituximab containing therapy is defined last therapy regimen containing at least one full dose rituximab
1, methylprednisolone hemisuccinate prostate cancer diagnosis participants reproductive potential who did not agree use accepted effective method contraception during treatment period
0, temozolomide recurrent childhood soft tissue sarcoma diagnosis fertile patients must use effective contraception
1, jx colorectal carcinoma diagnosis household contact exclusions
1, transoral robotic surgery stage iv squamous cell carcinoma oropharynx diagnosis evidence distant metastases below clavicle by clinical radiographic measures
1, capecitabine malignant neoplasms ill defined secondary unspecified sites diagnosis requirement chronic use full dose aspirin non steroidal anti inflammatory drugs nsaids
0, antibodies monoclonal stage iii grade two follicular lymphoma diagnosis ability understand willingness sign written informed consent all patients must have signed witnessed informed consent prior registration
1, liver extracts liver cancer diagnosis prior chemotherapy
1, immunoglobulin g grade iii meningioma diagnosis patients active implanted medical device skull defect such missing bone no replacement shunt bullet fragments examples active electronic devices include deep brain stimulators spinal cord stimulators vagus nerve stimulators pacemakers defibrillators programmable shunts
1, fludarabine recurrent grade three follicular lymphoma diagnosis patients diagnosis chronic myelomonocytic leukemia cmml
1, bevacizumab colorectal adenocarcinoma diagnosis history myocardial infarction unstable angina cardiac other vascular stenting angioplasty surgery within six months prior enrollment
1, camptothecin metastatic colorectal cancer diagnosis any history currently known brain metastases
1, docetaxel stage iv prostate cancer diagnosis subjects must not have received chemotherapy biologic therapy any other investigational drug any reason within twenty eight days prior start therapy must have recovered from toxicities prior therapy grade one less exception alopecia
0, cisplatin carcinoma larynx diagnosis oropharynx hpv positive hpv negative hypopharynx larynx primaries nasopharynx well those documented scc cervical lymph nodes unknown primaries
1, kanamycin colorectal neoplasms diagnosis steroid administration before surgery
1, isophosphamide mustard non hodgkin lymphoma diagnosis patient has received other investigational drugs cytotoxic chemotherapy within fourteen days enrollment
0, trastuzumab breast cancer diagnosis platelet greater one hundred zero mmthree
0, liposomal doxorubicin breast cancer diagnosis sentinel node biopsy negative metastasis sentinel node biopsy positive allowed if enrolled on american college surgery trial zeleven have beenrandomized receive no axillary dissection
1, bevacizumab primary brain tumor diagnosis coagulation disorder
0, electrochemotherapy histological confirmed breast cancer
0, isophosphamide mustard childhood diffuse large cell lymphoma diagnosis no other concurrent immunomodulating agents
1, sirolimus recurrent digestive system neuroendocrine tumor gone diagnosis unresolved toxicities from prior systemic therapy that common terminology criteria adverse events ctcae version doc greater equal grade two severity except alopecia
0, methotrexate recurrent childhood large cell lymphoma diagnosis subjects must be ineligible unable receive conventional myeloablative transplantation
0, antibodies stage iiib ovarian cancer diagnosis primary surgery patients
0, fludarabine phosphate lymphoma diagnosis disease characteristics
0, fluorouracil recurrent squamous cell carcinoma paranasal sinus nasal cavity diagnosis no non healing wounds within past four weeks
0, paclitaxel histologically confirmed invasive mammary carcinoma
0, docetaxel recurrent non small cell lung cancer diagnosis fertile patients must use effective contraception
0, carboplatin recurrent anal cancer diagnosis written signed informed consent patient must be aware that his her disease is neoplastic nature willingly consent after being informed procedure be followed experimental nature therapy alternatives potential benefits side effects risks discomforts
0, k pancreatic cancer diagnosis eighty one hundred nine l
1, bortezomib multiple myeloma relapse diagnosis patients may be receiving concomitant therapy bisphosphonates low dose corticosteroids prednisone up but no more ten mg its equivalent symptom management comorbid conditions
0, prednisolone lymphoma diagnosis gonadal involvement
1, vaccines nasopharyngeal carcinoma diagnosis autoimmune disease such systemic lupus erythematosis rheumatoid arthritis that is active requires current immunosuppressive therapy
1, anti bacterial agents peri ampullary cancer diagnosis patients allergy beta lactam
0, laboratory biomarker analysis recurrent adrenal cortex carcinoma diagnosis six less ten years age
0, docetaxel stage iv squamous cell carcinoma hypopharynx diagnosis no more one prior chemotherapy regimen metastatic disease
1, trastuzumab breast cancer diagnosis incapacity refusal provide informed consent
1, epirubicin non glandular breast cancers
0, cyclophosphamide contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis serum glutamic oxaloacetic transaminase sgot less two times normal clearance by ccf physician
0, asparaginase refractory lymphoblastic lymphoma diagnosis note
1, antibodies monoclonal recurrent small lymphocytic lymphoma diagnosis karnofsky score less seventy adult patients
1, interleukin prior systemic treatment one prior systemic treatment is allowed metastatic melanoma patients
0, angiogenesis inhibitors lung cancer diagnosis and
0, carboplatin prior temozolomide carboplatin frontline therapy adjuvant setting allowed provided patient did not experience severe toxicities related drug tumor progressed during this therapy
0, mycophenolic acid multiple myeloma diagnosis doc
1, mitomycin advanced cancer esophagogastric junction diagnosis history hypersensitivity any drugs drugs similar chemical structures
1, panobinostat high grade meningioma diagnosis subject has received prior course radiation therapy within target volume be treated part this protocol aside from whole brain radiation
0, antibodies monoclonal testicular lymphoma diagnosis platelet count greater equal one hundred zero mm three transfusion independent defined not receiving platelet transfusions at least seven days prior enrollment
1, trovax prostatic neoplasms diagnosis known allergy egg proteins
0, busulfan kidney cancer diagnosis previously treated leptomeningeal disease allowed provided csf cytology is negative at time assessment transplantation
0, fluorouracil metastatic pancreatic adenocarcinoma diagnosis serum albumin greater equal three dl
1, rituximab cancers that inactive that being treated hormonal therapy
0, fluorodeoxyglucose f lymphoma diagnosis ast less two times upper limit normal
0, etoposide stage iiib non small cell lung cancer diagnosis women child bearing potential wocbp must have negative pregnancy test within fourteen days registration urine human gonadotropin hcg is an acceptable pregnancy assessment
1, mycophenolate mofetil recurrent adult grade iii lymphomatoid granulomatosis diagnosis donor
1, gefitinib recurrent gastrointestinal carcinoid tumor diagnosis psychiatric illness social situation that would limit compliance requirement
0, rituximab stage iv adult diffuse small cleaved cell lymphoma diagnosis two below
1, bevacizumab recurrent adult brain tumor diagnosis no clinically significant cardiovascular disease including any following
1, erlotinib hydrochloride lung cancer diagnosis history corneal disease
0, antibodies monoclonal recurrent inflammatory breast carcinoma diagnosis has not undergone hysterectomy bilateral oophorectomy
0, antibodies endometrial papillary serous carcinoma diagnosis creatinine ratio less doc urine protein less one zero mg on twenty four hour urine collection
1, allogeneic donor derived b lymphocytes multiple myeloma diagnosis severe acute graft versus host disease gvhd glucksberg grade iii und iv
1, bevacizumab anaplastic oligo astrocytoma aoa diagnosis craniotomy wound that has not sufficiently healed
1, cyclosporins recurrent adult diffuse small cleaved cell lymphoma diagnosis patients rapidly progressive aggressive nhl unless minimal disease state
1, entinostat stage iiia breast cancer diagnosis patients permitted enroll if they have vitiligo type diabetes mellitus residual hypothyroidism due autoimmune condition only requiring hormone replacement psoriasis not requiring systemic treatment conditions not expected recur absence an external trigger precipitating event
0, citric acid lymphoplasmacytic lymphoma diagnosis fl criteria diagnosis
1, antibodies monoclonal multiple myeloma diagnosis subjects psoriasis not requiring systemic treatment
1, levoleucovorin stage iiib gallbladder cancer diagnosis patients any polymorphism ugtoneaone other one twenty eight
1, poly iclc recurrent pediatric low grade glioma diagnosis interleukins proleukin
1, melphalan multiple myeloma diagnosis patients who have had previous malignancy that is not remission
1, e cutaneous cell lymphoma diagnosis participant serious complications histories
1, hydroxychloroquine colorectal cancer diagnosis qtc greater five hundred ms at baseline average three determinations at ten minutes interval
0, pemetrexed rhabdomyosarcoma diagnosis eastern cooperative oncology group ecog performance zero one two
1, bendamustine hydrochloride multiple myeloma diagnosis individuals unable provide informed consent
0, antibodies monoclonal stage ivb verrucous carcinoma larynx diagnosis potassium within normal limits institution
1, bevacizumab anaplastic oligodendroglioma diagnosis concurrent use other standard chemotherapeutics investigative agents vasoconstrictors treatment migraine ergotamine zolmitriptan sumatriptan because potential exacerbation coronary vasoconstriction
0, carboplatin neuroblastoma diagnosis patient is less equal eighteen years age
1, botulinum toxins breast neoplasms diagnosis patients who pregnant
1, medical acupuncture gastrointestinal neoplasms diagnosis scheduled receive rt period less four weeks
1, cetuximab recurrent gastric cancer diagnosis major surgery significant traumatic injury occurring within twenty one days prior treatment
0, everolimus tufted angioma diagnosis prior therapy requirements
1, best supportive care carcinoma hepatocellular diagnosis patients who took thalidomide no more less equal three days before enrolment
0, doxorubicin coldrhood cancer diagnosis lifetime cumulative dose anthracycline
0, sirolimus cancer diagnosis bone marrow function anc greater one five hundred ul platelet greater one zero ul hb greater doc dl
0, compliance monitoring ovarian endometrioid adenocarcinoma diagnosis patients following histologic epithelial cell types eligible
1, vincristine solid tumors diagnosis treatment non approved investigational drug within thirty days before day one trial treatment
1, godin leisure time exercise questionnaire glteq prostate cancer diagnosis pregnancy confirmed suspected
1, bevacizumab desmoplastic small round cell tumor dsrct diagnosis pregnant breastfeeding females
0, fluorouracil mucinous adenocarcinoma colon diagnosis must have available tissue immunohistochemical analysis
0, diphosphonates hereditary breast ovarian cancer brcaone brcatwo diagnosis more onetwo months since prior no concurrent systemic corticosteroids
0, cisplatin gastrointestinal carcinoid tumor diagnosis no other concurrent chemotherapy this condition
0, surgery metastatic cancer diagnosis eligible treatment gamma knife linear accelerator based radiosurgery
0, tocopherols breast cancer diagnosis normal kidney function
0, bryostatin stage iv gastric cancer diagnosis no prior chemotherapy
0, formoterol fumarate lung cancer diagnosis patient characteristics
0, sirolimus stage iiia breast cancer diagnosis women child bearing potential defined sexually mature women who have not undergone hysterectomy who have not been naturally postmenopausal at least twelve consecutive months who has had menses any time preceding twelve consecutive months must have negative serum pregnancy test equal less fourteen days prior registration must use two forms highly effective contraception also applicable their partners who biologically able conceive
0, antibodies monoclonal international prognostic index ipi follicular lymphoma ipi flipi three more
1, romidepsin extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis men women childbearing potential who unwilling employ adequate contraception
0, mycophenolic acid recurrent childhood grade iii lymphomatoid granulomatosis diagnosis patient who refused be treated on conventional hct protocol this inclusion criterion transplants must be approved by both participating institution patient review committee such patient care conference pcc at fhcrc fhcrc principal investigators
0, antibodies monoclonal tongue carcinoma diagnosis including cetuximab panitumumab investigational egfr directed monoclonal antibodies will be allowed phase dose escalation patients who have received monoclonal antibody therapy must be off all monoclonal antibodies four weeks twenty eight days prior treatment no chemotherapy within twenty eight days trial medication
0, prednisone prostate cancer diagnosis serum testosterone levels less fifty ng dl documented non surgically castrated patients within twenty one days prior randomization
1, vorinostat recurrent squamous cell carcinoma nasopharynx diagnosis history allergic reactions attributed compounds similar chemical biologic composition agents used including hypersensitivity paclitaxel cremophor platins
0, progesterone stage iv breast cancer diagnosis patients must be post menopausal
0, bevacizumab stage iiib fallopian tube cancer diagnosis four weeks from an investigational agent not food drug administration fda approved five half lives whichever is shorter
1, carmustine stage iv grade three follicular lymphoma diagnosis patient has greater grade two peripheral neuropathy within fourteen days before enrollment
0, levoleucovorin colorectal cancer diagnosis candidate systemic therapy opinion primary oncologist
1, albumin bound paclitaxel non melanomatous skin cancer if adequately treated
1, maitake mushroom extract compound lung neoplasms diagnosis allergic text drug
1, prednisolone acetate myeloma diagnosis patients receiving any other investigational agent s
0, laboratory biomarker analysis stage iii squamous cell carcinoma larynx diagnosis no congenital long qt syndrome
1, immunoglobulins stage iva nasal cavity paranasal sinus squamous cell carcinoma diagnosis patients who have had chemotherapy radiotherapy within two weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more two weeks earlier
0, celecoxib recurrent bladder cancer diagnosis additional induction courses bcg allowed
1, immunoglobulins melanoma skin diagnosis underlying medical condition eg condition associated diarrhea that investigator opinion would make administration either drug both drugs hazardous patient obscure interpretation toxicity determination adverse events
0, doxorubicin breast cancer diagnosis marginal borderline etc
0, belinostat stage iii cutaneous cell non hodgkin lymphoma diagnosis toxicity
1, liposomal doxorubicin urethral cancer diagnosis female subject is pregnant breast feeding
0, liposomal doxorubicin ovarian cancer diagnosis life expectancy greater three months
0, immunoglobulin g adult anaplastic astrocytoma diagnosis platelet count greater equal one hundred zero mm three
1, mitogens stage iiib breast cancer diagnosis adverse events related trastuzumab murine proteins any excipients that resulted trastuzumab being permanently discontinued
1, lenalidomide multiple myeloma diagnosis poems syndrome
1, fludarabine phosphate recurrent refractory childhood hodgkin lymphoma diagnosis adult
0, recombinant albumin fusion protein sephb hsa patients hepatocellular carcinoma not need have histologic confirmation disease long they meet radiologic criteria diagnosis hcc evidence arterial phase enhancement corresponding venous delayed phase wash out
0, capecitabine stage iva hypopharyngeal squamous cell carcinoma diagnosis eligibility patients receiving any medications substances known affect potential affect activity vorinostat will be determined following review their case by principal investigator
0, holmium ho dotmp metastatic cancer diagnosis no more three prior systemic chemotherapy regimens
1, laboratory biomarker analysis stage iii squamous cell carcinoma larynx diagnosis evidence distant metastases below clavicle by clinical radiographic measures
0, etoposide aids related immunoblastic large cell lymphoma diagnosis kps greater equal fifty ecog ps zero one two
1, brivanib transitional cell carcinoma diagnosis other concurrent chemotherapy hormonal therapy immunotherapy regimens radiotherapy standard investigational
1, selenium stage iii squamous cell carcinoma hypopharynx diagnosis known be positive hepatitis human immunodeficiency virus hiv
1, bevacizumab splenic marginal zone lymphoma diagnosis patients clinically significant cardiovascular disease
0, prednisone metastatic androgen independent prostate cancer diagnosis one prior non taxane chemotherapy allowed
1, cytarabine prior chemotherapy radiotherapy lymphoma
0, vidarabine patients active twond malignancies other myelofibrosis aml excised skin cancer early stage cervical prostate cancer
0, estradiol metastatic breast cancer diagnosis international normalized ratio inr prothrombin time pt less doc uln unless patient is receiving anticoagulant therapy long pt ptt is within therapeutic range intended use anticoagulant
1, fludarabine stage ii childhood anaplastic large cell lymphoma diagnosis donor
1, paclitaxel cancer that has spread brain
1, metformin ovarian undifferentiated adenocarcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition metformin
1, maleic acid ovarian transitional cell carcinoma diagnosis prior use parp inhibitors
1, sirolimus adult anaplastic oligodendroglioma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated temsirolimus perifosine
1, cyclosporins b cell lymphoma refractory diagnosis fertile men women unwilling use contraceptive techniques during twelve months following treatment
0, fosaprepitant stage iia fallopian tube cancer diagnosis patients who able complete assessments
0, liposomal doxorubicin multiple myeloma diagnosis sexually active males should be willing use condom even if they have had prior vasectomy while having intercourse any women during course start therapy until thirty days after stem cell transplant
1, pembrolizumab breast cancer diagnosis systemic fungal bacterial viral other infection
1, paclitaxel stage iiia primary peritoneal cancer diagnosis stage not greater a grade one two no more superficial myometrial invasion without vascular lymphatic invasion no poorly differentiated subtypes including papillary serous clear cell other figo grade three lesions
1, nivolumab stage iii adrenal cortex carcinoma diagnosis ongoing active infection requiring systemic treatment
0, immunoglobulin g stage iia ovarian cancer diagnosis regimens ii
0, cyclosporins primary central nervous system non hodgkin lymphoma diagnosis complete disappearance all known disease exception persistent scan abnormalities unknown significance term unconfirmed is defined scan abnormalities unknown significance that not biopsied otherwise evaluated
0, lapatinib recurrent squamous cell carcinoma paranasal sinus nasal cavity diagnosis at least one unidimensionally measurable lesion greater twenty mm by conventional techniques greater one mm by spiral ct scan
1, paclitaxel ovarian serous cystadenocarcinoma diagnosis patient active pulmonary edema pleural effusion
1, fluorouracil solid tumors diagnosis major surgery within four weeks preceding start treatment
0, abiraterone acetate recurrent prostate cancer diagnosis hepatic enzymes aspartate aminotransferase ast alanine aminotransferase alt equal less doc times institutional uln
1, obatoclax mesylate gx ms hodgkin lymphoma diagnosis no other agents therapies administered intent treat malignancy
0, gemcitabine breast cancer diagnosis no prior chemotherapy
1, paclitaxel fallopian tube carcinoma diagnosis patient receiving concurrent additional biologic therapy
1, iv administration gadolinium containing contrast agent adult gliosarcoma diagnosis prisoners other individuals deemed be susceptible coercion
1, docetaxel head neck carcinoma diagnosis has known history human immunodeficiency virus hiv hiv one two antibodies
0, interleukin anaplastic meningioma diagnosis creatinine less doc
0, educational intervention psychosocial effects cancer its treatment diagnosis previously untreated disease receiving concurrent treatment previously treated disease treatment status unknown
0, cyclophosphamide recurrent breast carcinoma diagnosis estimated life expectancy greater equal eighty four days three months
1, cediranib ovarian serous adenocarcinoma diagnosis prior treatment affecting vegf vegfr pathway angiopoietin pathway recurrent setting including but not limited thalidomide bevacizumab sunitinib sorafenib pazopanib cediranib nintedanib trebananib bevacizumab used upfront setting conjunction chemotherapy maintenance treat newly diagnosed disease will be allowed
0, sirolimus childhood diffuse large cell lymphoma diagnosis must have less five marrow blasts at time transplant
0, dexamethasone phosphate stage iii multiple myeloma diagnosis psychiatric illness social situation that would limit compliance requirements
1, mycophenolate mofetil recurrent adult grade iii lymphomatoid granulomatosis diagnosis history brain metastases
1, hypofractionated whole breast radiation schedule previous concomitant malignancies any type except squamous basal cell carcinomas skin carcinoma fiin situ fr cervix which have been effectively treated
1, doxorubicin fallopian tube cancer diagnosis mental condition that would prevent patient comprehension nature risk associated study
1, cyclophosphamide advanced unresectable melanoma progressing after pdone blockade diagnosis concomitant medical condition that opinion treating physician would pose unreasonable additional risk therapeutic injection oncos one 
0, mycophenolate mofetil noncontiguous stage ii adult diffuse mixed cell lymphoma diagnosis myelodysplastic syndromes myeloproliferative disorders mds mpd
0, lenalidomide ds stage iii plasma cell myeloma diagnosis patients must have baseline skeletal survey include lateral skull anterior posterior ap pelvis posterior anterior pa chest within twenty eight days prior registration
0, levoleucovorin esophageal cancer diagnosis patient characteristics
0, capecitabine breast cancer diagnosis no allergies sulfa medication aspirin other nonsteroidal anti inflammatory drugs nsaids
1, antibodies monoclonal recurrent adult diffuse mixed cell lymphoma diagnosis patients bleeding diathesis clinical bleeding prothrombin time greater equal doc upper institutional normal value inr greater equal doc activated partial thromboplastin time aptt greater equal doc upper institutional normal value active gastric duodenal ulcer
0, alvocidib recurrent mantle cell lymphoma diagnosis nodular sclerosing
1, gamma pod breast cancer diagnosis regional nodal irradiation is part treatment plan
1, pharmacological recurrent adult grade iii lymphomatoid granulomatosis diagnosis john wort modafinil oxcarbazepine
1, antibodies monoclonal liver cancer diagnosis anti coagulant therapy bleeding clotting disorder
0, bevacizumab neuroendocrine carcinoma diagnosis myocardial infarction
1, cyclosporins recurrent marginal zone lymphoma diagnosis disease resulting severely limited performance status less seventy
1, mycophenolic acid stage iii childhood anaplastic large cell lymphoma diagnosis disease resulting severely limited performance status less seventy
1, changtai keli colon cancer diagnosis intentional severe liver kidney disease patients serious obstacle function
0, sunitinib recurrent squamous cell carcinoma nasopharynx diagnosis tipranavir
1, fludarabine phosphate stage ii childhood lymphoblastic lymphoma diagnosis addition cytotoxic agents cytoreduction exception hydroxyurea imatinib mesylate will not be allowed within two weeks initiation conditioning
1, octreotide recurrent meningiomas diagnosis uncontrolled diabetes mellitus defined by hbaonecgreater doc
0, mycophenolic acid testicular lymphoma diagnosis high risk all defined as
1, belinostat thymic carcinoma diagnosis patients taking medications that may cause qtc prolongation will be eligible long they comply recommendations appendix d
1, cabozantinib s malate childhood clear cell sarcoma soft parts diagnosis patients must not be receiving any following potent cypthreeafour inducers inhibitors
1, lomustine glioblastoma diagnosis must not have received prior treatment except surgical debulking first relapse progression recurrence gbm
0, adjuvant therapy brain central nervous system tumors diagnosis age
1, doxorubicin follicular lymphoma diagnosis known infection hbv hcv acute less six mos
1, aldesleukin stage iiia melanoma diagnosis any non oncology vaccine therapy used prevention infectious diseases up one month before after any dose ipilimumab
0, cabozantinib refractory soft tissue sarcomas diagnosis ability understand willingness sign written informed consent document
0, albumin bound paclitaxel endometrial endometrioid adenocarcinoma variant squamous differentiation diagnosis sgot sgpt no greater three times normal
0, hyperfractionated radiation therapy adult glioblastoma diagnosis anc greater one thousand five hundred mmÂ³ platelets greater one hundred zero mmÂ³ hgb greater nine dl
1, pemetrexed neoplasms lung diagnosis patients who had resection completed course cranial irradiation have no worsening cns symptoms have discontinued all corticosteroids that indication at least one month
0, thalidomide relapsed multiple myeloma diagnosis urine protein greater two hundred mg twenty four hours
1, nivolumab non small cell lung cancer diagnosis patients who have completed their participation an interventional trial who not receiving drug anymore who only followed up overall survival can be enrolled
1, gemcitabine recurrent primary peritoneal carcinoma diagnosis prior central thoracic radiation therapy rt including rt heart
1, prednisolone hemisuccinate cutaneous cell lymphoma diagnosis mycosis fungoides
1, pet ct scan esophageal cancer diagnosis pregnant lactating female
0, quality life assessment stage ia breast cancer diagnosis not already classified pr negative peri menopausal
1, hormones prior prostate cancer surgery including but not limited prostatectomy hyperthermia cryosurgery
1, everolimus recurrent adult non hodgkin lymphoma diagnosis down syndrome
1, fludarabine phosphate recurrent adult lymphoblastic lymphoma diagnosis patients life expectancy less six months reasons other their underlying hematologic oncologic disorder
1, doxorubicin optic glioma diagnosis arm a
0, methylprednisolone lymphoma diagnosis prior concurrent therapy
1, misonidazole stage iv small cell lung carcinoma diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible
1, bevacizumab solid cancers diagnosis significant vascular disease within six months prior first dose treatment
0, pembrolizumab stage iiia gastric cancer diagnosis note
1, fluorouracil adenocarcinoma colon diagnosis subject has had major surgery within twenty eight days day
1, quality life assessment stage iv squamous cell carcinoma nasopharynx diagnosis contraindication full course chemoradiotherapy
1, rituximab lymphoma diagnosis patient has history gastrointestinal surgery other procedures that might opinion investigator interfere absorption swallowing drugs
1, dacarbazine pancreatic polypeptide tumor diagnosis uncontrolled systemic fungal bacterial viral other infection defined exhibiting ongoing signs symptoms related infection without improvement despite appropriate antibiotics other treatment
0, antibodies monoclonal ovarian mucinous cystadenocarcinoma diagnosis following histologic epithelial cell types eligible
0, everolimus stage ivc salivary gland cancer diagnosis leukocytes greater equal three mm three
1, paclitaxel resectable pancreatic cancer diagnosis participation any investigational drug within four weeks preceding start treatment
0, vaccinium myrtillus macleaya cordata echinacea angustifolia extract granules stage iva verrucous carcinoma oral cavity diagnosis patient legal representative must understand investigational nature this sign an independent ethics committee institutional review board approved written informed consent form prior receiving any related procedure
1, tremelimumab refractory melanoma diagnosis potential requirement systemic corticosteroids
1, pf dacomitinib brain tumor recurrent diagnosis congestive heart failure previous six months
0, thalidomide lymphoma diagnosis no concurrent topical corticosteroids
1, antibodies monoclonal metastatic solid tumors diagnosis hcv tp hiv antibody positive
0, bortezomib recurrent adult cell leukemia lymphoma diagnosis eastern cooperative oncology group ecog performance status equal less two
0, deoxyuridine small intestine lymphoma diagnosis creatinine normal creatinine clearance greater equal sixty ml min
0, immunosuppressive agents history bleeding disorder that would make hematoma likely hemophilia von willebrand disease on anti coagulation therapy certain cases may be allowed each case will be assessed by doctor
1, docetaxel hertwo positive breast cancer diagnosis pregnant lactating females
0, everolimus patients must have histologically cytologically confirmed neuroendocrine tumours either carcinoid histology carcinoma pancreatic islet cell origin small cell variant endocrine organ carcinomas adrenal gland malignancies including paragangliomas excluded from this study
1, methylprednisolone acetate myeloma diagnosis patients who have had chemotherapy radiotherapy within four weeks prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
0, isophosphamide mustard childhood fibrosarcoma diagnosis life expectancy greater three months
1, fludarabine phosphate noncontiguous stage ii grade two follicular lymphoma diagnosis bone marrow bm donors
0, fluorouracil histologically proven squamous cell carcinoma esophagus include cardiac cancer
1, vaccines stage ivb uterine corpus cancer diagnosis lack availability patient immunological clinical follow up assessment
0, gamma secretase notch signalling pathway inhibitor ro stage iv melanoma diagnosis aspartate aminotransferase ast alanine aminotransferase alt equal less doc iuln
0, vidarabine noncontiguous stage ii mantle cell lymphoma diagnosis acute myeloid leukemia aml
0, beclomethasone noncontiguous stage ii grade three follicular lymphoma diagnosis exclusion
0, antibodies stage iii grade one follicular lymphoma diagnosis patients may not have received prior murine compounds due risk hama formation
1, mycophenolic acid recurrent adult diffuse large cell lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
1, single port access surgery colorectal cancer diagnosis patients not capable informed consent quality life assessment
1, retinol acetate contiguous stage ii adult lymphoblastic lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition at one hundred one other agents used study
0, vaccines stage iv pancreatic cancer diagnosis at least four weeks since prior immunotherapy recovered
1, trastuzumab cancer diagnosis cohort only
1, pembrolizumab grade one follicular lymphoma diagnosis note
1, bevacizumab stage iiia rectal cancer diagnosis inflammatory breast disease
1, antibodies monoclonal stage iiib ovarian cancer diagnosis concurrent use enzyme inducing anti epileptic drugs eiaed patients may be on non enzyme inducing anti epileptic drugs not be taking any anti epileptic drugs patients previously treated eiaed may be enrolled if they have been off eiaed ten days more prior first dose mlnone hundred twenty eight
1, niacinamide hepatocellular carcinoma diagnosis pregnancy
0, everolimus stage iiic ovarian cancer diagnosis adequate coagulation function defined by either following criteria
1, fludarabine phosphate stage marginal zone lymphoma diagnosis human immunodeficiency virus hiv positive patients
0, olaparib recurrent primary peritoneal carcinoma diagnosis platinum resistant is defined relapse within six months last platinum based chemotherapy progression while on platinum based therapy
1, gemcitabine solid neoplasm diagnosis initiation adjustment antihypertensive medication is allowed prior screening
0, paclitaxel ovarian cancer diagnosis neurologic function
0, sorafenib stage ii renal cell cancer diagnosis patients must have an absolute baseline left ventricular ejection fraction lvef greater equal fifty by multigated acquisition muga scan within four weeks prior randomization
0, cisplatin colorectal cancer diagnosis prior treatment sorafenib is not allowed
1, cortisone acetate b lymphoblastic lymphoma diagnosis routine systemic maintenance therapy abelson murine leukemia viral oncogene homolog one abl kinase inhibitor methotrexate six mercaptopurine vincristine etc
1, dasatinib adenocarcinoma colon diagnosis patient has received therapeutic radioisotopes such strontium eighty nine within four weeks before blood extraction
1, fosaprepitant stage iiia ovarian cancer diagnosis patients clinical symptoms signs gastrointestinal obstruction those who require parenteral hydration nutrition patients history current diagnosis inflammatory bowel disease not eligible
0, liposomal doxorubicin recurrent ovarian carcinoma diagnosis adequately controlled thyroid function no symptoms thyroid dysfunction thyroid stimulating hormone tsh within normal limits
1, melphalan renal cell carcinoma diagnosis current past history invasive mycotic infection
1, bb relapsed refractory multiple myeloma diagnosis serum total bilirubin greater doc mg dl three doc Î¼mol greater doc uln subjects hereditary benign hyperbilirubinemia
0, liposomal doxorubicin breast cancer diagnosis because standard care chemotherapy agents known be teratogenic women child bearing potential men must agree use adequate contraception hormonal barrier method birth control abstinence prior entry duration participation
1, cyclosporins contiguous stage ii adult immunoblastic large cell lymphoma diagnosis donor
0, liposomal doxorubicin stage iiia breast cancer diagnosis patient must have completed one procedures evaluation pathologic nodal status listed below
0, paclitaxel adenocarcinoma lung diagnosis patients exudative bloody cytologically malignant effusions not eligible if pleural effusion can be seen on chest computed tomography ct but not on chest ray cxr is too small tap patient will be eligible pleural effusion appearing only after thoracotomy other invasive thoracic procedure was attempted will not make patient ineligible
1, piperazine citrate pilomyxoid astrocytoma diagnosis group a
0, immunoglobulin g ovarian mucinous adenocarcinoma diagnosis hemoglobin greater equal doc dl patients may be transfused meet hemoglobin hgb requirement
0, antibodies ciliary body choroid melanoma small size diagnosis no more one prior systemic therapeutic regimen this includes chemotherapy biologic therapy biochemotherapy investigational treatment this does not include any therapies given adjuvant setting
0, doxorubicin stage ii breast cancer diagnosis patient must be aware neoplastic nature his her disease willingly provide written informed consent after being informed procedure be followed experimental nature therapy alternatives potential benefits side effects risks discomforts
0, glycosylated recombinant human interleukin stage iv prostate cancer diagnosis life expectancy at least six months
0, trastuzumab recurrent breast cancer diagnosis alkaline phosphatase no greater two times uln five times uln liver metastases
1, ct simulation prostate cancer diagnosis unwilling fill out quality life psychosocial forms
0, panobinostat recurrent glioblastoma diagnosis hemoglobin greater nine dl anc greater one five hundred cells platelets greater one zero cells l
1, questionnaire administration stage iv adult cell leukemia lymphoma diagnosis patients who have previously received chemotherapy other steroids intrathecal chemotherapy not eligible
1, robot assisted laparoscopic surgery recurrent renal cell cancer diagnosis pregnancy
1, immunoglobulins ovarian brenner tumor diagnosis patients uncontrolled infection
0, immunotoxins ovarian cancer diagnosis disease characteristics
1, rituximab recurrent marginal zone lymphoma diagnosis total bilirubin greater equal two times upper limits normal unless due gilberts disease nhl
1, fluorodeoxyglucose f stage iii squamous cell carcinoma lip oral cavity diagnosis patients known syndromes that alter radiosensitivity
0, methotrexate lymphoma diagnosis prior concurrent therapy
0, fulvestrant breast cancer diagnosis disease can be multi centric bilateral disease provided target lesion meets above eligibility criteria
1, temozolomide glioblastoma multiforme diagnosis gastrointestinal fistula
0, irinotecan childhood oligodendroglioma diagnosis negative pregnancy test
0, pharmacogenomic studies stage iii grade two follicular lymphoma diagnosis any other medical condition including mental illness substance abuse deemed by principal investigator likely interfere patient ability sign informed consent cooperate participate interfere interpretation results
1, vidarabine recurrent adult diffuse small cleaved cell lymphoma diagnosis inability achieve adequate venous access
0, laboratory biomarker analysis stage iv uterine sarcoma diagnosis hemoglobin greater equal nine dl
0, fludarabine peripheral cell lymphoma diagnosis patient must have clearance hsct after psychosocial evaluation
1, interferons advanced cancer diagnosis patients who use daily glucocorticoids except physiological replacement
0, whole brain radiation therapy patients presenting brain metastases from newly diagnosed cancer may have systemic disease brain disease at time initial cancer diagnosis
0, cetuximab stage ivc esthesioneuroblastoma paranasal sinus nasal cavity diagnosis hemoglobin greater equal nine dl
1, podophyllotoxin mantle cell lymphoma diagnosis patients evidence myelodysplastic syndromes mds acute myeloid leukemia aml abnormal cytogenetics analysis indicative mds on pre transplant bone marrow examination
1, antibodies monoclonal carcinoma non small cell lung diagnosis however dose escalation prior treatment marketed inhibitors immune checkpoint pathway such nivolumab pembrolizumab is allowed
0, antilymphocyte serum myeloproliferative neoplasm diagnosis signed informed consent
1, fulvestrant breast cancer diagnosis prior treatment greater two endocrine therapies
1, liposomal doxorubicin tumors diagnosis history arterial deep venous thromboembolism within twelve months prior enrollment
0, erythromycin ethylsuccinate ras wildtype colorectal cancer diagnosis willingness cope biweekly quality life questionnaires
0, albumin bound paclitaxel adenocarcinoma diagnosis at least eighteen years age
0, capecitabine unspecified adult solid tumor protocol specific diagnosis cardiovascular
0, mycophenolate mofetil recurrent adult burkitt lymphoma diagnosis waldenstrom macroglobulinemia
1, immunoglobulins stage iv squamous cell carcinoma hypopharynx diagnosis conduction abnormality requiring pacemaker
0, letrozole breast cancer diagnosis wbc greater doc ten nine granulocyte count polymorphs positive bands greater doc times ten nine l
0, technetium tc m sestamibi lung neoplasms diagnosis patients should have received either sunitinib sorafenib unless deemed ineligible treatment either agent
0, vorinostat stage iii grade one follicular lymphoma diagnosis mature cell malignancies
1, etoposide phosphate childhood grade iii lymphomatoid granulomatosis diagnosis no uncontrolled infection
1, bortezomib history other active malignancies other multiple myeloma within past three years prior entry following exceptions
1, immunoglobulins stage ivc squamous cell carcinoma paranasal sinus nasal cavity diagnosis uncontrolled comorbid illness
1, irinotecan esophageal cancer diagnosis urine protein
0, hormones prostate cancer diagnosis no unstable diabetes mellitus
0, isophosphamide mustard size primary tumor visible previously inadequately resected greater five cm at instrumental staging ct mri locally recurrent any size
1, patients negative pet after salvage therapy hodgkin lymphoma diagnosis any psychological familiar geographical conditions that could potentially hinder compliance protocol
0, methotrexate hepatosplenic cell lymphoma diagnosis chronic phase intolerant unresponsive imatinib other tyrosine kinase inhibitors second chronic phase accelerated phase who ineligible conventional myeloablative transplantation
1, dasatinib non hodgkin lymphoma diagnosis concurrent medical condition which may increase risk toxicity including
1, saracatinib primary peritoneal cancer diagnosis pregnant lactating females
1, irinotecan location tumor equal ctv less twelve mm laterally less fifteen mm cranio caudal stomach small intestine esophagus trachea bronchi right left pulmonary arteries right left
0, fenretinide recurrent neuroblastoma diagnosis at least two months
0, bevacizumab stage iv squamous cell carcinoma nasopharynx diagnosis measurable disease
0, blood samples collection during radiotherapy kidney neoplasms diagnosis registered social security system
1, omeprazole cancer head neck diagnosis patients on rilpivirine atazanavir indinavir nelfinavir will not be eligible participation because significant drug interaction unless patient can be switched different antiviral medication prior enrollment
1, duvortuxizumab lymphoma large cell diffuse diagnosis participant has received any following
1, cyclosporins small lymphocytic lymphoma diagnosis donor
0, oxaliplatin recurrent nasopharyngeal cancer diagnosis at least six months since prior craniospinal radiotherapy
0, cysteamine precancerous condition diagnosis eighteen over
1, bb stage iii multiple myeloma diagnosis subjects whom required program po iv fluid hydration is contraindicated eg due pre existing pulmonary cardiac renal impairment
1, azd neurofibromatosis type one diagnosis refractory nausea vomiting chronic grastointestinal disease inflammatory bowel disease significant bowel resection that would preclude adequate absorption
0, radiotherapy metastatic spine process patients tumor that has compressed only cauda equina spinal roots
1, albumin bound paclitaxel recurrent parathyroid cancer diagnosis known seropositive hepatitis surface antigen
1, nivolumab malignant reproductive system neoplasm diagnosis other disorders associated high risk fistula formation including percutaneous endoscopic gastrostomy peg tube placement within three months before first dose therapy
0, epirubicin histologically verified adenocarcinoma thoracic oesophagus type one two three tumours oesophagogastric junction type one refers lower oesophageal type two refers cardial type three refers subcardinal cancers
0, melphalan myelodysplastic myeloproliferative neoplasms diagnosis able lie supine full body cast thirty minutes
0, vaccines breast cancer diagnosis see disease characteristics
0, cisplatin carcinoma squamous cell diagnosis if not intermediate risk hnscc is high risk hnscc defined follows
0, fludarabine contiguous stage ii adult diffuse large cell lymphoma diagnosis must have failed two courses therapy
1, pembrolizumab stage iiib non small cell lung cancer diagnosis has received live vaccine within thirty days planned start therapy
0, cyclosporine recurrent mantle cell lymphoma diagnosis partial cytogenetic remission
0, antibodies monoclonal melanoma diagnosis subjects must be willing able discontinue antihypertensive medications if advised so days huone doc eight iltwo infusion
0, erlotinib hydrochloride pancreatic cancer diagnosis fertile patients must use effective contraception during six months after completion therapy
1, maleic acid stage iv adult hodgkin lymphoma diagnosis uncontrolled intercurrent illness including but not limited ongoing active infection requiring parenteral antibiotics on day one
1, cudc neuroblastoma diagnosis patients known history hiv hepatitis hepatitis testing not required part screening
1, sirolimus symptomatic pleural effusions symptomatic ascites
0, antibodies recurrent small lymphocytic lymphoma diagnosis must have failed two courses therapy
0, paclitaxel stage iii vulvar cancer diagnosis adequate hematopoietic cardiac renal hepatic function
1, paclitaxel non small cell lung cancer diagnosis this is final screening procedure
1, antibodies pancreatic neoplasms diagnosis any uncontrolled medical condition including presence laboratory abnormalities that places participant at unacceptable risk by participating confounds ability interpret data from study
0, bevacizumab carcinoma non small cell lung diagnosis postmenopausal women must have been amenorrheic at least twelve months be considered non childbearing potential
0, ar stage iv mantle cell lymphoma diagnosis patients mean qtcb greater four hundred fifty msec males greater four hundred seventy msec females
1, minocycline colon cancer diagnosis cannot communicated chinese mandarin
1, cyclosporine stage iii adult diffuse mixed cell lymphoma diagnosis donor
1, rgx malignant neoplasms diagnosis patient has cataract grade greater two posterior subcapsular cataract cortical cataract nuclear opalescence nuclear color based on lens opacities classification system iii locs iii
0, oxaliplatin colorectal cancer diagnosis hematopoietic
1, carboplatin fallopian tube cancer diagnosis participation an investigational drug within three weeks prior entry
1, antibodies monoclonal stage iv inflammatory breast carcinoma diagnosis patients who already received chemotherapy recurrent metastatic ibc not eligible
1, bevacizumab nephroid carcinoma diagnosis patients who received prior therapy vegf pathway inhibitor
0, bevacizumab recurrent squamous cell carcinoma larynx diagnosis platelet count greater seventy five zero mmÂ³
0, dacarbazine brain central nervous system tumors diagnosis patient must be willing provide tissue samples research purposes
0, docetaxel breast cancer diagnosis no concurrent cytokines during docetaxel bevacizumab administration
0, bortezomib has received no prior treatment any systemic therapy treatment multiple myeloma
0, cetuximab stage ivc nasal cavity paranasal sinus squamous cell carcinoma diagnosis able take aspirin eighty one three hundred twenty five mg daily prophylactic anticoagulation patients intolerant aspirin may use warfarin low molecular weight heparin
0, pembrolizumab mucosal melanoma diagnosis eastern cooperative oncology group ecog performance scale ps zero one karnofsky performance status greater zero
1, albumin bound paclitaxel breast cancer diagnosis prior radiation chemotherapy hormontherapy immunotherapy
1, antibodies monoclonal recurrent adult diffuse large cell lymphoma diagnosis chronic current infectious disease requiring systemic antibiotics antifungal anti viral treatment such but not limited chronic renal infection chronic chest infection bronchiectasis tuberculosis
1, dexamethasone acetate alk positive anaplastic large cell lymphoma sezary syndrome
1, irinotecan metastatic cancer diagnosis evidence central nervous system cns metastases
1, cetuximab oropharyngeal neoplasms diagnosis patient who is currently receiving treatment drugs known be moderate strong inhibitors inducers isoenzymes cypthirty foura cyptwoceight
0, cyclosporine childhood grade iii lymphomatoid granulomatosis diagnosis human leukocyte antigen hla genotypically phenotypically identical related donor
1, everolimus adult hepatocellular carcinoma diagnosis ace inhibitors allowed single agent bevacizumab cohort
0, interleukin advanced solid tumor diagnosis phase ii study
1, fludarabine phosphate stage iv adult diffuse large cell lymphoma diagnosis lansky play performance score less fifty pediatric patients
0, pain therapy cancer survivor diagnosis hemoglobin greater eleven dl
0, pharmacological recurrent renal cell cancer diagnosis ability provide informed consent
0, fulvestrant postmenopausal female participants histologically documented locally advanced metastatic pikthreeca mutant hr positive her negative breast cancer
0, paclitaxel breast cancer diagnosis eighteen over sex
1, immunoglobulin fc fragments recurrent ovarian carcinoma diagnosis stent placement
0, antibodies neuroblastoma diagnosis no grade three worse pulmonary toxicity
0, hspe cervical cancer diagnosis no other concurrent investigational commercial agents therapies intended treat cin
1, rituximab diffuse large cell lymphoma diagnosis unresolved toxicities greater grade two from previous therapy
1, tazemetostat relapsed refractory cell non hodgkin lymphoma diagnosis participant history presence central nerves invasion
0, dacarbazine brain neoplasms diagnosis all patients men women must agree use medically approved contraceptive measures simultaneously prior starting thalidomide therapy all during drug therapy at least one month after therapy has stopped
1, irinotecan colon cancer diagnosis hepatic arterial anatomy that would prevent catheterization administration sir spheres into liver
0, cyclosporins stage ii adult hodgkin lymphoma diagnosis cdfour count is allowed be greater one hundred cells ul
0, gemcitabine adult epithelioid sarcoma diagnosis hemoglobin greater equal nine dl doc mmol subjects may not have had transfusion within seven days screening assessment
1, aldesleukin stage iii multiple myeloma diagnosis presence medical complication that opinion investigators would result inability tolerate vaccination protocol
0, pemetrexed prostate cancer diagnosis evaluable disease by recist criteria at least one target non target lesion
1, octreotide untreated childhood visual pathway hypothalamic glioma diagnosis women who pregnant breastfeeding
0, niacinamide biliary tract cancer diagnosis any number previous lines chemotherapy is allowed phase portion
1, open traditional approach anal cancer diagnosis patients prohibitive cardiac pulmonary comorbidities
0, prednisone stage childhood small noncleaved cell lymphoma diagnosis not pregnant nursing
1, dasatinib chordoma diagnosis amiodarone sotalol ibutilide dofetilide
0, bb mpi smoldering multiple myeloma smm diagnosis igg greater three dl iga greater two dl flc ratio involved
0, dexamethasone acetate childhood medulloepithelioma diagnosis no prior gamma secretase inhibitor rofour million nine hundred twenty nine thousand ninety seven
1, obinutuzumab lymphoma diagnosis positive test results human lymphotropic one htlv one virus htlv testing is required patients from endemic countries japan countries caribbean basin south america central america sub saharan africa melanesia
0, antibodies recurrent colon cancer diagnosis one following histologically confirmed diagnoses
1, rituximab recurrent mantle cell lymphoma diagnosis patient has greater equal grade two peripheral neuropathy within fourteen days before enrollment at dsixty one hundred eighty after ahct patients who had greater equal grade two peripheral neuropathy within fourteen days before enrollment but resolves grade one lower peripheral neuropathy at dsixty done hundred eighty after ahct can be enrolled at this time
1, doxorubicin bone cancer diagnosis hiv positive patients will be excluded from due risk infection other serious side effects
1, entinostat bronchial neoplasms diagnosis patient has concomitant cardiovascular issue that precludes adequate treatment compliance increases patient risk
1, ergocalciferols non hodgkin lymphoma diagnosis bmd score less worse more negative than
0, interleukin recurrent mantle cell lymphoma diagnosis hemoglobin at least ten dl transfusion allowed
1, immunoglobulins stage iva uterine sarcoma diagnosis patients current serious non healing wound ulcer bone fracture
0, cyclophosphamide patients stage fours disease who very ill whom an open biopsy obtain tissue diagnosis biologic studies is considered medically contraindicated every effort should be made obtain some tumor tissue by either fine needle aspiration metastatic site disease sampling involved bone marrow so that this tumor sample can be submitted mycn determination
1, antibodies cervical adenocarcinoma diagnosis received oral intravenous iv antibiotics within two weeks prior cycle one day one patients receiving prophylactic antibiotics prevention urinary tract infection chronic obstructive pulmonary disease eligible
1, dexamethasone acetate intrahepatic cholangiocarcinoma diagnosis diagnosis gilbert disease
0, antibodies sarcoma diagnosis any age
0, alvespimycin hydrochloride stage iii esthesioneuroblastoma paranasal sinus nasal cavity diagnosis biochemical progression is defined minimum three rising psa values from baseline obtained at least one week apart two rising psa values obtained more one month apart greater equal two increase value
1, nelfinavir stage iib pancreatic cancer diagnosis sildenafil sildenafil shall not exceed maximum single dose twenty five mg forty eight hour period
1, proteasome inhibitors solid tumors diagnosis any condition which judgment investigator would place subject at undue risk interfere results make subject otherwise unsuitable risk factors neurological toxicities
0, dexamethasone prior therapy treatment solitary plasmacytoma is permitted but greater seven days should have elapsed from last day radiation
1, antibodies monoclonal stage iv adult diffuse mixed cell lymphoma diagnosis uncontrolled systemic vascular hypertension systolic blood pressure greater one hundred forty mmhg diastolic blood pressure greater ninety mmhg
1, dexamethasone phosphate multiple myeloma diagnosis doc female patients who lactating have positive serum pregnancy test during screening period positive urine pregnancy test on day one before first dose drug if applicable
0, succinylcholine hepatocellular carcinoma diagnosis patients may have been treated rfa past but no sooner four weeks before registration
0, dexamethasone phosphate stage iv adult lymphoblastic lymphoma diagnosis lly
1, antibodies monoclonal gastrointestinal cancer diagnosis prior treatment targeted therapy less equal thirty days
1, vinblastine breast cancer diagnosis evidence history bleeding diathesis coagulopathy
1, tacrolimus stage iv adult diffuse small cleaved cell lymphoma diagnosis fungal infections radiological progression after receipt amphotericin active triazole greater one month
0, vincristine recurrent adult diffuse small cleaved cell lymphoma diagnosis platelets greater equal fifty zero ul
1, trametinib recurrent solid neoplasm diagnosis treatment
1, doxorubicin epithelioid sarcoma diagnosis subjects any following cardiovascular conditions within past six months
1, cyclophosphamide recurrent adult immunoblastic large cell lymphoma diagnosis hiv htlv one positivity
0, cyclophosphamide lymphoma diagnosis life expectancy
1, trastuzumab stage iv breast cancer diagnosis new york heart association class ii greater congestive heart failure serious cardiac arrhythmia requiring medication unstable angina pectoris
0, cisplatin islet cell tumor diagnosis no investigational agent within past four weeks
1, hsppc kidney cancer diagnosis current malignancies any type other sites
1, comprehensive geriatric assessment recurrent breast carcinoma diagnosis any major surgery equal less twenty eight days prior initiation investigational products
1, immunoglobulins ovarian clear cell cystadenocarcinoma diagnosis patients clinically significant proteinuria urine protein should be screened by urine protein creatinine ratio upcr patients must have upcr less doc allow participation study
1, pertuzumab neuroendocrine tumors diagnosis male subject who is not willing use adequate contraception upon enrollment into this six months following last dose second line treatment
1, oxaliplatin stage ia pancreatic cancer diagnosis head pancreas
1, estrogens conjugated usp ductal breast carcinoma situ diagnosis active deep venous thrombosis pulmonary embolism retinal vascular thrombosis any arterial thrombosis including stroke myocardial infarction history these conditions
0, etoposide phosphate desmoplastic small round cell tumor diagnosis additional criteria group participants who will receive upfront window therapy does not apply participants who opt out window therapy
1, gemcitabine clear cell adenocarcinoma diagnosis this criterion applies only patients enrolled before august twenty nine two thousand eleven those enrolled after this date electing receive bevacizumab patients who have had major surgical procedure open biopsy dental extractions other dental surgery procedure that results an open wound significant traumatic injury within twenty eight days prior first date treatment on this anticipation need major surgical procedure during course patients placement vascular access device core biopsy within seven days prior first date treatment on this study
1, enb lung cancer diagnosis chest ct bronchoscopy shows that bronchial lumen occlusion deformation leading guided treatment equipment cannot reach peripheral lung lesion
1, carboplatin esophageal adenocarcinoma diagnosis male female patients reproductive potential need employ two highly effective acceptable forms contraception throughout their participation ninety days after last dose drug
1, liposomal doxorubicin extraosseous ewing sarcoma diagnosis pregnant women will not be entered on this pregnancy tests must be obtained female patients who post menarchal lactating females may not participate unless they have agreed not breastfeed their infants males females reproductive potential may not participate unless they have agreed use an effective contraceptive method duration treatment
1, ispinesib stage iiib colon cancer diagnosis amiodarone grapefruit juice bitter orange
0, cyclophosphamide non small cell lung cancer diagnosis seronegative hepatitis antigen seronegative hepatitis antibody
1, chemical exchange saturation transfer mri adult glioblastoma diagnosis patients who have any type bioimplant activated by mechanical electronic magnetic means cochlear implants pacemakers neurostimulators electronic infusion pumps etc because such devices may be displaced malfunction
1, sirolimus squamous cell lung cancer diagnosis radiation greater twenty five bone marrow
0, prednisone stage iii childhood hodgkin lymphoma diagnosis ast alt less doc times uln age
1, misonidazole adult glioblastoma diagnosis prior treatment implanted radiotherapy chemotherapy sources such wafers polifeprosan twenty carmustine
1, cyclosporins refractory multiple myeloma diagnosis human immunodeficiency virus hiv positive patients
0, interleukin melanoma skin diagnosis hepatic
1, eribulin mesylate stage iiib non small cell lung cancer diagnosis absolute neutrophil count greater one five hundred mmÂ³
0, mycophenolic acid hepatocellular carcinoma diagnosis hla matched haploidentical parent child sibling half sibling recipient
0, nivolumab head neck squamous cell carcinoma hnscc diagnosis immunosuppressive doses systemic medication such steroids absorbed topical steroids doses greater tenmg day prednisone equivalent must be discontinued at least fourteen days prior nivolumab administration
0, everolimus stage iii multiple myeloma diagnosis bone marrow plasmacytosis ten twenty nine
1, fludarabine myelodysplastic myeloproliferative neoplasm diagnosis individuals deemed unable undergo marrow harvesting pbsc mobilization leukapheresis
1, uniportal vats patients tumor invasion peripheral structures
1, extended hypofractionation radiotherapy history an invasive malignancy other this prostate cancer nonmetastatic basal squamous skin cancers last five years
1, bb multiple myeloma diagnosis patients prior use lenalidomide
1, immunoglobulins stage ii diffuse large cell lymphoma diagnosis has received live vaccine within thirty days prior first dose trial treatment
1, lenalidomide stage multiple myeloma diagnosis subjects known suspected amyloidosis any organ
1, dactinomycin untreated childhood rhabdomyosarcoma diagnosis patients evidence uncontrolled infection not eligible
1, pembrolizumab stage iiia hepatocellular carcinoma diagnosis active systemic immunosuppressive therapy
0, bevacizumab colon cancer liver metastasis diagnosis absence major hepatic insufficiency bilirubin less doc uln aspartate aminotransferase asat alanine aminotransferase alat less five uln
1, lee lymphomas diagnosis clinically significant resting bradycardia
1, calcium dietary stage prostate cancer diagnosis known cerebrovascular accidents within six months before day one treatment
1, sirolimus lymphoma small lymphocytic diagnosis bilirubin less threex institution upper limit normal except when gilbert syndrome hemolysis is present
1, bevacizumab anaplastic astrocytoma aa diagnosis men women childbearing potential who unwilling unable use an acceptable method avoid pregnancy entire period up minimum four months following last plerixafor dose six months following last bevacizumab dose
1, fluorouracil colonic neoplasms diagnosis linical uncontrolled active infection such acute pneumonia active hepatitis b
0, paclitaxel recurrent breast carcinoma diagnosis wp chemotherapy regimen lvef must be greater equal fifty five regardless cardiac imaging facility lower limit normal
0, cintredekin besudotox brain central nervous system tumors diagnosis radiotherapy
0, cyclosporine noncontiguous stage ii adult burkitt lymphoma diagnosis myelodysplastic syndromes at any following stages
1, vitamins stage iv colon cancer resectable liver metastases diagnosis known positive test human immunodeficiency virus hiv hepatitis virus acute chronic hepatitis infection
0, cyclosporine stage iiib colorectal cancer diagnosis patient must have measurable lesions defined by recist version doc criteria
0, pembrolizumab peritoneal cancer diagnosis hemoglobin greater nine dl greater doc mmol without transfusion epo dependency within seven days assessment
1, antibodies recurrent childhood anaplastic large cell lymphoma diagnosis patients active bacterial fungal infections unresponsive medical therapy
0, atlcar cd cells lymphoma diagnosis absolute neutrophil count anc greater five hundred cells mmthree three consecutive days note
1, antibodies clinically active brain metastases defined untreated symptomatic requiring therapy steroids anticonvulsants control associated symptoms
1, rituximab stage ii grade two contiguous follicular lymphoma diagnosis active infection hepatitis virus hcv
1, sham stimulation nonsmall cell lung cancer diagnosis patients who cannot coordinate investigators such dysphasia severe infectious disease disturbance consciousness
1, albumin bound paclitaxel ovarian neoplasms diagnosis requires administration prohibited medication treatment including
0, carboplatin ovarian sex cord stromal tumor mixed unclassified cell types diagnosis neuropathy sensory motor less equal ctcae grade one
0, cyclosporine multiple myeloma plasma cell neoplasm diagnosis stage iii iv disease
1, maytansine advanced breast cancer diagnosis pregnant breast feeding subjects
1, cpk dosage cancer diagnosis patient treated malignant hemopathy
0, lenalidomide ds stage iii plasma cell myeloma diagnosis patients should be between thirty days one hundred twenty days after transplant
0, ibrutinib contiguous stage ii mantle cell lymphoma diagnosis patients must have ability understand willingness sign written informed consent prior registration on study
0, bortezomib recurrent marginal zone lymphoma diagnosis ast alt less doc times upper limit normal uln five times uln presence liver metastases
0, hydroxyurea stage iii squamous cell carcinoma hypopharynx diagnosis karnofsky sixty one hundred
1, hydrocortisone acetate male breast cancer survivors
1, docetaxel adenocarcinoma gastro oesophageal junction diagnosis major surgery within four weeks start treatment serious not healing wound
0, carboplatin recurrent breast carcinoma diagnosis serum creatinine equal less doc mg dl
1, vaccines melanoma diagnosis this is consistent existing standards practice vaccine chemotherapy protocols
0, rf psa prostate neoplasm diagnosis patients less thirty years age physician certification prior smallpox immunization is required
1, liposomal doxorubicin stage iv childhood lymphoblastic lymphoma diagnosis pregnant lactating females ineligible
0, carboplatin brain central nervous system tumors diagnosis fibrillary protoplasmic mixed
0, lenalidomide recurrent metastatic squamous cell carcinoma neck occult primary diagnosis patients must have histologically cytologically confirmed malignancy that is metastatic unresectable which standard curative palliative measures not exist no longer effective eligible malignancies include
1, letrozole progesterone receptor positive breast cancer diagnosis female patients who pregnant breast feeding adults reproductive potential who not using effective birth control methods if barrier contraceptives being used these must be continued throughout trial by both sexes hormonal contraceptives not acceptable sole method contraception women childbearing potential must have negative urine serum pregnancy test within seven days prior administration everolimus
1, iodinated contrast dye prior medical treatment invasive cervical cancer
1, ispinesib stage ivb squamous cell carcinoma paranasal sinus nasal cavity diagnosis history allergic reactions attributed compounds similar chemical biologic composition sb seven hundred fifteen thousand nine hundred ninety two
0, bevacizumab lung cancer diagnosis low dose warfarin heparin deep venous thrombosis prophylaxis allowed
0, liposomal doxorubicin recurrent salivary gland cancer diagnosis see chemotherapy
1, antibodies monoclonal ongoing planned systemic anti cancer therapy radiation therapy
0, antibodies recurrent cell non hodgkin lymphoma diagnosis patients must have performance status zero one two according eastern cooperative oncology group
1, vaccines recurrent prostate cancer diagnosis known allergy cold
1, bortezomib non small cell lung cancer diagnosis prior exposure either velcade vorinostat
0, laboratory biomarker analysis breast cancer diagnosis patients undergoing allogeneic sct
1, cyclophosphamide metastatic cancer diagnosis any form primary immunodeficiency such severe combined immunodeficiency disease
1, placebo colorectal cancer diagnosis wbc doc one hundred nine anc doc one hundred nine plt one hundred one hundred nine hb ninetyg tbil doc limitation bun doc limitation cr doc limitation alt ast doc limitation without liver metastasis alt ast fivelimitation liver metastasis
1, liposomal doxorubicin breast cancer diagnosis patients distant metastatic disease will be excluded
1, analgesics opioid pain related cancer diagnosis patient treated medication that may result an interaction methadone such as
1, mycophenolate mofetil recurrent adult diffuse large cell lymphoma diagnosis donors less twelve years age
1, fludarabine phosphate lymphoma low grade diagnosis no evidence progressive disease defined twenty five increase from nadir sum product diameters spd any lymph node previously identified abnormal prior autologous transplant appearance any new lymph node greater doc cm greatest diameter new bone marrow involvement new solid organ nodule greater one cm diameter
0, antibodies recurrent metastatic squamous neck cancer occult primary diagnosis hemoglobin greater equal nine dl
0, deferasirox recurrent adult diffuse mixed cell lymphoma diagnosis albumin greater equal two dl
1, carboplatin untreated stage iii melanoma stage iv melanoma diagnosis any non oncology vaccine therapy used prevention infectious diseases up one month before after any dose ipilimumab
0, docetaxel breast cancer diagnosis lvef greater fifty by echocardiogram muga scan
0, fluorouracil pancreatic cancer diagnosis bilirubin less two times upper limit normal uln
1, bortezomib extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis ecog performance status ps three four
0, letrozole stage iiic breast cancer diagnosis patient must be willing undergo oophorectomy if indicated
0, cyclophosphamide recurrent adult grade iii lymphomatoid granulomatosis diagnosis aplastic anemia
1, tanespimycin anaplastic large cell lymphoma diagnosis no prior pulmonary symptoms greater equal grade two
1, irinotecan early stage cancer tone nzero
1, desipramine small cell lung cancer diagnosis strong inhibitors cytochrome pfour hundred fifty cyptwodsix see appendix c
1, exemestane second malignancy except basal skin carcinoma cervical situ carcinoma adequately treated
1, jcar dose schedule mantle cell lymphoma diagnosis presence graft vs host disease gvhd
0, cyclophosphamide multiple myeloma diagnosis patients must have adequate hepatic function defined serum transaminases less two uln direct bilirubin less doc mg dl
0, vincristine lymphoma diagnosis not specified other
0, calcium dietary stage iic rectal cancer diagnosis female patients should not be pregnant breast feeding
0, imatinib mesylate lung cancer diagnosis no prior radiotherapy target measurable lesion unless there is documented disease progression
0, etoposide extranodal nk cell lymphoma nasal type diagnosis stage iv disease at least one measurable lesion
0, bevacizumab unspecified adult solid tumor protocol specific diagnosis severe peripheral vascular disease claudication procedure on peripheral vasculature
0, liposomal doxorubicin stage iiia breast cancer diagnosis ecog performance status equal less two karnofsky greater equal sixty
1, placebo gastro intestinal stromal tumour diagnosis patient progressed under imatinib adjuvant therapy
0, capecitabine localized non resectable adult liver carcinoma diagnosis patients known history current evidence retinal vein occlusion rvo retinal pigment epithelial detachment rped not eligible
1, nivolumab malignant female reproductive system neoplasm diagnosis subjects brain metastases eligible if these have been treated there is no magnetic resonance imaging mri except where contraindicated which ct scan is acceptable evidence progression at least eight weeks after treatment is complete within eight days prior first dose drug administration
0, quality life assessment stage iia breast cancer diagnosis have co survivor friend family member willing participate this research study
1, carboplatin non small cell lung cancer diagnosis patients active brain metastases
1, immunoglobulin idiotypes neoplasm diagnosis patient unwilling give informed consent
1, trebananib glioblastoma multiforme diagnosis clinically significant cardiovascular disease within twelve months prior enrollment including myocardial infarction unstable angina grade two greater peripheral vascular disease cerebrovascular accident transient ischemic attack congestive heart failure arrhythmias not controlled by outpatient medication percutaneous transluminal coronary angioplasty stent
1, questionnaire breast cancer female diagnosis patient is not eligible avoid surgery if biopsy breast following nst demonstrates residual invasive situ disease
0, idarubicin age over sixty performance status greater one any elevation ldh more one extranodal site ann arbor stage iii iv negative cell nhl eligible if meeting all above criteria no primary cns lymphoma brain involvement eligible if not primary
0, antibodies stage ivb hodgkin lymphoma diagnosis all stages except ia not bulky disease if involved field is considered radiotherapy rt curative
0, cyclosporine stage marginal zone lymphoma diagnosis donor
1, doxorubicin breast cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition paclitaxel trastuzumab pertuzumab
0, edetic acid recurrent prostate carcinoma diagnosis rising psa after definitive therapy prostatectomy radiation therapy external beam brachytherapy
0, endothelial growth factors adult gliosarcoma diagnosis myocardial infarction coronary artery bypass graft unstable angina
1, gemcitabine histological evidence hepatocellular carcinoma hcc
1, lapatinib acoustic neuroma diagnosis subjects who have been free disease any prior malignancy five years eligible this study
1, talaporfin carcinoma hepatocellular diagnosis diffuse hcc
1, tdt mediated dutp nick end labeling assay stage iv melanoma diagnosis prior entry any ecg abnormality at screening has be documented by investigator not medically relevant
0, ifosfamide solid tumors diagnosis patients childbearing potential defined not post menopausal twelve months no previous surgical sterilization must have negative pregnancy test use adequate birth control
0, carboplatin stage iia gastric cancer diagnosis female patients childbearing potential must be willing use two methods birth control be surgically sterile abstain from heterosexual activity course through two days after last dose medication
1, mycophenolic acid recurrent adult lymphoblastic lymphoma diagnosis any leukemia morphologic relapse persistent disease bm greater equal twenty blasts cytogenetic relapse without morphologic evidence relapse cytogenetic persistent disease is acceptable
1, cediranib stage iv non small cell lung cancer diagnosis patients who have had systemic therapy radiotherapy major surgery within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
0, docetaxel stage iiib gallbladder cancer diagnosis arm cohort four
1, gemcitabine recurrent primary peritoneal cancer diagnosis at least twenty increase sum longest diameter target lesions taking reference smallest sum longest diameter recorded since treatment started appearance one more new lesions
0, melphalan refractory relapsed metastatic solid tumors diagnosis event that two more eligible donors identified following order priority will be used determine preferred donor
1, dexamethasone stage oropharyngeal squamous cell carcinoma diagnosis chronic alcohol abuse greater six alcoholic beverages daily
1, melphalan renal cell carcinoma diagnosis female only breast feeding
1, vitamin b b cell lymphoma diagnosis positive diagnosis cdfour less one hundred detectable viral load within past three months receiving anti retroviral therapy
0, paclitaxel recurrent non small cell lung cancer diagnosis patients history hypertension must be well controlled less one hundred fifty one hundred on stable regimen anti hypertensive therapy
0, antibodies uterine cervical cancer diagnosis within normal limits
0, biliodigestive anastomosis local tumor spread diagnosis adequate bone marrow reserves
1, succinylcholine patients who have residual toxicity ities from previous anti cancer treatment that is clinically significant greater grade one excluded those whose toxicity ities improved grade one better will be eligible
1, fulvestrant stage ia breast cancer diagnosis psychiatric illness which would prevent patient from giving informed consent
0, sirolimus doc patients advanced metastatic cancer that is refractory standard therapy relapsed after standard therapy have no standard therapy that induces cr rate at least ten improves survival by at least three months
0, albumin bound paclitaxel lung cancer diagnosis no active uncontrolled infection
0, immunoglobulins stage iv midline lethal granuloma paranasal sinus nasal cavity diagnosis more twelve weeks
1, fosbretabulin neoplasms ovarian diagnosis ongoing grade greater two toxic manifestations previous treatments
0, fludarabine phosphate stage iii adult diffuse small cleaved cell lymphoma diagnosis there is likelihood rapid disease progression while hla typing results preliminary search donor pool suggests that ten ten hla b drbone dqbone matched unrelated donor will not be found
0, cytarabine peripheral cell lymphoma diagnosis rituximab equal sixty six days epratuzumab equal sixty nine days
0, inject autologous adipose derived stem cells having any sign symptom that suggest investigator non healing adenocarcinoma
1, niacinamide breast cancer diagnosis cardiac ventricular arrhythmias requiring anti arrhythmic therapy
1, everolimus stage iv mucoepidermoid carcinoma oral cavity diagnosis chronic treatment systemic steroids another immunosuppressive agent
1, mycophenolic acid stage grade three follicular lymphoma diagnosis patient donor active hepatitis or detectable viral ribonucleic acid rna
0, bevacizumab gastric cancer diagnosis absolute neutrophil count greater one five hundred mm three
0, doxorubicin extraosseous ewing sarcoma diagnosis six less ten years
0, fluorouracil stage iiia gastric cancer diagnosis patients after menarche amenorrhea irregular cycles using contraceptive method that precludes withdrawal bleeding
0, antibodies stage iiia ovarian cancer diagnosis platelets greater equal one hundred zero mcl
0, immunoglobulins recurrent ovarian carcinoma diagnosis bilirubin equal less doc uln
1, dexamethasone acetate solid tumors diagnosis heart failure exacerbation at time enrollment
1, pemetrexed carcinoma ductal diagnosis currently pregnant breast feeding
1, capecitabine previous concomitant malignant neoplasia within five years prior basal evaluation excluding adequately treated basocellular spinocellular skin carcinoma situ carcinoma uterine cervix
1, placebo stage iib breast cancer diagnosis currently taking spironolactone
0, sirolimus stage iiic ovarian epithelial cancer diagnosis absolute neutrophil count anc greater equal one zero ul
1, pembrolizumab stage iii differentiated thyroid gland carcinoma diagnosis unwilling unable use two methods birth control be surgically sterile abstain from heterosexual activity course through two days after last dose medication note
1, sulfatinib neuroendocrine tumors diagnosis surgery except biopsy within twenty eight days prior initiation investigational treatment unhealed surgical incision
0, bevacizumab recurrent salivary gland carcinoma diagnosis upc ratio one is roughly equivalent twenty four hour urine protein one gm
1, isophosphamide mustard synovial sarcoma diagnosis cytochrome pfour hundred fifty threeafour cypthreeafour substrates narrow therapeutic indices
0, vinblastine lymphoma diagnosis hiv negative
0, isophosphamide mustard childhood supratentorial primitive neuroectodermal tumor diagnosis total bilirubin less doc upper limit normal uln age
1, cortisone stage iv diffuse large cell lymphoma diagnosis has received live vaccine within thirty days prior first dose trial treatment
0, cediranib recurrent childhood subependymal giant cell astrocytoma diagnosis at least one week since prior filgrastim csf sargramostim gm csf epoetin alfa two weeks pegfilgrastim
0, leucovorin tumor tissue primary metastasis typological classified ras wildtype codon twelve thirteen exon one at real time pcr
0, pemetrexed non small cell lung cancer diagnosis organs functioning well bone marrow reserve liver kidney lung
0, doxorubicin stage iv childhood large cell lymphoma diagnosis no known history congenital immune deficiency laboratory evidence acquired immune deficiency
0, levoleucovorin colorectal cancer diagnosis not specified
0, nivolumab tumor tissue sections must be available biomarker evaluation
0, everolimus prostatic neoplasms diagnosis progressive disease defined psa progression by confirmed rising psa levels
1, antibodies monoclonal lymphoma diagnosis clinically significant unrelated systemic illness such serious infections organ dysfunction which judgment principal associate investigators would compromise patient ability tolerate agents this trial likely interfere procedures results
1, paclitaxel metastatic breast cancer diagnosis known history bleeding diathesis coagulopathy eg von willebrand disease hemophilia
0, mycophenolate mofetil stage childhood anaplastic large cell lymphoma diagnosis patients will be accepted beyond chronic phase one cpone if they have received previous myelosuppressive chemotherapy hsct have less five marrow blasts at time transplant
0, oxaliplatin duct cell adenocarcinoma pancreas diagnosis radiographic evidence metastatic disease distant organs such masses distant organs ascites
0, doxorubicin breast cancer diagnosis hormone receptor status
1, bendamustine hydrochloride mantle cell lymphoma mcl diagnosis concurrent participation another therapeutic clinical trial
1, fludarabine stage iii childhood lymphoblastic lymphoma diagnosis donor
1, thalidomide thyroid neoplasms diagnosis patients may not have had prior revlimid therapy
0, cyclosporins adult grade iii lymphomatoid granulomatosis diagnosis patients will be accepted chronic phase accelerated phase patients who have received prior autografts after high dose therapy have undergone intensive chemotherapy filgrastim csf mobilized peripheral blood mononuclear cells pbmc autologous conventional hct advanced cml may be enrolled provided they cr cp have less five marrow blasts at time transplant
0, mechlorethamine non hodgkin lymphoma nhl diagnosis regarding donation eligibility is identified either
0, everolimus liver cancer diagnosis not pregnant nursing
0, lenograstim rhabdomyosarcoma diagnosis disseminated at diagnosis relapsed
1, fludarabine phosphate stage childhood lymphoblastic lymphoma diagnosis diffusion capacity carbon monoxide dlco less forty total lung capacity tlc less forty forced expiratory volume one second fevone less forty receiving supplementary continuous oxygen
0, tetrahydrofolates unresectable pancreatic carcinoma diagnosis platelets greater equal one hundred zero
0, irinotecan stage ivb cervical cancer diagnosis no chronic unconjugated hyperbilirubinemia
0, goal directed fluid therapy edwards ev system liver cancer diagnosis adults eighteen years old greater who able provide informed consent
0, lenograstim yolk sac tumor diagnosis bilirubin less doc upper limits normal uln
1, paclitaxel stage ii breast cancer diagnosis known hypersensitivity any component avastin gemcitabine other required drugs study
0, laboratory biomarker analysis childhood grade iii meningioma diagnosis alt less forty five l
1, camptothecin colorectal carcinoma diagnosis patients previous chronic inflammatory bowel disease chronic diarrhea recurrent bowel obstruction
0, alvocidib stage iii pancreatic cancer diagnosis no cardiac arrhythmia
0, epoetin alfa neoplasms diagnosis baseline hemoglobin value less equal eleven dl unrelated transfusion
0, temozolomide surgically confirmed diagnosis malignant glioma specifically anaplastic glioma anaplastic astrocytoma aa anaplastic oligodendroglioma ao anaplastic oligoastrocytoma aoa glioblastoma multiforme gbm
1, liposomal doxorubicin recurrent primary peritoneal carcinoma diagnosis any prior history hypertensive crisis hypertensive encephalopathy
1, everolimus male breast cancer diagnosis patients who have had major surgery significant traumatic injury within four weeks start drug patients who have not recovered from side effects any major surgery defined requiring general anesthesia patients that may require major surgery during course study
1, lenvatinib advanced cancer diagnosis poorly controlled hypertension defined requiring changes any hypertensive regimen within one week entry patients diagnosed hypertension based on repeat blood pressure measurements greater one ninety mmhg at screening
0, cyclosporine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis donors
1, busulfan stage iii multiple myeloma diagnosis potential donors who psychological physiological medical reasons cannot tolerate administration csf apheresis
1, antibodies monoclonal stage ivc squamous cell carcinoma oropharynx diagnosis history allogeneic transplant
1, modafinil triple negative breast cancer diagnosis involvement planning conduct applies both astrazeneca staff staff at site
1, behavioral intervention ovarian sarcoma diagnosis non ambulatory
0, letrozole breast cancer diagnosis one prior systemic therapy metastatic setting is allowed but patients who have not had any prior systemic therapies metastatic setting also eligible
0, prednisolone lymphoma diagnosis patients mds that present evolve aml must be re induced back remission prior initiating search an unrelated donor note
1, fludarabine recurrent plasma cell myeloma diagnosis patients available hla matched related donors
0, genistein prostate cancer diagnosis ecog zero one
0, methotrexate stage iii small lymphocytic lymphoma diagnosis inclusion
0, antilymphocyte serum lymphoma diagnosis any who classification histologic subtype
0, interleukin non hodgkin lymphoma diagnosis patient is not deemed eligible if there is any other serious medical psychiatric illness that would prevent informed consent
1, cyclophosphamide ovarian carcinoma diagnosis subjects who require likely require more two week course corticosteroids intercurrent illness
0, bevacizumab signet ring adenocarcinoma colon diagnosis ecog performance status equal less one karnofsky greater equal sixty
1, isophosphamide mustard undifferentiated embryonal sarcoma diagnosis subjects any condition that may impair ability swallow absorb oral medications investigational product including
1, laboratory biomarker analysis sarcoma differentiation score two diagnosis known active central nervous system cns metastases patients previously treated brain metastases may participate provided they stable without evidence progression by imaging at least four weeks prior first dose trial treatment any neurologic symptoms have returned baseline have no evidence new enlarging brain metastases not using steroids greater ten mg day prednisone equivalent
0, hormones recurrent prostate cancer diagnosis subjects must be able take oral medications
1, cyclosporine testicular lymphoma diagnosis patients other disease organ dysfunction that would limit survival less thirty days
1, transoral robotic surgery oropharyngeal squamous cell carcinoma diagnosis metastatic disease
0, bevacizumab non small cell lung cancer diagnosis urine protein
0, lenograstim supra tentorial primative neuro ectodermal tumor pnet diagnosis ast alt less doc upper limits normal uln if hepatic involvement less five uln bilirubin less doc upper limits normal uln
0, succinylcholine if bone scan is used solitary lesions which could be contributed causes other prostate cancer must be confirmed second modality
1, dexamethasone phosphate multiple myeloma diagnosis qtc interval greater four hundred eighty milliseconds
0, vincristine lymphoblastic lymphoma diagnosis medullary blasts rate less twenty
0, veliparib stage iva colon cancer diagnosis life expectancy greater twelve weeks
1, cyclosporine t cell non hodgkin lymphoma diagnosis acute leukemia not remission
0, incb diffuse large cell lymphoma diagnosis any dlbcl subtype
0, antibodies monoclonal adult primary hepatocellular carcinoma diagnosis no clinical encephalopathy
1, immunoglobulins malignant ovarian mixed epithelial tumor diagnosis persistent gastrointestinal symptoms resulting from clostridia difficile enterocolitis bowel surgery which may increase gastrointestinal toxicity from bevacizumab hearing loss neuropathy which would prevent tolerance cisplatin paclitaxel administration investigator should feel free consult chair co chairs uncertainty this regard twelve twenty ten
0, vaccines recurrent prostate carcinoma diagnosis five alpha reductase inhibitors
1, bexarotene patients must be disease free from prior malignancies greater five years except curatively treated basal cell squamous cell carcinoma skin carcinoma situ cervix
0, sirolimus stage iv melanoma diagnosis patients hyperlipidemia must have adequate control lipid lowering agent
0, gemcitabine ovarian brenner tumor diagnosis patients must have had complete response front line platinum taxane therapy at least three cycles
0, entinostat stage iiia non small cell lung cancer diagnosis creatinine within normal institutional limits creatinine clearance greater equal sixty ml min doc three two patients creatinine levels above institutional normal
0, dietary protein colorectal cancer diagnosis able complete all baseline assessments within two weeks commencement chemotherapy chemoradiotherapy radiotherapy when applicable
0, ifosfamide metastatic ewing sarcoma diagnosis contralateral pleural effusion contralateral pleural nodules
0, liposomal doxorubicin sclerosing epithelioid fibrosarcoma diagnosis patients meeting above criteria histology size grade exception histologies noted above may enroll on chemotherapy cohort non chemotherapy cohort at discretion enrolling investigator patients meeting these criteria exception histologies noted above but medically deemed unable receive chemotherapy who elect not receive chemotherapy eligible non chemotherapy cohort
1, paclitaxel breast neoplasm diagnosis recurrence free interval less one year if previous adjuvant neoadjuvant regimen contained taxane
1, sorafenib glioblastoma diagnosis corrected qt qtc greater four hundred eighty ms grade two greater on screening electrocardiogram ecg
0, epirubicin breast cancer diagnosis repeated core needle biopsy permitted
1, resistance bands adolescent young adult cancers diagnosis patients unable provide informed consent
0, aldesleukin unspecified adult solid tumor protocol specific diagnosis at least four weeks since prior chemotherapy endocrine therapy
1, albumin bound paclitaxel carcinoma non small cell lung diagnosis potential participants may not enroll be actively receiving treatment from therapeutic clinical trial
1, epothilones metastatic breast cancer diagnosis four weeks first dose drugs anticipation need
1, prednisone multiple myeloma diagnosis corticosteroids greater ten mg day prednisone equivalent within twenty one days enrollment
0, gemcitabine cancer pancreas diagnosis presence metastasis lymph nodes beyond field resection
0, high risk factors unspecified adult solid tumor protocol specific diagnosis nci zero zero 
0, interleukin malignant melanoma diagnosis ecog performance status zero one
0, thalidomide multiple myeloma diagnosis total bilirubin
0, cisplatin mesothelioma diagnosis age greater eighteen years
0, interferon beta anaplastic astrocytoma diagnosis must be greater equal eighteen years age
0, antineoplaston a lung cancer diagnosis no severe lung disease chronic obstructive pulmonary disease
0, succinylcholine stage iv bladder cancer diagnosis eastern cooperative oncology group ecog performance status equal less one
0, maleic acid unresectable extrahepatic bile duct cancer diagnosis patients must have measurable disease defined at least one lesion that can be accurately measured at least one dimension longest diameter be recorded greater twenty mm conventional techniques greater ten mm spiral ct scan
1, lapatinib stage iiib breast cancer diagnosis patients may not be receiving any other investigational agents
0, vinblastine metastatic breast cancer diagnosis clinically measurable disease defined unidimensionally measurable lesions clearly defined margins on ray ct scan mri physical examination
0, antibodies monoclonal patients burkitt leukemia lymphoma mature cell leukemia not eligible
0, alvespimycin hydrochloride recurrent esthesioneuroblastoma paranasal sinus nasal cavity diagnosis ovary
0, fludarabine phosphate recurrent follicular lymphoma diagnosis patients will undergo standard pre transplant work up dictated by standard practice guidelines results which may be used screening this study
1, poly adp ribose polymerase inhibitors childhood craniopharyngioma diagnosis absolute neutrophil count anc greater one five hundred mm three
1, vidarabine stage iii mantle cell lymphoma diagnosis addition cytotoxic agents cytoreduction exception hydroxyurea imatinib mesylate will not be allowed within two weeks initiation conditioning
1, tacrolimus refractory hodgkin lymphoma diagnosis donor
1, mk once weekly solid tumors diagnosis is currently participating has participated an investigational compound device within twenty eight days
1, denosumab giant cell tumor bone diagnosis subject is pregnant breast feeding planning become pregnant within five months after end treatment
1, fludarabine phosphate stage iv adult diffuse large cell lymphoma diagnosis karnofsky performance status less seventy adults lanksy score less fifty pediatrics
0, immunoglobulin g stage iiia ovarian cancer diagnosis patients must be greater equal four weeks from treatment show progressive disease liver after regional therapy must have measurable disease outside liver
0, isophosphamide mustard retinoblastoma diagnosis glomerular flow rate gfr greater fifty ml min doc threem two serum creatinine less doc upper limit normal uln age
0, antibodies adult rhabdomyosarcoma diagnosis patients may have received prior therapy oral tyrosine kinase inhibitors other similar agents at least seven days must have elapsed since completion therapy biologic agent all toxicities must have resolved less grade two prior enrollment
1, pembrolizumab gastric cancer diagnosis has received prior therapy an anti pd one anti pd lone anti pd ltwo agent
0, cyclophosphamide noncontiguous stage ii small lymphocytic lymphoma diagnosis patients previously harvested hematopoietic stem cells while complete partial remission case patients stable refractory disease undergoing autologous transplantation because it has been recommended by their treating physician representing their best treatment option goal at minimum two ten six cluster differentiation cd thirty four positive peripheral primed stem cells per kilogram actual body weight
1, bicalutamide castrate resistant prostate cancer crpc diagnosis significant vascular disease eg aortic aneurysm aortic dissection
0, dexamethasone phosphate mantle cell lymphoma diagnosis confirmed pathological diagnosis mcl according who classification
0, fluorouracil adenocarcinoma esophagus diagnosis may have had prior surgery radiation therapy combined modality chem negative radiation at most one prior chemotherapy regimen advanced recurrent metastatic disease
1, romidepsin recurrent hodgkin lymphoma diagnosis john wort within fourteen days prior first dose mlneight thousand two hundred thirty seven during patients must be cautiously co medicated agents that cause corrected qt interval qtc prolongation agents that strong moderate enzyme inhibitors during study
1, antibodies monoclonal breast cancer diagnosis patients receiving prophylactic antibiotics prevention urinary tract infection prevent chronic obstructive pulmonary disease exacerbation eligible
0, n n diethylnorspermine peripheral cell lymphoma
1, histone deacetylase inhibitors childhood solid neoplasm diagnosis patients who not able swallow intact tablets not eligible
1, mycophenolic acid adult nasal type extranodal nk cell lymphoma diagnosis adult
1, immunoglobulin g stage iv fallopian tube cancer diagnosis left ventricular ejection fraction lvef equal less fifty five determined by multi gated acquisition muga scan echocardiogram echo
1, scoring acute toxicity primary non operated squamous cell carcinoma hypopharynx diagnosis distant metastases
1, wild type reovirus recurrent primitive neuroectodermal tumor diagnosis males post menarchal females who unwilling employ adequate contraception throughout duration at least four weeks after treatment has ended
1, stereotactic body radiation therapy stage ivc hypopharyngeal squamous cell carcinoma diagnosis patients who receiving any other investigational agents
1, laboratory biomarker analysis stage iva thyroid gland undifferentiated anaplastic carcinoma diagnosis corrected qt interval qtc prolongation defined qtc interval greater equal four hundred eighty msecs other significant electrocardiogram ecg abnormalities frequent ventricular ectopy evidence ongoing myocardial ischemia note
0, thalidomide small lymphocytic lymphoma sll diagnosis prior therapy rituximab is permitted even setting rituximab refractory disease
0, docetaxel cervical cancer diagnosis performance status
0, vincristine multiple myleoma diagnosis donors less eighteen years old legal guardian must be able provide informed consent
0, recombinant interleukin kidney cancer diagnosis life expectancy greater three months
0, bortezomib stage iii grade one follicular lymphoma diagnosis no other concurrent investigational therapy
1, hpph stage papillary thyroid cancer diagnosis prothrombin time doc times above upper normal limit
0, albumin bound paclitaxel fallopian tube cancer diagnosis hematopoietic
0, romidepsin stage ii cutaneous cell non hodgkin lymphoma diagnosis note
1, stereotactic ablative radiotherapy metastatic tumors diagnosis prior radiotherapy site requiring treatment
0, tamoxifen breast cancer diagnosis not pregnant nursing
0, tacrolimus multiple myeloma plasma cell neoplasm diagnosis fertile patients must use effective contraception during six months after completion treatment
0, etoposide stage iii adrenocortical carcinoma diagnosis lansky performance status sixty one hundred patients less sixteen years old
1, rituximab stage iv grade two follicular lymphoma diagnosis patient has active central nervous system cns disease
1, belinostat stage iii small lymphocytic lymphoma diagnosis patients who have history serious ventricular arrhythmia vt vf greater equal three beats row qtc greater equal four hundred fifty msec men four hundred seventy msec women history long qt syndrome
0, rituximab lymphoma diagnosis disease characteristics
1, dexamethasone acetate multiple myeloma diagnosis if mm related enrolling investigator must document this
0, pedsql cancer module lymphoma non hodgkin diagnosis patient being treated at st
0, oxaliplatin metastatic colorectal adenocarcinoma diagnosis completed team geriatric questionnaire including spitzer qol index
1, immunoglobulins recurrent adult diffuse mixed cell lymphoma diagnosis known john cunningham jc virus infection progressive multifocal leukoencephalopathy pml
0, pentetic acid lymphoma diagnosis not specified
1, antibodies monoclonal melanoma diagnosis have severe cardiovascular disease ie
0, vaccines neuroblastoma diagnosis endocrine therapy
1, fulvestrant breast neoplasms diagnosis if unavoidable patients taking cypthreeafour inhibitors should be monitored closely
0, carboplatin primary peritoneal cavity cancer diagnosis ast alt less doc times upper limit normal uln
0, etoposide phosphate neuroblastoma diagnosis age more eighteen months greater five hundred forty seven days regardless biologic features age twelve eighteen months three hundred sixty five five hundred forty seven days any unfavorable biologic feature mycn amplification unfavorable pathology dna index equal one any biologic feature that is indeterminant unsatisfactory unknown
1, antibodies stage ivc verrucous carcinoma oral cavity diagnosis clinically significant cardiac disease congestive heart failure unstable uncontrolled angina myocardial infarction within six months dosing vtx two thousand three hundred thirty seven
1, hormones hormone refractory prostate cancer diagnosis patients uncontrolled hypertension
0, fluorouracil stage iva squamous cell carcinoma oropharynx diagnosis hpv testing using an esix eseven based assay is preferred does not require any validation hpv situ hybridization ish hpv esix eseven polymerase chain reaction pcr
0, trastuzumab confirmed adenocarcinoma breast
1, treatment group stomach neoplasms diagnosis bone marrow transplant within past year
1, mitomycins bladder cancer diagnosis anticipated use chemotherapy radiotherapy other immunotherapy not specified protocol while on study
1, questionnaire administration stage iia prostate cancer diagnosis body mass index equal greater thirty five
1, nivolumab metastatic renal cell carcinoma diagnosis previous enrollment randomization present study
0, tretinoin patients currently active second malignancy other non melanoma skin cancers
0, quality life assessment cancer survivor diagnosis no evidence metastatic disease
1, mitoxantrone other active primary malignancy other carcinoma situ cervix basal cell carcinoma skin
1, dexamethasone symptomatic coronary artery disease cad angina canadian class ii iv
1, prednisone recurrent prostate cancer diagnosis grade one diarrhea not controlled appropriate treatment
0, expressive writing breast cancer diagnosis no metastatic disease
0, prednisone aids related peripheral systemic lymphoma diagnosis patients already receiving erythropoeitin csf eligible
0, motexafin lutetium unresectable gallbladder cancer diagnosis creatinine normal
0, deferasirox stage iii adult diffuse large cell lymphoma diagnosis absolute neutrophil count anc greater equal one zero
1, oxaliplatin patients active bleeding pathologic conditions that carry high risk bleeding such known bleeding disorder coagulopathy tumor involving major vessels
1, copper adenocarcinoma gastroesophageal junction diagnosis subjects who opinion investigator may not be able comply safety monitoring requirements study
1, immunoglobulins undifferentiated fallopian tube carcinoma diagnosis has known psychiatric substance abuse disorders that would interfere cooperation requirements trial
0, thiotepa lymphoma diagnosis recipient must be less equal sixty years old at time registration
0, busulfan childhood burkitt lymphoma diagnosis donor must be genotypically hla identical sibling phenotypically hla matched first degree relative an unrelated donor who is molecularly matched patient at hla b drbone
0, alvocidib stage iv extragonadal non seminomatous germ cell tumor diagnosis serum creatinine less doc times upper limit normal uln
0, carboplatin prostate cancer diagnosis prior treatment by radiotherapy is allowed but radiation therapy must have been completed at least four weeks before inclusion irradiated areas must not represent more twenty five marrow reserves
0, palbociclib metastatic breast cancer diagnosis bone only subjects eligible if their disease can be documented evaluated by bone scans ct mri
1, dabrafenib symptomatic untreated leptomeningeal brain metastases spinal cord compression
1, cognitive rehabilitation breast cancer diagnosis two participants currently involved studies specifically aimed at improving cognitive symptoms will be excluded
1, bortezomib angioimmunoblastic cell lymphoma diagnosis concomitant use any other investigational agent
1, antibodies clear cell adenocarcinoma diagnosis patients concurrent severe medical problems unrelated malignancy that would significantly limit full compliance expose patient extreme risk decreased life expectancy
0, succinylcholine stage iii intrahepatic cholangiocarcinoma diagnosis aspartate transaminase ast equal less five uln
1, tacrolimus angioimmunoblastic cell lymphoma diagnosis fertile men women unwilling use contraceptives during twelve months post transplant
1, dexamethasone phosphate stage iii squamous cell carcinoma hypopharynx diagnosis peripheral neuropathy greater grade two
1, calcium heparin metastatic pancreatic cancer diagnosis co administration substrates inhibitors cyptwoceight cypthreeafour nab paclitaxel is not allowed
1, hormones adenocarcinoma prostate diagnosis men child bearing potential must be willing consent using effective contraception while on treatment at least three months thereafter
0, dexamethasone hematopoietic lymphoid cancer diagnosis cisplatin at dose greater seventymg two without other chemotherapy agent or
0, fludarabine multiple myeloma diagnosis ecog performance status zero one two
1, sildenafil citrate prostate cancer diagnosis neoadjuvant androgen deprivation therapy started more one month prior entry into intake bicalutamide alone does not constitute exclusion from entry
0, freund s adjuvant pancreatic cancer diagnosis performance status
0, paclitaxel stage iiia breast cancer diagnosis hormonal therapy allowed if had been given up total twenty eight days anytime after diagnosis before entry
0, topotecan ovarian cancer diagnosis age
1, minocycline currently have any known malignancy other multiple myeloma have history malignancy within previous five years exception basal cell squamous cell carcinoma skin that has been fully excised no evidence recurrence
0, cladribine small intestine cancer diagnosis see disease characteristics endocrine therapy
1, diketopiperazines stage iv non small cell lung cancer diagnosis subjects asthma that require intermittent use bronchodilators inhaled steroids local steroid injections would not be excluded from study
1, vitamin d colorectal cancer diagnosis pre existing hypercalcemia
1, trastuzumab prior anthracycline chemotherapy regimen anti hertwo therapy other prior biologic immunotherapy breast cancer treatment any malignancy
1, albumin bound paclitaxel genital neoplasms female diagnosis major injuries surgeries within past three weeks planned surgical procedures during trial incomplete wound healing
0, antibodies monoclonal stage marginal zone lymphoma diagnosis must have less five blasts at time transplant
0, prednisone prostate cancer diagnosis other
1, leucovorin stage iib rectal cancer diagnosis surgery including open biopsy significant traumatic injury within twenty eight days prior randomization minor surgery including insertion an indwelling catheter within twenty four hours prior first bevacizumab infusion is allowed
1, rituximab noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis no current malignancy
1, mycophenolate mofetil nodal marginal zone cell lymphoma diagnosis patients creatinine clearance less fifty ml min
0, physical activity intervention gastric cancer patient diagnosis patient who did not exercise regularly last six months
1, cyclosporine recurrent childhood lymphoblastic lymphoma diagnosis donors
1, antibodies prostatic neoplasms diagnosis patients history autoimmunity that has not required systemic immunosuppressive therapy does not threaten vital organ function including cns heart lungs kidneys skin gi tract will be allowed
0, immunoglobulins recurrent grade two follicular lymphoma diagnosis bilirubin
0, interferon alpha colorectal carcinoma diagnosis must have normal organ marrow function defined below
1, antibodies bispecific non hodgkin lymphoma diagnosis participants who have had chemotherapy within three weeks rituximab obinutuzumab within four weeks radioimmunotherapy within six weeks prior entering those who have not recovered from adverse events due agents administered more three weeks earlier
0, everolimus recurrent renal cell cancer diagnosis serum creatinine normal creatine clearance greater sixty ml min
1, vorinostat non hodgkin lymphoma diagnosis participation clinical trials other investigational agents not included this trial within fourteen days start this trial throughout duration this trial
1, tetrahydrofolates metastatic colorectal cancer diagnosis urine protein creatinine ratio greater one
1, levoleucovorin patients must not have history other malignant diseases within last five years other adequately treated non melanotic skin cancer situ carcinoma uterine cervix
0, etoposide phosphate stage iv adult immunoblastic large cell lymphoma diagnosis expected survival duration greater equal six months
0, pembrolizumab stage ivb major salivary gland carcinoma diagnosis subjects may be eligible receive mk three thousand four hundred seventy five second course phase this if remains open subject meets following conditions
0, niacinamide recurrent adult soft tissue sarcoma diagnosis serum creatinine equal less doc times uln
0, modafinil melanoma recurrent diagnosis age greater eighteen years
0, cisplatin endometrial cancer diagnosis neuropathy sensory motor should be less equal common toxicity criteria adverse effects ctcae grade one
1, procarbazine newly diagnosed non methylated glioblastoma multiforme grade four diagnosis prior systemic antiangiogenic therapy
0, paclitaxel urothelial carcinoma diagnosis previously received at least one but no more two lines therapy one therapy must have included platinum based regimen
1, calcitonin gene related peptide thyroid cancer diagnosis subject untreated by total thyroidectomy
0, paclitaxel childhood extragonadal germ cell tumor diagnosis doc mg dl thirteen greater sixteen years age female
0, tacrolimus refractory small lymphocytic lymphoma diagnosis harvesting criteria autologous hct
1, aldesleukin meningeal hemangiopericytoma diagnosis history ganciclovir magnetic resonance imaging mri contrast allergy intolerance history intolerance il two
1, cva prostate cancer diagnosis any other medical psychological condition that would preclude participation compromise ability give informed consent
0, goserelin hertwo negative breast cancer diagnosis patient must be able understand willing sign written informed consent document
0, extraperitoneal laparoscopic lymphadenectomy eplnd adenocarcinoma diagnosis patient information written informed consent form signed
1, flutamide patient lymph node metastatic spread prostatic adenocarcinoma suspected on imaging
1, vinorelbine carcinoma non small cell lung diagnosis pregnancy lactation period
0, leucovorin stage iiic esophageal cancer diagnosis patients must not have known immediate delayed hypersensitivity reaction drugs chemically related fluorouracil platins their excipients nor have known history dihydropyrimidine dehydrogenase dpd deficiency
0, everolimus gastrointestinal cancers diagnosis subject eastern cooperative oncology group ecog performance status zero two
0, antibodies monoclonal stage iii squamous cell carcinoma paranasal sinus nasal cavity diagnosis new york heart association class iii iv congestive heart failure
0, pharmaceutical solutions colorectal carcinoma diagnosis written informed consent
0, treosulfan multiple myeloma diagnosis cll relapsing after high dose chemotherapy
1, mycophenolic acid stage iii adult immunoblastic large cell lymphoma diagnosis expected survival less six months
1, carboplatin stage iv ovarian epithelial cancer diagnosis clinically significant gastrointestinal bleeding uncontrolled peptic ulcer disease
0, camptothecin recurrent mucoepidermoid carcinoma oral cavity diagnosis concurrent warfarin allowed
0, immunoglobulins stage iiic gastric cancer diagnosis more three weeks since prior radiotherapy recovered
1, niacinamide neoplasms diagnosis radiotherapy during within three weeks start drug
1, aldesleukin stage iv breast cancer diagnosis have an active infection
0, cyclophosphamide stage ii childhood hodgkin lymphoma diagnosis stage ia without bulk disease
1, rituximab lymphoma large cell diffuse diagnosis viral serological testing is not mandated entry but considered standard care
1, niacinamide hepatocellular carcinoma diagnosis liver function abnormality total bilirubin greater doc uln aspartate transaminase nineast alkaline phosphatase alt greater doc uln
1, irinotecan rectal cancer diagnosis other conditions
0, protein expression analysis melanoma skin diagnosis see disease characteristics
1, endothelial growth factors stage iva uterine corpus cancer diagnosis ace inhibitors allowed single agent bevacizumab cohort
0, decitabine recurrent mantle cell lymphoma diagnosis performance status
0, dexamethasone phosphate lymphoma mucosa associated lymphoid tissue diagnosis at least eighteen years age
1, nintedanib esophagogastric adenocarcinoma diagnosis legal incapacity limited legal capacity
1, erlotinib hydrochloride stage iv non small cell lung cancer diagnosis ritonavir cyclosporine ketoconazole itraconazole erythromycin verapamil quinidine tacrolimus nelfinavir saquinavir amiodarone part enrollment informed consent procedures patient will be counseled on risk interactions other agents what if new medications need be prescribed if patient is considering new over counter medicine herbal product subject must stop strong inducer inhibitor p glycoprotein seven days before five half lives before drug administration whichever timepoint is longer
1, etiracetam brain tumor without potential need chemotherapy meningioma without anaplastic features
0, topotecan undifferentiated ovarian carcinoma diagnosis life expectancy greater equal twelve weeks
1, everolimus non clear cell renal cell cancer diagnosis history organ allograft
1, ly have active symptomatic fungal bacterial known viral infection including active human immunodeficiency virus hiv viral b hepatitis
1, interleukin glioblastoma diagnosis significant heart disease that precludes administration anesthesia
0, methylprednisolone acetate acute myelogenous leukemia aml acute lymphoblastic leukemia non hodgkin lymphoma myelodysplastic syndrome mds chronic myelogenous leukemia cml myeloproliferative lymphoproliferative disorders
0, antibodies monoclonal colorectal cancer diagnosis no known hiv infection
0, phosphonoacetic acid recurrent marginal zone lymphoma diagnosis minimum organ function requirements should be same requirements hct
0, dexamethasone multiple myeloma diagnosis ethical other
0, interleukin recurrent grade two follicular lymphoma diagnosis prior interleukin two interferon alfa allowed
1, gemcitabine urethral cancer diagnosis inability comply follow up procedures
0, bortezomib stage iv adult hodgkin lymphoma diagnosis no serious intercurrent illnesses
1, mycophenolic acid peroxisomal disorders diagnosis any patient who judgment university minnesota inherited metabolic storage disease group has disease that is not likely benefit from allogeneic hsct based on its nature severity state progression
0, lenograstim rhabdomyosarcoma diagnosis external beam radiation therapy xrt
1, sirolimus stage ii contiguous adult diffuse small cleaved cell lymphoma diagnosis females who pregnant breast feeding
1, diphosphonates breast cancer metastatic bone disease diagnosis corrected adjusted serum albumin serum calcium concentration less doc mg dl doc zero mmol l
0, thalidomide stage adult soft tissue sarcoma diagnosis creatinine less doc mg dl
1, sorafenib rectal cancer diagnosis known suspected allergy sorafenib any agent given course this trial
0, panobinostat adult nasal type extranodal nk cell lymphoma diagnosis albumin greater doc dl
0, antibodies monoclonal recurrent melanoma diagnosis willing provide blood samples correlative research purposes
0, immunoglobulins stage iiib breast cancer diagnosis patients must not have hypersensitivity paclitaxel drugs using vehicle cremophor chinese hamster ovary cell products other recombinant human antibodies
1, stereotactic body radiation therapy stage prostate adenocarcinoma diagnosis significant urinary obstruction aua symptom score greater eighteen
1, bevacizumab astrocytoma oligoastrocytoma mixed diagnosis patient must not have evidence new cns hemorrhage greater doc cm on baseline mri obtained less fourteen days prior enrollment
1, levoleucovorin advanced adult primary liver cancer diagnosis pregnancy breastfeeding
0, vinblastine primary peritoneal cancer diagnosis greater equal four weeks interval between their last chemotherapy regimen start treatment
0, antibodies recurrent adult diffuse large cell lymphoma diagnosis hemoglobin greater equal doc dl unsupported by transfusion within prior two weeks
1, bortezomib multiple myeloma diagnosis patient has received other investigational drugs fourteen days before enrollment
1, sirolimus sarcoma diagnosis presence active brain metastases
0, busulfan multiple myeloma malignant plasma cell neoplasms diagnosis no diabetes mellitus thyroid disease that is not medically controlled
1, levoleucovorin b precursor lymphoblastic lymphoma
0, non juven supplement lymphoma diagnosis no concurrent omega three fatty acids their congeners prosure
1, pembrolizumab has known active central nervous system cns metastases carcinomatous meningitis
0, lenalidomide metastatic prostate cancer diagnosis and
1, electroencephalogram eeg head neck cancer diagnosis history xerostomia prior head neck radiation therapy history sjÃ¶gren disease another underlying systemic illness known cause xerostomia
0, lenograstim stage iv adult diffuse large cell lymphoma diagnosis voluntary written informed consent form before performance any related procedure not part normal medical care understanding that consent may be withdrawn by subject at any time without prejudice future medical care
0, sirolimus stage iv prostate cancer diagnosis hgb greater equal nineg l
0, mycophenolic acid stage iii adult diffuse mixed cell lymphoma diagnosis myelodysplastic syndrome mds myeloproliferative disorder mpd
0, s gastrointestinal neoplasms diagnosis patients must have normal organ marrow function defined below
0, albumin bound paclitaxel malignant ovarian mixed epithelial tumor diagnosis non cytotoxic biologic cytostatic agents include but not limited hormones monoclonal antibodies cytokines small molecule inhibitors signal transduction
0, valacyclovir mesothelioma diagnosis patients must have mpe defined positive pleural fluid cytology
1, niacinamide any previous malignancy treated curative intent subject has been disease free less five years prior randomization exception carcinoma situ cervix squamous carcinoma skin basal cell carcinoma skin
1, prostate biopsy focal brachytherapy assessment qol more fifty cancer any one biopsy core
0, laboratory biomarker analysis lobular breast carcinoma situ diagnosis creatinine less two uln
1, prednisone stage iv prostate cancer diagnosis subjects permitted have prior coumadin prophylaxis against agents that might produce blood clots
0, everolimus lymphoplasmacytic lymphoma diagnosis organ function criteria
0, immunoglobulins recurrent childhood medulloblastoma diagnosis patients must not have previously received bevacizumab irinotecan temozolomide other anti vascular endothelial growth factor vegf inhibitor
0, irinotecan recurrent childhood rhabdomyosarcoma diagnosis performance status
1, recombinant albumin fusion protein sephb hsa unspecified adult solid tumor protocol specific diagnosis cohort group four
1, vaccines carcinoma non small cell lung diagnosis patient has no measurable disease defined by recist criteria version doc
0, antibodies monoclonal subject must have documented diagnosis previously untreated cohort induction consolidation treatment along first autologous stem cell transplantation asct allowed symptomatic multiple myeloma mm defined by criteria below
0, leucovorin adenocarcinoma gastroesophageal junction diagnosis patients must not be pregnant nursing women men reproductive potential must have agreed use an effective contraceptive method
0, metformin recurrent ovarian epithelial cancer diagnosis leukocytes greater equal three zero mcl
1, bortezomib recurrent mantle cell lymphoma diagnosis patient has hypersensitivity bortezomib boron mannitol
0, dacarbazine gliosarcoma diagnosis this was designed include women minorities but was not designed measure differences intervention effects
1, dexamethasone refractory multiple myeloma diagnosis major surgery within four weeks before cycle one day one
0, prednisolone disseminated neuroblastoma diagnosis radiographic finding pulmonary edema does not exclude diagnosis ips provided other criteria have been met provided treating physician concludes by clinical echocardiographic criteria that pulmonary edema is not secondary cardiac dysfunction iatrogenic fluid overload
0, angiopeptin neuroendocrine tumors diagnosis signed informed consent
0, dce mri all patients histologically proven diagnoses os ewing sarcoma undergoing induction chemotherapy eligible study
1, vincristine diffuse large cell lymphoma diagnosis abnormal bone marrow function platelets less one hundredxone hundred nine neutrophils less doc xone hundred nine haemoglobin less nineg dl
0, bortezomib carcinoma non small cell lung diagnosis ecog performance status zero one two
0, everolimus recurrent childhood lymphoblastic lymphoma diagnosis prior therapy
1, vaccines concurrent malignancy malignancy other adenocarcinoma pancreas unless subject has been curatively treated disease free greater equal two years except non melanoma skin cancer situ cervical cancer
0, menthol malignant neoplasms independent primary multiple sites diagnosis subjects must be able understand be willing sign written informed consent form
0, doxorubicin ovarian clear cell adenocarcinoma diagnosis phase iii study
0, niacinamide hepatocellular cancer diagnosis adequate bone marrow liver renal function
1, androgens prostatic neoplasms diagnosis serum calcium greater one doc mg dl
0, capecitabine breast cancer diagnosis disease progression after at least one but no more two prior chemotherapy regimens metastatic disease
1, adrenocorticotropic hormone breast cancer diagnosis average score question one four greater five average score question five oneone
0, vorinostat stage iv marginal zone lymphoma diagnosis chronic myelomonocytic leukemia
0, temozolomide neuroblastoma diagnosis ecog zero two
0, antibodies stage iia breast cancer diagnosis women must not be pregnant breast feeding all females childbearing potential must have blood urine test within seven days prior randomization rule out pregnancy
0, lapatinib advanced adult primary liver cancer diagnosis no prior epidermal growth factor receptor targeting therapy
0, immunoglobulins stage iii esthesioneuroblastoma paranasal sinus nasal cavity diagnosis performance status
0, immunoglobulins stage iiia ovarian cancer diagnosis subject must have an range inr usually between two three on stable dose warfarin on stable dose low molecular weight lmw heparin
0, bortezomib non hodgkin lymphoma diagnosis anc greater equal one zero microliter
0, irinotecan liver cancer diagnosis patient characteristics
1, fludarabine phosphate stage adult diffuse large cell lymphoma diagnosis female patients who pregnant breastfeeding
1, sirolimus stage iiib non small cell lung cancer diagnosis pregnant women
1, antibodies fallopian tube clear cell adenocarcinoma diagnosis has received live vaccine within thirty days planned start therapy
1, camptothecin stage iiib gastric cancer diagnosis patients any polymorphism ugtoneaone other one twenty eight six
0, carboplatin stage iiic primary peritoneal cavity cancer diagnosis leukocytes greater equal three zero mcl
1, temozolomide glioblastoma diagnosis active infection requiring intravenous antibiotics
1, gemcitabine peripheral cell lymphoma diagnosis history documented congestive heart failure chf
1, bevacizumab cancer ovarian diagnosis serum creatinine greater doc mg dl greater one hundred seventy seven mol l
1, methylphenidate gastrointestinal cancer diagnosis doc mg dl
1, antibodies monoclonal recurrent ovarian carcinoma diagnosis co morbid systemic illnesses other severe concurrent disease which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety toxicity prescribed regimens
0, endothelial growth factors malignant peritoneal neoplasm diagnosis absolute neutrophil count anc greater equal one thousand five hundred mm three
0, methylphenidate cancer diagnosis life expectancy one year less reflected by hospice admission palliative care status
0, thiotepa breast cancer diagnosis no life threatening arrhythmia hypertension
0, bb multiple myeloma plasma cell neoplasm diagnosis no concurrent filgrastim csf other growth factors prophylaxis
1, amg advanced solid tumors diagnosis active brain metastases
0, irinotecan small cell lung cancer diagnosis two zero mmthree platelet count
1, ds b lymphoma cell diagnosis has received autologous hematopoietic stem cell transplantation within twelve weeks eighty four days start treatment
0, cyclosporins stage iii childhood large cell lymphoma diagnosis viral load is less fifty copies ml plasma
0, cyclophosphamide mesenchymal chondrosarcoma diagnosis adequate bone marrow function hb greater doc mmol absolute neutrophil count greater doc one hundred nine platelets greater eighty one hundred nine l
0, liposomal doxorubicin stage iv adult diffuse large cell lymphoma diagnosis antiretroviral naÃ¯ve participants
0, dacarbazine childhood high grade cerebellar astrocytoma diagnosis patients will be eligible this even if they receiving anti convulsants
1, morab non small cell lung cancer diagnosis patients who receiving chronic systemic anticoagulation therapy warfarin sodium heparin etc
0, denileukin diftitox breast cancer diagnosis patients who experienced disease progression during prior first line palliative chemotherapy must be advised regarding second line therapy before enrollment
0, cyclophosphamide stage ii non contiguous adult lymphoblastic lymphoma diagnosis patients shall have had no prior cytotoxic chemotherapy exception steroids it cytarabine
1, everolimus sarcoma diagnosis patients who have not recovered from side effects any major surgery
0, immunoglobulins metastatic squamous neck cancer occult primary diagnosis patients must be able take retain oral medications
0, epothilone b recurrent ovarian epithelial cancer diagnosis at least three weeks since prior radiotherapy recovered
0, goserelin male breast cancer diagnosis doc two mmol l
0, pazopanib hydrochloride stage iv bladder cancer diagnosis ergot derivatives dihydroergotamine ergonovine ergotamine methylergonovine
0, leucovorin colorectal cancer diagnosis hepatic
1, sirolimus head neck cancer diagnosis kps less seventy
0, female ar tnbc enzalutamide treated er positive breast cancer diagnosis assessment ar expression may have been performed any time past
1, albumin bound paclitaxel ovarian clear cell cystadenocarcinoma diagnosis patients clinically significant proteinuria urine protein should be screened by urine protein creatinine ratio upcr patients must have upcr less doc allow participation study
1, albumin bound paclitaxel cervical adenosquamous carcinoma diagnosis history hypertensive crisis hypertensive encephalopathy
1, antibodies monoclonal nodal marginal zone cell lymphoma diagnosis serious coexisting medical condition active infection which would compromise ability deliver standard chop chemotherapy
0, cyclophosphamide total bilirubin equal less doc institutional upper limit normal uln unless elevated secondary lymphomatous involvement liver biliary system due other hiv medications indinavir tenofovir atazanavir direct bilirubin greater doc due hepatic involvement by tumor initial dose epoch drug adjustment
1, penta vulvar cancer diagnosis bacterial endocarditis
0, methotrexate adequate bone marrow platelets count greater ten doc zero mmthree hemoglobin greater nine dl neutrophils countgreater doc zero mmthree renal creatinine clearance greater sixty ml min cardiac lvef greater fifty hepatic function total serum bilirubine less three mg dl ast alt ggt less doc per upper normal limit value unless abnormality is due lymphoma infiltration
1, dexamethasone acetate primary central nervious system lymphoma diagnosis malignancy treated curative intent no evidence active disease present more three years prior screening felt be at low risk recurrence by treating physician
0, methylprednisolone lymphoma diagnosis surgery
0, ibandronic acid breast cancer diagnosis no malabsorption syndrome
0, lenograstim stage iii multiple myeloma diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvate transaminase sgpt less two times upper limit normal uln
1, methamphetamine stage iiia hepatocellular carcinoma diagnosis anti phospholipid syndrome
1, questionnaire administration lung cancer diagnosis receiving chemotherapy combination radiotherapy
0, topotecan primary peritoneal cavity cancer diagnosis renal
1, camptothecin ganglioneuroblastoma diagnosis patients history grade four allergic reactions anti gdtwo antibodies reactions that required discontinuation anti gdtwo therapy not eligible
0, sunitinib metastatic cancer diagnosis patient characteristics
0, endothelial growth factors undifferentiated carcinoma diagnosis patients must have met pre entry requirements specified
0, cetuximab stage iib pancreatic cancer diagnosis total bilirubin within normal institutional limits
1, rituximab recurrent adult diffuse large cell lymphoma diagnosis absolute neutrophil count anc less one thousand mm three
0, cisplatin siewert type tumor gastroesophageal junction
0, antibodies monoclonal continued from above patient has no active bleeding pathological condition that carries high risk bleeding tumor involving major vessels known varices
0, obinutuzumab central nervous system lymphoma diagnosis karnofsky performance status kps greater equal sixty eastern cooperative oncology group ecog zero one two
0, ad cmv p gene ovarian cancer diagnosis see disease characteristics at least four weeks since chemotherapy no concurrent chemotherapy endocrine therapy
1, everolimus astrocytoma diagnosis known history hiv seropositivity
0, ifosfamide recurrent adult hodgkin lymphoma diagnosis creatinine equal less doc times upper limit normal uln
0, bicalutamide prostate cancer diagnosis no pelvic lymph node disease that would necessitate pelvic radiotherapy
0, olaparib colorectal cancer diagnosis patients must have adequately controlled blood pressure on maximum three antihypertensive medications
1, pomalidomide multiple myeloma diagnosis any clinically significant medical disease psychiatric condition that investigator opinion may interfere protocol adherence patient ability give informed consent
0, immunoglobulins stage iva nasal cavity paranasal sinus squamous cell carcinoma diagnosis fasting glucose equal less one hundred twenty mg dl glycosylated hemoglobin hbaonec equal less doc
1, vermurafenib multiple myeloma diagnosis history retinal vein occlusion rvo
0, armodafinil a hypothalamic tumor
0, zd vandetanib mg non small cell lung carcinoma diagnosis life expectancy twelve weeks longer
1, talazoparib stage iiib non small cell lung cancer diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible
1, docetaxel stage ivb uterine sarcoma diagnosis absolute neutrophil count anc less one thousand five hundred mmthree
0, laboratory biomarker analysis recurrent retinoblastoma diagnosis controls must meet one following criteria
0, methotrexate stage ii contiguous mantle cell lymphoma diagnosis stage i
1, nivolumab composite lymphoma nodular lymphocyt negative predominant hodgkin lymphoma nlphl
0, pembrolizumab metastatic urothelial carcinoma renal pelvis ureter diagnosis female subjects childbearing potential should be willing use two methods birth control be surgically sterile abstain from heterosexual activity course through onetwo days after last dose medication subjects childbearing potential those who have not been surgically sterilized have not been free from menses greater one year
0, antibodies monoclonal testicular yolk sac tumor teratoma diagnosis hematologic relapse by standard criteria hematologic persistence evidenced by bone marrow blasts greater ten after day thirty post ahsct
1, albumin bound paclitaxel stage iii pancreatic cancer diagnosis other cardiac arrhythmia not controlled medication
1, etoposide phosphate diffuse large cell lymphoma diagnosis uncontrolled hepatitis infection
0, vincristine lymphoblastic lymphoma complete remission diagnosis patients should have at least six months therapy pomp regimen remaining prior starting ixazomib
1, niacinamide stage ivb squamous cell carcinoma paranasal sinus nasal cavity diagnosis evidence history bleeding diathesis coagulopathy
0, olanzapine cancer diagnosis anc greater one five hundred mmthree platelet count greater one zero mmthree total bilirubine less two uln ast less three uln alt less three uln subjects known liver metastases total bilirubin less three uln ast less five uln alt less five uln creatinine less doc uln ccr greater five ml min
0, asparaginase patients previously untreated de novo aml who meet criteria aml greater equal twenty bone marrow blasts set out world health organization who myeloid neoplasm classification
1, cisplatin non small cell lung cancer diagnosis prior therapy thymosin alpha one
0, everolimus stage ii non contiguous mantle cell lymphoma diagnosis matched human leukocyte antigen hla b drbone dqbone by high resolution typing
1, etoposide phosphate sarcoma kaposi diagnosis any prior investigational agent if given only prior treatment ks
1, enalapril cancer diagnosis planned treatment dexrazoxane
1, immunoglobulins recurrent pancreatic carcinoma diagnosis treatment any investigational agent within fourteen days prior being registered protocol therapy
1, everolimus patients history another malignancy within fiveyears prior entry except curatively treated non melanotic skin cancer situ cervical cancer skin other solid tumors curatively treated no evidence disease greater threeyears
0, pertuzumab tumors diagnosis surgery must have confirmed recurrence
0, immunoglobulins stage iv verrucous carcinoma larynx diagnosis unstable angina
1, interleukin metastatic renal cell carcinoma diagnosis history abdominal fistula gastrointestinal perforation intrabdominal abscess within six months prior starting treatment
1, capecitabine gastric stomach cancer diagnosis any following concurrent severe uncontrolled medical conditions within twenty four weeks enrollment which could compromise participation study
0, paclitaxel male breast carcinoma diagnosis breast conservation surgery includes lumpectomy partial mastectomy excisional biopsy
1, f rgd k lung cancer diagnosis subject has known hyper hypo coagulation syndromes
0, fludarabine phosphate stage iii adult immunoblastic large cell lymphoma diagnosis must have less five marrow blasts at time transplant
0, carboplatin stage iv melanoma diagnosis no brain metastases by mri ct scan
0, antibodies monoclonal carcinoma non small cell lung diagnosis total bilirubin less doc uln unless there is known history gilberts syndrome
0, irinotecan breast cancer diagnosis life expectancy greater three months
1, interleukin recurrent melanoma diagnosis ejection fraction less fifty echocardiogram multi gated acquisition scan muga
0, alvocidib recurrent childhood malignant germ cell tumor diagnosis no uncontrolled diabetes mellitus
1, vaccines small cell lung cancer diagnosis any known pre existing autoimmune disorder
1, invitation screening colorectal cancer diagnosis inflammatory bowel disease ibd
0, palbociclib advanced malignant neoplasm diagnosis note
0, vincristine brain central nervous system tumors diagnosis ecog zero two
1, apaziquone bladder cancer diagnosis patient has history allergy red color food dye
0, cytarabine recurrent adult burkitt lymphoma diagnosis fourteen days prior again within twenty four hours prescribing lenalidomide prescriptions must be filled within seven days
0, antibodies monoclonal recurrent lung adenocarcinoma diagnosis patients who bevacizumab appropriate bevacizumab is planned
0, tacrolimus lymphoma diagnosis note
1, docetaxel bladder cancer diagnosis concomitant use phenytoin carbamazepine barbiturates rifampin phenobarbital st
0, etoposide phosphate stage iii childhood small noncleaved cell lymphoma diagnosis bone marrow involvement at least twenty five blasts cns involvement meeting one more following criteria
0, survey administration psychosocial effects cancer its treatment diagnosis understands english
1, carmustine diffuse large cell lymphoma dlbcl diagnosis hiv infection
0, cyclosporine secondary central nervous system hodgkin lymphoma diagnosis first subsequent chronic phase
1, estradiol stage iiic breast cancer diagnosis patients receiving strong inducers inhibitors cytochrome pfour hundred fifty threeafour cypthreeafour
0, chpp cisplatin peritoneal neoplasms diagnosis patients must have adequate renal function serum creatinine less equal doc creatinine clearance greater equal forty five ml min
1, salmonella typhimurium biliary cancer diagnosis breast feeding mothers will be asked discontinue feeding infants prior enrolling study
1, antibodies monoclonal stage iib gastric cancer diagnosis patients must not have serious non healing wound skin ulcers unhealed bone fracture known human immunodeficiency virus hiv infection
0, pemetrexed recurrent non small cell lung cancer diagnosis creatinine normal creatinine clearance greater equal sixty ml min
0, cyclophosphamide patients leukemia lymphoma other solid tumor who also have overt meningeal involvement by their tumor
0, dacarbazine central nervous system tumors diagnosis no infection requiring systemic antibiotics within past fourteen days
1, immunoglobulin g recurrent glioblastoma diagnosis any condition that opinion investigator would interfere evaluation treatment interpretation patient safety results
0, everolimus melanoma skin diagnosis performance status
1, proton cge prostate cancer diagnosis active inflammatory bowel disease crohn disease diverticulitis ulcerative colitis affecting rectum
0, calcium dietary stage iiib rectal cancer diagnosis at least four weeks since prior major surgery recovered
0, medoc advanced medical systems pathway model ats cerebellar neoplasm diagnosis ability complete mri without sedation
1, albumin bound paclitaxel stage iia breast cancer diagnosis one two
0, fludarabine lymphoma diagnosis potential patients referred may not be eligible experimental protocol therapy due reasons such uncertainty about donor hla typing need control malignant disease infection metabolic abnormality such hypercalcemia on emergent basis
1, leucovorin mucinous adenocarcinoma colon diagnosis documented brain metastases
0, sunitinib neuroendocrine tumors diagnosis total abstinence or
0, immunoglobulin g pancreatic neuroendocrine tumor gone diagnosis cystic lesions
1, goserelin previous treatment prostate cancer
1, vinorelbine evidence tumor relapse prior adjuvant therapy
1, rituximab known involvement central nervous system by lymphoma
1, gemcitabine stage iiia non small cell lung cancer diagnosis patient has other prior concurrent malignancy except following
1, b papillomavirus infections diagnosis drugs known have major organ toxicity
1, bb refractory plasma cell myeloma diagnosis concomitant high dose corticosteroids other what is part treatment protocol concurrent use corticosteroids exception
1, ifosfamide diffuse large cell lymphoma diagnosis patients known be hiv positive but without clinical evidence an immunocompromised state eligible this trial patients hiv on antiretroviral therapy other zidovudine azt stavudine without prior acquired immunodeficiency syndrome aids defining conditions adequate cdfour count greater four eligible
1, vemurafenib melanoma diagnosis history current evidence central serous retinopathy csr retinal vein occlusion rvo history retinal degenerative disease
1, busulfan regional neuroblastoma diagnosis female patients who lactating must agree stop breast feeding
0, cyclophosphamide renal cancer diagnosis total bilirubin less equal doc mg dl except patients gilberts syndrome who must have total bilirubin less doc mg dl
1, triptorelin pamoate sarcoma diagnosis pregnant
1, lipegfilgrastim breast cancer diagnosis pregnancy
1, antibodies monoclonal small intestine lymphoma diagnosis patient has poorly controlled hypertension on multiple antihypertensives
1, vaccines liver cell carcinoma adult diagnosis females child bearing potential premenopausal not surgically sterilized must have negative serum hcg pregnancy test within day fourteen day zero
0, pain therapy breast cancer diagnosis performance status
0, paclitaxel recurrent breast carcinoma diagnosis absolute neutrophil count greater equal one five hundred ul
0, vincristine neuroblastoma diagnosis have no dyspnea at rest
0, proton beam radiation therapy breast cancer diagnosis no sln identified internal mammary nodes
0, cyclophosphamide lymphoma diagnosis endocrine therapy
1, everolimus symptomatic congestive heart failure new york heart association class iii iv
0, antibodies stage iii squamous cell carcinoma lip oral cavity diagnosis no non healing wounds within past four weeks
0, aldesleukin stage iv grade one follicular lymphoma diagnosis negative pregnancy test
1, pharmacological prostate cancer diagnosis patients permitted have received up twenty four months neoadjuvant adjuvant hormone ablation conjunction their primary definitive therapy androgen deprivation must have been completed at least six months prior registration testosterone level must be greater fifty no complementary alternative therapy st
1, cediranib recurrent ovarian carcinoma diagnosis ca one hundred twenty five only disease without recist doc measurable otherwise evaluable disease
1, methamphetamine melanoma diagnosis previous radiation therapy lungs upper abdomen
1, laboratory biomarker analysis uncontrolled brain metastases including symptomatic lesions lesions requiring glucocorticoids anticonvulsants suppress symptoms
0, fluorouracil primary tumor was tone ttwo nzero mzero
1, gemcitabine pancreatic cancer diagnosis no cardiovascular disease problems including unstable angina therapy life threatening ventricular arrhythmia myocardial infarction stroke congestive heart failure within last six months
0, dexamethasone acetate at least three weeks since prior radiotherapy solitary plasmacytoma
0, norgestimate ethinyl estradiol drug combination multiple myeloma plasma cell neoplasm diagnosis disease characteristics
1, metronidazole stage iv pancreatic cancer diagnosis pregnant nursing women
0, tacrolimus myelodysplastic myeloproliferative neoplasms diagnosis creatinine less doc mg dl creatinine clearance greater seventy ml min
1, propranolol primary operable breast cancer diagnosis patients renal failure measured by creatinine level greater doc
1, crizotinib glioblastoma diagnosis radiation therapy within two weeks starting treatment
1, allostim melanoma diagnosis prior allogeneic bone marrow stem cell solid organ transplant
0, blood samples at inclusion at months at months cases relapse solid tumor diagnosis remission
1, cediranib recurrent glioblastoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition olaparib cediranib bevacizumab
0, epirubicin stage ii breast cancer diagnosis if stage should be deemed sufficiently high risk developing recurrent disease warrant participation
1, albumin bound paclitaxel sarcoma osteogenic diagnosis patient has any condition including presence laboratory abnormalities that places patient at unacceptable risk if he she were participate study
1, dexamethasone acetate lymphoma diagnosis any following this regimen may be harmful developing fetus nursing child
0, thalidomide non secretory multiple myeloma no protein serum urine by immunofixation
1, pembrolizumab carcinoma non small cell lung diagnosis history current evidence any condition therapy laboratory abnormality that might confound results trial interfere subject participation full duration trial is not is not best interest subject participate opinion treating investigator
1, thalidomide multiple myeloma diagnosis aged sixty six years over
1, cetuximab colorectal cancer metastatic diagnosis urinary protein excretion greater equal two positive dipstick
0, prednisolone lymphoma diagnosis hepatic
1, nbi function colon adenoma diagnosis emergency severe rectal bleeding
0, fluorouracil rectal cancer diagnosis patients must have metastatic disease liver at least one lesion that is measurable by recist criteria within four weeks prior entry study
1, pembrolizumab head neck cancer diagnosis patients may not be receiving any other investigational agents chemotherapy immunotherapy radiotherapy molecular targeted agents within four weeks start treatment
0, antibodies malignant ovarian mixed epithelial tumor diagnosis an approved informed consent authorization permitting release personal health information must be signed by patient guardian
0, bortezomib ds stage ii plasma cell myeloma diagnosis patients must not have poems syndrome plasma cell dyscrasia polyneuropathy organomegaly endocrinopathy monoclonal protein skin changes
1, palbociclib estrogen receptor positive breast cancer diagnosis qtc interval greater four hundred eightymsec brugada syndrome known history qtc prolongation torsade de pointes
1, fludarabine recurrent mantle cell lymphoma diagnosis pregnancy
1, niacinamide hepatocellular carcinoma diagnosis comedication known strong cypthreeafour inhibitors cypthreeafour five inducers
0, alemtuzumab recurrent adult lymphoblastic lymphoma diagnosis donor
0, survey administration breast cancer diagnosis prior concurrent therapy
0, etoposide phosphate lymphoma diagnosis platelet count greater one hundred zero Î¼l unless decreased counts due marrow involvement nhl
1, bevacizumab primary peritoneal cancer diagnosis drug bevacizumab
0, paclitaxel rhabdomyosarcoma diagnosis myelosuppressive chemotherapy
0, antibodies ovarian cancer diagnosis prior concurrent therapy
1, paclitaxel stage iia ovarian cancer diagnosis new york heart association nyha grade ii greater congestive heart failure
0, tacrolimus multiple myeloma plasma cell neoplasm diagnosis no syngeneic donors
1, letrozole breast cancer diagnosis participation other studies involving investigational drug phases iv within two weeks before current treatment begins
1, laboratory biomarker analysis adult grade iii lymphomatoid granulomatosis diagnosis patients who previously have had their uterus ovary ies removed not eligible
0, antibodies monoclonal kras nras wild type colorectal cancer diagnosis biopsy metastatic lesion is not required
1, immunoglobulins stage ivb rectal cancer diagnosis any following prior therapies
0, ispinesib stage iv prostate cancer diagnosis psa greater five ng ml
0, rituximab massive ie at least six cm below left costal margin progressive symptomatic splenomegaly
1, antibodies lung cancer diagnosis patients any nonmalignant intercurrent illness example cardiovascular pulmonary central nervous system disease which is either poorly controlled currently available treatment which is such severity that investigators deem it unwise enter patient on protocol shall be ineligible
0, idarubicin lymphoma diagnosis hiv negative
0, carboplatin sarcoma diagnosis radiographic nuclear image biopsy confirmation disease within past four weeks
0, dactinomycin childhood renal wilms tumor diagnosis all patients their parents legal guardians must sign written informed consent
1, magnetic resonance imaging mri anal cancer patients diagnosis hip prosthesis
1, dalteparin bone cancer diagnosis r
0, docetaxel endometrial cancer diagnosis patient characteristics
1, melphalan recurrent adult diffuse mixed cell lymphoma diagnosis pregnant breast feeding females lactating females must agree not breast feed while taking lenalidomide
0, levoleucovorin colorectal cancer diagnosis estimated life expectancy greater three months
0, hormones hormone resistant prostate cancer diagnosis patients enrolled on calgb ninety thousand two hundred two who have documented disease progression have received at least four weeks open label zoledronic acid treatment eligible this study
0, bortezomib iris melanoma diagnosis no more two prior immunotherapy regimens either adjuvant metastatic setting
0, cyclosporine refractory hodgkin lymphoma diagnosis must have less five marrow blasts at time transplant
0, etoposide stage iii adult diffuse small cleaved cell lymphoma diagnosis patients clinical signs pulmonary insufficiency must have diffusion capacity lung carbon monoxide dlco be measured at greater equal fifty predicted value
1, niacinamide hepatocellular carcinoma diagnosis bclc stage a
0, lenograstim neuroblastoma diagnosis age
0, ifosfamide adult liposarcoma diagnosis not pregnant nursing patients undergoing radiotherapy chemotherapy
0, capecitabine pancreatic cancer diagnosis serum creatinine less doc mg dl
0, histone deacetylase inhibitors stage ii papillary thyroid cancer diagnosis concurrent oral iv bisphosphonates bony metastases allowed at discretion investigator
1, oxaliplatin stage iv pancreatic cancer diagnosis combination following positive positive positive c
1, testosterone beta cypionate recurrent prostate cancer diagnosis inability provide informed consent
0, cisplatin stage iva oropharyngeal squamous cell carcinoma diagnosis calculated creatinine clearance must be greater sixty ml min using cockcroft gault formula
0, dkn solid tumors diagnosis urinalysis
0, gene expression analysis lymphoma diagnosis all all patients
0, dexamethasone lymphoma diagnosis chemotherapy
1, midazolam solid tumor diagnosis pregnant women
0, temozolomide recurrent childhood supratentorial embryonal tumor not otherwise specified diagnosis stem cell transplant sct
0, vidarabine renal cell cancer diagnosis radiation therapy surgery is not counted treatment
1, thalidomide small intestine lymphoma diagnosis active grades iii iv acute graft versus host disease gvhd
1, cisplatin gastric cancer diagnosis is currently participating receiving therapy has participated an investigational agent received therapy used an investigational device within four weeks first dose treatment
0, maleic acid stage intraocular melanoma diagnosis ecog performance statusequal less two karnofskygreater equal sixty
1, paclitaxel recurrent adenoid cystic carcinoma oral cavity diagnosis history significant peripheral neuropathy significant central nervous system disease
1, etoposide advanced solid tumor diagnosis major surgery less two weeks before starting drug incomplete recovery from prior major surgical procedure
1, morphine lung neoplasms diagnosis oxygen treatment if changed twenty min before start
1, fluorouracil colorectal cancer diagnosis uncontrolled arterial hypertension systolic pressure greater one hundred fifty mmhg diastolic pressure greater one hundred mmhg without antihypertensive medication
0, tacrolimus stage iii adult burkitt lymphoma diagnosis complete cytogenetic remission
1, third eye retroscope auxiliary imaging system colorectal cancer diagnosis patients who pregnant
0, cyclosporins contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis crone unconfirmed cruone
1, tacrolimus recurrent mantle cell lymphoma diagnosis more twenty zero circulating cdtwenty positive cells ul
0, itraconazole skin cancer diagnosis consent research use their bcc tissue
1, sirolimus stage iiib breast cancer diagnosis pregnant nursing lactating women
0, dexamethasone smoldering multiple myeloma diagnosis all participants must be registered into mandatory revlimid rems program be willing able comply requirements rems program
1, liposomal doxorubicin prior systemic treatment regimens breast cancer
1, bevacizumab malignant pancreatic gastrinoma diagnosis serious non healing wound ulcer bone fracture
1, sunitinib stage iva thyroid gland papillary carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition sunitinib
0, antibodies lymphoma diagnosis pulmonary
1, cortisone stage iib hodgkin lymphoma diagnosis sexually active patients reproductive potential who have not agreed use an effective contraceptive method duration their participation thirty days after last dose chemotherapy
0, laboratory biomarker analysis stage iii renal cell cancer diagnosis colon
0, melphalan prior treatment less four days total four mg prednisone an equivalent potency another steroid myeloma is not considered regimen
1, immunoglobulin g childhood pleomorphic rhabdomyosarcoma diagnosis greater ninety fiveth percentile systolic diastolic blood pressure based on age height that is not controlled by one antihypertensive medication
1, laboratory biomarker analysis gastrin producing neuroendocrine tumor diagnosis history abdominal fistula gastrointestinal perforation intra abdominal abscess within twenty eight days treatment
1, dexamethasone stage ii lymphoblastic lymphoma diagnosis sexually active patients reproductive potential not eligible unless they have agreed use an effective contraceptive method duration their participation
0, lenalidomide stage iii grade two follicular lymphoma diagnosis patients must be willing give written informed consent sign an institutionally approved consent form before performance any related procedure not part normal medical care understanding that consent may be withdrawn by subject at any time without prejudice future medical care
1, alemtuzumab childhood nasal type extranodal nk cell lymphoma diagnosis patient has poorly controlled hypertension on multiple antihypertensives
0, irinotecan stage iv squamous cell carcinoma nasopharynx diagnosis creatinine no greater doc times uln
1, everolimus recurrent malignant neoplasm diagnosis highly effective contraception male condom spermicide diaphragm spermicide intra uterine device total abstinence must be used by both sexes during must be continued six months after end treatment note
0, aromatase inhibitors stage iiic breast cancer diagnosis hypersensitivity letrozole zoledronic acid any its excipients
0, nivolumab pancreatic acinar cell carcinoma diagnosis all baseline assessments must have been completed within twenty eight days prior registration
0, niacinamide recurrent colon carcinoma diagnosis life expectancy greater equal eighty four days three months
0, sorafenib untreated metastatic squamous neck cancer occult primary diagnosis ecog performance status zero one two
0, albumin bound paclitaxel stage iiib non small cell lung cancer diagnosis no known brain metastases by contrast enhanced ct scan gadolinium enhanced mri brain
0, antibodies breast neoplasms diagnosis be willing provide tissue from newly obtained core excisional biopsy tumour lesion
0, paclitaxel ovarian cancer diagnosis renal
1, cyclophosphamide stage adult diffuse mixed cell lymphoma diagnosis use any other experimental drug within twenty eight days baseline
1, bortezomib refractory multiple myeloma diagnosis patient history allergy boron mannitol bortezomib
0, melphalan colorectal cancer diagnosis bilirubin less doc mg dl doc mg dl patients gilbert syndrome
0, cisplatin endometrial adenosquamous carcinoma diagnosis patients may have received prior hormone therapy systemic chemotherapy such therapy must have been completed at least six months prior entry patient has clear evidence disease subsequent such therapy patients must not have received neoadjuvant chemotherapy present recurrent disease
1, atamestane significant neurological dysfunction including seizures clinical signs other significant neurological diseases other active malignancy within past five years except basal cell skin cancer carcinoma situ cervix contraindication toremifene its excipients any excipients atamestane not pregnant nursing
1, laboratory biomarker analysis recurrent breast cancer diagnosis patients who have significant cardiac disease including heart failure that meets new york heart association nyha class iii iv definitions history myocardial infarction within one year entry uncontrolled dysrhythmias poorly controlled angina excluded
1, mycophenolate mofetil peripheral cell lymphoma diagnosis history central nervous system cns involvement disease
0, tamoxifen sarcoma diagnosis performance status
0, prednisolone phosphate lymphoma diagnosis no concurrent disease that would dangerously alter drug metabolism obscure toxicity
1, prednisolone phosphate diffuse large cell lymphoma diagnosis presence any limitations that compromise patient ability comply treatment
1, rasburicase tumors diagnosis planned treatment rituximab
1, therapeutic allogeneic lymphocytes intraocular lymphoma diagnosis diagnosis cml except patients who have failed prior donor leukocyte infusion minimum cell dose onexone eight cells kg
0, thymalfasin esophageal cancer diagnosis zero one
1, rituximab noncontiguous stage ii small lymphocytic lymphoma diagnosis unrelated donor products received from deutsche knochenmarkspenderdatei dkms registry not eligible optional study
0, selumetinib stage iv thyroid gland papillary carcinoma diagnosis total bilirubin normal
1, dexamethasone acetate multiple myeloma diagnosis laboratory abnormalities
0, bortezomib refractory multiple myeloma diagnosis serum creatinine equal less doc
0, antibodies monoclonal recurrent pancreatic cancer diagnosis no uncontrolled hypertension
1, adjuvants immunologic glioblastoma diagnosis white blood cell count wbc decrease less doc xone hundred nine increase greater one doc xone hundred nine l
1, antibodies monoclonal metastatic gastrointestinal carcinoid tumor diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
1, chemoprevention stage ivb salivary gland cancer diagnosis although there no known adverse effects black raspberries upon fetus if patients become pregnant during period lyophilized black raspberries lbr administration then lbr will be discontinued patient will be removed from we should however emphasize given this is food based that risks likely extremely low even though participant should become pregnant such we not recommending active contraception women but rather if participants become pregnant that they notify their doctor that they will likely be removed from there no expected logical risks if men were father child such no contraception will be recommended men
0, cortisone plasmablastic lymphoma diagnosis although not required it is encouraged that myc bcl two be measured by immunohistochemistry ihc clearly documented
1, olaparib fallopian tube cancer diagnosis patients serious non healing wound ulcer bone fracture including history abdominal fistula gastrointestinal perforation intra abdominal abscess within twenty eight days
1, imidazole lymphoma diagnosis prior chemotherapy
1, rituximab follicular lymphoma diagnosis patients who pregnant childbearing potential lactating
1, perindopril metastatic colorectal cancer diagnosis previous assignment treatment during this study
0, radiosurgery neoplasm recurrence local diagnosis lesions associated significant surgical risk
1, long course concurrent chemoradiation adenocarcinoma rectum diagnosis defined mucinous tumour
1, oxaliplatin metastatic colorectal cancer diagnosis diverticulitis
0, etoposide phosphate childhood germ cell tumor diagnosis creatinine no greater doc times uln or
1, carboplatin ovarian neoplasms diagnosis exception this rule following malignancies may be included if adequately treated
0, cyclosporins recurrent adult diffuse small cleaved cell lymphoma diagnosis mature cell malignancies
0, isotretinoin breast neoplasm diagnosis patients must have renal criteria of
1, heparin low molecular weight pancreatic cancer diagnosis ibuprofen naproxen
0, liposomal doxorubicin stage adult immunoblastic large cell lymphoma diagnosis patients bone marrow involvement allowed at investigator discretion regardless cytopenias
1, methotrexate noncontiguous stage ii grade one follicular lymphoma diagnosis patients evidence human immunodeficiency virus hiv seropositivity positive polymerase chain reaction pcr assay human lymphotropic virus htlv one htlvtwo seropositivity safety allogeneic hsct is not yet well established this population
0, mycophenolic acid refractory small lymphocytic lymphoma diagnosis donor
1, cetuximab head neck cancer diagnosis uncontrolled diabetes
0, rituximab lymphoma diagnosis no prior pentostatin
1, lenalidomide multiple myeloma diagnosis polyneuropathy organomegaly endocrinopathy monoclonal protein skin changes poems syndrome
0, erlotinib hydrochloride adult brain stem glioma diagnosis at least three months since prior suramin
0, decitabine recurrent breast cancer diagnosis absolute granulocyte count at least one five hundred mm three
0, liposomal doxorubicin fallopian tube serous adenocarcinoma diagnosis patient must have provided specific informed consent prior entry
0, rfa patients one three tumors less five cm
0, carboplatin patients must have measurable disease according response evaluation criteria solid tumors recist criteria
0, interleukin gestational trophoblastic tumor diagnosis not specified performance status
1, cortisone acetate stage ii grade three non contiguous follicular lymphoma diagnosis absolute cdfour count less fifty cells mm three
1, leucovorin stage ia esophageal cancer diagnosis known hypersensitivity any component bevacizumab
1, carboplatin endometrial undifferentiated carcinoma diagnosis any condition associated increased risk metformin associated lactic acidosis congestive heart failure defined new york heart association nyha class iii iv functional status history acidosis any type habitual intake three more alcoholic beverages per day
0, melphalan multiple myeloma plasma cell neoplasm diagnosis fertile patients must use two methods effective contraception during four weeks after completion treatment
0, docetaxel adenosquamous cell lung cancer diagnosis pleural effusions ascites laboratory parameters not acceptable only evidence disease
1, azacitidine myeloproliferative neoplasms diagnosis acute myeloid leukemia rara translocations apl acute promyelocytic leukemia
1, bb advanced cancer various nos diagnosis subjects involuntary incarcerated
0, antibodies recurrent breast cancer diagnosis no psychiatric illness social situation that would preclude study
0, gefitinib prostate cancer diagnosis not specified
0, methylprednisolone extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis patients bone marrow donors who htlv iii hiv antibody positive ineligible this study
0, vincristine multiple myeloma plasma cell neoplasm diagnosis no concurrent anticoagulants
1, doxorubicin breast cancer diagnosis inadequately controlled hypertension defined systolic blood pressure greater one hundred fifty mmhg diastolic blood pressuregreater one hundred mmhg on antihypertensive medications new york heart association nyha grade two greater congestive heart failure
0, immunoglobulins bilirubin no greater three mg dl unless elevated secondary tumor
0, laboratory biomarker analysis recurrent childhood central nervous system neoplasm diagnosis no history congenital prolonged corrected qt interval qtc syndrome new york heart association nyha class iii iv congestive heart failure chf
1, albumin bound paclitaxel patient has symptomatic cns metastases
0, nivolumab malignant melanoma diagnosis nsclc patients must have minimum thirty pack year smoking history
0, cyclophosphamide stage adult diffuse large cell lymphoma diagnosis lactate dehydrogenase ldh greater upper limit normal one point
0, histone deacetylase inhibitors childhood solid neoplasm diagnosis doc mg dl males females
1, oxaliplatin cancer diagnosis prior radiotherapy unless treatment was limited target lesion only one measurable lesion was treated
0, cediranib recurrent hypopharyngeal squamous cell carcinoma diagnosis no other concurrent investigational agents
1, molecular mechanisms pharmacological action neoplasms diagnosis untreated brain meningeal metastases
0, maleic acid advanced adult primary liver cancer diagnosis one per common terminology criteria adverse events ctcae peripheral motor neuropathy greater gr
0, cyclosporine multiple myeloma plasma cell neoplasm diagnosis acute lymphoblastic leukemia meeting one following criteria
1, sorafenib recurrent adult primary liver cancer diagnosis hepatitis virus hcv recurrence at time randomization
0, succinylcholine stage iva oropharyngeal squamous cell carcinoma diagnosis total bilirubin equal less upper limit normal uln
1, busulfan testicular lymphoma diagnosis positive anti donor lymphocytotoxic crossmatch
1, temozolomide anaplastic oligoastrocytoma diagnosis use biologic response modifiers such csf within three week entry
0, temozolomide recurrent solid neoplasm diagnosis absolute neutrophil count greater equal one zero ul mcl
0, gemcitabine recurrent grade one follicular lymphoma diagnosis must anticipate that patient will complete at least two cycles chemotherapy
0, rituximab recurrent marginal zone lymphoma diagnosis no history uncontrolled orthostatic hypotension
1, cisplatin bladder carcinoma diagnosis no history immunization attenuated live vaccines within one week prior registration protocol therapy during period
0, carboplatin anaplastic oligodendroglioma diagnosis eligibility level hemoglobin may be reached by transfusion
1, gemcitabine bladder cancer diagnosis patients should not receive immunization attenuated live vaccines within one week entry during period
0, antibodies monoclonal adult non hodgkin lymphoma diagnosis following histologic types by real classification international working formulation iwf when applicable note
0, oxaliplatin esophageal neoplasms diagnosis not breast feeding
0, fludarabine contiguous stage ii mantle cell lymphoma diagnosis related donor who is hla genotypically identical at least at one haplotype may be phenotypically genotypically identical at allele level at hla b drbone dqbone
0, carboplatin fallopian tube cancer diagnosis ast sgot alt sgpt less doc upper limit normal range uln
0, albumin bound paclitaxel progesterone receptor negative breast cancer diagnosis peripheral neuropathy equal less grade one
0, antibodies monoclonal recurrent pancreatic cancer diagnosis performance status
1, pembrolizumab triple negative breast cancer diagnosis seasonal influenza vaccines injection generally inactivated flu vaccines allowed however intranasal influenza vaccines flu mist live attenuated vaccines not allowed
0, paclitaxel cancer head neck diagnosis adequate bone marrow organ function defined below
0, cetuximab recurrent verrucous carcinoma oral cavity diagnosis inr ptt ratio less doc
1, lenvatinib thyroid cancer anaplastic diagnosis currently totally abstinent their preferred usual lifestyle who not agree be totally abstinent during period thirty days after drug discontinuation
1, temozolomide other malignancies within past five years except adequately treated carcinoma cervix basal squamous cell carcinoma skin
1, everolimus stage iii mantle cell lymphoma diagnosis patients rapidly progressive intermediate high grade nhl
1, antibodies rectal cancer diagnosis patients must not have received prior chemotherapy radiation greater equal two weeks before enrollment
1, bioelectric impedance analysis stage ib vulvar cancer diagnosis patients who have history congestive heart failure chronic renal disease chronic liver disease
1, gm csf resectable pancreatic adenocarcinoma diagnosis patients known contraindications analgesia endoscopy
0, fludarabine phosphate recurrent grade three follicular lymphoma diagnosis myelofibrosis without splenectomy intermediate high risk features
0, docetaxel soft tissue sarcoma diagnosis ethinylestradiol gestodene itraconazole ketoconazole cimetidine erythromycin carbamazepine high dose chronic steroids phenobarbital phenytoin rifampin rifampcin sulfinpyrazone
0, immunoglobulins recurrent rectal cancer diagnosis no prior cetuximab
0, antilymphocyte serum multiple myeloma plasma cell neoplasm diagnosis disease characteristics
1, cyclophosphamide recurrent marginal zone lymphoma diagnosis donors
0, immunoglobulin g stage iva uterine corpus cancer diagnosis upc ratio one is roughly equivalent twenty four hour urine protein one gm
0, sirolimus stage iiic skin melanoma diagnosis fertile patients must use effective contraception during greater six months after completion treatment
0, radiation therapy recurrent tumor visible on aa pet mri tone gd diameter measuring one cm six cm by either technique
1, anastrozole concomitant anti cancer therapies not permitted
1, irinotecan colorectal cancer diagnosis history evidence inherited bleeding diathesis coagulopathy risk bleeding
1, oxaliplatin pancreatic cancer diagnosis life expectancy less three months
1, interleukin stage iiib breast cancer diagnosis manifested cardiac complications during initial transplant period including arrhythmias that required therapy congestive heart failure angina myocardial infarct decreased lvef less forty five
0, olaparib inflammatory breast carcinoma diagnosis negative urine serum pregnancy test within twenty one days treatment
1, gemcitabine symptomatic brain metastases that not stable that require steroids that potentially life threatening that have required radiation within last fourteen days
1, cyclophosphamide metastatic cancer diagnosis active systemic infections coagulation disorders other active major medical illnesses cardiovascular respiratory immune system evidenced by positive stress thallium comparable test myocardial infarction cardiac arrhythmias obstructive restrictive pulmonary disease
0, liquid chromatography children newly diagnosed neuroblastoma ganglioneuroblastoma
0, bicalutamide recurrent prostate cancer diagnosis no history liver disease other forms hepatitis cirrhosis
0, veliparib untreated childhood giant cell glioblastoma diagnosis doc mg dl six less ten years age
1, veliparib childhood supratentorial ependymoma diagnosis patients any clinically significant unrelated systemic illness serious infections significant cardiac pulmonary hepatic other organ dysfunction that would compromise patient ability tolerate protocol therapy would likely interfere procedures results
1, quality life assessment recurrent progressive endometrial cancer
1, etoposide phosphate recurrent cutaneous cell non hodgkin lymphoma diagnosis patients should not have any uncontrolled illness including ongoing active infection requiring therapy
1, e solid tumors diagnosis subjects who cannot take oral medication
0, morphine tumor diagnosis aged more eighteen years
1, paclitaxel gastroesophageal junction adenocarcinoma diagnosis history primary immunodeficiency
1, valganciclovir glioblastoma multiforme diagnosis patient not tolerating drug
1, temozolomide adult anaplastic astrocytoma diagnosis patients malabsorption syndrome other condition that would interfere intestinal absorption patients must be able swallow tablets
1, gemcitabine stage ib pancreatic cancer diagnosis erectile dysfunction agent
0, dasatinib breast cancer diagnosis quinidine
0, fluorouracil recurrent metastatic squamous neck cancer occult primary diagnosis no non healing wounds within past four weeks
0, sirolimus rhabdomyosarcoma diagnosis foxoone fusion negative
1, antibodies monoclonal cervical squamous cell carcinoma diagnosis patients anticipation invasive procedures defined below
0, alvespimycin hydrochloride recurrent cutaneous cell non hodgkin lymphoma diagnosis any following allowed
0, fludarabine stage marginal zone lymphoma diagnosis donor
1, radiation therapy treatment planning simulation glioma diagnosis allergy gadolinium contrast
0, sorafenib recurrent metastatic squamous neck cancer occult primary diagnosis patients active prior central nervous system cns metastasis not eligible
0, gemcitabine biliary tract cancer diagnosis one prior gemcitabine based doublet chemotherapy eg gemcitabine cisplatin unresectable btc not treated by any other chemotherapy btc
0, propranolol presenting hemangioma following characteristics
0, camptothecin histologically cytologically confirmed epithelial cancer exocrine pancreas
0, cyclosporine prostate cancer diagnosis fevone at least sixty five predicted
0, folic acid recurrent rectal carcinoma diagnosis eastern cooperative oncology group ecog performance status ps zero one
1, carboplatin ovarian cancer diagnosis other significant co morbid condition which investigator feels might compromise effective safe participation including history congestive cardiac failure an electrocardiogram ecg suggesting significant conduction defect myocardial ischemia
1, tacrolimus noncontiguous stage ii adult diffuse large cell lymphoma diagnosis patients who not candidate an unrelated donor allogeneic hsct based on current institutional bone marrow transplant bmt program clinical practice guidelines organ function criteria will be utilized per current institutional bmt program clinical practice guidelines there will be no restriction entry based on hematological parameters
1, bb stage iiia breast cancer diagnosis known contraindication five htthree receptor antagonists including palonosetron dexamethasone
0, questionnaire administration adult cell leukemia lymphoma diagnosis willing be seen at baseline six weeks twelve weeks six weeks time points
0, methionine low grade cns tumors diagnosis female participants childbearing age must not be lactating due theoretical potential harm infant from exposure radiation
1, antibodies recurrent renal cell carcinoma diagnosis history venous arterial thromboembolism within twelve months prior enrollment randomization
0, fludarabine phosphate stage ii childhood small noncleaved cell lymphoma diagnosis match grade doc
0, dexamethasone multiple myeloma plasma cell neoplasm diagnosis zubrod zero three hematopoietic
0, nk cell infusion sarcoma diagnosis hematopoietic growth factors
1, rituximab refractory burkitt lymphoma diagnosis recent major surgery within six weeks prior start treatment other diagnosis
1, oxaliplatin an active second primary malignancy except situ carcinoma cervix adequately treated basal cell carcinoma skin within less one year enrollment into this study
0, letrozole breast cancer diagnosis life expectancy greater five years
1, mycophenolate mofetil recurrent grade three follicular lymphoma diagnosis marrow donors
1, docetaxel clinically significant cardiovascular disease including myocardial infarction unstable angina symptomatic congestive heart failure serious uncontrolled cardiac arrhythmia less one year before enrollment
0, vaccines breast cancer diagnosis http
0, albumin bound paclitaxel solid tumors diagnosis both male female patients willing consent using effective contraception hormonal barrier method abstinence prior entry while on treatment at least three months thereafter
1, exercise intervention stage iia ovarian cancer diagnosis patients who have participated marathon triathlon other endurance related physical activity within previous twenty four months
0, cyclosporins recurrent small lymphocytic lymphoma diagnosis only patients mds refractory anemia ra mds refractory anemia ringed sideroblasts rars will be eligible this protocol additionally patients myeloproliferative syndromes mps will be eligible those patients mds mps greater five marrow blasts including those transformation aml must receive cytotoxic chemotherapy achieve less five marrow blasts at time transplant
0, bb multiple myeloma diagnosis patient measurable progressive disease defined by at least one following two measurements
0, staurosporine hertwo negative breast cancer diagnosis hemoglobin greater ten dl
1, busulfan multiple myeloma diagnosis active hepatitis either active carrier hbsag positive viremic hbv dna greater equal ten zero copies ml greater equal two zero iu ml
0, triamcinolone acetonide non melanomatous skin cancer diagnosis not specified chemotherapy
1, cart t cells multiple myeloma diagnosis subjects must not
1, deferasirox small intestine lymphoma diagnosis patients active disease undergoing chemotherapy treatment
1, tacrolimus nodal marginal zone cell lymphoma diagnosis patient donor history hepatitis or positive serology consistent previous hepatitis infection patients donor who received hepatitis vaccination acceptable
0, carboplatin liver cancer diagnosis chemotherapy
1, fluorouracil stage iv pancreatic cancer diagnosis lactating females
0, rituximab brain central nervous system tumors diagnosis cerebrospinal fluid csf cytology
1, romidepsin refractory burkitt lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition mlneight thousand two hundred thirty seven including but not limited established allergic reaction benzodiazepines romidepsin agents that alter gastric ph may change mlneight thousand two hundred thirty seven absorption not permitted proton pump inhibitors need be stopped four days prior first dose mlneight thousand two hundred thirty seven histamine two htwo receptor antagonists not permitted from day prior day one through end mlneight thousand two hundred thirty seven dosing antacid preparations not permitted two hours before two hours after administration mlneight thousand two hundred thirty seven
1, leuprolide prostate cancer diagnosis evidence suspicion myelodysplastic syndrome by complete blood test cbc must be confirmed by bone marrow biopsy
1, cpi multiple myeloma diagnosis serum cardiac troponin ctn level greater ninety nine percentile upper reference limit
0, dabrafenib stage iiib melanoma diagnosis absolute neutrophil count anc greater equal doc ten nine l
0, fludarabine recurrent marginal zone lymphoma diagnosis bilirubin equal less doc mg dl
0, citalopram psychosocial effects cancer its treatment diagnosis meets one following criteria
1, gemcitabine pancreatic cancer diagnosis potassium less doc mmol despite supplementation greater doc mmol l
0, vinblastine lymphoma diagnosis renal
1, vidarabine mesothelioma diagnosis history severe immediate hypersensitivity reaction any agents used this study
0, albumin bound paclitaxel stage iv melanoma diagnosis non childbearing potential physiologically incapable becoming pregnant including any female who has had
1, chlorotrianisene history symptomatic coronary artery disease myocardial infarction within six months before enrollment
0, cisplatin stage iiic breast cancer diagnosis patients must have histologically cytologically confirmed solid organ malignancy
0, pentostatin carcinoma renal cell diagnosis chronic myeloid leukemia first subsequent chronic phase accelerated phase
0, cilengitide brain central nervous system tumors diagnosis no serious concurrent infection medical illness that would preclude study
1, fludarabine phosphate contiguous stage ii adult diffuse mixed cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
0, iodine squamous cell carcinoma esophagus scc
1, placebo advanced hepatocellular carcinoma diagnosis has only infiltration type hcc
0, etoposide phosphate anaplastic large cell lymphoma diagnosis concomitant administration nonsteroidal anti inflammatory drugs nsaids trimethoprim sulfamethoxazole will not be allowed since these may result delayed clearance pralatrexate
1, g eyeâ„¢ colonoscopy colorectal cancer diagnosis subjects who currently enrolled another clinical investigation
1, pemetrexed gastric cancer diagnosis active infection
0, rrx malignant solid tumor diagnosis subject has acceptable hematologic status at screening
1, vaccines prostate cancer diagnosis participant has an acute infection requiring intravenous antibiotic antiviral antifungal agents within two weeks entry part b
1, dexamethasone acetate multiple myeloma diagnosis john wort within fourteen days before enrollment
1, busulfan myeloma diagnosis availability appropriate willing hla matched related stem cell donor
1, fludarabine recurrent adult diffuse mixed cell lymphoma diagnosis donor
0, paclitaxel stage iiib primary peritoneal cancer diagnosis platelets greater equal one hundred zero mcl
0, aminopurine stage ii contiguous adult lymphoblastic lymphoma diagnosis all patients must be enrolled on aalleightbone prior treatment enrollment on aallfour hundred thirty four
0, cyclosporins stage grade one follicular lymphoma diagnosis mature cell malignancies
0, interleukin non small cell lung cancer nsclc diagnosis patients must have at least one unidimensionally measurable lesion by computed tomography defined by recist criteria see section appendix a
0, brivanib alaninate endometrial undifferentiated carcinoma diagnosis all patients must have measurable disease measurable disease is defined at least one lesion that can be accurately measured at least one dimension longest dimension be recorded each lesion must be greater equal twenty mm when measured by conventional techniques including palpation plain ray computed tomography ct magnetic resonance imaging mri greater equal ten mm when measured by spiral ct
0, antibodies stage ii diffuse large cell lymphoma diagnosis rochester division hematopathology central confirmation diagnosis tissue adequacy mandatory research studies
1, antibodies monoclonal metastatic melanoma diagnosis also patients history known hypersensitivity reactions mouse humanized monoclonal antibodies excluded
0, human papillomavirus e peptide cervical cancer diagnosis hepatic
1, alemtuzumab recurrent small lymphocytic lymphoma diagnosis any illness condition that opinion investigator may affect safety treatment evaluation any endpoints
1, gemcitabine pancreatic cancer diagnosis minor surgical procedures fine needle aspirations core biopsies within seven days
0, questionnaire administration stage iii verrucous carcinoma larynx diagnosis patients no distant metastatic disease
1, fluorine f d fmau hormone resistant prostate cancer diagnosis cardiovascular disorders including
0, vorinostat recurrent uveal melanoma diagnosis patients enrolled at vanderbilt university medical center may have gnaq gnaeleven mutational status determined on clinical laboratory improvement act clia approved assay at vanderbilt university medical center cumc mskcc tissue must be sent mskcc bapone mutational status determination
0, anastrozole progesterone receptor positive breast cancer diagnosis aspartate aminotransferase ast alanine aminotransferase alt less two unl unless related primary disease
1, part c twice weekly dosing cantrixil fallopian tube neoplasms diagnosis patients known hypersensitivity serious reaction benzopyrans excluded
1, antibodies monoclonal stage iv squamous cell carcinoma nasopharynx diagnosis prior treatment sorafenib cetuximab
0, pemetrexed lung cancer diagnosis life expectancy greater three months
0, mycophenolic acid kidney cancer diagnosis karnofsky performance status sixty one hundred lansky performance status fifty one hundred pediatric patients
1, ganciclovir triphosphate stage iii adult diffuse large cell lymphoma diagnosis concomitant anti graft versus host disease gvd treatment includes vivo cell depletion
0, dacarbazine untreated childhood fibrillary astrocytoma diagnosis doc mg dl two less six years age
0, fludarabine lymphoma hodgkins diagnosis at least fourteen days must have elapsed since any prior systemic therapy prior apheresis prior initiation chemotherapy including systemic corticosteroids at any dose
1, paclitaxel uterine carcinosarcoma diagnosis patients who have had radiotherapy within four weeks prior entering those who have not recovered from adverse events ctcae vfour grade two greater excluding alopecia due agents administered more four weeks earlier
1, cetuximab totally resected tumors
1, mycophenolate mofetil extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis unable provide informed consent
1, laboratory biomarker analysis recurrent islet cell carcinoma diagnosis no clinically significant gastrointestinal abnormalities that may increase risk gastrointestinal bleeding within twenty eight days prior registration including but not limited to
0, bb multiple myeloma plasma cell neoplasm diagnosis able take aspirin three hundred twenty five mg daily prophylactic anticoagulation
0, observation gastrointestinal stromal tumors diagnosis all operated patients gist
0, vidarabine lymphoma non hodgkin diagnosis a
1, antibodies monoclonal prior chemotherapy immunotherapy tumor vaccine cytokine growth factor given control prostate cancer
0, temozolomide neuroectodermal tumor diagnosis no evidence active graft vs
0, dexamethasone recurrent mantle cell lymphoma diagnosis male subjects even if surgically sterilized status postvasectomy must agree one following
0, immunoconjugates all patients must provide tumor tissue sample formalin fixed paraffin embedded ffpe slides from archival tissue fresh biopsy collected any time before general screening under separate informed consent
1, bevacizumab non small cell lung cancer diagnosis blood pressure greater one hundred fifty one hundred millimeter mercury mmhg
1, cortisol succinate stage iii prostate cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition calcitriol ketoconazole other agents used study
0, niacinamide recurrent colon cancer diagnosis able swallow whole pills
1, irinotecan signet ring adenocarcinoma rectum diagnosis patient is more six months since last dose folfiri
1, romidepsin small intestine lymphoma diagnosis baseline testing hiv is not required
0, everolimus mantle cell lymphoma diagnosis received at least one prior rituximab containing chemotherapy regimen separate lines therapy defined single combination therapies that either separated by disease progression by greater six month treatment free interval
1, liposomal doxorubicin lymphoma non hodgkin diagnosis prior stem cell transplant
1, dexamethasone phosphate retinal lymphoma diagnosis other concurrent chemotherapy immunotherapy radiotherapy any ancillary therapy considered investigational utilized non food drug administration fda approved indication context research investigation
0, immunoglobulins lymphoma diagnosis hematopoietic
0, liposomal doxorubicin prior treatment cancer allowed provided patient meet prior therapy requirements
1, lenalidomide stage ivb colon cancer diagnosis patient confirmed history interstitial lung disease
0, cetuximab stage iii squamous cell carcinoma lip oral cavity diagnosis rifampin
0, fluorouracil recurrent squamous cell carcinoma larynx diagnosis wbc at least three zero mm three
1, everolimus metastatic locally advanced solid tumors diagnosis cardiovascular
0, prednisolone acetate lymphoma diagnosis patient characteristics
1, anticonvulsants glioblastoma diagnosis prior failure cpt eleven
1, lapatinib neoplasms breast diagnosis known immediate delayed hypersensitivity reaction idiosyncrasy drugs chemically related any drugs their excipients that opinion investigator gsk medical monitor contraindicates participation
0, everolimus stage iiib endometrial carcinoma diagnosis no prior chemotherapy
1, cd cd activated t cells non hodgkin lymphoma diagnosis active chronic acute gvhd greater grade i
1, vinblastine breast neoplasms diagnosis prior chemotherapy within last three weeks last six weeks nitrosureas mitomycin
0, bevacizumab malignant pancreatic glucagonoma diagnosis radiation therapy adjuvant palliative must be completed greater equal four weeks prior registration if applicable
1, hemostatics pancreas cancer diagnosis mental disorder
1, idelalisib recurrent extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis has received an allogeneic stem cell transplant
0, sirolimus recurrent mucoepidermoid carcinoma oral cavity diagnosis absolute neutrophil count greater equal doc mm three
1, succinylcholine stage iiia gallbladder cancer diagnosis patients must not have known human immunodeficiency virus hiv infection
0, ipilimumab b cell lymphoma diagnosis patients legal guardians must sign an informed consent indicating that they aware this is research have been told its possible benefits toxic side effects
0, antibodies monoclonal patients lymphoma breast cancer lung cancer progressive disease pre period refractory conventional standard treatments will be enrolled study
0, sirolimus stage iv skin melanoma diagnosis have been informed other treatment options
0, stereotactic radiosurgery metastatic cancer diagnosis see disease characteristics
0, calcium dietary stage iiib colon cancer diagnosis no prior irinotecan other camptothecin derivative topotecan
0, topotecan recurrent childhood ependymoma diagnosis no contraindications stem cell collection by apheresis by bone marrow harvesting
1, niacinamide stage iv squamous cell carcinoma nasopharynx diagnosis patients who receiving any other investigational agents
0, epoetin alfa unspecified adult solid tumor protocol specific diagnosis myelodysplastic syndromes myeloproliferative disorders acute myeloid leukemia
0, antibodies small lymphocytic lymphoma diagnosis patient must not be on any other systemic immunosuppressant therapy other corticosteroids within twenty eight days first dose drug
1, ispinesib recurrent marginal zone lymphoma diagnosis concurrent alcohol use based on discretion treating physician
0, mycophenolic acid lymphoma follicular diagnosis liver function
1, pembrolizumab gastric adenocarcinoma diagnosis live vaccine within thirty days planned start therapy
1, medical chart review previous diagnosis cancer urethra bladder ureter renal pelvis within ten years prior current diagnosis
0, everolimus regional digestive system neuroendocrine tumor gone diagnosis hypervascular liver masses greater two cm either serum alpha fetoprotein afp greater four hundred ng ml or
0, everolimus hertwo positive breast cancer diagnosis signed informed consent
1, cyclosporine stage iii cutaneous cell non hodgkin lymphoma diagnosis patients rapidly progressive intermediate high grade nhl
1, mga prostate cancer diagnosis major surgery trauma within four weeks before enrollment
1, gem nab pac ductal adenocarcinoma pancreas diagnosis continuing anticoagulant therapy coumarin derivatives treatment low molecular weight heparin allowed
0, doxorubicin metastatic cancer diagnosis no prior hepatic arterial infusion chemotherapy
0, abt ovarian cancer diagnosis see disease characteristics
0, carmustine refractory mature cell nk cell non hodgkin lymphoma diagnosis body mass index bmi greater thirty five will be considered on case by case basis by radiation oncology principal investigator
1, imiquimod neurofibromatosis type one diagnosis history allergic reactions attributed compounds similar chemical biologic composition imiquimod
0, camptothecin recurrent squamous cell carcinoma hypopharynx diagnosis measurable disease
0, antibodies monoclonal recurrent marginal zone lymphoma diagnosis patients must not have had prior exposure mammalian target rapamycin tor inhibitors sirolimus temsirolimus everolimus
1, levoleucovorin stage iiib rectal cancer diagnosis active uncontrolled bleeding
0, mycophenolate mofetil lymphoplasmacytic lymphoma diagnosis renal
1, immunoglobulins stage iv childhood lymphoblastic lymphoma diagnosis invasive procedures defined follows
1, docetaxel prostatic neoplasms diagnosis has myelodysplastic syndrome
1, bevacizumab metastatic colorectal cancer diagnosis prolonged corrected qt qtc interval on pre entry electrocardiogram greater four hundred fifty msec
0, hormones hormone refractory prostate cancer diagnosis exceptions may be made low dose nonmyelosuppressive radiotherapy after consultation principal investigator
1, fludarabine phosphate stage iii small lymphocytic lymphoma diagnosis donor centers who will exclusively donate marrow
1, clofarabine neoplasm recurrent diagnosis patient has cns two cns three status
0, isophosphamide mustard adult leiomyosarcoma diagnosis no concurrent hormonal therapy except estrogen replacement therapy
1, camptothecin metastatic colorectal cancer diagnosis arterial thrombotic events less six months prior randomization note
1, cisplatin stage iii oropharyngeal squamous cell carcinoma diagnosis psychiatric illness social situations that would limit compliance requirements
0, fludarabine stage iii adult diffuse mixed cell lymphoma diagnosis they have been treated more one regimen haart total at least six months duration
1, ganciclovir stage iv adult diffuse mixed cell lymphoma diagnosis recipient had prior polymerase chain reaction pcr positive cmv infection blood organ specific disease past twelve months
0, laromustine unspecified adult solid tumor protocol specific diagnosis granulocyte count at least one five hundred mm three
0, mycophenolate mofetil hodgkin non hodgkin lymphoma diagnosis does not meet twenty one cfr one thousand two hundred seventy one eligibility requirements but has declaration urgent medical need completed by principal investigator physician sub investigator per twenty one cfr one thousand two hundred seventy one
1, vaccines history other prior malignancy exception curatively treated basal cell squamous cell carcinoma skin cervical cancer stage ib effectively treated malignancy that has been remission over five years is highly likely have been cured
0, fluorouracil colorectal cancer diagnosis biologic therapy
1, modified measles virus lumbar puncture medulloblastoma recurrent diagnosis patients evidence extraneural disease
1, cetuximab recurrent squamous cell carcinoma paranasal sinus nasal cavity diagnosis thrombotic embolic events such cerebrovascular accident including transient ischemic attacks within past six months
1, prednisone active malignancy other prostate cancer except non melanoma skin cancer within five years enrollment
0, camptothecin esophageal cancer diagnosis cardiovascular
0, brachytherapy prostate cancer diagnosis platelet count greater one hundred zero Î¼l
1, succinylcholine pancreatic adenocarcinoma diagnosis patients must not have had any active bleeding last equal less four weeks have an otherwise known bleeding diathesis
0, doxorubicin lymphoma diagnosis disease characteristics
0, questionnaire administration stage iiib non small cell lung cancer diagnosis diagnosis crc nsclc
0, antibodies stage iiib fallopian tube cancer diagnosis alkaline phosphatase less equal doc uln
1, vismodegib unclassified pleomorphic sarcoma bone diagnosis history allergic reactions attributed compounds similar chemical biologic composition gdc four hundred forty nine rofour million nine hundred twenty nine thousand ninety seven used study
0, crizotinib recurrent solid neoplasm diagnosis patients must not have any uncontrolled intercurrent illness including but not limited to
0, pharmaceutical solutions stage iii endometrial carcinoma diagnosis women must have ability understand willingness sign written informed consent document
1, ketogenic diet head neck neoplasms diagnosis life expectancy three less months
1, indomethacin stage iii prostate adenocarcinoma diagnosis total bilirubin greater doc upper limit normal uln
1, albumin bound paclitaxel refractory cancer diagnosis negative urine serum pregnancy test within twenty eight days treatment confirmed prior treatment
0, immunoglobulins adult nasal type extranodal nk cell lymphoma diagnosis myelodysplastic mds myeloproliferative disorders
1, cpg non hodgkin lymphoma diagnosis systemic lupus erythematosus rheumatoid arthritis multiple sclerosis sjogren syndrome autoimmune thrombocytopenia but excluding controlled thyroid disease presence autoantibodies without clinical autoimmune disease
1, dasatinib ovarian clear cell cystadenocarcinoma diagnosis concomitant use histamine two blockers proton pump inhibitors ppis dasatinib is not recommended use antacids should be considered place htwo blockers proton pump inhibitors patients receiving dasatinib therapy if antacid therapy is needed antacid dose should be administered two hours before after dose dasatinib patients who cannot tolerate discontinuation htwo blockers ppis ineligible
1, thymalfasin small cell lung cancer diagnosis patients undergoing therapy other investigational agents
1, mek melanoma diagnosis current evidence corneal disorder keratopathy incl
1, paclitaxel non small cell lung carcinoma diagnosis prior history other malignancy except
1, paclitaxel undifferentiated fallopian tube carcinoma diagnosis history tuberculosis history purified protein derivative ppd positivity
0, clofarabine multiple myeloma diagnosis cml who has failed tyrosine kinase inhibitors
0, quality life assessment patient must be willing able comply protocol duration including attending scheduled visits examinations bx procedure having their tumor blood molecularly characterized
0, fludarabine stage adult diffuse mixed cell lymphoma diagnosis only filgrastim csf mobilized peripheral blood mononuclear cell pbmc only will be permitted hsc source on this protocol
0, vismodegib basal cell carcinoma diagnosis suitable treatment mohs surgical excision
0, alternative product therapy islet cell carcinoma diagnosis not high medical psychiatric risk
1, folic acid centrally located tumors radiographic evidence ct mri local invasion major blood vessels
1, cyclosporins noncontiguous stage ii marginal zone lymphoma diagnosis patients poorly controlled hypertension on multiple antihypertensives
1, paclitaxel metastatic melanoma diagnosis known history allergy il two taxanes other intravenously administered human proteins peptides antibodies
1, albumin bound paclitaxel squamous cell cancer mixed tumors any small cell element
0, light activated wst renal cancer diagnosis activated partial thromboplastin time appt less doc uln
0, antilymphocyte serum angioimmunoblastic cell lymphoma diagnosis myelofibrosis without splenectomy intermediate high risk features
0, pemetrexed lung cancer diagnosis no significant traumatic injury within past eight weeks
1, lapatinib recurrent bladder cancer diagnosis any concomitant medication that may cause qtc prolongation induce torsades de pointes induce cytochrome pfour hundred fifty threeafour cypthreeafour function
0, azacitidine malignant mesothelioma diagnosis extrathoracic metastatic disease allowed if no evidence active intracranial leptomeningeal metastases
1, dexamethasone phosphate multiple myeloma diagnosis no patients will be allowed enrol this trial more once
1, belinostat carcinoma unknown primary diagnosis pregnant lactating females
0, counseling intervention colorectal cancer diagnosis absolute granulocyte count greater one zero mmÂ³
1, fludarabine stage iii grade three follicular lymphoma diagnosis patients greater grade ii hypertension by common toxicity criteria ctc
0, bortezomib unresectable gallbladder cancer diagnosis no unstable angina pectoris
1, cyclosporins lymphoma non hodgkin diagnosis prior allogeneic transplant
0, bbi advanced solid tumors diagnosis life expectancy greater three months
0, bortezomib stage iii multiple myeloma diagnosis no serious medical psychiatric illness that would preclude compliance
0, docetaxel prostate cancer diagnosis absolute lymphocyte count greater five hundred Âµl
1, leucovorin adenocarcinoma colon diagnosis subject has known intolerance bevacizumab
0, etoposide phosphate lung cancer diagnosis concurrent corticosteroids brain metastases allowed
1, dacarbazine glioblastoma multiforme diagnosis any prior history hypertensive crisis hypertensive encephalopathy
1, antibodies monoclonal metastatic colorectal cancer diagnosis recent pulmonary embolism deep vein thrombosis other significant venous event
1, niacinamide stage iva squamous cell carcinoma oropharynx diagnosis patients active clinically significant infection fever greater equal three doc c within three days first scheduled day protocol treatment
0, paclitaxel stage iva uterine sarcoma diagnosis alkaline phosphatase less equal doc times uln ctcae doc grade one
0, immunoglobulin g recurrent renal cell carcinoma diagnosis no prior cytotoxic chemotherapy maximum one prior regimen either vaccine cytokine based immunotherapy disease is permitted
1, laboratory biomarker analysis recurrent grade one follicular lymphoma diagnosis patients known immunodeficiency virus hiv infection must not have cluster differentiation cd four cells less four mm three who must not have prior acquired immunodeficiency syndrome aids defining diagnosis cannot be on antiretroviral therapy hiv
0, mycophenolate mofetil stage iv adult burkitt lymphoma diagnosis patient donor pairs homozygous at mismatched allele graft rejection vector considered two allele mismatch patient is one hundred one donor is two hundred one this type mismatch is not allowed
0, fluorodeoxyglucose f squamous cell carcinoma esophagus diagnosis serum creatinine equal less doc mg dl
1, trebananib fallopian tube cancer diagnosis previous abdominal pelvic radiotherapy
0, lenograstim recurrent childhood small noncleaved cell lymphoma diagnosis negative pregnancy test
0, interleukin brain central nervous system tumors diagnosis not specified chemotherapy
1, thalidomide smoldering multiple myeloma diagnosis major surgery within four weeks before inclusion study
1, vitamin b complex other pediatric cancers diagnosis missing data on gender
0, cyclophosphamide any size primary tumor tone three no ntwo disease ipsilateral nodes clinically fixed one another other structures no skeletal pain unless
0, prednisolone phosphate lymphoma diagnosis performance status
0, pharmacological recurrent grade one follicular lymphoma diagnosis brain metastases allowed after definitive radiotherapy
0, walk by faith cancer diagnosis resident an appalachia county
0, questionnaire administration hertwo positive breast cancer diagnosis signed specific informed consent prior entry
1, calcium dietary stage iiic rectal cancer diagnosis surgery including open biopsy significant traumatic injury within twenty eight days prior randomization minor surgery including insertion an indwelling catheter within twenty four hours prior first bevacizumab infusion is allowed
1, fluorouracil symptomatic peripheral neuropathy greater equal grade two
0, cediranib recurrent adult primary liver cancer diagnosis measurable disease defined greater equal one unidimensionally measurable lesiongreater equal twenty mm by conventional techniques greater equal one mm by spiral ct scan
0, cisplatin unspecified adult solid tumor protocol specific diagnosis disease characteristics
1, vinblastine breast cancer diagnosis patients may not be receiving any other investigational agents
1, i clr solid tumors diagnosis active medical condition organ disease that may either compromise patient safety interfere safety outcome evaluation drug
1, docetaxel carcinoma non small cell lung diagnosis pregnant lactating females
1, doxorubicin cerebral lymphoma cell refractory diagnosis hypersensitivity any component treatment
1, cyclophosphamide splenic marginal zone lymphoma diagnosis pregnancy
1, capecitabine pancreatic ductal adenocarcinoma diagnosis have had major surgery within seven days prior initiation drug allow postoperative healing surgical wound site s
0, epirubicin diffuse large cell lymphoma diagnosis agegreater equal fourteen less equal seventy five
0, nivolumab lymphoma diagnosis note
1, dexamethasone phosphate ovarian cancer diagnosis subjects prior brain metastases permitted but must have completed treatment have no evidence active central nervous system cns disease at least four weeks prior first dose
1, cytarabine myeloproliferative neoplasm diagnosis patients equal less thirty days from last dose cytarabine used treatment tmd
1, dexamethasone acetate multiple myeloma diagnosis use any investigational agents within twenty eight days five half lives whichever is longer treatment
0, ixabepilone breast cancer diagnosis histologically cytologically confirmed metastatic unresectable solid malignancy which no standard curative therapies exist no longer effective
0, antibodies monoclonal recurrent fallopian tube carcinoma diagnosis alkaline phosphatase equal less doc times uln
1, nintedanib previous chemotherapy metastatic esophagogastric cancer diagnosis this requirement should be followed from screening through twenty four weeks after last treatment
0, n monoacetylcystine stage ivb mucoepidermoid carcinoma oral cavity diagnosis ability complete questionnaire by themselves assistance
0, paclitaxel peritoneal cancer diagnosis bone marrow function renal function hepatic function neurologic function
0, prednisone lymphoma diagnosis surgery
1, liposomal doxorubicin stage iv childhood lymphoblastic lymphoma diagnosis patient has hypersensitivity bortezomib boron mannitol
1, bibw neoplasms diagnosis patients unable comply protocol
1, bortezomib multiple myeloma diagnosis patient is known be seropositive human immunodeficiency virus hiv hepatitis surface antigen positive active hepatitis infection
0, bortezomib mature cell nk cell neoplasms diagnosis no known hypersensitivity trial drugs hypersensitivity any other component trial drugs
1, pembrolizumab breast cancer stage ii diagnosis resolved childhood asthma atopy
1, fludarabine phosphate adult grade iii lymphomatoid granulomatosis diagnosis adult
1, pharmacological wilms tumor diagnosis patients any medical surgical conditions that would interfere gastrointestinal absorption this oral agent not eligible
1, p gene therapy tumor locate very close important blood vessels nerves which affect injection
1, bevacizumab breast cancer diagnosis pregnancy lactation
1, carboplatin non squamous non small cell lung cancer diagnosis active hepatitis hepatitis c
1, antibodies monoclonal ovarian serous adenocarcinoma diagnosis new york heart association nyha grade ii greater congestive heart failure
0, bevacizumab stage ib breast cancer diagnosis axillary lymph node negative disease
0, paclitaxel adenosquamous lung carcinoma diagnosis granulocyte greater equal one five hundred mcl
0, hydroxyurea stage iv adenoid cystic carcinoma oral cavity diagnosis not pregnant nursing
0, immunoglobulins adult grade ii meningioma diagnosis evidence metastatic disease
1, rituximab small lymphocytic lymphoma diagnosis diagnosis fever neutropenia within one week prior drug administration
0, everolimus adult solid neoplasm diagnosis doc patients on therapeutic doses warfarin coumadin
0, topotecan retinoblastoma diagnosis adequate renal function defined as
0, fluorouracil recurrent rectal cancer diagnosis advanced metastatic disease
0, mercaptopurine myelodysplastic myeloproliferative neoplasms diagnosis no other concurrent illness that would preclude study
0, albumin bound paclitaxel cystic tumors that increased size during observation period
1, carboplatin carcinoma non small cell lung diagnosis untreated superior vena cava syndrome
1, rituximab lymphoma diagnosis treatment other investigational agents less fourteen days prior enrollment
1, laboratory biomarker analysis recurrent non small cell lung carcinoma diagnosis patients who have contraindication cyclophosphamide chemotherapy
0, imatinib mesylate brain central nervous system tumors diagnosis at least four weeks since prior cytotoxic therapy
0, exercise guidebook breast cancer diagnosis willing accept random assignment
1, tacrolimus stage iv marginal zone lymphoma diagnosis identical twin
0, placebo metastatic colorectal cancer diagnosis no symptoms peripheral neuropathy nci ctc grade four within four weeks before treatment start
0, epothilones childhood synovial sarcoma diagnosis at least two months since prior autologous sct
0, ct guided core biopsy all patients aged greater eighteen years peripheral pulmonary lesion suspected lung cancer requiring biopsy
1, mycophenolate mofetil recurrent childhood small noncleaved cell lymphoma diagnosis left ventricular ejection fraction less thirty five
1, sunitinib stage ivb cervical cancer diagnosis all women childbearing potential must have negative urine bet negative human chorionic gonadotropin beta hcg pregnancy test within seven days prior registration
1, topotecan untreated childhood supratentorial primitive neuroectodermal tumor diagnosis all patients their parents legal guardians must sign written informed consent
0, iodine esophageal cancer diagnosis wbc greater three five hundred mmthree platelet count greater one hundred fifty zero mmthree hemoglobin greater ten dl hepatic
1, tacrolimus contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis patients chronic myelomonocytic leukemia cmml
1, rta dose malignant melanoma diagnosis clinically significant illnesses which could compromise participation including
1, anesthetics cancer diagnosis patients under tutorship curatorship
0, gold sodium thiomalate lung cancer diagnosis no prior biologic therapy within past three weeks
0, prednisone acute adult cell leukemia lymphoma diagnosis serum creatinine no more doc times unl
1, ifosfamide diffuse large cell lymphoma diagnosis myocardial infarction within six months prior enrollment has new york hospital association nyha class iii iv heart failure uncontrolled angina severe uncontrolled ventricular arrhythmias electrocardiographic evidence acute ischemia active conduction system abnormalities
1, lenalidomide lymphoma diagnosis addition these patients at increased risk lethal infections when treated marrow suppressive therapy
0, interleukin metastatic renal cell cancer diagnosis creatinine less one two mg dl
0, liposomal doxorubicin primary effusion lymphoma diagnosis granulocytes absolute neutrophil count anc greater equal one zero mm three
1, busulfan non hodgkin lymphoma diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible
0, epirubicin stage iiic breast cancer diagnosis platelets greater equal one hundred zero cells mm three
1, tacrolimus stage cutaneous cell non hodgkin lymphoma diagnosis fertile men women unwilling use contraceptives during up twelve months post treatment
0, tremelimumab urothelial cancer diagnosis cisplatin ineligibility is defined meeting one following criteria
0, sorafenib pancreatic cancer diagnosis two thousand one and
0, bortezomib metastatic transitional cell cancer renal pelvis ureter diagnosis creatinine equal less doc mg dl measured calculated creatinine clearance greater thirty ml min
1, everolimus low grade glioma diagnosis topical inhaled corticosteroids treatment low dose decadron sixmg daily allowed
0, antilymphocyte serum lymphoma diagnosis disease characteristics
1, abiraterone acetate prior cytotoxic chemotherapy biological therapy treatment prostate cancer
1, endothelial growth factors recurrent colorectal carcinoma diagnosis current recent equal less twenty eight days prior randomization use sorivudine brivudine st
1, crizotinib non small cell lung cancer diagnosis prior therapy specifically directed against alk rosone fusion genes
0, gemcitabine small cell lung cancer sclc diagnosis eligibility criteria
0, alvespimycin hydrochloride recurrent mucoepidermoid carcinoma oral cavity diagnosis patients who received an antiandrogen part first line hormonal therapy must show disease progression after discontinuing treatment
1, antibodies grade ii meningioma diagnosis cardiac arrhythmia new york heart association nyha criteria
0, nitrogen mustard compounds recurrent follicular lymphoma diagnosis within three weeks prior start trial
1, topotecan high grade glioma diagnosis participation another investigational drug prior four weeks
0, epirubicin breast cancer diagnosis patients who candidates neoadjuvant chemotherapy according ago guidelines ww go onlin unifocal lesion
0, blood draw baseline questionnaire individuals at risk hereditary cancer syndrome under age eighteen will eligible hcp testing if they meet eligibility criteria written parental consent child assent where appropriate
0, lomustine infantile desmoplastic ganglioglioma
0, dexamethasone childhood favorable prognosis hodgkin lymphoma diagnosis lactating females must agree that they will not breastfeed child while on this study
0, immunoglobulins non hodgkin lymphoma diagnosis signed informed consent
0, ixazomib myeloma diagnosis periodic abstinence calendar ovulation symptothermal post ovulation methods withdrawal not acceptable methods contraception
0, carmustine lymphoma diagnosis renal
1, palbociclib breast neoplasms diagnosis pikthreeca wild type cohort
0, cyclophosphamide stage ii multiple myeloma diagnosis serum immunoglobulin free light chain greater equal ten mg dl abnormal serum immunoglobulin kappa lambda free light chain ratio monoclonal bone marrow plasmacytosis greater equal thirty evaluable disease
1, bind having received treatment their cancer including chemotherapy surgery radiation within thirty days prior screening
0, lenograstim ovarian cancer diagnosis prior concurrent therapy
0, bowman birk inhibitor concentrate unspecified adult solid tumor protocol specific diagnosis amylase normal
1, capecitabine metastatic breast cancer diagnosis prior treatment capecitabine cisplatin
1, mssm biir hdc vax host dendritic cells chronic lymphocytic lymphoma diagnosis pregnancy nursing
0, liposomal doxorubicin adult alveolar soft part sarcoma diagnosis not pregnant nursing patients undergoing radiotherapy chemotherapy
1, immunoglobulins recurrent midline lethal granuloma paranasal sinus nasal cavity diagnosis chronic treatment systemic steroids another immunosuppressive agent
0, needle localized breast biopsy specimen x ray breast cancer diagnosis prior concurrent therapy
0, paclitaxel endometrial adenocarcinoma diagnosis no prior pelvic abdominal radiotherapy
1, dasatinib head neck cancer diagnosis have positive pregnancy test at baseline or
1, gsk tumor diagnosis history diabetes
1, sirolimus prostate cancer diagnosis use cytotoxic biologic hormonal therapies within four weeks entry
1, hydroxocobalamin non small cell lung cancer diagnosis progressive brain metastases
0, subjects mailed informational educational materials have had either an abnormal screening test an abnormal diagnostic test an abnormal clinical finding leading diagnostic testing cervical breast colorectal cancer diagnosis cervical breast colorectal cancer
1, ketogenic diet glioblastoma multiforme brain diagnosis history human immunodeficiency virus hepatitis c
1, bis neodecanoato diaminocyclohexaneplatinum ii neoplasms diagnosis no other active malignancies
1, antibodies monoclonal metastatic colorectal cancer diagnosis residual ae from previous treatment greater grade one
1, sirolimus stage iiic uterine corpus cancer diagnosis patients undergoing invasive procedures defined below
0, adjuvants immunologic breast cancer diagnosis disease characteristics
1, everolimus primary non metastatic breast cancer diagnosis patients pnonemi sole nodal involvement
0, antibodies neuroblastoma diagnosis no obstructive hydrocephalus
1, panobinostat glioma diagnosis transfusions
1, vincristine primary effusion lymphoma diagnosis these potential risks may also apply other agents used this study
1, paclitaxel hrpos breast neoplasms diagnosis prior use parp inhibitor
0, bevacizumab neuroendocrine carcinoma diagnosis patient has an range inr between two three on stable no change prior two weeks dose oral anticoagulant on stable no change prior two weeks dose low molecular weight heparin
0, dexetimide gastric cancer diagnosis no history head trauma
1, cyclophosphamide research participants presence other active malignancy except non melanoma skin tumors situ cervical cancer within two years entry participants history prior malignancy treated within two years curative intent complete remission eligible
1, albumin bound paclitaxel stage iia breast cancer diagnosis valvular disease documented compromise cardiac function or
0, dexamethasone multiple myeloma diagnosis be surgically sterile or
1, mycophenolic acid stage iv adult cell leukemia lymphoma diagnosis lansky play performance score less sixty pediatric patients
0, antibodies monoclonal stage iv non small cell lung cancer diagnosis myocardial infarction stroke cerebrovascular accident transient ischemic attack within past six months
0, norgestimate ethinyl estradiol drug combination gestational trophoblastic tumor diagnosis see disease characteristics
1, everolimus patients diagnosed rhabdomyosarcoma second malignant neoplasm not eligible
0, antilymphocyte serum myelodysplastic myeloproliferative neoplasms diagnosis eligible related unrelated donor transplantation
0, vorinostat stage small lymphocytic lymphoma diagnosis philadelphia chromosome positive ph positive metaphases greater zero but less thirty five
1, levoleucovorin prior enteritis that was symptomatic required medical intervention equal less six months prior registration known toxicity pembrolizumab
0, albumin bound paclitaxel brain central nervous system tumors diagnosis no effective curative therapy exists
0, sirolimus stage iiia fallopian tube cancer diagnosis any human leukocyte antigen hla type historic hla typing is permitted
1, paclitaxel undifferentiated carcinoma diagnosis this criterion applies only patients enrolled before august twenty nine two thousand eleven those enrolled after this date electing receive bevacizumab patients known hypersensitivity chinese hamster ovary cell products other recombinant human humanized antibodies
1, dexamethasone acetate multiple myeloma diagnosis ethical other
1, cisplatin stage iva intrahepatic cholangiocarcinoma diagnosis participants who require anticoagulation should receive low molecular weight standard heparin not warfarin
1, capecitabine advanced solid tumors diagnosis severe renal impairment creatinine clearance below thirty ml min
0, n benzoylstaurosporine women childbearing potential is defined sexually active mature woman who has not undergone hysterectomy who has not had menses at any time preceding twenty four consecutive months
1, etoposide phosphate noncontiguous stage ii small lymphocytic lymphoma diagnosis patients uncontrolled seizures defined by having any seizure activity within three months prior screening
1, doxorubicin stage iiic breast cancer diagnosis cardiac arrhythmia requiring medication
0, pharmacological unspecified adult solid tumor protocol specific diagnosis discontinue four hours prior procedure an aptt measurement obtained if clinically indicated
1, pembrolizumab bladder cancer diagnosis has clinically relevant hearing impairment greater grade two
0, reduced intensity conditioning lymphoma low grade diagnosis creatinine less doc times normal age
1, fluorouracil hertwo positive esophagogastric cancer diagnosis concurrent treatment drugs known be strong inhibitors inducers isoenzyme cypthreea that cannot be discontinued switched different medication prior starting drug
0, cisplatin fallopian tube carcinoma diagnosis no poorly differentiated subtypes including papillary serous clear cell other figo grade three lesion
1, bb ovarian cancer diagnosis known suspected human immunodeficiency virus hiv infection subjects who hiv seropositive
1, nik peretinoin patients confirmed having another malignant neoplasm who had undergone radical therapy hcc within past five years treat another malignant neoplasm however this does not apply endoscopic resection resection intraepithelial carcinoma
1, mycophenolate mofetil recurrent grade three follicular lymphoma diagnosis pregnancy
0, liposomal doxorubicin small intestine lymphoma diagnosis stratum three other leukemias
1, anti bcma car transduced t cells multiple myeloma diagnosis concurrent use systemic steroids chronic use immunosuppressant medications
0, mitogens stage iib breast cancer diagnosis willing return consenting institution follow up during active monitoring phase study
0, laboratory biomarker analysis breast cancer diagnosis no prior breast implantation on proposed lavage side
0, irofulven brain central nervous system tumors diagnosis creatinine no greater doc mg dl
0, melphalan multiple myeloma diagnosis age over eighteen under sixty seven years old
0, thalidomide all previous cancer therapy including radiation hormonal therapy surgery must have been discontinued at least four weeks prior treatment this study
1, endothelial growth factors ovarian seromucinous carcinoma diagnosis major surgical procedure open biopsy significant traumatic injury equal less four weeks prior registration
0, ifosfamide childhood nodular sclerosis hodgkin lymphoma diagnosis ld diffuse fibrosis
0, low dose computed tomography annual scan x lung cancer diagnosis eighty years either gender any ethnic group
1, leucovorin stage iva colon cancer diagnosis lymphangitis cutis pulmonis
1, maleic acid stage iiia non small cell lung cancer diagnosis there is no mass effect present radiologically no steroids requirement symptom control more four weeks
0, isotretinoin lymphoma cell diagnosis patients may not have serious intercurrent medical illness
1, fludarabine high grade non hodgkin lymphoma diagnosis history hiv infection
0, calcium dietary diffuse adenocarcinoma stomach diagnosis case one both these thresholds exceeded patient can only be included after initiation appropriate lipid lowering medication
1, thalidomide prior glucocorticoid treatment multiple myeloma exceeding dexamethasone twentymg day maximum seven days
0, melphalan multiple myeloma diagnosis men must agree not father child agree use latex condom even if he has had successful vasectomy if partner is fcbp
0, temozolomide brain central nervous system tumors diagnosis bilirubin normal
0, mfolfox metastatic pancreatic cancer diagnosis ability understand willingness sign written informed consent document
0, vidarabine stage iv adult burkitt lymphoma diagnosis all patients must be cr defined by hematologic recovery less five blasts by morphology within bone marrow cellularity greater equal five
0, vidarabine squamous cell carcinoma diagnosis patients may have undergone minor surgical procedures local radiotherapy within past four weeks
1, bb noncontiguous stage ii grade two follicular lymphoma diagnosis patient has significant heart disease new york heart classification iii iv heart disease iii
0, anastrozole breast cancer diagnosis new york heart association class iii iv congestive heart failure
0, carboplatin extrahepatic bile duct cancer diagnosis no active infection requiring iv antibiotic therapy unless infection has resolved
1, antibodies monoclonal urinary bladder cancer diagnosis have planned major surgery
1, radiotherapy cancer diagnosis patients disabling co morbid conditions which not permit effective immobilization
0, antibodies monoclonal ovarian cancer diagnosis women must not be breastfeeding
0, isophosphamide mustard retinoblastoma diagnosis hematologic
0, conventional surgery stage verrucous carcinoma oral cavity diagnosis patients must have an eastern cooperative oncology group ecog performance status zero two
1, dexamethasone acetate angioimmunoblastic cell lymphoma diagnosis pregnant nursing women men women reproductive potential may not participate unless they have agreed use an effective contraceptive method
0, bowel obstruction management gastrointestinal stromal tumor diagnosis chemotherapy
1, vidarabine hematopoietic lymphoid cancer diagnosis cross match positive donor
0, antibodies adult gliosarcoma diagnosis must have received prior temozolomide
0, interferon alpha malignant melanoma diagnosis life expectancy three months
1, paclitaxel endometrial cancer diagnosis evidence interstitial lung disease
1, nadroparin hepatocellular carcinoma diagnosis prothrombin time prolonged more fours
0, bortezomib lymphoma diagnosis uncontrolled severe cardiovascular disease including any following
1, trastuzumab stomach neoplasms diagnosis appropriate studies will be undertaken patients receiving combination antiretroviral therapy when indicated
1, epirubicin breast cancer diagnosis negative pregnant test serum urine fourteen days prior randomization
1, carboplatin stage iv fallopian tube cancer diagnosis patients acute hepatitis active infection that requires parenteral antibiotics
0, docetaxel metastatic pancreatic cancer diagnosis absolute neutrophil count greater one five hundred Î¼l
0, physiologic testing psychosocial effects cancer its treatment diagnosis patients only cystic sellar parasellar malformation rathke pouch cysts suprasellar cysts allowed but will undergo observation only
1, pharmacological stage iv adult burkitt lymphoma diagnosis patients ineligible participation drug interaction can be deemed be ineligible receive certain drug probes if they have
0, gemcitabine lymphoma hodgkin disease diagnosis patients must have pretreatment serum bilirubin less two institutional uln serum creatinine less two institutional uln measured estimated creatinine clearance greater sixty cc min by following formula all tests must be performed within two days prior registration
1, veliparib progesterone receptor negative breast cancer diagnosis contraception must be used during study
0, paclitaxel cervical squamous cell carcinoma not otherwise specified diagnosis alkaline phosphatase less equal doc uln
0, albumin bound paclitaxel mucinous adenocarcinoma
1, prednisone diffuse large cell lymphoma diagnosis patients malignancy that has been treated surgery alone curative intent will also be excluded unless malignancy has been documented remission without treatment greater three years prior enrollment
0, immunoglobulins cervical adenosquamous carcinoma diagnosis creatinine equal less doc uln
0, erlotinib hydrochloride histologically cytologically confirmed locally advanced squamous cell carcinoma head neck
0, cetuximab recurrent verrucous carcinoma oral cavity diagnosis no prior erlotinib gefitinib lapatinib therapy is permitted nor is prior exposure any investigational egfr panerbb reversible irreversible inhibitor any prior panitumumab investigational egfr directed monoclonal antibody permitted
1, fludarabine recurrent adult diffuse small cleaved cell lymphoma diagnosis donor
1, liposomal doxorubicin recurrent platinum sensitive ovarian cancer diagnosis surgery including open biopsy within four weeks prior anticipated first dose bevacizumab
0, laboratory biomarker analysis recurrent cutaneous cell non hodgkin lymphoma diagnosis pulse oximetry at rest on exercise greater eighty eight
0, antibodies stage iii rectal cancer diagnosis no concurrent antiplatelet agents dipyridamole ticlopidine clopidogrel cilostazol
1, sargramostim refractory brain neoplasm diagnosis growth factors
0, tetrathiomolybdate lung cancer diagnosis prior malignancy allowed if disease free greater five years
1, quality life assessment prostate cancer diagnosis documented distant metastatic disease
0, octreotide vaginal cancer diagnosis no other concurrent medical condition that would preclude participation
1, carboplatin small cell lung carcinoma diagnosis severe uncontrolled medical disease uncontrolled diabetes congestive heart failure myocardial infarction within six months chronic renal disease chronic pulmonary disease active uncontrolled infection
1, cadexomer iodine stage ivb papillary thyroid cancer diagnosis coronary artery bypass graft surgery
0, prednisolone lymphoma diagnosis renal
1, fulvestrant breast cancer diagnosis patient has received prior treatment chemotherapy except neoadjuvant adjuvant chemotherapy fulvestrant any pithreek mtor akt inhibitor pre treatment cdkfour six inhibitors is allowed
0, gemcitabine bladder cancer diagnosis no serious cardiac arrhythmias including first second third degree heart block
1, albumin bound paclitaxel stage iv esophageal cancer diagnosis poorly controlled diabetes mellitus patients history diabetes mellitus allowed participate provided that their blood glucose is within normal range fasting glucose equal less one hundred sixty mg dl doc mmol below uln hemoglobin aonec equal less seven doc seven si units that they on stable dietary therapeutic regimen this condition
0, methylprednisolone intraocular lymphoma diagnosis this protocol will allow use donors who unrelated but hla b d dr identical mlc mixed lymphocyte culture compatible
1, tasquinimod mg mg prostate cancer diagnosis abiraterone acetate takseven hundred fourteen days washout is needed
1, paclitaxel cervical cancer diagnosis recent past condition active disease central nervous system including seizures
1, erlotinib hydrochloride metastatic non small cell lung cancer diagnosis ongoing treatment cypthreeafour inducers strong moderate inhibitors
1, paclitaxel neoplasm metastasis diagnosis pregnancy nursing status
1, folic acid interstitial pneumonitis symptomatic pulmonary fibrosis
1, krn chemotherapy tio other malignant tumors within four months prior screening
1, cabozantinib urothelial carcinoma diagnosis clinically significant hematemesis gastrointestinal bleeding
0, etoposide phosphate lymphoma non hodgkin diagnosis adequate cardiac function defined shortening fraction greater twenty seven ejection fraction greater forty five
0, interferons sarcoma diagnosis radiotherapy
1, musculoskeletal complications management prevention stage iv ovarian germ cell tumor diagnosis current previous bisphosphonate use
0, liver extracts liver cancer diagnosis patients planning undergo local ablative therapy after transplant listing enrollment eligible provided they undergo ct scan mri within twenty eight sixty days after completing last ablative therapy session
0, mycophenolate mofetil stage ii childhood small noncleaved cell lymphoma diagnosis hla phenotypically identical unrelated donor match grades allowed
0, immunoglobulins cervical carcinosarcoma diagnosis ability understand willingness sign written informed consent document
0, thiotepa breast cancer diagnosis no prior hemorrhagic cystitis no active systemic infection no active cns disease seizures hiv negative no second malignancy within two years except
0, sirolimus histological cytological diagnosis solid tumors types which treatment an anthracycline containing combination might be indicated
0, antilymphocyte serum recurrent grade two follicular lymphoma diagnosis diagnosis histology documented hematologic malignancy marrow disorder
0, epirubicin breast cancer diagnosis performance status
0, sorafenib carcinoma hepatocellular diagnosis radiographic diagnosis needs typical findings hcc by radiographic method on multi dimensional dynamic ct ct hepatic arteriography ctha ct arterial portography ctap mri
1, irinotecan osteosarcoma diagnosis patients thrombotic embolic events such cerebrovascular accident including transient ischemic attacks within past six months
0, everolimus patients not considered have currently active malignancy if they have completed anticancer therapy considered be at less thirty risk relapse
1, questionnaire administration stage iii mantle cell lymphoma diagnosis patients who have previously received chemotherapy other steroids intrathecal chemotherapy not eligible
0, etoposide diffuse large cell non hodgkin lymphoma
0, antineoplaston a contiguous stage ii mantle cell lymphoma diagnosis platelet count greater twenty zero mm three
1, frozen tumor specimens gastro esophageal ge junction cancer diagnosis none
0, fenofibrate multiple myeloma diagnosis platelets greater equal seventy five zero mmthree
0, anti cd car transduced t cells lymphoma diagnosis cdthirty expression malignant cells must be detected by immunohistochemistry by flow cytometry
1, interleukin recurrent bladder cancer diagnosis history inflammatory bowel disease
1, immunoglobulin g primary peritoneal high grade serous adenocarcinoma diagnosis known clinically significant liver disease including active viral alcoholic other hepatitis cirrhosis fatty liver inherited liver disease
1, bevacizumab colorectal adenocarcinoma diagnosis john wort
1, antilymphocyte serum lymphoma cell diagnosis antibody test hiv must be performed within forty two days registration
0, fludarabine phosphate precancerous nonmalignant condition diagnosis chronic myelomonocytic leukemia
0, albumin bound paclitaxel non small cell lung cancer diagnosis no prior chemotherapy biological including targeted therapies such epidermal growth factor receptor egfr vascular epidermal growth factor vegf inhibitors immunological therapy
0, cyclosporine contiguous stage ii adult diffuse large cell lymphoma diagnosis cytogenetic abnormalities addition ph positive
1, mycophenolate mofetil stage iv childhood anaplastic large cell lymphoma diagnosis human immunodeficiency virus hiv positive patients
1, trastuzumab occult non small cell lung cancer diagnosis brain central nervous system metastasis at entry
0, vaccines recurrent ovarian epithelial cancer diagnosis sgot less doc times upper limit normal
0, fluorodeoxyglucose f stage iv breast cancer diagnosis able remain still duration each imaging procedure about one hour
1, cetuximab metastatic colorectal cancer diagnosis active infection requirement systemic antibiotics treatment serious cardiovascular disease evidence active hepatitis infection human immunodeficiency virus infection
0, albumin bound paclitaxel extragonadal germ cell tumor diagnosis hepatic metastases
1, hydrocortisone butyrate propionate stage iv prostate cancer diagnosis heart failure significant heart disease including significant arrhythmias myocardial infarction within last three months unstable angina documented ejection fraction less three current digoxin therapy
1, fludarabine lymphoma diagnosis known infection hiv htlv hepatitis hepatitis c
1, dexamethasone phosphate multiple myeloma diagnosis seropositive hiv active hepatitis b infection
0, albumin bound paclitaxel tubular breast cancer stage iii diagnosis cttwo
0, thalidomide recurrent follicular lymphoma diagnosis patients must be eighteen years age older
0, reverse transcriptase polymerase chain reaction stage iv grade one follicular lymphoma diagnosis recent current use inhaled steroids is not exclusionary
1, cyclosporine recurrent grade two follicular lymphoma diagnosis female patient must have negative serum pregnancy test all women child bearing potential must have test performed
0, paclitaxel extragonadal germ cell tumor diagnosis prior concurrent therapy
1, dexamethasone phosphate multiple myeloma diagnosis serious concurrent illness medical psychiatric uncontrolled infection significant cardiac disease characterized by significant ischemic coronary disease an imbalance between myocardial functional requirements capacity coronary vessels supply sufficient blood flow congestive heart failure condition which heart is unable pump out sufficient blood meet metabolic need body not under medical control any uncontrolled medical condition example
1, chemotherapy sarcoma greater thirty two cm any direction
0, tacrolimus stage iv adult diffuse large cell lymphoma diagnosis donor recipient must have human leukocyte antigen hla eight eight allelic match at hla b drbone high resolution typing is required all alleles
1, sorafenib stage iva rectal cancer diagnosis any following
1, fostamatinib disodium carcinoma non small cell lung diagnosis patients will also be required keep diary record any side effects that occur during any other medications taken
1, veliparib ependymoma diagnosis seizures
0, pharmacological stage iii salivary gland cancer diagnosis no new york heart association class iii iv congestive heart failure
1, pembrolizumab recurrent head neck cancer diagnosis has diagnosis immunodeficiency is receiving systemic steroid therapy any other form immunosuppressive therapy within seven days prior first dose trial treatment
1, veliparib stage iiib breast cancer diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
1, irinotecan neoplasms diagnosis not have known treated untreated leptomeningeal metastasis metastatic central nervous system lesion
0, panobinostat recurrent grade three follicular lymphoma diagnosis anc greater equal one thousand ul
1, dexamethasone acetate stage iv marginal zone lymphoma diagnosis patient has significant heart disease new york heart classification iii iv heart disease iii
1, ondansetron stage breast cancer diagnosis any vomiting retching nci common toxicity criteria version doc grade two four nausea twofour hours preceding chemotherapy
0, dexamethasone phosphate multiple myeloma diagnosis absolute neutrophil count anc greater one thousand cells Î¼l growth factor cannot be used within previous seven days
1, lapatinib unresolved unstable serious toxicity from prior administration another investigational drug prior cancer treatment
1, maleic acid recurrent childhood lymphoblastic lymphoma diagnosis patients bleeding diathesis clinical bleeding prothrombin time greater equal doc upper institutional normal value inr greater equal doc activated partial thromboplastin time aptt greater equal doc upper institutional normal value active gastric duodenal ulcer
0, calcium dietary breast cancer diagnosis no calcium based kidney stones
0, tacrolimus stage iii small lymphocytic lymphoma diagnosis matched human leukocyte antigen hla b drbone dqbone by high resolution typing
1, albumin bound paclitaxel breast cancer diagnosis unstable angina
0, methylprednisolone hemisuccinate neoplasm breast diagnosis serum creatinine less doc uln
1, paclitaxel solid tumors diagnosis right bundle branch block left anterior hemiblock bifasicular block
0, doxorubicin small intestine cancer diagnosis no severe pulmonary disease that would preclude participation limit life expectancy
0, immunoglobulins stage ii grade three non contiguous follicular lymphoma diagnosis no known human anti chimeric antibody haca positivity
0, laboratory biomarker analysis myxofibrosarcoma diagnosis leukocytes greater equal three zero mcl
0, cetuximab stage iv verrucous carcinoma larynx diagnosis serious cardiac arrhythmia requiring medication
1, dexamethasone acetate multiple myeloma diagnosis patients non secretory mm no measurable monoclonal protein free light chains spike blood urine
0, antineoplaston as brain central nervous system tumors diagnosis hemoglobin at least nine dl
1, eortc qlq ov questionnaire neoplasms ovarian diagnosis actively receiving any investigational agents
0, endothelial growth factors stage iv fallopian tube cancer diagnosis afp greater three times normal doubling value antecedent three months
0, methotrexate stage adult immunoblastic large cell lymphoma diagnosis estimated actual glomerular filtration rate gfr greater fifty ml min doc three two patients creatinine levels above institutional normal gfr should be corrected body surface area bsa
0, dexamethasone acetate lymphoma diagnosis females childbearing potential fcbp must have negative serum urine pregnancy test within thirty days initiation protocol therapy must be willing use acceptable methods birth control
0, thiotepa primary malignant brain neoplasms diagnosis pd after conventional dose salvage cisplatin positive ifosfamide based regimen
1, poly iclc head neck squamous cell carcinoma diagnosis other serious illnesses serious infections requiring antibiotics bleeding disorders
0, etoposide phosphate newly diagnosed childhood ependymoma diagnosis clear cell
1, questionnaire administration recurrent squamous cell carcinoma larynx diagnosis received an investigational agent within thirty days prior enrollment
0, vaccines melanoma skin diagnosis more four weeks since prior steroids
1, niacinamide liver cancer diagnosis unable swallow medication suspected malabsorption
0, erlotinib hydrochloride stage iv squamous cell carcinoma lip oral cavity diagnosis creatinine within normal institutional limits creatinine clearance greater equal sixty ml min doc three two patients creatinine levels above institutional normal
0, doxorubicin breast cancer diagnosis adequate bone marrow hepatic cardiac renal functions
1, sirolimus metastatic renal cell cancer diagnosis radiation therapy bone metastasis within two weeks any other external radiation therapy within four weeks before planned first dose drug
0, cyclophosphamide unspecified adult solid tumor protocol specific diagnosis creatinine clearance greater fifty ml min
1, mitomycin anal carcinoma diagnosis prior chemotherapy
0, dexamethasone high risk smoldering multiple myeloma diagnosis periodic abstinence eg calendar ovulation symptothermal post ovulation methods withdrawal not acceptable methods contraception
1, stereotactic radiosurgery stage prostate cancer diagnosis patients unable undergo an mri contrast
1, oxaliplatin stage iiic rectal cancer diagnosis known existing uncontrolled coagulopathy subjects on therapeutic anticoagulation may be enrolled provided that they have been clinically stable on anti coagulation at least two weeks
1, transcutaneous acupoint electrical stimulation head neck carcinoma diagnosis patients normal saliva production no salivary gland changes no xerostomia
1, cyclosporins stage multiple myeloma diagnosis identical twin
1, androgens prostate cancer diagnosis known suspected brain metastasis active leptomeningeal disease
0, cytology specimen collection procedure cervical cancer diagnosis disease characteristics
1, cyclosporine recurrent childhood grade iii lymphomatoid granulomatosis diagnosis eligible high priority curative autologous transplant
0, antibodies localized unresectable adult primary liver cancer diagnosis unresectable locally advanced metastatic disease
0, paclitaxel hrpos breast neoplasms diagnosis centrally confirmed negative hertwo status
0, vidarabine recurrent childhood lymphoblastic lymphoma diagnosis hodgkin disease hd
1, tacrolimus recurrent childhood hodgkin lymphoma diagnosis donors who hiv positive medical conditions that would result increased risk csf mobilization harvest pbmc
1, fluorouracil adenocarcinoma colon diagnosis pregnant lactating women
0, bendamustine hydrochloride mantle cell lymphoma diagnosis age greater equal sixty five years greater eighteen year ineligible hdt asct
1, albumin bound paclitaxel carcinoma transitional cell diagnosis any condition that confounds ability interpret data from study
1, prednisone neoplasm prostatic diagnosis use ketoconazole itraconazole ritonavir cyclosporine carbamazepine phenytoin phenobarbital within two weeks prior while on therapy
0, lenograstim stage childhood hodgkin lymphoma diagnosis patients newly diagnosed pathologically confirmed hodgkin disease all histologies eligible this protocol if they meet following clinical stage guidelines
1, vaccines other malignancy within past three years except treated nonmelanoma skin cancer carcinoma situ cervix
0, nivolumab recurrent urothelial carcinoma renal pelvis ureter diagnosis ability understand willingness sign written informed consent document
1, liposomal doxorubicin other prior concurrent malignancy within past ten years except inactive nonmelanoma skin cancer carcinoma situ cervix
1, immunoglobulin g recurrent cervical carcinoma diagnosis no requirement concurrent antibiotics antifungal agents prevention opportunistic infections
0, gemcitabine transitional cell cancer renal pelvis ureter diagnosis radiologically measurable disease according recist doc criteria
0, hormones prostate cancer diagnosis part one
1, dacarbazine anaplastic astrocytoma diagnosis uncontrolled psychotic disorders epilepsy
0, fluorouracil stage iv pancreatic cancer diagnosis part oncology patient enrollment network open registration process treating institution identity is provided order ensure that current within three hundred sixty five days date institutional review board approval this has been entered into system
0, bevacizumab stage iiia fallopian tube cancer diagnosis patients who have met pre entry requirements specified
1, estradiol benzoate estrogen receptor positive breast cancer diagnosis prior malignancy except following
0, vincristine lymphoma diagnosis age less ten less equal fifteen
0, cytology specimen collection procedure stage ivb rectal cancer diagnosis have an eastern cooperative oncology group performance status ecog ps zero two
0, methylprednisolone acetate lymphoma diagnosis hiv negative
0, albumin bound paclitaxel head neck cancer diagnosis hypericum perforatum st
0, antibodies small intestinal lymphoma diagnosis eastern cooperative oncology group ecog performance status equal less two karnofsky greater equal sixty
0, temozolomide recurrent childhood medulloblastoma diagnosis agents that have known adverse events occurring beyond seven days after administration this period must be extended beyond time during which adverse events known occur duration this interval must be discussed chair
0, cyclophosphamide nodal marginal zone cell lymphoma diagnosis written informed consent written informed consent unrelated donor is required participate optional studies
1, vidarabine stage iii childhood small noncleaved cell lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
1, rituximab stage iii adult burkitt lymphoma diagnosis known hypersensitivity rituximab
0, sapacitabine cutaneous cell lymphoma ctcl diagnosis adequate bone marrow hepatic renal function
0, placebo rectal cancer diagnosis twenty seventy five
0, lenograstim bronchoalveolar cell lung cancer diagnosis meets one following stage criteria
1, cyclophosphamide non hodgkin lymphoma diagnosis pregnant breast feeding women
0, immunoglobulins recurrent non small cell lung carcinoma diagnosis female patients childbearing potential male patients partners childbearing potential agreement by patient partner use highly effective form contraception
0, doxorubicin histologically confirmed diagnosis primary early breast cancer tumor size greater equal two centimeters cm stages ttwo tfour nzero two
0, imatinib mesylate unspecified adult solid tumor protocol specific diagnosis no prior radiotherapy greater twenty five bone marrow
1, gemcitabine bladder cancer diagnosis hormonal contraceptives not acceptable sole method contraception
1, mechlorethamine mature cell nk cell non hodgkin lymphoma diagnosis any perceived inability directly without means legal guardian provide informed consent
0, lenalidomide extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis further at investigator discretion patients who unstable one cycle chop is allowed prior enrollment but no more one cycle
0, immunoglobulin idiotypes multiple myeloma diagnosis karnofsky performance status greater equal seventy percent
0, mycophenolic acid recurrent mantle cell lymphoma diagnosis cb graft must be matched at minimum at four six hla b drbone loci recipient
1, hormones prostate cancer diagnosis history myocardial infarction within six months first treatment
1, panobinostat multiple myeloma diagnosis patient has not recovered from all therapy related toxicities associated above listed treatments less grade two ctcae
0, antibodies stage iii renal cell cancer diagnosis no new york heart association nyha class greater equal two congestive heart failure
1, chlorotrianisene liver neoplasms diagnosis uncontrolled encephalopathy
1, antibodies adult glioblastoma diagnosis not history being serologically positive hepatitis b c
1, panobinostat adult nodular sclerosis hodgkin lymphoma diagnosis right bundle branch block positive left anterior hemiblock bifascicular block
0, intensity modulated radiation therapy stage iiib colon cancer diagnosis leukocytes greater equal three zero mcl
0, capecitabine melanoma diagnosis patients must have failed prior standard curative chemotherapy their disease refuse existing therapies proposed chemotherapy regimen which amten is added represents an acceptable standard treatment their disease
1, vismodegib recurrent adult unclassified pleomorphic sarcoma bone diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated gdc four hundred forty nine rofour million nine hundred twenty nine thousand ninety seven
1, gemcitabine metastatic urothelial carcinoma renal pelvis ureter diagnosis patients hypersensitivity docetaxel polysorbate eighty arm only
1, panitumumab other concurrent systemic agents cancer therapy
0, maytansine metastatic breast cancer diagnosis prior trastuzumab lapatinib pertuzumab trastuzumab emtansine dmone allowed
0, camptothecin esophageal cancer diagnosis age
1, alemtuzumab melanoma diagnosis prior allogeneic hematopoietic stem cell transplant
1, dacarbazine glioblastoma multiforme diagnosis frequent vomiting medical condition which could interfere oral medication intake partial bowel obstruction
0, antineoplaston as adenocarcinoma colon diagnosis other
1, azacitidine metastatic melanoma diagnosis is not considered form systemic treatment
1, trioxsalen acinar cell adenocarcinoma pancreas diagnosis esophageal gastric varices
1, cb advanced solid tumors diagnosis ev i ov ftpone ctcae abou tml
1, thalidomide multiple myeloma diagnosis pregnant breastfeeding females
1, lenalidomide extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis known hypersensitivity thalidomide
0, carboplatin recurrent endometrial carcinoma diagnosis at least four weeks since prior radiotherapy except low dose palliative radiotherapy recovered
1, liposomal doxorubicin prior current systemic anti cancer therapy ovarian cancer example chemotherapy monoclonal antibody therapy tyrosine kinase inhibitor therapy vascular endothelial growth factor vegf therapy hormonal therapy except first line platinum based chemotherapy without bevacizumab
0, methotrexate stage iii grade two follicular lymphoma diagnosis intermediate two risk high risk disease
0, gemcitabine urothelial carcinoma diagnosis age greater eighteen years
1, cyclosporine relapsed non hodgkin hodgkin lymphoma diagnosis active viral bacterial fungal infection
0, internet based intervention fallopian tube cancer diagnosis hair loss
1, niacinamide stage ivc verrucous carcinoma oral cavity diagnosis patients hiv who taking antiretroviral mediations will be excluded because potential interactions anti retroviral medications these agent however given potential immune modulating effects sorafenib investigators should still be very cautious about placing hiv positive patients on this trial effects these medications on hiv virus itself not know
0, etoposide phosphate liver cancer diagnosis more seven days since prior filgrastim csf sargramostim gm csf interleukin eleven
0, high risk factors stage ib cervical cancer diagnosis enrollment vulvar patients was closed on june nine two thousand fourteen no vulvar patients will be enrolled after closure this arm
0, lapatinib patient must pathologically documented stage iv breast cancer
0, edotreotide breast cancer diagnosis greater four weeks since prior investigational drugs no other concurrent investigational drug therapy no other concurrent antineoplastic therapy concurrent bisphosphonates allowed
0, fluorouracil gastric cancer diagnosis bone marrow
1, etoposide anaplastic large cell lymphoma diagnosis patients who have had major surgical procedures significant traumatic injury within twenty eight days prior treatment
1, caffeine sodium benzoate drug combination cancer diagnosis gastroesophageal reflux disease
1, pf melanoma diagnosis part two
0, urokinase derived peptide a tumors within previously irradiated field designated non target lesions unless progression is documented biopsy is obtained confirm persistence disease greater ninety days following completion radiotherapy
1, htert mrna dc concurrent second malignancy other non melanoma skin cancer controlled superficial bladder cancer
0, albumin bound paclitaxel pancreatic carcinoma non resectable diagnosis expected survival greater six months
0, prednisolone hemisuccinate small intestine lymphoma diagnosis donor
1, paclitaxel advanced solid tumors diagnosis uncontrolled significant cardiovascular disease
1, ketamine cancer diagnosis under eighteen years
1, female ar tnbc enzalutamide naÃ¯ve cancer breast diagnosis patients history adrenal insufficiency
0, quality life assessment refractory multiple myeloma diagnosis total bilirubin equal less doc times upper limit institutional normal uln values
0, insulin globin zinc gastro enteropancreatic neuroendocrine tumor diagnosis is not being transferred from an ongoing clinical trial which they still eligible
1, laboratory biomarker analysis stage iv squamous cell carcinoma lip oral cavity diagnosis antibiotics
0, paclitaxel lung cancer diagnosis bilirubin less doc times upper limit normal uln
0, sirolimus recurrent ovarian carcinoma diagnosis capable understanding investigational nature potential risks benefits able provide valid informed consent
0, niacinamide hepatoma diagnosis eastern cooperative oncology group zero one
0, interferon alpha lymphoma diagnosis biologic therapy
0, doxorubicin stage iiib breast cancer diagnosis note
0, therapeutic conventional surgery stage iiib melanoma diagnosis hemoglobin greater ten dl
1, starvation esophagus cancer diagnosis pregnant breast feeding women
0, thiotepa recurrent adult hodgkin lymphoma diagnosis left ventricular end diastolic function lvef greater fifty
1, fluorouracil pancreatic adenocarcinoma diagnosis received an investigational agent within thirty days prior enrollment
1, metformin stage ivb oropharyngeal squamous cell carcinoma diagnosis uncontrolled intercurrent illness including but not limited ongoing active infection unstable angina pectoris cardiac arrhythmia psychiatric illness social situations that would limit compliance requirements
0, standard wb fractionation boost carcinoma ductal breast diagnosis patient life expectancy greater five years
1, cisplatin head neck cancer diagnosis pregnant positive pregnancy test breast feeding
1, pharmacological stage iv adult soft tissue sarcoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition gdc four hundred forty nine rofour million nine hundred twenty nine thousand ninety seven used study
1, aromatase inhibitors breast cancer diagnosis combination vaccine against yellow fever
1, everolimus kidney cancer diagnosis hypersensitivity everolimus sirolimus other rapamycin derivatives any excipients
1, gemcitabine adenocarcinoma pancreas diagnosis vitiligo is allowed
1, cisplatin stage iiic primary peritoneal cancer diagnosis patients serious non healing wound ulcer bone fracture this includes history abdominal fistula gastrointestinal perforation intra abdominal abscess within twenty eight days patients granulating incisions healing by secondary intention no evidence fascial dehiscence infection eligible but require weekly wound examinations
1, valrubicin carcinoma situ concurrent papillary tumors diagnosis immunosuppressive therapy including
1, mycophenolate mofetil stage iii grade one follicular lymphoma diagnosis cardiac ejection fraction less thirty five ejection fraction is required if age greater fifty years there is history anthracycline exposure history cardiac disease
0, etoposide neuroblastoma diagnosis clinically normal pulmonary function
0, mycophenolic acid stage iv adult burkitt lymphoma diagnosis patients blast crisis bc must receive therapy must achieve accelerated phase ap chronic phase cp order be eligible patients who remain bc not eligible
1, albumin bound paclitaxel recurrent breast carcinoma diagnosis cardiac disease history active disease that would preclude use drugs included treatment regimens this includes but is not confined to
0, metronidazole stage iia prostate cancer diagnosis there must be one psa measurement referred baseline psa obtained within one week prior registration baseline psa value must be greater doc ng ml after prostatectomy greater doc ng ml after radiation therapy
1, gemcitabine recurrent gallbladder carcinoma diagnosis patients must not have central lesion radiologic evidence arterial involvement
0, antibodies stage iii adult hodgkin lymphoma diagnosis subjects required be on antiretroviral regimens that accordance current international aids society guidelines concurrently chemotherapy
0, vincristine disseminated neuroblastoma diagnosis no known contraindication peripheral blood stem cell pbsc collection examples contraindications might be weight size less that determined be feasible at collecting institution physical condition that would limit ability child undergo apheresis catheter placement if necessary apheresis procedure
1, antibodies monoclonal liver cancer diagnosis doc
0, cisplatin localized osteosarcoma diagnosis bilirubin less doc times upper limit normal
1, camptothecin colorectal neoplasms diagnosis no treatment cytotoxic biologic agents within four weeks prior beginning treatment on this six weeks mitomycin nitrosoureas
1, laboratory biomarker analysis anaplastic large cell lymphoma alk positive diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier steroids symptom palliation allowed but must be either discontinued on stable doses at time initiation protocol therapy
1, lenvatinib columnar cell variant thyroid gland papillary carcinoma diagnosis corrected qt qtc prolongation greater four hundred eighty msec calculated by either bazett fridericia formula per institutional standard
0, sirolimus malignant solid tumor diagnosis no known active pneumonitis
1, methotrexate patients congenital immunodeficiency chromosomal breakage syndrome prior organ transplantation previous malignancy any type known positive hiv serology
1, paclitaxel stage iii squamous cell carcinoma nasopharynx diagnosis active unstable cardiovascular disease cardiac disease requiring drug device intervention history coronary artery disease congestive heart failure
0, dexamethasone acetate myelodysplastic myeloproliferative neoplasms diagnosis candidate per institutional requirements autologous peripheral blood stem cell transplantation
0, azacitidine recurrent adult burkitt lymphoma diagnosis fertile patients must use effective contraception
1, metformin stage iiic fallopian tube cancer diagnosis pregnant nursing women excluded from this study
0, liposomal doxorubicin lymphoma diagnosis pbsc bmt patients only
1, laboratory biomarker analysis recurrent glioblastoma diagnosis any following
1, bortezomib patient has peripheral neuropathy grade two greater defined by national cancer institute common toxicity criteria nci ctc
0, cytarabine lymphoma large cell diffuse diagnosis chemo sensitive disease
0, hormones metastatic breast cancer diagnosis patients may have received radiation therapy painful bone metastases areas impending bone fracture long radiation therapy is completed greater equal two weeks prior entry
0, antibodies monoclonal stage ia breast cancer diagnosis patient must have completed one procedures evaluation pathologic nodal status listed below
0, fludarabine recurrent adult hodgkin lymphoma diagnosis acute leukemia twond greater cr cr greater equal two
1, dexamethasone acetate multiple myeloma diagnosis participants who have radiation therapy within fourteen days first dose
0, paclitaxel lung cancer diagnosis wbc greater three zero mmthree absolute neutrophil count at least one five hundred mmthree platelet count greater one zero mmthree hepatic
1, etoposide lymphoma diagnosis prior treatment carboplatin cisplatin ifosfamide gemcitabine vinorelbine
1, antibodies monoclonal anaplastic large cell lymphoma diagnosis uncontrolled systemic vascular hypertension systolic blood pressure greater one hundred forty mmhg diastolic blood pressure greater ninety mmhg
1, methylene blue stage ii breast cancer diagnosis non blue dye non iodine containing dye may be used these patients
0, albumin bound paclitaxel childhood extragonadal germ cell tumor diagnosis bilirubin less doc times upper limit normal uln age
0, fluorouracil malignant neoplasm cardio esophageal junction stomach diagnosis age greater eighteen years
0, immunoglobulins stage iib breast cancer diagnosis age fifty five younger no spontaneous menses at least twelve months prior entry spontaneous secondary hysterectomy documented estradiol level postmenopausal range according local institutional laboratory standard or
1, prednisone prostate cancer diagnosis administration an investigational therapeutic within thirty days cycle one day one
1, dasatinib glioma diagnosis any hemorrhage bleeding event greater ctcae within four weeks onest dose drug
0, dexamethasone acetate childhood choroid plexus tumor diagnosis fully recovered from acute toxic effects all prior chemotherapy immunotherapy radiotherapy
1, oxaliplatin stage iic rectal cancer diagnosis treatment any other investigational agent participation another investigational drug trial within twenty eight days prior randomization
0, albumin bound paclitaxel cervical carcinosarcoma diagnosis life expectancy greater equal ninety days three months
1, fludarabine phosphate recurrent marginal zone lymphoma diagnosis active involvement central nervous system malignancy
1, vidarabine adult nasal type extranodal nk cell lymphoma diagnosis uncontrolled diabetes mellitus cardiovascular disease active serious infection other condition which opinion treating physician would make this protocol unreasonably hazardous patient
1, irinotecan metastatic colorectal cancer diagnosis rior chemotherapy systemic therapy mcrc
1, dexamethasone phosphate multiple myeloma diagnosis known human immunodeficiency hiv seropositive hepatitis infection hepatitis except patients hepatitis surface antigen sag core antibody receiving responding antiviral therapy directed at hepatitis b
1, methylprednisolone diffuse large cell lymphoma diagnosis history chronic liver disease suspected alcohol abuse
1, tacrolimus recurrent childhood grade iii lymphomatoid granulomatosis diagnosis patients who opinion treating physician unlikely comply restrictions allogeneic stem cell transplantation based on formal psychosocial screening
1, immunoglobulins ovarian brenner tumor diagnosis history cva within six months
1, vaccines large cell carcinoma diagnosis active infection antibiotics within one week prior including unexplained fever temp
0, n monoacetylcystine recurrent primary peritoneal carcinoma diagnosis patients allowed receive but not required receive biologic noncytotoxic therapy part their treatment regimen bevacizumab
0, nivolumab testicular non seminomatous germ cell tumor diagnosis cluster differentiation cd four positive cell count greater equal two hundred fifty cells mm three
1, endothelial growth factors fallopian tube adenocarcinoma diagnosis history hypertensive crisis hypertensive encephalopathy
1, endothelial growth factors malignant pancreatic insulinoma diagnosis patients on anticoagulant therapy
1, camptothecin colorectal cancer liver metastases diagnosis psychiatric disorders neurologic disease other conditions that would make it impossible comply protocol procedures
0, doxorubicin noncontiguous stage ii marginal zone lymphoma diagnosis further at investigator discretion patients who unstable one cycle chop is allowed prior enrollment but no more one cycle
1, temozolomide concurrent anti vegf anti tumor agents
1, vandetanib oral cavity verrucous carcinoma diagnosis involvement planning conduct applies both astra zeneca staff staff at site
1, tipifarnib splenic marginal zone lymphoma diagnosis peripheral neuropathy greater equal grade three
0, vinblastine metastatic breast cancer diagnosis patients who received six eight cycles chemotherapy having received at least four cycles chemotherapy definitively stopped toxicity reasons who presenting sd pr at randomization
0, cisplatin fallopian tube cancer diagnosis fertile patients must use effective contraception
1, albumin bound paclitaxel recurrent vulvar cancer diagnosis any other major illness which investigator judgment will substantially increase risk associated patient participation this study
0, rituximab lymphoma diagnosis bilirubin no greater two times upper limit normal uln
0, busulfan kidney cancer diagnosis philadelphia chromosome ph
0, thalidomide angioimmunoblastic cell lymphoma diagnosis all participants must be registered into mandatory revassist program be willing able comply requirements revassist
1, dasatinib history prior chemotherapy primary breast cancer
0, vismodegib adult unclassified pleomorphic sarcoma diagnosis eastern cooperative oncology group ecog performance status equal less two karnofsky greater equal sixty
1, stenting only cholangiocarcinoma non resectable diagnosis cardiac pacemaker
0, cyclophosphamide multiple myeloma plasma cell neoplasm diagnosis prior concurrent therapy
1, endothelial growth factors stage iva uterine corpus cancer diagnosis prior treatment sorafenib other vascular endothelial growth factor vegf inhibitors note
1, levoleucovorin stage iib gastric cancer diagnosis body mass index bmi greater equal thirty five mg two equal less fifty six days prior registration
0, methylprednisolone hemisuccinate fallopian tube cancer diagnosis aspartate aminotransferase ast alanine transaminase alt total bilirubin alkaline phosphatase less five times upper limit institutional normal uln
0, etoposide hodgkin lymphoma diagnosis number prior chemotherapies
0, alvespimycin hydrochloride recurrent verrucous carcinoma oral cavity diagnosis progressive disease indicated by following
1, cyclosporins testicular lymphoma diagnosis marrow donors who have increased anesthetic risk
0, gefitinib stage iv rectal cancer diagnosis fertile patients must use effective contraception
0, veliparib stage ivb oropharyngeal carcinoma diagnosis stage iva scchn other opc or
1, erlotinib hydrochloride other concurrent anticancer therapy
1, antibodies monoclonal recurrent meningioma diagnosis patients proteinuria within fourteen days registration demonstrated by either
1, xl thyroid cancer diagnosis subject is incapable understanding complying protocol unable provide informed consent
1, paclitaxel patients small cell sarcomatoid variant prostate cancer
1, liposomal doxorubicin urethral cancer diagnosis patient have uncontrolled brain metastases central nervous system disease
0, cediranib squamous cell carcinoma
0, reverse transcriptase polymerase chain reaction stage iv mantle cell lymphoma diagnosis at least two prior combination chemotherapy regimens not including single agent monoclonal antibody rituxan therapy
0, etoposide phosphate central nervous system tumor diagnosis negative pregnancy test
1, social contact intervention colon cancer diagnosis patients crohn disease
0, lonaprisan zk bay metastatic breast cancer diagnosis total bilirubin
0, fludarabine recurrent marginal zone lymphoma diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum glutamic pyruvic transaminase sgpt equal less doc institutional upper limit normal uln
0, beclomethasone noncontiguous stage ii marginal zone lymphoma diagnosis inclusion
0, camptothecin stage iii adult soft tissue sarcoma diagnosis female patients who breast feeding must agree stop breast feeding
0, levoleucovorin liver cancer diagnosis negative pregnancy test
0, etoposide phosphate anaplastic large cell lymphoma diagnosis prior start mobilization subjects must have
0, mycophenolic acid noncontiguous stage ii small lymphocytic lymphoma diagnosis matched at allele level hla b drbone dqbone
1, visual examination oropharynx cancer diagnosis female that is lactating demonstrating positive pregnancy test
1, sorafenib squamous cell cancer diagnosis thrombolic embolic events such cerebrovascular accident including transient ischemic attacks within past six months
1, vitamin b complex stage iv ovarian cancer diagnosis co morbid systemic illnesses other severe concurrent disease which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety toxicity prescribed regimens
1, immunoglobulin g high grade ovarian serous adenocarcinoma diagnosis new york heart association functional classification ii iii iv
0, irinotecan bladder cancer diagnosis performance status
1, ebrfa sems cholangiocarcinoma diagnosis presence main portal vein thrombosis
0, palbociclib stage iva pancreatic cancer diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum glutamate pyruvate transaminase sgpt less doc institutional upper limit normal up five upper limit normal uln patients liver metastasis
1, carboplatin non small cell lung cancer diagnosis no known gi pathology that would interfere drug bioavailability
1, interferons stage iv melanoma diagnosis dofetilide tikosyn
0, carmustine brain central nervous system tumors diagnosis age
1, oxaliplatin metastatic colorectal cancer diagnosis ileus bowel obstruction
1, monopolar electrocautery loop transurethral resection bladder tumors patients diffuse tumor throughout bladder that is deemed unresectable by surgeon
1, focus group pediatric patient pediatric cancers diagnosis speak understand english
0, liposomal doxorubicin breast cancer diagnosis not specified
1, wee inhibitor azd untreated childhood glioblastoma diagnosis patients who currently receiving drugs that strong moderate inhibitors inducers cytochrome pfour hundred fifty family three subfamily polypeptide four cypthreeafour sensitive cypthreeafour substrates cypthreeafour substrates narrow therapeutic range not eligible exception corticosteroids use aprepitant an antiemetic is prohibited
0, thalidomide multiple myeloma diagnosis patients must normal chest ray an evaluation pulmonary function studies on mechanical aspects fevone fvc etc diffusion capacity dlco is optional
1, everolimus breast cancer diagnosis wide field radiotherapy including therapeutic radioisotopes such strontium eighty nine administered less twenty eight days limited field radiation palliation less seven days metastatic disease prior first dose everolimus has not recovered from side effects such therapy
1, methotrexate myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis ten whole liver
1, rituximab recurrent adult diffuse large cell lymphoma diagnosis known hypersensitivity thalidomide
1, interferon alpha neuroendocrine tumors diagnosis hypersensitivity against interferon cyclophosphamide
0, fluorouracil histologically confirmed squamous cell carcinoma head neck considered incurable by surgery radiotherapy newly diagnosed extensive locoregional disease distant metastases locoregionally recurrent persistent disease distant metastases occurring after initial surgery radiotherapy no nasopharyngeal carcinoma no history brain metastases measurable evaluable disease documented progressive disease biopsy proven residual carcinoma required if sole measurable site previously irradiated
0, albumin bound paclitaxel primary peritoneal carcinoma diagnosis stage less ib disease
1, heparin low molecular weight carcinoma only present completely excised polyp no residual tumour evident colon
1, irinotecan stomach cancer diagnosis evidence bleeding diathesis coagulopathy
1, paclitaxel gastric adenocarcinoma diagnosis prior chemotherapy targeted small molecule therapy radiation therapy within two weeks prior day one not recovered from adverse events due previously administered agent surgery
1, recombinant vaccinia gm csf rac vac gm csf jx rhabdomyosarcoma diagnosis children less one years old
1, vorinostat adult diffuse large cell lymphoma diagnosis patient has known psychiatric substance abuse disorders that would interfere cooperation requirements trial
0, lenograstim yolk sac tumor diagnosis male gender
1, doxorubicin lung cancer diagnosis left ventricle ejection fraction lvef by muga echo less fifty
1, albumin bound paclitaxel prior malignancy other nsclc except situ basal cell carcinoma situ cervical cancer unless it has been treated curative intent there is no evidence disease greater three years prior randomization
0, cediranib tongue carcinoma diagnosis platelet count greater one hundred zero mmÂ³
1, dasatinib high grade glioma diagnosis metastatic disease stratum only
0, brachytherapy stage iia prostate cancer diagnosis prostate biopsy within one hundred eighty days prior registration
0, gemcitabine unspecified adult solid tumor protocol specific diagnosis age
1, rituximab contiguous stage ii grade two follicular lymphoma diagnosis patient is unwilling unable practice contraception during treatment one year thereafter
0, dasatinib localized resectable adult liver carcinoma diagnosis prolonged corrected qt interval qtc greater equal four hundred eighty msec fridericia correction
1, everolimus diagnosed advanced refractory solid malignancies intolerant standard therapy stage disease because there is currently no standard approved therapy adenoidcystic carcinoma therefore there is no requirement prior therapy this patient population
1, sodium glycididazole esophageal neoplasms diagnosis patients distant metastasis
0, ondansetron multiple myeloma plasma cell neoplasm diagnosis disease characteristics
0, western blotting adult anaplastic oligodendroglioma diagnosis metastatic disease brain that has progressed after treatment whole brain radiation therapy stereotactic radiosurgery patients who have resectable brain metastasis only site disease no evidence systemic disease not eligible participate
0, photodynamic therapy stage esthesioneuroblastoma paranasal sinus nasal cavity diagnosis patients must have an eastern cooperative oncology group ecog performance status zero two
0, albumin bound paclitaxel malignant germ cell neoplasm diagnosis platelet count greater one hundred zero mm three
1, antibodies monoclonal stage iv diffuse large cell lymphoma diagnosis subjects known active hepatitis virus hbv hepatitis virus hcv infection
0, vaccines melanoma diagnosis age greater equal toeighteen years
0, bicalutamide prostate cancer diagnosis none disease
1, immunoglobulins received prior radiotherapy any portion abdominal cavity pelvis other treatment endometrial cancer
1, antibodies monoclonal malignant female reproductive system neoplasm diagnosis subjects brain metastases eligible if these have been treated there is no magnetic resonance imaging mri except where contraindicated which ct scan is acceptable evidence progression at least eight weeks after treatment is complete within eight days prior first dose drug administration
1, management therapy complications stage iv ovarian epithelial cancer diagnosis body mass index bmi less leightkg two
0, levoleucovorin colorectal cancer diagnosis measurable disease
0, sorafenib metastatic breast cancer diagnosis have undergone appropriate treatment
1, azacitidine hepatocellular carcinoma diagnosis known history human immunodeficiency virus hiv
0, low let electron therapy head neck cancer diagnosis histopathologically positive surgical margins no gross residual disease perineural involvement extranodal spread disease oral cavity oropharyngeal lesions metastatic nodes at level four five vascular embolisms neck no metastases at diagnosis no known cns disease
1, octreotide pancreatic polypeptide tumor diagnosis liver disease such cirrhosis severe hepatic impairment child pugh class note
0, bevacizumab anaplastic astrocytoma aa diagnosis karnofsky performance status sixty greater
1, immunoglobulin g advanced adult hepatocellular carcinoma diagnosis untreated central nervous system cns metastases exceptions
1, cetuximab rectal cancer diagnosis serious uncontrolled concurrent infection s
1, micafungin cancer diagnosis patients receiving antifungal prophylaxis other fluconazole at time enrollment
1, rituximab testicular lymphoma diagnosis pregnant women women childbearing age who not practicing adequate contraception men who not willing use an effective method contraception
0, antibodies metastatic prostate cancer diagnosis creatinine less doc mg dl creatinine clearance greater sixty ml min
1, immunoglobulins adult nodular sclerosis hodgkin lymphoma diagnosis previous treatment brentuximab vedotin any other prior anti cdthirty based antibody therapy
1, androgens prostate cancer diagnosis concurrent anti androgen secondary hormonal therapy prior concurrent chemotherapy concurrent radiotherapy radioisotope therapy strontium
1, fludarabine phosphate contiguous stage ii adult immunoblastic large cell lymphoma diagnosis donor
1, tremelimumab ovarian cancer diagnosis other active serious illnesses serious infections requiring antibiotics
1, fluorouracil stage iva colorectal cancer diagnosis if on anticoagulation participant must be on stable therapeutic dose prior enrollment
1, doxorubicin metastatic leiomyosarcoma diagnosis cytotoxic chemotherapy
1, cyclophosphamide marginal zone lymphomas diagnosis severe medicinal not adjustable hypertonia
1, liposomal doxorubicin micropapillary serous carcinoma diagnosis known hepatitis virus hbv hepatitis virus hcv infection patients chronic cleared hbv hcv infection eligible patients human immunodeficiency virus hiv not eligible if on anti retroviral medications
0, ifosfamide adult malignant meningioma diagnosis not pregnant nursing
0, etoposide phosphate osteosarcoma diagnosis adequate liver function evidenced by
0, vaccines unspecified adult solid tumor protocol specific diagnosis chemotherapy
1, leuprolide stage iv prostate cancer diagnosis cyptwoceight inhibitors gemfibrozil
0, immunoglobulins adenocarcinoma lung diagnosis urine protein must be screened by urine analysis urine protein creatinine upc ratio upc ratio greater doc twenty four hour urine protein must be obtained level must be less one zero mg patient enrollment
1, paclitaxel stage iiia fallopian tube cancer diagnosis patients medical conditions that opinion investigator render treatment on this protocol unsafe should be excluded
0, mycophenolic acid cutaneous cell non hodgkin lymphoma diagnosis al negative relapse persistent disease less twenty bone marrow blasts
1, vidarabine stage iv adult diffuse mixed cell lymphoma diagnosis pregnancy
1, rituximab prior history malignancies other lymphoma except basal cell squamous cell carcinoma skin situ carcinoma cervix breast unless subject has been free disease greater three years
1, dexamethasone phosphate stage iiia primary peritoneal cancer diagnosis patients clinical symptoms signs gastrointestinal obstruction those who require parenteral hydration nutrition patients history current diagnosis inflammatory bowel disease not eligible
0, temozolomide lymphoma diagnosis chemotherapy
1, antibodies monoclonal peripheral cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
1, cetuximab cancer lung diagnosis concurrent malignancy
0, fludarabine stage mantle cell lymphoma diagnosis no pulmonary dysfunction that would impair tolerance compliance therapy
0, melphalan stage fours neuroblastoma diagnosis doc mg dl
0, camptothecin signet ring adenocarcinoma colon diagnosis total bilirubin equal less uln
0, microdialysis adult gliosarcoma diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot equal less three times institutional upper limit normal
0, mycophenolic acid childhood diffuse large cell lymphoma diagnosis donor
1, lenograstim stage iii adult immunoblastic large cell lymphoma diagnosis serious medical psychiatric illness likely interfere participation this clinical study
0, succinylcholine stage iia fallopian tube cancer diagnosis patients who have met pre entry requirements specified
1, mechlorethamine stage iii mantle cell lymphoma diagnosis relapse pneumocystis carinii pneumonia within past year
1, sorafenib stage ivb squamous cell carcinoma larynx diagnosis history allergic reactions attributed compounds similar chemical biologic composition sorafenib docetaxel cisplatin
0, carboplatin stage ic ovarian cancer diagnosis absolute neutrophil count anc greater equal one five hundred mcl
0, sirolimus recurrent melanoma diagnosis phenytoin carbamazepine phenobarbital rifampin hypericum perforatum st
1, immunoglobulins recurrent salivary gland cancer diagnosis women who pregnant breast feeding adults reproductive potential not employing an effective method birth control double barrier contraceptives must be used through trial by both sexes oral implantable injectable contraceptives may be affected by cytochrome pfour hundred fifty interactions therefore not considered effective this women child bearing potential defined sexually mature women who have not undergone hysterectomy who have not been naturally postmenopausal at least twelve consecutive months who has had menses any time preceding twelve consecutive months must have negative serum pregnancy test equal less seventy two hours prior initiating treatment
1, olaparib fallopian tube serous adenocarcinoma diagnosis prior treatment anthracyclines
1, liver extracts secondary malignant neoplasm liver diagnosis inability follow procedures due language problems psychological disorders dementia etc
0, dexamethasone acetate lymphoma diagnosis cardiac ejection fraction fifty greater by multigated radionuclide angiography muga echocardiogram
0, topotecan histologically cytologically confirmed ovarian epithelial cancer primary peritoneal cancer fallopian tube cancer refractory recurrent disease after combination platinum paclitaxel only prior chemotherapy regimen platinum resistant refractory relapsed within six months after completion last therapy regimen no more two prior platinum paclitaxel combination regimens measurable disease no cns metastases
1, cyclophosphamide spindle cell rhabdomyosarcoma diagnosis pregnancy test is required female patients childbearing potential prior entry
1, cyclophosphamide intraocular lymphoma diagnosis patients suitably matched related unrelated donors
0, physiologic testing breast cancer diagnosis disease characteristics
0, albumin bound paclitaxel metastatic pancreatic adenocarcinoma diagnosis arm cohort two
0, endothelial growth factors recurrent ovarian carcinoma diagnosis no known hypersensitivity chinese hamster ovary cell products other recombinant human antibodies
0, antibodies lymphoma diagnosis hiv negative
1, albumin bound paclitaxel recurrent breast cancer diagnosis major surgery within four weeks day one
1, niacinamide metastatic colorectal cancer diagnosis hiv positive patients not receiving antiretroviral therapy excluded due possibility that bay forty three nine thousand six may worsen their condition likelihood that underlying condition may obscure attribution adverse events respect bay forty three nine thousand six
0, fluorouracil gastric cancer diagnosis no concurrent phenytoin phenobarbital other antiepileptic prophylaxis no concurrent prochlorperazine on day irinotecan administration no other concurrent medications except analgesics chronic treatments concurrent medical conditions agents required life threatening medical problems
1, hsc burkitt lymphoma diagnosis prior myeloablative allotransplantation autologous transplant
0, cetuximab adenocarcinoma gastroesophageal junction diagnosis ptt less doc times uln
1, exemestane breast cancer diagnosis surgery
0, cetuximab recurrent verrucous carcinoma oral cavity diagnosis performance status
0, tamoxifen stage iib breast cancer diagnosis patient physician must be agreeable initiate standard chemotherapy hormonal therapy adjuvant therapy
0, paclitaxel stage ib breast cancer diagnosis no prior surgical axillary staging procedure
1, temozolomide recurrent childhood brain stem glioma diagnosis doc mg dl maximum serum creatinine
0, erlotinib hydrochloride head neck cancer diagnosis must be able swallow erlotinib celecoxib pills
1, rifampin subject has received anti cancer therapy including investigational agents cytotoxic chemotherapy radiation therapy biologic therapy within twenty one days within period defined by five half lives whichever is shorter prior drug administration
0, antibodies monoclonal metastatic pancreatic cancer diagnosis is post menopausal surgically sterilized willing use acceptable methods birth control duration study
0, cefixime neuroblastoma diagnosis no prior temozolomide irinotecan combination therapy
0, fluorouracil metastatic cancer diagnosis performance status
0, everolimus stage iiib primary peritoneal cancer diagnosis triglycerides equal less doc uln mg dl mmol patients triglyceride levels greater doc uln can be started on lipid lowering agents reevaluated within one week if levels go equal less doc uln they can be considered trial continue lipid lowering agents note
1, bortezomib nasopharyngeal carcinoma diagnosis prior bortezomib therapy
0, etoposide phosphate choriocarcinoma diagnosis patients late relapses who have unresectable disease eligible
0, gemcitabine pancreatic carcinoma metastatic diagnosis age greater equal seventy years
0, interferons recurrent intraocular melanoma diagnosis inr ptt less doc upper limit normal
1, antibodies stage iv marginal zone lymphoma diagnosis concurrent use other investigational agents
0, capecitabine stage ib breast cancer diagnosis be informed investigational nature this provide written informed consent accordance institutional federal guidelines prior specific screening procedures
1, cyclophosphamide recurrent adult grade iii lymphomatoid granulomatosis diagnosis performance status greater two eastern cooperative oncology group ecog less fifty lansky patients less sixteen years old
0, busulfan nodal marginal zone cell lymphoma diagnosis inv three threeq del threeq complex karyotype
1, thalidomide lymphoma diagnosis significant neuropathy grades two grade one pain within one days prior enrollment
1, cyclosporins hematopoietic lymphoid cell neoplasm diagnosis karnofsky scores less sixty lansky score less fifty
1, gemcitabine carcinoma non small cell lung diagnosis recent myocardial infarction within six months
1, lenvatinib stage iva differentiated thyroid gland carcinoma diagnosis male subjects
1, etoposide stage iv adult immunoblastic large cell lymphoma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide similar drugs
0, perifosine recurrent prostate cancer diagnosis absolute neutrophil count greater equal one five hundred ul
0, busulfan recurrent adult hodgkin lymphoma diagnosis patients must not have active infection
0, antibodies monoclonal recurrent salivary gland cancer diagnosis patients may have been previously treated systemic therapy but otherwise deemed currently platinum refractory would be deemed inappropriate intolerant platinum based chemotherapy
0, etoposide myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis at least ninety days since prior transplant
1, sirolimus esophageal cancer diagnosis sterilization
0, antibodies monoclonal stage iii colon cancer diagnosis no prior radiotherapy greater fifteen bone marrow
0, vidarabine recurrent adult diffuse large cell lymphoma diagnosis chronic phase intolerant unresponsive imatinib other tyrosine kinase inhibitors second chronic phase accelerated phase who ineligible conventional myeloablative transplantation
1, endothelial growth factors recurrent childhood pineoblastoma diagnosis patients known hypersensitivity chinese hamster ovary cell products other recombinant human antibodies
0, tipifarnib recurrent childhood supratentorial primitive neuroectodermal tumor diagnosis zileuton
0, interleukin cohort patients must have measurable metastatic renal cancer fibroblast growth factor five fgf five tumor expression
0, fludarabine wilms tumor diagnosis malignancy has no reasonable expectation cure available alternative salvage therapy
1, liposomal doxorubicin breast cancer diagnosis peripheral neuropathy
1, succinylcholine stage iib ovarian cancer diagnosis core biopsy within seven days prior first date bevacizumab therapy cycle two
1, thalidomide recurrent marginal zone lymphoma diagnosis baseline testing hiv is not required
0, endothelial growth factors recurrent fallopian tube carcinoma diagnosis patients who have met pre entry requirements
0, bevacizumab ovarian cancer diagnosis this reason wocbp must agree use appropriate method contraception six months after last dose treatment per fda recommendations on use contraception following bevacizumab
1, sorafenib anaplastic oligoastrocytoma diagnosis refusal use effective contraception
1, immunoglobulin fc fragments endometrial adenosquamous carcinoma diagnosis active bleeding active hemoptysis defined bright red blood greater equal Â½ teaspoon doc ml any twenty four hour period within two weeks prior registration gastrointestinal bleeding within three months prior registration
1, antibodies noncontiguous stage ii grade three follicular lymphoma diagnosis serious non malignant disease active uncontrolled bacterial viral fungal infections other conditions which opinion principal investigator would compromise other protocol objectives
1, cyclophosphamide patients history curative surgically treated basal squamous cell carcinoma stage one melanoma skin situ carcinoma cervix eligible
1, capecitabine recurrent adult immunoblastic large cell lymphoma diagnosis hiv positive patients who not on anti retroviral therapy but have cdfour cells less two hundred should be excluded hiv positive patients eligible if they on haart highly active anti retroviral therapy which not cypthreeafour substrates inducers inhibitors meet all other criteria
1, cetuximab squamous cell carcinoma head neck diagnosis if female pregnant lactating
1, everolimus lymphangioleiomyomatosis lam diagnosis bleeding diathesis on oral anti vitamin medication
0, cisplatin stage iii oral cavity squamous cell carcinoma diagnosis patients who have positive margin undergo re resection final negative margin eligible only if they can be enrolled within sixty three days initial gross total resection extracapsular nodal extension was also present patients who have positive margin undergo re resection final negative margin not have extracapsular nodal extension not eligible
1, etoposide hepatosplenic cell lymphoma diagnosis active infection requiring systemic antibiotic therapy antibacterial antifungal antiviral agents excluding hiv
0, vitamin d must be female have primary diagnosis stage ii iii hormone receptor positive breast cancer
1, topotecan recurrent cervical carcinoma diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior first date bevacizumab therapy
0, antibodies recurrent squamous cell carcinoma nasopharynx diagnosis performance status
1, carboplatin carcinoma non small cell lung diagnosis severe active comorbidity defined follows
1, prednisone multiple myeloma diagnosis prior treatment hypercalcemia spinal cord compression corticosteroids radiation therapy respectively does not disqualify subject dose corticosteroids should not exceed equivalent one hundred sixty mg dexamethasone two week period
1, thalidomide mantle cell lymphoma diagnosis patients planned upfront consolidation high dose therapy autologous stem cell transplant
1, cetuximab stage iv esophageal cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition cetuximab
1, everolimus oligodendrogliomas diagnosis topical inhaled corticosteroids allowed treatment low dose decadron less threemg daily is allowed
0, fludarabine phosphate kidney cancer diagnosis ecog zero one
1, immunoglobulins recurrent squamous cell carcinoma paranasal sinus nasal cavity diagnosis patients an active bleeding diathesis on therapeutic anticoagulation except low dose coumadin
1, niacinamide anaplastic oligodendroglioma diagnosis congestive heart failure greater nyha class two active cad cardiac arrythmias requiring anti arrythmic therapy uncontrolled hypertension within last two months
0, azd hepatocellular carcinoma metastatic diagnosis metastatic locally advanced meeting any criteria below
1, melphalan peripheral cell lymphoma diagnosis any serious medical condition laboratory abnormality psychiatric illness that would prevent subject from signing informed consent form
1, afuresertib ect fed state cancer diagnosis history regular alcohol consumption within six months defined as
1, vinblastine lymphoma diagnosis no prior therapy mustargen oncovin procarbazine prednisone mopp
1, pentostatin hematologic neoplasms diagnosis severe organ dysfunction such as
0, oxaliplatin colorectal cancer diagnosis not pregnant nursing
1, crizotinib carcinoma non small cell lung diagnosis pregnant lactating females
1, akt inhibitor mk stage iia breast cancer diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible
1, trametinib prior systemic therapy chemotherapy immunotherapy hormone therapy targeted therapy any investigational anti cancer drug metastatic pancreatic adenocarcinoma
1, aminopterin relapsed peripheral cell lymphoma diagnosis inadequate blood levels bone marrow other organ function specified protocol
0, liposomal doxorubicin regional neuroblastoma diagnosis group aone
0, cyclosporine hematologic neoplasm diagnosis fit receive csf give peripheral blood stem cells normal blood count normotensive no history stroke
1, cediranib childhood nasal type extranodal nk cell lymphoma diagnosis qtc prolongation greater five hundredmsec other significant ecg abnormality noted within fourteen days registration
0, levoleucovorin stage iii adult lymphoblastic lymphoma diagnosis all
0, doxorubicin lymphoma diagnosis no other concurrent standard investigational chemotherapy
1, palbociclib metastatic breast cancer diagnosis confirmed diagnosis hertwo positive disease
1, endothelial growth factors undifferentiated ovarian carcinoma diagnosis has diagnosis immunodeficiency is receiving systemic steroid therapy any other form immunosuppressive therapy within seven days prior first dose trial treatment is taking any other medication that might affect immune function
0, topotecan multiple myeloma plasma cell neoplasm diagnosis at least three months hematopoietic
0, cc prostate cancer diagnosis anc greater one five hundred Î¼l
0, amifostine childhood germ cell tumor diagnosis not specified renal
1, hormones breast cancer diagnosis prior use pazopanib
0, cyclophosphamide stage iii mantle cell lymphoma diagnosis patients crtwo prtwo initial short remission less six months eligible
0, cyclosporins contiguous stage ii adult diffuse mixed cell lymphoma diagnosis intermediate two risk high risk disease
0, folic acid patients must have histological confirmation metastatic urothelial carcinoma
0, chloroethyl nitrosoamino carbonyl amino propanamide colorectal cancer diagnosis no ongoing active uncontrolled infection
1, pharmacological stage iv small lymphocytic lymphoma diagnosis phenytoin carbamazepine phenobarbital
0, antibodies monoclonal recurrent adult brain tumor diagnosis serum glutamic oxaloacetic transaminase sgot aspartate aminotransferase ast equal less doc times upper limit normal
1, musculoskeletal complications management prevention myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis any artificial limbs
1, vitamin k malignant neoplasm diagnosis any active facial chest rash including adult acne at time randomization
1, bb multiple myeloma diagnosis patient has contraindication use any components treatment regimen per summary product characteristics
1, cyclosporine noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis unable provide informed consent
1, bevacizumab solid tumors diagnosis doc dasatinib is metabolized primarily by cypthreeafour liver enzyme
1, gastroscopes pentax tokyo japan precancerous conditions diagnosis known allergy fluorescein sodium
1, nutritional counseling solid tumors diagnosis unavailability planned measurements
1, dovitinib first second recurrence glioblastoma diagnosis any following within six months prior starting tkitwo hundred fifty eight
0, albumin bound paclitaxel cancer that has spread brain
0, carboplatin stage iib fallopian tube cancer diagnosis prothrombin time pt such that international normalized ratio inr is less doc uln an range inr usually between two three if patient is on stable dose therapeutic warfarin
1, liposomal doxorubicin fibrohistiocytic neoplasm diagnosis female patients who pregnant ineligible
0, immunoglobulins stage iib breast cancer diagnosis absolute neutrophil count greater equal one zero mm three
0, liposomal doxorubicin follicular lymphoma diagnosis female subject is either post menopausal surgically sterilized willing use an acceptable method birth control hormonal contraceptive intra uterine device diaphragm spermicide condom spermicide abstinence duration study
0, levoleucovorin stage iiia colon cancer diagnosis serum hepatitis virus hbv dna twenty zero iu ml one hundred five copies ml lower values two zero twenty zero iu ml one hundred four one hundred five copies ml often seen hepatitis virus antigen hbeag negative chronic hepatitis b
0, cisplatin stage ii squamous cell carcinoma nasopharynx diagnosis no tone two none disease which node positivity is based on presence retropharyngeal lymph nodes
1, antibodies recurrent fallopian tube carcinoma diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible
1, self administered coping intervention cancer diagnosis taking psychotropic medication altering dosages past three months
1, romidepsin recurrent grade two follicular lymphoma diagnosis prolongation corrected qt interval greater four hundred eighty ms
0, prednisolone acetate lymphoma diagnosis at least four weeks since prior chemotherapy
0, antibodies cutaneous cell lymphoma diagnosis any number prior systemic therapies
0, erlotinib hydrochloride lung cancer diagnosis disease characteristics
1, sunitinib breast neoplasms diagnosis no prior treatment cytotoxics advanced disease setting
0, topotecan childhood central nervous system germ cell tumor diagnosis high dose chemotherapy
1, etoposide recurrent cutaneous cell non hodgkin lymphoma diagnosis any cytogenetic abnormality bone marrow that is known be associated predictive myelodysplasia is excluded this includes but is not limited del five del seven del eleven
1, fluorouracil human papilloma virus infection diagnosis patients receiving other investigational agents
0, motexafin gadolinium breast cancer diagnosis disease characteristics
1, sirolimus kidney neoplasms diagnosis hemoglobin less nine dl may be transfused receive epoetin alfa maintain exceed this level
1, prednisolone clinical suspicion that follicular lymphoma has transformed aggressive lymphoma
0, cyclosporins stage iii childhood anaplastic large cell lymphoma diagnosis must have failed previous myelosuppressive chemotherapy hsct have less five marrow blasts at time transplant
0, cyclosporine recurrent grade three follicular lymphoma diagnosis donor
1, cisplatin head neck squamous cell carcinoma hnscc diagnosis patients recist v
0, pf aggressive fibromatosis diagnosis doc
0, cyclophosphamide lymphoblastic lymphoma diagnosis chronic myelogenous leukemia excluding refractory blast crisis
0, selumetinib neurofibromatosis type one diagnosis first degree relative nfone
1, nivolumab stage ii non small cell lung cancer diagnosis patients major surgery radiotherapy within four weeks prior start treatment done cycle one however prior surgery radiation therapy aimed at local palliation attempted local disease control except case thoracic radiotherapy is permitted but has be completed one week before treatment start
1, cyclosporine unrecognized condition mature cell neoplasm diagnosis hiv infection
0, sunitinib stage iii renal cell cancer diagnosis women child bearing potential men must agree use adequate contraception hormonal barrier method birth control abstinence prior entry duration participation
1, cost condition patients history colorectal cancer colon resection
1, camptothecin metastatic colorectal cancer diagnosis prior radiotherapy within thirty days treatment start
0, vorinostat recurrent childhood lymphoblastic lymphoma diagnosis performance status
0, endothelial growth factors stage ib breast cancer diagnosis accelerated partial breast radiation apbi after chemotherapy
0, albumin bound paclitaxel stage iiia primary peritoneal cancer diagnosis patients childbearing potential must have negative serum pregnancy test prior entry be practicing an effective form contraception
0, fludarabine phosphate lymphoma diagnosis must have received prior autologous transplantation demonstrate chemosensitivity at time relapse defined greater fifty reduction component plasma cell marrow infiltration
1, antibodies monoclonal stage iv non small cell lung cancer diagnosis history another primary malignancy except for
0, romidepsin stage iv adult soft tissue sarcoma diagnosis karnofsky fifty one hundred
0, antibodies monoclonal histologically confirmed nonhematologic malignancy refractory disease disease which no effective standard therapy exists hertwo overexpression tumor tissue measurable evaluable disease no cns metastases hormone receptor status
1, fludarabine childhood burkitt lymphoma diagnosis liver function abnormalities
0, fludarabine cervical cancer diagnosis more four weeks must have elapsed since any prior systemic therapy at time patient receives preparative regimen patients toxicities must have recovered grade one less except toxicities such alopecia vitiligo
1, esomeprazole history clinical evidence central nervous system cns metastases leptomeningeal carcinomatosis except individuals who have previously treated cns metastases asymptomatic have had no requirement steroids anti seizure medication two months prior first dose drug
0, mycophenolic acid noncontiguous stage ii adult lymphoblastic lymphoma diagnosis single allele disparity hla b drbone dqbone
0, laboratory biomarker analysis recurrent childhood large cell lymphoma diagnosis refractory acute myelogenous lymphoid leukemia
1, carboplatin stage iiia breast cancer diagnosis uncontrolled hypertension defined sustained systolic blood pressure bp greater one hundred fifty mmhg diastolic bp greater ninety mmhg patients initial bp elevations eligible if initiation adjustment bp medication lowers pressure meet entry criteria
0, lum imaging device colorectal cancer diagnosis subjects ecog performance status zero one
0, cyclophosphamide male breast carcinoma diagnosis calculated measured greater thirty ml min
1, aldesleukin stage iiib melanoma diagnosis women childbearing potential wocbp who
1, mesna tumor subarachnoid space by csf cytology
0, dexamethasone crab means presence organ damage multiple myeloma related renal impairment anemia new bone lesions hypercalcemia
1, antibodies monoclonal clear cell metastatic renal cell carcinoma diagnosis history deep vein thrombosis dvt unless adequately treated low molecular weight heparin
0, aldesleukin melanoma skin diagnosis eighteen over
0, prototype system stage iv ovarian cancer diagnosis eighteen years old older
1, carmustine recurrent cell non hodgkin lymphoma diagnosis prior bone marrow stem cell transplant
0, pharmacological stage iii melanoma diagnosis absolute neutrophil count greater equal one five hundred mm three
1, bevacizumab ependymoma diagnosis serious non healing wound active ulcer untreated bone fracture
0, vaccines colorectal cancer diagnosis scleroderma
1, albumin bound paclitaxel carcinoma unknown primary origin diagnosis this diagnostic laparoscopy without other intervention biopsies needle aspirate core biopsy open biopsy etc
1, carboplatin non small cell lung cancer diagnosis use contact lenses is not recommended
1, antibodies recurrent islet cell carcinoma diagnosis serious non healing wound active ulcer untreated bone fracture
0, therapeutic conventional surgery clear cell renal cell carcinoma diagnosis an intrauterine device documented failure rate less one per year vasectomized partner who is sterile prior female subject entry is sole sexual partner that female complete abstinence from sexual intercourse one days before exposure investigational product through dosing period at least one days after last dose investigational product double barrier contraception condom spermicidal jelly foam suppository film diaphragm spermicide male condom diaphragm spermicide
1, rituximab t lymphoblastic lymphoma diagnosis patients philadelphia chromosome positive ph positive all they must not have progressed within three months receiving imatinib have documented abl kinase mutation known confer resistance imatinib tthree i
0, immunoglobulin idiotypes lung cancer diagnosis creatinine clearance greater sixty ml min
0, goserelin prostate cancer diagnosis no prior chemotherapy including suramin endocrine therapy
0, estramustine prostate cancer diagnosis no concurrent vitamin supplements containing vitamin arm ii only
0, pembrolizumab bladder cancer diagnosis females must not be pregnant negative human chorionic gonadotropin test within seventy two hours prior receiving first dose medication breastfeeding
1, computed tomography lymphoma diagnosis participants severe claustrophobia not relieved by oral anxiolytic medication patients weighing greater one hundred thirty six kg weight limit scanner table
1, tacrolimus lymphoma follicular diagnosis planned post transplant therapy including use tyrosine kinase inhibitors tki
0, cediranib cholangiocarcinoma gallbladder diagnosis acceptable contraception includes abstinence oral contraceptives intra uterine device iud diaphragm norplant approved hormone injections condoms documentation medical sterilization
0, antibodies recurrent nasal cavity paranasal sinus squamous cell carcinoma diagnosis patients must have histologically cytologically confirmed malignancy that is metastatic unresectable which standard curative palliative measures not exist no longer effective eligible malignancies include
1, breast mri breast cancer diagnosis absence breast reconstruction prior rt placement tissue expander is sufficient group two
1, radiotherapy prior use any systemic anti cancer treatment hcc eg
0, thalidomide retinoblastoma diagnosis sgot ast sgpt alt less doc uln sgot less fourx uln if on zantac
1, mycophenolate mofetil adult grade iii lymphomatoid granulomatosis diagnosis marrow donors who have increased anesthetic risk
1, olaparib stage iv non small cell lung cancer diagnosis patients who have received prior inhibitor vegf signaling poly adp ribose polymerases parp inhibitor administered combination unless administered combination patients who received prior parp inhibitor prior vegf signaling inhibitor agent allowed after discussing pi
1, ispinesib stage ivc squamous cell carcinoma paranasal sinus nasal cavity diagnosis antifungals
1, exemestane metastatic breast cancer diagnosis local relapse exception cutaneous thoracic nodes
1, paclitaxel estrogen recepto negative negative breast cancer diagnosis subjects history interstitial lung disease history slowly progressive dyspnea unproductive cough sarcoidosis silicosis idiopathic pulmonary fibrosis pulmonary hypersensitivity pneumonitis multiple uncontrolled unstable allergies which opinion investigator may lead serious complications
1, antibodies monoclonal stage iii salivary gland cancer diagnosis uncontrolled inter current illness pre planned surgery procedure requiring hospitalization during period any other condition circumstance that could interfere adherence procedures requirements otherwise compromise objectives
1, vaccines cancer anus diagnosis autoimmune disease such systemic lupus erythematosis rheumatoid arthritis that is active requires current immunosuppressive therapy
0, val stage iv prostate carcinoma diagnosis absolute neutrophil count greater doc one hundred nine l
0, iodine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis all patients eligible therapeutic must have autologous hematopoietic stem cells two ten six cdthirty four positive cells kg harvested cryopreserved
1, carmustine small intestine lymphoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast greater three times upper limits normal unless determined be result primary hematologic malignancy attributed gilbert syndrome
0, oxaliplatin stage ivb colon cancer diagnosis myocardial infarction unstable angina within past six months
0, camptothecin stage ivb rectal cancer diagnosis patients must not have experienced nephrotic range proteinuria from prior bevacizumab therapy urine protein must be screened by urine analysis urine protein creatinine upc ratio upc ratio greater doc twenty four hour urine protein must be obtained level must be less one zero mg patient enrollment urine protein creatinine used calculating upc ratio must be obtained within twenty eight days prior registration
0, palbociclib female breast carcinoma diagnosis hepatic
0, fluorouracil curatively resected node positive esophageal squamous cell carcinoma diagnosis no prior chemotherapy except neoadjuvant ones
1, immunoglobulin g fallopian tube endometrioid adenocarcinoma diagnosis history hemoptysis greater equal one two teaspoon bright red blood per episode within one month enrollment
0, pqr metastatic breast cancer diagnosis expansion part
1, cyclophosphamide contiguous stage ii adult diffuse large cell lymphoma diagnosis prior chemotherapy radiation therapy radioimmunotherapy immunotherapy short course equal less fourteen days prior registration corticosteroids is allowed
0, technetium tc m ethylenedicysteine pancreas cancer diagnosis if alkaline phosphatase is outside these parameters is due bone metastases verified by assessment isoenzymes then subject is eligible
1, computed tomography stage ib malignant mesothelioma diagnosis patients must have fully recovered from all acute reversible toxicities defined common terminology criteria adverse events ctcae doc equal less grade one associated previous treatment
0, registry prostate cancer diagnosis these therapies include but they not limited prostate biopsy thermotherapy microwave therapy laser urethral resection prostate urethral catheterization lower genitourinary tract endoscopy
1, levoleucovorin kaposi sarcoma if rapidly progressive visceral involvement causing peripheral edema
0, pomalidomide multiple myeloma diagnosis partner vasectomy
1, interleukin multiple myeloma diagnosis age less eighteen years greater seventy years
0, hypofractionated radiotherapy hyport non small cell lung cancer diagnosis creatinine clearance greater fortymls min patients calculated creatinine clearance greater fortymls min less sixtymls min must have this confirmed by nuclear medicine gfr scan
0, doxorubicin endometrial adenocarcinoma diagnosis creatinine no greater doc mg dl
0, adjustment mechanical ventilator inspiratory expiratory time ratio urinary bladder neoplasm diagnosis patients who voluntarily decides participate trial has agreed written informed consent
0, gemcitabine breast cancer diagnosis prior trastuzumab may have been administered within one week initiation treatment on this trial if last dose was two mg kg
0, tacrolimus angioimmunoblastic cell lymphoma diagnosis chronic myelomonocytic leukemia
0, gemcitabine pancreatic cancer diagnosis bone marrow reserve evidenced by
0, iodobenzylguanidine localized unresectable neuroblastoma diagnosis ejection fraction greater equal fifty by radionuclide evaluation
1, hydroxyitraconazole advanced inoperable non small cell lung cancer diagnosis cisapride oral midazolam nisoldipine pimozide quinidine dofetilide triazolam levacetylmethadol levomethadyl three hydroxy three methyl glutaryl coenzyme hmg coa
0, carboplatin stage iib breast cancer diagnosis patient must have an eastern cooperative oncology group ecog performance status zero one
0, laboratory biomarker analysis hepatoblastoma diagnosis at least seven days must have elapsed since completion therapy growth factor at least fourteen days must have elapsed after receiving pegfilgrastim
1, gossypol acetic acid stage iv adult diffuse mixed cell lymphoma diagnosis failure recover fully judged by investigator from prior surgical procedures failure recover from adverse events due agents administered more four weeks earlier
0, bevacizumab uveal melanoma diagnosis no potential contributing causes decreased vision other macular edema
1, bevacizumab stage iiib primary peritoneal cancer diagnosis hemoptysis liver rupture
1, niraparib advanced breast cancer diagnosis replacement therapy eg thyroxine insulin physiologic corticosteroid replacement therapy adrenal pituitary insufficiency etc
1, cyclophosphamide colorectal cancer diagnosis patients unhealed surgical wounds more thirty days
0, oxaliplatin mucinous adenocarcinoma rectum diagnosis no prior oxaliplatin
1, mycophenolate mofetil nodal marginal zone cell lymphoma diagnosis donor
1, selinexor breast cancer diagnosis electrocardiogram ecg abnormalities requiring treatment congestive heart failure chf new york hearth association nyha class greater three myocardial infarction mi within three months
0, immunoglobulins stage iv ovarian cancer diagnosis hemoglobin greater equal doc dl
1, alovudine stage iii renal cell cancer diagnosis patients pre existing thyroid abnormality who unable maintain thyroid function normal range medication ineligible patients history hypothyroidism eligible provided they currently euthyroid
1, sorafenib stage iva verrucous carcinoma larynx diagnosis subject any pulmonary hemorrhage bleeding event nci ctcae doc grade two higher within four weeks before randomization any other hemorrhage bleeding event nci ctcae doc grade three higher within four weeks before randomization
0, sirolimus extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis total bilirubin equal less doc upper limit normal uln if total bilirubin is greater doc uln direct bilirubin must be normal
0, crizotinib carcinoma non small cell lung diagnosis positive alk fusion gene test provided by central laboratory
1, fluorouracil adenocarcinoma gastroesophageal junction diagnosis received live vaccine equal less thirty days prior registration
0, mycophenolic acid childhood nasal type extranodal nk cell lymphoma diagnosis single antigen mismatch at b dr transplant from family member is associated higher risk gvhd but similar overall survival when compared full identity at these three regions related donor recipient pairs must be matched at five six hla antigens b drbone
0, topotecan carcinoma unknown primary diagnosis not specified
1, antibodies monoclonal hepatocellular carcinoma diagnosis doc patients who have undergone prior liver transplantation ineligible
1, fludarabine recurrent small lymphocytic lymphoma diagnosis known allergy csf
1, immunoglobulins unspecified childhood solid tumor protocol specific diagnosis patients prior history known metastatic cns disease involvement excluded note
1, antibodies stage ib breast cancer diagnosis any prior history arrhythmia cardiac valvular disease requiring medications clinically significant
1, vinblastine breast cancer diagnosis major surgery within four weeks start treatment without complete recovery
1, fludarabine phosphate recurrent adult diffuse mixed cell lymphoma diagnosis child class liver failure
1, cisplatin ovarian seromucinous tumor diagnosis note
1, trametinib stage iv melanoma diagnosis use other prohibited medications within five half lives fourteen days prior first dose drugs requires any these medications while receiving medication on this pregnant lactating female
0, vaccines cancer types
1, leuprolide prostatic neoplasms diagnosis participant who participated another clinical received investigational product within thirty days screening
1, pembrolizumab multiple myeloma diagnosis other relevant diseases adverse clinical conditions
1, pharmacological stage iv marginal zone lymphoma diagnosis previous intolerance benzodiazepam therapies
0, cyclophosphamide breast cancer diagnosis any status
1, isophosphamide mustard stage iii soft tissue sarcoma diagnosis systolic blood pressure greater equal one hundred forty mmhg diastolic blood pressure greater equal ninety mmhg that is not controlled by one anti hypertensive medication
0, thalidomide recurrent grade one follicular lymphoma diagnosis able adhere visit schedule other protocol requirements
1, dexa scan breast neoplasms diagnosis former og actual use cytostatics
0, paclitaxel germinoma diagnosis minimum three weeks after last day start previous chemotherapy regimen before first day chemotherapy on protocol
0, thalidomide stage iv small lymphocytic lymphoma diagnosis no history congestive heart failure myocardial infarction unstable angina uncontrolled arrhythmia any class three four cardiac disease defined by new york heart association functional classification last six months
0, thiotepa refractory multiple myeloma diagnosis secondary aml prior therapy hematologic malignancy
1, pemetrexed recurrent breast cancer diagnosis systolic blood pressure bp greater one hundred sixty mmhg diastolic bp greater one hundred mmhg despite optimal medical management
0, sunitinib esophageal cancer diagnosis no ongoing cardiac dysrhythmias greater grade two atrial fibrillation any grade prolongation qtc interval greater four hundred fifty msec males greater four hundred seventy msec females
0, leucovorin stage iii childhood hepatocellular carcinoma diagnosis prior concurrent therapy criteria
0, laboratory biomarker analysis stage iiia skin melanoma diagnosis alkaline phosphatase equal less three uln
1, everolimus radiotherapy prostate cancer within twenty eight days prior day one except single fraction radiotherapy pain control
1, hydrocortisone acetate stage iv childhood lymphoblastic lymphoma diagnosis diagnosis down syndrome trisomy twenty one
0, etoposide phosphate regional neuroblastoma diagnosis age greater eighteen months greater five hundred forty seven days unfavorable pathology regardless mycn status
1, immunoglobulin g hormone resistant prostate cancer diagnosis external beam radiation therapy within four weeks registration is prohibited anticipated need radiation therapy imminent pathological fracture spinal cord compression within three months registration
0, antibodies extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis at least fourteen days after local palliative radiotherapy xrt small port at least one hundred fifty days must have elapsed if prior total body irradiation tbi craniospinal xrt if greater equal fifty radiation pelvis at least forty two days must have elapsed if other substantial bone marrow bm radiation
0, etoposide phosphate stage ii non contiguous adult diffuse large cell lymphoma diagnosis participants must be able swallow oral medications
0, fludarabine phosphate recurrent adult burkitt lymphoma diagnosis creatinine clearance greater sixty ml min
0, ifosfamide stage ii adult soft tissue sarcoma diagnosis no known hypercoagulable disorders such following
1, ixazomib multiple myeloma diagnosis patients pacemakers eligible if hr greater fifty bpm
0, dexamethasone multiple myeloma plasma cell neoplasm diagnosis serum monoclonal protein greater doc g
1, cisplatin recurrent non small cell lung cancer diagnosis history previous radiation therapy which would result overlapping radiation fields
0, antibodies fallopian tube adenocarcinoma diagnosis negative pregnancy test done equal less seven days prior registration women childbearing potential only
0, erlotinib hydrochloride recurrent esthesioneuroblastoma paranasal sinus nasal cavity diagnosis ecog zero two
1, carboplatin carcinoma non small cell lung diagnosis failure recover from prior surgery
1, antibodies stage iiia ovarian cancer diagnosis protein concentration mg dl creatinine mg dl patients must have upcr less doc allow participation study
0, targeted therapy based on molecular profiling metastatic cancer diagnosis prior randomization patients metastatic disease must have been treated established standard care therapy physicians have determined that such established therapy is not sufficiently efficacious patients have declined receive standard care therapy
0, bevacizumab peripheral cell lymphoma diagnosis ecog performance status equal less two karnofsky greater equal sixty
1, pxfk peptide rhabdomyosarcoma diagnosis patients who require daily oral corticosteroid therapy any underlying disease will be excluded
0, bortezomib primary peritoneal cavity cancer diagnosis at least one target lesion outside previously irradiated field
1, lenograstim stage ia breast cancer diagnosis uncontrolled hypertension diastolic greater one hundred mm hg systolic greater two hundred mm hg
0, ci pancreatic cancer diagnosis patient characteristics
1, lapatinib newly diagnosed glioblastoma multiforme diagnosis patients who have any disease that will obscure toxicity dangerously alter drug metabolism
1, antibodies monoclonal histological diagnosis different from classical hodgkin lymphoma
0, etoposide brain central nervous system tumors diagnosis biologic therapy
0, docetaxel recurrent salivary gland carcinoma diagnosis maximum one prior radiotherapy regimen curative palliative head neck is allowed if radiation is combined chemotherapy cetuximab minimum four months must elapse between end radiotherapy registration if radiation is given alone minimum eight weeks must elapse between end radiotherapy registration minimum three weeks must elapse between prior radiation other areas registration
1, docetaxel cancer larynx diagnosis patients grade greater two peripheral neuropathy
1, calcium dietary lung neoplasms diagnosis cerebral spinal ophthalmologic operation history
1, dexamethasone phosphate plasma cell myeloma diagnosis history significant cardiovascular disease within past six months unless disease is well controlled
1, isotretinoin neuroendocrine tumor diagnosis external beam radiation both kidneys scatter doses less five hundred cgy single kidney radiation less fifty single kidney is acceptable
1, liposomal doxorubicin ovarian cancer diagnosis patients previously diagnosed brain metastases eligible if they have completed their treatment have recovered from acute effects radiation therapy surgery prior entry have discontinued corticosteroid treatment these metastases at least four weeks prior entry neurologically stable
1, antibodies ovarian endometrioid adenocarcinoma diagnosis patients childbearing potential not practicing adequate contraception patients who pregnant patients who breastfeeding not eligible this trial
0, capecitabine inflammatory breast carcinoma diagnosis more four weeks since prior chemotherapy recovered
0, dexamethasone phosphate aggressive marginal zone lymphoma mzl diagnosis this requirement also applies women childbearing potential who practice complete continued abstinence
0, doxorubicin breast cancer diagnosis no psychiatric addictive disorders that would preclude informed consent
0, pemetrexed neoplasms diagnosis patients must receive four mg dexamethasone by mouth twice daily one day prior dose day day after every dose pemetrexed
0, proteasome inhibitors stage ivc squamous cell carcinoma paranasal sinus nasal cavity diagnosis leukocytes greater equal three zero ul
1, cisplatin gastric cancer diagnosis has known history active bacillus tuberculosis
0, thiotepa atypical teratoid rhabdoid tumor at rt diagnosis anc greater seven hundred fifty Âµl hemoglobin greater eight gm dl may receive prbc transfusions platelet count greater seventy five zero Âµl transfusion independent
0, cetuximab one two three prior chemotherapy lines colorectal cancer
1, mitomycin previous malignancy within last five years except curatively treated non melanoma skin cancer carcinoma situ cervix uteri
0, carboplatin adenocarcinoma proximal stomach diagnosis male female aged equal greater eighteen years
0, tipifarnib stage iiia breast cancer diagnosis ast no greater doc times uln
0, antibodies monoclonal recurrent gallbladder cancer diagnosis clinical lesions will only be considered measurable when they superficial
0, antibodies monoclonal recurrent small lymphocytic lymphoma diagnosis women childbearing potential sexually active males must use an accepted effective method contraception throughout eight weeks following discontinuation everolimus
0, capecitabine stage iii rectal cancer diagnosis patients regular menses
1, pancreatin twond line threerd line greater metastatic pancreatic cancer diagnosis valvular heart disease that requires antibiotic prophylaxis prevention endocarditis
1, etoposide phosphate refractory lymphoblastic lymphoma diagnosis patients must not have received chemotherapy within fourteen days enrollment two following exceptions
1, dexamethasone acetate multiple myeloma relapse diagnosis transfusion may not be used meet platelet eligibility criteria within seven days obtaining screening evaluation
0, rituximab refractory diffuse large cell lymphoma diagnosis measurable disease at least one lesion greater equal doc cm diameter detected by pet ct
1, ixazomib multiple myeloma diagnosis uncontrolled hypertension uncontrolled diabetes within fourteen days prior first dose drug
0, carboplatin head neck cancer diagnosis all patients will need an indwelling central venous access catheter
0, thalidomide recurrent small lymphocytic lymphoma diagnosis females childbearing potential fcbp must have negative serum urine pregnancy test sensitivity at least twenty five miu ml within ten fourteen days again within twenty four hours prior starting cycle one lenalidomide further they must either commit continued abstinence from heterosexual intercourse begin two acceptable methods birth control
0, nitrogen mustard compounds localized unresectable neuroblastoma diagnosis mycn amplification greater four fold increase mycn signals compared reference signals regardless age additional biologic features
1, bendamustine hydrochloride mantle cell lymphoma diagnosis receiving other agents
0, laboratory biomarker analysis childhood solid neoplasm diagnosis blood pressure bp equal less ninety fiveth percentile age height gender not receiving medication treatment hypertension please note that three serial blood pressures should be obtained averaged determine baseline bp
1, fludarabine recurrent non hodgkin lymphoma diagnosis donor
1, paclitaxel breast cancer female nos diagnosis inadequate general condition not fit anthracycline taxane targeted agents based chemotherapy
1, vidarabine noncontiguous stage ii adult lymphoblastic lymphoma diagnosis karnofsky performance status less seventy adults lanksy score less fifty pediatrics
1, fludarabine splenic marginal zone lymphoma diagnosis child class liver failure
0, dacarbazine previously treated childhood rhabdomyosarcoma diagnosis at least three months since prior stem cell transplantation no evidence active graft versus host disease
1, niacinamide adult gliosarcoma diagnosis patients who pregnant breast feeding anti proliferative activity this experimental drug may be harmful developing fetus nursing infant
1, placebo stomatitis diagnosis patients who have taken velafermin cgfifty three thousand one hundred thirty five five previously
1, docetaxel symptomatic peripheral neuropathy greater grade two according national cancer institute common toxicity criteria
1, prednisone prostatic neoplasms diagnosis prior treatment cabozantinib mitoxantrone
1, antibodies monoclonal recurrent melanoma diagnosis significant cardiovascular abnormalities defined by any one following
1, antibodies stage iv adult diffuse large cell lymphoma diagnosis uncontrolled systemic vascular hypertension systolic blood pressure greater one hundred forty mmhg diastolic blood pressure greater ninety mmhg
0, tas advanced metastatic non small cell lung cancer diagnosis patients who had received at least two prior therapies advanced metastatic disease condition including platinum doublet pemetrexed docetaxel immunotherapy were refractory unable tolerate their last prior therapy
1, lenalidomide relapsed multiple myeloma diagnosis planned radiation therapy that occurs after start treatment
1, lenograstim prior malignancy except adequately treated basal cell squamous cell skin cancer adequately treated noninvasive carcinoma other cancer from which patient has been disease free at least five years
1, pemetrexed non small cell lung cancer diagnosis heart attack within past six months
1, estd gastrointestinal stromal tumors gists diagnosis endoscopic ultrasound eus ct signs metastasis
1, dabrafenib stage iiia skin melanoma diagnosis history known immediate delayed hypersensitivity reactions attributed compounds similar chemical biologic composition atthirteen thousand three hundred eighty seven dabrafenib trametinib excipients dimethyl sulfoxide dmso
1, podophyllotoxin refractory diffuse large cell lymphoma diagnosis prior exposure bruton tyrosine kinase btk inhibitor
0, mycobacterium w bladder cancer diagnosis patients who immuno compromised will not be enrolled
0, imatinib mesylate refractory multiple myeloma diagnosis no concurrent therapeutic doses warfarin anticoagulation
0, veliparib male breast cancer diagnosis male subjects including those who vasectomized whose partners pregnant might be pregnant must agree use condoms duration ninety days following completion therapy
0, cyclophosphamide refractory lymphoblastic lymphoma diagnosis relapsed after failed respond greater equal one previous chemotherapy regimen
1, spyÂ® intraoperative imaging system rectal neoplasms diagnosis subject has previous history adverse reaction allergy icg iodine shellfish iodine dyes
1, lithium carbonate stage iii grade one follicular lymphoma diagnosis secondary malignancy
0, trimetrexate sarcoma diagnosis at least six months since prior allogeneic stem cell transplantation no evidence active graft versus host disease
0, prednisolone hemisuccinate lung cancer diagnosis subjects must be discontinued from ipilimumab nivolumab monotherapy combination regimen
1, robotic assisted laparoscopic surgery synchronous colorectal tumors requiring multi segment surgical resection benign lesion within resection field addition main cancer would not exclude patient
0, razoxane childhood diffuse large cell lymphoma diagnosis stratus one
1, albumin bound paclitaxel stage iv ovarian epithelial cancer diagnosis clinically significant gastrointestinal bleeding uncontrolled peptic ulcer disease
0, dexamethasone acetate lung cancer diagnosis adequate bone marrow renal liver function required
1, memantine colorectal cancer diagnosis patients currently taking antidepressant antianxiety medications must have been on stable dose four weeks prior registration
0, doxorubicin resected tumor free margins no neoplastic cells on resected margin
0, paclitaxel primary peritoneal serous adenocarcinoma diagnosis hemoglobin greater doc mg dl transfusions permitted achieve baseline hemoglobin level
1, sirolimus pancreatic delta cell adenoma diagnosis patients who had surgical resection cns metastases brain biopsy equal less three months prior registration will be excluded
1, antibodies monoclonal history evidence cns disease including primary brain tumor any brain metastases upon physical examination
1, epirubicin tubular breast cancer stage ii diagnosis male patients
0, cyclosporine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis donor must consent granulocyte colony stimulating factor csf administration leukopheresis
1, bevacizumab recurrent renal cell carcinoma diagnosis history bleeding diathesis coagulopathy
0, fluorides hormone resistant prostate cancer diagnosis expected lifespan twelve weeks less
1, antibodies monoclonal ewing family tumor diagnosis history another malignancy
0, vaccines recurrent glioblastoma diagnosis no history abdominal fistula gastrointestinal perforation intra abdominal abscess within past twelve months
1, mycophenolic acid splenic marginal zone lymphoma diagnosis inability obtain informed consent
1, cisplatin carcinoma squamous cell diagnosis prior history radiation therapy head neck
0, dextrans patients newly diagnosed pelvic urological tumors including prostate carcinomas bladder carcinomas penile carcinomas
0, fludarabine phosphate stage iv adult cell leukemia lymphoma diagnosis cdfour count is allowed be greater one hundred cells ul
0, valganciclovir noncontiguous stage ii grade one follicular lymphoma diagnosis diagnosis
0, eltrombopag a woman child bearing potential is defined woman who has not been naturally post menopausal at least twelve consecutive months no previous surgical sterilization
1, dasatinib pre existent toxicities severity grade two due previous anti cancer treatments
1, bb prior concurrent anti myeloma therapy except steroids
0, metformin ovarian undifferentiated adenocarcinoma diagnosis subjects undergoing primary debulking surgery must have stage iii iv disease have undergone surgery include at minimum removal uterus ovaries fallopian tubes these patients may be optimally debulked less one cm residual disease but must have grossly visible macroscopic residual disease be suboptimally debulked
0, mitomycin liver cancer diagnosis serum total bilirubin less doc mg dl serum creatinine less doc mg dl within four weeks registration
1, tivozanib recurrent primary peritoneal cancer diagnosis requirement hemodialysis peritoneal dialysis
1, group a closed face shell brain tumor adult diagnosis patients requiring conformal inverse planned radiotherapy
0, erlotinib hydrochloride stage iv squamous cell carcinoma lip oral cavity diagnosis creatinine doc
0, leuprolide prostate cancer diagnosis biologic therapy
1, sirolimus ureter cancer diagnosis women childbearing potential must have negative serum pregnancy test within fourteen days prior administration everolimus
0, liposomal doxorubicin breast cancer diagnosis patient characteristics
1, vitamins glioblastoma multiforme diagnosis calcium greater uln
1, mycophenolate mofetil peripheral cell lymphoma diagnosis fungal infections radiological progression after receipt amphotericin active triazole greater one month
0, antibodies stage squamous cell carcinoma paranasal sinus nasal cavity diagnosis large vessel cerebrovascular accident within past six months
0, liposomal doxorubicin breast cancer diagnosis platelet count at least one hundred zero mm three
1, single photon emission computed tomography recurrent malignant peripheral nerve sheath tumor diagnosis history tuberculosis history purified protein derivative ppd positivity
0, albumin bound paclitaxel pancreatic cancer diagnosis creatinine within doc upper limit normal or
0, carboplatin endometrial undifferentiated carcinoma diagnosis patients must be able swallow whole tablets
0, doxorubicin stage iiic breast cancer diagnosis axillary lymphadenectomy without sn isolation procedure
1, sirolimus adenocarcinoma renal cell diagnosis patients receiving chronic systemic treatment corticosteroids another immunosuppressive agent
1, carboplatin lung cancer diagnosis history pulmonary embolism other venous thrombosis within one year screening except catheter related clots
0, topotecan lymphoma diagnosis prior primary radiotherapy allowed if relapse is high risk recurrence radiation field symptoms liver bone marrow involvement
1, dexamethasone symptomatic peripheral sensory neuropathy
0, ibrutinib recurrent adult lymphoblastic lymphoma diagnosis subjects who hepatitis antibody positive without positive hepatitis ribonucleic acid rna level must meet liver function test criteria listed above have no evidence cirrhosis patients diagnosed hepatitis less six months before enrollment will be considered have acute hepatitis will be ineligible unless hepatitis viral load is undetectable
1, gtx mg metastatic breast cancer diagnosis previous therapy testosterone testosterone like agents is acceptable thirty day washout if previous testosterone therapy was long term depot within past six months site should contact medical monitor one eight hundred seventy seven six two thousand seven hundred twenty three this determine appropriate washout period
0, antilymphocyte serum hodgkin lymphoma diagnosis not pregnant confirmed by negative serum urine pregnancy test within fourteen days prior enrollment
0, fatigue assessment management psychosocial effects cancer its treatment diagnosis currently undergoing chemoradiotherapy
1, immunoglobulins stage ib breast cancer diagnosis conduction abnormality requiring pacemaker
0, trastuzumab breast cancer diagnosis no evidence residual locally recurrent metastatic disease after completion surgery chemotherapy neoadjuvant adjuvant
1, niacinamide recurrent glioblastoma multiforme diagnosis concurrent administration st
1, everolimus stage iii adult diffuse small cleaved cell lymphoma diagnosis patient has poorly controlled hypertension on multiple antihypertensives
0, glycine high risk multiple myeloma defined by cytogenetic fluorescence situ hybridization fish detection any one more following
0, temozolomide melanoma diagnosis lesions that considered non measurable include
0, zoledronic acid sarcoma diagnosis shortening fraction greater twenty eight by echocardiogram ejection fraction greater fifty by radionuclide angiogram
0, edetic acid bclc stage zero adult hepatocellular carcinoma diagnosis ct features suggestive hcc including those features which have been described herein they also enumerated below
0, antibodies hodgkin lymphoma diagnosis forced vital capacity fvc greater equal forty predicted value pulse oximetry value greater equal ninety two on room air
1, methotrexate central nervous system lymphoma diagnosis hbsag hcv positivity
0, bortezomib stage iii adult cell leukemia lymphoma diagnosis negative pregnancy test
1, melphalan refractory cutaneous cell non hodgkin lymphoma diagnosis significant prior external beam dose limiting radiation critical organ based on review prior radiation treatment records by radiation oncology pi patients who have had prior external beam radiation greater two thousand cgy at one hundred eighty two hundred cgy per day lung will be ineligible patients any prior radiation heart ineligible patients greater five hundred cgy kidney will be excluded from note
1, vinblastine other malignancy within past five years except cured basal cell skin cancer carcinoma situ cervix contralateral breast cancer
0, vaccines breast cancer diagnosis because there is an unknown but potential risk adverse events nursing infants secondary treatment mother mva brachyury tricom breastfeeding should be discontinued if mother is treated mva brachyury tricom
0, cyclophosphamide sarcoma diagnosis not specified
0, cisplatin stage iiia vulvar cancer diagnosis absolute neutrophil count anc greater equal doc ten nine l
0, questionnaire administration stage adult diffuse mixed cell lymphoma diagnosis patients any performance status eligible enrollment
1, bevacizumab tumors diagnosis uncontrolled clinically significant active infection
1, vaccines lung cancer diagnosis concurrent use systemic steroids except physiologic doses systemic steroid replacement local topical nasal inhaled steroid use
0, sorafenib insulinoma diagnosis eastern cooperative oncology group ecog zero two
0, bortezomib recurrent cutaneous cell non hodgkin lymphoma diagnosis at least twelve weeks
1, bevacizumab undifferentiated ovarian carcinoma diagnosis this criterion applies only patients enrolled before august twenty nine two thousand eleven those enrolled after this date electing receive bevacizumab patients clinically significant cardiovascular disease this includes
0, dexamethasone acetate multiple myeloma diagnosis laboratory
1, vidarabine recurrent adult grade iii lymphomatoid granulomatosis diagnosis child class liver failure
0, maleic acid hormone resistant prostate cancer diagnosis short gut syndrome
1, paclitaxel fallopian tube endometrioid adenocarcinoma diagnosis left ventricular ejection fraction lvef less normal per institutional guidelines less fifty five if threshold normal not otherwise specified by institutional guidelines
0, rituximab recurrent mantle cell lymphoma diagnosis prior chemotherapy allowed
1, carboplatin symptomatic brain metastases those patients should be treated first either whole brain radiation therapy radiosurgery
1, pazopanib sarcoma diagnosis if protein is one positive higher twenty four hour urine protein should be obtained level should be less oneg patient enrollment
1, bevacizumab advanced non squamous non small cell lung cancer diagnosis known hypersensitivity any component bevacizumab
1, mycophenolate mofetil noncontiguous stage ii adult lymphoblastic lymphoma diagnosis fungal infections radiological progression after receipt amphotericin active triazole greater one month
0, bevacizumab soft tissue sarcoma diagnosis patients must have measurable disease defined at least one lesion greater onecm greatest dimension
0, temozolomide stage iiib uveal melanoma diagnosis gastrointestinal perforation
1, iodine recurrent adult immunoblastic large cell lymphoma diagnosis pregnancy
1, gemcitabine breast cancer diagnosis uncontrolled angina
0, oxaliplatin stage iv pancreatic cancer diagnosis patient must not have received prior treatment fluorouracil irinotecan leucovorin calcium oxaliplatin folfirinox folfox oxaliplatin based chemotherapy mitogen activated protein kinase mek inhibitors phosphoinositide three kinase pithreek inhibitors protein kinase akt inhibitors
0, aprepitant stage iv fallopian tube cancer diagnosis patients receiving initial course chemotherapy including
0, dacarbazine recurrent childhood supratentorial embryonal tumor not otherwise specified diagnosis major procedures
1, epirubicin stage iiib breast cancer diagnosis hormonal birth control
0, erlotinib hydrochloride pancreatic cancer diagnosis patient is ineligible if any following occur part ii
1, pomalidomide multiple myeloma diagnosis subjects peripheral neuropathy greater grade two
0, thalidomide multiple myeloma diagnosis patient has not active infectious hepatitis type no known hiv infection
0, boronophenylalanine fructose complex melanoma skin diagnosis recent coronary artery disease
1, rituximab non hodgkin lymphoma diagnosis women childbearing age who not accept use an effective contraceptive method during treatment one year post treatment
1, hepatic resection hepatocellular carcinoma diagnosis severe coagulation disorders prothrombin activity less forty platelet count less forty zero mmthree
1, laboratory biomarker analysis stage iiia breast cancer diagnosis past treatment chemotherapy
0, fludarabine multiple myeloma plasma cell neoplasm diagnosis no other liver disease
0, pazopanib hydrochloride stage iii renal cell cancer diagnosis renal nephrometry score ten twelve
0, bb stage ii multiple myeloma diagnosis at least four weeks since prior chemotherapy radiotherapy recovered
1, bkm thymoma diagnosis female subjects on vasectomised male partner should be sole partner that patient
0, antibodies adenocarcinoma gastroesophageal junction diagnosis measurable disease is not required this since primary endpoint is complete pathologic response
0, genistein breast cancer diagnosis no significant abnormality spleen other abdominal organs by physical exam
1, ascorbic acid anaplastic astrocytoma diagnosis inability co operate requirements protocol
1, carmustine follicular lymphoma diagnosis poorly controlled diabetes mellitus dm
1, antibodies monoclonal recurrent non small cell lung carcinoma diagnosis currently receiving has received systemic corticosteroids within four weeks prior starting drug who have not fully recovered from side effects such treatment
1, lucas decision aid lung neoplasms diagnosis reporting demonstrating significant psychological distress
1, gemcitabine adult extraskeletal myxoid chondrosarcoma diagnosis prior malignancy note
1, ropivacaine breast cancer diagnosis pregnant women child bearing potential lactating women
0, capecitabine liver cancer diagnosis no major surgery within four weeks randomization
1, lenograstim stage adult lymphoblastic lymphoma diagnosis myocardial infarction within six months prior enrollment has new york heart association nyha class iii iv heart failure uncontrolled angina severe uncontrolled ventricular arrhythmias electrocardiographic evidence acute ischemia active conduction system abnormalities prior entry any electrocardiogram ecg abnormality at screening has be documented by investigator not medically relevant
1, digoxin endemic kaposi sarcoma diagnosis antidiarrheal adsorbents kaolin pectin
0, etoposide phosphate participants who receiving any other investigational agents have received investigational therapy any anti cancer monoclonal antibody mab within four weeks prior onest dose pembrolizumab
0, vinblastine stage iiia breast cancer diagnosis exclusion
0, recmage a as asci patients who have received isolated limb infusion ili isolated limb perfusion ilp melanoma will not be eligible unless they have experienced tumor progression after ili ilp ili ilp was not performed within prior twelve weeks
1, trastuzumab patients currently receiving anticancer therapies who have received anticancer therapies within four weeks start everolimus including chemotherapy radiation therapy antibody based therapy etc
1, nivolumab non small cell lung cancer part diagnosis administration any following within one week prior administration drug
0, mifepristone stage iiia breast cancer diagnosis patients may have received adjuvant chemotherapy up four prior chemotherapy regimens metastatic locally recurrent disease cannot have received prior nab paclitaxel mifepristone therapy metastatic disease
0, isotretinoin recurrent grade three follicular lymphoma diagnosis no suspected gilbert syndrome
0, cyclosporins recurrent adult burkitt lymphoma diagnosis intermediate two risk high risk disease
1, b papillomavirus infections diagnosis if limits cervical lesion cannot be readily visualized
0, paclitaxel stage iiib non small cell lung cancer diagnosis arm cohort one
1, capecitabine stage iib fallopian tube cancer diagnosis patients known hypersensitivity chinese hamster cell products other recombinant human humanized antibodies
1, antibodies metastatic pancreatic adenocarcinoma diagnosis chronic treatment systemic steroids another immuno suppressive agent
1, rituximab cns lymphoma hiv htlv one positivity some creatinine greater doc mg dl serum bilirubin greater doc mg dl
0, oxaliplatin metastatic pancreatic cancer diagnosis metastatic locally advanced disease
1, mechlorethamine recurrent plasma cell myeloma diagnosis patients available hla matched related donors
1, olaparib fallopian tube transitional cell carcinoma diagnosis history intra abdominal abscess within past three months
0, liposomal doxorubicin metastatic breast cancer diagnosis patients bone only lesions not eligible entry
1, mitomycin carcinoma situ diagnosis note
1, vaccines prior corticosteroids lymphoma
1, fludarabine solid tumors diagnosis left ventricular ejection fraction lvef
1, placebo recurrent squamous cell carcinoma larynx diagnosis at discretion physician
0, maleic acid stage iv renal cell cancer diagnosis no combination antiretroviral therapy hiv positive patients
0, doxorubicin neuroblastoma diagnosis doc
0, quality life assessment long term effects cancer treatment diagnosis early stage disease
0, sirolimus stage iiib skin melanoma diagnosis negative pregnancy test
0, isophosphamide mustard recurrent childhood anaplastic large cell lymphoma diagnosis at least three weeks since prior myelosuppressive chemotherapy six weeks nitrosoureas
0, laboratory biomarker analysis stage iiib primary peritoneal cancer diagnosis women all races ethnic groups eligible this trial
0, sargramostim kidney cancer diagnosis more two weeks since prior corticosteroids
1, bevacizumab somatostatinoma diagnosis uncontrolled systemic fungal bacterial viral other infection defined exhibiting ongoing signs symptoms related infection without improvement despite appropriate antibiotics other treatment
1, vitamins personal history invasive situ breast cancer
0, dexamethasone acetate recurrent adult diffuse mixed cell lymphoma diagnosis patients must have serum lactate dehydrogenase ldh performed within fourteen days prior treatment
0, chemoprevention stage iii verrucous carcinoma larynx diagnosis patients taking cyclooxygenase cox one cox two inhibitors indomethacin ibuprofen celebrex chronically herbal supplements who cannot be taken off medication supplement due their clinical condition eligible participate but should document daily doses these medications their logbooks
1, doxorubicin sarcoma diagnosis history abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior day zero
1, bb multiple myeloma relapse diagnosis other clinically significant heart disease chf ny heart association class iii iv uncontrolled hypertension history labile hypertension history poor compliance an antihypertensive regimen
0, lapatinib advanced cancers diagnosis total bilirubin less equal threex uln alt sgpt less equal eightx uln
0, podophyllotoxin recurrent neuroblastoma diagnosis ten less sixteen years
1, pemetrexed rectal cancer diagnosis history significant neurological mental disorder including seizures dementia
1, cyclophosphamide therapeutic monoclonal antibodies rituximab tositumomab ibritumomab alemtuzumab etc
1, pemetrexed malignant pleural mesothelioma diagnosis significant cardiovascular morbidity assessed by cardiologist precluding surgery
0, albumin bound paclitaxel lung cancer diagnosis no other severe underlying disease that would preclude participation
0, albumin bound paclitaxel testicular embryonal carcinoma diagnosis no dyspnea at rest
0, histone deacetylase inhibitors small intestine lymphoma diagnosis history presence sustained ventricular tachyarrhythmia patients history atrial arrhythmia eligible but should be discussed pi prior enrollment
0, methotrexate stage iv small lymphocytic lymphoma diagnosis mature cell malignancies
1, thalidomide intraocular lymphoma diagnosis any condition including presence laboratory abnormalities which places subject at unacceptable risk if he she were participate confounds ability interpret data from study
0, etoposide phosphate bronchoalveolar cell lung cancer diagnosis at least four weeks since prior thoracic other major surgery excluding mediastinoscopy recovered
1, immunoglobulin g ovarian endometrioid adenocarcinoma diagnosis patients prior allogeneic bone marrow transplantation prior solid organ transplantation
1, pembrolizumab stage iiic hepatocellular carcinoma diagnosis clinically significant lung disease including known history evidence interstitial lung disease chronic obstructive pulmonary disease copd that requires oxygen therapy
1, imatinib mesylate stage iiia skin melanoma diagnosis if subject received major surgery they must have recovered adequately from toxicity complications from intervention prior starting therapy
1, lenvatinib recurrent endometrial cancer diagnosis patients history clotting disorders must be excluded
1, cyclosporine recurrent grade two follicular lymphoma diagnosis donor
0, antibodies monoclonal childhood hepatoblastoma diagnosis doc mg dl patients two five years age
0, melphalan neuroblastoma diagnosis cardiovascular
0, ifosfamide lymphoma diagnosis no ecg evidence acute ischemia active conduction system abnormalities
0, temozolomide childhood cerebellar anaplastic astrocytoma diagnosis hemoglobin greater doc mg dl transfusion independent
1, temozolomide solid tumor diagnosis new york heart association class iii iv heart disease uncontrolled angina
1, capecitabine curatively resected non melanomatous skin cancer
0, cyclophosphamide lymphoma diagnosis dlco greater fifty expected value corrected blood hemoglobin level alveolar volume
1, folfiri regimen history other malignancies except cured basal cell carcinoma skin carcinoma situ uterine cervix
0, o benzylguanine stage ii cutaneous cell non hodgkin lymphoma diagnosis dlco greater eighty normal exception patients who demonstrate clinically normal lung function based on history physical examination chest ray interpreted by principal investigator
1, rituximab recurrent grade three follicular lymphoma diagnosis known human immunodeficiency virus hiv infection
1, doxorubicin primary liver cancer diagnosis any co morbid disease condition event that investigator judgment would place patient at undue risk that would preclude safe use dc bead tace
0, everolimus thyroid gland medullary carcinoma diagnosis patients must have adequate liver functions
1, succinylcholine stage ivb cervical cancer diagnosis patients anticipation invasive procedures defined below
1, albumin bound paclitaxel carcinoma non small cell lung diagnosis has received prior systemic treatment taxane advanced metastatic disease
1, lapatinib advanced metastatic erbbtwo overexpressing breast cancer diagnosis is receiving any prohibited medication within timeframe indicated on prohibited medication list protocol
0, docetaxel breast cancer diagnosis prior concurrent therapy
0, albumin bound paclitaxel head neck cancer diagnosis not pregnant nursing
0, idarubicin myelodysplastic myeloproliferative neoplasms diagnosis renal
0, bevacizumab recurrent colon cancer diagnosis no cardiac arrhythmia
0, gemcitabine pancreatic cancer diagnosis not specified radiotherapy
0, erlotinib hydrochloride tongue cancer diagnosis patients who had surgery recurrent disease second primary previously radiated field eligible if their surgical pathology specimen from resection exhibits high risk features such positive margins extracapsular extension
1, aldesleukin patients who undergoing have undergone past four weeks any other form therapy except surgery their cancer including radiation therapy any site
0, therapeutic conventional surgery recurrent adult brain tumor diagnosis no other investigational commercial agents therapies may be administered intent treat patient malignancy
1, abiraterone acetate breast cancer diagnosis persistent toxicities greater grade two from any cause except chemotherapy induced alopecia grade two peripheral neuropathy
1, dexamethasone breast cancer diagnosis cardiac pacemakers
1, antibodies monoclonal colorectal cancer diagnosis intra
1, narrow band imaging withdrawal personal colorectal cancer history
1, lenalidomide mantle cell lymphoma diagnosis known brain metastases
0, gemcitabine pancreatic cancer diagnosis hepatic
0, dabrafenib recurrent solid neoplasm diagnosis enrollment onto another investigational study
0, fluorouracil breast cancer diagnosis no evidence other disease that opinion investigator places patient at high risk treatment related complications
0, antibodies brain central nervous system tumors diagnosis negative pregnancy test
0, fluorouracil recurrent pancreatic carcinoma diagnosis aspartate aminotransferase ast alanine aminotransferase alt equal less doc iuln patients liver metastases may have ast alt equal less doc iuln
0, cisplatin osteosarcoma diagnosis shortening fraction on echocardiogram greater twenty eight
1, htert metastatic breast cancer diagnosis initiation hormonal agent such tamoxifen anastrazole letrozole thirty days before treatment
0, lenalidomide recurrent adult grade iii lymphomatoid granulomatosis diagnosis magnesium greater equal doc mg dl
0, combined systemic intrathecal chemotherapy followed by hd asct lymphoma non hodgkin diagnosis adequate renal function creatinine clearance greater fifty ml min
1, antibodies monoclonal ovarian endometrioid adenocarcinoma diagnosis no ongoing requirement dexamethasone cns disease patients on stable dose anticonvulsants permitted
1, support group therapy stage ii breast cancer diagnosis there no exclusion requirements due co morbid disease incurrent illness
1, thalidomide recurrent childhood visual pathway glioma diagnosis partner vasectomy
0, memorial anxiety scale prostate cancer patients biopsy confirmed primary tumor prostate
0, fludarabine recurrent adult hodgkin lymphoma diagnosis myeloproliferative myelodysplastic syndrome mds
1, cetuximab stage ivb verrucous carcinoma oral cavity diagnosis major active psychiatric disorders which would limit compliance
1, albumin bound paclitaxel patients who have received prior radiotherapy any portion abdominal cavity pelvis within last three years excluded prior radiation localized cancer breast head neck skin is permitted provided that it was completed more three years prior registration patient remains free recurrent metastatic disease
1, sorafenib ovarian cancer diagnosis patients prior therapy containing avastin other vegfr tkone
1, immunoglobulins stage iva squamous cell carcinoma lip oral cavity diagnosis impairment gastrointestinal gi function gi disease that may significantly alter absorption bkmone hundred twenty ulcerative diseases uncontrolled nausea vomiting diarrhea malabsorption syndrome small bowel resection patients unresolved diarrhea will be excluded previously indicated
0, proteomic profiling lymphoma diagnosis hepatic
0, irinotecan recurrent melanoma diagnosis bilirubin less doc times upper limit normal uln
0, dexrazoxane cutaneous cell non hodgkin lymphoma diagnosis at least seven days since completion therapy growth factor
0, interferon alpha diffuse intrinsic pontine glioma diagnosis histological diagnosis
1, bortezomib recurrent small lymphocytic lymphoma diagnosis any following prior therapies
1, interleukin oesophageal cancer diagnosis previous allogeneic transplant
1, txa multiple myeloma diagnosis subjects known be seropositive hiv htlv i
0, leuprolide prostatic neoplasms diagnosis tnm stage ttwoc tthreea tthreeb
1, doxorubicin stage mantle cell lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition ofatumumab other agents used study
0, tanespimycin bladder cancer diagnosis hematopoietic
1, hypofractionation contralateral breast cancer including dcis irrespective date diagnosis
0, immunoglobulins recurrent salivary gland cancer diagnosis one following histologically confirmed diagnoses
0, liposomal doxorubicin endometrial cancer diagnosis not specified
0, interleukin recurrent grade two follicular lymphoma diagnosis patients must have received prior rituxan
1, bendamustine hydrochloride recurrent adult diffuse mixed cell lymphoma diagnosis more three cycles myelotoxic salvage chemotherapy within past four months specific regimens include ice dhap mtx hidac hypercvad vtd pace
1, antibodies monoclonal stage iiib fallopian tube cancer diagnosis patients medical history conditions not otherwise previously specified which opinion investigator should exclude participation this examples this would be
1, methotrexate peripheral cell lymphoma diagnosis adult thirty pediatric
0, antineoplaston a lymphoma diagnosis no concurrent immunomodulatory agent interferon interleukin two
0, hyaluronic acid kidney cancer diagnosis prior concurrent therapy
0, dexamethasone phosphate multiple myeloma diagnosis more information regarding bms clinical trial participation please visit ww msstudyconnec om
1, gemcitabine pancreatic cancer diagnosis decision unsuitableness by principal investigator physician charge
0, everolimus lymphoma low grade diagnosis these stem cells may have been collected from pbsc pheresis bone marrow harvest combination
1, interferon beta glioblastoma multiforme diagnosis serum potassium less doc meq greater doc meq l
1, cyclophosphamide other concurrent investigational agents anticancer therapies including cytotoxic agents immunotherapy
0, f fmiso liver cancer diagnosis ast sgot alt sgpt less equal doc institutional upper limits normal
0, yoga therapy ductal breast carcinoma situ diagnosis duration rt participants must have access an existing broadband internet connection computer laptop desktop tablets not sufficient full sized computer screen following specifications
0, epirubicin gastro esophageal junction cancer diagnosis treatment must begin between day twenty day fifty six after gastrectomy
0, antibodies monoclonal male breast cancer diagnosis at least one unidimensionally measurable lesion meeting one following criteria
1, cediranib stage iv non small cell lung cancer diagnosis patients may not be receiving any other investigational agents within past thirty days have been previously treated gamma secretase inhibitor cediranib exposure other angiogenesis inhibitors sorafenib bevacizumab is acceptable
0, american ginseng precancerous condition diagnosis malnutrition active infection significant pulmonary disease cardiovascular disease determined by physician they could impact fatigue
0, dexamethasone phosphate multiple myeloma diagnosis subjects affiliated an appropriate social security system
1, omegaven colon cancer diagnosis pre operative hemoglobinless doc mmol l
1, educational intervention stage iiic primary peritoneal cancer diagnosis patients body mass index bmi less twenty kg two
0, tacrolimus terminology indolent aggressive lymphoma will replace former terminology low intermediate high grade lymphoma
1, vidarabine stage iv small lymphocytic lymphoma diagnosis donor
1, dexamethasone acetate history steroid induced glaucoma either eye
0, levoleucovorin stage ii colon cancer diagnosis serum creatinine within below normal limits laboratory
1, fluorouracil neoplasm metastasis diagnosis requires continuous treatment systemic steroids
1, carboplatin recurrent urethral cancer diagnosis serious concurrent infection requiring intravenous antibiotic therapy
0, sirolimus stage iv melanoma diagnosis must show clear evidence disease progression within lesion if only site measurable disease is within previously irradiated volume
1, androgens prostate cancer diagnosis lunar bmd cmtwo
0, etoposide phosphate contiguous stage ii adult lymphoblastic lymphoma diagnosis patients previously harvested hematopoietic stem cells while complete partial remission case patients stable refractory disease undergoing autologous transplantation because it has been recommended by their treating physician representing their best treatment option goal at minimum two ten six cluster differentiation cd thirty four positive peripheral primed stem cells per kilogram actual body weight
1, piperazine citrate brainstem glioma diagnosis age less one year greater one years
1, immunoglobulin g recurrent fallopian tube carcinoma diagnosis urine protein should be screened by urinalysis if protein is two positive higher two hour urine protein should be obtained level should be less one thousand mg patient enrollment
0, levoleucovorin colorectal cancer diagnosis serum creatinine less equal one fivex uln
1, pharmacological gliosarcoma diagnosis requirement inotropic support excluding digoxin serious uncontrolled cardiac arrhythmia including atrial flutter fibrillation ventricular fibrillation ventricular tachycardia
1, cisplatin postobstructive pneumonia preventing exact delineation tumor volume
0, stereotactic radiosurgery brain central nervous system tumors diagnosis not specified other
0, mycophenolic acid recurrent adult diffuse small cleaved cell lymphoma diagnosis low grade nhl less six month duration cr between courses conventional therapy
1, pemetrexed non small cell lung carcinoma diagnosis known active tuberculosis hepatitis c
1, sunitinib adult nasal type extranodal nk cell lymphoma diagnosis female subjects who pregnant breast feeding
0, poly i c gastric cancer diagnosis see disease characteristics
0, paclitaxel primary breast cancer diagnosis complete staging work up within three months prior randomization
0, vinorelbine non small cell lung cancer stage diagnosis must be able receive therapy within four weeks after completely resection
0, albumin bound paclitaxel stage iv bladder urothelial carcinoma diagnosis hemoglobin greater equal doc dl
1, immunoglobulins stage iii childhood anaplastic large cell lymphoma diagnosis inclusion hiv positive patients will be considered at later date
1, antibodies monoclonal metastatic colorectal cancer diagnosis adjuvant fluoropyrimidine based chemotherapy prior fluoropyrimidine therapy administered solely purpose radiosensitization
1, dexamethasone phosphate angioimmunoblastic cell lymphoma diagnosis patients that have other medical conditions that would contraindicate treatment aggressive chemotherapy
1, niacinamide carcinoma hepatocellular diagnosis patients clinically significant gastrointestinal bleeding within thirty days prior entry
1, isophosphamide mustard ewing sarcoma bone diagnosis contralateral pleural effusion contralateral pleural nodules
0, immunoglobulin g recurrent fallopian tube carcinoma diagnosis patients must have gynecologic oncology group gog performance status zero one
0, vincristine lymphoma diagnosis other
0, capecitabine patients advanced biopsy proven cancer which there is no standard curative therapy
1, sirolimus leiomyosarcoma diagnosis inadequate recovery from any prior surgical procedure having undergone any major surgical procedure within two weeks prior first dose ridaforolimus
1, liposomal doxorubicin ovarian seromucinous carcinoma diagnosis new york heart association functional classification iii iv
1, epothilone b colorectal cancer diagnosis patient has received any other investigational agent within twenty eight days first day drug dosing
0, tacrolimus stage iii grade two follicular lymphoma diagnosis cord blood transplant recipients
0, carboplatin gastric cancer diagnosis recovered from prior therapy
0, doxorubicin metastatic ewing sarcoma diagnosis doc males females
1, antibodies monoclonal melanoma diagnosis prisoners subjects who involuntarily incarcerated
0, dalteparin pancreatic cancer diagnosis patient characteristics
1, induction chemotherapy concurrent radiation non small cell lung cancer diagnosis women who pregnant breast feeding
1, temozolomide metastatic cancer diagnosis is known have human immunodeficiency virus hiv has active hepatitis virus hcv active hepatitis virus hbv
0, etoposide lymphoma diagnosis see disease characteristics
1, naloxone cancer diagnosis radiotherapy that investigators opinion would influence bowel function pain during double blind phase study
1, sirolimus ovarian neoplasms diagnosis acute chronical infection
1, azacitidine non hodgkin lymphoma diagnosis subjects white blood cell counts greater twenty zero Î¼l must be excluded
1, busulfan stage iv adult immunoblastic large cell lymphoma diagnosis patients who have not recovered from adverse events due agents administered more four weeks earlier or
0, etoposide phosphate stage iii adult immunoblastic large cell lymphoma diagnosis further at investigator discretion patients who unstable one cycle chop is allowed prior enrollment but no more one cycle
0, cladribine thymoma diagnosis waldenstrom macroglobulinemia must have failed either purine analogue based chemotherapy fludara twocda standard cvp therapy hyperviscosity cytopenias
1, levoleucovorin malignant neoplasm esophagus diagnosis patient already included another clinical trial testing an experimental drug
1, gemcitabine metastatic pancreatic adenocarcinoma diagnosis therapeutic doses defined doses need achieve target inr greater doc warfarin sodium coumadin any other coumadin derived anti coagulant anticoagulants not derived from warfarin allowed dabigatran rivaroxaban apixaban
0, bevacizumab pancreatic cancer diagnosis eighteen years age older
0, fatigue inventory stage iii grade three follicular lymphoma diagnosis women potential child bearing must have negative pregnancy test at screening both men women required use appropriate contraception during study
1, soy isoflavones prior treatment prostate cancer including radiotherapy systemic chemotherapy surgery investigational drugs
0, cyclosporine testicular lymphoma diagnosis this protocol will allow use donors who unrelated but hla b d dr identical mlc mixed lymphocyte culture compatible
0, efatutazone lymphoma diagnosis life threatening visceral disease other severe concurrent disease
1, tq b advanced cancer diagnosis patients drug abuse history unable get rid patients mental disorders
1, estrogens conjugated usp prostate cancer diagnosis use anti coagulation low molecular weight heparin coumadin
1, camptothecin advanced cancers diagnosis patients receiving any medications substances that strong inhibitors inducers cypthreeafour complex ineligible
1, gsk cancer diagnosis any malignancy related human immunodeficiency virus hiv solid organ transplant history known hiv history known hepatitis virus hbv surface antigen positivity subjects documented laboratory evidence hbv clearance may be enrolled positive hepatitis virus antibody confirmed by recombinant immunoblot assay
0, antibodies monoclonal stage iv squamous cell carcinoma hypopharynx diagnosis platelet count at least one hundred zero mm three
1, vitamin b complex rectal neoplasms diagnosis inability unwillingness take folic acid vitamin btwelve dexamethasone
0, cyclosporine recurrent adult hodgkin lymphoma diagnosis patient must be not eligible conventional transplants must have disease expected be stable at least one hundred days without chemotherapy
0, tacrolimus recurrent adult diffuse mixed cell lymphoma diagnosis matched human leukocyte antigen hla b drbone dqbone by high resolution typing
1, palonosetron malignant glioma diagnosis ongoing vomiting from any organic etiology
1, dasatinib breast cancer diagnosis concurrent treatment ovarian hormonal replacement therapy
1, antibodies monoclonal recurrent childhood large cell lymphoma diagnosis history cva within six months
0, dabrafenib recurrent melanoma diagnosis serum creatinine less doc mg dl creatinine clearance greater fifty ml min determined by twenty four hour urine collection
0, vinorelbine metastatic breast cancer diagnosis adequate organ function evidenced by following laboratory results
1, thalidomide extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis use following strong inhibitors prohibited equal less seven days prior registration
0, camptothecin colorectal cancer diagnosis urinalysis normal
0, camptothecin cancer diagnosis ability understand willingness sign written informed consent document
0, niacinamide lung cancer diagnosis absolute neutrophil count anc greater equal one five hundred mmthree
0, etoposide peripheral cell lymphomas not otherwise specified ptcl nos diagnosis absence active hepatitis virus hcv infection
0, succinylcholine stage childhood hodgkin lymphoma diagnosis all stage iiia iiiae iiias iiiae positive regardless bulk disease
1, traction neurectomy neuroma amputation diagnosis participation other ongoing studies related neuropathic pain
1, cetuximab pancreatic cancer diagnosis prior bortezomib cetuximab
1, fulvestrant breast cancer diagnosis active second malignancy regardless ongoing treatment
0, panobinostat recurrent adult cell leukemia lymphoma diagnosis serum immunoglobulin free light chain greater equal ten mg dl abnormal serum immunoglobulin kappa lambda free light chain ratio
0, prednisone lymphoma diagnosis chemotherapy
1, dasatinib stage iva salivary gland cancer diagnosis echocardiogram less institutional normal measured by echocardiogram subjects history congestive heart failure symptoms congestive heart failure clinical evidence suggesting impaired cardiac function
0, silymarin carcinoma non small cell lung diagnosis platelet count
0, lenograstim childhood extracranial germ cell tumor diagnosis recovered from prior chemotherapy immunotherapy radiotherapy
1, erlotinib hydrochloride stage ivb squamous cell carcinoma oropharynx diagnosis patients may not be receiving any other investigational agents
1, vinorelbine pregnant lactating woman childbearing potential either positive no pregnancy test at baseline excluded postmenopausal woman must have been amenorrheic at least twelve months be considered non childbearing potential patients must agree continue contraception thirty days from date last drug administration woman childbearing potential not using reliable appropriate contraceptive method excluded
0, albumin bound paclitaxel stage iib breast cancer diagnosis patients who require full dose anticoagulation may enroll provided they meet following criteria
1, estrogens breast cancer diagnosis history chronic glucocorticoid therapy
0, succinylcholine fallopian tube clear cell adenocarcinoma diagnosis creatinine equal less doc institutional upper limit normal uln ctcae grade one
0, interleukin lymphoma diagnosis life expectancy
1, ado trastuzumab emtansine stage iib breast cancer diagnosis note
1, veliparib metastatic malignant neoplasm diagnosis psychiatric illness social situations that would limit compliance requirements
1, vincristine lymphoma follicular diagnosis patients who receiving any other investigational agents
1, dexamethasone acetate congestive heart failure new york heart association class iii iv symptomatic ischemia conduction abnormalities uncontrolled by conventional intervention myocardial infarction previous six months
1, folic acid non small cell lung cancer diagnosis malignancies other nsclc that expected alter life expectancy may interfere disease assessment
1, ado trastuzumab emtansine stage iv breast cancer diagnosis current unstable ventricular arrhythmia requiring treatment
0, diagnostic laboratory biomarker analysis noncutaneous extranodal lymphoma diagnosis doc male doc female
1, lipotecan advanced solid tumors diagnosis male female patients childbearing potential must agree use appropriate birth control barrier methods spermicides oral parenteral contraceptives intrauterine devices during entire duration patient must be surgically sterile documentation patient medical records
0, thalidomide recurrent adult diffuse mixed cell lymphoma diagnosis willing be registered into mandatory revlimid rems program willing able comply requirements rems program
1, bevacizumab malignant gliomas diagnosis prior ischemic events
1, everolimus cancer liver diagnosis acidosis will be suspected if serum bicarbonate is less twenty two meq l
0, liposomal doxorubicin sarcoma diagnosis patient characteristics
0, carmustine recurrent adult hodgkin lymphoma diagnosis addition patients must meet at least one following criteria ix vii at time diagnosis pre autograft
1, doxorubicin stage iiib primary peritoneal cavity cancer diagnosis doubling serum ca one hundred twenty five level
1, exercise intervention stage iiic ovarian cancer diagnosis patients enrolled weight loss program who taking weight loss medications dietary supplements unwilling discontinue
1, ifosfamide stage iib uterine sarcoma diagnosis patients known hypersensitivity e
0, hormones prostate cancer diagnosis not specified
1, dc cik immunotherapy malignant tumor diagnosis uncontrolled central nervous system metastases
0, albumin bound paclitaxel stage iiia non small cell lung cancer diagnosis no history allergic reactions attributed carboplatin taxane
0, dexrazoxane histologically confirmed advanced incurable cancer that is unresponsive prior chemotherapy regimens which no standard chemotherapy regimen exists
1, laboratory biomarker analysis stage iva hepatocellular carcinoma diagnosis must not have any evidence bleeding diathesis active gastrointestinal bleeding
1, camptothecin pediatric solid tumors diagnosis there should be no anticipation need major surgical procedures during course study
1, heparin asymptomatic routine post operative blood products post surgical cavity not an exclusion
0, fludarabine noncontiguous stage ii small lymphocytic lymphoma diagnosis chronic lymphocytic leukemia
0, cyclosporins cutaneous cell lymphoma diagnosis doc
1, interleukin gastrointestinal cancer metastatic diagnosis exclusion enrollment
0, succinylcholine metastatic malignant neoplasm brain diagnosis life expectancy greater twelve months
1, tetrahydrofolates stage iic rectal cancer diagnosis transmural myocardial infarction within last six months
0, rituximab stage mantle cell lymphoma diagnosis normal greater equal forty five left ventricular cardiac ejection fraction determined by echocardiogram muga scan
0, mitomycins carcinoma diagnosis eastern cooperative oncology group ecog status zero two
0, aldesleukin male breast cancer diagnosis bone metastases
1, succinylcholine stage iiia fallopian tube cancer diagnosis no poorly differentiated subtypes including papillary serous clear cell other international federation gynecology obstetrics figo grade three lesions
1, rituximab lymphoma diagnosis contraindication any required concomitant drugs supportive treatments intolerance hydration due preexisting pulmonary cardiac impairment including pleural effusion requiring thoracentesis ascites requiring paracentesis
1, endothelial growth factors childhood alveolar rhabdomyosarcoma diagnosis female patients childbearing potential not eligible unless negative pregnancy test result has been obtained
1, paclitaxel breast neoplasm diagnosis calculated creatinine clearance below thirty ml min calculation see p
0, medical chart review cervical cancer diagnosis underwent cervical biopsy removal cervical tissue diagnosed cervical intraepithelial neoplasia cin grades one three
1, everolimus myeloproliferative neoplasm diagnosis cardiac ejection fraction less thirty five if unable obtain ejection fraction shortening fraction less twenty six ejection fraction is required if age greater fifty years there is history anthracycline exposure history cardiac disease patients shortening fraction less twenty six may be enrolled if approved by cardiologist
0, placebo epithelial ovarian cancer diagnosis adequate renal function defined serum creatinine less doc uln
0, vorinostat adult grade iii lymphomatoid granulomatosis diagnosis patients known brain metastases should have had brain irradiation whole brain gamma knife more four weeks before starting protocol treatment
0, estramustine prostate cancer diagnosis no prior concurrent treated untreated brain metastases
1, mitomycins carcinoma squamous cell diagnosis clinically significant cardiovascular disorders myocardial infarction less six months before visit stroke less less six months before visit instable angina less three months before visit arrhythmia uncontrolled hypertension greater six one hundred mm hg
1, methotrexate hertwo positive breast cancer diagnosis angina pectoris that requires use antianginal medication
1, fludarabine stage iv grade one follicular lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
0, dasatinib diffuse intrinsic pontine glioma diagnosis bone marrow
0, fludarabine phosphate recurrent plasma cell myeloma diagnosis previously collected pbmc may be used
0, etoposide lymphoma diagnosis other
1, melphalan angioimmunoblastic cell lymphoma diagnosis any prior use lenalidomide
1, bevacizumab intestinal adenocarcinoma stomach diagnosis patients psychiatric addictive disorders other conditions that opinion investigator would preclude them from meeting requirements not eligible
0, placebo prostate cancer diagnosis patients who underwent radical prostatectomy never achieved undetectable serum psa after surgery not eligible
1, laboratory biomarker analysis stage iva colon cancer diagnosis patients who receiving have received any other investigational agents within thirty days day one who have previously received mk two thousand two hundred six at any time
0, cortisone stage ii childhood hodgkin lymphoma diagnosis negative pregnancy test
1, fludarabine recurrent adult diffuse mixed cell lymphoma diagnosis heart any volume thirty six gy
0, prednisone multiple myleoma diagnosis however patients lvef between thirty five forty four may also be eligible provided that such patients cleared by cardiology consultation that must include cardiac stress test
1, pembrolizumab urethelial carcinoma diagnosis history allogeneic bone marrow stem cell solid organ transplant
1, fludarabine noncontiguous stage ii grade three follicular lymphoma diagnosis history brain metastases
1, fludarabine phosphate recurrent refractory childhood hodgkin lymphoma diagnosis ten small bowel
1, laboratory biomarker analysis extensive stage small cell lung cancer diagnosis current participation an exercise program
0, antibodies monoclonal melanoma diagnosis documentation flu vaccination if enrolled during flu season defined by availability vaccine
0, writing c control informative writing hematological cancers diagnosis have telephone service
1, prednisone prostate cancer diagnosis any known allergy compounds under investigation
0, neulasta pegfilgrastim lung cancer diagnosis chemotherapy naive have received adjuvant therapy have no more one regimen chemotherapy metastatic disease
0, vincristine patients must not have had any radiation therapy chemotherapy medulloblastoma prior enrollment
1, gemcitabine advanced solid tumor diagnosis part cthree
1, letrozole breast cancer diagnosis patient who received any cdkfour six inhibitor
0, tacrolimus stage grade three follicular lymphoma diagnosis waldenstrom macroglobulinemia
0, pembrolizumab stomach cancer diagnosis have newly diagnosed localized locally advanced tonenone threemzero ttwo fournanymzero potentially resectable disease without any prior systemic chemotherapy
0, oxaliplatin stage iiic rectal cancer diagnosis phase ib
0, docetaxel stage iiia breast cancer diagnosis patient must have completed one procedures evaluation pathologic nodal status listed below
0, mycophenolic acid stage ii childhood lymphoblastic lymphoma diagnosis have seventeenp deletion cytogenetic abnormality patients should have received induction chemotherapy but could be transplanted onest cr
1, cyclosporins recurrent adult diffuse mixed cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
0, cetuximab stage iii squamous cell carcinoma larynx diagnosis other significant ecg abnormalities
0, fluorouracil recurrent squamous cell carcinoma paranasal sinus nasal cavity diagnosis at least four weeks since prior major surgery
1, sirolimus stage ii adult non contiguous immunoblastic lymphoma diagnosis diffusion capacity carbon monoxide dlco less forty total lung capacity tlc less forty forced expiratory volume one second fevone less forty receiving supplementary continuous oxygen
1, topotecan glioblastoma diagnosis patients must not have received prior therapy topotecan pazopanib related drugs such tyrosine kinase inhibitors vegf inhibitors except bevacizumab
0, aprepitant colorectal cancer diagnosis no clinical signs active systemic infection involving gastrointestinal tract
1, laboratory biomarker analysis recurrent childhood malignant germ cell tumor diagnosis use daily benzodiazepine therapy excludes patient from being eligible because potential benzodiazepine like effects mlneight thousand two hundred thirty seven
1, surgery non small cell lung cancer diagnosis pregnant lactating women treatment involves unforeseeable risks embryo fetus
1, laboratory biomarker analysis recurrent adult diffuse mixed cell lymphoma diagnosis antifungals
1, epirubicin mucinous breast cancer diagnosis patients medical conditions taht indicate intolerant neoadjuvant therapy including uncontrolled cardiovascular disease severe infection
1, paclitaxel head neck squamous cell carcinoma diagnosis prior chemotherapy within previous three years
0, niacinamide liver cancer diagnosis total bilirubin less doc times uln
1, high intensity focused ultrasound ablation prior radiotherapy prostate cancer
1, gemcitabine bladder cancer urothelial carcinoma diagnosis uncontrolled tumour related pain hypercalcemia
1, gemcitabine metastatic pancreatic adenocarcinoma diagnosis prior therapies
1, thymosin Î± cancer related fatigue diagnosis other specific causes fatigue
0, interleukin kidney cancer diagnosis no prior recombinant human interleukin two
1, methylprednisolone hemisuccinate prostate cancer diagnosis prior isotope therapy radiotherapy greater thirty bone marrow
0, fluorouracil gastric cancer diagnosis alkaline phosphatase ap normal ast alt less five times uln
1, cisplatin esophageal cancer diagnosis patients any history an allogeneic transplant will not be eligible
1, capecitabine have current active hepatic biliary disease exception patients gilbert syndrome asymptomatic gallstones liver metastases stable chronic liver disease per investigator assessment
1, vinblastine lymphocyte predominant nodular type nodular paragranuloma
0, niacinamide unspecified adult solid tumor protocol specific diagnosis creatinine clearance greater equal sixty ml min patients creatinine levels above doc institutional uln
0, zoledronic acid bone neoplasms diagnosis all female subjects childbearing potential male subjects female partners childbearing potential must agree use effective contraception eg implants injectables combined oral contraceptives intrauterine device iud sexual abstinence vasectomy vasectomized partner duration study
0, tretinoin stage four neuroblastoma diagnosis recurrent progressive disease at any time biopsy not required even if partial response intervening therapy
0, laboratory biomarker analysis classical hodgkin lymphoma diagnosis eastern cooperative oncology group ecog performance status zero one two
0, nelfinavir colorectal tumors diagnosis less ten weight loss last six months
1, vatalanib rectal neoplasms diagnosis peripheral neuropathy functional impairment
1, doxorubicin mantle cell lymphoma diagnosis patients must have any active infections under control
1, intensity modulated radiotherapy melanoma diagnosis pregnant breastfeeding
0, liposomal doxorubicin diagnosed breast cancer
1, mass spectrometry prior invasive cancer first degree relative known history crc healthy volunteers patients colorectal polyps
1, fluorouracil head neck cancer diagnosis peripheral neuropathy greater grade two
0, cyclophosphamide breast cancer diagnosis hepatic
1, t mri glioblastoma diagnosis world health organization who performance scale greater three
0, alvespimycin hydrochloride unspecified adult solid tumor protocol specific diagnosis no concurrent routine colony stimulating factors filgrastim csf sargramostim gm csf
0, liposomal doxorubicin prostate cancer diagnosis no predominant visceral metastases
1, fludarabine contiguous stage ii grade three follicular lymphoma diagnosis use any other experimental drug within twenty eight days baseline
1, veliparib metastatic pancreatic cancer diagnosis unstable angina pectoris cardiac arrhythmia
0, erlotinib hydrochloride stage iii pancreatic cancer diagnosis no prior surgical procedures affecting absorption
0, irinotecan adult rhabdomyosarcoma diagnosis doc mg dl
0, microwave thermography rtm res breast cancer diagnosis ten different breast diseases
0, melphalan metastatic cancer diagnosis not pregnant nursing
1, cyclophosphamide lymphoma diagnosis autologous hsct less six months prior proposed haplo sct
1, antibodies monoclonal non squamous non small cell lung cancer diagnosis prior treatment cdone hundred thirty seven agonists immune checkpoint blockade therapies anti pdone anti pd lone therapeutic antibody
0, sorafenib neuroendocrine tumor diagnosis adequate bone marrow liver renal function outlined protocol
0, mycophenolic acid a new classification scheme adult non hodgkin lymphoma has been adopted by pdq
1, fludarabine noncontiguous stage ii adult diffuse large cell lymphoma diagnosis donor
0, thalidomide stage iii adult diffuse mixed cell lymphoma diagnosis females childbearing potential fcbp must have negative serum urine pregnancy test sensitivity at least fifty miu ml within ten
1, carboplatin stage iib cervical cancer diagnosis para aortic nodal involvement above level common iliac nodes lthree lfour if biopsy proven pet positive greater equal fifteen mm short axis diameter on computed tomography ct
0, dasatinib signet ring adenocarcinoma rectum diagnosis ability understand willingness sign written informed consent document
1, succinylcholine stage iia cervical cancer diagnosis para aortic nodal involvement above level common iliac nodes lthree lfour if biopsy proven pet positive greater equal fifteen mm short axis diameter on computed tomography ct
1, calcium dietary lymphoma diagnosis inability sit stand upright at least thirty minutes
1, medroxyprogesterone advanced persistent recurrent endometrial cancer diagnosis screening hepatitis c
1, paclitaxel angiosarcoma diagnosis see protocol
0, cisplatin head neck cancer diagnosis recovered from prior surgery
1, cisplatin carcinoma squamous cell head neck diagnosis currently receiving treatment medication known risk prolong qt interval inducing torsades de pointes treatment cannot either be discontinued switched different medication prior starting drug
0, melphalan multiple myeloma diagnosis lower values permitted if they due bm infiltration
1, immunoglobulins recurrent fallopian tube carcinoma diagnosis significant st depression greater equal doc mm two more leads wave inversions greater equal two leads
0, thiotepa small cell glioblastoma
0, cyclophosphamide lymphoma diagnosis optimal glycemic control should be achieved before starting trial therapy
1, immunoglobulins stage ivc verrucous carcinoma oral cavity diagnosis john wort rifampin rifampicin
1, cetuximab stage iva verrucous carcinoma larynx diagnosis more two prior lines cytotoxic chemotherapy recurrent metastatic disease setting palliative treatment intent excluding single agent use an egfr inhibitor
0, kw adult cell leukemia lymphoma atl diagnosis neutrophil count greater one five hundred mmthree
0, fluorouracil recurrent metastatic squamous cell carcinoma neck occult primary diagnosis no prior history severe hypersensitivity reaction docetaxel other drugs formulated polysorbate eighty if physician choice chemotherapy regimen is docetaxel
1, dexamethasone congestive heart failure new york heart association class iii iv symptomatic ischemia conduction abnormalities uncontrolled by conventional intervention myocardial infarction within six months before first dose
1, hydroxychloroquine refractory plasma cell myeloma diagnosis absolute neutrophil count anc equal less doc ten nine l
1, rituximab prostate cancer diagnosis positive test results hepatitis hepatitis virus hcv antibody serology testing
1, de ct s se ct non small cell lung cancer diagnosis not able give written informed consent
1, iv fluorescein administration malignant tumor diagnosis patient known suspected allergy fluorescein
1, linsitinib refractory ewing sarcoma diagnosis significant cardiac disease includes second third degree heart block clinically significant ischemic heart disease superior vena cava svc syndrome poorly controlled hypertension congestive heart failure new york heart association nyha class ii worse slight limitation physical activity comfortable at rest but ordinary physical activity results fatigue palpitation dyspnea
0, erlotinib hydrochloride stage iii squamous cell carcinoma lip oral cavity diagnosis none following allowed part two
1, alemtuzumab recurrent refractory childhood hodgkin lymphoma diagnosis life expectancy severely limited by diseases other malignancy
0, antilymphocyte serum lymphoma diagnosis creatinine normal or
0, doxorubicin neuroblastoma diagnosis must be able adhere dose visit schedules
0, antibodies monoclonal uterine cancer diagnosis patients eastern cooperative oncology group ecog performance grade zero one
0, vidarabine lymphoma diagnosis chronic myelogenous leukemia meeting one following criteria
1, trastuzumab metastatic breast cancer diagnosis patient has known family history congenital hereditary immunodeficiency
1, cyclosporins adult grade iii lymphomatoid granulomatosis diagnosis donor
0, adenosine other active malignancy except localized skin cancer bladder prostate breast cervical carcinoma situ
0, laboratory biomarker analysis lymphoma diagnosis ifosfamide
1, obinutuzumab refractory diffuse large cell lymphoma diagnosis receipt live virus vaccines within twenty eight days prior initiation treatment need live virus vaccines at any time during treatment
1, erlotinib hydrochloride recurrent pancreatic carcinoma diagnosis failure fully recover from acute reversible effects prior therapy regardless interval since last treatment
1, paclitaxel epithelial ovarian cancer diagnosis women childbearing potential who sexually active unwilling use medically acceptable method contraception oral contraceptive diaphragm spermicide intrauterine device condom spermicide
0, laboratory biomarker analysis recurrent adult brain tumor diagnosis prior surgical procedures affecting absorption
0, topotecan ovarian cancer diagnosis absolute neutrophil count greater one five hundred mmÂ³
1, lenalidomide recurrent adult burkitt lymphoma diagnosis receiving any medications that prolong corrected qt qtc have known risk torsades de pointes note
1, dexamethasone acetate recurrent childhood lymphoblastic lymphoma diagnosis patients must not be known be refractory red cell platelet transfusion
1, oxaliplatin metastatic esophagogastric adenocarcinoma diagnosis concurrent palliative radiation non target lesions is allowed if other target lesions available outside involved field previous radiotherapy including target lesions must have been finished at least twenty eight days before start induction treatment
1, jx ovarian cancer diagnosis severe unstable cardiac disease including significant coronary artery disease requiring angioplasty stenting within preceding twelve months unless well controlled on stable medical therapy at least three months
0, erlotinib hydrochloride colorectal cancer diagnosis renal
0, antibodies monoclonal metastatic castration sensitive prostate cancer diagnosis fifty rise psa is across three determinations these determinations not need be sequential
0, albumin bound paclitaxel cancer diagnosis performance status less two ecog scale life expectancy greater two months
0, mycophenolate mofetil multiple myeloma plasma cell neoplasm diagnosis chronic myelomonocytic leukemia
0, antibodies monoclonal lymphoma diagnosis chronic renal disease
1, prednisolone phosphate primary central nervous system cns lymphoma histologic evidence transformation burkitt lymphoma primary mediastinal dlbcl primary effusion lymphoma primary cutaneous dlbcl primary dlbcl testis
0, mln b cell small lymphocytic lymphoma sll diagnosis there is no restriction regarding maximum number prior regimens
1, vinblastine cancer diagnosis prior use vinflunine other active medical disorders severe nerve damage
1, cytarabine splenic marginal zone lymphoma diagnosis end organ function not appropriate transplantation
1, rituximab non hodgkin lymphoma diagnosis female subject is pregnant breast feeding
1, immunoglobulin g undifferentiated ovarian carcinoma diagnosis patients clinically significant proteinuria urine protein should be screened by urine protein creatinine ratio upcr upcr has been found correlate directly amount protein excreted twenty four hour urine collection specifically upcr doc is equivalent doc gram protein twenty four hour urine collection obtain at least four ml random urine sample sterile container does not have be twenty four hour urine send sample lab request urine protein creatinine levels separate requests lab will measure protein concentration mg dl creatinine concentration mg dl upcr is derived follows
1, maleic acid stage iv breast cancer diagnosis patients who cannot undergo mri safely
1, temozolomide glioblastoma diagnosis contraindicated mri examination
0, paclitaxel breast cancer diagnosis adequate hematologic hepatic renal function
1, colposcopy uterine cervical neoplasms diagnosis cervical cytology specimen collected within last four months
1, vidarabine recurrent childhood grade iii lymphomatoid granulomatosis diagnosis karnofsky performance status less sixty adult patients
0, etoposide lung cancer diagnosis not specified
1, tazemetostat c tazemetostat primary mediastinal lymphoma diagnosis ww ov drugs developmentapprovalprocess developmentresources druginteractionslabeling ucmeight thousand forty nine tm http
1, fludarabine phosphate peripheral cell lymphoma diagnosis bone marrow bm donors
1, vaccines non small cell lung cancer diagnosis other medical psychiatric conditions that opinion principal
0, cyproterone acetate prostate cancer diagnosis locally confined disease
1, rituximab recurrent small lymphocytic lymphoma diagnosis pioglitazone
0, dexamethasone acetate multiple myeloma diagnosis serum sgpt alt less doc upper limits normal uln
0, antibodies monoclonal stage iiib rectal cancer diagnosis hemoglobin greater equal nine dl may be transfused maintain exceed this level
0, erlotinib hydrochloride recurrent rectal cancer diagnosis no prior abnormal slit lamp exam using vital dye fluorescein bengal rose
0, irinotecan lymphoma diagnosis at least four weeks since prior biologic therapy
0, vinorelbine lymphoma diagnosis lvef normal
0, romidepsin recurrent grade one follicular lymphoma diagnosis female patients childbearing age should have negative pregnancy test pregnant breast feeding women will not be eligible because antiproliferative effects depsipeptide may be harmful developing fetus nursing infants
0, fluorouracil colorectal cancer diagnosis folfiri therapy is appropriate patient is recommended by investigator
1, caffeine cancer diagnosis uncontrolled hypertension heart disease
1, tacrolimus stage grade two follicular lymphoma diagnosis donor
1, external beam radiation prostate cancer diagnosis artificial heart valve
0, pemetrexed non small cell lung cancer diagnosis adequate bone marrow renal liver function
0, oxaliplatin unspecified adult solid tumor protocol specific diagnosis no psychiatric illness social situation that would preclude compliance
1, taxane stage iv cancer
0, bevacizumab breast cancer diagnosis calculated creatinine clearance must be greater fifty ml min
1, bevacizumab colon cancer diagnosis medications
0, carboplatin breast cancer diagnosis adequate bone marrow function anc greater doc one hundred nine platelets greater one hundred one hundred nine l
1, mycophenolate mofetil contiguous stage ii adult burkitt lymphoma diagnosis positive serology toxoplasma gondii on treatment evidence active infection
1, interleukin kidney cancer diagnosis has received live vaccine within thirty days planned start therapy
1, saline malignant glioma diagnosis progression disease defined by rano criteria
1, irreversible electroporation ire system pancreatic cancer diagnosis women who pregnant women child bearing potential who not using an acceptable method contraception
0, cytarabine childhood lymphoblastic lymphoma diagnosis all patients must have an initial white blood cell count less fifty zero ul
1, ins prior treatment current suspicious tumor unless current lesion is recurrence same tumor same location which prior treatment was received at least one hundred eighty days prior study
0, pembrolizumab mesothelioma diagnosis physical exam using calipers
1, veliparib fallopian tube mucinous adenocarcinoma diagnosis patients known hypersensitivity chinese hamster ovary cell products other recombinant human humanized antibodies
0, pharmacological stage ib pancreatic cancer diagnosis ecog performance status zero one
0, interleukin recurrent grade one follicular lymphoma diagnosis not pregnant nursing
0, irinotecan childhood embryonal rhabdomyosarcoma diagnosis patients must be able undergo radiation therapy if necessary specified protocol
1, elective vs therapeutic neck dissection early oral cancer oral cancer diagnosis prior radiotherapy surgery malignancy head neck region
0, bb stage iv childhood lymphoblastic lymphoma diagnosis nhl patients tissue available flow cytometry criterion diagnosis should be analogous all tissue processed by other means paraffin blocks methodology criteria immunophenotypic analysis establish diagnosis nhl defined by submitting institution will be accepted
0, mycophenolate mofetil stage adult diffuse mixed cell lymphoma diagnosis must have less five marrow blasts at time transplant
1, gemcitabine recurrent pancreatic cancer diagnosis gdc four hundred forty nine inhibits cyptwoceight cyptwocnine cyptwoc nine drug metabolism enzymes vitro at concentrations that may be clinically relevant
0, carboplatin recurrent squamous cell lung carcinoma diagnosis upc ratio spot urine is an estimation twenty four hour urine protein excretion
1, rituximab recurrent marginal zone lymphoma diagnosis pregnant women
1, thalidomide neuroectodermal tumors primitive diagnosis patient must not be pregnant breastfeeding
0, maleic acid undifferentiated fallopian tube carcinoma diagnosis phase iii study
1, etoposide refractory small lymphocytic lymphoma diagnosis baseline serum creatinine greater doc mg dl calculated measured creatinine clearance less fifty ml minute
0, camptothecin stage iv esthesioneuroblastoma paranasal sinus nasal cavity diagnosis karnofsky sixty one hundred
0, everolimus recurrent gastric cancer diagnosis international normalized ratio inr partial thromboplastin time ptt equal less doc anticoagulation is allowed if target inr equal less doc on stable dose warfarin on stable dose low molecular weight lmw heparin greater two weeks at time randomization
0, ifosfamide noncontiguous stage ii mantle cell lymphoma diagnosis patients must have ct chest abdomen pelvis within twenty eight days enrollment patients evidence adenopathy neck must have ct neck
1, laboratory biomarker analysis recurrent adult diffuse large cell lymphoma diagnosis st
0, hormones men over eighteen years age histologically confirmed diagnosis prostate cancer
0, carboplatin renal tumors diagnosis zero zero years
1, diphosphonates prostate cancer diagnosis iv calcitonin administration less thirty days prior randomization
1, cetuximab locally advanced cancer anal region diagnosis any investigational agent within thirty days before enrolment
1, vitamins cancer diagnosis hemodynamically significant primary valvular outflow tract obstruction mitral stenosis asymmetric septal hypertrophy malfunctioning prosthetic valve
0, paclitaxel stage iiia non small cell lung cancer diagnosis no prior epidermal growth factor receptor targeted therapy
0, thalidomide plasma cell myeloma diagnosis provide informed written consent
1, mycophenolic acid recurrent grade two follicular lymphoma diagnosis patients who have experienced progressive disease within three months prior bexxar zevalin
0, cyclosporine noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis increasing splenomegaly
1, sorafenib recurrent hepatocellular carcinoma diagnosis underlying condition predisposing them bleeding currently exhibits signs clinically significant bleeding
0, flutamide prostate cancer diagnosis disease characteristics
0, rituximab recurrent mantle cell lymphoma diagnosis patients must have southwest oncology group swog performance status zero one two
1, immunoglobulins stage iii rectal cancer diagnosis evidence metastatic disease confirmed by ct scan magnetic resonance imaging mri ultrasound liver chest ct scan chest ray within past six months
1, nivolumab stage iva cervical cancer diagnosis patients known brain metastases leptomeningeal metastases excluded unless following conditions met
1, levoleucovorin stage iiic esophageal cancer diagnosis patients who have received pelvic external beam radiotherapy not eligible
1, hands on healing breast cancer diagnosis patients other diseases that known induce fatigue thyroid disorder sleep disorders
1, sulindac known history familial adenomatous polyposis hereditary nonpolyposis colorectal cancer inflammatory bowel disease
0, bleomycin ovarian neoplasms diagnosis has undergone initial surgery diagnosis staging cytoreduction within past eight weeks
0, cyclophosphamide lymphoma diagnosis hepatic
1, whole breast irradiation plus simultaneous tumor bed boost early stage breast cancer diagnosis patient unlikely comply protocol uncooperative attitude inability return follow up visits unlikely complete study
1, liposomal doxorubicin sarcoma diagnosis history abdominal fistula gastrointestinal perforation intra abdominal abscess within six months prior day zero
0, everolimus recurrent diffuse large cell lymphoma diagnosis one donor is heterozygous one
0, fluorouracil breast cancer diagnosis no history serious underlying medical illness psychiatric addictive disorder no second malignancy within five years except
0, cyclophosphamide lymphoma diagnosis fevone fvc dlco at least fifty predicted other
1, morab non small cell lung cancer diagnosis investigational drugs which five half lives is less twenty one days minimum ten days between termination investigational drug administration morab sixty six is required
0, fluorodeoxyglucose f stage iib prostate cancer diagnosis arm two patients must have lymph node soft tissue bone visceral metastatic disease measuring greater one cm lytic component if bone documented by either ct mri imaging within six weeks signing consent
0, touch caring cancer dvd program cancer diagnosis asian
0, dacarbazine malignant adult intracranial hemangiopericytoma diagnosis absolute neutrophil count greater one five hundred mcl
0, everolimus stage iv renal cell cancer diagnosis concurrent zoledronate bone metastases hypercalcemia allowed provided therapy was initiated prior entry
0, fludarabine noncontiguous stage ii adult lymphoblastic lymphoma diagnosis highly active antiretroviral therapy haart is initiated within one month hematopoietic cell transplant
0, docetaxel metastatic pancreatic adenocarcinoma diagnosis creatinine equal less doc institutional uln creatinine clearance greater equal fifty ml min calculated cockcroft gault formula
0, pharmacological non resectable hepatocellular carcinoma diagnosis child pugh liver function class a
1, maleic acid recurrent adult burkitt lymphoma diagnosis clinically significant peripheral vascular disease
0, folic acid colorectal cancer diagnosis creatinine less doc mg dl
0, maleic acid childhood atypical teratoid rhabdoid tumor diagnosis no clinically significant unrelated systemic illness including serious infections significant cardiac pulmonary hepatic other organ dysfunction that would preclude participation
1, lactobacillus acidophilus probiotic unspecified adult solid tumor protocol specific diagnosis patients currently undergoing treatment above listed therapeutics at time initiation trial patients can have had prior treatment one more agents if they initiating new treatment another agent on list provided they have had at least two week washout period
1, azacitidine triple negative breast carcinoma diagnosis note
0, leucovorin stage ib esophageal cancer diagnosis alkaline phosphatase must be less uln
1, medical chart review prior cancer
1, laboratory biomarker analysis stage iii adult soft tissue sarcoma diagnosis known untreated central nervous system cns metastasis
0, gamma secretase inhibitor ro adult epithelioid sarcoma diagnosis absolute neutrophil count greater equal one five hundred mcl
0, interleukin anaplastic oligodendroglioma diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvic transaminase sgpt less two upper limits normal
0, cd cart lymphoma cell diagnosis eastern cooperative oncology group ecog performance status zero two expected survival greater six months
0, hydrocortisone butyrate propionate lymphoma diagnosis hematopoietic
1, gemcitabine recurrent adult burkitt lymphoma diagnosis patients that have other medical conditions that would contraindicate treatment aggressive chemotherapy
0, prednisone prostate cancer diagnosis patients must have normal organ marrow function defined below
1, rituximab active cns disease defined symptomatic meningeal lymphoma known cns parenchymal lymphoma
1, trastuzumab urethral cancer associated invasive bladder cancer diagnosis exposure any investigational drug within three weeks prior start dosing
0, carboplatin fallopian tube transitional cell carcinoma diagnosis patients must be entered within twelve weeks diagnostic staging surgery
0, doxorubicin stage iiic breast cancer diagnosis left ventricular ejection fraction lvef assessment must be performed within ninety days prior randomization lvef assessment performed by two dimensional echocardiogram is preferred however multi gated acquisition muga scan maybe substituted based on institutional preferences
0, levoleucovorin metastatic cancer diagnosis more three sites disease
1, fludarabine phosphate stage iv adult cell leukemia lymphoma diagnosis expected survival less six months
1, veliparib pontine glioma diagnosis hypertension
1, fosaprepitant cancer diagnosis patients drug abuse mental disease difficult communicate investigators
1, niacinamide stage ivc squamous cell carcinoma oropharynx diagnosis cardiac disease
1, rituximab small lymphocytic lymphoma diagnosis any condition including presence laboratory abnormalities which places subject at unacceptable risk if he she were participate confounds ability interpret data from study
1, rituximab stage grade one follicular lymphoma diagnosis any serious medical condition laboratory abnormality psychiatric illness that opinion investigator would prevent subject from providing written informed consent
1, liposomal doxorubicin recurrent primary peritoneal carcinoma diagnosis new york heart association functional classification ii iii iv
1, interleukin extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis known central nervous system involvement nhl
1, temozolomide glioblastoma diagnosis treatment prohibited concomitant medication defined section
1, dexamethasone phosphate splenic marginal zone lymphoma diagnosis patient is pregnant lactating
0, prednisolone lymphoma diagnosis initial disease bulk less ten cm
0, interferons melanoma diagnosis surgery
1, erlotinib hydrochloride metastatic colorectal cancer diagnosis requirement concurrent use antiviral agent sorivudine antiviral chemically related analogues such brivudine
0, antilymphocyte serum recurrent adult diffuse small cleaved cell lymphoma diagnosis written informed consent written informed consent unrelated donor is required participate optional studies
0, radiation protons brain tumors diagnosis both proton photon therapy possible from medical point view that is no standard indication protons standard indication example one time stereotaxy
0, erlotinib hydrochloride stage iii squamous cell carcinoma paranasal sinus nasal cavity diagnosis no cardiac arrhythmia
0, maytansine recurrent synovial sarcoma diagnosis patients must have lansky karnofsky performance status score greater equal fifty corresponding eastern cooperative oncology group ecog categories zero one two use karnofsky patients greater one years age lansky patients equal less one years age patients who unable walk because paralysis but who up wheelchair will be considered ambulatory purpose assessing performance score
0, bortezomib multiple myeloma diagnosis lower values allowed if they due marrow infiltration
1, vaccines pancreatic cancer diagnosis significant uncontrolled congestive heart failure chf myocardial infarction significant ventricular arrhythmias within last six months
1, antibodies monoclonal urethral urothelial carcinoma diagnosis subject has not recovered baseline common terminology criteria adverse events ctcae equal less grade one from toxicity due all prior therapies except alopecia other non clinically significant adverse events aes defined lab elevation no associated symptoms sequelae
1, carboplatin stage iv fallopian tube cancer diagnosis patients taking warfarin
0, vinblastine stage iv breast cancer diagnosis last radiation therapy within last four weeks before start therapy except palliative radiotherapy
0, albumin bound paclitaxel adenocarcinoma oesophago gastric junction diagnosis adequate renal function
0, gdc non hodgkin lymphoma solid cancers diagnosis documented willingness use an effective means contraception both men women while participating study
0, leukotriene antagonists breast cancer diagnosis platelets plt greater one hundred one hundred nine l
0, epacadostat stage iv primary peritoneal cancer diagnosis leukocytes greater equal three zero mcl
1, enzalutamide clear cell renal cell carcinoma diagnosis current use exogenous testosterone
1, laboratory biomarker analysis primary cutaneous anaplastic large cell lymphoma diagnosis have taken fish oil another dedicated three supplement sh seed from another source within last twenty eight days patients on multivitamins that contain three eligible
1, transplant conditioning recurrent hodgkin lymphoma diagnosis pulmonary disease
0, mycophenolate mofetil stage adult immunoblastic lymphoma diagnosis fhcrc matching allowed will be grades doc doc
1, regorafenib adenocarcinoma colon diagnosis prior use regorafenib
0, trastuzumab metastatic breast cancer diagnosis patient has adequate bone marrow reserve indicated by
0, fludarabine phosphate anaplastic large cell lymphoma diagnosis quantitative qualitative congenital platelet disorders including but not limited congenital amegakaryocytopenia absent radii syndrome glanzmann thrombasthenia
1, bibw afatinib active symptomatic brain metastases
1, carboplatin recurrent fallopian tube carcinoma diagnosis abdominal surgery laparotomy laparoscopy such colostomy enterostomy reversal interval secondary cytoreductive surgery second look surgery please consult chair prior patient entry any questions related classification surgical procedures
1, norethindrone ovarian cancer risk diagnosis hx bariatric surgery
1, antibodies monoclonal recurrent lymphoepithelioma nasopharynx diagnosis patients may not have received prior cetuximab therapy
0, hormones documented positive hormone receptor status er positive ve pgr positive ve primary metastatic tumor issue according local laboratory parameters
1, trastuzumab hertwo positive carcinoma breast diagnosis psychiatric illness social situations that would limit compliance requirements
0, butyric acid small intestine cancer diagnosis cardiovascular
1, cytochrome p cyp a inhibitors advanced non small cell lung cancer diagnosis concomitant medication contraindicated use itraconazole including but not limited to
0, antibodies monoclonal stage iii adult diffuse small cleaved cell lymphoma diagnosis absolute neutrophil count greater equal one five hundred mm three
0, rituximab lymphoma diagnosis a
0, epirubicin breast cancer diagnosis following patients will be ineligible
1, cyclophosphamide breast cancer diagnosis thrombotic embolic events such stroke transient ischemic attack within past six months
1, liposomal doxorubicin ovarian serous cystadenocarcinoma diagnosis history myocardial infraction unstable angina within six months
0, liver extracts liver cancer diagnosis patients scheduled resection three more liver segments any indication without other planned procedures
1, everolimus glucagonoma diagnosis highly effective contraception methods include combination any two following
1, pazopanib liposarcoma diagnosis unable unwilling discontinue use prohibited medications at least fourteen days five half lives drug whichever is longer prior first dose drug duration treatment
1, phenylephrine stomatitis diagnosis open sores wound ulcerations oral cavity
0, lenalidomide stage iv adult lymphoblastic lymphoma diagnosis able collect greater equal doc ten six cdthirty four positive kg cell transplantation
1, abiraterone acetate prior chemotherapy prostate cancer except if administered adjuvant neoadjuvant setting
0, erlotinib hydrochloride recurrent inverted papilloma paranasal sinus nasal cavity diagnosis doc mg dl any ast
1, ck stereotactic accelerated partial breast irradiation invasive ductal carcinoma diagnosis patients collagen vascular diseases
1, fosaprepitant stage iii squamous cell carcinoma hypopharynx diagnosis vomiting within twenty four hours prior cisplatin infusion
1, mycophenolic acid hepatosplenic cell lymphoma diagnosis total bilirubin greater two upper limit normal
1, bevacizumab lung cancer diagnosis cardiac dysrhythmias nci ctcae grade greater two within last two days
0, cryotherapy immunosuppressive therapies current treatment cancer
1, albumin bound paclitaxel squamous non small cell lung cancer diagnosis adequate hepatic renal function defined as
0, paclitaxel recurrent fallopian tube carcinoma diagnosis patients must not be eligible higher priority gynecologic oncology group gog protocol if one exists general this would refer any active gog phase iii protocol same patient population
0, dmuc a incurable locally advanced metastatic disease which no standard therapy exists consisting unresectable pancreatic ductal adenocarcinoma including recurrence previously resected disease that is considered unresectable curative intent
0, epirubicin breast cancer diagnosis other tests may be performed clinically indicated
0, docetaxel stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis no significant traumatic injury within past twenty one days
0, dcc tablet cancers met genomic alterations diagnosis able swallow tablets
0, cyclophosphamide metastatic cancer evaluable disease
0, irinotecan patients must have histologically confirmed adenocarcinoma colon rectum
1, autologous tumor cell cpg vaccine colorectal neoplasms diagnosis prior radiation greater twenty five marrow
1, fludarabine recurrent childhood anaplastic large cell lymphoma diagnosis current serious systemic illness that would result increased risk csf mobilization harvest peripheral blood stem cells pbsc
1, everolimus metastatic prostate carcinoma diagnosis lack availability patient immunological clinical follow up assessment
0, melphalan recurrent adult soft tissue sarcoma diagnosis no other medical psychosocial problems which opinion primary physician principal investigator would place patient at unacceptable risk from this regimen
0, pharmacological recurrent adult hepatocellular carcinoma diagnosis at least three half lives must have elapsed since prior therapy that included monoclonal antibody
1, hydrocortisone b cell lymphoma unclassifiable features intermediate between diffuse large cell lymphoma burkitt lymphoma diagnosis patients who have clinically active hepatitis virus infection not eligible note
0, paclitaxel metastatic pancreatic cancer diagnosis patients must have recovered from side effects any major surgery at start treatment
1, aminopterin human mammary carcinoma diagnosis dementia other altered mental status that would prevent patient from understanding giving informed consent limit her ability follow requirements
0, hormones prostate cancer diagnosis no brain metastases
0, antibodies monoclonal prostate cancer diagnosis no concurrent medication support platelet count oprelvekin
0, metronidazole stage iii gastric cancer diagnosis see disease characteristics
1, gossypol acetic acid adult glioblastoma diagnosis patients serious concurrent infection medical illness which would jeopardize ability patient receive treatment outlined this protocol reasonable safety examples medical illnesses but not limited following
0, succinylcholine cervical adenocarcinoma diagnosis patients must have signed an approved informed consent authorization permitting release personal health information
1, insulin globin zinc lymphoma diagnosis patients who develop blood glucose greater two hundred thirty five mg dl after admission will be eligible enrollment based on following
0, laboratory biomarker analysis recurrent midline lethal granuloma paranasal sinus nasal cavity diagnosis dyspnea less grade two at rest on room air
1, vidarabine recurrent childhood small noncleaved cell lymphoma diagnosis infection hiv
0, endothelial growth factors recurrent melanoma diagnosis willing return enrolling institution follow up two four weeks after treatment discontinuation
0, fludarabine cutaneous cell non hodgkin lymphoma diagnosis there must be no uncontrolled infections active acute chronic illnesses such diabetes angina myocardial ischemia cardiac arrhythmia venous thrombosis embolism cerebrovascular disease seizure disorder psychiatric illness other intercurrent illness that is not well controlled is anticipated be difficult control during proposed therapy
0, vidarabine noncontiguous stage ii small lymphocytic lymphoma diagnosis no serious uncontrolled psychiatric illness
1, dexamethasone acetate prior hormones radiation chemotherapy prostate cancer
1, capecitabine stage ivc thyroid gland medullary carcinoma diagnosis history severe hypersensitivity reaction capecitabine five fu temozolomide dtic will be excluded anaphylaxis anaphylactoid reactions
1, cetuximab metastatic colorectal cancer diagnosis pregnant breast feeding women
0, paclitaxel metastatic transitional cell cancer renal pelvis ureter diagnosis all patients must be informed investigational nature this must sign an informed consent accordance institutional federal guidelines
0, melphalan multiple myeloma diagnosis disease characteristics
1, carboplatin ovarian brenner tumor diagnosis only applies patients who elect receive bevacizumab
1, aurolase therapy primary metastatic lung tumors diagnosis subjects evidence an active bacterial infection fever greater three doc Âºc ten doc Âºf within three days first scheduled day dosing
1, fulvestrant hertwo negative breast cancer diagnosis surgical axillary staging procedure prior entry
1, standard postpartum tubal ligation ovarian cancer diagnosis preterm delivery less thirty six weeks gestation
1, cd tk transduced donor lymphocytes lymphoma non hodgkin diagnosis medications treatments not allowed
1, conventional wound closure stoma closure technic diagnosis evidence any other disease metabolic dysfunction physical examination finding laboratory finding giving reasonable suspicion disease condition that puts patient at high risk treatment related complications
1, expanded prostate cancer index composite sf prostate cancer diagnosis prior radiation therapy prostate lower pelvis
0, fluorouracil neoplasm metastasis diagnosis if participant is reproductive potential must agree use medically approved contraceptive precautions during three months following last dose drug
1, methylprednisolone diffuse large cell lymphoma diagnosis previous treatment chemotherapy radiotherapy
1, cyclosporins refractory multiple myeloma diagnosis ongoing radiotherapy
0, carboplatin non small cell lung cancer diagnosis ecog ps zero two
1, carboplatin large cell lung carcinoma diagnosis history bleeding diathesis coagulopathy
1, questionnaire administration head neck cancer diagnosis prior concurrent therapy
0, camptothecin recurrent breast cancer diagnosis hormone receptor status
0, antibodies recurrent salivary gland cancer diagnosis efavirenz
0, endocrine therapy breast cancer diagnosis newly diagnosed disease
1, vincristine contiguous stage ii grade one follicular lymphoma diagnosis positive serology hepatitis hc defined positive test hcab
1, paclitaxel peritoneal neoplasms diagnosis prior radiotherapy
0, mycophenolic acid stage iv adult lymphoblastic lymphoma diagnosis high risk crone example but not limited to
1, fludarabine phosphate stage iii childhood large cell lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
0, epothilones distal urethral cancer diagnosis no ventricular dysrhythmia
1, cognitive assessment recurrent small cell lung cancer diagnosis patients who have not recovered less common terminology criteria adverse events ctcae grade two toxicities related prior therapy not eligible participate this study
1, rituximab stage iii grade three follicular lymphoma diagnosis patient donor infected human immunodeficiency virus hiv
0, thalidomide multiple myeloma diagnosis creatinine clearance grater equal forty ml min estimated calculated
0, doxorubicin ovarian cancer diagnosis aspartate aminotransferase ast alanine transaminase alt less doc upper normal limit institution normal range
0, cyclophosphamide stage mantle cell lymphoma diagnosis mcl patients hbsag negative but hbcab positive regardless hbsab status should have hepatitis virus hbv deoxyribonucleic acid dna testing done protocol eligibility determined follows
0, pemetrexed previously untreated stage iv non squamous non small cell lung cancer diagnosis female subjects who not childbearing potential fertile female subjects childbearing potential who agree use adequate contraceptive measures who not breastfeeding who have negative serum urine pregnancy test within seventy two hours prior start treatment
1, immunoglobulin g adult giant cell glioblastoma diagnosis transmural myocardial infarction within one hundred eighty days six months prior registration
1, prednisone previous treatment anti myeloma therapy does not include radiotherapy bisphosphonates single short course steroid less equivalent dexamethasone forty mg day four days
0, pomalidomide myeloma diagnosis measured by twenty four hour urine collection estimated by cockcroft gault formula
0, capecitabine histologically proven metastatic her two negative breast cancer part two only
1, taxane ovarian cancer diagnosis any dermatological condition that opinion investigator will affect absorption medication atopic dermatitis etc
1, bevacizumab carcinoma non small cell lung diagnosis anticoagulation at treatment therapeutic doses
0, cisplatin advanced esophageal squamous carcinoma diagnosis wbcgreater four zero mmthree absolute neutrophil count greater zero mmthree plateletgreater one hundred zero mmthree hbgreater nineg dl within seven days before enrollment
0, methotrexate contiguous stage ii adult burkitt lymphoma diagnosis life expectancy greater six months
1, epirubicin triple negative breast cancer diagnosis levf less fifty muga scan echocardiography
0, erlotinib hydrochloride stage iib pancreatic cancer diagnosis serum total bilirubin equal less twice institutional upper limit normal uln within twenty one days registration on within twenty one days prior day one chemotherapy post surgery those patients having started chemotherapy prior first step registration
1, antibodies stage iv skin melanoma diagnosis active infection requiring parenteral antibiotics
1, anastrozole female breast carcinoma diagnosis prior hematopoietic stem cell bone marrow transplantation
1, albumin bound paclitaxel squamous cell carcinoma penis usual type diagnosis nonsquamous malignancy penis
1, hormones tumors diagnosis radiation therapy within four weeks start drug
0, bevacizumab stage iib non small cell lung carcinoma diagnosis patients must not have received following
0, maleic acid recurrent nasopharyngeal keratinizing squamous cell carcinoma diagnosis fertile patients must use effective contraception
1, etoposide phosphate refractory childhood hodgkin lymphoma diagnosis karnofsky score less sixty pediatric criteria
0, paclitaxel adenocarcinoma gastroesophageal junction diagnosis acceptable hematologic status of
1, prednisolone phosphate classical hodgkin lymphoma diagnosis significant concurrent uncontrolled medical condition which may represent risk patient
0, precise treatment liver neoplasms diagnosis voluntarily participate agree sign informed consent form
0, gadobutrol malignant adult intracranial hemangiopericytoma diagnosis subject must sign specific informed consent
0, rh il lymphoma diagnosis absolute neutrophil count greater equal one five hundred mm three platelets greater equal one zero mm three
1, entospletinib sdd follicular lymphoma diagnosis concurrent participation an investigational drug trial therapeutic intent
1, albumin bound paclitaxel pancreatic cancer diagnosis is pregnant breastfeeding expecting conceive father children within projected duration trial starting screening visit through one hundred twenty days after last dose trial treatment
0, gemcitabine bladder cancer diagnosis no sensory neuropathy grade three four no prior peripheral neuropathy grade two worse other
0, antibodies large cell lung cancer diagnosis no concurrent full dose anticoagulants low molecular weight unfractionated heparin warfarin
1, sirolimus estrogen receptor positive breast cancer diagnosis doc five one doc twenty nine
1, antibodies monoclonal stage ivb nasal cavity paranasal sinus squamous cell carcinoma diagnosis patients may not be receiving any other investigational agents
0, ef known suspected non small cell lung cancer patients without histologically cytologically documented non small cell lung cancer nsclc must be estimated by their physician have at least seventy five probability having nsclc probability malignancy will be predicted on basis known probabilities individual clinical characteristics using bayesian model
1, carboplatin epithelial ovarian cancer diagnosis this does not include atrial fibrillation
1, cytarabine classical hodgkin lymphoma diagnosis hiv positive
0, fludarabine noncontiguous stage ii grade three follicular lymphoma diagnosis patients blast crisis bc must receive therapy must achieve accelerated phase ap chronic phase cp order be eligible patients who remain bc not eligible
1, pancreatin metastatic pancreatic adenocarcinoma diagnosis surgery within twenty eight days treatment some exceptions minor procedures
1, antibodies recurrent primary peritoneal carcinoma diagnosis right bundle branch block positive left anterior hemiblock bi fascicular block
1, busulfan recurrent adult lymphoblastic lymphoma diagnosis patient unable give informed consent
0, fludarabine myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis acute leukemia less ten blasts
1, calcium dietary resectable pancreatic cancer diagnosis carbamazepine phenobarbital
1, carmustine hepatosplenic cell lymphoma diagnosis uncontrolled diabetes mellitus
1, albumin bound paclitaxel stage iiib non small cell lung cancer diagnosis patients untreated brain metastases should be excluded from this clinical trial however patients who have stable brain disease should be off corticosteroids at least three weeks after completion appropriate therapy eligible
1, lenograstim recurrent grade three follicular lymphoma diagnosis an acute medical condition resulting from prior chemotherapy
1, hormones prostate neoplasms diagnosis active uncontrolled autoimmune disease that may require corticosteroid therapy during study
1, dasatinib multiple myeloma diagnosis patient agrees that iv bisphosphonates will be withheld first eight weeks dasatinib therapy due risk hypocalcemia
1, sunitinib stage iiic fallopian tube cancer diagnosis use agents proarrhythmic potential terfenadine quinidine procainamide disopyramide sotalol probucol bepridil haloperidol risperidone indapamide flecainide is not permitted during study
0, letrozole stage iv breast cancer diagnosis patients must not have history abdominal fistula intra abdominal abscess within six months prior registration
1, antibodies monoclonal solid tumor diagnosis bevacizumab specific exclusions arms b
0, dexamethasone recurrent childhood anaplastic large cell lymphoma diagnosis doc mg dl male patients thirteen less sixteen years
1, cisplatin recurrent nasal cavity paranasal sinus squamous cell carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition mk one thousand seven hundred seventy five cisplatin
1, docetaxel stage iva verrucous carcinoma oral cavity diagnosis patients may not be receiving any other investigational agents
1, sorafenib carcinoma hepatocellular diagnosis urine protein creatinine upc ratio greater doc twenty four hour urine protein will need be obtained level should be less two thousand mg patient enrollment
0, oxaliplatin stage iiia gallbladder cancer diagnosis measurable non measurable disease will be allowed
0, hormones participants must have operable breast cancer tumors greater equal two cm size participants must not have any evidence metastatic disease
0, mycophenolate mofetil stage ii contiguous adult diffuse large cell lymphoma diagnosis donor
0, bevacizumab lung cancer diagnosis creatinine clearance greater forty five ml min
0, liposomal doxorubicin primary peritoneal serous adenocarcinoma diagnosis defined disease that has progressed by imaging while receiving platinum had recurrence within six months last receipt platinum based chemotherapy rising caone hundred twenty five only is not considered platinum resistant refractory disease
0, bb multiple myeloma diagnosis hemoglobin greater ten dl
1, fluorouracil stage ivb colon cancer diagnosis subjects who opinion investigator may not be able comply safety monitoring requirements will be excluded
1, temozolomide glucagonoma diagnosis serious non healing wound active ulcer untreated bone fracture
0, estradiol breast cancer diagnosis serum creatinine less doc times uln
1, pentetic acid colon cancer diagnosis participants whom enrollment would significantly delay greater two weeks scheduled standard care therapy
0, sirolimus stage multiple myeloma diagnosis absolute neutrophil count greater one zero mm three
0, chemotherapy breast cancer diagnosis more two weeks since prior no concurrent regular use any following
0, antibodies monoclonal recurrent neuroblastoma diagnosis recurrent progressive disease at any time prior enrollment
0, management therapy complications fitbit zip portable pedometer device malignant gastrointestinal neoplasm diagnosis histologically cytologically confirmed gastrointestinal peritoneal malignancy
1, cyclosporine myelodysplastic myeloproliferative neoplasms diagnosis previous history congestive heart failure allowed
0, fluciclovine f cancer prostate diagnosis i
0, gemcitabine pancreatic cancer diagnosis serum bilirubin less doc mg dl
1, therapeutic conventional surgery stage iiia fallopian tube cancer diagnosis patients who had within past six months cardiovascular accident cva at risk arterial thrombus such severe peripheral vascular disease pvd carotid artery disease cad
1, folic acid rectal neoplasms diagnosis second primary malignancy
0, succinylcholine infiltrating bladder urothelial carcinoma associated urethral carcinoma diagnosis patients known hypersensitivity chinese hamster ovary cell products other recombinant human antibodies not eligible
0, fludarabine stage iii childhood large cell lymphoma diagnosis following diseases will be permitted although other diagnoses can be considered if approved by pcc participating institutions patient review committees principal investigators
0, trastuzumab histologically cytologically confirmed breast carcinoma greater one suspected known parenchymal brain metastases which surgical resection biopsy is clinically indicated
1, lenograstim stage ivb uterine sarcoma diagnosis patients who pregnant nursing
0, temozolomide adult gliosarcoma diagnosis female patients childbearing potential defined follows
1, antibodies monoclonal pancreatic insulinoma diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior enrollment anticipation need major surgical procedure during course study
1, etoposide recurrent adult burkitt lymphoma diagnosis myocardial infarction within six months prior enrollment has new york heart association nyha class iii iv heart failure uncontrolled angina severe uncontrolled ventricular arrhythmias electrocardiographic evidence acute ischemia active conduction system abnormalities
0, isophosphamide mustard myxofibrosarcoma diagnosis platelet count greater equal one hundred zero ul note
0, vidarabine somatic psychiatric disorder making patient unable sign informed consent
1, antibodies stage ia esophageal cancer diagnosis significant vascular disease aortic dissection aortic aneurysm
0, sirolimus adult glioblastoma diagnosis at least twenty eight days since prior investigational agent cytotoxic therapy
1, questionnaire cancer diagnosis on inpatient service expected scheduled inpatient admission hospitalized
0, vaccines stage ic ovarian epithelial cancer diagnosis prothrombin time pt international normalized ratio inr equal less doc
1, vaccines ovarian clear cell cystadenocarcinoma diagnosis immunocompromised patients patients known be human immunodeficiency virus hiv positive currently receiving antiretroviral therapy note
0, fluorouracil stage iv gastric cancer diagnosis this protocol met high will be defined as
1, zoledronic acid prostate cancer diagnosis patients who have received prior treatment systemic corticosteroids within past twelve months
1, antibodies colorectal neoplasms diagnosis chemotherapy radiation therapy immunotherapy within four weeks before entry six weeks nitrosoureas
1, bevacizumab stage iiia colon cancer diagnosis gastrointestinal tract disease resulting an inability take oral medication requirement iv alimentation prior surgical procedures affecting absorption active peptic ulcer disease
1, tacrolimus peripheral cell lymphoma diagnosis donor
0, quality life assessment breast cancer diagnosis who performance status ps zero three karnofsky ps zero zerozero
0, topotecan aids related diffuse large cell lymphoma diagnosis performance status
1, carboplatin bladder cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition palbociclib carboplatin cisplatin
1, bortezomib recurrent adult lymphoblastic lymphoma diagnosis patients who have previously received bortezomib other proteasome inhibitors not eligible
0, hydroxyurea recurrent mucoepidermoid carcinoma oral cavity diagnosis no psychiatric illness social situation that would preclude compliance
1, folic acid lung cancer diagnosis if you qualify personnel will explain trial detail answer any questions you may have
0, heparin low molecular weight myeloma diagnosis patients men women aged more eighteen years
0, cyproterone prostate cancer diagnosis no other concurrent hormonal therapy
0, levoleucovorin stage ivb rectal cancer diagnosis ptt less forty seconds
1, fluorouracil stage iv pancreatic cancer diagnosis uncontrolled systemic disease like active infections
0, interleukin multiple myeloma diagnosis patient must have adequate bone marrow function total wbc greater two zero ul hgb greater seven mg dl platelet count greater fifty zero ul unless this abnormality is believed be due underlying disease
0, masitinib gastro intestinal stromal tumour diagnosis male female patient age greater eighteen years
1, dexamethasone acetate known cns involvement by multiple myeloma
1, mycophenolic acid recurrent adult non hodgkin lymphoma diagnosis addition cytotoxic agents cytoreduction exception hydroxyurea imatinib mesylate will not be allowed within two weeks initiation conditioning
1, fulvestrant stage iv breast cancer diagnosis documented cardiomyopathy
0, fludarabine phosphate refractory plasma cell myeloma diagnosis donors must consent be eligible undergo granulocyte colony stimulating factor gcsf mobilization pbsc harvest marrow is not allowed source stem cells on this study
1, mycophenolate mofetil refractory lymphoplasmacytic lymphoma diagnosis any cord blood units without full maternal testing negative results hepatitis b hiv human lymphotropic virus htlv one viruses
1, cyclosporins stage iii adult cell leukemia lymphoma diagnosis history brain metastases
0, romidepsin stage iv breast cancer diagnosis sign separate consent form which outlines lack efficacy observed prior studies
1, immunoglobulins splenic marginal zone lymphoma diagnosis creatinine ratio greater doc twenty four hour urine protein should be obtained level should be less one thousand mg patient enrollment
0, erlotinib hydrochloride cancer diagnosis adequate baseline laboratory assessments including
1, thalidomide stage iv mantle cell lymphoma diagnosis inability comply follow up testing procedures
0, oxaliplatin extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis no more three prior treatment regimens follows
0, fes pet epithelial ovarian cancer diagnosis no history other er positive malignancies
0, everolimus renal cell carcinoma diagnosis must have consenting sibling matched at six six human leukocyte antigen hla antigens b dr
0, endothelial growth factors recurrent renal cell carcinoma diagnosis at least thirty days since prior no other concurrent investigational agents
0, pertuzumab stage iii rectal cancer diagnosis no evidence left ventricular wall motion abnormalities measured by echo muga scan
1, oxaliplatin patients clinical situation growing teratoma normal declining markers radiographic clinical progression should be considered surgery
1, carboplatin head neck cancer diagnosis age less eighteen years
1, midazolam tumors diagnosis participants unwilling exclude grapefruit juice grapefruit from their diet
0, carfilzomib multiple myeloma diagnosis age mass kg seventy two creatinine mg dl
0, quality life assessment stage breast cancer diagnosis dieli conwright at baseline visit
1, poly adp ribose polymerase inhibitors recurrent childhood brain stem glioma diagnosis total bilirubin sum conjugated positive unconjugated less doc times institutional upper limit normal uln age
1, sirolimus brain central nervous system tumors diagnosis hiv positive patients receiving anti retroviral therapy excluded from due possibility pk interactions temsirolimus however patients will not be routinely screened hiv
0, fluorouracil esophageal cancer diagnosis no coagulopathy bleeding disorder
0, antibodies monoclonal recurrent squamous cell carcinoma hypopharynx diagnosis ast alt less doc times uln
1, camptothecin advanced solid neoplasm diagnosis concomitant administration strong inhibitors inducers cypthreeafour should be avoided medications that enhance glucuronidation phenytoin phenobarbital carbamazepine rifampin etc
0, fludarabine metastatic cancer that express mage athree hla aone antigen diagnosis chemistry
1, tacrolimus recurrent childhood anaplastic large cell lymphoma diagnosis cardiac ejection fraction less thirty five ejection fraction is required if age greater fifty years there is history anthracycline exposure history cardiac disease
1, conventional surgery stage verrucous carcinoma larynx diagnosis serum creatinine greater two mg
1, dasatinib recurrent adult brain neoplasm diagnosis unstable angina congestive heart failure requiring hospitalization within past six months
0, busulfan myelodysplastic myeloproliferative neoplasms diagnosis scheduled undergo peripheral blood stem cell transplantation from suitable hla matched mismatched unrelated donor determined by treating physician
0, endothelial growth factors cervical adenosarcoma diagnosis eastern cooperative oncology group ecog performance status ps zero one
1, mitomycin neoplasms by site diagnosis known suspected reduced bladder capacity
1, nelfinavir stage ib pancreatic cancer diagnosis patients recognized acquired hereditary congenital immunodeficiency disease including cellular immunodeficiency hypogammaglobulinemia dysgammaglobulinemia
0, bortezomib noncontiguous stage ii grade three follicular lymphoma diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvate transaminase sgpt less two times upper limit normal uln
0, immunoglobulins extraocular extension melanoma diagnosis no active chronic infection hepatitis c
1, epirubicin other prior malignancy except curatively treated basal cell skin cancer carcinoma situ cervix
0, folic acid metastatic colorectal cancer diagnosis life expectancy greater twelve weeks
1, p prior radiation therapy chemotherapy biologic targeted anticancer agents within four weeks drug administration
0, doxorubicin stage iii adult diffuse mixed cell lymphoma diagnosis ability read understand sign written informed consent approved by each institutional irb
1, niacinamide recurrent progressive optic pathway gliomas opg diagnosis patients any non healed wounds
0, cyclosporine lymphoma diagnosis alkaline phosphatase no greater three times upper limit normal uln
1, laboratory biomarker analysis hertwo positive breast cancer diagnosis baseline qtcf greater four hundred fifty msec male qtcf greater four hundred seventy msec female
1, capecitabine advanced recurrent esophageal squamous cell carcinoma diagnosis pregnant lactating women
0, liposomal doxorubicin sarcoma diagnosis not specified life expectancy
0, prednisolone lymphoma non hodgkin diagnosis one hundred forty mg mtwo iv day two
1, fludarabine recurrent adult lymphoblastic lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
0, antibodies monoclonal recurrent adult brain tumor diagnosis urine protein urine creatinine
0, docetaxel unspecified adult solid tumor protocol specific diagnosis not specified performance status
1, fludarabine anaplastic large cell lymphoma diagnosis donor
0, carboplatin solid tumors diagnosis no myelosuppressive chemotherapy less equal two weeks four weeks if prior nitrosourea
0, tacrolimus stage iii adult diffuse mixed cell lymphoma diagnosis complete cytogenetic remission
1, atorvastatin calcium recurrent hodgkin lymphoma diagnosis patients fungal pneumonia radiological progression after receipt amphotericin formulation mold active azoles greater one month
0, dexamethasone diffuse large cell lymphoma diagnosis more ninetyg l
0, antibodies stage ii pancreatic cancer diagnosis protein less one on twenty four hr urine collection
1, tesla mri rectal neoplasms diagnosis contraindications sevent mri
1, flucytosine adult anaplastic astrocytoma diagnosis patient is allergic five fc leucovorin five fu
0, bevacizumab fallopian tube cancer diagnosis patients must have an intraperitoneal ip port place
0, ifosfamide unspecified adult solid tumor protocol specific diagnosis not specified hematopoietic
0, gemcitabine pancreatic cancer diagnosis no inadequate hepatic function within two weeks prior randomization evidenced by following
1, folic acid subjects will have pre cancerous colorectal polyp diagnosis any excessive bleeding clotting disorder if you taking blood thinners
1, laboratory biomarker analysis metastatic endometrioid adenocarcinoma diagnosis john wort not permitted within two weeks prior start treatment duration treatment copanlisib
0, tomotherapy patients whom surgery is deemed an appropriate option standard care isolated lung metastasis from sarcoma isolated liver metastasis from colon cancer but who refuse surgical therapy eligible
0, cisplatin head neck cancer diagnosis more twelve weeks
1, cyclosporins malignant lymphoma large cell type diagnosis active central nervous system malignancy
0, etoposide refractory mediastinal thymic large cell cell lymphoma diagnosis measurable disease at least one lesion greater equal doc cm diameter detected by pet ct
0, telephone based intervention cancer survivor diagnosis peer mentor eligibility
0, antilymphocyte serum childhood nasal type extranodal nk cell lymphoma diagnosis patients will be eligible clinical trial under following conditions
0, bb stage multiple myeloma diagnosis ecog three allowed patients bone pain due mm
0, gemcitabine stage ia pancreatic cancer diagnosis creatinine levels equal less twice institutional upper limit normal within twenty one days registration on within twenty one days prior day one chemotherapy post surgery those patients having started chemotherapy prior first step registration
0, fludarabine phosphate non hodgkin lymphoma diagnosis able comply requirements care after allogeneic stem cell transplantation
0, mycophenolate mofetil stage iv marginal zone lymphoma diagnosis must have received failed frontline therapy patients must have had prior autologous transplant were not eligible autologous transplant planned tandem transplants allowed patients at high risk relapse
0, oxaliplatin age greater equal eighteen years provide uniform oncologic phenotype adult onset colorectal cancer
1, tacrolimus angioimmunoblastic cell lymphoma diagnosis patient rapidly progressive aggressive nhl unless minimal disease state
1, management therapy complications stage iv adult hodgkin lymphoma diagnosis these survivors will however have full access website if they have completed required baseline assessment they will be asked also complete follow up assessments
1, carboplatin breast cancer diagnosis previous treatment mtor inhibitors carboplatin cisplatin oxaliplatin
1, fludarabine refractory multiple myeloma diagnosis expected survival less six months
0, cyclosporins secondary central nervous system hodgkin lymphoma diagnosis cytogenetic abnormalities addition ph positive
1, steroids recurrent high grade gliomas diagnosis laboratory results sustained at
0, etanidazole adult subependymoma diagnosis no unstable angina pectoris
0, paclitaxel lung cancer diagnosis sufficiently fluent willing complete quality life questionnaires
1, albumin bound paclitaxel advanced gastric cancer diagnosis legal incapacity
0, gemcitabine adult rhabdomyosarcoma diagnosis is post menopausal
1, rituximab lung who grade iii iv liver kidney creatinine greater two mg dl got positive gpt bilirubin three uln except caused by lymphoma
0, gallium nitrate granulocyte count at least seven hundred fifty mmthree platelet count at least fifty zero mmthree hemoglobin at least doc dl unless bone marrow infiltrated by lymphoma hepatic
1, cat lymphoma diagnosis pregnant breast feeding females
0, pemetrexed genital neoplasms female diagnosis patients must receive one thousand mcg vitamin btwelve injection seven days prior receiving first treatment pemetrexed
0, epothilones recurrent gallbladder cancer diagnosis no unstable angina pectoris
1, hiv protease inhibitors stage iia pancreatic cancer diagnosis lovastatin simvastatin
1, isophosphamide mustard adult supratentorial primitive neuroectodermal tumor pnet diagnosis all patients their parents legal guardians must sign written informed consent
0, docetaxel ovarian neoplasms diagnosis agree be compliant requirements
0, fluorouracil neoplasms breast diagnosis fifty ml min
0, erlotinib hydrochloride stage iii renal cell cancer diagnosis serum bilirubin less doc institutional upper limits normal
1, atorvastatin calcium recurrent aggressive adult non hodgkin lymphoma diagnosis patients who refuse be treated on conventional autologous allogeneic hct protocol
0, capecitabine pancreatic cancer diagnosis no concurrent dipyridamole allopurinol
0, tpi prostate cancer diagnosis must be able read understand sign informed consent
1, fludarabine phosphate aggressive non hodgkin lymphoma diagnosis fungal infections radiological progression after receipt amphotericin formulation mold active azoles greater one month
1, immunoglobulin g ovarian mucinous adenocarcinoma diagnosis patients clinically significant proteinuria urine protein should be screened by urine protein creatinine ratio upcr upcr has been found correlate directly amount protein excreted twenty four hour urine collection specifically upcr doc is equivalent doc gram protein twenty four hour urine collection obtain at least four ml random urine sample sterile container does not have be twenty four hour urine send sample lab request urine protein creatinine levels separate requests lab will measure protein concentration mg dl creatinine concentration mg dl upcr is derived follows
1, assessment therapy complications stage ib breast cancer diagnosis known bleeding disorders
0, bb recurrent childhood gliomatosis cerebri diagnosis alanine aminotransferase alt serum glutamate pyruvate transaminase sgpt
1, niacinamide synovial sarcoma diagnosis pregnancy nursing
1, albumin bound paclitaxel cervical adenosquamous carcinoma diagnosis nursing women
0, antibodies recurrent mantle cell lymphoma diagnosis total bilirubin equal less two uln mg dl if abnormal direct bilirubin equal less doc uln
0, paclitaxel lung cancer diagnosis lvef greater fifty patients significant cardiac history even if controlled
0, hydroxyurea myelodysplastic myeloproliferative neoplasms diagnosis eighteen over
0, vinblastine stage iv endometrial carcinoma diagnosis female patients must not be pregnant due potential mutagenicity teratogenicity this treatment pregnancy test must be administered seven days prior administration therapy women childbearing potential patients must agree use some form contraception while on this at initiation duration participation sexually active males must also use reliable appropriate method contraception post menopausal women must be amenorrheic at least twelve months be considered nonchildbearing potential
0, cyclophosphamide stage iv adult diffuse large cell lymphoma diagnosis myelodysplasia mds
0, etoposide phosphate recurrent adult grade iii lymphomatoid granulomatosis diagnosis all participants must be registered into mandatory revassist program be willing able comply requirements revassist
0, mycophenolic acid cancer diagnosis no fungal infection without radiographic evidence improvement during continued antifungal therapy
1, poly i c sarcoma diagnosis history severe allergic reactions any unknown allergens any components drugs
1, mycophenolic acid extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis twenty six whole lung s
0, topotecan central nervous system tumors diagnosis patient characteristics
1, niacinamide metastatic prostate cancer diagnosis poorly controlled hyperglycemia
1, olaparib recurrent gastric carcinoma diagnosis patient has experienced any arterial thrombotic events including but not limited myocardial infarction transient ischemic attack cerebrovascular accident unstable angina within six months prior enrollment
0, cisplatin according local institutional definition using either psixteen immunohistochemistry human papillomavirus hpv testing
0, laboratory biomarker analysis stage iv primary peritoneal cavity cancer diagnosis alt ast equal less three times upper limit normal
0, carboplatin epithelial ovarian cancer diagnosis cytored
1, sorafenib soft tissue sarcoma diagnosis concomitant treatment ketoconazole itraconazole ritonavir rifampicin st
1, fludarabine phosphate recurrent grade one follicular lymphoma diagnosis mediastinum forty gy
0, mesna multiple myeloma diagnosis children unable perform pulmonary function tests less seven years old pulse oximetry greater equal ninety two on room air
1, zoledronic acid prostate cancer diagnosis clinically significant ascites nyha iii iv cardiac failure clinically relevant pathologic findings ecg
0, metronidazole stage iiia fallopian tube cancer diagnosis hematology biochemistry laboratory results within limits normally expected patient population without evidence major organ failure
0, hydroxyurea astrocytoma diagnosis thrombocytes greater eight doc zero Âµl be controlled once week
1, antibodies monoclonal recurrent digestive system neuroendocrine tumor gone diagnosis patients on an active liver transplant list considered likely receive liver transplant equal less six months following registration
1, esophagogastroduodenoscopy subjects severe symptomatic dysphagia unable pass solids
1, dexamethasone multiple myeloma diagnosis patient has greater equal grade two peripheral neuropathy within fourteen days before enrollment
1, erlotinib hydrochloride stage iiib colon cancer diagnosis john wort saquinavir telithromycin tipranavir ritonavir verapamil voriconazole
1, oxaliplatin metastatic cancer diagnosis prior concurrent therapy
1, metronidazole stage iv fallopian tube cancer diagnosis known hepatitis hepatitis hiv
0, temozolomide adult gliosarcoma diagnosis patients must not be on chronic coumadin therapy prior medical problems cardiac valve prophylaxis this is due presumed interaction coumadin zarnestra leading significant increase inr patients who develop have recently developed deep venous thrombosis pulmonary embolism who on will take coumadin will be allowed participate however investigator should be prepared monitor patients inr closely
1, lyophilized black raspberry lozenge stage iii squamous cell carcinoma oropharynx diagnosis inability grant informed consent
0, paclitaxel advanced indolent non hodgkin lymphoma diagnosis group one
1, calcium dietary mucinous adenocarcinoma colon diagnosis uncontrolled intercurrent illness including but not limited to
1, tacrolimus stage iv adult hodgkin lymphoma diagnosis patients who not candidate an unrelated donor allogeneic hsct based on current institutional bone marrow transplant bmt program clinical practice guidelines organ function criteria will be utilized per current institutional bmt program clinical practice guidelines there will be no restriction entry based on hematological parameters
1, dabrafenib braf mutant melanoma diagnosis patients intra cardiac defibrillators permanent pacemakers
1, mycophenolic acid recurrent diffuse large cell lymphoma diagnosis must have received prior chemotherapy consolidation chemotherapy by autografting prior nonmyeloablative hct is permitted
1, accelarated radiotherapy schedule breast cancer diagnosis psychiatric addictive disorders which preclude obtaining informed consent adherence protocol
1, sirolimus fallopian tube cancer diagnosis patients an active bleeding diathesis on oral anti vitamin medication except low dose coumadin
0, cortisol succinate malignant tumor breast diagnosis inr international normalized ratio less two
1, cisplatin carcinoma squamous cell diagnosis hbs positive
1, akt inhibitor mk stage iva gallbladder cancer diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible because potential pharmacokinetic interactions azdsix thousand two hundred forty four hydrogen sulfate mk two thousand two hundred six addition these patients at increased risk lethal infections when treated marrow suppressive therapy appropriate studies will be undertaken patients receiving combination antiretroviral therapy when indicated
0, dexamethasone childhood central nervous system yolk sac tumor diagnosis patients who unable walk because paralysis but who up wheelchair will be considered ambulatory purpose assessing ps
0, camptothecin recurrent childhood medulloblastoma diagnosis presence malignant pleural effusion
1, leucovorin stage ib gastric cancer diagnosis patients history hypertension must measure less one hundred fifty ninety mmhg be on stable regimen anti hypertensive therapy patients history hypertension who have blood pressure one hundred fifty ninety mmhg greater not eligible patients history hypertension who have blood pressure less one hundred fifty ninety mmhg but not on stable regimen anti hypertensive therapy not eligible
0, tamoxifen breast cancer diagnosis wbc greater three zero mcl
0, prostvac v f prostatic neoplasms diagnosis subjects must be able start drug within ninety days after surgery
0, trastuzumab breast cancer diagnosis no pre existing clinically significant renal disease that is not related malignancy
1, bb multiple myeloma relapse diagnosis negative eligible
1, bendamustine hydrochloride multiple myeloma diagnosis pregnant breast feeding females
1, anastrozole breast carcinoma diagnosis pregnant breastfeeding
1, liposomal doxorubicin recurrent primary peritoneal carcinoma diagnosis rash must cover less ten body surface area bsa
0, rituximab stage iii grade two follicular lymphoma diagnosis serum creatinine equal less doc mg dl
1, maleic acid prior invasive malignancy except non melanomatous skin cancer unless disease free greater equal three years example carcinoma situ breast oral cavity cervix all permissible
0, folic acid stage iva colorectal cancer diagnosis serum creatinine equal less doc uln lab measured calculated creatinine clearance greater equal thirty ml min
0, melphalan nodal marginal zone cell lymphoma diagnosis low high risk disease first second cr greater patients whom risks an allogeneic transplant outweigh benefits
1, lenalidomide myeloma diagnosis patients who have not collected hematopoietic progenitors potential candidates autologous transplantation
1, ilorasertib unresectable malignant neoplasm diagnosis subject has had major surgery within twenty eight days prior day one
1, vaccines vulvar cancer diagnosis received marketed hpv vaccine participated an hpv trial
1, prolactin release inhibiting factors prostate cancer diagnosis evidence suspicion myelodysplastic syndrome by complete blood test cbc must be confirmed by bone marrow biopsy
0, immunoglobulins stage iii mantle cell lymphoma diagnosis waldenstrom macroglobulinemia
1, melphalan recurrent grade one follicular lymphoma diagnosis known hypersensitivity thalidomide
0, capecitabine recurrent pancreatic cancer diagnosis documentation disease radiographic staging
0, cyclophosphamide recurrent grade two follicular lymphoma diagnosis calculated creatinine clearance greater equal sixty ml min measured creatinine clearance greater equal sixty ml min by two hour urine collection if creatinine greater equal doc history renal dysfunction
1, pemetrexed lung neoplasms diagnosis eye inflammation eye infection not fully treated conditions predisposing subject this
0, irinotecan stage iii rectal cancer diagnosis unstable angina
1, adjuvant chemotherapy only esophageal squamous cell carcinoma diagnosis pregnancy women childbearing potential men who sexually active not willing able use medically acceptable forms contraception
0, misonidazole sufficiently healthy undergo cancer treatment
0, liposomal doxorubicin carcinoma diagnosis transaminases sgot sgpt may be up doc institutional upper limit normal uln if alkaline phosphatase is less equal uln alkaline phosphatase may be up four uln if transaminases less equal uln
0, flt ligand protein stage iiic uveal melanoma diagnosis hemoglobin greater nine dl
0, interferon gamma osteosarcoma diagnosis aspartate transaminase ast alanine transaminase alt less equal doc fold upper limit normal uln
1, copper stage iia gastric cancer diagnosis patients may not be receiving any other investigational agents
0, antibodies monoclonal recurrent osteosarcoma diagnosis twenty one days must have elapsed from infusion last dose antibody toxicity related prior antibody therapy must be recovered grade equal less one
1, vitro expanded autologous invariant natural killer t cells malignant melanoma diagnosis pregnant nursing women
0, isophosphamide mustard lymphoma diagnosis age
1, interferon alpha peritoneal carcinomatosis diagnosis patients on systemic immunosuppressive agents including steroids
0, silicon lymphoma diagnosis xeroderma pigmentosum
0, oxaliplatin stage ii breast cancer diagnosis prior capecitabine allowed provided patient tolerated three thousand five hundred mg mÂ² seven days out fourteen days
0, questionnaire administration bladder cancer diagnosis no prior hyperbaric oxygen therapy excluding treatment decompression illness
1, isophosphamide mustard pericytic neoplasm diagnosis coronary artery bypass graft surgery
1, focal brachytherapy localized prostate cancer diagnosis image favour crossing capsule based on pre implantation multimodal mri stage ttwo mri only
1, bendamustine hydrochloride t cell lymphoma diagnosis presence active infection within seventy two hours treatment
0, antibodies patients history peritoneal carcinomatosis not eligible
0, mycophenolate mofetil recurrent adult immunoblastic large cell lymphoma diagnosis waldenstrom macroglobulinemia failed one standard regimen
1, doxorubicin low grade fibromyxoid sarcoma diagnosis lactating females not eligible unless they have agreed not breastfeed their infants during treatment period one month following completion treatment
1, trastuzumab metastatic breast cancer diagnosis pregnant lactating women
1, mycophenolate mofetil stage iv cutaneous cell non hodgkin lymphoma diagnosis marrow donors who have increased anesthetic risk
1, antibodies monoclonal glioblastoma multiforme diagnosis new york heart association nyha grade ii greater congestive heart failure
0, irinotecan esophageal cancer diagnosis no coagulopathy bleeding disorder
1, bortezomib multiple myeloma plasma cell neoplasm diagnosis no known macular degeneration retinopathy diabetic otherwise porphyria psoriasis
1, stereotactic ablative radiotherapy sabr pancreatic neoplasm diagnosis contra indications mri since no safety data doc five tesla mri scanners available on electronic devices such pacemakers implanted defibrillators deep brain stimulators cochlear implants this constitutes an absolute contraindication this even devices that have been considered safe mri scans higher field strengths
1, cediranib intraocular lymphoma diagnosis patients may not be receiving any other investigational agents
0, alemtuzumab recurrent grade three follicular lymphoma diagnosis patients eligible following an autologous transplant remission relapse
0, stereotactic body radiation therapy sbrt melanoma diagnosis one lesion that can be biopsied before treatment sbrt msbten thousand four hundred forty five
1, poly adp ribose polymerase inhibitors medulloblastoma diagnosis total bilirubin sum conjugated positive unconjugated less equal doc times institutional upper limit normal uln age
1, erlotinib hydrochloride solid tumors diagnosis have known immediate delayed hypersensitivity reaction idiosyncrasy drugs chemically related drug excipients dimethyl sulfoxide dmso
0, everolimus extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis willingness return mayo clinic enrolling institution follow up
0, alvespimycin hydrochloride stage iv adult hodgkin lymphoma diagnosis performance status
0, erlotinib hydrochloride recurrent esthesioneuroblastoma paranasal sinus nasal cavity diagnosis metastatic unresectable disease meets one following criteria
1, lee gastrointestinal cancer diagnosis patients unwilling unable comply protocol
1, i tenatumomab pancreatic neoplasm diagnosis murine antibodies treated patients
1, breast mri breast cancer diagnosis patients myocardial infarction within six months entry
0, fluorouracil colorectal neoplasms diagnosis absence any psychological familial sociological geographical condition potentially hampering compliance protocol follow up schedule those conditions should be discussed subject before registration trial
0, prednisolone phosphate lymphoma diagnosis endocrine therapy
0, dexamethasone phosphate cholangiocellular carcinoma icc diagnosis confirmation diagnosis must be made at mskcc at participating institution prior initiating protocol therapy
1, cetuximab metastatic colorectal cancer diagnosis well controlled type diabetes allowed
1, epz advanced solid tumors phase one diagnosis females must not be lactating pregnant at screening baseline documented by negative beta human chorionic gonadotropin beta hcg test minimum sensitivity twenty five iu equivalent units beta hcg
0, antibodies monoclonal stage iv renal cell cancer diagnosis ptt inr less doc unless receiving full dose warfarin part two only
1, antibodies monoclonal stage adult diffuse small cleaved cell lymphoma diagnosis positive cross match exists between donor recipient
0, survey administration stage iiic breast cancer diagnosis cardiac conduction disturbances
1, sorafenib brain tumor diagnosis patients who have history hbv hcv infection eligible however they must receive prophylactic antiviral therapy one two weeks prior receiving drug
1, trastuzumab stage iva cervical cancer diagnosis active unstable cardiovascular disease cardiac disease requiring drug device intervention history coronary artery disease congestive heart failure
1, immunoglobulins grade threeb follicular lymphoma diagnosis has known history human immunodeficiency virus hiv hiv one two antibodies
0, biologic sample preservation procedure brain central nervous system tumors diagnosis not specified
0, cyclosporine stage iv renal cell cancer diagnosis low grade nh negative less six month duration complete remission cr between courses conventional therapy
1, endothelial growth factors stage iiia uterine sarcoma diagnosis cardiovascular function specifically patient may not have
0, erlotinib hydrochloride lung cancer diagnosis platelet count greater one hundred zero mmÂ³
0, antibodies monoclonal gliosarcoma diagnosis must be able undergo mri imaging
0, temozolomide brain central nervous system tumors diagnosis must be maintained on stable decreasing corticosteroid regimen no increase seven days prior start treatment
0, bleomycin lymphoma diagnosis left ventricular ejection fraction lvef greater equal fifty serum creatinine less twomg dl serum bilirubin less twomg dl
0, liposomal doxorubicin breast cancer diagnosis eastern cooperative oncology group ecog performance status zero one within one days entry
0, vinorelbine hertwo negative metastatic breast cancer diagnosis which cannot be adequately treated by operation radiotherapy on its own
1, capecitabine colorectal cancer metastatic diagnosis uncontrolled hypertension defined systolic blood pressure greater one hundred forty mmhg diastolic pressure greater ninety mmhg measured on three consecutive pre enrollment assessments despite optimal medical management
0, liposomal doxorubicin recurrent neuroblastoma diagnosis no significant end organ dysfunction that would compromise tolerability decitabine interfere procedures results
0, cisplatin lymphoma non hodgkin diagnosis biochemistry
1, laboratory biomarker analysis stage iv verrucous carcinoma larynx diagnosis calcium channel blockers
0, iodine i lung cancer diagnosis poor left ventricular function defined an ejection fraction forty less
0, dexamethasone phosphate multiple myeloma diagnosis they must commit continued abstinence from heterosexual intercourse begin two acceptable methods birth control one highly effective method one additional effective method used at same time beginning at least four weeks before initiation revlimid treatment
1, o benzylguanine glioblastoma diagnosis patients who human immunodeficiency virus hiv positive
0, fludarabine phosphate stage grade two follicular lymphoma diagnosis patients equal less fifty years age who have received previous high dose transplantation not require patient review committee approvals all children less two years must be discussed fhcrc principal investigator pi brenda sandmaier md two six million six hundred seventy four thousand nine hundred sixty one prior registration
1, bortezomib previous cancer therapy hormonal therapy surgery less four weeks prior registration
0, carboplatin ovarian stromal cancer diagnosis no history allergic reactions attributed compounds similar chemical biological composition temsirolimus
0, liposomal doxorubicin plasmacytomas on tissue biopsy
1, vidarabine stage iv cutaneous cell non hodgkin lymphoma diagnosis any current central nervous system cns involvement disease refractory intrathecal chemotherapy
1, diphosphonates refractory multiple myeloma diagnosis patients who pregnant breast feeding will be excluded
0, immunoglobulins recurrent squamous cell carcinoma larynx diagnosis no unstable angina pectoris
1, topotecan recurrent ovarian carcinoma diagnosis john wort kava ephedra ma huang gingko biloba dehydroepiandrosterone dhea yohimbe saw palmetto ginseng
0, antibodies stage iii squamous cell carcinoma larynx diagnosis no gastrointestinal gi tract disease resulting an inability take oral medication
0, bendamustine hydrochloride lymphoma non hodgkin diagnosis all participants must be willing be registered into mandatory revlimid rems program after completion induction chemoimmunotherapy prior maintenance therapy be willing able comply requirements revlimid rems program
0, temozolomide childhood atypical teratoid rhabdoid tumor diagnosis alt less one hundred ten l
1, o benzylguanine glioma diagnosis known diagnosis human immunodeficiency virus hiv infection hiv testing is not mandatory
0, aldesleukin kidney cancer diagnosis no concurrent active infections requiring antibiotic therapy
0, ispinesib recurrent childhood grade iii lymphomatoid granulomatosis diagnosis voriconazole
0, liposomal doxorubicin progesterone receptor positive breast cancer diagnosis all included patients must have normal cardiac function defined by an ejection fraction greater fifty no decrease wall motion by echocardiogram
1, cyclosporine noncontiguous stage ii adult burkitt lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
1, sputum collection tumors diagnosis suffering from severe blood coagulation disorders
0, everolimus unspecified adult solid tumor protocol specific diagnosis platelets greater equal one hundred zero cells mm three
1, liposomal doxorubicin stages ii iii breast cancer diagnosis history severe hypersensitivity reaction nab paclitaxel
1, vorinostat recurrent grade one follicular lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition vorinostat
1, dacarbazine glioblastoma diagnosis aa progression during first two months standard temozolomide therapy five two 
0, mycophenolate mofetil stage iii multiple myeloma diagnosis acute myeloid leukemia aml high risk cytogenetics del fiveq five del sevenq seven abnormal threeq nineq elevenq twentyq twenty oneq sevenp six
1, cyclosporine splenic marginal zone lymphoma diagnosis donors less twelve years age
0, bevacizumab colorectal cancer diagnosis no prior chemotherapy metastatic disease except adjuvant therapy that was completed greater six months before first evidence metastasis
1, magnetic resonance imaging recurrent breast cancer diagnosis patients who have had prior systemic chemotherapy not eligible study
0, i h tumors other dsrct patients must have history tumor progression recurrence failure achieve complete response standard therapy less twenty chance long term disease free survival
0, thalidomide unspecified adult solid tumor protocol specific diagnosis no preexisting peripheral neuropathy grade two greater
0, niacinamide adult glioblastoma diagnosis no significant traumatic injury within past twenty one days
0, liposomal doxorubicin unspecified childhood solid tumor protocol specific diagnosis patients who currently receiving another investigational drug not eligible
1, recombinant human interleukin recurrent skin carcinoma diagnosis hiv positive patients
1, prednisone multiple myeloma diagnosis one variety other types end organ dysfunctions can occasionally occur lead need therapy
0, albumin bound paclitaxel ewing sarcoma diagnosis no evidence active graft vs
0, irinotecan stage ivb colon cancer diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamic pyruvate transaminase sgpt equal less doc iuln if there known liver metastases sgot sgpt must be equal less five iuln these results must be obtained within twenty eight days prior registration
0, sirolimus osteosarcoma diagnosis alanine aminotransferase aspartate aminotransferase less doc upper limit normality uln
0, bevacizumab uterine corpus carcinosarcoma diagnosis doc
1, igimrt gy fractions ovarian cancer diagnosis existing cortical bone destruction where orthopedic stabilization would be required
1, antibodies recurrent grade two follicular lymphoma diagnosis medical condition that would contraindicate allogeneic transplantation
1, antibodies stage iv childhood anaplastic large cell lymphoma diagnosis fertile men women unwilling use contraceptives during up twelve months post treatment
0, mycophenolic acid stage iv grade one follicular lymphoma diagnosis must have failed two courses therapy
0, doxorubicin lymphoma diagnosis creatinine no greater doc times uln
1, fluorouracil anal carcinoma diagnosis psychological familial sociological geographical condition that would preclude compliance
1, sorafenib metastatic osteosarcoma diagnosis patients undergoing renal dialysis
1, topotecan recurrent ovarian carcinoma diagnosis new york heart association classification iii iv
0, melphalan neuroblastoma diagnosis not pregnant nursing
0, camptothecin stage iv adult hodgkin lymphoma diagnosis no leukemia
0, bronchoscopy myelodysplastic myeloproliferative neoplasms diagnosis no preexisting chest disease
0, tacrolimus stage adult burkitt lymphoma diagnosis complete disappearance all known disease exception persistent scan abnormalities unknown significance term unconfirmed is defined scan abnormalities unknown significance that not biopsied otherwise evaluated
1, standard care taking active cancer treatment
1, paclitaxel stage ic fallopian tube cancer diagnosis coli derived drug preparations pegfilgrastim filgrastim csf
1, estrogen antagonists postmenopausal women advanced breast cancer diagnosis chemotherapy metastatic locoregional recurrent disease
1, ifosfamide recurrent diffuse large cell lymphoma diagnosis uncontrolled autoimmune hemolytic anemia idiopathic thrombocytopenic purpura itp resulting evidenced by declining platelet hemoglobin hgb levels within four weeks prior first dose drug
1, oral impact head neck cancer diagnosis persons deprived liberty under guardianship
1, vaccines contiguous stage ii adult lymphoblastic lymphoma diagnosis planned immunosuppression alemtuzumab any equivalent vivo cell depleting agent
1, albumin bound paclitaxel breast cancer diagnosis willingness ability comply scheduled visits treatment plan laboratory tests other procedures necessary participation this clinical trial
1, stereotactic ablative radiotherapy metastasis malignant neoplasm lymph node diagnosis severe active comorbidities which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety adverse events protocol limit compliance requirements defined follows
0, succinylcholine stage iiia ovarian cancer diagnosis albumin greater equal doc dl
0, vincristine pretext stage two hepatoblastoma diagnosis total bilirubin less doc upper limit normal uln age
1, sativex head neck squamous cell carcinoma diagnosis positive result presence hepatitis surface antigen hepatitis virus antibodies human immunodeficiency virus antibodies
1, cva breast cancer diagnosis pregnancy breastfeeding
1, s gastric cancer diagnosis pregnant lactating females
1, carboplatin esophageal neoplasms diagnosis chemotherapy epirubicin oxaliplatin carboplatin cisplatin docetaxel less six months before entry
0, mart antigen intraocular melanoma diagnosis no prior radiotherapy spleen
1, iodine renal cell carcinoma diagnosis exposure murine proteins chimeric antibodies within last five years
1, lenalidomide plasmacytoma diagnosis any following because this involves an agent that has known genotoxic mutagenic teratogenic effects
1, laboratory biomarker analysis stage iva oral cavity squamous cell carcinoma diagnosis although there no known adverse effects black raspberries upon fetus if patients become pregnant during period lyophilized black raspberries lbr administration then lbr will be discontinued patient will be removed from we should however emphasize given this is food based that risks likely extremely low even though participant should become pregnant such we not recommending active contraception women but rather if participants become pregnant that they notify their doctor that they will likely be removed from there no expected logical risks if men were father child such no contraception will be recommended men
1, immunoconjugates refractory hodgkin lymphoma diagnosis other concurrent chemotherapy immunotherapy radiotherapy any ancillary therapy considered investigational utilized non food drug administration fda approved indication context research investigation
1, dexamethasone acetate multiple myeloma diagnosis pregnant breastfeeding females
0, vidarabine lymphoma diagnosis fractionated total body irradiation ftbi etoposide patients aml all cml accelerated phase
1, rituximab follicular lymphoma diagnosis infection hepatitis hepatitis human immunodeficiency virus hiv
1, laboratory biomarker analysis prior active malignancies other curatively treated situ carcinoma cervix uterus basal cell squamous cell carcinoma skin
1, albumin bound paclitaxel history symptomatic chf grade greater three by nci ctcae class greater ii by new york heart association nyha criteria
1, cisplatin mesothelioma diagnosis doc
0, piperazine citrate anaplastic astrocytoma diagnosis biopsy proven
1, vaccines ovarian serous cystadenocarcinoma diagnosis ankylosing spondylitis
0, vincristine pretext stage three hepatoblastoma diagnosis three less sixteen years
1, laboratory biomarker analysis gastrinoma diagnosis left ventricular ejection fraction lvef assessed by two dimensional two echocardiogram echo less fifty lower limit normal whichever is higher two multiple gated acquisition scan muga less forty five lower limit normal whichever is higher
0, etoposide lymphoma diagnosis age
0, cyclophosphamide thymic carcinoma diagnosis concurrent corticosteroids myasthenia gravis other paraneoplastic syndromes other chronic conditions allowed
0, dexamethasone phosphate recurrent childhood cerebellar astrocytoma diagnosis not pregnant nursing
1, mycophenolate mofetil nodal marginal zone cell lymphoma diagnosis donor
1, procarbazine hodgkin lymphoma diagnosis serological positivity hbv hcv hiv
1, levothyroxine neoplasms diagnosis hyperthyroidism
0, polystyrene sulfonic acid lymphoma diagnosis female only is not pregnant negative serum urine pregnancy test be conducted within seven days prior admission transplant
1, sorafenib carcinoma hepatocellular diagnosis child pugh index class combination more slight ascites hepatic encephalopathy greater grade see child pugh index appendix four
1, sorafenib lung cancer diagnosis known human immunodeficiency virus hiv infection chronic hepatitis c
1, laboratory biomarker analysis recurrent malignant neoplasm diagnosis concurrent uncompensated hypothyroidism thyroid dysfunction within seven days before first dose treatment
1, pancreatin bile duct cancer diagnosis preexisting asthma
1, panobinostat recurrent grade one follicular lymphoma diagnosis major surgery equal less four weeks prior registration have not recovered from side effects such therapy
1, vincristine recurrent childhood lymphoblastic lymphoma diagnosis note
0, alvespimycin hydrochloride untreated metastatic squamous neck cancer occult primary diagnosis pt normal
0, fatigue inventory stage iii adult cell leukemia lymphoma diagnosis patients significant cardiovascular disease including myocardial infarction unstable angina within six months unstable cardiac arrhythmias not eligible study
1, thalidomide extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis pregnant breast feeding females lactating females must agree not breast feed while taking lenalidomide
0, anastrozole patients must have completed either breast conserving surgery total mastectomy negative margins appropriate axillary staging negative margin is defined no evidence tumor ductal carcinoma situ dcis at line resection additional operative procedures may be performed obtain clear margins
1, ag d cik digestive system neoplasms diagnosis known history human immunodeficiency virus hiv hepatitis virus hcv treponemapallidun tp infection
0, allostim sarcoma diagnosis no psychiatric addictive disorders other condition that opinion investigator would preclude participation
1, methylprednisolone hemisuccinate childhood diffuse large cell lymphoma diagnosis participation another investigational drug clinical trial
0, fludarabine intraocular melanoma diagnosis serum creatinine doc mg dl less total bilirubin doc mg dl less alanine transaminase aspartic transaminase alt ast less threex institutional upper limit normal uln
1, endothelial growth factors fallopian tube clear cell adenocarcinoma diagnosis no metastases brain stem midbrain pons medulla cerebellum within ten mm optic apparatus optic nerves chiasm
1, immunoglobulins ovarian serous cystadenocarcinoma diagnosis ctcae grade two greater peripheral vascular disease at least brief less two hrs episodes ischemia managed non surgically without permanent deficit
1, albumin bound paclitaxel peritoneal neoplasms diagnosis pregnancy breast feeding
0, bibw plus tmz histologically confirmed who grade iii iv malignant glioma that is recurrent after prior chemoradiotherapy
0, romidepsin carcinoma small cell diagnosis patients must have had no chemotherapy biologic therapy radiation therapy their malignancy at least thirty days prior treatment
1, bevacizumab glioblastoma multiforme diagnosis concurrent anti coagulation anti platelet medication including aspirin non steroidal anti inflammatory agents cyclooxygenase two cox two inhibitors
0, sorafenib liver cancer diagnosis patients slight mild limitation activity they comfortable rest mild exertion
1, pembrolizumab carcinoma non small cell lung diagnosis subject is pregnant breast feeding
0, topotecan lymphoma diagnosis other
0, oxaliplatin colorectal cancer diagnosis no prior chemotherapy advanced disease
0, nivolumab incurable hpv sixteen solid tumors defined tumors which not curable by salvage approaches including resection re irradiation
0, albumin bound paclitaxel ovarian cancer diagnosis pre menopausal women must have negative pregnancy test before entry agree use medically acceptable method contraception throughout treatment period at least six weeks after treatment discontinuation
1, camptothecin solid tumor diagnosis subjects marked baseline prolongation qt qtc interval qtc interval greater equal four hundred seventy msec females qtc interval greater equal four hundred fifty msec males
1, albumin bound paclitaxel recurrent squamous cell carcinoma nasopharynx diagnosis clinically significant gastrointestinal bleeding uncontrolled peptic ulcer disease
1, sildenafil citrate glioblastoma diagnosis contraindication antiangiogenic agents including
0, azacitidine recurrent adult diffuse large cell lymphoma diagnosis absolute neutrophil count greater one five hundred mm three
0, albumin bound paclitaxel bronchoalveolar cell lung cancer diagnosis cerebrovascular accident within past six months
1, albumin bound paclitaxel concurrent medical conditions which may increase risk toxicity including ongoing active infection history significant bleeding disorder unrelated cancer congenital bleeding disorders acquired bleeding disorders within one year hiv positive
1, tacrolimus childhood nasal type extranodal nk cell lymphoma diagnosis left ventricular ejection fraction less thirty five
0, everolimus bladder cancer diagnosis understand sign written informed consent
1, allostim colorectal cancer diagnosis all infections must be resolved patient must remain afebrile seven days without antibiotics prior being placed on study
0, dexamethasone phosphate multiple myeloma diagnosis prior treatment four days less total four hundred mg prednisone an equivalent potency another steroid mm will not be considered regimen
0, carboplatin arenfive hundred thirty four uses guideline that wilms tumor single lesion one cm greater contralateral kidney multiple lesions any size contralateral kidney should be treated on synchronous bilateral wilms tumor stratum patients an isolated lesion less one cm contralateral kidney should be treated on appropriate unilateral wilms tumor on unilateral wilms tumor contralateral nephrogenic rest stratum this if they have not undergone nephrectomy under one year age
0, razoxane stage iiia breast cancer diagnosis creatinine no greater doc times uln
0, lapatinib a tumor lesion that can be readily biopsied using core needle via clinical exam ultrasound ct fluoroscopic guidance
0, sirolimus lymphoma diagnosis creatinine clearance greater seventy ml min
0, liposomal doxorubicin histologically proven soft tissue sarcoma pulmonary metastases which radical metastasectomy is feasible eligible subtypes
1, paclitaxel stage iii pancreatic cancer diagnosis arm cohort two
1, calypso beacon implantation non small cell lung cancer nsclc diagnosis patients enrolled any other clinical studies investigator believes be conflict this investigation
0, fludarabine phosphate skin cancer diagnosis willing sign durable power attorney
1, talaporfin colorectal neoplasms diagnosis known uncontrollable serious reactions such anaphylaxis contrast agents used this study
0, doxorubicin stage iii adenoid cystic carcinoma oral cavity diagnosis no known brain metastases
0, on na ovarian cancer diagnosis measurable disease will be defined lesions that can be accurately measured at least one dimension longest diameter greater twenty mm using conventional techniques greater ten mm spiral ct scan
1, will be assigned based on molecular profile rpma patients symptomatic cns metastasis
0, fialuridine nasopharyngeal cancer diagnosis anthracyclines example doxorubicin pegylated doxorubicin
1, mycophenolic acid stage iv adult burkitt lymphoma diagnosis donor centers who will exclusively donate marrow
1, cyclophosphamide stage adult diffuse mixed cell lymphoma diagnosis presence uncontrolled psychiatric disorder
0, radiopharmaceuticals neuroendocrine tumors net diagnosis ninety years age
1, immunoglobulin g history leptomeningeal carcinomatosis
1, gemcitabine cancer breast diagnosis subjects who receiving immunosuppressive myelosuppressive medications that would opinion investigator increase risk serious neutropenic complications
1, antibodies monoclonal regional neuroblastoma diagnosis females childbearing potential must have negative pregnancy test
0, fluorouracil signet ring adenocarcinoma rectum diagnosis previously untreated patients
0, octreotide gastrointestinal carcinoid tumor diagnosis karnofsky thirty one hundred life expectancy
0, observation sarcoma
0, mesna renal tumors diagnosis hepatic
1, dexamethasone phosphate participant has peripheral neuropathy neuropathic pain grade two higher defined by national cancer institute common terminology criteria adverse events nci ctcae version four
1, everolimus b cell lymphoma diagnosis impaired hepatic renal function demonstrated by any following laboratory values
1, paclitaxel stage iii iv recurrent endometrial cancer diagnosis concurrent treatment immunosuppressive investigational agents
1, antibodies monoclonal prior chemotherapy lymphoma endocrine therapy
0, gemcitabine lung cancer diagnosis progressive disease after one prior gemcitabine containing chemotherapy regimen stage iii iv nsclc must have achieved at least once partial response complete response stable disease during therapy
0, interferon alpha colorectal cancer diagnosis no evidence residual disease after surgery
1, gemcitabine active bleeding pathologic condition that confers high risk bleeding tumor involving major vessels known varices
0, paclitaxel fallopian tube neoplasms diagnosis females aged greater eighteen years
1, trametinib soft tissue sarcoma diagnosis pregnant currently breastfeeding
0, vidarabine recurrent childhood small noncleaved cell lymphoma diagnosis unrelated donors who prospectively
0, fludarabine metastatic malignant neoplasm brain diagnosis serum alanine aminotransferase alt aspartate aminotransferase ast equal less doc times upper limit normal
1, rituximab recurrent mantle cell lymphoma diagnosis creatinine greater doc mg dl
0, antibodies stage iii lymphoepithelioma oropharynx diagnosis no significant ongoing active infection
1, cisplatin endometrial cancer diagnosis patients renal dysfunction chronic acute kidney disease renal failure which opinion treating physician would make treatments prescribed on unreasonably hazardous patient
1, cyclosporine noncontiguous stage ii adult lymphoblastic lymphoma diagnosis active recent prior six months invasive fungal infection without id consult approval
1, everolimus marginal zone cell lymphoma diagnosis active central nervous system malignancy
1, mycophenolic acid stage iv adult immunoblastic large cell lymphoma diagnosis uncontrolled viral bacterial infection at time enrollment
0, bevacizumab recurrent adult primary liver cancer diagnosis no abdominal fistula gi perforation intra abdominal abscess within past twenty eight days
0, ganciclovir melanoma skin diagnosis at least four weeks since prior chemotherapy six weeks nitrosoureas melphalan mitomycin recovered no concurrent antineoplastic chemotherapy endocrine therapy
1, albumin bound paclitaxel breast cancer diagnosis these potential risks may also apply other agents used this study
0, antibodies monoclonal stage iic colon cancer diagnosis patients must not have had invasive procedures defined follows
0, camptothecin recurrent rectal cancer diagnosis group i
1, antibodies monoclonal colorectal cancer diagnosis intake st
0, image guided radiation therapy unspecified adult solid tumor protocol specific diagnosis if metastatic site is within two cm either kidney creatinine level must be less doc times upper limit normal uln
1, romidepsin recurrent grade two follicular lymphoma diagnosis history life threatening allergic reactions attributed agents used study
0, cyclophosphamide lymphoma diagnosis renal
1, fludarabine phosphate recurrent childhood lymphoblastic lymphoma diagnosis donor centers who will exclusively donate marrow
1, tailored health partnership program gastric cancer diagnosis dyspnea
0, gemcitabine stage iv non small cell lung cancer diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transferase sgot alanine aminotransferase alt serum glutamate pyruvate transferase sgpt equal less doc institutional upper limit normal
1, tocopherols head neck neoplasms diagnosis ast greater doc institutional upper limit normal uln
0, gemcitabine stage iv pancreatic cancer diagnosis absolute neutrophil count anc greater one thousand five hundred cells mm three
1, pfk cancer diagnosis patients any other concurrent uncontrolled illness including mental illness substance abuse which may interfere ability patient cooperate participate trial other examples such conditions would include copd diabetes mellitus that has required two more hospitalizations last year severe peripheral vascular disease poorly controlled auto immune conditions recent serious trauma
1, vidarabine noncontiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis whole brain thirty gy enrollment patients who previously receive higher allowed dose radiation small volume lungs liver brain will be determine by discretion radiation oncologist on study
0, bb myelodysplastic myeloproliferative neoplasms diagnosis no concurrent illegal drugs
1, thalidomide ds stage plasma cell myeloma diagnosis patients allergic lenalidomide biaxin dexamethasone
0, isophosphamide mustard choriocarcinoma diagnosis documentation disease
0, cyclophosphamide embryonal tumor abundant neuropil true rosettes diagnosis patients must have received prior radiation before current recurrence unless patient is less thirty six months old at diagnosis has progressed after at least one upfront chemotherapy regimen which case no prior radiation is required
0, mutation analysis breast cancer diagnosis enrolled on clinical trial swog eight thousand eight hundred ninety seven
0, cisplatin lung neoplasms diagnosis tfour category patients pleural pericardial effusion multiple nodules same lobe excluded
1, immunoglobulins recurrent adult immunoblastic large cell lymphoma diagnosis patient life expectancy is severely limited by diseases other malignancy
1, albumin bound paclitaxel glucagonoma diagnosis exposure any investigational drug within three weeks prior start dosing
0, cyproterone prostate cancer diagnosis life expectancy greater ten years
0, antibodies cancer breast diagnosis patients previously treated patients no measurable disease patients metastatic disease will be excluded
0, pemetrexed lung cancer malignant pleural mesothelioma diagnosis ability understand willing sign written informed consent participate including donation diagnostic biopsy tissue research
0, camptothecin recurrent colon cancer diagnosis creatinine clearance greater sixty ml min
1, tremelimumab prostate cancer diagnosis mental impairment that may compromise ability give informed consent comply requirements study
1, immunoglobulin fc fragments squamous cell carcinoma head neck diagnosis major surgery within four weeks prior day one patients must have recovered completely from any previous surgery prior day one
1, trametinib cancer diagnosis history evidence current greater class ii congestive heart failure defined by new york heart association nyha one thousand nine hundred ninety four appendix three note
1, carboplatin high grade ovarian serous adenocarcinoma diagnosis patients known brain metastases should be excluded from this clinical trial
0, celecoxib esophageal cancer diagnosis ast alt less doc times upper limit normal uln
0, melphalan thymic carcinoma diagnosis myelodysplastic syndrome mds that is refractory medical management cytogenetic abnormalities predictive transformation into acute leukemia including five negative seven negative monosomy seven trisomy eight de novo primary therapy related secondary mds refractory anemia refractory anemia ringed sideroblasts only
1, thalidomide multiple myeloma diagnosis known history allergy contributable compounds containing boron mannitol
1, external beam radiation therapy cervical adenocarcinoma diagnosis other diseases
1, pharmacological recurrent adult brain tumor diagnosis patients taking drug that can prolong qt interval if potential patient is taking one prohibited drugs but he can safely stop it then washout period greater equal seven days is required prior starting bafetinib
0, antilymphocyte serum small intestine cancer diagnosis see disease characteristics
0, fluorouracil breast cancer diagnosis hematopoietic
0, bevacizumab hepatosplenic cell lymphoma diagnosis patients must be willing able review understand provide written consent before starting therapy
1, antibodies monoclonal patients who received systemic steroids within one week entry except patients on maintenance steroid therapy non cancerous disease
0, carboplatin large cell lung cancer diagnosis more three weeks since prior major surgery
0, antibodies monoclonal melanoma skin diagnosis minimum one measurable lesion defined as
1, paclitaxel endometrial adenosquamous carcinoma diagnosis uncontrolled hypertension defined systolic greater one hundred forty mmhg diastolic greater ninety mm hg
1, irinotecan stage iva colon cancer diagnosis patients on full dose anticoagulants eligible provided patient has been on stable dose at least two weeks low molecular weight heparin warfarin has an inr range two three aspirin doses greater threetwo mg po daily not allowed
0, interferons multiple myeloma plasma cell neoplasm diagnosis other
0, rituximab stage iv grade one follicular lymphoma diagnosis prior rituximab other monoclonal immunotherapy permitted eligible rituximab monotherapy
1, doxorubicin human epidermal growth factor two negative carcinoma breast diagnosis hypersensitivity allergy metformin
0, sunitinib pancreatic neuroendocrine tumors diagnosis platelet count greater equal one hundred zero Î¼l
1, antibodies monoclonal alk positive anaplastic large cell lymphoma diagnosis evidence current uncontrolled cardiovascular conditions including cardiac arrhythmias congestive heart failure chf angina electrocardiographic evidence acute ischemia active conduction system abnormalities
0, fluorouracil esophageal cancer diagnosis bilirubin less doc upper limit normal
1, antibodies recurrent marginal zone lymphoma diagnosis pregnancy
1, mycophenolic acid stage iii adult burkitt lymphoma diagnosis patients medical history noncompliance haart medical therapy
1, carboplatin head neck cancer diagnosis unstable angina pectoris cardiac arrhythmia
1, lenalidomide plasma cell myeloma diagnosis known gastrointestinal gi disease gi procedure that could interfere oral absorption tolerance ixazomib including difficulty swallowing
0, dexamethasone phosphate liver cancer diagnosis uncontrolled hypertension defined systolic blood pressure bp greater one hundred fifty mm hg diastolic bp greater one hundred mm hg on antihypertensive medications
1, carboplatin erbbtwo positive stage iii breast cancer diagnosis history significant ischaemic heart disease
0, cyclophosphamide recurrent adult burkitt lymphoma diagnosis patients history serious allergic anaphylactic reaction humanized monoclonal antibodies not eligible
1, mycophenolate mofetil burkitt lymphoma diagnosis females childbearing potential must have negative pregnancy test prior starting therapy
1, nivolumab various advanced cancer diagnosis positive test hepatitis virus surface antigen hbv ag hepatitis virus ribonucleic acid hcv antibody indicating acute chronic infection
0, sirolimus patients must have histologically cytologically proven nsclc including adenocarcinoma broncho alveolar cell large cell anaplastic carcinoma
0, cyclosporins noncontiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis match grade doc
1, rituximab non hodgkin lymphoma diagnosis if patients have known diagnosis any above evidence disease control is required by negative endoscopy within last twenty eight days
1, antibodies unresectable extrahepatic bile duct cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition erlotinib
1, erlotinib hydrochloride prostate cancer diagnosis uncontrolled hypertension resting blood pressure greater one hundred sixty one hundred mm hg clinical episodes congestive heart failure angina pectoris myocardial infarction within last year
1, albumin bound paclitaxel ovarian cancer diagnosis this is an acceptable method when this is consistent preferred usual lifestyle patient
0, crizotinib alk positive non small cell lung cancer nsclc rosone positive nsclc diagnosis treatment naÃ¯ve ie no prior chemotherapy metastatic disease setting no prior alk inhibitor therapy allowed
1, sorafenib angioimmunoblastic cell lymphoma diagnosis candidates potentially curative therapy such hematopoietic stem cell transplantation hsct
0, medical chart review prostate cancer diagnosis no limited exercise tolerance precluding participation lifestyle intervention component this study
0, gy targeted radiotherapy patients past history histologically cytologically confirmed breast lung cancer now presenting new likely brain metastasis from that primary
0, sunitinib renal cell carcinoma diagnosis no maximum age
0, quality life assessment nasal type extranodal nk cell lymphoma diagnosis remission complete remission cr partial remission pr stable disease based on clinical not necessarily radiologic assessment currently being observed no current cytotoxic chemotherapy planned patients may be on rituximab maintenance
1, antibodies hertwo negative breast cancer diagnosis evidence bleeding diathesis coagulopathy
0, panobinostat multiple myeloma relapse diagnosis all three following criteria must have been met
1, fluorouracil stage iiic colon cancer diagnosis serious medical illness that would potentially increase patients risk toxicity
1, antibodies monoclonal cervical adenosquamous carcinoma diagnosis history cerebrovascular accident cva within six months
1, hypofractionated rt cancer other head neck cancer within previous five years baso cellular skin carcinoma cervix carcinoma excepted
0, etanercept disseminated neuroblastoma diagnosis more fourteen days since prior etanercept
1, mycophenolate mofetil stage iv adult burkitt lymphoma diagnosis patient rapidly progressive aggressive nhl unless minimal disease state
0, bevacizumab recurrent basal cell carcinoma lip diagnosis brain metastases
0, prednisolone peripheral cell lymphoma unspecified diagnosis informed consent
0, palbociclib recurrent childhood anaplastic oligodendroglioma diagnosis patients should have received their last dose biologic agent greater equal seven days prior enrollment event patient has received another biologic agent has experienced greater equal grade two myelosuppression then at least three three weeks must have elapsed prior enrollment if investigational biologic agent has prolonged half life then at least three three weeks interval is required
1, rituximab any other malignancies within past five years except curatively treated non melanoma skin cancer situ carcinoma cervix uteri
0, isotretinoin stage fours neuroblastoma diagnosis mycn amplification greater four fold increase mycn signals compared reference signals age greater equal three hundred sixty five days regardless additional biologic features
0, hydroxystaurosporine recurrent mucoepidermoid carcinoma oral cavity diagnosis ast alt no greater three times upper limit normal uln
1, abiraterone acetate prostate cancer diagnosis any chronic medical condition requiring higher dose corticosteroid fivemg prednisone prednisolone twice daily
1, paclitaxel uterine corpus carcinosarcoma diagnosis patients that have had primary therapy brain metastasis surgical resection whole brain radiation stereotactic radiotherapy srt even if stable not eligible
0, metal patch tests head neck cancer diagnosis no other conditions that interfere patch testing
1, hanarostent tm covered esophageal stent esophageal cancer diagnosis patient unstable endoscopic procedure
0, osimertinib lymphoma diagnosis new immunotherapy regimen is permitted but lack response must also be documented prior registration step zero
1, immunoglobulins stage iiib colon cancer diagnosis core biopsy other minor procedure excluding placement vascular access device within seven days prior randomization
0, fludarabine phosphate refractory small lymphocytic lymphoma diagnosis acute myeloid leukemia acute lymphoblastic leukemia including biphenotypic acute leukemia mixed lineage leukemia
0, gemcitabine pancreatic cancer diagnosis patients not have known metastases
0, oxaliplatin recurrent adult immunoblastic large cell lymphoma diagnosis no concurrent antiretroviral therapy hiv positive patients
0, endothelial growth factors endometrial clear cell adenocarcinoma diagnosis patients must have gynecologic oncology group gog performance status zero one two
1, cyclosporine recurrent adult lymphoblastic lymphoma diagnosis uncontrolled infection
1, histone deacetylase inhibitors recurrent grade one follicular lymphoma diagnosis persistent toxicities greater equal grade two from prior chemotherapy biological therapy regardless interval since last treatment
0, levoleucovorin stage ivb colon cancer diagnosis at least two weeks since prior minor surgery recovered
0, dexamethasone multiple myeloma diagnosis ast less doc upper limit normal uln
1, whole brain radiation therapy wbrt hertwo positive breast cancer diagnosis patients who have not recovered less common terminology criteria adverse events ctcae grade two toxicities related prior therapy not eligible participate this study
0, organic germanium localized prostate cancer diagnosis patients may have received be receiving hormonal therapy
1, cisplatin head neck cancer diagnosis clinically significant cardiovascular disease
1, pulmonary complications management prevention recurrent non small cell lung cancer diagnosis if they have angina unstable coronary disease
0, camptothecin pancreatic cancer diagnosis no known gilbert disease
0, erlotinib hydrochloride adult gliosarcoma diagnosis prostate
1, vinorelbine breast cancer diagnosis history intolerance including grade three four infusion reaction hypersensitivity trastuzumab murine proteins
1, thalidomide stage iii adult lymphoblastic lymphoma diagnosis pregnant breast feeding females lactating females must agree not breast feed while taking lenalidomide
0, tak advanced metastatic melanoma diagnosis have suitable venous access conduct blood sampling
0, angiogenesis inhibitors glioblastoma multiforme diagnosis subjects using hrt must have experienced total cessation menses greater equal oneyear be greater forty five years age have had documented evidence menopause based on fsh estradiol concentrations prior initiation hrt
0, celecoxib planning undergo surgery at memorial sloan kettering cancer center
1, vidarabine contiguous stage ii grade one follicular lymphoma diagnosis donor
0, trastuzumab stage iia breast cancer diagnosis patient agrees provide pretreatment biopsies
0, capecitabine stage iii pancreatic cancer diagnosis absolute neutrophil segmented bands count anc greater equal doc ten nine l
1, camptothecin ovarian cancer diagnosis case cytoreductive surgery progression disease less two weeks before onest treatment allowed
0, antibodies monoclonal lymphoma cell diagnosis female patients who not pregnant lactating
0, cediranib noncutaneous extranodal lymphoma diagnosis ecog performance status equal less two karnofsky greater equal sixty
1, vaccines basal cell carcinoma skin cervical intra epithelial neoplasia other cancer curatively treated no evidence disease at least five years
1, docetaxel stage iv head neck cancer diagnosis no known allergies any drug therapies being used this protocol
1, bendamustine hydrochloride recurrent marginal zone lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition abt eight hundred eighty eight bendamustine mannitol patients enrolling cohort expansion phase two portions who have been intolerant repeated doses rituximab past will be excluded patients who have had infusion reactions their initial dose rituximab will not be excluded
1, external beam radiation therapy recurrent prostate cancer diagnosis requirement systemic immunosuppressive therapy any reason
0, sirolimus stage ii non contiguous adult diffuse large cell lymphoma diagnosis ages equal less fifty years age chronic lymphocytic leukemia cll these patients not require patient review committee approvals
0, self administered coping intervention cancer diagnosis able give their own consent
0, sorafenib stage ii pancreatic cancer diagnosis locally advanced metastatic disease
1, antibodies monoclonal stage iib breast cancer diagnosis pregnant women
1, sorafenib liver cancer diagnosis history any following within last six months prior registration
0, liposomal doxorubicin breast cancer diagnosis fertile patients must use effective contraception
1, antibodies monoclonal ureter cancer diagnosis all female patients reproductive potential must have negative pregnancy test serum within seven days prior first dose
1, trabectedin recurrent ewing sarcoma diagnosis patients newly diagnosed first relapse
1, carboplatin lungcancer diagnosis evidence new optic disc cupping
0, levoleucovorin signet ring adenocarcinoma rectum diagnosis ecog zero two
1, etoposide extraosseous ewing sarcoma diagnosis karnofsky performance status less sixty lansky performance status less fifty patients younger sixteen years old
0, tanespimycin kidney cancer diagnosis renal
1, immunoglobulin g stage iiic ovarian cancer diagnosis patients ctcae grade two greater peripheral vascular disease at least brief less two hours episodes ischemia managed non surgically without permanent deficit
0, niacinamide stage iva squamous cell carcinoma oropharynx diagnosis alkaline phosphatase equal less two institutional upper limit normal
0, dexamethasone multiple myeloma diagnosis subject must voluntarily sign understand written informed consent
1, serum prostate antigen test stage iia prostate cancer diagnosis transmural myocardial infarction within last six months
0, akt inhibitor mk small intestine lymphoma diagnosis peripheral absolute neutrophil count anc greater equal one thousand mm three
1, asn dose part b prostate cancer diagnosis part only patients rapidly progressive disease who candidates other approved therapies such docetaxel abiraterone enzalutamide
0, nivolumab recurrent breast carcinoma diagnosis hemoglobin hgb greater equal doc dl
1, tamoxifen breast neoplasms diagnosis patient an history significant cardiovascular impairment congestive heart failuregreater nyha grade ii unstable angina myocardial infraction within past six months serious cardiac arrhythmia
0, melphalan noncontiguous stage ii adult diffuse mixed cell lymphoma diagnosis compatibility at four most informative hla loci
1, methotrexate adult grade iii lymphomatoid granulomatosis diagnosis adult forty pediatric equal less eighteen yrs
1, protein kinase inhibitors cancer diagnosis blood pressure must be less one hundred sixty ninety five mmhg at time screening on stable antihypertensive regimen
1, carboplatin uterine cervical neoplasms diagnosis prior treatment nintedanib any other vegfr inhibitor
1, immunoglobulins stage iiic colon cancer diagnosis previous oxaliplatin therapy metastatic disease prior adjuvant therapy oxaliplatin is allowed long one hundred twenty days have elapsed since last oxaliplatin treatment
1, fludarabine follicular lymphoma diagnosis active cns disease
0, vitamins breast cancer diagnosis four age eighteen years older
0, immunoglobulins stage ii non contiguous adult diffuse large cell lymphoma diagnosis performance status ps zero one two per eastern cooperative oncology group ecog performance status scale karnofsky performance score greater equal zero
1, endothelial growth factors non small cell lung cancer diagnosis patients who have had radiotherapy less four weeks prior starting drug less two weeks prior starting drug case localized radiotherapy who have not recovered from radiotherapy toxicities
0, dexamethasone phosphate patient has relapsed relapsed refractory mm measurable disease parameters according international myeloma working group imwg criteria
0, antibodies monoclonal adenocarcinoma lung diagnosis patients history gross hemoptysis defined bright red blood one two teaspoon more will be excluded from this trial
0, endothelial growth factors stage ivc lip oral cavity squamous cell carcinoma diagnosis minimum four months is required between last dose chemotherapy chemoradiotherapy treatment addition patients must be progression free at least four months after completion chemotherapy chemoradiotherapy radiation plus cetuximab given curative intent cetuximab therapy
0, albumin bound paclitaxel breast cancer diagnosis age weight kg serum cr seventy two female crcl equal one hundred forty
1, fluorouracil neoplasms squamous cell diagnosis investigators will exclude small proportion who get their kcs special reasons other ultraviolet radiation exposure see list below since that etiologic difference which is associated prognostic difference could be associated biologic difference response chemoprevention efforts
1, bevacizumab lung cancer diagnosis evidence bleeding diathesis significant coagulopathy absence therapeutic anticoagulation
1, etoposide lymphoma follicular diagnosis clinically significant concomitant disease states
1, apo cutaneous cell lymphoma diagnosis primary acquired thrombocytopenia
0, carboplatin non small cell lung cancer diagnosis subjects must have at least one lesion that is measurable using recist doc
0, gw iv carcinoma renal cell diagnosis eastern cooperative oncology group ecog performance status zero one
1, bevacizumab fallopian tube neoplasms diagnosis known hypersensitivity bevacizumab its excipients chinese hamster ovary cell products other recombinant human humanised antibodies
1, immunoglobulins recurrent mantle cell lymphoma diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin three weeks rituximab prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
1, everolimus extra adrenal paraganglioma diagnosis patient functioning carcinoid
1, trastuzumab breast neoplasms diagnosis clinical symptoms bowel obstruction evidence rectosigmoid bowel involvement on exam transmural bowel wall involvement on computed tomography ct magnetic resonance imaging mri
0, histone deacetylase inhibitors angioimmunoblastic cell lymphoma diagnosis patients must have had at least one prior systemic chemotherapy not just steroids local radiation last chemotherapy radiation must be at least four weeks prior enrollment on this patients who decline other potentially curative therapy may be eligible prior radiation therapy must not have been more twenty five bone marrow whole pelvic radiation is considered be over twenty five
0, pembrolizumab advanced unresectable melanoma progressing after pdone blockade diagnosis able provide valid written informed consent
0, cyclophosphamide metastatic malignant neoplasm bone marrow diagnosis patients pulmonary nodules considered have metastatic disease if patient has
0, amphotericin b cancer diagnosis removal infected catheters
0, thermal ablation therapy breast cancer diagnosis creatinine less doc mg dl
1, cyclophosphamide other active malignancies including other hematologic malignancies other malignancies except cured nonmelanoma skin cancer cervical intraepithelial neoplasia
1, pemetrexed lung cancer diagnosis bleeding clotting disorders
0, camptothecin stage iv salivary gland cancer diagnosis must have undergone prior therapy an anthracycline taxane either adjuvant metastatic setting
0, capecitabine stage iv small lymphocytic lymphoma diagnosis patients after menarche amenorrhea irregular cycles using contraceptive method that precludes withdrawal bleeding
0, bleomycin testicular germ cell tumor diagnosis any primary site
0, estramustine prostate cancer diagnosis at least eight weeks since prior bicalutamide
0, fludarabine phosphate multiple myeloma plasma cell neoplasm diagnosis chemosensitive stable non bulky disease prior transplant
1, docetaxel carcinoma non small cell lung diagnosis hypertension not controlled by medical therapy unstable angina history myocardial infarction within past six months congestive heart failure greater nyha ii serious cardiac arrhythmia pericardial effusion
0, dexamethasone phosphate relapsed refractory multiple myeloma diagnosis subject must have adequate coagulation renal hepatic function per laboratory reference range at screening
0, semaxinib cervical cancer diagnosis life expectancy
0, donor nk cell infusion neuroblastoma diagnosis if first relapse must have recurred greater four lung nodules bilateral lung involvement relapse outside lungs
0, paclitaxel tubular breast cancer stage ii diagnosis pathology at charitÃ© berlin prior randomization
0, antilymphocyte serum myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis acute myeloid leukemia aml
0, counseling intervention recurrent grade two follicular lymphoma diagnosis able communicate english indicated by ability communicate adequately staff participate clinical phone calls complete patient reported outcomes pro assessments english
0, antibodies stage iiic uterine corpus cancer diagnosis eastern cooperative oncology group ecog performance status ps zero one
1, simvastatin prostate cancer diagnosis prior treatment cap by surgery irradiation local ablative cryosurgery high intensity focused ultrasound androgen deprivation therapy
0, methotrexate head neck cancer diagnosis disease characteristics
1, temozolomide recurrent childhood brain tumor diagnosis documented within fourteen days registration within seven days starting treatment
0, hydroxystaurosporine stage iv lymphoepithelioma nasopharynx diagnosis karnofsky sixty one hundred
1, fluorouracil advanced cancers diagnosis uncontrolled intercurrent illness including but not limited uncontrolled infection uncontrolled asthma need hemodialysis need ventilatory support
0, cyclosporine myelodysplastic myeloproliferative neoplasms diagnosis disease characteristics
1, questionnaire administration splenic marginal zone lymphoma diagnosis patients who have previously received chemotherapy other steroids intrathecal chemotherapy not eligible
0, citric acid fallopian tube cancer diagnosis progression recurrence during first line platinum based chemotherapy platinum refractory disease progression recurrence during first six months following end last platinum containing chemotherapy platinum resistant disease
1, bevacizumab stomach cancer diagnosis known cns disease brain metastases
1, albumin bound paclitaxel cancer diagnosis diabetes insipidus
0, immunoglobulin g stage iv skin melanoma diagnosis patients excluded if they have history hemoptysis bright red blood one two teaspoon more per episode within three months prior randomization
0, cetuximab colorectal cancer diagnosis no brain metastasis
0, carboplatin soft tissue sarcoma diagnosis have performance status less one on eastern cooperative oncology group ecog scale
0, carmustine brain central nervous system tumors diagnosis life expectancy
0, antibodies monoclonal recurrent ovarian carcinoma diagnosis no proteinuria less one positive
1, paclitaxel cervical adenosquamous carcinoma diagnosis patients clinical symptoms signs gastrointestinal obstruction who require parenteral hydration nutrition
1, vadimezan refractory tumors diagnosis sick sinus syndrome sinus pauses greater two seconds
1, dexamethasone acetate solid tumor cancer diagnosis is currently taking plans take following cyptwoceight substrates at any time during study
1, paclitaxel breast cancer diagnosis bisphosphonates may be continued
1, vitamins peripheral cell lymphoma diagnosis patients history autologous hematopoietic stem cell transplantation within one hundred days prior initial administration drug
0, cyclophosphamide non rhabdomyosarcoma soft tissue sarcoma diagnosis patient nineteen years age younger
1, antibodies monoclonal stage ivb verrucous carcinoma larynx diagnosis topical applications rash inhaled sprays obstructive airways diseases eye drops local injections intra articular allowed patients previously treated brain metastases who on stable low dose corticosteroids treatment eg
0, cyclosporins stage grade three follicular lymphoma diagnosis refractory cytopenia multilineage dysplasia
0, laboratory biomarker analysis stage iii renal cell cancer diagnosis hematocrit greater equal twenty eight
1, etoposide stage iii mantle cell lymphoma diagnosis participants who receiving any other investigational agents
0, pharmacological stage iii melanoma diagnosis oxygen saturation greater eighty eight
0, doxorubicin peripheral cell lymphoma diagnosis hemoglobin greater equal doc dl may receive red blood cell rbc transfusions
1, vidarabine recurrent grade two follicular lymphoma diagnosis inability achieve adequate venous access
0, laboratory biomarker analysis head neck cancer diagnosis no myocardial infarction within past six weeks
0, antibodies monoclonal metastatic solid neoplasm diagnosis international normalized ratio inr activated partial thromboplastin time aptt equal less doc uln this applies only patients who not receive therapeutic anticoagulation patients receiving therapeutic anticoagulation such low molecular weight heparin warfarin should be on stable dose
1, antibodies monoclonal antibodies neoplasm diagnosis patients who currently receiving another investigational drug not eligible
1, cyclosporins myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis age greater seventy five years
0, antibodies breast cancer diagnosis creatinine no greater doc mg dl
1, laboratory biomarker analysis colorectal cancer diagnosis pregnant lactating women
0, cyclophosphamide recurrent mantle cell lymphoma diagnosis forced expiratory volume one second fevone forced vital capacity fvc diffusion capacity carbon monoxide dlco diffusion capacity greater equal forty predicted corrected hemoglobin if unable perform pulmonary function tests then oxygen otwo saturation greater two on room air
1, pacritinib colorectal cancer diagnosis currently receiving any other investigational agents
1, trastuzumab stage ia breast cancer diagnosis active cardiac disease
1, fluorouracil uncontrolled central nervous system metastases carcinomatous meningitis
1, fludarabine phosphate lymphoma diagnosis evidence hiv infection known hiv positive serology
1, lapatinib invasive breast cancer diagnosis one fna core biopsy an axillary node any patient two although not recommended pre neoadjuvant therapy sn biopsy patients clinically negative axillary nodes
0, ipss questionnaire prostate adenocarcinoma diagnosis if prior malignancy is remission greater five years then patient is eligible
1, bevacizumab optic nerve glioma diagnosis patients history current condition that would preclude use bevacizumab
0, lenograstim multiple myeloma diagnosis doc
0, busulfan recurrent adult diffuse small cleaved cell lymphoma diagnosis mds myelodysplastic syndrome specific subtypes ra refractory anemia rars refractory anemia ringed sideroblasts subtypes
1, lapatinib neoplasms breast diagnosis anticoagulant therapy other coumadin aspirin catheter prophylaxis at entry
0, laboratory biomarker analysis recurrent verrucous carcinoma larynx diagnosis no active ongoing infection
0, prednisolone hemisuccinate thymic carcinoma diagnosis no hla abc dr identical related bone marrow ucb donor no five six antigen matched related bone marrow ucb donor condition precludes waiting search find donor national marrow donor registry must have backup autologous haploidentical related marrow must have available serologic match umbilical cord blood unit new york blood center placental blood project
1, online adaptive mr guided sbrt pancreatic cancer diagnosis currently receiving any other investigational agents
1, sirolimus pten overgrowth syndrome vascular anomaly diagnosis patients who have received prior treatment an mtor inhibitor
0, albumin bound paclitaxel progesterone receptor negative breast cancer diagnosis serum creatinine less equal doc mg dl
0, busulfan lymphoma diagnosis has potentially suitable human leukocyte antigen hla haploidentical donor available
1, palonosetron stage iiia breast cancer diagnosis need receive radiotherapy during study
0, prednisolone hemisuccinate anaplastic large cell lymphoma diagnosis patients must be htlv iii hiv anti body negative
0, paclitaxel ovarian neoplasms diagnosis hemoglobin greater nine dl or
0, doxorubicin breast cancer diagnosis no history any following
1, mycophenolic acid recurrent adult non hodgkin lymphoma diagnosis patients greater grade ii hypertension by common toxicity criteria ctc
1, bevacizumab digestive system neoplasms diagnosis current treatment atazanavir sulfate
1, liposomal doxorubicin plexiform fibrohistiocytic tumor diagnosis note
0, isophosphamide mustard childhood nodular lymphocyte predominant hodgkin lymphoma diagnosis no prior bortezomib other proteasome inhibitors
0, prednisolone lymphoma diagnosis not specified
0, pet ct fdg pet ct esophageal cancer diagnosis patient must have undergone baseline fdg pet ct at mdacc an outside institution
1, antibodies monoclonal cervical squamous cell carcinoma not otherwise specified diagnosis women who not childbearing potential who postmenopausal surgically sterile have undergone definitive radiation not require contraception
1, carboplatin stage iiib non small cell lung cancer diagnosis note
0, antibodies monoclonal stage iv non small cell lung cancer diagnosis women greater equal fifty years age would be considered post menopausal if they have been amenorrheic twelve months more following cessation all exogenous hormonal treatments had radiation induced oophorectomy last menses greater one year ago had chemotherapy induced menopause greater one year interval since last menses underwent surgical sterilization bilateral oophorectomy hysterectomy
1, conventional surgery recurrent squamous cell carcinoma lip oral cavity diagnosis serum glutamic oxaloacetic transaminase sgot greater three times upper normal limit
0, mycophenolic acid contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis patients cll nhl scheduled reduced intensity non myeloablative conditioning should have no evidence bulky disease greater fifty bone marrow involvement masses greater ten cm at start conditioning
0, rituximab splenic marginal zone lymphoma diagnosis history medically significant ascites requiring repetitive paracentesis
1, rituximab non hodgkin lymphoma diagnosis patients not establishing all above mentioned prerequisites
0, cyclosporine adult nasal type extranodal nk cell lymphoma diagnosis potwo greater sixtymmhg
0, etoposide stage childhood small noncleaved cell lymphoma diagnosis at least one week since prior steroids except emergency steroids initiated within seventy two hours entry
0, cetuximab non small cell lung cancer diagnosis bone marrow function renal function hepatic function outlined protocol
1, cognitive behavioral therapy hypnosis group breast cancer diagnosis no cognitive dysfunction
0, capecitabine colorectal cancer diagnosis no history transient ischemic attacks stroke
0, melphalan unspecified childhood solid tumor protocol specific diagnosis all patients their legal guardians must have signed voluntary informed consent accordance institutional federal guidelines
0, mri examination prostate cancer diagnosis time interval between last biopsy mr exam must be at least four weeks
0, docetaxel ovarian neoplasms diagnosis figo stage iiic twocm extrapelvic disease figo iv
1, maleic acid stage iv skin melanoma diagnosis surgery within two weeks prior registration
1, sorafenib hepatocellular carcinoma diagnosis have had treatment any following within specified timeframe prior randomization
0, antibodies recurrent diffuse large cell lymphoma diagnosis provide informed written consent
1, vincristine diffuse large cell lymphoma diagnosis patients who have had radiotherapy within fourteen days before registration not eligible note
1, modafinil melanoma recurrent diagnosis medical condition requiring any form chronic systemic immunosuppressive therapy steroid other except physiologic replacement doses hydrocortisone equivalent no more thirty mg hydrocortisone ten mg prednisone equivalent daily less thirty days duration
1, capecitabine colorectal cancer diagnosis myocardial ischemia infarction arterial thrombosis pulmonary emboli
1, busulfan active infection occult untreated infection hiv negative not eligible children cancer group ccg pediatric oncology group pog transplant donor criteria
1, sorafenib advanced solid tumors diagnosis pregnancy breast feeding
1, antibodies stage iiib primary peritoneal cancer diagnosis history any following within six months prior start mlnone hundred twenty eight
1, vorinostat ds stage plasma cell myeloma diagnosis total bilirubin greater two mg ml unless history gilbert disease
0, fludarabine skin cancer diagnosis patients who hiv seropositive can have decreased immune competence thus be less responsive experimental treatment more susceptible its toxicities
0, vidarabine stage iv adult burkitt lymphoma diagnosis low grade nh negative less six months duration complete response cr between courses conventional therapy
0, thalidomide stage ii multiple myeloma diagnosis step i
1, blood tests muscular biopsies lung cancer diagnosis non caucasian
1, fludarabine refractory cell non hodgkin lymphoma diagnosis southwest oncology group swog eastern cooperative oncology group ecog performance score greater equal two
1, vadimezan metastatic cancer impaired renal function diagnosis administration cyponeatwo cypthreeafour five enzyme inducing inhibiting drugs within onefour days prior starting drug
0, vidarabine metastatic malignant neoplasm brain diagnosis serum alanine aminotransferase alt aspartate aminotransferase ast equal less doc times upper limit normal
0, antibodies monoclonal stage iii inverted papilloma paranasal sinus nasal cavity diagnosis karnofsky performance status sixty one hundred
0, antibodies lymphoma diagnosis not specified
1, etoposide phosphate stage iv grade two follicular lymphoma diagnosis history significant cerebrovascular disease past three months ongoing event active symptoms sequelae
0, liposomal doxorubicin ovarian cancer metastatic recurrent diagnosis wash out period twenty eight days
0, doxorubicin glioblastoma diagnosis highly effective methods birth control include sexual abstinence hormonal birth control intrauterine device women vasectomy condom spermicide men combination barrier methods
1, vidarabine splenic marginal zone lymphoma diagnosis significant elevation bilirubin transaminases should be discussed at participating institutions patient review committees case by case basis evidence synthetic dysfunction severe cirrhosis will result patient exclusion
0, fluorouracil esophageal cancer diagnosis no second malignancy within five years except
1, ispinesib recurrent small lymphocytic lymphoma diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from acute aes due agents administered more four weeks earlier
1, liposomal doxorubicin lymphoma diagnosis patients active hepatitis hepatitis infection
0, fluorodeoxyglucose f melanoma diagnosis women child bearing potential must have negative urinary serum pregnancy test within seven days baseline imaging
0, busulfan lymphoma diagnosis progression after initial response therapy
0, preventive intervention stage iiia non small cell lung cancer diagnosis patients must be registered prior their first cycle systemic therapy chemotherapy immunotherapy biologic therapy combination regimens this diagnosis if patient has had any prior systemic therapy another malignancy patient must not have had any systemic therapy one hundred eighty days just prior registration
0, carboplatin priority will be given patients neuroendocrine tumors such as
0, isophosphamide mustard stage iv extragonadal non seminomatous germ cell tumor diagnosis laboratory test results must be within ranges established protocol
1, palbociclib recurrent childhood medulloblastoma diagnosis two chemotherapy regimens
1, surgery needed by patientÂ´s tumor stage sarcoma diagnosis human immunodeficiency virus hiv hepatitis hepatitis syphilis infection
0, cyclophosphamide indolent non hodgkin lymphoma diagnosis myelodysplastic syndrome mds
1, brachytherapy other pathological invasive tumor dcis
1, osimertinib stage iv non small cell lung cancer diagnosis past medical history interstitial lung disease drug induced interstitial lung disease radiation pneumonitis requiring steroid treatment any evidence clinically active interstitial lung disease
1, sirolimus estrogen receptor positive breast cancer diagnosis topical applications rash inhaled sprays obstructive airways diseases eye drops local injections intra articular allowed
0, carboplatin stage ivb uterine corpus cancer diagnosis patients any cardiopulmonary symptoms unknown cause shortness breath chest pain etc
1, trametinib melanoma diagnosis history acute coronary syndromes including myocardial infarction unstable angina coronary angioplasty stenting within six months prior commencement treatment d
0, cytarabine recurrent small lymphocytic lymphoma diagnosis hiv seropositive
1, bevacizumab endometrial serous adenocarcinoma diagnosis presence unstable atrial fibrillation ventricular response greater one hundred beats per minute
0, stereotactic radiosurgery adult oligodendroglioma diagnosis life expectancy greater two months
0, arsenic trioxide stage iv esophageal cancer diagnosis fertile patients must use effective contraception
1, strengthening rhabdomyosarcoma diagnosis patients serious non healing wound ulcer bone fracture other pathologic fracture
0, immunoglobulins metastatic cancer diagnosis at least four weeks since other prior investigational agents no concurrent immunosuppressive agents
1, mln solid tumor diagnosis laboratory values specified protocol
1, melphalan other malignancy within past five years except adequately treated basal cell squamous cell skin cancer
0, copper stage ib gastric cancer diagnosis patients must have normal cardiac ejection fraction
1, prednisone multiple myeloma diagnosis lactating women
0, cyclophosphamide lymphoma diagnosis diagnosis resistant hodgkin disease eligible subtypes
0, mesna sarcoma diagnosis other
1, pembrolizumab ovarian cancer diagnosis has active autoimmune disease that has required systemic treatment past two years use disease modifying agents corticosteroids immunosuppressive drugs
1, vinblastine childhood pleomorphic rhabdomyosarcoma diagnosis patients documented chronic non healing wound ulcer significant trauma injury those bone fractures including pathological fractures requiring surgical intervention within twenty eight days prior beginning therapy ineligible
1, fludarabine stage adult immunoblastic large cell lymphoma diagnosis fhcrc pi must approve enrollment all patients pulmonary nodules
1, antibodies monoclonal solid tumor diagnosis currently receiving have had prior use immunosuppressive medication within twenty eight days before first dose drug exceptions intranasal inhaled corticosteroids systemic corticosteroids at physiological doses which not exceed ten milligrams day prednisone an equivalent corticosteroid
0, albumin bound paclitaxel progesterone recepto negative negative breast cancer diagnosis immunohistochemistry ihc zero one fluorescence situ hybridization fish negative equivalent negative test
0, tetrahydrouridine melanoma diagnosis patients must have recovered from non hematologic toxicities associated treatment malignancy less equal grade one
0, lenograstim stage iv fallopian tube cancer diagnosis effective xx xx two thousand fourteen only patients seventy five years age older eligible enrollment four twenty three two thousand twelve eight twelve two thousand thirteen
0, antibodies primary peritoneal cavity cancer diagnosis fertile patients must use effective contraception
1, sirolimus carcinoma renal cell diagnosis any signs eg radiologic symptoms brain metastases must be stable at least four weeks before starting treatment
0, interferons pancreatic cancer diagnosis at least four weeks since prior hormonal therapy
0, lapatinib recurrent verrucous carcinoma larynx diagnosis adequate swallowing function gastric tube drug administration
1, sirolimus stage iv adult lymphoblastic lymphoma diagnosis addition cytotoxic agents cytoreduction exception tyrosine kinase inhibitors such imatinib cytokine therapy hydroxyurea low dose cytarabine chlorambucil rituxan will not be allowed within three weeks initiation conditioning
0, antibodies monoclonal patients multiple myeloma experiencing diagnosis men must agree use latex condom during sexual contact fcbp even if they have had successful vasectomy
1, antibodies recurrent refractory childhood hodgkin lymphoma diagnosis donor is hiv positive has medical condition that would result increased risk filgrastim csf mobilization harvest pbsc
0, methylprednisolone acetate gestational trophoblastic tumor diagnosis karnofsky performance status ps twenty one hundred lanksy ps twenty one hundred
1, carboplatin adenocarcinoma proximal stomach diagnosis chronic use immunosuppressive agents exception corticosteroids
0, td glioblastoma multiforme diagnosis signed informed consent
0, cyclosporine contiguous stage ii adult diffuse mixed cell lymphoma diagnosis acute myeloid leukemia aml
1, ganciclovir triphosphate hepatocellular carcinoma diagnosis accept clinical trials other drugs
1, jm non hodgkin lymphoma diagnosis prior granulocyte macrophage colony stimulating factor gm csf pegfilgrastim within three weeks prior first dose csf
0, methotrexate b cell lymphoma unclassifiable features intermediate between diffuse large cell lymphoma burkitt lymphoma diagnosis exceptions can be granted from principal investigator pi instances gilbert disease primarily indirect bilirubinemia if due recent transfusion hemolysis
0, dasatinib stage iii small lymphocytic lymphoma diagnosis should be evaluated by baseline echocardiogram without stress test needed addition electrocardiogram ekg rule out qtc prolongation patient may be referred cardiologist at discretion principal investigator patients underlying cardiopulmonary dysfunction should be excluded from study
1, billroth ii b ii stomach cancer diagnosis treating diabetics insulin
1, olaparib fallopian tube serous adenocarcinoma diagnosis participants may not have dependency on intravenous iv hydration total parenteral nutrition tpn
0, isophosphamide mustard childhood nodular sclerosis hodgkin lymphoma diagnosis patients who achieved complete response after treatment on protocol cog ahodfour hundred thirty one who experience biopsy proven recurrence after doxorubicin hydrochloride vincristine prednisone cyclophosphamide without involved field radiotherapy
0, busulfan unspecified childhood solid tumor protocol specific diagnosis inborn errors metabolism
1, carbon ion radiotherapy tumor invading adjacent gastrointestine tfour
0, eflornithine neuroblastoma diagnosis measurable disease including at least one following
0, tipifarnib stage iiia breast cancer diagnosis normal organ function including
1, everolimus cancer diagnosis qtc interval greater four hundred eighty msecs
0, cyclosporine recurrent childhood hodgkin lymphoma diagnosis signed informed consent
0, levoleucovorin lymphoma diagnosis recovered from prior surgery
1, antibodies renal cancer diagnosis prior treatment combination ctla four pd one pd lone blockade
0, dexamethasone acetate multiple myeloma diagnosis previously allogeneic autologous bone marrow transplants prior therapy bortezomib permitted
1, bevacizumab malignant ovarian mixed epithelial tumor diagnosis patients history cva within six months
1, mycophenolic acid myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis cardiac ejection fraction less thirty five ejection fraction is required if there is history anthracycline exposure history cardiac disease
0, bi bibw neoplasms diagnosis two
1, liposomal doxorubicin endometrial cancer diagnosis history hereditary hemorrhagic telangiectasia hht osler weber rendu syndrome
1, everolimus childhood rhabdomyosarcoma mixed embryonal alveolar features diagnosis new york heart association grade two greater congestive heart failure
0, tocotrienols breast cancer diagnosis ps zero two suited surgery
1, cbt physical activity menopausal symptoms breast cancer patients treatment induced complaints diagnosis since physical exercise may be contraindicated treatment hot flushes obese women forty nine patients bmi greater thirty will be excluded from study
0, fluorouracil bclc stage adult hepatocellular carcinoma diagnosis myocardial infarction within past six months uncontrolled angina within past six months class ii iv new york heart association nyha congestive heart failure grade three cardiac valve dysfunction cardiac arrhythmia not controlled by medication history stroke transient ischemic attack within six months history arterial thrombotic event ate any type past six months treatment refractory hypertension defined blood pressure systolic greater one hundred forty mmhg diastolic greater ninety mmhg which cannot be controlled anti hypertensive therapy known intra cardiac defibrillators known cardiac metastases
1, trastuzumab metastatic breast cancer diagnosis women considered post menopausal not child bearing potential if they have had twelve months natural spontaneous amenorrhea an appropriate clinical profile age appropriate history vasomotor symptoms six months spontaneous amenorrhea serum fsh levels greater forty miu ml us only
0, cyclophosphamide rhabdoid tumor diagnosis serum glutamate pyruvate transaminase sgpt alt less one hundred thirty five l
1, gamma secretase inhibitor ro stage iii uterine sarcoma diagnosis patients must be able swallow pills patients malabsorption syndrome other condition that would interfere intestinal absorption
1, melphalan multiple myeloma diagnosis uncontrolled severe cardiovascular disease including myocardial infarction within six months enrolment new york heart association nyha class iii iv heart failure attachment six nyha classification cardiac disease uncontrolled angina clinically significant pericardial disease cardiac amyloidosis
1, carboxymethylcellulose sodium stage iiia uveal melanoma diagnosis history pulmonary disease such emphysema chronic obstructive pulmonary disease copd forced expiratory volume one second fevone less sixty predicted height age pulmonary function tests pfts required patients prolonged smoking history symptoms respiratory dysfunction
0, cyclophosphamide multiple myeloma plasma cell neoplasm diagnosis second greater remission
1, glycine multiple myeloma diagnosis prior entry any ecg abnormality at screening must be documented by investigator not medically relevant
1, albumin bound paclitaxel stage iva uterine corpus cancer diagnosis new york heart association nyha class ii greater congestive heart failure
0, max pc questionnaire prostate adenocarcinoma diagnosis zubrod performance status less two karnofsky eastern cooperative oncology group ecog performance status may be used estimate zubrod
0, dexamethasone lymphoma small lymphocytic diagnosis all participants must be registered into mandatory revassist program be willing able comply requirements revassist
1, cisplatin esophageal squamous cell cancer diagnosis social situations limiting compliance requirements
0, alpha tocopherol prostate cancer diagnosis psa recurrence rising psa defined by
1, everolimus stage ii contiguous mantle cell lymphoma diagnosis diffusion capacity carbon monoxide dlco less forty total lung capacity tlc less forty forced expiratory volume one second fevone less forty receiving supplementary continuous oxygen
1, antibodies monoclonal squamous cell carcinoma head neck diagnosis may consent tissue collection biopsy pre endoscopy minor surgery then begin protocol therapy one day after procedure
1, testosterone undecanoate advanced cancer diagnosis if patient has not had blood drawn hematocrit level past twenty eight days one will be performed at baseline determine eligibility
1, laboratory biomarker analysis recurrent refractory childhood hodgkin lymphoma diagnosis pregnant lactating females
0, lenograstim refractory multiple myeloma diagnosis forced vital capacity greater fifty predicted
0, cyclophosphamide brain tumors diagnosis no more six weeks since prior surgery
0, antibodies recurrent squamous cell carcinoma lip oral cavity diagnosis twenty four hour urinary protein less doc required if more trace proteinuria at baseline
0, cyclophosphamide refractory childhood hodgkin lymphoma diagnosis hla genotypically phenotypically identical related donor
0, fludarabine recurrent grade three follicular lymphoma diagnosis mantle cell nhl may be treated first complete response cr diagnostic lumbar puncture lp required pretransplant
1, pharmacological metastatic squamous neck cancer occult primary squamous cell carcinoma diagnosis nefazodone fluovoxamine
1, laboratory biomarker analysis stage iib prostate cancer diagnosis prior brachytherapy is not allowed
0, aromatase inhibitors metastatic carcinoma diagnosis major surgery
1, apatinib advanced metastatic gastric cancer diagnosis disability serious uncontrolled intercurrence infection objective evidence previous current pulmonary fibrosis history interstitial pneumonia pneumoconiosis radiation pneumonitis drug related pneumonia pulmonary function damaged seriously etc
0, bevacizumab stage iva oropharyngeal squamous cell carcinoma diagnosis minimum four months is required between last dose chemotherapy chemoradiotherapy treatment addition patients must be progression free at least four months after completion chemotherapy chemoradiotherapy radiation plus cetuximab given curative intent cetuximab therapy
1, temozolomide brain central nervous system tumors diagnosis concurrent enzyme inducing anticonvulsants eiacs other strong inducers cypthreeafour carbamazepine phenytoin phenobarbital primidone rifabutin rifampin st
1, adjuvants immunologic patients other active cancers within past two years excluding basal cell squamous carcinomas skin cervical carcinoma situ not eligible
1, dalteparin cancer diagnosis previous dvt pe
1, antibodies monoclonal adult anaplastic oligodendroglioma diagnosis patients who have had any curatively treated malignancy have been disease free without treatment one year prior entry eligible participation
0, belinostat angioimmunoblastic cell lymphoma diagnosis absolute neutrophil count greater equal one five hundred mcl
1, fludarabine stage iv childhood small noncleaved cell lymphoma diagnosis diffusing capacity lung carbon monoxide dlco less forty receiving supplementary continuous oxygen
1, cyclophosphamide patients who have completed lumpectomy segmental mastectomy modified radical mastectomy therefore no longer have any measurable cancer left their breast not eligible
0, crizotinib received available standard therapies metastatic melanoma progressed unable tolerate standard therapy standard therapy contraindicated
1, prevastein hcÂ® prostate cancer diagnosis current use nutritional supplements including modular supplements other agents antioxidant properties retinoids beta carotene isoflavones
0, gefitinib carcinoma non small cell lung diagnosis creatinine less doc mg dl
1, docetaxel primary tumor cavitation tumor within one cm major vessel
1, thalidomide extramedullary plasmacytoma diagnosis participants must not have life threatening co morbidities
1, immunoglobulins stage iv adult diffuse small cleaved cell lymphoma diagnosis conditions requiring concurrent use drugs biologics proarrythmic potential these drugs prohibited during studies azdtwo thousand one hundred seventy one refer appendix listing these agents
1, oxaliplatin liver cancer diagnosis proteinuria greater one positive urine protein
0, doxorubicin bclc stage adult hepatocellular carcinoma diagnosis such therapy must be completed at least four weeks prior registration patients that have received palliative radiation therapy bone need not wait four weeks begin protocol therapy
0, autologous hematopoietic stem cell transplantation recurrent grade two follicular lymphoma diagnosis research participant does not have evidence disease progression after salvage therapy
0, melphalan recurrent neuroblastoma diagnosis high dose chemotherapy
0, temozolomide adult solid neoplasm diagnosis doc
0, mechlorethamine sarcoma wilms tumor diagnosis group will require evaluation by physician st
1, trametinib cancer diagnosis predisposing factors rvo including uncontrolled hypertension uncontrolled diabetes uncontrolled hyperlipidemia coagulopathy
0, oxaliplatin stage ii pancreatic cancer diagnosis no prior biologic therapy
0, prednisolone acetate lymphoma diagnosis creatinine no greater doc mg dl creatinine clearance at least sixty ml min cardiovascular
1, topotecan recurrent small cell lung cancer diagnosis concurrent uncontrolled illness including but not limited any following
1, rituximab transformed lymphoma dlbcl pmbcl diagnosis patients who have received live attenuated vaccines within one week start everolimus during study
1, dexamethasone refractory multiple myeloma diagnosis diagnosis waldenstrom macroglobulinemia polyneuropathy organomegaly endocrinopathy monoclonal gammopathy skin changes poems syndrome plasma cell leukemia primary amyloidosis myelodysplastic syndrome myeloproliferative syndrome
1, interleukin primary peritoneal cavity cancer diagnosis known seropositive hepatitis surface antigen
0, vaccines glioblastoma diagnosis female participants enrolled who not free from menses greater two years post hysterectomy oophorectomy surgically sterilized must be willing use either two adequate barrier methods barrier method plus hormonal method contraception prevent pregnancy abstain from sexual activity throughout starting visit one through four weeks after last dose therapy
0, niacinamide stage iv uterine sarcoma diagnosis no concurrent cytochrome pfour hundred fifty enzyme inducing antiepileptic drugs phenytoin carbamazepine phenobarbital
0, bb stage multiple myeloma diagnosis serum monoclonal protein greater equal doc by protein electrophoresis
1, cyclosporins adult nasal type extranodal nk cell lymphoma diagnosis donor
0, open total gastrectomy gastric cancer diagnosis bmi body mass index thirty kg mtwo
1, albumin bound paclitaxel squamous cell lung carcinoma diagnosis chronic obstructive pulmonary disease exacerbation other respiratory illness requiring hospitalization precluding therapy within thirty days registration
1, irinotecan stage iv breast cancer diagnosis any patient requiring cytochrome pfour hundred fifty family three subfamily polypeptide four cypthreeafour isoform inducing drugs phenytoin phenobarbital carbamazepine rifampin rifabutin ketoconazole st
0, docetaxel fallopian tube clear cell adenocarcinoma diagnosis absolute neutrophil count anc greater equal one five hundred mm three equivalent common toxicity criteria adverse events version doc ctcae grade one
0, standard white light cystoscopy patients should be indicated cystoscopic examination suspected verified papillary bladder cancer fulfill one more following criteria
0, chloroquine asymptomatic atrial fibrillation controlled on medication is allowed
1, albumin bound paclitaxel concurrent chronic immunosuppressive hormone anticancer therapy except other physiologic hormone replacement
0, mycophenolic acid recurrent childhood lymphoblastic lymphoma diagnosis positive anti donor cytotoxic crossmatch is an absolute donor exclusion
0, androgens prostate cancer diagnosis screening testosterone level above lower limit normal range globally defined greater doc ng ml
1, antibodies monoclonal cancer diagnosis limited radiotherapy two weeks prior first dose drug s
1, laboratory biomarker analysis stage iiib breast cancer diagnosis inability tolerate scanning
1, mg kg Î± tea metastatic carcinoma diagnosis patients who require brief courses steroids manage allergic reaction intravenous contrast used radiographic studies eligible
1, paclitaxel carcinoma breast diagnosis grade two greater neuropathy per nci ctcav doc
1, antibodies recurrent squamous cell carcinoma oropharynx diagnosis john wort kava ephedra ma huang gingko biloba dehydroepiandrosterone dhea yohimbe saw palmetto ginseng fruits include cytochrome pfour hundred fifty family three subfamily cypthreea inhibitors seville oranges grapefruit pummelos exotic citrus fruits
0, immunoglobulins recurrent rectal cancer diagnosis leukocytes greater equal three zero mcl
0, stem cells lymphomas non hodgkin diagnosis if biological mother is not available then other available haploidentical donors will be selected based upon presence nk alloreactivity between donor recipient
0, albumin bound paclitaxel brenner tumor diagnosis no anticipation invasive procedures including any following applies part only
0, paclitaxel recurrent squamous cell carcinoma oropharynx diagnosis absolute neutrophil count greater equal one five hundred ul
1, f miso pet hypoxia rectal cancer diagnosis previous pelvic radiotherapy
1, fludarabine recurrent adult grade iii lymphomatoid granulomatosis diagnosis donor
0, cyclophosphamide breast cancer diagnosis absolute neutrophil count anc greater equal doc one hundred nine platelet count greater equal one hundred one hundred nine hemoglobin greater equal doc dl
0, cyclophosphamide lymphoblastic lymphoma diagnosis intrathecal therapy cytarabine is allowed prior registration patient convenience
1, ofloxacin cancer diagnosis patients child bearing potential must use adequate contraception
0, tamoxifen histologically cytologically confirmed stage iia breast carcinoma that is considered operable
1, fludarabine childhood burkitt lymphoma diagnosis female patients who pregnant breastfeeding
1, jm anaplastic astrocytoma aa diagnosis note
1, hiv protease inhibitors carcinoma adenoid cystic diagnosis uncontrolled diabetes
0, trametinib stage iiic skin melanoma diagnosis platelets greater equal one hundred zero ul
1, cetuximab multiple myeloma diagnosis brain disorders psychiatric illness
1, albumin bound paclitaxel non squamous non small cell lung cancer diagnosis concurrent estrogens anti estrogens progesterone compounds
1, ifosfamide epithelioid sarcoma diagnosis inflammatory bowel disease ulcerative colitis crohn disease other gastrointestinal conditions which increase risk perforation
1, sevoflurane hepatocellular carcinoma diagnosis patients chronic kidney disease allergic any anesthetic agents used also excluded
0, prednisolone a new classification scheme adult non hodgkin lymphoma has been adopted by pdq
0, hormones hormone refractory prostate cancer diagnosis metastatic disease evidenced by soft tissue bony metastases
1, cyclophosphamide colorectal cancer diagnosis previous diagnosis an autoimmune disease
1, busulfan myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis known adverse reaction csf
1, everolimus adult glioblastoma diagnosis men women childbearing potential who unwilling employ adequate contraception
0, antibodies pancreatic delta cell adenoma diagnosis hepatic artery chemoembolization
0, antibodies stage iv squamous cell carcinoma larynx diagnosis new york heart association class ii iv heart disease
0, etoposide childhood alveolar rhabdomyosarcoma diagnosis doc mg dl males doc mg dl females patients greater equal sixteen years age
1, immunoglobulins stage iv adult diffuse small cleaved cell lymphoma diagnosis any serious medical condition laboratory abnormality psychiatric illness that opinion investigator would prevent subject from providing written informed consent
1, cetuximab stage ivc squamous cell carcinoma larynx diagnosis patients known hypersensitivity bkmone hundred twenty its excipients hypersensitivity cetuximab
0, cyclosporine multiple myeloma plasma cell neoplasm diagnosis bone marrow failure syndromes except fanconi anemia
0, camptothecin recurrent grade two follicular lymphoma diagnosis see disease characteristics
1, dexamethasone acetate pancreatic cancer diagnosis ejection fraction on muga less fifty
1, albumin bound paclitaxel breast cancer diagnosis hiv chronic hepatitis c
1, norethindrone prior hrt initiated after breast cancer diagnosis
0, bevacizumab prostate cancer diagnosis potential candidate radical prostatectomy
1, cyclosporins recurrent aggressive adult non hodgkin lymphoma diagnosis concurrent treatment strong inhibitors hepatic cytochrome pfour hundred fifty family three subfamily polypeptide four cyp threeafour clarithromycin erythromycin protease inhibitors azole antifungals
1, hydroxyurea recurrent glioblastoma multiforme gbm diagnosis there was new radiographical enhancement outside field radiation or
0, prednisone cancer diagnosis has undergone nonmyeloablative allogeneic hematopoietic stem cell transplantation hsct from an hla matched related unrelated donor greater fourteen days ago
0, bevacizumab stage iii adenoid cystic carcinoma oral cavity diagnosis no other severe complicating medical illness that would preclude participation
1, pembrolizumab stage iiic skin melanoma diagnosis grade three four immune related toxicity associated prior ipilimumab therapy that has not resolved grade zero one
0, pembrolizumab stage iv breast cancer diagnosis at least one lesion greater one mm long axis diameter non lymph nodes greater one mm short axis diameter lymph nodes that is serially measurable according recist version doc using computerized tomography magnetic resonance imaging panoramic close up color photography
0, everolimus nodal marginal zone cell lymphoma diagnosis recovered from acute side effects prior myelosuppressive chemotherapy biological therapy
1, immunoglobulin g primary peritoneal serous adenocarcinoma diagnosis ctep ctcae version doc grade two higher peripheral ischemia brief less two hours hrs episode ischemia managed non surgically without permanent deficit
1, hormones prostate cancer diagnosis prior gene therapy immunotherapy
1, exercise intervention stage iiia non small cell lung cancer diagnosis if survival is deemed less six months any medical condition
1, docetaxel stage iii breast cancer diagnosis being pregnant nursing
0, go c solid tumors diagnosis adequate renal function
0, etoposide unspecified childhood solid tumor protocol specific diagnosis at least one week since prior cytokines
0, carboplatin gastro esophageal junction cancer diagnosis written voluntary informed consent
1, dacomitinib pf carcinoma non small cell diagnosis prior systemic therapy advanced disease cohort only
1, oxymetazoline neoplasm diagnosis patients who have had any complication that makes risk death during transplantation from non malignant causes greater risk relapse
0, laboratory biomarker analysis metastatic childhood soft tissue sarcoma diagnosis cns relapse defined at least five wbc ml by cytospin any cerebrospinal fluid csf specimen less five wbc ml by cytospin two consecutive csf specimens obtained greater equal four weeks apart having definitive confirmation that blasts derived from original leukemic clone by molecular cytogenetics multiparameter flow cytometry immunostaining greater equal two antigens
1, vaccines glioblastoma multiforme diagnosis corticosteroids beyond peri operative period
0, carmustine testicular germ cell tumor diagnosis no compatible donor identified
0, albumin bound paclitaxel tubular breast cancer stage iii diagnosis other tests may be performed clinically indicated
1, exercise program colorectal cancer diagnosis class iii iv heart failure according nyha classification system
1, antibodies recurrent intraocular melanoma diagnosis patients excluded if they have any concurrent medical condition requiring use systemic steroids use inhaled topical steroids is permitted
0, albumin bound paclitaxel esophageal cancer diagnosis no prior major esophageal surgery
1, docetaxel stage ivc verrucous carcinoma larynx diagnosis patients may not be receiving any other investigational agents
0, pf sarcoma diagnosis patient should have received at least one therapy recurrent metastatic disease including both standards care investigational therapies
0, delta rgd adenovirus recurring glioblastoma diagnosis patients must have adequate hepatic renal bone marrow function defined as
0, mycophenolate mofetil stage iv cutaneous cell non hodgkin lymphoma diagnosis cdfour count is allowed be greater one hundred cells ul
0, dexamethasone multiple myeloma diagnosis serum protein greater equal one dl greater one g urine protein greater two hundred mg twenty four hours
0, pharmacological recurrent renal cell cancer diagnosis ecog zero one
0, prednisone stage adult immunoblastic large cell lymphoma diagnosis please see schema further details
0, sorafenib hepatocellular carcinoma diagnosis ptt less doc uln
0, bb myeloma diagnosis subject must be able adhere visit schedule other protocol requirements
1, vaccines stage iia fallopian tube cancer diagnosis concomitant systemic treatment corticosteroids anti histamine non steroidal antiinflammatory drugs other platelet inhibitory agents strong inhibitors inducers cytochrome pfour hundred fifty threeafour cypfour hundred fifty threeafour
1, irinotecan non small cell lung cancer diagnosis subjects receiving other investigational therapy non approved therapy within thirty days before day one protocol treatment
1, antibodies monoclonal cancer rectum diagnosis patients history pelvic radiation
1, laboratory biomarker analysis nodal marginal zone cell lymphoma diagnosis rifampin rifabutin rifapentine
1, behavioral psychological informational intervention stage iiia ovarian epithelial cancer diagnosis residence greater seventy miles from research site
1, afuresertib gc fasted state cancer diagnosis history regular alcohol consumption within six months defined as
0, medical chart review colorectal cancer diagnosis not living nursing home
1, psychosocial assessment care malignant neoplasm diagnosis currently off treatment longer two weeks at time enrollment
1, antibodies monoclonal merkel cell carcinoma diagnosis unwilling unable use an acceptable method contraception avoid pregnancy up twelve weeks after last dose investigational product
1, imatinib mesylate advanced gastrointestinal stromal tumors diagnosis patients who treated planned be treated concomitantly other cytotoxic antineoplastic treatments such chemotherapy immunotherapy biological response modifiers radiotherapy
0, diagnostic laboratory biomarker analysis stage iii adult soft tissue sarcoma diagnosis ecog zero two
1, tacrolimus stage iv childhood lymphoblastic lymphoma diagnosis infection hiv
0, immunoglobulins adenocarcinoma rectum diagnosis no concurrent combination antiretroviral therapy hiv positive patients
1, fludarabine anaplastic large cell lymphoma diagnosis donor
1, ethicon physiomesh parastomal hernia diagnosis patients prior ileal conduit surgery undergoing revision
1, prednisone prostatic neoplasms diagnosis known brain metastasis
1, rituximab nodal marginal zone lymphoma diagnosis drug alcohol addiction
1, endothelial growth factors ovarian serous cystadenocarcinoma diagnosis clinically significant resting bradycardia
0, triamcinolone acetonide melanoma diagnosis at least one measurable index brain metastasis greater doc cm no larger three cm diameter that had not been previously irradiated two measurable lesions greater doc cm visible on contrast magnetic resonance
0, paclitaxel breast cancer diagnosis creatinine ratio less doc proteinuria less two positive by urine dipstick less one protein on two hour urine collection
1, daunorubicin myeloproliferative neoplasms diagnosis hiv positivity
0, cisplatin sarcomatous mesothelioma diagnosis alt ast less doc times uln
1, sorafenib adult primary hepatocellular carcinoma diagnosis inability comply protocol not willing not available follow up assessments
0, cyclophosphamide fallopian tube cancer diagnosis patient characteristics
0, cytarabine lymphoma diagnosis bone marrow blasts less twenty within four weeks transplantation
1, hormones breast cancer diagnosis concurrent severe uncontrolled medical disease systemic infection diabetes hypertension coronary artery disease congestive heart failure ongoing recent gastrointestinal bleed hepatic cardiac compromise hypocalcemia known platelet function abnormality
1, prednisone adult grade iii lymphomatoid granulomatosis diagnosis known hypersensitivity lenalidomide thalidomide
1, paclitaxel treatment any investigational anticancer drug within twenty one days first treatment administration
0, fludarabine refractory plasma cell myeloma diagnosis patient donor pairs homozygous at mismatched allele graft rejection vector considered two allele mismatch patient is one hundred one donor is one hundred two this type mismatch is not allowed
1, tamoxifen stage iiic breast cancer diagnosis pregnant lactating women
0, bkm metastatic breast cancer diagnosis patient is able swallow retain oral medication
1, anti cd car vector transduced autologous t cells hematopoietic lymphoid cancer diagnosis recent current use inhaled steroids is not exclusionary
0, leucovorin recurrent pancreatic cancer diagnosis patients diabetes eligible this trial all diabetic patients who enrolled on this should discuss need change their diabetes management regimen their primary care physician endocrinologist prior enrollment
1, tasquinimod prostate cancer diagnosis previous therapy antiandrogens within four weeks within six weeks bicalutamide eg casodex prior treatment
1, bevacizumab glioblastoma diagnosis claustrophobia
0, doxorubicin stage iic adult soft tissue sarcoma diagnosis see disease characteristics
1, bevacizumab colorectal cancer diagnosis any laboratory values at baseline follows
1, mycophenolate mofetil intraocular lymphoma diagnosis patient has fungal infection radiological progression after receipt amphotericin active triazole greater one month
1, carboplatin head neck cancer diagnosis these potential risks may also apply other agents used this study
0, paclitaxel primary peritoneal cavity cancer diagnosis at least three weeks since prior chemotherapy six weeks since nitrosoureas mitomycin recovered
0, bioluminescence head neck cancer diagnosis patient characteristics
0, dexamethasone multiple myeloma diagnosis serum creatinine value less twomg dl
0, ifosfamide ovarian cancer diagnosis not specified
0, lenograstim sarcoma diagnosis other
1, questionnaire administration sarcoma diagnosis patients known brain metastases must be excluded from this clinical trial because their poor prognosis because they often develop progressive neurologic dysfunction that would confound evaluation neurologic other adverse events
1, fludarabine recurrent refractory childhood hodgkin lymphoma diagnosis donor is hiv positive has medical condition that would result increased risk filgrastim csf mobilization harvest pbsc
1, thalidomide multiple myeloma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide similar drugs
1, vemurafenib zelborafÂ® patients symptomatic untreated leptomeningeal brain metastases spinal cord compression patients previous brain metastases will be allowed enter trial if metastases have been surgically removed all known sites metastases have been treated stereotactic high dose radiosurgery
0, albumin bound paclitaxel male breast carcinoma diagnosis serum urine beta hcg negative premenopausal women child bearing potential
0, methotrexate multiple myeloma plasma cell neoplasm diagnosis prior concurrent therapy
1, paclitaxel ovarian clear cell adenocarcinoma diagnosis patients serious non healing wound ulcer bone fracture this includes history abdominal fistula gastrointestinal perforation intra abdominal abscess within twenty eight days patients granulating incisions healing by secondary intention no evidence fascial dehiscence infection eligible but require weekly wound examinations
1, paclitaxel carcinoma non small cell lung diagnosis prior treatment egfr hertwo targeting small molecules antibodies
1, phenylephrine stomatitis diagnosis pregnant
0, vorinostat mantle cell lymphoma diagnosis anc greater doc xone hundred nine l
1, capecitabine malignant neoplasms digestive organs diagnosis positive history hiv active hepatitis active hepatitis severe uncontrolled intercurrent illness infection
0, mesna stage fours neuroblastoma diagnosis ejection fraction greater equal fifty by radionuclide evaluation
1, dexamethasone phosphate multiple myeloma diagnosis lactating females must agree not breast feed while taking lenalidomide
1, pazopanib advanced metastatic neuroendocrine tumors diagnosis doc
0, albumin bound paclitaxel tumors diagnosis patients stable clinically insignificant central nervous system cns disease allowed
0, laboratory biomarker analysis cervical squamous cell carcinoma not otherwise specified diagnosis patients an invasive malignancy cervix uterine corpus including all stages grades common cell types
1, fludarabine phosphate recurrent refractory childhood hodgkin lymphoma diagnosis donor
1, analgesics opioid advanced cancer diagnosis has experienced myocardial infarction clinically significant cardiac dysfunction within last twelve months has cardiac disorder that opinion investigator would put patient at risk clinically significant arrhythmia myocardial infarction
1, glucocorticoids breast cancer diagnosis addition mifepristone pre existing drug regimen may cause mild temporary increase plasma drug concentration drugs significant cypthreeafour metabolism
0, dexamethasone multiple myeloma light chain induced renal insufficiency diagnosis hypercalcemia
1, caspase inhibitors carcinoma hepatocellular diagnosis extrahepatic malignancy
1, delayed cbt postcancer fatigue diagnosis contra indication mr examinations claustrophobia
0, oxaliplatin neoplasm rectum diagnosis platelets greater one hundred zero cells mmthree
1, cyclosporine contiguous stage ii adult lymphoblastic lymphoma diagnosis patients rapidly progressive intermediate high grade nhl
0, cyclophosphamide spindle cell rhabdomyosarcoma diagnosis stage two three group iii
1, sorafenib breast cancer diagnosis women who not postmenopausal have not undergone hysterectomy must have documented negative serum pregnancy test within seven days prior initiating treatment
0, vidarabine recurrent grade one follicular lymphoma diagnosis patient must have adequate insurance other support meet anticipated financial burden imposed by costs therapy
1, dexamethasone acetate multiple myeloma diagnosis previous velcade therapy
1, misonidazole stage iiic breast cancer diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible
0, niacinamide stage iii pancreatic cancer diagnosis ast alt less doc times upper limit normal
0, liposomal doxorubicin stage mantle cell lymphoma diagnosis define dhl patients must have evidence myc defined as
0, paclitaxel stage iv pancreatic cancer diagnosis karnofsky performance status kps greater equal seventy
0, lenograstim angioimmunoblastic cell lymphoma diagnosis platelet count greater equal one hundred ten nine l
1, dexamethasone acetate adult nasal type extranodal nk cell lymphoma diagnosis previous systemic chemotherapy immunotherapy within three weeks before entry
0, vidarabine recurrent grade three follicular lymphoma diagnosis research participant without clinically significant encephalopathy new focal deficits
0, dexamethasone acetate recurrent childhood lymphoblastic lymphoma diagnosis negative pregnancy test
0, rituximab contiguous stage ii adult lymphoblastic lymphoma diagnosis phase ii subjects must have estimated measured creatinine clearance greater equal thirty ml min
0, prednisone double hit variant defined having myc avian myelocytomatosis viral oncogene homolog myc gene rearrangement presence cell chronic lymphocytic leukemia cll lymphoma bcl two bclsix gene rearrangement
0, dexamethasone phosphate stage multiple myeloma diagnosis male subjects must agree use latex condom during sexual contact females childbearing potential while participating at least twenty eight days following discontinuation from even if he has undergone successful vasectomy
1, cadexomer iodine recurrent cell non hodgkin lymphoma diagnosis prior allogeneic bone marrow stem cell transplant
1, immunoglobulins stage iia rectal cancer diagnosis evidence any other disease neurological metabolic dysfunction physical examination finding laboratory finding giving reasonable suspicion disease condition that contraindicates use bevacizumab puts patient at high risk treatment related complications
1, mycophenolic acid stage iv adult diffuse large cell lymphoma diagnosis patients rapidly progressive intermediate high grade nhl
1, cryoablation ovarian cancer diagnosis topical inhaled corticosteroids permitted
0, razoxane recurrent childhood anaplastic large cell lymphoma diagnosis creatinine clearance radioisotope glomerular filtration rate gfr greater equal seventyml min doc three two serum creatinine based on age gender follows
1, antibodies adult solid neoplasm diagnosis patients may not be receiving any other investigational agents
0, bevacizumab brain cancer diagnosis sgot sgpt both less three times upper limit normal
0, sunitinib renal cell cancer diagnosis investigator is requested advise patient how achieve an adequate contraception
1, mycophenolate mofetil refractory multiple myeloma diagnosis current serious systemic illness
1, fast track rehabilitation colorectal tumor diagnosis creation colo rectal colo anal ileo anal anastomosis without loop ileostomy
0, fluorouracil recurrent gallbladder cancer diagnosis patients who chemotherapy naive unless chemotherapy was given adjuvant post surgical treatment at least six months have elapsed since adjuvant chemotherapy
0, fluorouracil mucinous adenocarcinoma rectum diagnosis absolute neutrophil count greater equal one five hundred ul
0, questionnaire administration unspecified adult solid tumor protocol specific diagnosis able provide written informed consent
1, pembrolizumab recurrent merkel cell carcinoma diagnosis patient has history current evidence any condition therapy laboratory abnormality that might confound results trial interfere patient participation full duration trial is not best interest patient participate opinion treating investigator
1, theophylline non small cell lung cancer diagnosis subjects evidence history bleeding diathesis any hemorrhage bleeding event ctcae grade greater three higher within four weeks start investigational treatment
0, methotrexate cutaneous cell non hodgkin lymphoma diagnosis philadelphia chromosome positive ph positive metaphases greater zero but less thirty five
0, fluorouracil stage ii gallbladder cancer diagnosis patients must have zubrod performance status zero one
0, docetaxel recurrent hypopharyngeal squamous cell carcinoma diagnosis no known brain metastases
1, albumin bound paclitaxel tubular breast cancer diagnosis any evidence sense motor nerve disorders
0, thalidomide multiple myeloma diagnosis patients must provide written informed consent indicating that they aware investigational nature this study
0, niacinamide recurrent verrucous carcinoma larynx diagnosis creatinine equal less doc uln
0, antibodies monoclonal adult ependymoma diagnosis inadequately controlled hypertension systolic bp greater one hundred forty mm hg diastolic bp greater ninety mm hg despite antihypertensive medication
0, dasatinib breast neoplasms diagnosis ability understand willingness sign written informed consent document
0, o benzylguanine unspecified adult solid tumor protocol specific diagnosis prothrombin time less doc times normal
1, fludarabine tumor cell invasion into cns
0, rituximab lymphoma diagnosis measurable disease
0, levoleucovorin pancreatic cancer diagnosis biologic therapy
0, everolimus non small cell lung cancer diagnosis patients may not have had grade three hemorrhage within four weeks drug administration
0, docetaxel breast cancer diagnosis ecog performance status
1, therapeutic allogeneic lymphocytes recurrent refractory childhood hodgkin lymphoma diagnosis diffusing capacity lung carbon monoxide dlco less fifty corrected hemoglobin
1, colo ad resectable bladder cancer diagnosis ribavirin adefovir lamivudine cidofovir within seven days prior day one
1, methylprednisolone anaplastic large cell lymphoma alk negative diagnosis patient is pregnant breastfeeding expecting conceive father children within one year finishing treatment
0, paclitaxel uterine cancer diagnosis creatinine less equal doc mg dl
0, dacarbazine neuroblastoma diagnosis serum creatinine based on age gender table
0, sunitinib histologic cytologic diagnosis breast carcinoma
0, cisplatin stage iii squamous cell carcinoma hypopharynx diagnosis have an eastern cooperative oncology group ecog performance status equal less two
1, mifamurtide osteosarcoma diagnosis mental social conditions that can compromise correct adherence protocol its procedures
1, transartery chemoembolization diffuse tumor morphology extensive lesions involving both lobes
1, mycophenolic acid recurrent grade two follicular lymphoma diagnosis donor
0, vinblastine adult nodular sclerosis hodgkin lymphoma diagnosis patients must have bone marrow biopsy bilateral preferred unilateral acceptable within sixty days prior registration
0, calcium dietary stage iiib rectal cancer diagnosis group ii
0, oxaliplatin small intestine lymphoma diagnosis histologically confirmed diagnosis one following
1, ondansetron cancer diagnosis no history allergy drugs
1, everolimus stage iv adult soft tissue sarcoma diagnosis adverse events due agents administered equal less four weeks prior entry
0, antibodies monoclonal lymphoma diagnosis hemoglobin greater eight zero dl five zero mmol ran greater one five onezero platelets greater onezerozero onezero l
1, mycophenolate mofetil recurrent adult diffuse small cleaved cell lymphoma diagnosis thirty six whole brain
1, isatuximab plasma cell myeloma diagnosis above information is not intended contain all considerations relevant patient potential participation clinical trial
1, paclitaxel a regimen is defined greater equal two cycles systemic anti cancer therapy containing one more agents following classes
1, midazolam received total body irradiation cranial irradiation cancer
0, prednisolone acetate multiple myeloma plasma cell neoplasm diagnosis patient characteristics
0, ex vivo expanded autologous t cells modified express cd car stage iv grade one follicular lymphoma diagnosis creatinine less doc mg dl
0, bortezomib recurrent marginal zone lymphoma diagnosis at least three months since prior autologous stem cell transplantation relapsed greater equal one year since prior allogeneic transplantation relapsed no active related infections fungal viral
1, nuclear breast imaging using mbi gamma camera breast cancer diagnosis unable undergo mri because of
0, bortezomib anaplastic oligodendroglioma
0, albumin bound paclitaxel measurable disease according response evaluation criteria solid tumors recist criteria at least one measurable lesion not previously irradiated
1, propofol supratentorial brain tumor diagnosis nausea vomiting
0, tacrolimus lymphoma diagnosis performance status
0, disulfiram solid neoplasm diagnosis intrauterine device non progesterone t
1, nivolumab oligometastatic melanoma diagnosis unwillingness inability follow procedures required protocol
1, gemcitabine breast cancer diagnosis patients clinically significant medical psychiatric problems which may interfere treatment on study
1, fludarabine phosphate lung cancer diagnosis history coronary revascularization ischemic symptoms
0, nivolumab endometrial adenocarcinoma diagnosis no other prior malignancy is allowed except following
0, paclitaxel ovarian serous cystadenocarcinoma diagnosis no poorly controlled systolic diastolic hypertension diastolic blood pressure consistently greater one hundred mm hg
0, brachytherapy adenocarcinoma prostate diagnosis gleason score three positive threeequal six
0, bb metastatic cancer diagnosis wbc at least three zero mm three
0, carboplatin carcinoma non small cell lung diagnosis stage ii above tcc patients stage iv nsclc patients that will receive platinum based chemotherapy will be eligible this study
1, liposomal doxorubicin urethral cancer associated invasive bladder cancer diagnosis no persistently uncontrolled diabetes mellitus
0, cyclosporins recurrent non hodgkin lymphoma diagnosis donor
1, cisplatin stage iv ovarian cancer diagnosis patients who pregnant nursing date no fetal studies animals humans have been performed possibility harm fetus is likely
1, chi l protein human stage iiia primary peritoneal cancer diagnosis stage not greater ib no more superficial myometrial invasion without vascular lymphatic invasion no poorly differentiated subtypes including papillary serous clear cell other figo grade three lesions
0, isophosphamide mustard extraskeletal myxoid chondrosarcoma diagnosis patients following histologies only eligible chemotherapy cohort cannot enroll on non chemotherapy cohort
1, healthy nutrition breast cancer diagnosis serious other diseases such recent myocardial infarction clinical signs cardiac failure clinically significant arrhythmias
0, phenylbutyric acid brain neoplasms diagnosis renal
0, psma adc glioblastoma multiforme diagnosis hemoglobin hgb greater doc dl
0, bleomycin childhood lymphocyte depleted classical hodgkin lymphoma diagnosis creatinine no greater doc times normal
1, immunosuppressive agents stage iv cutaneous cell non hodgkin lymphoma diagnosis presence active central nervous system cns disease history adequately treated cns disease is acceptable
0, pentostatin lymphoma diagnosis not pregnant nursing
0, best supportive care carcinoma hepatocellular diagnosis liver transaminases ast alt less equal five times upper normal limits unls serum bilirubin less equal doc times unl less equal two mg dl
1, mycophenolic acid stage iii adult cell leukemia lymphoma diagnosis donor
1, docetaxel patient will be receiving gnrh agonists such goserelin zoladex leuprolide acetate lupron concomitantly chemotherapy purpose preventing breast cancer recurrence
1, diphosphonates hodgkin lymphoma diagnosis prior organ allograft
1, sym cytotoxic cytostatic anti cancer chemotherapy within four weeks
0, succinylcholine metastatic anal canal carcinoma diagnosis absolute neutrophil count anc greater equal doc ten nine l
1, niacinamide stage ivc squamous cell carcinoma lip oral cavity diagnosis any malabsorption condition
1, antibodies monoclonal metastatic renal cell carcinoma diagnosis idiopathic pulmonary fibrosis other risk pneumonitis
1, endostatins neurofibromatosis type two diagnosis six uncontrolled neural mental diseases poor compliance
1, internet based intervention stage iiic colorectal cancer diagnosis any physical mental health condition that would interfere full participation including individuals who unable read consent materials appear lack capacity consent
0, cyclophosphamide hodgkin non hodgkin lymphoma diagnosis does not have any other active malignancy other one which this transplant is indicated
1, mycophenolate mofetil stage iii adult immunoblastic large cell lymphoma diagnosis seropositive human immunodeficiency virus hiv
1, darinaparsin bone marrow neoplasms diagnosis prior history neurological deficits stroke dementia ischemia that has potential confound post dose neurological assessment
1, quercetin primary prevention prostate cancer diagnosis participation any other trial an investigational new drug
1, abiraterone acetate metastatic castrate resistant prostate cancer diagnosis uncontrolled medical conditions such myocardial infarction uncontrolled hypertension stroke treatment major active infection within three months randomization well any significant concurrent medical illness that opinion investigator would preclude protocol therapy
1, liposomal doxorubicin breast cancer stage ii diagnosis known presumed hypersensitivity decitabine pembrolizumab any their excipients
1, etoposide phosphate stage iv small lymphocytic lymphoma diagnosis pregnant breastfeeding women excluded from this breastfeeding should be discontinued if mother is treated busulfan cyclophosphamide etoposide
1, cyclophosphamide extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis prior entry any electrocardiogram ecg abnormality at screening has be documented by investigator not medically relevant
1, methotrexate lymphoblastic lymphoma diagnosis participation other clinical trials including those other investigational agents not included this trial within twenty onedays start this trial throughout induction consolidation one portions this trial while on mln nine thousand seven hundred eight
0, carboplatin recurrent grade one follicular lymphoma diagnosis patients must sign informed consent
0, capecitabine gastric cancer diagnosis leukocytes greater three zero mcl
0, molecular diagnostic method lcis presenting an incidental finding together invasive breast cancer any morphological subtype
0, antibodies monoclonal stage ivb squamous cell carcinoma paranasal sinus nasal cavity diagnosis locally advanced recurrent no longer amenable local surgical radiation therapy or
1, ferrosoferric oxide stage iv ovarian cancer diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated any these agents
0, fluorouracil breast cancer diagnosis surgery
1, therapeutic allogeneic lymphocytes childhood nasal type extranodal nk cell lymphoma diagnosis bilirubin greater equal three uln unless gilbert syndrome
0, sorafenib recurrent gallbladder carcinoma diagnosis leukocyte count greater three zero mm three
0, cisplatin esophageal cancer diagnosis negative pregnancy test
0, laboratory biomarker analysis effects mlnfive hundred eighteen on developing human fetus at recommended therapeutic dose unknown this reason because receptor tyrosine kinase inhibitors known be teratogenic women child bearing potential men must agree use adequate contraception hormonal barrier method birth control abstinence prior entry duration participation should woman become pregnant suspect she is pregnant while participating this she should inform her treating physician immediately sexually active patients must continue use contraception three months after completion therapy
1, rituximab recurrent grade three follicular lymphoma diagnosis participants should not have taken valproic acid another histone deacetylase inhibitor at least two weeks prior enrollment
1, rrx lymphomas diagnosis subjects history acute cerebral infarction transient ischemic attack within ninety days prior day one
1, etoposide phosphate stage iv childhood anaplastic large cell lymphoma diagnosis patients down syndrome not eligible
1, etoposide lymphoma large cell immunoblastic diagnosis patients evidence myelodysplastic syndrome acute myeloid leukemia mds aml abnormal cytogenetic analysis indicative mds on pre transplant bone marrow examination
0, dexamethasone acetate prostate adenocarcinoma diagnosis patients must have rising psa on two successive measurements at least two weeks apart
0, cyclophosphamide stage iv adult diffuse large cell lymphoma diagnosis eligible after initial therapy greater equal crone greater equal prone
0, pharmacological primary peritoneal cavity cancer diagnosis qtc interval less four hundred fifty msec no factors that increase risk qt prolongation arrhythmic events including but not limited any following
0, everolimus advanced solid tumors non small cell lung cancer diagnosis patients who pregnant lactating excluded from this study
0, paclitaxel metastatic melanoma diagnosis men women reproductive potential must agree use an acceptable method birth control during treatment twelve months after completion treatment
0, erlotinib hydrochloride pancreatic acinar cell carcinoma diagnosis aspartate aminotransferase ast equal less three times upper limit normal uln
0, albumin bound paclitaxel stage ib breast cancer diagnosis note
0, pembrolizumab recurrent grade three follicular lymphoma diagnosis eastern cooperative oncology group ecog performance status ps zero one two
0, fludarabine phosphate recurrent small lymphocytic lymphoma diagnosis waldenstrom macroglobulinemia must have failed two courses therapy
1, isophosphamide mustard malignant triton tumor diagnosis cardiac arrhythmia
1, camptothecin extensive stage small cell lung cancer diagnosis patients uncontrolled brain metastases patients treated brain metastases must have stable neurologic status off steroids anticonvulsants at least two weeks must be without neurologic dysfunction that would confound evaluation neurologic other adverse events
0, vemurafenib malignant melanoma diagnosis pediatric participants twelve seventeen years age inclusive
0, mycophenolic acid childhood diffuse large cell lymphoma diagnosis acute lymphoid leukemia onest twond morphological remission
1, albumin bound paclitaxel breast cancer diagnosis serious non healing wound ulcer bone fracture
1, antibodies monoclonal metastatic castration sensitive prostate cancer diagnosis patients that meet any criteria listed below will not be eligible cohort entry
1, immunoglobulins adult glioblastoma diagnosis history venous arterial thromboembolism within twelve months prior registration
0, testosterone beta cypionate prostate cancer diagnosis subject is willing able comply all protocol requirements assessments
0, decitabine stage iv small lymphocytic lymphoma diagnosis hematopoietic growth factors colony stimulating factors treatment cytopenia may be permitted at discretion principal investigator
0, epothilone b non small cell lung cancer diagnosis world health organization who performance status zero one two corresponding karnofsky performance status zero better
1, arzoxifene hydrochloride prior hormonal therapy metastatic breast cancer except tamoxifen concurrent supplemental estrogen progesterone at least three weeks since prior estrogen replacement therapy other concurrent hormone therapy radiotherapy
0, cyclophosphamide multiple myeloma diagnosis patients must be seventy five years age less at time registration
1, doxorubicin atypical burkitt lymphoma diagnosis all males females reproductive potential must consent use an effective form contraception while on study
0, maleic acid recurrent ovarian carcinoma diagnosis less equal one positive proteinuria on two consecutive dipsticks taken no less one week apart less one gm protein on twenty four hour urine collection urine protein
0, niacinamide hepatocellular carcinoma diagnosis patients on warfarin inr should be measured prior initiation sorafenib monitored at least weekly defined by local standard care until inr is stable
1, sirolimus estrogen receptor positive breast cancer diagnosis male patients whose sexual partner wocbp who not willing use adequate contraception during eight weeks after end treatment
0, carboplatin tumors diagnosis ecog zero two
0, bleomycin childhood germ cell tumor diagnosis stage iv
1, immunoglobulins recurrent salivary gland cancer diagnosis patients known hypersensitivity bkmone hundred twenty its excipients hypersensitivity cetuximab
1, immunoglobulin g ovarian mucinous cystadenocarcinoma diagnosis complete left bundle branch block
0, antibodies stage iii prostate cancer diagnosis if second third confirmatory value is less previous value patient will still be eligible if repeat value no
0, chlorogenic acid glioblastoma diagnosis patients who have sufficient baseline organ function whose laboratory data can meet following criteria at enrollment
0, bortezomib multiple myeloma diagnosis women childbearing potential negative serum pregnancy test is required within four weeks starting cycle one then every four weeks during first four cycles induction therapy
1, vatalanib recurrent renal cell cancer diagnosis uncontrolled infection
0, everolimus recurrent digestive system neuroendocrine tumor gone diagnosis child pugh equal less six points better liver status
0, cyclophosphamide multiple myeloma plasma cell neoplasm diagnosis myeloproliferative disease
0, capecitabine a woman child bearing potential is any female regardless sexual orientation having undergone tubal ligation remaining celibate by choice who meets following criteria
0, immunoglobulins stage grade three follicular lymphoma diagnosis men must agree use latex condom during sexual contact fcbp even if they have had successful vasectomy
0, lenalidomide multiple myeloma diagnosis patient has life expectancy greater six months
0, carboxymethylcellulose sodium newly diagnosed pediatric high grade glioma diagnosis all patients must sign an irb approved informed consent document
1, temozolomide gliosarcoma diagnosis patients on phase one portion may not have had more three prior regimens
0, bevacizumab stage verrucous carcinoma oral cavity diagnosis platelet count greater seventy five zero mm three
1, iodine thyroid cancer diagnosis unstable angina
0, paclitaxel esophagus cancer diagnosis able perform activities daily living minimal assistance
1, alemtuzumab contiguous stage ii grade one follicular lymphoma diagnosis positive cross match exists between donor recipient
1, clinical observation extracranial multiple meningioma hemangiopericytoma
0, carboplatin endometrial clear cell adenocarcinoma diagnosis major conduction abnormality unless cardiac pacemaker is present
1, compliance monitoring ovarian endometrioid adenocarcinoma diagnosis patients gog performance grade three four
0, vincristine cns brain cancer diagnosis men women reproductive potential must agree use an acceptable method birth control during treatment six months after completion treatment
1, bortezomib recurrent adult grade iii lymphomatoid granulomatosis diagnosis patient has an absolute neutrophil count anc less doc ten nine within fourteen days before enrollment
0, albumin bound paclitaxel bladder cancer diagnosis ast alt less doc upper limit normal alkaline phosphatase less doc upper limit normal bilirubin less doc mg dl
0, cadexomer iodine recurrent adult diffuse small cleaved cell lymphoma diagnosis patients must have an expected survival greater sixty days must be free major infection
0, taxane breast cancer diagnosis placement intrauterine device system
0, liposomal doxorubicin peripheral primitive neuroectodermal tumor soft tissues diagnosis all patients their parents legal guardians must sign written informed consent
0, radiation therapy histologically confirmed invasive unilateral breast cancer that is considered operable
0, ascorbic acid desmoplastic small round cell tumor diagnosis eighteen years older at time entry on study
1, bevacizumab metastatic colorectal cancer diagnosis use full dose oral parenteral anticoagulants at least ten days before start treatment thrombolytic agents
0, topotecan lung cancer diagnosis cns metastases treated whole brain radiotherapy wbrt allowed after completion wbrt
1, mechlorethamine recurrent plasma cell myeloma diagnosis known allergy filgrastim csf
1, sirolimus composed mostly sarcomatoid carcinoma
0, mycophenolic acid recurrent adult lymphoblastic lymphoma diagnosis good performance status
0, educational intervention psychosocial effects cancer its treatment diagnosis alkaline phosphatase less doc times uln
0, sirolimus pancreatic cancer diagnosis is age patient greater eighteen years
1, melphalan burkitt lymphoma diagnosis adult
1, cabozantinib carcinoid tumor diagnosis major surgery radiation treatment less four weeks prior enrollment
0, antibodies monoclonal splenic marginal zone lymphoma diagnosis serum albumin greater equal two dl
0, levoleucovorin colorectal cancer diagnosis no other clinically significant cardiac disease
1, doxorubicin melanoma diagnosis alkaline phosphatase levels greater doc uln if no liver metastases greater five uln patients liver metastases greater ten uln patients bone metastases
1, antibodies monoclonal stage iii prostate cancer diagnosis proteinuria at screening demonstrated by
1, cyclosporins clear cell renal cell carcinoma diagnosis donor
0, cisplatin complete pathological specimens including newly diagnosed prostate cancer disease progress crpc
1, etoposide recurrent grade one follicular lymphoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast greater three times upper limits normal unless determined be result primary hematologic malignancy attributed gilbert syndrome
0, abiraterone acetate prostate cancer diagnosis visceral high risk disease
1, everolimus cancer diagnosis active peptic ulcer disease inflammatory bowel disease ulcerative colitis other gastrointestinal conditions increased risk perforation
0, azacitidine metastatic melanoma diagnosis patients must have had disease progression on following their most recent treatment regimen on presentation first time metastatic disease surgical option can be entertained if this is localized relapse
0, paclitaxel cancer diagnosis male female patients childbearing potential must agree use contraception avoidance pregnancy measures during thirty days after last dose
1, tivantinib childhood solid neoplasm diagnosis patients who have an uncontrolled infection not eligible
1, cortisol succinate peripheral cell lymphoma diagnosis ggt must be less doc institutional upper limit normal grade one less per ctcae four
1, immunoglobulins stage iva squamous cell carcinoma oropharynx diagnosis john wort kava ephedra ma huang gingko biloba dehydroepiandrosterone dhea yohimbe saw palmetto ginseng fruits include cytochrome pfour hundred fifty family three subfamily cypthreea inhibitors seville oranges grapefruit pummelos exotic citrus fruits
0, cisplatin esophageal cancer diagnosis hemogram
0, albumin bound paclitaxel lung cancer diagnosis sulfinpyrazone
0, levoleucovorin colorectal cancer diagnosis folfox four oxaliplatin fluorouracil leucovorin calcium
1, fludarabine phosphate stage ii contiguous adult lymphoblastic lymphoma diagnosis donor
0, fludarabine stage ii adult non contiguous immunoblastic lymphoma diagnosis acute lymphocytic leukemia all must have less five marrow blasts at time transplant
1, dexamethasone multiple myeloma diagnosis known chronic obstructive pulmonary disease copd forced expiratory volume one second fevone less fifty predicted normal
1, placebo administration colorectal cancer diagnosis any other serious uncontrolled illness which opinion investigator makes it undesirable patient enter trial
1, paclitaxel metastatic pancreatic cancer diagnosis patient has known historical active infection hiv hepatitis hepatitis c
1, enalaprilat lymphoma diagnosis coronary artery disease
1, magnetic resonance imaging stage ib breast cancer diagnosis metastatic malignancy any kind
0, oxaliplatin colorectal cancer diagnosis no predominant extrahepatic disease
1, vinorelbine metastatic non small cell lung cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition pazopanib vinorelbine
1, doxorubicin relapsed follicular lymphoma diagnosis prior treatment cumulative dose doxorubicin more one hundred mg mtwo if assigned arm velcade cap
0, interferon alpha malignant mesothelioma diagnosis prior concurrent therapy
1, ixazomib marginal zone lymphoma diagnosis any serious medical psychiatric illness that could investigator opinion potentially interfere completion treatment according this protocol
1, dexamethasone multiple myeloma diagnosis subjects any following laboratory abnormalities
1, bupivacaine breast cancer diagnosis patients under age eighteen over age seventy nine
0, cyclophosphamide recurrent grade three follicular lymphoma diagnosis patients aml all cml scheduled reduced intensity conditioning non myeloablative conditioning should be complete morphologic remission at start conditioning residual disease by flow cytometry cytogenetics incomplete recovery neutrophil platelet count acceptable
0, maytansine wilms tumor diagnosis doc mg dl males females
1, pv rose bengal disodium hepatocellular carcinoma that is not amenable resection transplant other potentially curative diagnosis pregnancy
0, cisplatin untreated childhood medulloblastoma diagnosis fertile patients must use effective contraception
1, prednisolone hemisuccinate symptomatic peripheral neuropathy grade greater two nci ctcae v
1, fluorouracil signet ring adenocarcinoma rectum diagnosis cystic lesions
1, mycophenolate mofetil childhood non hodgkin lymphoma diagnosis donor
1, full field digital mammogram tumors breast diagnosis have been previously included this study
0, dacarbazine glioblastoma diagnosis alkaline phosphatase less two uln
0, nelfinavir mature cell nk cell neoplasms diagnosis absolute neutrophil count greater one five hundred mmÂ³
1, vaccines recurrent brain neoplasm diagnosis active infection requiring treatment including human immunodeficiency virus hiv infection
0, docetaxel unspecified adult solid tumor protocol specific diagnosis mild intermittent asthma requiring only occasional beta agonist inhaler use mild localized eczema allowed
0, busulfan soft tissue plasmacytoma
1, lansoprazole neoplasm advanced metastatic diagnosis has lactose intolerance only part two
1, olaparib persistent toxicities greater equal ctcae grade two exception alopecia caused by previous cancer therapy
0, oxaliplatin stage iiic colon cancer diagnosis no unstable angina
1, etoposide phosphate previous radiotherapy chemotherapy head neck district tumors surgical treatment relapses admitted
0, pembrolizumab refractory hodgkin lymphoma diagnosis no laboratory aes noted on protocol defined screening laboratories greater grade one by ctcae criteria probably definitely attributed cart exceptions noted below
0, bevacizumab liver cancer diagnosis more seven days since prior minor surgical procedures fine needle aspirations core biopsies excluding placement vascular access device
0, plx sarcoma diagnosis two more lisch nodules
0, nivolumab recurrent anal canal carcinoma diagnosis absolute neutrophil count greater equal one five hundred mcl
0, doxorubicin stage ib breast cancer diagnosis absolute neutrophil count anc must be greater equal one two hundred mm three
0, vinorelbine sarcoma diagnosis embryonal spindle cell botryoid rms favorable pathology
1, blz central nervous system tumors diagnosis anticoagulation
1, trioxsalen brain tumor recurrent diagnosis pregnancy breast feeding
1, capecitabine recurrent rectal cancer diagnosis medical social psychological factors that would interfere consent follow up
0, carboplatin ovarian serous adenocarcinoma diagnosis bilirubin less equal doc uln ctcae grade one
0, busulfan unspecified adult solid tumor protocol specific diagnosis hiv negative
0, mycophenolic acid recurrent small lymphocytic lymphoma diagnosis patients hematologic malignancies treatable hct will be included
0, cytarabine myeloid sarcoma myeloid proliferations related down syndrome blastic plasmacytoid dendritic cell neoplasm
1, dexamethasone acetate multiple myeloma diagnosis no waiting required following port cath placement
1, celecoxib colorectal neoplasms diagnosis exceptions
0, vinorelbine stage iii neuroendocrine carcinoma skin diagnosis patients must have adequate liver functions
1, pembrolizumab stage ivb oropharyngeal squamous cell carcinoma diagnosis severe active co morbidity defined follows
1, internet based intervention stage iii marginal zone lymphoma diagnosis does not complete baseline assessment through hads hospital anxiety depression scale
1, cortisone acetate hormone resistant prostate cancer diagnosis patients may not have received cabazitaxel past
1, bevacizumab colorectal cancer diagnosis central nervous system metastases
1, sorafenib stage ivb squamous cell carcinoma paranasal sinus nasal cavity diagnosis subjects who have used strong cytochrome pfour hundred fifty family three subfamily polypeptide four cypthreeafour inducers phenytoin carbamazepine phenobarbital st
1, vincristine t cell all cell non hodgkin lymphoma
0, bb pituitary basophilic adenoma diagnosis doc mg dl male patients greater sixteen years
1, lenalidomide noncontiguous stage ii mantle cell lymphoma diagnosis development erythema nodosum if characterized by desquamating rash while taking thalidomide similar drugs
1, ganciclovir triphosphate primary secondary cns lymphoma hiv related lymphoma
0, lapatinib metastatic pancreatic cancer diagnosis cardiac ejection fraction within institutional range normal measured by echocardiogram muga scan
1, cediranib fallopian tube clear cell adenocarcinoma diagnosis history myocardial infarction within six twelve months patients history myocardial infarction within six months excluded from study
1, rituximab lymphoma diagnosis unstable cardiac disease despite treatment myocardial infarction within six months prior entry ii
1, antibodies monoclonal gastroesophageal junction adenocarcinoma diagnosis participant experienced any arterial thromboembolic event within six months
1, vaccines stage adult hodgkin lymphoma diagnosis post hct specific exclusions
1, blood sampling ovarian cancer diagnosis person deprived liberty
1, lovastatin neurofibromatosis one diagnosis non fluency english
0, fludarabine phosphate noncontiguous stage ii adult diffuse large cell lymphoma diagnosis patients will be accepted chronic phase accelerated phase patients who have received prior autografts after high dose therapy have undergone intensive chemotherapy filgrastim csf mobilized peripheral blood mononuclear cells pbmc autologous conventional hct advanced cml may be enrolled provided they cr cp have less five marrow blasts at time transplant
1, vidarabine recurrent adult burkitt lymphoma diagnosis donor
1, fludarabine phosphate metastatic cancer diagnosis any patient known have an left ventricular ejection fraction lvef less equal forty five percent
1, paclitaxel pancreatic neoplasms diagnosis topical ocular intra articular intranasal inhalational corticosteroids minimal systemic absorption some uses systemic corticosteroids permitted per section doc
0, niacinamide adult gliosarcoma diagnosis treatment any number prior relapses defined disease progression after initial therapy radiotherapy without chemotherapy if used initial treatment allowed phase i
1, dexamethasone acetate newly diagnosed multiple myeloma diagnosis subjects pleural effusions requiring thoracentesis ascites requiring paracentesis within fourteen days prior enrolment
0, bendamustine hydrochloride extensive stage lung cancer diagnosis adequate bone marrow liver renal function defined as
0, antibodies monoclonal stage iii squamous cell carcinoma paranasal sinus nasal cavity diagnosis cardiac arrhythmia serious ventricular arrhythmia ventricular fibrillation ventricular tachycardia greater three beats row within past twelve months
1, avelumab osteosarcoma diagnosis patients who have previously received anti pdone anti pd lone therapy
1, mycophenolic acid recurrent small lymphocytic lymphoma diagnosis liver abnormalities
0, prednisolone hemisuccinate childhood nasal type extranodal nk cell lymphoma diagnosis pulmonary function tests demonstrating fevone greater sixty predicted age
0, leucovorin stage iiib esophageal cancer diagnosis patients must not be taking current medications substances that inhibitors inducers cytochrome pfour hundred fifty family three subfamily polypeptide four cypthreeafour
1, laboratory biomarker analysis extensive stage small cell lung cancer diagnosis baseline qtcf greater four hundred fifty msec male qtcf greater four hundred seventy msec female
1, life bronchoscopy non small cell lung carcinoma diagnosis persons who pregnant nursing
1, educational dvd colonic neoplasms diagnosis patients
1, liposomal doxorubicin oligodendroglioma diagnosis multi focal metastatic disease
0, bevacizumab gliosarcoma diagnosis serum total bilirubin less doc upper limit normal uln within fourteen days prior registration
1, cyclosporine recurrent marginal zone lymphoma diagnosis positive anti donor lymphocytotoxic crossmatch
0, immunotoxins ovarian cancer diagnosis life expectancy
0, oxaliplatin stage iiib colon cancer diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum glutamate pyruvate transaminase sgpt equal less three uln patients known hepatic involvement ast alt equal less five uln allowed
0, doxorubicin ovarian cancer diagnosis no new york heart association class ii iv cardiac disease
1, gefitinib non small cell lung cancer metastatic diagnosis unwillingness use contraception during women who were pregnant lactating
1, heparin colorectal cancer diagnosis which would preclude their being subject chemotherapy treatment option
0, glycine advanced cancers diagnosis absolute neutrophil count anc greater equal one zero mm three platelet count greater equal seventy five zero mm
1, preoperative hyperbaric oxygen common bile duct neoplasms diagnosis upper respiratory tract infection viral infection relative contra indications due difficulty such patients may have clearing their ears sinuses
0, pemetrexed tumors diagnosis creatinine within normal institutional limits or
0, docetaxel pancreatic cancer diagnosis no prior chemotherapy metastatic disease
0, dexamethasone multiple myeloma diagnosis absolute increase must be greater ten mg dl
0, fluorouracil adenocarcinoma rectum diagnosis no concurrent cimetidine
0, antibodies monoclonal stage ib non small cell lung carcinoma diagnosis no prior receipt systemic treatment chemotherapy targeted therapy immunotherapy lesion under consideration treatment
1, trametinib stage iv skin melanoma diagnosis clarithromycin telithromycin troleandomycin
0, fludarabine stage iv mantle cell lymphoma diagnosis unrelated donors who prospectively
0, somatostatin previous treatment lanreotide another somatostatin analogue is not required entry
1, carboplatin carcinoma non small cell lung diagnosis except alopecia
1, leucovorin currently active second malignancy other non melanoma skin cancer carcinoma situ cervix
1, leucovorin colorectal cancer metastatic diagnosis use clearance central line catheter is permitted
0, temozolomide neuroblastoma diagnosis renal
1, phosphonoacetic acid noncontiguous stage ii adult lymphoblastic lymphoma diagnosis recipient had prior polymerase chain reaction pcr positive cmv infection blood organ specific disease past twelve months
1, radiation therapy sarcoma differentiation score two diagnosis primary immunodeficiency state such severe combined immunodeficiency disease
1, vidarabine noncontiguous stage ii small lymphocytic lymphoma diagnosis diffusing capacity lung carbon monoxide dlco less forty predicted corrected hemoglobin hb alveolar ventilation
1, dexamethasone phosphate multiple myeloma diagnosis males whose sexual partners wocbp not using effective birth control
0, protein expression analysis sarcoma diagnosis prior concurrent therapy
1, carcinoembryonic antigen expressing measles virus ovarian cancer diagnosis other concurrent chemotherapy immunotherapy radiotherapy any ancillary therapy considered investigational utilized non fda approved indication context research investigation
1, dexamethasone acetate multiple myeloma diagnosis peripheral neuropathy grade three greater painful grade two
1, gemcitabine mixed mullerian tumors uterus diagnosis any other medical condition including mental illness substance abuse deemed by investigator be likely interfere patient ability sign informed consent
1, albumin bound paclitaxel stage ivb uterine corpus cancer diagnosis patient any prior chemotherapy radiotherapy pelvic malignancy
1, dexamethasone acetate basal cell carcinoma skin
1, mycophenolic acid contiguous stage ii grade one follicular lymphoma diagnosis donor
0, prednisone lymphoma diagnosis see disease characteristics no prior rituximab
0, etoposide phosphate adult burkitt lymphoma diagnosis periodic abstinence eg calendar ovulation symptothermal post ovulation methods withdrawal not acceptable methods contraception
0, etoposide phosphate recurrent adult hodgkin lymphoma diagnosis patients must have an eastern cooperative oncology group ecog performance status zero one
1, gemcitabine stage iii pancreatic cancer diagnosis patients currently receiving radiation therapy those having received radiation within four weeks entry
0, immu marginal zone lymphoma diagnosis patients capable reproduction male patients who have partners capable reproduction must agree use an effective contraceptive method during course two months following completion their last treatment
0, liposomal doxorubicin primary mediastinal cell lymphoma
0, dexamethasone phosphate multiple myeloma plasma cell neoplasm diagnosis at least three weeks since prior major surgery
1, estradiol valerate endometrial cancer diagnosis positive serum pregnancy test at baseline evaluation
0, topotecan recurrent small cell lung carcinoma diagnosis patients must have histologically cytologically confirmed sclc
1, veliparib lung carcinoma diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier patients who have been administered abt eight hundred eighty eight part single limited dosing such phase zero should not necessarily be excluded from participating this solely because receiving prior abt eight hundred eighty eight
1, cyclosporine stage iv mantle cell lymphoma diagnosis consenting five six six six hla matched related donor available
0, sirolimus stage iva cervical cancer diagnosis patients may have had prior radiation therapy minimum twenty eight days must have elapsed between end radiotherapy registration onto exceptions may be made however low dose palliative radiotherapy patients must have recovered from any acute toxic effects from radiation prior registration
1, trastuzumab tubular breast cancer stage iii diagnosis known suspected congestive heart failure greater nyha coronary heart disease angina pectoris requiring antianginal medication previous history myocardial infarction evidence transmural infarction on ecg uncontrolled poorly controlled arterial hypertension bp greater one hundred forty ninety mm hg under treatment two antihypertensive drugs rhythm abnormalities requiring permanent treatment clinically significant valvular heart disease
1, temozolomide gliosarcoma diagnosis proteinuria at screening demonstrated by either urine protein
0, vaccines gastric cancer diagnosis ast sgot alt sgpt less equal doc institutional upper limit of
1, trastuzumab stage iib breast cancer diagnosis known positive human immunodeficiency virus hiv infectious hepatitis type b or active hepatitis
0, cortisone stage iii diffuse large cell lymphoma diagnosis be willing able provide written informed consent assent trial
0, irinotecan small cell lung carcinoma diagnosis extensive
0, gemcitabine recurrent endometrial carcinoma diagnosis an individual one up four radiosurgical target lesion must not exceed volume no greater one hundred sixty cubic centimeters cc
1, navitoclax stage iv pancreatic cancer diagnosis use other investigational drugs within twenty eight days five half lives whichever is shorter minimum fourteen days from last dose preceding first dose drug during study
0, vinorelbine patient must have histological diagnosis breast cancer metastasis
0, dasatinib patients must have tumor amenable image guided direct vision biopsy be willing able undergo tumor biopsy molecular profiling patients multiple myeloma have bone marrow aspirate obtain tumor cells biopsy must not be considered be more minimal risk patient
0, mycophenolate mofetil recurrent childhood small noncleaved cell lymphoma diagnosis age less seventy five years
1, dacarbazine patients history second malignant tumor other common skin cancers
0, irinotecan stage ivb rectal cancer diagnosis sexually active women childbearing potential sexually active males strongly advised use an accepted effective method contraception
1, cgx pancreatic adenocarcinoma diagnosis radiotherapy within two weeks first dose drug
1, mitogens neoplasm diagnosis participants taking medications known have significant risk causing qtc prolongation torsades de pointes
0, epirubicin testicular germ cell tumor diagnosis creatinine less doc mg dl creatine clearance greater sixty ml min cardiovascular
1, everolimus unspecified childhood solid tumor protocol specific diagnosis pregnant breast feeding women will not be entered on this pregnancy tests must be obtained girls who post menarchal males females reproductive potential may not participate unless they have agreed use an effective contraceptive method duration three months after last dose imc atwelve
1, oxaliplatin hepatocellular carcinoma diagnosis cns metastasis
1, mkc administration cancer specific therapy within following periods prior drug initiation
1, sirolimus recurrent adult hodgkin lymphoma diagnosis receiving corticosteroids greater twenty mg prednisone per day equivalent note
1, calcium dietary stage iva rectal cancer diagnosis prior history hypertensive crisis hypertensive encephalopathy
0, umbilical cord blood transplantation multiple myeloma plasma cell neoplasm diagnosis not specified
1, mitomycins colorectal neoplasm diagnosis bleeding diathesis coagulopathy
0, lapatinib metastatic breast cancer diagnosis patients will have baseline ct chest abdomen pelvis within thirty days registration
1, dabrafenib subjects small less equal one cm longest dimension asymptomatic brain metastases that not need immediate local therapy can be enrolled
0, laboratory biomarker analysis stage iv small lymphocytic lymphoma diagnosis fertile patients must use effective double barrier contraception one week before during at least two weeks after participation
0, methylprednisolone hemisuccinate multiple myeloma diagnosis major criterion three plus minor criterion one three
1, morphine minor procedures dental work skin biopsy tumor biopsies biliary stent placement allowed
0, pertuzumab thirty invasive tumor cells showing strong complete circumferential membrane staining score three positive
0, immunoglobulins supratentorial meningioma diagnosis serum creatinine equal less doc institutional uln
1, placebo neoplasms diagnosis history thyroid surgery
1, paclitaxel stage iiib breast cancer diagnosis biologic therapy equal less fourteen days prior registration
0, nivolumab adult solid neoplasm diagnosis skin lesion selected non completely biopsied target lesion that can be accurately measured recorded by color photography ruler document size target lesion s
0, cisplatin ovarian mucinous cystadenocarcinoma diagnosis patients this trial may receive ovarian estrogen positive
1, antibodies monoclonal stage iv squamous cell carcinoma hypopharynx diagnosis patient has history cardiac dysfunction including any following
0, antibodies monoclonal adult gliosarcoma diagnosis patients must be maintained on stable corticosteroid regimen from time their baseline scan until start treatment at least five days before starting treatment
0, nivolumab stage iv skin cancer diagnosis albumin greater equal doc dl
0, liposomal doxorubicin any tumor size age
1, paclitaxel stage iii squamous cell carcinoma oropharynx diagnosis patient is enrolled another investigational trial
0, paclitaxel ovarian mucinous cystadenocarcinoma diagnosis patients following histologic epithelial cell types eligible
0, laboratory biomarker analysis recurrent esthesioneuroblastoma paranasal sinus nasal cavity diagnosis performance status
1, antibodies stage iiia primary peritoneal cancer diagnosis note
1, liposomal doxorubicin optic glioma diagnosis inability undergo mri due personal medical reasons
1, prednisone castration resistant prostate cancer diagnosis corrected qt interval qtc greater five hundred ms last four weeks
0, bortezomib stage iii grade three follicular lymphoma diagnosis fertile patients must use effective contraception
0, niacinamide stage renal cell cancer diagnosis patients must have an absolute baseline left ventricular ejection fraction lvef greater equal fifty by multigated acquisition muga scan within four weeks prior randomization
0, cetuximab colorectal cancer diagnosis platelet count greater seventy five zero Î¼l
1, antibodies monoclonal stage ivb colorectal cancer diagnosis any other significant vascular disease aortic aneurysm aortic dissection carotid stenosis that requires medical surgical intervention including angioplasty stenting
0, sorafenib advanced cancer diagnosis men women reproductive potential may not participate this unless they have agreed use an effective contraceptive method while on study
1, exemestane human epidermal growth factor two negative carcinoma breast diagnosis if clinically indicated pulmonary function tests including measures predicted lung volumes dlco otwo saturation at rest on room air should be considered exclude restrictive pulmonary disease pneumonitis pulmonary infiltrates
1, gemcitabine pancreatic cancer diagnosis hiv infection confirmed judged increase subject risk due pharmacologic activity vatalanib
0, niacinamide recurrent gallbladder carcinoma diagnosis no prior treatment any antiangiogenic agent any egfr inhibitors any reason
1, ifosfamide plexiform fibrohistiocytic tumor diagnosis cypthreeafour inducers
0, nilutamide prostate cancer diagnosis no concurrent homeopathic therapy pc spes genistein
0, trioxsalen stage ii esophageal squamous cell carcinoma diagnosis hbgreater eightyg absolute neutrophil count greater doc one hundred nine pltgreater ninety one hundred nine alt astless doc crless doc n
1, pemetrexed cancer head neck diagnosis any investigational drug dose within twenty eight days planned start trial
0, etoposide stage iii adult diffuse large cell lymphoma diagnosis will be permitted
1, dexamethasone acetate multiple myeloma diagnosis prior carfilzomib treatment
0, azacitidine stage iv small lymphocytic lymphoma diagnosis patients previously untreated aml who refuse induction chemotherapy allowed
1, covidien radial reload stapler tri staple technology rectal cancer diagnosis participant is unable unwilling comply requirements follow up schedule
1, temozolomide glioblastoma diagnosis patients must not have elevated liver transaminase levels
1, dexamethasone phosphate genital neoplasms female urogenital neoplasms diagnosis current pregnancy lactation childbearing potential without adequate method contraception
0, sorafenib renal pelvis cancer diagnosis non measurable disease
0, lenalidomide original diagnosis myeloma patients must have met following criteria at one point their disease course
1, dactinomycin gestational trophoblastic neoplasms diagnosis who risk score greater six
0, interferon gamma colorectal cancer diagnosis age
1, mesna precursor cell lymphoblastic leukemia lymphoma diagnosis received any other investigational agent cytotoxic chemotherapy within preceding two weeks
0, thiotepa non hodgkin lymphoma diagnosis brain biopsy
0, trabectedin carcinosarcoma ovarian diagnosis written informed consent
0, leucovorin stage iva rectal cancer diagnosis if patient has previously received murine chimeric antibody then serum anti antibody testing must be negative
0, bevacizumab adult hepatocellular carcinoma diagnosis radiation therapy adjuvant palliative must be completed greater equal four weeks prior registration if applicable
1, romidepsin small intestine lymphoma diagnosis co morbid systemic illnesses other severe concurrent disease which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety toxicity prescribed regimens
1, peginterferon alfa b metastatic melanoma diagnosis creatinine clearance less seventy ml min
1, temozolomide glioma diagnosis receiving concurrent chemotherapeutics investigational agents within thirty days baseline assessments including gliadel wafers gliasite application
1, fludarabine stage iv adult hodgkin lymphoma diagnosis age greater seventy five years
0, camptothecin lung cancer diagnosis no myocardial infarction within past year
1, vaccines rectal cancer diagnosis concurrent treatment steroids immunosuppressing agent
0, rituximab indolent lymphoma including grades one threea follicular small lymphocytic lymphoplasmacytic marginal zone lymphoma stages iii iv bulky disease stage ii
0, rituximab mantle cell lymphoma diagnosis voluntary consent before performance any related procedure
1, antibodies monoclonal stage iv non small cell lung cancer diagnosis patient has active cardiac disease history cardiac dysfunction including any following
0, cyclosporins recurrent adult burkitt lymphoma diagnosis must have failed two courses therapy
1, sunitinib stage renal cell cancer diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible appropriate studies will be undertaken patients receiving combination antiretroviral therapy when indicated
1, pancreatin pancreatic cancer diagnosis patients cannot administration drug due severe postoperative morbidities
0, cetuximab stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis karnofsky sixty one hundred
0, sirolimus malignant pancreatic somatostatinoma diagnosis triglycerides equal less doc uln mg dl mmol patients triglyceride levels greater doc uln can be started on lipid lowering agents reevaluated within one week if levels go equal less doc uln they can be considered trial continue lipid lowering agents note
1, camptothecin ewing sarcoma diagnosis active infection unexplained fever
1, succinylcholine recurrent non small cell lung carcinoma diagnosis patients must not have any other condition including mental illness substance abuse deemed by investigator be likely interfere patient ability sign informed consent cooperate participate interferes interpretation results
1, leucovorin stage ivb colon cancer diagnosis current grade three higher neuropathy
0, immunoconjugates refractory plasma cell myeloma diagnosis patient must not have hypokalemia value less institutional lower limit normal
0, fludarabine phosphate stage iv skin melanoma diagnosis patients must have magnetic resonance imaging mri computed tomography ct positron emission tomography pet brain within two months before consenting if known history brain metastasis if clinically indicated if new lesions present principal investigator pi designee should make final determination regarding enrollment
1, lenalidomide stage iva oropharyngeal squamous cell carcinoma diagnosis patients may not be receiving any other investigational agents
0, palbociclib advanced breast cancer diagnosis d
1, vidarabine stage iv childhood lymphoblastic lymphoma diagnosis patients chronic myelomonocytic leukemia cmml
1, paclitaxel cervical adenosquamous carcinoma diagnosis patients significant peripheral vascular disease
0, cilengitide recurrent childhood brain tumor diagnosis at least six six weeks from prior radiation therapy entry greater three three months from prior craniospinal irradiation greater twenty four gy total body irradiation entry greater two two weeks from local palliative irradiation entry
1, laboratory biomarker analysis mantle cell lymphoma diagnosis major surgery other diagnostic surgery equal less four weeks prior registration
1, dacarbazine adult glioblastoma diagnosis patients who known be human immunodeficiency virus hiv positive receiving combination antiretroviral therapy ineligible
1, isophosphamide mustard adult supratentorial primitive neuroectodermal tumor pnet diagnosis patients who require irradiation more five disease sites excluded
1, levoleucovorin stage iiib gastric cancer diagnosis any following because this involves an agent where genotoxic mutagenic teratogenic effects unknown
0, psychosocial assessment care psychosocial effects cancer its treatment diagnosis brushing teeth eating up one hour prior saliva collection
1, mycophenolic acid stage ii non contiguous mantle cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml mds all cml
0, liposomal doxorubicin aids related primary effusion lymphoma diagnosis participants who untreated who received maximum one one cycle combination chemotherapy including rituximab containing regimens prior eligible start previous chemotherapy cycle must occur at least one days prior beginning treatment under this protocol such cycle will count towards total maximum six cycles under this study
1, albumin bound paclitaxel ovarian cancer diagnosis subjects active infection that requires parenteral antibiotics
1, cisplatin esophageal cancer diagnosis due embryotoxic effects chemotherapy pregnant lactating women men unable unwilling practice contraception excluded
1, panobinostat non small cell lung carcinoma adenocarcinoma diagnosis human immunodeficiency virus hiv active hepatitis hcv virus
1, cisplatin stage iii hypopharyngeal squamous cell carcinoma diagnosis concurrent use all herbal supplements is prohibited during including but not limited st
0, anastrozole ovarian cancer diagnosis ecog performance status less equal one
0, liposomal doxorubicin karnofsky performance scoregreater seventy barcelona cancer liver category stage c
1, vertical mattress suture squamous cell carcinoma diagnosis incarceration
0, phenylbutyric acid brain tumor diagnosis evaluable lesions must not have had any radiotherapy within eight weeks radiosurgery within four months start this protocol
1, etoposide phosphate anaplastic large cell lymphoma alk negative diagnosis major surgery within two weeks drug administration
1, standard support cervical cancer diagnosis transgender status
0, antibiotics antitubercular lymphoma diagnosis none following should be present
0, cisplatin head neck cancer diagnosis bilirubin no greater doc mg dl sgot no greater three times upper limit normal renal
0, dacarbazine childhood low grade cerebellar astrocytoma diagnosis no patients who opinion investigator may not be able comply safety monitoring requirements study
0, interleukin stage iv breast cancer diagnosis not pregnant nursing
1, vitamins glioma diagnosis history oxalate nephrolithiasis urine oxalate greater sixty mg dl
0, antibodies primary peritoneal cavity cancer diagnosis at least three weeks since prior major surgery recovered
1, antibodies prior malignancy other lymphoma except adequately treated skin cancer situ cervical cancer other cancer which they had been disease free greater five years
0, vincristine neuroblastoma diagnosis one one performance status
1, immunoglobulins fallopian tube transitional cell carcinoma diagnosis myocardial infarction unstable angina less six months prior registration
1, everolimus stage adult burkitt lymphoma diagnosis human immunodeficiency virus hiv positive patients
0, carotenoids prostate cancer diagnosis other
0, bortezomib recurrent salivary gland cancer diagnosis unidimensionally measurable disease
0, biomarker sample collection before after dosing cytotoxic agent s tumors diagnosis gemcitabine monotherapy
1, sirolimus breast cancer diagnosis edentulous jaw both upper lower jaws
0, maleic acid all patients must have measurable disease measurable disease is defined by response evaluation criteria solid tumors recist version doc measurable disease is defined at least one lesion that can be accurately measured at least one dimension longest diameter be recorded each lesion must be greater equal ten mm when measured by computed tomography ct magnetic resonance imaging mri caliper measurement by clinical exam greater equal twenty mm when measured by chest ray lymph nodes must be greater equal fifteen mm short axis when measured by ct mri
1, levoleucovorin stage iva rectal cancer diagnosis any following within six months prior inclusion
0, angiotensin i non hodgkins lymphoma diagnosis subjects bone marrow blasts less ten
0, jm nodal marginal zone cell lymphoma diagnosis no uncontrolled infections
1, aldesleukin stage iv skin melanoma diagnosis clinically significant psychiatric disease which opinion pi sub investigator would render immunotherapy its potential sequelae unsafe compliance procedural requirements unlikely
0, albumin bound paclitaxel stage iib ovarian cancer diagnosis all patients enrolled into gog two hundred sixty two at sites where acrin six thousand six hundred ninety five is open will be enrolled advanced imaging protocol patients receiving adjuvant neoadjuvant chemotherapy eligible acrin six thousand six hundred ninety five following sentence does not apply those patients entered after two eight two thousand twelve
0, antibodies monoclonal stage iii adenoid cystic carcinoma oral cavity diagnosis no other uncontrolled illness
0, cyclosporine refractory hodgkin lymphoma diagnosis acute myeloid leukemia aml
0, fludarabine one progressive disease two relapse from cr described international uniform response criteria multiple myeloma listed below
1, endothelial growth factors gastric cancer diagnosis participant has serious nonhealing wound ulcer bone fracture
0, antilymphocyte serum noncontiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis no serious uncontrolled psychiatric illness
0, paclitaxel ovarian gynandroblastoma diagnosis patients must have signed an approved informed consent health insurance portability accountability act hipaa authorization
1, octreotide stage iv prostate cancer diagnosis prior treatment cabazitaxel
1, antibodies monoclonal malignant neoplasm digestive organs intestinal tract primary diagnosis minor surgical procedures
1, paclitaxel unresectable metastatic melanoma diagnosis subjects condition requiring systemic treatment either corticosteroids greater tenmg daily prednisone equivalent other immunosuppressive medications within fourteen days drug administration
0, systemic therapy prostate cancer diagnosis documented serum testosterone less fifty ng dl
0, cisplatin testicular germ cell tumor diagnosis not specified
1, mycophenolic acid stage adult burkitt lymphoma diagnosis uncontrolled viral bacterial infection at time enrollment
1, trametinib recurrent rectal cancer diagnosis history acute coronary syndromes including myocardial infarction unstable angina coronary angioplasty stenting within six months prior enrollment
0, gemcitabine cervical cancer diagnosis ecog performance status zero one
1, irinotecan rhabdomyosarcomas diagnosis active intercurrent serious uncontrolled illness
1, rituximab marginal zone lymphoma diagnosis patients child pugh hepatic impairment
0, olaparib breast cancer diagnosis patients gilbert syndrome bilirubin greater two uln is accepted if there is no evidence biliary obstruction
1, cyclosporins non hodgkin lymphoma diagnosis chemotherapy refractory large cell high grade nhl
1, gemcitabine neoplasms lung diagnosis uncontrolled active infection
0, gemcitabine head neck cancer diagnosis patients mild moderate renal insufficiency should avoid taking nsaid short elimination half lives ibuprofen period two days before day two days following administration pemetrexed
1, cyclosporins childhood diffuse large cell lymphoma diagnosis patients poorly controlled hypertension who unable have blood pressure kept below one hundred fifty ninety on standard medication
0, fludarabine lymphoma diagnosis patient characteristics
0, etoposide ovarian granulosa cell tumor diagnosis patients must have newly diagnosed stage iia
1, levoleucovorin stage iiib gastric cancer diagnosis acute bacterial viral fungal infection requiring treatment at time registration
1, antibodies monoclonal stage iiib rectal cancer diagnosis systolic greater one hundred fifty mmhg diastolic greater one hundred mmhg
0, cyclosporins lymphoma diagnosis must have related hla haploidentical mismatched three six fewer loci donor available
0, immunoglobulins melanoma diagnosis prior therapy
0, albumin bound paclitaxel metastatic breast cancer diagnosis all patients enrolled required have adequate hematologic hepatic renal function
1, sir sphere breast cancer metastatic liver diagnosis twenty lung shunting on maa
1, carboplatin intracranial germ cell tumors diagnosis participation within different trial treatment germ cell tumours concurrent treatment within any other clinical trial
0, leuprolide prostate cancer diagnosis no uncontrolled diabetes
0, cyclosporins plasma cell neoplasm diagnosis age graft criteria all patients
1, doxorubicin peripheral cell lymphoma diagnosis abnormal cardiac hepatic functions
1, epirubicin inflammatory breast carcinoma diagnosis no minor surgical procedure within seven days entry major surgery within twenty eight days entry anticipation need major surgical procedure during course study
0, assessment therapy complications extragonadal germ cell tumor diagnosis at least five years since completion therapy these clinical trials
0, o benzylguanine kidney cancer diagnosis recovered from prior radiotherapy
0, etoposide choroid plexus carcinoma
0, everolimus stage iv non small cell lung cancer diagnosis negative serum pregnancy test done equal less seven days prior registration
1, single photon emission computed tomography stage iii malignant mesothelioma diagnosis exception topical inhaled steroids
1, antibodies monoclonal urothelial carcinoma diagnosis patients unwilling unable comply protocol
0, antibodies monoclonal ovarian mixed germ cell tumor diagnosis hematologic persistence evidenced by cytopenias not attributable other post transplant causes accompanied by characteristic morphological changes more ninety days after ahsct cytogenetic persistence evidenced by persistence clonal abnormality more ninety days after ahsct
0, acetylcysteine stage iii basal cell carcinoma lip diagnosis receiving concurrent chemoradiotherapy chemobiotherapy minimum dose equivalent sixty gy thirty fractions adjuvant definitive setting
0, leucovorin stage iv adult lymphoblastic lymphoma diagnosis able adhere visit schedule other protocol requirements
1, cyclosporine recurrent childhood lymphoblastic lymphoma diagnosis patient has central nervous system cns involvement disease refractory intrathecal chemotherapy
0, everolimus advanced cancer esophagogastric junction diagnosis at baseline ct mri scan must demonstrate measurable disease by recist criteria presence at least one measurable lesion
0, docetaxel adenocarcinoma prostate diagnosis potential candidate radical prostatectomy
0, therapeutic conventional surgery stage iva laryngeal squamous cell carcinoma diagnosis creatinine less doc uln
0, quality life assessment stage iia prostate cancer diagnosis primary treatment is active surveillance planned annual surveillance biopsies
0, androgens prostate cancer diagnosis no history brain metastases current treated untreated brain metastases
0, e coli nissle suspension colorectal cancer diagnosis male female adults
0, antibodies monoclonal stage iiib skin melanoma diagnosis platelets greater equal one hundred ten three ul
0, irinotecan unspecified adult solid tumor protocol specific diagnosis nifedipine
1, ethosuximide cancer diagnosis patients currently taking any anti depressant medication example fluoxetine paroxetine citalopram venlafaxine amitriptyline within past week
1, sirolimus advanced cancers diagnosis history hypersensitivity metformin any component formulation lapatinib metformin arm only
1, sirolimus hepatocellular carcinoma diagnosis evidence significant local systemic infection
0, metronidazole gastric cancer diagnosis hematopoietic
1, everolimus recurrent merkel cell carcinoma diagnosis patients who have had hormonal therapy other replacement within four weeks prior entering study
1, placebo non small cell lung cancer diagnosis have alkaline phosphatase greater three times uln total bilirubin levels above two mg dl at baseline
0, vidarabine diffuse large cell lymphoma diagnosis chronic myeloid leukemia cml accepted if they beyond chronic phase cp one if they have received previous myelosuppressive chemotherapy hct have less five marrow blasts at time transplant
0, etoposide recurrent grade two follicular lymphoma diagnosis all participants must be registered into mandatory revassist program be willing able comply requirements revassist
0, immunoglobulins stage ii diffuse large cell lymphoma diagnosis absence history deep venous thrombosis embolism threatening thromboembolism known thrombophilia patients history deep vein thrombosis dvt pulmonary embolism pe thrombophilia may participate if they willing be on full anticoagulation during treatment if randomized rituximab cyclophosphamide doxorubicin hydrochloride vincristine sulfate prednisone rtwochop arm full anticoagulation is defined warfarin factor inhibitors low molecular weight heparin at therapeutic doses
0, immunoconjugates stage iv mantle cell lymphoma diagnosis creatinine equal less two institutional uln
1, capecitabine breast cancer diagnosis history noncompliance medical regimens
1, lamivudine neoplasms diagnosis patients autoimmune hepatitis hepatitis delta virus infection hiv infection radiological evidence liver metastasis
0, regorafenib gastrointestinal stromal tumors diagnosis investigator designated associate is requested advise subject on how achieve an adequate birth control
0, tamoxifen breast cancer diagnosis no serious disease that would preclude surgery
0, dacarbazine refractory central nervous system neoplasm diagnosis sgpt alt equal less two hundred twenty five l purpose this uln sgpt is forty five l
0, fludarabine phosphate refractory multiple myeloma diagnosis relapsed refractory after front line therapy
1, lenalidomide stage ivc laryngeal squamous cell carcinoma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated either agent
0, protein kinase inhibitors non small cell lung carcinoma diagnosis effects azdsix thousand two hundred forty four erlotinib on developing human fetus at recommended therapeutic dose unknown
1, capecitabine recurrent islet cell carcinoma diagnosis however patients may be on stable doses low molecular weight heparin allowed ie
1, antibodies monoclonal primary peritoneal cancer diagnosis patients active interstitial pneumonitis
0, thalidomide multiple myeloma diagnosis creatinine clearance greater sixty ml min
0, capecitabine liver cancer diagnosis no cardiac arrhythmia
0, bevacizumab endometrial cancer will include all carcinomas including endometrioid carcinoma papillary serous carcinoma clear cell carcinoma
1, lenalidomide patients history non hematologic malignancies except non melanoma skin cancers currently complete remission who less five years from time complete remission have greater twenty risk disease recurrence
1, albumin bound paclitaxel ovarian cancer diagnosis previous exposure pegfilgrastim
0, next generation sequencing patients malignant tumor
0, mycophenolic acid childhood burkitt lymphoma diagnosis karnofsky score greater equal seventy adults lansky score greater equal fifty pediatrics
1, antibodies recurrent adult diffuse mixed cell lymphoma diagnosis any non oncology vaccine therapy used prevention infectious diseases up one month before after any dose ipilimumab
0, bb recurrent childhood visual pathway hypothalamic glioma diagnosis bilirubin sum conjugated unconjugated less doc times upper limit normal uln age
1, radiotherapy followed by chemotherapy extranodal natural killer cell lymphoma nasal type diagnosis severe allergies investigational drugs
0, bortezomib recurrent grade two follicular lymphoma diagnosis fl patients must have disease related symptoms cytopenias threatened end organ function bulky progressive disease it is patient preference be treated
0, cetuximab esophageal cancer diagnosis granulocyte count greater one five hundred mm three
1, thalidomide childhood medulloepithelioma diagnosis patients receiving any other chemotherapeutics investigational agents
1, sunitinib metastatic renal cell carcinoma diagnosis negative imaging examination result four weeks prior enrollment
1, acupuncture colorectal neoplasms diagnosis metastatic disease central nervous system brain spinal cord
0, metformin adenocarcinoma diagnosis eligibility curative surgery no distant metastasis invasion bony structures pelvis
0, liposomal doxorubicin breast cancer diagnosis female
1, dexamethasone acetate relapsed multiple myeloma diagnosis subjects whom required program oral intravenous fluid hydration is contraindicated due pre existing pulmonary cardiac renal impairment
1, mitomycins history prior experimental cancer vaccine treatment dendritic cell therapy heat shock vaccine
0, dexamethasone phosphate multiple myeloma diagnosis measurable urinary light chain secretion by quantitative analysis using urine protein electrophoresis upep greater two hundred mg twenty four hours
1, cyclophosphamide metastatic neoplasm diagnosis patients will be excluded if they have history clinically significant electrocardiogram ecg abnormalities symptoms cardiac ischemia arrhythmias have left ventricular ejection fraction lvef less forty five on cardiac stress test stress thallium stress multi gated acquisition scan muga dobutamine echocardiogram other stress test
0, topotecan recurrent ovarian carcinoma diagnosis phase i
1, antibodies monoclonal ovarian cancer diagnosis investigational drug therapy outside this trial during within four weeks entry
0, dexamethasone phosphate tsh secreting adenoma diagnosis doc mg dl patients ten less thirteen years
0, ifosfamide extraskeletal osteosarcoma diagnosis lansky performance status score greater equal seventy patients equal less sixteen years age
0, clinical observation precancerous condition diagnosis cdfour count greater two hundred mmÂ³
1, carmustine recurrent marginal zone lymphoma diagnosis patients who hepatitis virus hcv antibody positive hepatitis virus hbv surface antigen positive must be free clinical evidence cirrhosis that would otherwise make them ineligible hct determined by principal investigator consultation gastrointestinal service patients hbv ongoing evidence viral replication may require therapy prior receiving high dose chemotherapy
0, antibodies stage ib breast cancer diagnosis nodal status
0, cisplatin bronchoalveolar cell lung cancer diagnosis mediastinal hilar adenopathy measurable only one dimension
1, cyclosporine recurrent childhood anaplastic large cell lymphoma diagnosis current serious systemic illness
1, vaccines human papilloma virus male diagnosis young men that live outside pre identified dorm halls
1, doxorubicin ovarian endometrioid adenocarcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition egen one other agents used this study
0, calcium dietary primary peritoneal cavity cancer diagnosis no inability submit follow up medical testing geographical social psychological reasons
0, dexamethasone multiple myeloma diagnosis see appendix two mm diagnostic criteria
1, bevacizumab colorectal neoplasms diagnosis unresolved toxicity grade greater one based on nci ctc version doc except alopecia related any previous therapy procedure
1, antibodies monoclonal advanced solid tumors part b d diagnosis strong inhibitors inducers cypthreeafour including grapefruit products herbal supplements
1, fludarabine recurrent adult grade iii lymphomatoid granulomatosis diagnosis liver function abnormalities
0, acp acp non hodgkins lymphoma diagnosis diagnosis b cell malignancy documented by medical records histology based on criteria established by world health organization who
0, etoposide phosphate recurrent adult hodgkin lymphoma diagnosis patients must have measurable disease defined lesions that can be accurately measured two dimensions by computed tomography ct magnetic resonance imaging mri medical photograph skin oral lesion plain ray other conventional technique greatest transverse diameter one cm greater palpable lesions both diameters greater equal two cm
0, immunoglobulins adenocarcinoma rectum diagnosis life expectancy greater two years
1, vidarabine stage iii adult lymphoblastic lymphoma diagnosis eligible high priority curative autologous transplant
0, vemurafenib metastatic cancers diagnosis nsclc
0, conventional t cells tcon regulatory t cells treg lymphoma non hodgkin diagnosis at start cohort twoa beyond eligibility will be expanded allow pediatric patients age greater thirteen yo
1, gdc non hodgkin lymphoma solid cancers diagnosis significant traumatic injury within four weeks day one
1, mycophenolic acid hepatosplenic cell lymphoma diagnosis life expectancy severely limited by diseases other malignancy
1, once daily radiotherapy prior surgical resection primary tumour prior radiotherapy lung cancer
1, antibodies monoclonal recurrent grade two follicular lymphoma diagnosis unable perform self care during radiation isolation
0, levoleucovorin stage iiic esophageal cancer diagnosis patients their legal representatives must be able read understand provide sign informed consent participate trial
1, fludarabine stage adult burkitt lymphoma diagnosis identical twin
0, imatinib mesylate recurrent adult cell leukemia lymphoma diagnosis creatinine clearance at least sixty ml min
0, fluorouracil mucinous adenocarcinoma rectum diagnosis must have negative serum pregnancy test
0, romidepsin recurrent childhood visual pathway hypothalamic glioma diagnosis recovered from prior radiotherapy
1, antibodies monoclonal lymphoma diagnosis any medical psicologycal condition that can modify capacity give consent
1, chemotherapy rectal cancer diagnosis any unhealed wound fracture peptic ulcer intraabdominal abscess
0, antibodies monoclonal recurrent hodgkin lymphoma diagnosis female subject is either post menopausal surgically sterilized willing use an acceptable method birth control hormonal contraceptive intra uterine device diaphragm spermicide condom spermicide abstinence duration study
0, fluorouracil carcinoma diagnosis twenty years older
1, sorafenib hepatocellular carcinoma diagnosis pregnant breastfeeding
0, pasireotide long acting release lar measureable disease by response evaluation criteria solid tumors recist
0, live freeze dried lactic acid bacteria probiotic unspecified adult solid tumor protocol specific diagnosis no use probiotics less two weeks prior registration
0, vidarabine lymphoma diagnosis unit will have greater doc one hundred seven nc kg recipient body weight pediatric patients cell dose greater doc one hundred seven nc kg recipient body weight is acceptable
0, mycophenolate mofetil stage adult diffuse small cleaved cell lymphoma diagnosis acute myeloid leukemia aml
0, thalidomide stage small lymphocytic lymphoma diagnosis eastern cooperative oncology group ecog performance status equal less two karnofsky greater equal sixty
0, bortezomib symptomatic multiple myeloma asymptomatic multiple myeloma related organ tissue damage
0, carboplatin brain neoplasms diagnosis alt no greater two times normal
1, axitinib soft tissue sarcomas diagnosis seasonal influenza vaccines injection generally inactivated flu vaccines allowed however intranasal influenza vaccines flu mist live attenuated vaccines not allowed
0, vidarabine stage adult diffuse large cell lymphoma diagnosis patient has no existing zero one hla b drbone dqbone matched related donor
0, thalidomide stage ivb rectal cancer diagnosis life expectancy greater three months
1, dalteparin lymphoma diagnosis concurrent high dose chemotherapy stem cell transplantation
0, cyclophosphamide lung cancer diagnosis fertile patients must use effective contraception
0, vidarabine angioimmunoblastic cell lymphoma diagnosis unrelated donor
0, bevacizumab stage iv lymphoepithelioma nasopharynx diagnosis no peripheral neuropathy greater grade two
1, rituximab contiguous stage ii mantle cell lymphoma diagnosis prior use lenalidomide either concurrently rituximab within eight weeks following dose rituximab
1, alemtuzumab recurrent small lymphocytic lymphoma diagnosis patient received cytotoxic agents cytoreduction within three weeks interval which cycle standard chemotherapy would be administered non transplant setting prior initiating nonmyeloablative transplant conditioning exceptions hydroxyurea imatinib mesylate
0, antibodies monoclonal kidney cancer diagnosis absolute neutrophil count anc greater equal one five hundred platelets greater equal one zero total bilirubin less equal doc mg dl ast alt less equal threex upper limit normal creatinine clearance greater fifty cc min measured calculated by cockcroft formula
0, antibodies monoclonal noncontiguous stage ii grade one follicular lymphoma diagnosis one allele or
0, etoposide phosphate neuroblastoma diagnosis under ten years at diagnosis
0, sorafenib advanced adult hepatocellular carcinoma diagnosis target lesion that has not been subjected local therapy or
1, cediranib stage iiia non small cell lung cancer diagnosis note
0, panobinostat lymphoma non hodgkin diagnosis adequate hepatic function defined as
1, cediranib stage intraocular melanoma diagnosis conditions requiring concurrent use drugs biologics proarrhythmic potential these drugs prohibited during studies azdtwo thousand one hundred seventy one
1, sorafenib liver cancer diagnosis known history human immunodeficiency virus hiv positivity
1, chloroquine diphosphate cholangiocarcinoma diagnosis palliative therapy is permitted such as
0, aerobic exercise training lymphoma diagnosis no uncontrolled hypertension cardiac illness psychiatric condition
1, mitomycins urologic neoplasms diagnosis known impaired immune response positive hiv serology patients receiving systemic steroids immunosuppressive therapy
1, vitamins previous familial colon ovarian breast cancer
1, capecitabine stage iiic breast cancer diagnosis ppp
1, loperamide rectal cancer diagnosis chemotherapy
1, antibodies monoclonal advanced renal cell carcinoma diagnosis concurrent prior within seven days before enrollment anticoagulation therapy except
1, capecitabine recurrent breast cancer diagnosis there is no washout period required trastuzumab
1, cetuximab stage iva squamous cell carcinoma oropharynx diagnosis cardiac disease
0, immunoglobulins stage iv rectal cancer diagnosis rifabutin
1, remifentanil pregnant breast feeding woman
0, sirolimus recurrent ovarian carcinoma diagnosis triglycerides equal less doc uln mg dl mmol patients triglyceride levels greater doc uln can be started on lipid lowering agents reevaluated within one week if levels go equal less doc uln they can be considered trial continue lipid lowering agents note
0, nivolumab gastrointestinal cancer diagnosis pancreatic bronchial intestinal carcinoid tumours rare gynaecological tumours including but will not be limited to
1, dehydroepiandrosterone breast cancer diagnosis prior radical pelvic surgery specifically vaginectomy pelvic exenteration tah bso is allowed
0, interferons stage iv renal cell cancer diagnosis at least one week since prior no concurrent steroids
1, dexamethasone phosphate non hodgkin lymphoma diagnosis known suspected hypersensitivity intolerance rifampicin other antibiotics corticosteroids boron mannitol
0, gemcitabine transitional cell cancer renal pelvis ureter diagnosis creatinine clearance thirty fifty nine ml min
1, antibodies recurrent childhood anaplastic large cell lymphoma diagnosis donors less twelve years age
0, paclitaxel undifferentiated carcinoma
0, navitoclax platinum resistant refractory ovarian cancer diagnosis patients must have documented disease progression
0, etoposide multiple myeloma plasma cell neoplasm diagnosis cdthirty four positive at least four million kg hepatic
0, irinotecan stage iii marginal zone lymphoma diagnosis bilirubin normal
1, interleukin carcinoma appendix diagnosis known seropositive hiv antibody
0, trastuzumab metastatic breast cancer diagnosis hormone receptor status known
0, fludarabine phosphate myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis patients will be accepted beyond chronic phase one cpone if they have received previous myelosuppressive chemotherapy hsct have less five marrow blasts at time transplant
1, cdx metastatic renal cell carcinoma diagnosis radiation therapy within four weeks prior start treatment palliative radiotherapy bone lesions allowed up two weeks prior treatment start
1, gemcitabine localized gallbladder cancer diagnosis immunotherapy equal less four weeks prior registration
0, albumin bound paclitaxel stage ia breast cancer diagnosis pttwo estrogen receptor er negative progesterone receptor pgr negative or
1, sirolimus recurrent grade one follicular lymphoma diagnosis male patients whose sexual partner wocbp who not willing use adequate contraception during eight weeks after end treatment
0, histone deacetylase inhibitors patients must have histologic cytologic confirmation cancer which there is no known standard therapy capable extending life expectancy
0, esophagectomy three field lymphnode dissection adenocarcinoma diagnosis written informed consent
0, norethindrone acetate breast cancer diagnosis no prior concurrent deep vein thrombosis
0, etoposide stage marginal zone lymphoma diagnosis there is no restriction on number prior chemotherapeutic regimens radiation exposure exception prior autologous allogeneic stem cell transplantation
1, vaccines metastatic melanoma diagnosis il two interferon other non immunotherapy regimens cytotoxic chemotherapy immunosuppressive agents other investigation therapies chronic use systemic corticosteroids
0, deoxyuridine adult grade iii lymphomatoid granulomatosis diagnosis concurrent megestrol acetate bisphosphonates allowed provided they were started one month prior enrollment
0, paclitaxel stage iv fallopian tube cancer diagnosis prothrombin time pt equal less doc uln
1, capecitabine breast cancer diagnosis proteinuria at screening demonstrated by urine dipstick proteinuria greater two positive patients discovered have greater two positive proteinuria on dipstick urinalysis at baseline should undergo two hour
1, imatinib mesylate gastrointestinal stromal tumors diagnosis use ketoconazole erythromycin carbamazepine phenobarbital rifampin phenytoin quinidine two weeks prior baseline
1, doxorubicin cns metastases that symptomatic
0, goserelin prostate cancer diagnosis chemotherapy
0, mitoxantrone recurrent prostate cancer diagnosis no prior hypersensitivity reaction agents containing cremophor el
1, bevacizumab pancreatic cell adenoma diagnosis current therapy cytochrome pfour hundred fifty threeafour cypthreeafour inhibitor inducer note
0, romidepsin histologically cytologically confirmed soft tissue sarcoma sts including but not limited following histologies
0, epirubicin advanced gastric cancer diagnosis adequate major organ functions
0, levoleucovorin colorectal cancer diagnosis no concurrent radiotherapy
0, linear accelerator brain cancer diagnosis systemic therapy
1, mycophenolic acid recurrent hodgkin lymphoma diagnosis hla genotypically identical sibling
0, doxorubicin liver cancer diagnosis cardiac arrhythmia
1, immunoglobulins adenocarcinoma rectum diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
0, histone deacetylase inhibitors stage iv grade three follicular lymphoma diagnosis no concurrent tetracycline
1, bevacizumab somatostatinoma diagnosis subjects meeting any following criteria ineligible entry
0, antibodies monoclonal stage iv skin melanoma diagnosis investigational agents
0, calcium dietary pancreatic cancer diagnosis metastatic disease
0, aprepitant ovarian brenner tumor diagnosis patients following histologic epithelial cell types eligible
1, bortezomib myeloma diagnosis uncontrolled diabetes mellitus fasting blood sugar greater four hundred mg dl despite medical treatment
1, cytarabine recurrent childhood non hodgkin lymphoma diagnosis cardiac ejection fraction ef less forty on multi gated acquisition muga scan cardiac echocardiogram echo if unable obtain ejection fraction shortening fraction less twenty six patients active history cardiac disease should be evaluated appropriate cardiac studies consult ejection fraction is required if age greater fifty years there is history anthracyclines history cardiac disease patients shortening fraction less twenty six may be enrolled if approved by cardiologist
0, liposomal doxorubicin neuroblastoma diagnosis no inss stage four disease age twelve eighteen months all three favorable biologic features nonamplified mycn favorable pathology dna index greater one
0, thalidomide diagnosis mantle cell lymphoma must be excluded by negative fish analysis eleven fourteen igh ccndone on peripheral blood tissue biopsy negative immunohistochemical stains cyclin done on involved tissue biopsy note
0, hormones hormone resistant prostate cancer diagnosis rising psa defined at least two consecutive rises psa be documented over reference value first rising psa should be taken at least seven days after reference value third confirmatory psa measure should be greater second measure it must be obtained at least seven days after twond measure if this is not case fourth psa is required be taken be greater second measure
1, vitamin b complex recurrent primary peritoneal carcinoma diagnosis co morbid systemic illnesses other severe concurrent disease which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety toxicity prescribed regimens
0, poly iclc medulloblastoma diagnosis patient must have normal cardiac function documented by
0, dexamethasone stage iv squamous cell carcinoma larynx diagnosis adequate organ function hepatic
0, carboplatin noncontiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis ast sgot alt sgpt equal less doc institutional uln
0, fludarabine adult nasal type extranodal nk cell lymphoma diagnosis donor
1, antibodies monoclonal ovarian transitional cell carcinoma diagnosis new york heart association class ii iv congestive heart failure serious cardiac arrhythmia requiring medication
1, paclitaxel stage ia fallopian tube cancer diagnosis history cerebrovascular accident cva stroke transient ischemic attack tia subarachnoid hemorrhage within six months first date bevacizumab therapy
1, rituximab recurrent adult hodgkin lymphoma diagnosis autologous allogeneic transplantation within twelve months radioimmunotherapy within six months registration prior failed less five ten six cdthirty four kg peripheral blood stem cell pbsc collection
0, vidarabine recurrent small lymphocytic lymphoma diagnosis patient must be aware high risk experimental nature treatment provide informed consent
1, dexamethasone acetate splenic marginal zone lymphoma diagnosis patients that refractory not responded progressed within six months carboplatin cisplatin based regimen gemcitabine based regimen
1, vaccines triple negative breast cancer diagnosis pregnant breastfeeding
0, rituximab lymphoma diagnosis no suspected documented cns involvement by nhl note
0, isophosphamide mustard untreated childhood supratentorial primitive neuroectodermal tumor diagnosis total bilirubin less doc upper limit normal uln age
1, immunoglobulin g stage iv fallopian tube cancer diagnosis previous history malabsorption other conditions preventing oral treatment
1, sns t diffuse large cell lymphoma relapse diagnosis be receiving other concurrent investigational therapies have received investigational therapies within four weeks screening five half lives if known whichever is shorter
0, prednisone lymphoma extranodal nk cell diagnosis systematic central nervous system involvement previous concomitant malignancies any coexisting medical problems that could cause poor compliance protocol
0, lapatinib stage iv breast cancer diagnosis cystic lesions
0, antibodies monoclonal squamous non small cell lung cancer diagnosis at least one measurable lesion defined by recist doc which can be followed by computed tomography ct magnetic resonance imaging mri
1, antibodies unspecified adult solid tumor protocol specific diagnosis patients known hypersensitivity chinese hamster ovary cell products other recombinant human antibodies
0, trastuzumab salivary gland poorly differentiated carcinoma diagnosis bilirubin equal less doc institutional upper limit normal within twenty eight days prior registration
1, cyclophosphamide non hodgkin lymphoma diagnosis hiv infection
1, melphalan recurrent childhood small noncleaved cell lymphoma diagnosis active bacterial viral fungal infection
1, thiotepa testicular lymphoma diagnosis allogeneic bmt not possible not desirable
0, lenograstim head neck cancer diagnosis creatinine clearance at least fifty ml min
0, indomethacin ovarian neoplasms diagnosis age greater eighteen years
0, vincristine alveolar childhood rhabdomyosarcoma diagnosis recovered from prior radiotherapy
0, gemcitabine primary central nervous system hodgkin lymphoma diagnosis ecog performance status less two
0, topotecan large cell neuroendocrine ne tumors diagnosis ecog performance status zero two
1, immunoglobulins high grade fallopian tube serous adenocarcinoma diagnosis uncontrolled hypertension systolic blood pressure sbp greater one hundred fifty diastolic blood pressure dbp greater ninety
0, dexamethasone lymphoblastic lymphoma diagnosis cytotoxic therapy
1, melphalan mature cell nk cell non hodgkin lymphoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition basiliximab
1, fluorouracil recurrent esophageal cancer diagnosis patients should not receive immunization attenuated live vaccines within one week entry during period
0, dexamethasone phosphate recurrent childhood spinal cord neoplasm diagnosis at least six months since prior total body irradiation tbi craniospinal radiotherapy radiotherapy greater fifty pelvis
0, internet based intervention stage iii adult lymphoblastic lymphoma diagnosis hematopoietic stem cell transplant recipient between three twenty five years since last transplant
1, gene modified hiv protected hematopoietic stem cells aids related hodgkin lymphoma diagnosis active infection requiring systemic antibiotic therapy antibacterial antifungal antiviral agents excluding hiv
1, mycophenolic acid recurrent childhood large cell lymphoma diagnosis donor
1, erlotinib hydrochloride non small cell lung cancer metastatic diagnosis any previous treatment pdone pd lone inhibitor including medifour thousand seven hundred thirty six
0, sirolimus patients histologically confirmed adenocarcinoma prostate
0, zinc oxide esophageal cancer diagnosis prior concurrent therapy
0, tacrolimus recurrent adult diffuse large cell lymphoma diagnosis disease is completely absent no relapse occurred prior preparative regimen requires all following
1, angiogenesis inhibitors central nervous system neoplasms diagnosis patients known hypersensitivity pazopanib topotecan their excipients
0, fludarabine phosphate stage iii childhood burkitt lymphoma diagnosis failed flu cy rituximab fcr combination chemotherapy at any time point or
1, dexamethasone stage iiia primary peritoneal cancer diagnosis patients who opinion treating physician have medical condition currently take medications which felt contraindicate safe effective administration standard three drug anti emetic regimen used this study
1, fatigue assessment management recurrent mantle cell lymphoma diagnosis does not complete baseline assessment through hads hospital anxiety depression scale
0, fludarabine solid tumor diagnosis hla phenotype hla two
0, thermal ablation therapy metastatic cancer diagnosis not specified
0, cisplatin gastrointestinal carcinoid tumor diagnosis radiotherapy
0, pentetic acid multiple myeloma plasma cell neoplasm diagnosis no local systemic infection defined by evidence fever body temperature greater three doc degrees within twenty four hours including any following
1, trametinib metastatic melanoma diagnosis anticoagulants antiplatelet agents except low dose eighty one mg aspirin
1, mycophenolate mofetil recurrent childhood grade iii lymphomatoid granulomatosis diagnosis patients active bacterial fungal infections unresponsive medical therapy
1, aromatase inhibitors cancer diagnosis have electrically magnetically mechanically activated implants including cardiac pacemaker cochlear implants magnetic surgical clips prostheses
1, bexarotene sarcoma kaposi diagnosis local topical therapy such but not limited vitamin tretinoin all trans retinoic acid other retinoid class drugs intralesional injection therapy any ks indicator lesion
0, interferon alpha kidney cancer diagnosis renal
0, gemcitabine stage iv pancreatic cancer diagnosis pt ptt no greater uln
1, gx head neck cancer diagnosis alanine aminotransferase alt greater doc xunl
0, temozolomide neuroectodermal tumor diagnosis egfr erbbtwo jaktwovsix hundred seventeenf jaktwo
1, rituximab stage iii cutaneous cell non hodgkin lymphoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast greater equal four times upper limits normal
1, bortezomib lymphoma diagnosis no concurrent moderate strong cypthreeafour inducers inhibitors other protease inhibitors
1, gemcitabine b symptomatic congestive heart failure
1, antilymphocyte serum recurrent small lymphocytic lymphoma diagnosis females childbearing potential positive pregnancy test
1, antibodies monoclonal advanced cancer diagnosis patients on sunitinib treatment arm trastuzumab lapatinib treatment arm only left ventricular ejection fraction less fifty unless patient is receiving an angiotensin converting enzyme ace inhibitor angiotensin receptor blocker arb beta blocker
1, female er bc patients breast cancer diagnosis history loss consciousness transient ischemic attack within twelve months before drug initiation
0, romidepsin hertwo negative breast cancer diagnosis ecog performance status zero one two
0, mycophenolic acid multiple myeloma plasma cell neoplasm diagnosis esophageal varices
1, pemetrexed non small cell lung cancer diagnosis moderate dose ibuprofen may be continued
0, dutasteride prostate cancer diagnosis any other investigational fiveÎ± reductase inhibitors within past twelve months
0, albumin bound paclitaxel stage iiia breast cancer diagnosis ecog performance status zero two
0, antibodies stage ia ovarian cancer diagnosis bilirubin equal less doc uln
1, tacrolimus recurrent adult diffuse large cell lymphoma diagnosis adult
1, paclitaxel adenocarcinoma distal esophagus diagnosis history interstitial lung disease pneumonitis pulmonary fibrosis any evidence interstitial lung disease on baseline chest ct scan
0, epirubicin malignant mesothelioma diagnosis no new york heart association class iii iv heart disease
1, tacrolimus stage iii grade one follicular lymphoma diagnosis cross match positive donor
0, etoposide phosphate lymphoma diagnosis measurable disease
0, oxaliplatin gastric cancer diagnosis patient must be chronologic less equal seventy five
0, cognitive assessment stage iiic primary peritoneal cancer diagnosis no distal neuropathy action tremor other motor dysfunction that would substantially decrease keyboard accuracy
0, epirubicin diffuse large cell lymphoma dlbcl diagnosis adl activity daily living score six
0, digoxin prostate cancer diagnosis at least three psa values necessary calculate psa doubling time via psadt calculator at
0, doxorubicin lymphoma diagnosis agrees protocol defined use effective contraception women these restrictions apply twelve months after last dose rituximab one month after last dose drug whichever is later men these restrictions apply twelve months after last dose rituximab three months after last dose drug whichever is later
1, pembrolizumab lymphoma diagnosis have had prior therapy an anti pd one anti pd lone monoclonal antibody
0, antibodies recurrent squamous cell carcinoma lip oral cavity diagnosis inr less doc
1, interleukin renal cancer diagnosis history coronary revascularization ischemic symptoms
0, fluorouracil metastatic cancer diagnosis surgery
0, temozolomide adult anaplastic astrocytoma diagnosis leukocytes greater three zero mcl
0, levoleucovorin stage iiia colon cancer diagnosis hepatitis virus surface antigen hbsag detectable greater six months
0, niacinamide stage iv rectal cancer diagnosis no other concurrent chemotherapy
1, everolimus refractory multiple myeloma diagnosis systemic amyloidosis known history hepatitis c human immunodeficiency virus hiv any current uncontrolled infection
1, carboplatin evidence malignancy past two years except adequately treated basal cell squamous cell skin cancer situ cervical cancer other situ cancer
1, cyclophosphamide other malignancy within past five years except curatively treated cutaneous basal cell squamous cell carcinoma carcinoma situ cervix cutaneous kaposi sarcoma
1, peg hydrogel spaceoar cancer prostate diagnosis anal fistula perianal abscess
1, antibodies second primary malignancy exceptions one patient had second primary malignancy but has been treated disease free at least three years two situ carcinoma situ carcinoma cervix three non melanomatous carcinoma skin
1, etoposide recurrent diffuse large cell lymphoma diagnosis known history allergy captisol cyclodextrin derivative used solubilize carfilzomib
0, laboratory biomarker analysis refractory plasma cell myeloma diagnosis prior palliative localized radiation therapy is permitted provided at least fourteen days have passed from date last radiation therapy
0, carmustine lymphoma diagnosis biologic therapy
0, antibodies childhood alveolar rhabdomyosarcoma diagnosis patients aged greater seventeen years
1, fludarabine recurrent adult lymphoblastic lymphoma diagnosis donor
0, tamoxifen breast cancer diagnosis ecog zero one hematopoietic
1, oxaliplatin pancreatic cancer diagnosis treatment any investigational agent within fourteen days prior being registered protocol therapy protocol version
0, vinorelbine recurrent non small cell lung cancer diagnosis hepatic function
0, trioxsalen grade three four astrocytoma defined by daumas duport classification
0, ergocalciferols stage iii colon cancer diagnosis participants receiving anti platelet agents eligible
0, liposomal doxorubicin stage iiic breast cancer diagnosis by pathologic evaluation ipsilateral nodes must be pnzero pnone pnonemi pnonea pnoneb pnonec pntwoa pntwob pnthreea pnthreeb
1, temozolomide neuroblastoma diagnosis must not have uncontrolled diabetes mellitus
1, lifesealâ„¢ kit rectal cancer diagnosis subject has history hypersensitivity porcine derived gelatin collagen
0, trastuzumab metastatic malignant neoplasm brain diagnosis no increase steroid dose during week prior screening brain mri
0, antibodies recurrent ovarian carcinoma diagnosis five half lives whichever is shorter
0, gefitinib colorectal cancer diagnosis not pregnant nursing
1, antibodies monoclonal hodgkin lymphoma diagnosis peripheral neuropathy greater ctc grade one
1, uterine fibroid embolization beadblockâ„¢ uterine neoplasms diagnosis patients uteri less two hundred fifty ml cm calculated volume greater twenty four weeks
0, methotrexate stage iii childhood large cell lymphoma diagnosis clinical spinal cord compression
1, thalidomide myeloma diagnosis known active central nervous system involvement
1, fludarabine phosphate mantle cell lymphoma diagnosis diffusion capacity carbon monoxide dlco less thirty total lung capacity tlc less thirty forced expiratory volume one second fevone less thirty receiving supplementary continuous oxygen fhcrc principal investigator pi must approve enrollment all patients pulmonary nodules
1, ascorbic acid multiple myeloma diagnosis impaired cardiac function clinically significant cardiac diseases including myocardial infarction within six months prior enrollment new york heart association nyha class ii greater heart failure uncontrolled angina clinically significant pericardial disease severe uncontrolled ventricular arrhythmias echocardiogram multigated acquisition scan muga evidence left ventricular ejection fraction lvef below institutional normal within twenty eight days prior enrollment electrocardiographic evidence acute ischemia active conduction system abnormalities
0, lenalidomide recurrent adult grade iii lymphomatoid granulomatosis diagnosis cardiac arrhythmia
0, everolimus recurrent adult brain tumor diagnosis no other disease that would obscure toxicity dangerously alter drug metabolism
1, endothelial growth factors stage iiic fallopian tube cancer diagnosis patients clinically significant cardiovascular disease this includes
1, veno veno arterial ecmo lymphangioleiomyomatosis diagnosis patients arrhythmia
1, huluc multiple myeloma diagnosis any condition that investigator opinion makes subject unsuitable participation
1, mammography mx ultrasonography us breast cancer diagnosis contraindications any intravenous administration contrast agent
0, erlotinib hydrochloride histologically cytologically confirmed non small cell lung cancer nsclc including any following histologies
1, etoposide phosphate recurrent adult hodgkin lymphoma diagnosis consent may not be obtained by means legal guardian
1, antibodies monoclonal recurrent marginal zone lymphoma diagnosis prior radioimmunotherapy including ninety zevalin one hundred thirty one iodine anti bone antibody lym one
0, poly adp ribose polymerase inhibitors childhood low grade cerebellar astrocytoma diagnosis temozolomide
1, sorafenib patients currently receiving any anti cancer therapy except sorafenib who have received any local anti cancer therapy equal less four weeks prior baseline computed tomography ct magnetic resonance imaging mri scan prior cycle one treatment
1, hydroxyurea glioblastoma diagnosis pts history chf arrhythmias who receiving treatment digoxin verapamil treatment cannot be discontinued switched different drug prior starting drug
1, reduced fluid volume secondary malignant neoplasm intestinal tract diagnosis mental disease addictive disorders impairing ability provide informed consent
1, questionnaire administration stage iii squamous cell carcinoma oropharynx diagnosis patients who have had major surgery defined requiring general anesthesia but not including tonsillectomy neck dissection panendoscopy triple endoscopy examination under general anesthesia significant traumatic injury within four weeks patients who have not recovered from side effects any above surgeries
0, methotrexate multiple myeloma plasma cell neoplasm diagnosis no known hypersensitivity e
0, rituximab lymphoma diagnosis centroblastic
0, mitogens retinoblastoma diagnosis two hundred thirty units l
0, sorafenib recurrent melanoma diagnosis patients must not have any evidence bleeding diathesis
0, doxorubicin patients must agree undergo pretreatment needle biopsy primary tumor breast molecular profiling
1, sirolimus recurrent solid neoplasm diagnosis pregnant breast feeding women will not be entered on this pregnancy tests must be obtained girls who post menarchal males females reproductive potential may not participate unless they have agreed use an effective contraceptive method both during six months after participation this abstinence is an acceptable method contraception
1, everolimus plexiform neurofibroma diagnosis acute viral hepatitis
1, docetaxel squamous cell non small cell lung cancer diagnosis patients known be hiv positive
1, laboratory biomarker analysis precancerous condition diagnosis alkaline phosphatase alp greater doc ulrr
0, dexamethasone phosphate multiple myeloma diagnosis lambda light chain ratio
1, bevacizumab mixed adenocarcinoma stomach diagnosis patients non malignant systemic disease cardiovascular renal hepatic etc
0, paclitaxel primary peritoneal cavity cancer diagnosis ca one hundred twenty five at least one hundred units ml ca one hundred twenty five level must have at least doubled from baseline determination
0, resistance training ovarian cancer diagnosis able read write english
0, musculoskeletal complications management prevention stage iv grade two follicular lymphoma diagnosis pre transplant karnofsky performance status kps greater equal seventy
1, busulfan contiguous stage ii grade two follicular lymphoma diagnosis presence active central nervous system cns disease history adequately treated cns disease is acceptable
0, cisplatin uterine cervical neoplasms diagnosis no prior surgical therapy metastatic lesions lung inside pelvic cavity
0, celecoxib neurofibrosarcoma
0, trametinib multiple myeloma diagnosis have hemoglobin greater doc dl
0, levoleucovorin metastatic cancer diagnosis not specified hematopoietic
1, rituximab contiguous stage ii small lymphocytic lymphoma diagnosis known human immunodeficiency virus hiv infection
1, folic acid stage ib pancreatic cancer diagnosis methadone dosage methadone may need be increased when coadministered viracept
0, doxorubicin multiple myeloma diagnosis doc uln and
1, sirolimus stage iii multiple myeloma diagnosis women who pregnant lactating
0, vorinostat childhood immunoblastic large cell lymphoma diagnosis no evidence gross hematuria patients group three
1, ramucirumab gastroesophageal junction adenocarcinoma diagnosis have known active fungal bacterial known viral infection
0, immunoglobulins recurrent oropharyngeal squamous cell carcinoma diagnosis presence measurable lesions by recist
1, fludarabine aggressive non hodgkin lymphoma diagnosis karnofsky scores less sixty lansky score less fifty
1, letrozole stage iv breast cancer diagnosis note
1, temozolomide glioma diagnosis patients platelet count less seventy five zero mmthree anc less one thousand five hundred mmthree within seventy two hours prior itv depocyt oral temozolomide treatment
0, laboratory biomarker analysis clear cell renal cell carcinoma diagnosis not lactating female subjects who lactating should discontinue nursing prior first dose drug should refrain from nursing throughout treatment period fourteen days following last dose drug
1, endothelial growth factors stage iiic fallopian tube cancer diagnosis patients known hypersensitivity chinese hamster ovary cell products other recombinant human humanized antibodies patients known allergy cremophor polysorbate eighty
0, sirolimus pancreatic cancer diagnosis investigator will select appropriate treatment arm patient following requirements
1, doxorubicin prior systemic anticancer therapy breast cancer immunotherapy hormonotherapy chemotherapy
0, bevacizumab stage ivb cervical cancer diagnosis absolute neutrophil count anc greater equal one thousand five hundred mcl
1, paclitaxel ovarian cancer diagnosis note
1, capecitabine kidney cancer diagnosis patients who have had an organ allograft
1, erlotinib hydrochloride cancer diagnosis mental cognitive disorders
0, bevacizumab recurrent childhood medulloblastoma diagnosis histologic confirmation required
0, melphalan noncontiguous stage ii adult diffuse mixed cell lymphoma diagnosis age greater equal three equal less seventy five years blood bone marrow transplants age greater equal three less sixty cord blood transplants
0, pembrolizumab bladder cancer diagnosis activated partial thromboplastin time aptt
1, alemtuzumab contiguous stage ii grade two follicular lymphoma diagnosis diffusion capacity carbon monoxide dlco less thirty five total lung capacity tlc less thirty five forced expiratory volume one second fevone less thirty five receiving supplementary continuous oxygen
0, laboratory biomarker analysis stage prostate cancer diagnosis no evidence regional nodal distant metastases based on computed tomography ct abdomen pelvis whole body bone scan within one hundred twenty days prior entry nodes less doc cm will be considered reactive biopsy is not required nodes doc cm larger required undergo biopsy be negative prior registration bone scan findings absence blastic lytic lesion correlates on ct imaging will also be deemed non neoplastic
0, estradiol breast neoplasms diagnosis must have adequate bone marrow renal liver function
1, nerve spring radical hysterectomy pathologically diagnosed pathologically diagnosed squamous carcinoma small cell carcinoma small cell carcinoma
1, vidarabine stage iii adult diffuse mixed cell lymphoma diagnosis presence circulating leukemic blasts peripheral blood detected by standard pathology patients aml all cml
0, thiotepa recurrent adult diffuse large cell lymphoma diagnosis acute myeloid leukemia aml
1, placebo head neck cancer diagnosis allergy glutamine
0, questionnaire administration recurrent uterine corpus sarcoma diagnosis no concurrent treatment gog treatment trial
0, camptothecin recurrent colorectal carcinoma diagnosis absolute neutrophil count anc greater equal doc ten nine l
1, carboplatin non small cell lung cancer diagnosis patients who not agree avoid excessive sun exposure use adequate sunscreen protection
1, cytarabine mature cell nk cell non hodgkin lymphoma diagnosis patients who have had electron beam therapy still eligible will be evaluated on case by case basis by radiation oncology pi
1, bortezomib multiple myeloma diagnosis acute diffuse infiltrate pulmonary disease pericardial dise
0, immunoglobulins stage iv squamous cell carcinoma oropharynx diagnosis absolute neutrophil count anc greater one thousand five hundred cells mcl
0, bortezomib multiple myeloma diagnosis not pregnant lactating
0, vaccines intraocular melanoma diagnosis anginal syndrome requiring ongoing medications history myocardial infarction arrhythmia disorder
0, bb ds stage iii plasma cell myeloma diagnosis uncontrolled blood pressure hypertension
0, cisplatin recurrent laryngeal squamous cell carcinoma diagnosis alkaline phosphatase greater one but equal less doc uln ast alt greater one but equal less doc uln
1, screening questionnaire administration prostate carcinoma diagnosis males who have had more one psa blood test past three years
0, hormones prostate cancer adenocarcinoma metastatic diagnosis patients willing receive docetaxel
0, cisplatin cervical cancer diagnosis grossly no residual disease
0, antilymphocyte serum non hodgkins lymphoma diagnosis malignant conditions which cdthirty four positive selected cell depleted allogeneic hematopoietic stem cell transplantation is indicated such as
0, doxorubicin regional neuroblastoma diagnosis total bilirubin less doc times upper limit normal uln age
1, antibodies monoclonal stage iva verrucous carcinoma larynx diagnosis active autoimmune disease
1, bb multiple myeloma diagnosis patient received immunotherapy antibody therapy within eight weeks before enrollment
1, lenalidomide recurrent marginal zone lymphoma diagnosis prolongation corrected qt interval greater four hundred eighty ms
0, mycophenolate mofetil childhood immunoblastic large cell lymphoma diagnosis donor
1, ifosfamide lymphoma diagnosis serum creatinine greater doc mg dl
1, bone marrow sparing imrt radiation therapy rectal neoplasms diagnosis history allergic reactions attributed compounds similar chemical biologic composition flt
0, prednisone lymphoma diagnosis hiv negative
0, motexafin lutetium stage ii ovarian germ cell tumor diagnosis body weight less one hundred thirty kg
1, vaccines stage iia fallopian tube cancer diagnosis clinically significant heart disease yha class iii iv
0, interleukin recurrent parathyroid cancer diagnosis patient must have failed standard curative palliative therapies their disease
1, tetrahydrofolates stomach neoplasms diagnosis patient must have negative urine pregnancy test within fourteen days entry
0, ixazomib refractory extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis eastern cooperative oncology group ecog performance status other performance status zero one two
0, gefitinib recurrent parathyroid cancer diagnosis serum creatinine equal less institutional upper limit normal
0, quality life assessment testicular germ cell tumor diagnosis no contraindication mri ferrous metal implants any type cardiac pacemaker defibrillator history injury by metal fragments
0, irinotecan stage ivb rectal cancer diagnosis ecog zero two
1, camptothecin unspecified childhood solid tumor protocol specific diagnosis patients who have had prior stem cell transplantation without tbi
1, antibodies monoclonal stage iii adult diffuse small cleaved cell lymphoma diagnosis residual grade three grade four non hematologic toxicity after asct
1, nivolumab chronic adult cell leukemia lymphoma diagnosis any condition requiring greater ten mg prednisone equivalents
0, epirubicin stage iv breast cancer diagnosis evidence adequate organ function liver bone marrow kidney
0, antilymphocyte serum lymphoma diagnosis patient characteristics
1, adct hodgkin lymphoma diagnosis pregnant breastfeeding women
0, everolimus non small cell lung cancer diagnosis adequate blood clotting levels
0, questionnaire administration stage iib colorectal cancer diagnosis criteria survivors
0, bortezomib mantle cell lymphoma diagnosis platelets greater equal seventy five zero cells ul
0, carboxymethylcellulose sodium gastric cancer diagnosis creatinine less doc mg dl
0, perifosine pancreatic cancer diagnosis hematopoietic
1, poly iclc glioblastoma diagnosis ggtsix greater doc uln
0, dacarbazine childhood choroid plexus tumor diagnosis anti convulsants
1, famitinib gastrointestinal stromal tumor diagnosis preexisting arrhythmia including qt interval greater four hundred fiftyms male four hundred seventyms female greater grade heart failure
1, irinotecan metastatic cancer diagnosis previous irinotecan anti egfr therapy eg cetuximab panitumumab erlotinib gefitinib lapatinib vaccine treatment mcrc
0, scar gd solid tumor diagnosis five at least one weeks since any radiation therapy at time entry
0, vorinostat unspecified adult solid tumor protocol specific diagnosis patients must have histologically confirmed epithelial malignancy that is metastatic unresectable which standard curative palliative measures not exist no longer effective
1, tetrahydrofolates rectal cancer diagnosis any unstable oncologic emergency syndromes
1, selenium breast neoplasms diagnosis venous thrombosis upper limbs
0, imatinib mesylate prostate cancer diagnosis see disease characteristics
1, epinephrine supratentorial neoplasms diagnosis craniotomy incision extending beyond field block
0, gemcitabine histologically proven invasive primary carcinoma cervix
1, cisplatin squamous cell carcinoma neck diagnosis concurrent treatment other experimental drugs participation another clinical trial any investigational drug within thirty days prior screening
0, cediranib neurofibromatosis type one diagnosis no concurrent enzyme inducing anticonvulsants phenytoin carbamazepine phenobarbital
1, everolimus recurrent adult diffuse large cell lymphoma diagnosis impaired cardiac function clinically significant cardiac diseases including any one following
1, immunoglobulins presence second active tumor other non melanoma skin cancer carcinoma situ cervix kaposi sarcoma ks that requires systemic therapy
1, docetaxel non small cell lung cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition erlotinib docetaxel
0, radiofrequency ablation carcinoma hepatocellular diagnosis age eighteen seventy five years
1, photodynamic therapy stage lymphoepithelioma nasopharynx diagnosis has not recovered from toxicity prior therapy
0, aldesleukin breast cancer diagnosis hepatitis antibody negative
0, sorafenib carcinoma renal cell diagnosis prior palliative radiotherapy metastatic lesion is permitted
1, lenalidomide smoldering plasma cell myeloma diagnosis new york heart association nyha class three four congestive heart failure chf symptoms
1, bevacizumab metastatic solid tumors diagnosis hcv tp hiv antibody positive
1, antibodies monoclonal diffuse large cell lymphoma lymphoma follicular diagnosis major surgical procedure other diagnosis within twenty eight days prior day one cycle one day one anticipation major surgical procedure during course study
1, antibodies monoclonal recurrent small lymphocytic lymphoma diagnosis life expectancy severely limited by diseases other malignancy
1, online non adaptive mr guided sbrt pancreas cancer diagnosis currently receiving any other investigational agents
1, oxaliplatin cancer pancreas diagnosis females must not be breastfeeding
0, camptothecin stage iii adult diffuse small cleaved cell lymphoma diagnosis bilirubin normal
0, doxorubicin cervical cancer diagnosis surgery
0, vincristine stage b lymphoblastic lymphoma diagnosis all patients their parents legal guardians must sign written informed consent
0, albumin bound paclitaxel hertwo negative breast cancer diagnosis patients alkaline phosphatase greater uln but less equal doc uln eligible inclusion if liver imaging ct mri pet pet ct scan performed within four weeks prior randomization does not demonstrate metastatic disease requirements criteria below unexplained skeletal pain met
1, albumin bound paclitaxel stage iiic uterine corpus cancer diagnosis patients who have had radiotherapy within four weeks prior entering those who have not recovered from adverse events ctcae vfour grade two greater excluding alopecia due agents administered more four weeks earlier
1, biopsy nonsmall cell lung cancer diagnosis known hiv positivity on combination antiretroviral therapy because potential pharmacokinetic interactions rociletinib
1, r y reconstruction pancreatic cancer diagnosis body weight loss greater ten during six months prior surgery
1, doxorubicin breast cancer diagnosis prior treatment any anthracyclines anthracenedione containing regimen
0, liposomal doxorubicin lymphoma diagnosis no prior myocardial infarction
0, vidarabine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis aplastic anemia
0, nilotinib growing vestibular schwannomas diagnosis women who pregnant breastfeeding childbearing potential without negative serum pregnancy test within seven days prior registration
1, fluorouracil rectal cancer diagnosis hypersensitivity contraindication drug associated planned choice systemic chemotherapy capox folfox single agent five fu capecitabine stated smpc each drugs
0, lapatinib erbbtwo positive stage iii breast cancer diagnosis signed informed consent from patient legal representative
1, fludarabine noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis donor
1, vinorelbine childhood alveolar rhabdomyosarcoma diagnosis patients embryonal histology stage clinical group one at initial disease presentation who present local regional recurrence ineligible
1, antibodies monoclonal stage iv skin melanoma diagnosis planned anticipated major surgical procedure during course study
0, docetaxel head neck neoplasm diagnosis alt astless doc times uln
1, paclitaxel recurrent adenocarcinoma pancreas diagnosis history malignancy last five years
1, bevacizumab breast cancer diagnosis patients documented metastatic disease ineligible
0, fulvestrant stage iv breast cancer diagnosis bilirubin equal less doc five upper limit normal
0, endostar esophageal squamous cell carcinoma diagnosis tb less unl alt ast less doc unl akp less five unl
1, pemetrexed lung cancer diagnosis active pregnancy inability unwillingness employ appropriate contraception
0, vidarabine noncontiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis must have less five blasts at time transplant
1, paclitaxel ovarian serous adenocarcinoma diagnosis therapeutic anticoagulation requiring international normalized ratio inr greater doc
0, immunoglobulins ovarian polyembryoma diagnosis at least fifty donor chimerism cell lineage full greater ninety donor chimerism unseparated blood on last assessment within three months before entry
1, mycophenolate mofetil recurrent adult burkitt lymphoma diagnosis fertile men women unwilling use contraceptive techniques during twelve months following treatment
1, antibodies monoclonal recurrent grade three follicular lymphoma diagnosis donor age less twelve years
1, cyclosporine splenic marginal zone lymphoma diagnosis patients other disease organ dysfunction that would limit survival less thirty days
1, paclitaxel large cell lung carcinoma diagnosis uncontrolled neuropathy greater equal grade two regardless cause
0, trastuzumab breast cancer diagnosis two weeks must have elapsed since receiving any radiotherapy greater three weeks five half lives whichever is shorter treatment cytotoxic biologic agents greater six weeks mitomycin nitrosoureas
1, paclitaxel fallopian tube cancer diagnosis suboptimal greater one cm residual disease cytoreduction
1, fludarabine phosphate stage iii adult diffuse small cleaved cell lymphoma diagnosis donors whom medical psychologic reasons would make donor procedure intolerable
0, adrenergic agonists lipoma diagnosis you have body mass index bmi between twenty less forty kg mtwo
1, irinotecan gastric cancer diagnosis known brain metastases
1, albumin bound paclitaxel fallopian tube cancer diagnosis patients human immunodeficiency virus hiv
1, succinylcholine stage iic ovarian cancer diagnosis core biopsy within seven days prior first date bevacizumab therapy cycle two
1, bb stage iic ovarian cancer diagnosis patients clinical symptoms signs gastrointestinal obstruction those who require parenteral hydration nutrition patients history current diagnosis inflammatory bowel disease not eligible
1, antibodies monoclonal non hodgkin lymphoma diagnosis history severe allergic anaphylactic reactions human humanized chimeric murine monoclonal antibodies
1, quality life assessment stage iii verrucous carcinoma larynx diagnosis presence other medical conditions causing mucositis rheumatologic severe gastroesophageal reflux etc
0, olaparib high grade ovarian serous adenocarcinoma diagnosis ability understand willingness sign written informed consent document
0, vinca alkaloids ovarian cancer diagnosis radiographic evidence measurable disease by recist criteria
0, paclitaxel malignant head neck neoplasm diagnosis ability understand willingness sign written informed consent document
1, carboplatin non hodgkin lymphoma diagnosis patient has history allergy hypersensitivity any drugs any their excipients patient exhibits any events outlined contraindication special warnings precautions sections product comparator smpc prescribing information
1, albumin bound paclitaxel gastroesophageal junction adenocarcinoma diagnosis participant experienced any grade three four venous thromboembolic event that is not adequately treated
0, camptothecin esophageal neoplasms diagnosis no major surgery within one month starting drug
0, prednisolone phosphate neuroblastoma diagnosis lansky eighty one hundred
0, bevacizumab recurrent ovarian carcinoma diagnosis patients both platinum sensitive platinum resistant disease eligible patients platinum refractory disease not eligible platinum refractory disease is defined patients who have progression disease during preceding platinum treatment
0, gemcitabine pancreatic cancer diagnosis no cardiac insufficiency despite optimal medication
1, folfiri colorectal cancer diagnosis known dihydropyrimidine dehydrogenase deficiency special screening not required
0, irinotecan relapsed solid tumors diagnosis informed consent
0, doxorubicin small intestine cancer diagnosis concurrent consolidation radiotherapy may be given at clinician discretion
0, dexamethasone phosphate multiple myeloma diagnosis pulmonary infection if any must be controlled effectively
1, pol metastatic breast cancer diagnosis radiation therapy within fourteen days prior day one
0, fluorouracil recurrent rectal cancer diagnosis metastatic disease by imaging
1, cortisone acetate stage iii prostate adenocarcinoma diagnosis hemoglobin less nine dl
1, cytarabine stage iii small lymphocytic lymphoma diagnosis prior entry any electrocardiogram ecg abnormality at screening has be documented by investigator not medically relevant
0, entinostat childhood brain stem neoplasm diagnosis autologous stem cell infusion including boost infusion
0, laboratory biomarker analysis recurrent breast carcinoma diagnosis women human epidermal growth factor her two positive disease must have received progressed on at least one prior anti her two directed regimen trastuzumab lapatinib their metastatic disease
0, temozolomide newly diagnosed non methylated glioblastoma multiforme grade four diagnosis platelets greater one hundred zero mmthree
0, antibodies monoclonal recurrent small lymphocytic lymphoma diagnosis patients must be anticipated complete at least two cycles chemotherapy
1, tacrolimus stage adult diffuse small cleaved cell lymphoma diagnosis more twenty zero circulating cdtwenty positive cells ul
0, immunoglobulins nodal marginal zone cell lymphoma diagnosis patients must have an expected survival greater sixty days must be free major infection
0, carboplatin breast cancer diagnosis bilirubin within normal limits within ninety days prior registration
1, ramucirumab stomach cancer diagnosis grade three four gi bleeding within three months prior enrollment
1, fludarabine phosphate recurrent refractory childhood hodgkin lymphoma diagnosis karnofsky score less fifty
0, dexamethasone phosphate stage iv squamous cell carcinoma larynx diagnosis willingness complete patient diary questionnaires
1, vatalanib retinal capillary hemangioblastoma diagnosis diagnosis hiv infection
0, kanglaite gelcap undergone definitive treatment surgery surgery radiation therapy cryotherapy radiation therapy brachytherapy primary prostate tumor rising psa
1, etoposide diffuse large cell lymphoma diagnosis females childbearing potential who not agree undergo pregnancy tests repeated use effective birth control while included clinical trial
1, irinotecan colorectal cancer diagnosis previous chemotherapy treatment adjuvant neoadjuvant disease no metastatic mzero immunotherapy active passive advance metastatic disease
0, isophosphamide mustard ovarian yolk sac tumor diagnosis doc mg dl six months less one year age
0, isotretinoin recurrent childhood large cell lymphoma diagnosis at least two weeks since prior valproic acid
0, dexamethasone phosphate relapse refractory multiple myeloma diagnosis patient has measurable component serum urine at screening
0, endothelial growth factors recurrent glioblastoma diagnosis creatinine upc ratio less doc urine dipstick proteinuria equal less two positive note
1, sorafenib advanced adult hepatocellular carcinoma diagnosis patients active hepatitis infection should be on adequate antiviral therapy
1, doxorubicin breast cancer diagnosis uncontrolled intercurrent illness including but not limited ongoing active infection
1, vaccines prostate cancer diagnosis no evidence immunosuppression on treatment immunosuppressive agents
0, dexrazoxane solid tumors
0, fludarabine splenic marginal zone lymphoma diagnosis waldenstrom macroglobulinemia
0, aldesleukin metastatic melanoma diagnosis absolute neutrophil count greater one thousand mm three
0, mycophenolate mofetil contiguous stage ii small lymphocytic lymphoma diagnosis donor
0, amiloride glaucoma
1, cyclosporins childhood immunoblastic large cell lymphoma diagnosis alanine aminotransferase alt aspartate aminotransferase ast more three fold higher laboratory upper normal limits
0, estradiol recurrent breast carcinoma diagnosis patients must be disease free prior invasive malignancies greater equal five years exception of
1, navitoclax non hodgkin lymphoma diagnosis received steroid therapy seven days prior onest dose drug anti neoplastic intent
1, vinorelbine breast cancer diagnosis patients variety factors that affect oral administration absorption drugs
1, quality life assessment angioimmunoblastic cell lymphoma diagnosis rituximab maintenance patients participating on mayo clinic vitamin allowed
0, gemcitabine recurrent adult lymphoblastic lymphoma diagnosis no other concurrent uncontrolled illness that would preclude participation
1, dexamethasone phosphate follicular lymphoma grade iii fl iii diagnosis creatininegreater two times upper reference limit liver
0, immunoglobulins adenocarcinoma colon diagnosis stage iii disease
0, trebananib recurrent digestive system neuroendocrine tumor gone diagnosis patients must be greater one weeks from regional treatments show progressive disease liver after regional therapy must have measurable disease outside liver patients may have received one prior line anti vegf treatment bevacizumab sunitinib sorafenib prior treatment agents targeting pithreek akt mtor pathway is not allowed
1, vidarabine solid tumor diagnosis patient is pregnant confirmed by serum hcg if applicable is breastfeeding
1, thiotepa lymphoblastic lymphoma diagnosis unrelated donors donating outside united states america usa
1, lenalidomide nodal marginal zone cell lymphoma diagnosis st
1, atorvastatin calcium recurrent mantle cell lymphoma diagnosis must have failed two courses therapy
1, dacarbazine pancreatic polypeptide tumor diagnosis prior full field radiotherapy less equal four weeks limited field radiotherapy less equal two weeks prior enrollment
0, dexamethasone multiple myeloma diagnosis uncontrolled diabetes mellitus
0, questionnaire administration psychosocial effects cancer its treatment diagnosis no other concurrent treatment
0, antibodies childhood hepatoblastoma diagnosis no prior small molecule kinase inhibitors igf ir
1, erlotinib hydrochloride pancreatic cancer metastatic diagnosis impairment gastrointestinal function gastrointestinal disease ulcerative disease uncontrolled nausea vomiting diarrhea
1, mycophenolate mofetil noncontiguous stage ii marginal zone lymphoma diagnosis patient donor active hepatitis or detectable viral ribonucleic acid rna
0, antibodies monoclonal advanced breast cancer diagnosis estrogen receptors ers progesterone receptors prs positive
1, dovitinib first second recurrence glioblastoma diagnosis alt ast greater doc ulrr
0, silicon phthalocyanine lymphoma diagnosis male female
1, melphalan stage multiple myeloma diagnosis seropositivity human immunodeficiency virus
1, mg kg Î± tea metastatic carcinoma diagnosis abnormal thyroid function euthyroid but on medication thyroid disorders
0, tb â‰¤ mg kg relapsed refractory medulloblastoma mb part also include neuroblastoma nb ewing sarcoma es alveolar rhabdomyosarcoma arms diagnosis international normalized ratio inr less doc partial thromboplastin time ptt less doc upper limit normal uln dimer less two hundred fiftyng ml
1, rituximab untreated cell angioimmunoblastic lymphoma diagnosis concurrent severe disease according investigator decision
1, bicalutamide prostate cancer diagnosis patients any significant history non compliance medical regimens inability grant reliable informed consent
0, doxorubicin stage iiib breast cancer diagnosis hemoglobin greater nine dl
0, paclitaxel stage iiia breast cancer diagnosis patients must have an eastern cooperative oncology group ecog performance status less two
1, carboplatin prior therapies allowed treatment newly diagnosed breast cancer patients prior diagnosis malignancy treated greater equal five years ago eligible provided that they have not received prior taxanes carboplatin part their prior treatment regimen that they meet all eligibility criteria
0, rituximab lymphoma diagnosis no prior nucleoside analogue therapy
1, mindfulness based stress reduction malignant female reproductive system neoplasm diagnosis prisoner incarcerated
1, romidepsin non small cell lung carcinoma diagnosis myocardial infarction within one year study
0, laboratory biomarker analysis stage iv skin melanoma diagnosis willingness return mayo clinic rochester follow up
0, cediranib advanced malignant mesothelioma diagnosis no history long qt syndrome
1, carboplatin small cell lung cancer diagnosis pregnant positive pregnancy test lactating
0, etoposide phosphate lymphoma diagnosis other
1, atlcar cd cells lymphoma non hodgkin diagnosis active infection is defined not being well controlled on therapy note
1, fluorouracil stage iva oral cavity squamous cell carcinoma diagnosis other previous malignancy within five years
0, lenalidomide stage iii adult diffuse mixed cell lymphoma diagnosis expected survival duration greater equal six months
0, ferrosoferric oxide stage iib cervical cancer diagnosis eastern cooperative oncology group ecog performance status equal less two karnofsky greater equal sixty
0, paclitaxel cervical cancer diagnosis hemoglobin equal greater nine l
1, immunoglobulin g adult oligodendroglioma diagnosis chronic obstructive pulmonary disease exacerbation other respiratory illness requiring hospitalization precluding therapy at time registration
0, laboratory biomarker analysis liposarcoma diagnosis patient must have life expectancy at least three months appropriate therapy
0, dacarbazine adult anaplastic astrocytoma diagnosis fertile patients must use effective contraception prior during at least six months after completion treatment
0, o benzylguanine childhood supratentorial ependymoma diagnosis xrt
1, fludarabine recurrent adult lymphoblastic lymphoma diagnosis donors
1, dexamethasone acetate myeloma diagnosis creatinine clearance less thirty ml min cockroft gault calculation
0, dynamic susceptibility contrast enhanced magnetic resonance imaging stage iii renal cell cancer diagnosis patients metastatic disease may have received prior nephrectomy prior systemic therapy no limit on number their baseline pmri would be performed prior starting new treatment
0, ispinesib neurologic deficits patients cns tumors must have been relatively stable greater one week
1, everolimus recurrent childhood anaplastic large cell lymphoma diagnosis cardiac ejection fraction less thirty five ejection fraction is required if age greater fifty years there is history anthracycline exposure history cardiac disease
1, bortezomib mantle cell lymphoma diagnosis female subject who is pregnant currently breast feeding
1, donor nk cell infusion rhabdomyosarcoma diagnosis hiv seropositive patients
0, nivolumab non small cell lung cancer recurrent diagnosis effect nab paclitaxel nivolumab on fetus is unknown
0, preventative dietary intervention unspecified adult solid tumor protocol specific diagnosis other
0, cytarabine lymphoma diagnosis evaluable disease defined only nonmeasurable disease including any following
0, isophosphamide mustard kidney cancer diagnosis greater one week since prior radiotherapy no concurrent radiotherapy surgery
0, mycophenolic acid stage iii marginal zone lymphoma diagnosis patients will be accepted beyond chronic phase one cpone if they have received previous myelosuppressive chemotherapy hsct have less five marrow blasts at time transplant
0, nk immunotherapy body tumor one six maximum tumor length less five cm
1, bevacizumab advanced gastrointestinal cancer diagnosis major surgery within four weeks prior first dose
0, immunoglobulin g locally advanced malignant neoplasm diagnosis platelets greater one hundred zero ul
1, rucaparib ovarian cancer diagnosis any other condition which investigator opinion would not make patient good candidate clinical trial
0, antibodies monoclonal stage squamous cell carcinoma paranasal sinus nasal cavity diagnosis at least six months since prior radiotherapy
1, pertuzumab neuroblastoma diagnosis any following concurrent severe uncontrolled medical conditions within twenty four weeks enrollment which could compromise participation study
0, immunoglobulins brain cancer diagnosis no exclusion this will be based on race
1, cyclophosphamide prior hormonal therapy breast cancer
1, dexamethasone phosphate recurrent mantle cell lymphoma diagnosis enrollment subjects who require concurrent radiotherapy which must be localized its field size should be deferred until radiotherapy is completed three weeks have elapsed since last date therapy
0, interleukin breast cancer diagnosis measurement regressed stable disease must be confirmed by repeat evaluation no less four weeks after initial determination
0, immunoglobulins stage ii ovarian epithelial cancer diagnosis bone metastases that can be assessed by ct scan mri considered evaluable
1, methotrexate lymphoma diagnosis allergies bortezomib boron mannitol
0, irinotecan stage iiic rectal cancer diagnosis group i
1, irinotecan brain cancer diagnosis agent dose time administration will be recorded patient diary
1, thoracic d conformal radiotherapy thoracic neoplasms diagnosis allergic reactions attributed compounds similar chemical biologic composition platinum based drugs
1, uterine fibroid embolization beadblockâ„¢ leiomyomatosis diagnosis patients adenomyosis
1, paclitaxel succinate dehydrogenase sdh deficient non gastrointestinal stromal tumors diagnosis major surgery within twenty eight days before cycle one day one
1, prednisolone phosphate metastatic castration resistant prostate cancer diagnosis participant who has had surgery local prostatic intervention within four weeks prior scheduled date initial administration abiraterone acetate
1, niacinamide hepatocellular carcinoma diagnosis antiviral treatment is allowed
0, immunoglobulin g stage iiia non small cell lung cancer diagnosis patients who will receive pemetrexed pemetrexed disodium cisplatin therapy must also meet following criteria
1, desipramine ds stage plasma cell myeloma diagnosis use monoamine oxidase inhibitor mao during within two weeks desipramine therapy
0, trastuzumab colorectal cancer diagnosis concurrent contraception estrogen replacement therapy megestrol acetate anorexia allowed
1, carboplatin stage iiia ovarian cancer diagnosis new york heart association nyha grade ii greater congestive heart failure
0, etoposide phosphate choroid plexus tumors diagnosis postoperative imaging has been done result is available
0, phosphonoacetic acid angioimmunoblastic cell lymphoma diagnosis informed consent
1, cisplatin cervical cancer diagnosis patient is known be human immunodeficiency virus hiv positive
0, succinylcholine stage iva uterine corpus cancer diagnosis patients gynecologic oncology group gog performance status zero one two
1, hydroxocobalamin bladder cancer diagnosis however if investigator opinion effusion represents progression disease patient should be discontinued from therapy
1, oxaliplatin adenocarcinoma gastroesophageal junction diagnosis pleural effusion requiring drainage equal less twelve months prior registration
1, dexamethasone multiple myeloma diagnosis known hypersensitivity uncontrolled side effects related trial drug hypersensitivity any other component trial drugs
1, quality life assessment brain neoplasms diagnosis bevacizumab naÃ¯ve patients
0, liposomal doxorubicin patients metastatic hormone refractory prostate cancer defined by resistance both ablative therapy either lhrh agonists orchiectomy anti androgens
1, rituximab recurrent mantle cell lymphoma diagnosis lactating females
1, cyclosporine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis total bilirubin greater twox upper limit normal
0, vincristine lymphoma diagnosis relapse post fludarabine non cr after salvage regimen
0, isophosphamide mustard brain central nervous system tumors diagnosis ast alt less three times uln
1, fluorodeoxyglucose f have small cell carcinoma neuroendocrine component greater fifty
0, fludarabine phosphate lymphoma diagnosis cardiac
1, s plus leucovorin pancreatic cancer diagnosis evidence any other disease metabolic dysfunction physical examination finding clinical laboratory finding giving reasonable suspicion disease condition that contraindicates use an investigational drug patient at high risk from treatment complications
0, lapatinib breast cancer diagnosis adequate hematologic hepatic function defined table one
1, dexamethasone phosphate malignant neoplasm diagnosis has stage iv metastatic disease
1, thalidomide diffuse large cell lymphoma diagnosis female childbearing potential excluded
1, bevacizumab stage iiic fallopian tube cancer diagnosis known human immunodeficiency virus hiv positive
1, sirolimus recurrent lymphoepithelioma nasopharynx diagnosis patients may not be receiving any other investigational agents addition patients must not have received investigational treatment equal less thirty days prior registration
0, niacinamide kidney cancer diagnosis no clinical radiologic evidence bowel obstruction perforation
1, doxorubicin stage mantle cell lymphoma diagnosis known hiv positive status
0, romidepsin recurrent adult diffuse small cleaved cell lymphoma diagnosis phase i
0, bevacizumab stage iv non small cell lung cancer diagnosis no history abnormalities cornea dry eye syndrome sjÃ¶gren syndrome congenital abnormality fuch dystrophy
0, cisplatin sgot no greater three times uln five times uln if there is liver involvement by tumor
0, paclitaxel stage iv gastric cancer diagnosis life expectancy at least three months
0, bortezomib multiple myeloma diagnosis alanine transaminase ast
1, cisplatin head neck cancer diagnosis because there is an unknown but potential risk adverse events nursing infants secondary treatment mother chemotherapy breastfeeding should be discontinued if mother is treated chemotherapy
0, camptothecin colorectal cancer diagnosis other
0, phosphoramide mustards kidney cancer diagnosis first line advanced hcc no prior systemic therapy
0, nivolumab patients who were treated blinatumomab past will be allowed on long they have persistent cdnineteen expression on leukemia cells did not experience unacceptable toxicities prior blinatumomab administration
1, cyclophosphamide recurrent melanoma diagnosis chemotherapeutic agents standard experimental radiation therapy other immunosuppressive therapies less three weeks prior cell therapy
0, mycophenolate mofetil recurrent cutaneous cell non hodgkin lymphoma diagnosis left ventricular end diastolic function lvef greater fifty
0, melphalan multiple myeloma plasma cell neoplasm diagnosis serum monoclonal protein greater one dl
0, hypofractionated radiation therapy melanoma skin diagnosis eastern cooperative oncology group ecog performance status zero two
0, oxaliplatin stage iiic gastric cancer diagnosis total bilirubin less doc upper limit normal
1, questionnaire administration recurrent mantle cell lymphoma diagnosis patients should stop using these fruits herbal medications seven days prior first dose drug
1, cytarabine recurrent diffuse large cell lymphoma diagnosis bilirubin greater doc mg dl transaminases greater three times upper normal limit
1, ado trastuzumab emtansine stage ib breast cancer diagnosis note
0, fludarabine phosphate noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis donor
0, simrt prostate adenocarcinoma diagnosis tonea is permitted if peripheral zone biopsies positive
1, doxorubicin patients receiving therapeutic dosages steroids multiple myeloma
0, pembrolizumab stage iv prostate adenocarcinoma diagnosis serum creatinine equal less doc upper limit normal uln measured calculated creatinine clearance greater equal sixty ml min subject creatinine levels greater doc institutional uln glomerular filtration rate gfr can also be used place creatinine creatinine clearance crcl creatinine clearance should be calculated per institutional standard
0, prednisolone hemisuccinate stomatitis diagnosis surgical menopause bilateral oophorectomy note
1, pemetrexed carcinoma non small cell lung diagnosis inability interrupt aspirin other nonsteroidal anti inflammatory drugs nsaids two days before day two days after dose pemetrexed
0, bortezomib stage iv grade one follicular lymphoma diagnosis qtc less five hundred msec men four hundred seventy msec women
1, mitogens noncontiguous stage ii small lymphocytic lymphoma diagnosis presence generalized rash involving more fifty body surface
1, maytansine ovarian neoplasms diagnosis subjects who have received any investigational drug treatment outside this within four weeks before start anetumab ravtansine
1, maleic acid ovarian seromucinous carcinoma diagnosis participants receiving any medications substances that strong inhibitors inducers cypthreeafour ineligible
1, gemcitabine solid tumors diagnosis note
1, piperazine pilocytic astrocytoma diagnosis patients history current condition that would preclude use bevacizumab
0, fluorouracil colorectal cancer diagnosis hematopoietic
0, irinotecan intestinal adenocarcinoma stomach diagnosis performance status
1, paclitaxel cancer breast diagnosis male subjects
1, paclitaxel solid tumors diagnosis clinically uncontrolled central nervous system cns involvement
1, immunoglobulins stage iv ovarian cancer diagnosis myocardial infarction unstable angina less six months prior registration
1, antibodies monoclonal stage ivb oropharyngeal squamous cell carcinoma diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy ineligible
0, antibodies monoclonal adult grade iii lymphomatoid granulomatosis diagnosis absolute neutrophil count anc greater equal one thousand ul
1, tacrolimus recurrent small lymphocytic lymphoma diagnosis patients poorly controlled hypertension despite multiple antihypertensive medications
1, aldesleukin skin cancer diagnosis atrial fibrillation ventricular tachycardia second third degree heart block
1, k pancreatic cancer diagnosis having received any following treatment within specific time period before inclusion
0, fludarabine splenic marginal zone lymphoma diagnosis high risk cytogenetics including but not limited to
1, fludarabine melanoma experimental diagnosis any form primary immunodeficiency such severe combined immunodeficiency disease acquired immune deficiency syndrome aids
1, dexamethasone acetate cholangiocellular carcinoma icc diagnosis clinical ascites
1, flucytosine anaplastic oligoastrocytoma diagnosis received avastin
0, erlotinib hydrochloride metastatic pancreatic adenocarcinoma diagnosis eastern cooperative oncology group ecog performance status equal less one
1, erlotinib hydrochloride hertwo negative breast cancer diagnosis significant vascular disease aortic aneurysm aortic dissection
0, sirolimus metastatic breast cancer diagnosis patients must have recovered grade one better from any adverse events except alopecia related previous therapy prior enrollment
0, etoposide head neck cancer diagnosis no concurrent barbiturates acetaminophen
1, interleukin stage iiia skin melanoma diagnosis cardiac ischemia symptoms coronary artery disease
1, etoposide non hodgkins lymphoma diagnosis you cannot participate this if any following apply you
0, erlotinib hydrochloride adenocarcinoma lung diagnosis negative pregnancy test
0, imidazole stage ivb hodgkin lymphoma diagnosis serum creatinine equal less doc mg dl if creatinine greater doc mg dl creatinine clearance must be greater equal sixty ml minute
1, bevacizumab somatostatinoma diagnosis current recent within four weeks first infusion this planned participation an experimental drug study
1, antibodies monoclonal hodgkin lymphoma diagnosis has received live vaccine within thirty days prior first dose drug
1, cetuximab stage ivb colorectal cancer diagnosis uncontrolled severe cardiovascular disease including myocardial infarct unstable angina within six months prior treatment new york heart association nyha class ii greater congestive heart failure serious arrhythmias requiring medication treatment clinically significant pericardial disease cardiac amyloidosis
0, camptothecin based on neurosurgeon judgment there is no anticipated physical connection between post resection tumor cavity cerebral ventricles
1, tlr agonist sd grade one follicular lymphoma diagnosis pregnant breast feeding
0, wild type reovirus recurrent childhood brain neoplasm diagnosis life expectancy greater equal three months
0, krn unspecified adult solid tumor protocol specific diagnosis not specified radiotherapy
1, chloroquine diphosphate astrocytoma grade iv diagnosis prior chemotherapy
0, ifosfamide sarcoma diagnosis hematopoietic
1, dasatinib brain central nervous system tumors diagnosis myocardial infarction less six months congestive heart failure requiring use ongoing maintenance therapy life threatening ventricular arrhythmias
1, lenalidomide noncontiguous stage ii mantle cell lymphoma diagnosis positive serology because prior vaccination is allowed
1, paclitaxel metastatic gastrointestinal carcinoid tumor diagnosis serious concurrent infection requiring intravenous antibiotic therapy
0, fasteem system oral tumors diagnosis subjects ability willingness sign an informed consent authorization
0, liposomal doxorubicin breast cancer diagnosis creatinine clearance greater fifty ml min
0, vinorelbine metastatic breast cancer diagnosis three positive over expression by ihc or
1, primovist mri colorectal neoplasms diagnosis patients known anaphylactoid anaphylactic reaction any contrast media hypersensitivity any allergen including drugs
0, imatinib mesylate solid tumors diagnosis patients may not have received chemotherapy within thirty days prior enrollment
0, thalidomide lymphoma non hodgkin diagnosis females reproductive potential must adhere scheduled pregnancy testing required revlimid rems program
1, radiofrequency ablation microwave radiation therapy metastatic colo rectal cancer diagnosis significant cardiac other medical illness that would limit activity survival such severe congestive heart failure unstable angina serious cardiac arrhythmia
1, rituximab recurrent adult burkitt lymphoma diagnosis saquinavir invirase
1, leuprolide prostate cancer diagnosis creatinine less doc dl
0, qs breast cancer diagnosis hematopoietic
0, dexamethasone phosphate plasma cell myeloma diagnosis agree practice true abstinence when this is line preferred usual lifestyle subject
0, bevacizumab recurrent endometrial carcinoma diagnosis seizures allowed provided they controlled standard medical therapy
0, cadexomer iodine lymphoma non hodgkin diagnosis patients must have performance status at least sixty on karnofsky scale an anticipated survival at least three months
0, endothelial growth factors stage iia fallopian tube cancer diagnosis serum glutamic oxaloacetic transaminase sgot less equal three uln
0, carboplatin ovarian carcinosarcoma diagnosis ptt less doc times upper limit normal applies part only
1, albumin bound paclitaxel women adenocarcinoma isolated peritoneal involvements
0, ap carcinoma non small cell lung diagnosis expansion cohorts five additional cohorts
1, u patient has had another active malignancy within past three years except nonmelanoma carcinoma skin cervical carcinoma situ superficial bladder tumours
0, vaccines head neck squamous cell carcinoma diagnosis patients prior anti pd one anti pd lone anti pd ltwo treatment can also be included
1, fenretinide non hodgkin lymphoma diagnosis alt ast greater doc uln
1, bi bs intravenous neoplasms diagnosis absolute neutrophil count less one thousand five hundred mmthree
1, azd brainstem glioma diagnosis if subject has qtc interval greater four hundred seventy msec on screening ecg screen ecg may be repeated twice at least twenty four hours apart
0, allogeneic epstein barr virus specific cytotoxic t lymphocytes radiographic evidence lymphadenopathy lymphomatous lesions combined clinical signs epstein barr virus lymphoproliferative disease ebv lpd such fevers lymphadenopathy
1, pomalidomide multiple myeloma diagnosis hypersensitivity such rash that can be medically managed is allowable
0, etanidazole adult choroid plexus tumor diagnosis bilirubin less doc mg dl
0, fludarabine phosphate skin cancer diagnosis serum creatinine less equal to doc mg dl
0, antibodies monoclonal stage iv mucoepidermoid carcinoma oral cavity diagnosis no gi tract disease resulting requirement iv alimentation
0, bendamustine hydrochloride lymphoma diagnosis patient must have flipi one score three four five one point per criterion below
1, vincristine t lymphoblastic lymphoma
0, armodafinil mid line brain tumor
0, liposomal doxorubicin histologically confirmed multiple myeloma
1, rituximab stage small lymphocytic lymphoma diagnosis history significant cerebrovascular disease past three months ongoing event active symptoms sequelae
1, en bloc resection colorectal adenoma mild dysplasia diagnosis patients chronic inflammatory bowel diseases
0, antibodies monoclonal ovarian transitional cell carcinoma diagnosis negative pregnancy test done equal less seven days prior registration women childbearing potential only
1, sirolimus recurrent squamous cell carcinoma hypopharynx diagnosis patients an active bleeding diathesis on therapeutic anticoagulation except low dose coumadin
1, bortezomib diagnosis treatment malignancy other multiple myeloma nhl within one year randomization who have previously been diagnosed malignancy other multiple myeloma nhl have any radiographic biochemical marker evidence malignancy
1, topotecan recurrent primary peritoneal carcinoma diagnosis patients history current evidence risk retinal vein occlusion rvo
1, paclitaxel male breast cancer diagnosis be pregnant breast feeding female subjects must be surgically sterile be postmenopausal must agree use effective contraception during period therapy all female subjects reproductive potential must have negative pregnancy test serum urine prior enrollment male subjects must be surgically sterile must agree use effective contraception during period therapy definition effective contraception will be based on judgment principal investigator designated associate
0, irinotecan colorectal cancer diagnosis no myocardial infarction within past six months
0, trastuzumab breast cancer diagnosis adequate renal function including serum creatinine less uln measured calculated creatinine clearance greater sixty ml min
0, mycophenolic acid multiple myeloma plasma cell neoplasm diagnosis secondary aml
0, bortezomib childhood burkitt lymphoma diagnosis serum albumin greater two dl
1, trastuzumab breast cancer diagnosis major organ failure systemic disease precluding safe administration medications
0, azacitidine pleural mesotheliomas diagnosis and
0, antibodies adult papillary meningioma diagnosis no history major surgical procedure open biopsy significant traumatic injury within twenty eight days prior day one treatment anticipation need major surgical procedure during course study
1, pharmacological recurrent ewing sarcoma peripheral primitive neuroectodermal tumor diagnosis patients who unable swallow tablets not eligible
1, data collection childhood cancer diagnosis jude consult only patients
1, cyclophosphamide stage iic fallopian tube cancer diagnosis active infection requiring antibiotics
1, etoposide phosphate low malignant potential ovarian tumor
1, mycophenolic acid stage grade one follicular lymphoma diagnosis presence uncontrolled psychiatric disorder
0, tacrolimus recurrent adult grade iii lymphomatoid granulomatosis diagnosis forced vital capacity fvc greater fifty
1, oxaliplatin rectal cancer diagnosis severe medical problems such uncontrolled diabetes mellitus cardiovascular disease active infections
1, liposomal doxorubicin thymic carcinoma diagnosis marked baseline prolongation q wave wave qt corrected qt interval qtc interval repeated demonstration qtc interval greater five hundred ms long qt syndrome
1, pemetrexed non squamous non small cell lung cancer diagnosis unable unwilling take folic acid vitamin btwelve
0, hydroxychloroquine colorectal cancer diagnosis uncontrolled arrhythmia
0, sorafenib ewing sarcoma bone soft tissue diagnosis must not have had prior chemotherapy radiation therapy
1, bevacizumab glioblastoma diagnosis serious non healing wound ulcer bone fracture
1, antibodies monoclonal lymphoma diagnosis pregnant lactating women excluded
1, cyclosporins recurrent marginal zone lymphoma diagnosis pregnancy
0, methylprednisolone lymphoma diagnosis not specified hematopoietic
0, immunoglobulin g ovarian serous cystadenocarcinoma diagnosis absolute neutrophil count anc greater equal one five hundred mcl equivalent common terminology criteria adverse events doc ctcae grade one this anc cannot have been induced supported by granulocyte colony stimulating factors
1, management therapy complications stage squamous cell carcinoma hypopharynx diagnosis subjects may not be receiving other investigational agents
0, everolimus mixed adenocarcinoma stomach diagnosis patients should have controlled diabetes evidenced by hemoglobin hb aonec equal less eight
1, antibodies monoclonal patients current diagnosis borderline epithelial ovarian tumor formerly tumors low malignant potential recurrent invasive epithelial ovarian cancer treated surgery only such those stage ia ib low grade lesions not eligible patients prior diagnosis borderline tumor that was surgically resected who subsequently develop an unrelated new invasive epithelial ovarian peritoneal primary cancer eligible provided that they have not received prior chemotherapy any ovarian tumor
0, cisplatin squamous non small cell lung cancer diagnosis estimated life expectancy at least twelve weeks
0, educational intervention stage ivb uterine sarcoma diagnosis living within fifty mile radius city hope
0, collection non craniotomy melanoma diagnosis an external ventricular drain evd may be utilized if clinically indicated source csf lp evd clearly recorded this is not required enrollment overall protocol if there any contra indications performance this procedure
0, fludarabine myeloproliferative neoplasm diagnosis donor
1, acetylcysteine stage ivc lymphoepithelioma oropharynx diagnosis history myocardial infarction equal less six months congestive heart failure requiring use ongoing maintenance therapy life threatening ventricular arrhythmias
1, cyclosporine burkitt lymphoma diagnosis active recent prior six month invasive fungal infection without interdisciplinary id consult approval
0, bevacizumab stage iib cervical cancer diagnosis history aneurysms cerebrovascular accident arteriovenous malformations
1, etoposide phosphate aids related peripheral systemic lymphoma diagnosis positive serology toxoplasma gondii requiring treatment evidence active infection
0, peginterferon alfa b cancer diagnosis patients must have negative serology tests hiv human immunodeficiency virus
0, immunoglobulins metastatic squamous neck cancer occult primary squamous cell carcinoma diagnosis urine protein no greater trace
0, immunoglobulins contiguous stage ii small lymphocytic lymphoma diagnosis histologically confirmed cdthirty positive ebv positive lymphoid malignancy addition there must be evidence cdtwenty expression at any level
0, liposomal doxorubicin stage iv breast cancer diagnosis amplification her two by fish
1, hormones prostate cancer diagnosis patients whose clinical condition would make chemotherapy clearly indicated
1, questionnaire patients an active second malignancy exception non melanoma skin cancer
1, docetaxel non small cell lung cancer diagnosis major surgery within two weeks other serious concomitant systemic disorders that would compromise safety patient patient ability complete study
0, pentostatin hematopoietic lymphoid cancer diagnosis predominant population lymphocytes share both cell antigens cdnineteen cdtwenty cdtwenty three well cdfive absence other pan cell markers cdthree cdtwo etc
0, carboplatin stage iiib ovarian cancer diagnosis alkaline phosphatase less equal doc times uln ctcae doc grade one
1, gemcitabine bladder cancer diagnosis unwilling unable comply protocol cooperate fully investigator site personnel
0, fulvestrant stage iiic breast cancer diagnosis willing limit daily alcohol intake following
0, nevirapine kaposi sarcoma diagnosis documented hiv positive status confirmed by two elisas hiv one rna testing
0, pembrolizumab recurrent extranodal marginal zone lymphoma mucosa associated lymphoid tissue diagnosis weight loss greater equal ten within previous six months
1, antibodies solid neoplasm diagnosis acute myocardial infarction equal less twelve months prior starting drug
1, caffeine sodium benzoate drug combination cancer diagnosis liver failure alanine aminotransferase greater equal one hundred iu l
1, iodine anti b antibody anaplastic large cell lymphoma diagnosis circulating anti mouse antibody hama
0, bortezomib multiple myeloma plasma cell neoplasm diagnosis spot radiotherapy less three vertebrae allowed
0, bevacizumab breast cancer diagnosis normal organ function outlined protocol
1, mycophenolate mofetil recurrent adult grade iii lymphomatoid granulomatosis diagnosis patients who homozygous at mismatched major histocompatibility complex mhc class locus
0, epirubicin breast cancer diagnosis hemoglobin greater ten dl
1, pembrolizumab squamous cell carcinoma head neck diagnosis history allergic reactions attributed compounds similar chemical biologic composition mk three thousand four hundred seventy five other agents used study
1, vorinostat untreated childhood gliosarcoma diagnosis pregnant breast feeding women will not be entered on this pregnancy tests must be obtained girls who post menarchal males females reproductive potential may not participate unless they have agreed use an effective contraceptive method
0, dexamethasone phosphate multiple myeloma diagnosis addition all participants ndmm rrmm must meet all remaining criteria
0, dexamethasone childhood infratentorial ependymoma diagnosis karnofsky performance status ps fifty one hundred patients greater sixteen years age lansky ps fifty one hundred patients less sixteen years age
0, antibodies monoclonal stage iv adult soft tissue sarcoma diagnosis doc mg dl patients six eleven months age
0, etoposide phosphate if greater five days have elapsed from time obtaining original markers tumor markers must be repeated before enrollment low risk patients before initiating therapy intermediate risk patients results repeated tumor markers not have be known at time enrollment
1, paclitaxel stage iiia breast cancer diagnosis hormone therapy
1, prednisone leukemia lymphoma adult cell diagnosis acute active infection requiring acute therapy
1, bortezomib multiple myeloma diagnosis patient has known allergy hypersensitivity bortezomib dexamethasone cyclophosphamide lenalidomide any constituent compounds such boron mannitol lactose
0, endothelial growth factors recurrent childhood rhabdomyosarcoma diagnosis must not have received within three weeks prior entry onto this four weeks if prior nitrosourea
1, standard post lobectomy wound care plus use prp pppc prepared by gps plasmax respectively lung cancer diagnosis wedge resection alone
0, ly reference formulation tumors diagnosis particular subjects should have normal near normal screening liver tests at discretion investigator
0, vidarabine lymphoma malignant diagnosis if there is any question principal investigator can make decision
1, trastuzumab recurrent adrenocortical carcinoma diagnosis history significant peripheral neuropathy significant central nervous system disease
1, clostridium novyi nt spores tumors diagnosis patients any clinically significant ascites portosystemic hypertension chronic jaundice cirrhosis
1, intravenous t sodium non hodgkin lymphoma diagnosis major surgery within four weeks enrollment
0, pembrolizumab solid neoplasm diagnosis metastatic locally advanced disease that progressed after at least one prior therapy
0, intensity modulated radiation therapy histologically proven soft tissue sarcoma
1, consultation evaluation questionnaire lymphoma diagnosis previous line neo adjuvant medical treatment
1, immunoglobulins stage ib breast cancer diagnosis excisional biopsy lumpectomy performed prior randomization
1, otx mk triple negative breast cancer diagnosis participation another clinical trial treatment any investigational drug within thirty days prior entry
1, albumin bound paclitaxel neoplasms diagnosis serum creatinine more doc upper limit institutional norm
0, dexamethasone multiple myeloma diagnosis patients must have signed an irb approved written informed consent form demonstrate willingness meet follow up schedule procedure obligations
0, bevacizumab prostate cancer diagnosis no prior hormonal therapy luteinizing hormone releasing hormone lhrh agonists antagonists antiandrogens estrogens megestrol pc spes progressive disease
0, tandemâ„¢ hepatocellular carcinoma diagnosis no invasion major blood vessel hepatic portal hepatic vein bile duct by magnetic resonance imaging mri computed tomography ct
0, paclitaxel germ cell tumor diagnosis note
0, cabozantinib s malate recurrent childhood central nervous system neoplasm diagnosis bilirubin sum conjugated positive unconjugated equal less doc upper limit normal uln age
0, fludarabine phosphate splenic marginal zone lymphoma diagnosis compatibility at four most informative hla loci
0, fluorouracil recurrent salivary gland cancer diagnosis previously untreated disease allowed only if prognosis is poor estimated two year survival less ten if treated standard therapy alone
1, etoposide phosphate peripheral cell lymphoma diagnosis more three cycles myelotoxic salvage chemotherapy within past four months specific regimens include ice dhap mtx hidac hypercvad vtd pace
1, prednisone adverse events from any prior anticancer therapy grade greater one at time enrollment
0, niacinamide hepatocellular carcinoma diagnosis fourteen must fit stereotactic body immobilization device per institutional manufacturer guidelines
0, antibodies monoclonal metastatic carcinoma liver diagnosis platelet count greater equal seventy five ten nine greater equal seventy five zero per mm three
1, sirolimus metastatic breast cancer diagnosis bilirubin greater doc xuln
1, topotecan extraosseous ewing sarcoma diagnosis karnofsky performance status less sixty lansky performance status less fifty patients younger sixteen years old
1, fentanyl colon cancer diagnosis noncompliance bowel regiment
1, mitogens stage iv renal cell cancer diagnosis pregnant women excluded from this breastfeeding must be discontinued if mother is treated amg three hundred eighty six
1, doxorubicin stage iiib primary peritoneal cavity cancer diagnosis patients whose disease has progressed following at least three cycles neoadjuvant chemotherapy defined by at least one following
0, bleomycin lymphoma diagnosis not pregnant nursing
1, paclitaxel stage ic uterine sarcoma diagnosis patients known hypersensitivity mesna other thiol compounds
1, sorafenib anticancer chemotherapy immunotherapy during within four weeks entry
0, control obese patients prostate cancer disease diagnosis bmi greater equal thirty
0, dihydroxyphenylalanine childhood low grade cerebral astrocytoma diagnosis provides written informed consent
0, cisplatin lung cancer diagnosis no prior radiotherapy chest other area containing large amount bone marrow more seventy five pelvic bone
0, irinotecan stage iii pancreatic cancer diagnosis serum creatinine less doc mg dl creatinine clearance greater equal fifty ml mm can be calculated measured
1, cetuximab stage iii squamous cell carcinoma larynx diagnosis chemotherapy therapy palliative radiation therapy within previous two weeks prior dosing cetuximab vtx two patients should have recovered from major toxicities prior therapy if deemed reversible toxicities should return baseline equal less grade two severity
0, lenograstim kidney cancer diagnosis acquired bone marrow failure syndromes
0, entinostat recurrent non small cell lung carcinoma diagnosis total bilirubin within normal institutional limits
1, dutasteride prior ongoing systemic therapy prostate cancer including but not limited to
0, dexamethasone recurrent childhood subependymal giant cell astrocytoma diagnosis platelet count greater twenty zero mm three may receive platelet transfusions
1, mycophenolic acid diffuse large cell lymphoma diagnosis fertile men women unwilling use contraceptive techniques during twelve months following treatment
1, erlotinib hydrochloride squamous cell lung carcinoma diagnosis preclinical studies indicated transient changes corrected qt qtc interval during mk two thousand two hundred six treatment prolongation qtc interval is potentially safety concern while on mk two thousand two hundred six therapy cardiovascular
1, liposomal doxorubicin undifferentiated fallopian tube carcinoma diagnosis major surgical procedure within twenty eight days prior cycle one day one anticipation need major surgical procedure during course study
1, bevacizumab malignant neoplasms female genital organs diagnosis non healing wound ulcer bone fracture
1, decitabine invasive adenocarcinoma breast diagnosis administration condition requiring administration systemic steroid therapy any other form immunosuppressive therapy within seven days prior initiating treatment exception
0, carboplatin ovarian stromal cancer diagnosis an individual one up four radiosurgical target lesion must not exceed volume no greater one hundred sixty cubic centimeters cc
1, fulvestrant breast cancer diagnosis known severe hypersensitivity everolimus similar drugs any excipients this product
1, sirolimus recurrent marginal zone lymphoma diagnosis patient has poorly controlled hypertension on multiple antihypertensives
0, gemcitabine biliary tract cancer diagnosis creatinine less doc upper limit normal uln
0, vincristine brain central nervous system tumors diagnosis bilirubin less doc mg
0, cyclophosphamide sarcoma diagnosis no distant nodule disease
1, capecitabine breast cancer diagnosis patients tfour lesions neoadjuvant setting not eligible
0, lenalidomide non hodgkin lymphoma diagnosis patients must be ineligible relapsed after an autologous allogeneic stem cell transplant if clinically appropriate
1, fludarabine received systemic treatment cancer including immunotherapy within one month prior initiation dosing within this protocol
0, docetaxel stage iv salivary gland cancer diagnosis no other concurrent uncontrolled illness that would preclude participation
0, mycophenolic acid nodal marginal zone cell lymphoma diagnosis pbmc only will be permitted hsc source on this protocol
1, bendamustine hydrochloride active heart disease including but not limited symptomatic congestive heart failure symptomatic coronary artery disease symptomatic angina pectoris symptomatic myocardial infarction symptomatic congestive heart failure
0, antibodies monoclonal stage iv inflammatory breast carcinoma diagnosis serum creatinine less doc uln upper limit normal
1, obinutuzumab non hodgkin lymphoma diagnosis known cdtwenty negative status at relapse progression
1, pomalidomide myeloma diagnosis infection requiring systemic antibiotic therapy other serious infection within fourteen days before enrollment
0, laboratory biomarker analysis stage iv grade three follicular lymphoma diagnosis ability understand willingness sign written informed consent document
0, celecoxib familial adenomatous polyposis diagnosis willingness ability sign informed consent
0, antibodies bispecific non hodgkin lymphoma diagnosis creatinine clearance greater fifty ml min doc three mtwo participants creatinine levels above doc uln
1, immunoglobulins recurrent mantle cell lymphoma diagnosis known history uncontrolled sleep apnea syndrome other conditions that could result excessive daytime sleepiness such severe chronic obstructive pulmonary disease requirement supplemental oxygen any conditions that could result excessive toxicity associated benzodiazepine like effects mlneight thousand two hundred thirty seven
0, methyltestosterone unspecified adult solid tumor protocol specific diagnosis radiotherapy
1, olaparib metastatic pancreatic adenocarcinoma diagnosis current use natural herbal products other folk remedies if using previously patients must stop using natural herbal products while participating this study
0, identification sentinel nodes full pelvic lymph node dissection situ carcinoma stage iaone without lvsi
1, antibodies monoclonal ovarian clear cell adenocarcinoma diagnosis participant requires is likely require more two week course corticosteroids intercurrent illness participant must complete course corticosteroids two weeks before screening meet eligibility
1, gefitinib refractory germ cell tumors expressing egrf diagnosis class iii iv heart disease
0, angiogenesis inhibitors sarcoma ewing diagnosis height ht should be measured cm serum creatinine cr mg dl
0, sirolimus stage iii renal cell cancer diagnosis prior cytokine therapy is allowed
1, vidarabine stage iii multiple myeloma diagnosis donor
1, docetaxel salivary gland squamous cell carcinoma diagnosis subject any pulmonary hemorrhage bleeding event nci ctcae doc grade two higher within four weeks before randomization any other hemorrhage bleeding event nci ctcae doc grade three higher within four weeks before randomization
0, antibodies monoclonal lung cancer diagnosis prior surgery allowed provided that wound healing has occurred
0, metronidazole recurrent gastric cancer diagnosis hashimoto thyroiditis
0, alvocidib adult nodular sclerosis hodgkin lymphoma diagnosis patients only cutaneous subcutaneous disease no measurable lymph node bone marrow disease eligible if extent rash skin involvement size nodules measurable
0, hormones breast cancer diagnosis at least one objective measurable disease parameter
1, maytansine carcinoma squamous cell diagnosis pregnancy lactation
0, fluorouracil stage ivb rectal cancer diagnosis able swallow capsules
0, adjuvant therapy sarcoma diagnosis negative pregnancy test
1, lapatinib prostate cancer diagnosis patients taking drugs that may further prolong qt intervals present known risk torsades de pointes excluded
1, antibodies stage iiib breast cancer diagnosis supraventricular nodal arrhythmias requiring pacemaker not controlled medication
0, niacinamide childhood hepatoblastoma diagnosis doc mg dl ten less thirteen years age
1, mocetinostat gastric cancer diagnosis presence serious illness medical condition other medical history including abnormal laboratory parameters which opinion investigator would be likely interfere subject participation interpretation results
0, tacrolimus non hodgkin lymphoma diagnosis all patients must be cr defined by hematological recovery less five blasts by light microscopy within bone marrow cellularity greater five
1, pharmacological stage iv melanoma diagnosis lipid lowering drugs statins
1, vaccines tumor mgmt promoter methylated partially methylated methylation status not determined
0, docetaxel prostate cancer diagnosis adequate organ function including following
1, laboratory biomarker analysis stage iv adult burkitt lymphoma diagnosis verapamil diltiazem
1, decitabine myeloproliferative neoplasm diagnosis history allergic reactions attributed compounds similar chemical biologic composition pacritinib other agents used study
0, sirolimus stage iib fallopian tube cancer diagnosis patient legal representative must understand investigational nature this sign an independent ethics committee institutional review board approved written informed consent form prior receiving any related procedure
1, cyclophosphamide breast cancer diagnosis currently active infection incomplete wound healing
0, fludarabine phosphate kidney cancer diagnosis creatinine clearance greater fifty ml min
0, dexamethasone acetate lymphoma diagnosis cardiovascular
0, albumin bound paclitaxel stage iv verrucous carcinoma larynx diagnosis leukocytes greater equal three zero mcl
0, antibodies monoclonal non small cell lung cancer recurrent diagnosis however participants must have received at least two cycles platinum doublet based chemotherapy before discontinuation toxicity
0, citric acid recurrent breast carcinoma diagnosis abdominal masses that not confirmed followed by imaging techniques
1, fludarabine recurrent grade three follicular lymphoma diagnosis left ventricular ejection fraction less forty
1, fluorouracil colorectal cancer diagnosis sensory peripheral neuropathy greater equal grade two
1, antilymphocyte serum stage iv grade two follicular lymphoma diagnosis uncontrolled diabetes mellitus cardiovascular disease active serious infection other condition which opinion treating physician would make this protocol unreasonably hazardous patient
0, alvocidib stage iv adult soft tissue sarcoma diagnosis no concurrent combination antiretroviral therapy hiv positive patients
1, liposomal doxorubicin oligodendroglioma diagnosis pregnant breastfeeding
0, sunitinib transitional cell cancer renal pelvis ureter diagnosis creatinine less doc mg dl
1, nintedanib poorly differentiated neuroendocrine carcinoma high grade neuroendocrine carcinoma adenocarcinoid goblet cell carcinoma small cell carcinoma
1, ramucirumab gastric adenocarcinoma diagnosis aspirin use at doses up three hundred twenty five milligrams mg day is permitted
1, cyclophosphamide relapsed solid tumors diagnosis patient illness psychiatric disorder social issue that could compromise patient safety compliance protocol treatment procedures interfere consent participation follow up interpretation results
0, immunoglobulins recurrent squamous cell carcinoma lip oral cavity diagnosis no immune deficiency hiv positivity
0, capecitabine stage iib pancreatic cancer diagnosis serum glutamic oxaloacetic transaminase sgot must be equal less doc institutional uln within twenty one days registration on within twenty one days prior day one chemotherapy post surgery those patients having started chemotherapy prior first step registration
0, aldesleukin lymphoma diagnosis radiotherapy
0, doxorubicin lymphoma diagnosis negative pregnancy test
0, cediranib endometrial serous adenocarcinoma diagnosis patients who have received one prior regimen must have gog performance status zero one two patients who have received two prior regimens must have gog performance status zero one
0, cyclophosphamide recurrent neuroblastoma diagnosis group atwo
1, cytarabine stage iii grade two follicular lymphoma diagnosis history life threatening recurrent thrombosis embolism patients may participate if they adequately anticoagulated during treatment
1, cyclosporins childhood diffuse large cell lymphoma diagnosis one this type mismatch is considered two antigen mismatch is not allowed
0, histone deacetylase inhibitors intraocular lymphoma diagnosis no suspected gilbert syndrome
0, irinotecan mucinous adenocarcinoma colon diagnosis women childbearing potential wocbp sexually active males must agree use an accepted effective method contraception prior entry duration wocbp include any female who has experienced menarche who has not undergone successful surgical sterilization hysterectomy bilateral tubal ligation bilateral oophorectomy is not postmenopausal even women who using oral implanted injectable contraceptive hormones mechanical products such an intrauterine device barrier methods diaphragm condoms spermicides prevent pregnancy practicing abstinence where partner is sterile vasectomy should be considered be child bearing potential
1, ad ycd muttksr rep adp pancreatic cancer diagnosis serious non malignant disease congestive heart failure uncontrolled infections which opinion investigator would compromise objectives
1, everolimus colorectal cancer diagnosis radiotherapy within fourteen days commencing treatment
0, erlotinib hydrochloride lung adenocarcinoma diagnosis eastern cooperative oncology group ecog zero one
0, physiologic testing colorectal cancer diagnosis not specified
0, cetuximab colon rectal cancer diagnosis ability swallow pills without difficulty
1, paclitaxel ovarian clear cell adenocarcinofibroma diagnosis major surgical procedure anticipated during course this includes but is not limited abdominal surgery laparotomy laparoscopy prior disease progression such colostomy enterostomy reversal secondary cytoreductive surgery second look surgery please consult sdc randomization desk prior patient entry any questions related classification surgical procedures
1, bexarotene patients known symptomatic brain metastases excluded from this clinical trial because their poor prognosis those treated asymptomatic brain metastases eligible proved they have not required any therapy including steroids at least four weeks
1, cyclosporins clear cell renal cell carcinoma diagnosis patients rapidly progressive intermediate high grade nhl
1, lenograstim recurrent adult lymphoblastic lymphoma diagnosis prior failed less five ten six cdthirty four kg pbsc collection due inability mobilize stem cells
0, cyclophosphamide multiple myeloma diagnosis patients bulky disease nodal mass greater five cm should be considered debulking chemotherapy before transplant
1, cisplatin concurrent administration any other tumor therapy
1, mitomycins bladder cancer tnm staging primary tumor ta diagnosis other concurrent chemo therapy radio therapy treatment biological response modifiers
0, sirolimus advanced cancers diagnosis women childbearing potential men must agree use adequate contraception hormonal barrier method birth control abstinence prior entry duration participation thirty days after last dose
0, fluorouracil metastatic colorectal cancer diagnosis adequate hematological status
0, methotrexate stage ii adult hodgkin lymphoma diagnosis mature cell malignancies
0, sirolimus neurofibromatosis type one diagnosis one is not required trial entry
0, anti kir multiple myeloma diagnosis eastern cooperative oncology group ecog performance status zero one
1, fludarabine prostate cancer diagnosis other associated concomitant medical conditions that would interfere conduct opinion treating physician
1, sirolimus stage iiia ovarian cancer diagnosis mental impairment that may compromise ability give informed consent comply requirements study
1, cyclophosphamide recurrent adult diffuse mixed cell lymphoma diagnosis donors
0, antibodies monoclonal nodal marginal zone cell lymphoma diagnosis no active infection requiring oral iv antibiotics
0, procarbazine aids related diffuse large cell lymphoma diagnosis adults eighteen years age older date birth should be determined based on best possible information source documentation available
0, dacarbazine melanoma skin diagnosis hemoglobin greater ten dl wbc greater three zero mmthree platelet count greater ten zero mmthree hepatic
1, etoposide lymphoma large cell diffuse diagnosis prior treatment anti cdtwenty monoclonal antibodies at any time treated other monoclonal antibodies within three months prior start therapy exception rituximab both instances
0, antibodies stage iv breast cancer diagnosis if patient needs escalation steroids prior therapy on unstable doses steroids they not eligible
0, carboplatin histologically cytologically confirmed advanced metastatic solid tumor bcell malignancies which have progressed after treatment approved therapies which there no standard therapies available phase one
0, aldesleukin melanoma diagnosis mri csf evidence by mri csf cytology cohort d
0, ketoconazole prostate cancer diagnosis progressive disease after androgen deprivation
0, rituximab lymphoma diagnosis failed prior autologous stem cell transplantation at least pr after salvage chemotherapy
0, dexamethasone recurrent adult diffuse small cleaved cell lymphoma diagnosis three fewer prior myelotoxic treatment regimens specific regimens include ifosfamide carboplatin etoposide ice cisplatin cytarabine dexamethasone dhap methotrexate mtx high dose cytarabine hidac cyclophosphamide vincristine doxorubicin dexamethasone hypercvad bortezomib thalidomide dexamethasone four day continuous infusions cisplatin doxorubicin cyclophosphamide etoposide vtd pace
0, trebananib primary peritoneal cancer diagnosis life expectancy greater three months per investigator opinion
1, cetuximab colorectal cancer diagnosis uncontrolled hypertension
1, etoposide stage iv adult diffuse large cell lymphoma diagnosis chemosensitive nhl except patients receiving greater equal three prior chemotherapy regimens patients having transformed nhl ptcl mcl alcl alk neg
1, hyperfractionated radiation therapy medullary ductal breast carcinoma lymphocytic infiltrate diagnosis prior radiotherapy that would result overlap radiation therapy fields
1, fludarabine phosphate childhood diffuse large cell lymphoma diagnosis inability achieve adequate venous access
0, carmustine mature cell nk cell non hodgkin lymphoma diagnosis serum creatinine less doc mg dl measured creatinine clearance greater sixty ml min
0, methylprednisolone breast cancer diagnosis grade iib iv disease
1, dexamethasone patients stage ie primary central nervous system lymphoma
0, fludarabine anaplastic large cell lymphoma diagnosis human leukocyte antigen hla genotypically phenotypically identical related donor
1, camptothecin renal cell carcinoma diagnosis agents examined this clinical trial carry potential teratogenic abortifacient effects
0, taa specific ctls multiple myeloma diagnosis patients bilirubin less equal two times upper limit normal ast less equal three times upper limit normal hgb greater doc transfusion allowed
1, etoposide recurrent lymphoplasmacytic lymphoma diagnosis note
0, cetuximab urologic neoplasm diagnosis must have tissue available egfr assessment additional correlative studies
1, vaccines stage iic ovarian cancer diagnosis concomitant systemic treatment corticosteroids anti histamine non steroidal anti inflammatory drugs aspirin greater three hundred twenty five mg specific cyclooxygenase cox two inhibitors permitted
1, interferon alpha stage iv melanoma diagnosis patients prior history solid organ allografts allogeneic bone marrow transplant
0, vorinostat recurrent melanoma diagnosis total bilirubin within institutional limits
0, fludarabine phosphate hepatosplenic cell lymphoma diagnosis patient donor must be matched at least one drbone allele one dqbone allele
1, bevacizumab epithelial ovarian cancer diagnosis patient non affiliated social security scheme
0, stereotactic radiosurgery kidney cancer diagnosis hemoglobin greater eight dl
1, nanoknife procedure biologic therapy prostate cancer
1, glycine plasma cell myeloma diagnosis if machine reading is above this value ecg should be reviewed by qualified reader confirmed on subsequent ecg
1, transplant conditioning recurrent hodgkin lymphoma diagnosis hepatitis virus hcv antibody positive detectable hcv quantitative ribonucleic acid rna clinical evidence cirrhosis
1, etoposide classical hodgkin lymphoma diagnosis patients who have received any previous chemotherapy radiation therapy not eligible
1, bevacizumab evidence cns disease including primary brain tumor any brain metastasis
1, sirolimus human epidermal growth factor two negative carcinoma breast diagnosis patients known history hiv seropositivity
1, cyclosporine recurrent adult grade iii lymphomatoid granulomatosis diagnosis patients evidence human immunodeficiency virus hiv seropositivity positive polymerase chain reaction pcr assay human lymphotropic virus htlv one htlvtwo seropositivity safety allogeneic hsct is not yet well established this population
0, vaccines malignant conjunctival neoplasm diagnosis unresectable recurrent disease
1, docetaxel carcinoma non small cell lung diagnosis patients requiring concurrent treatment corticosteroids unless chronic treatment greater six months at low doses less twenty mg day methylprednisolone equivalent
1, methotrexate progressive desmoids tumors diagnosis history cardiovascular disease last six months
1, rituximab mantle cell lymphoma diagnosis hypersensitivity rituximab
1, doxorubicin myxofibrosarcoma diagnosis systolic blood pressure sbp greater one hundred sixty mmhg less ninety mmhg at screening if initial screening sbp is outside eligible range blood pressure may be re checked after intervention sbp must be documented stable within eligible range prior starting drug
1, mart antigen stage iic skin melanoma diagnosis any following
1, doxorubicin stage iiic breast cancer diagnosis inability cooperate treatment protocol
0, camptothecin recurrent lymphoepithelioma nasopharynx diagnosis ast alt no greater three times upper limit normal uln
1, antibodies monoclonal recurrent verrucous carcinoma larynx diagnosis abnormalities cornea based on history dry eye syndrome sjogren syndrome congenital abnormality fuch dystrophy abnormal slit lamp examination using vital dye fluorescein bengal rose an abnormal corneal sensitivity test schirmer test similar tear production test
0, mycophenolate mofetil recurrent marginal zone lymphoma diagnosis following diseases will be permitted although other diagnoses can be considered if approved by pcc participating institution patient review committees principal investigator
0, blood tumor samples patient having developed cancerous pathology presenting one several anomalies development diagnosis disorder growth weight cranial perimeter
0, cyclophosphamide sarcoma ewing diagnosis patients age must be less equal twenty five years
0, rituximab lymphoma diagnosis nodal mass greater five cm its greater diameter
0, cisplatin gastric cancer diagnosis disease characteristics
0, etoposide neuroblastoma diagnosis patients childbearing potential must agree use an effective birth control method
1, sorafenib localized unresectable adult primary liver cancer diagnosis patients taking chronic erythropoietin permitted provided no dose adjustment is undertaken within one month prior during study
1, estradiol benzoate endometrial cancer diagnosis age greater equal thirty five current tobacco smoker
0, epothilones breast cancer diagnosis no concurrent coumadin other agents containing warfarin
0, cyclophosphamide disease free prior malignancies equal over five years exception currently treated basal cell squamous cell carcinoma skin carcinoma situ cervix breast
0, gemcitabine nasopharyngeal cancer diagnosis patient must sign consent form prior randomization registration
0, hydroxyurea myelodysplastic myeloproliferative neoplasms diagnosis duration first cr less twelve months
1, vaccines ovarian fallopian tube peritoneal cancer diagnosis acute therapy must have been completed at least seven days prior enrollment
1, leucovorin stage iiia gastric cancer diagnosis dementia altered mental status that would prohibit understanding giving informed consent
1, diphosphonates ovarian cancer diagnosis recent within six weeks planned dental jaw surgery extraction implants
0, dexamethasone phosphate squamous cell carcinoma head neck diagnosis adequate hepatic function
1, bortezomib multiple myeloma diagnosis participants known brain metastases
1, l lysine stage iv verrucous carcinoma larynx diagnosis inability unwillingness take daily lysine supplementation prescribed
1, eribulin mesylate stage iiib cervical cancer diagnosis prior treatment eribulin
0, arsenic trioxide stage ii multiple myeloma diagnosis absolute qt interval less four hundred sixty msec potassium greater doc meq magnesium greater doc mg dl
1, ursodeoxycholic acid t cell lymphoma diagnosis inability provide informed consent
1, albumin bound paclitaxel fallopian tube clear cell adenocarcinoma diagnosis patients who pregnant nursing
1, lenograstim contiguous stage ii grade one follicular lymphoma diagnosis patient has an absolute neutrophil count anc less doc one nine within one days before enrollment
0, oxaliplatin stage iia colon cancer diagnosis unstable angina
0, vorinostat recurrent adult diffuse mixed cell lymphoma diagnosis stable not hematologic remission
1, methotrexate recurrent grade one follicular lymphoma diagnosis adult
1, arsenic trioxide splenic marginal zone lymphoma diagnosis patients requiring amphotericin therapy
1, afatinib carcinoma non small cell lung diagnosis history co existing condition that opinion investigator would compromise patient ability comply trial interfere evaluation safety trial drug
0, cyclophosphamide adult liposarcoma diagnosis zubrod performance status zero one
1, etoposide phosphate stage iii diffuse large cell lymphoma diagnosis prior high dose chemotherapy hdc asct
1, acute normovolemic hemodilution epithelial ovarian cancer diagnosis gog performance status greater two
0, laboratory biomarker analysis recurrent adult hodgkin lymphoma diagnosis no new york heart association class iii iv congestive heart failure
1, niacinamide adenoma liver cell diagnosis proteinuria demonstrated by twenty four hour protein greater equal two thousand mg
1, sildenafil citrate gynecologic cancer diagnosis pregnant nursing
1, cytology specimen collection procedure stage iiib colon cancer diagnosis patients known history allergic reactions attributed compounds similar chemical biologic composition agents used study
0, podophyllotoxin stage four neuroblastoma diagnosis patients newly diagnosed inss stage twoa twob mycn amplification greater four fold increase mycn signals compared reference signals regardless age additional biologic features
1, dexamethasone phosphate multiple myeloma diagnosis development desquamating rash while taking thalidomide
1, metformin pancreatic cancer diagnosis self reported average consumption greater fourteen alcoholic drink per week
1, mitogens recurrent breast cancer diagnosis history clinically significant cardiac dysfunction including
0, antibodies recurrent adult brain tumor diagnosis no severe active comorbidity defined any following
0, levoleucovorin colorectal cancer diagnosis fertile patients must use effective contraception
1, preoperative hyperbaric oxygen duodenal neoplasms diagnosis evidence suggests that this drug blocks production superoxide dismutase
0, doxorubicin malignant mesothelioma diagnosis no prior radiotherapy more twenty total lung volume
0, colchicine prostate cancer diagnosis no prior use colchicine within last two years
0, interferon alpha recurrent melanoma skin diagnosis is not considered form systemic treatment
1, alkylating agents sarcoma diagnosis creatinine ratio greater equal doc
0, tomotherapy kidney cancer diagnosis no history lupus erythematosus scleroderma
0, trastuzumab breast cancer diagnosis congestive heart failure
0, liposomal doxorubicin extragonadal germ cell tumor diagnosis not specified
0, leucovorin colorectal cancer diagnosis at least ten days since prior anticoagulants
1, everolimus stage iiia primary peritoneal cancer diagnosis core biopsy equal less seven days prior registration
1, dexamethasone phosphate cancer diagnosis patients who need radiation therapy during period receiving radiation therapy within two weeks before chemotherapy
0, albumin bound paclitaxel histologic confirmation ovarian primary peritoneal fallopian tube cancer any subtype
0, vidarabine childhood burkitt lymphoma diagnosis patient who refused be treated on conventional hct protocol this inclusion criterion transplants must be approved by both participating institution patient review committee such patient care conference pcc at fhcrc fhcrc principal investigators
1, intraoperative lymphatic mapping patients preoperative diagnosis grade endometrioid adenocarcinoma uterus
1, chemotherapy stomach neoplasms diagnosis new york heart association class iii iv heart disease
1, everolimus stage iiic uterine corpus cancer diagnosis prior therapy vascular endothelial growth factor receptor vegfr targeting agents mammalian target rapamycin mtor inhibitors except hcc islet cell single agent bevacizumab alone cohort where prior mtor inhibitor is allowed note
0, irinotecan solid tumors diagnosis prior chemotherapy radiotherapy is allowed if four weeks more have elapsed prior starting treatment patients have recovered from toxicities prior treatment
0, acetylcysteine stage ivc salivary gland cancer diagnosis negative pregnancy test done equal less seven days prior registration women childbearing potential only
1, vidarabine penile cancer diagnosis atrial fibrillation ventricular tachycardia second third degree heart block ii age greater equal sixty years old
1, immunoglobulin g ovarian endometrioid adenocarcinoma diagnosis severe active co morbidity defined follows
0, fludarabine phosphate ebv positive nasopharyngeal carcinoma diagnosis karnofsky lansky score greater equal fifty
0, cyclosporins stage iv adult immunoblastic large cell lymphoma diagnosis hematologic remission
0, docetaxel cancer diagnosis however patients who have both transaminase elevation greater doc uln alkaline phosphatase greater doc uln not eligible this due decreased clearance docetaxel increased risk toxicity
0, dextromethorphan lymphoma diagnosis not specified
0, zoledronic acid prostate cancer diagnosis if taking more one thousand mg day elemental calcium must be willing able discontinue reduce their calcium use use non calcium based therapies duration study
1, duloxetine hydrochloride breast cancer diagnosis new musculoskeletal pain that is due specifically fracture traumatic injury
0, cisplatin stage iv squamous cell carcinoma oropharynx diagnosis no prior surgery except biopsy
1, sunitinib adenoid cystic carcinoma diagnosis patients qtc prolongation other significant ecg abnormalities
0, etoposide phosphate stage diffuse large cell lymphoma diagnosis patients must not have any significant toxicity associated prior surgery radiation therapy chemotherapy immunotherapy per principal investigator pi discretion
0, levoleucovorin stage ivb colorectal cancer diagnosis platelets plt greater equal one hundred ten nine without transfusions
0, pembrolizumab recurrent ovarian carcinoma diagnosis prior immunotherapy is not allowed
0, calcitriol cancer diagnosis ecog performance score zero one within one days prior registration
1, polydextrose colorectal cancer diagnosis iatrogenic perforation at endoscopy
1, antibodies monoclonal recurrent colon carcinoma diagnosis patients neurological symptoms must undergo computed tomography ct scan magnetic resonance imaging mri brain exclude brain metastasis
0, mycophenolate mofetil recurrent small lymphocytic lymphoma diagnosis acute leukemias
0, romidepsin angioimmunoblastic cell lymphoma diagnosis aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot alanine aminotransferase alt serum pyruvate glutamate transaminase spgt equal less three uln
1, cabozantinib s malate metastatic osteosarcoma diagnosis any following within six months before first dose treatment
0, liposomal doxorubicin liver cancer diagnosis bilirubin less three mg dl
0, metronidazole recurrent fallopian tube cancer diagnosis patients child bearing potential must agree use acceptable contraceptive methods double barrier during treatment
0, busulfan lymphoma diagnosis see disease characteristics
0, antibodies meningeal melanocytoma diagnosis hemoglobin greater equal doc dl
1, bb prior other concurrent malignancy excepted cases follows basal cell carcinoma squamous cell carcinoma skin superficial ptis pta ptone bladder cancer including immunotherapy treated adequately any other cancer completed chemotherapy more five years ago been more five years disease free duration
0, dexamethasone acetate myeloma diagnosis surgically sterile or
0, motexafin lutetium ovarian sarcoma diagnosis wbc greater two zero mm three
1, dexamethasone multiple myeloma diagnosis patients assessed by investigator be at risk hiv infection should be tested accordance local regulations
1, tesevatinib glioblastoma diagnosis prior intracerebral agent
1, capecitabine recurrent adult hodgkin lymphoma diagnosis patients who serologically positive hepatitis b or have history liver disease other forms hepatitis cirrhosis ineligible
1, vandetanib selumetinib cancer diagnosis pregnant lactating women excluded
1, bevacizumab patients nervous system tumors associated nftwo schwannomas meningiomas ependymomas gliomas will not be excluded from this clinical trial long these tumors not require treatment radiation surgery medical treatment at time enrollment on trial
1, levoleucovorin lymphoma non hodgkin diagnosis prior medication
0, dacarbazine sarcoma diagnosis see disease characteristics prior dacarbazine allowed at least four weeks since prior chemotherapy no other concurrent chemotherapy endocrine therapy
0, dideoxynucleosides unspecified adult solid tumor protocol specific diagnosis girth weight must be suitable enter gantry
0, reduced port robotic distal gastrectomy gastric cancer diagnosis ecog
0, molybdenum melanoma diagnosis absolute neutrophil count greater one five hundred ul
0, cyclosporins myelodysplastic myeloproliferative neoplasms diagnosis life expectancy must not be limited by disease other malignancy
1, paclitaxel urothelial cancer diagnosis women who pregnant breastfeeding
1, eus guided celiac plexus neurolysis cancer diagnosis refractory coagulopathy inr greater doc thrombocytopenia platelet count less fifty zero aspirin clopidogrel use within seven days procedure
1, epirubicin patients whose tumors express er pr hertwo neu gene amplification
1, liposomal doxorubicin adults unresectable liver dominant neuroendocrine tumor metastases that are symptomatic progressive involve twenty five liver volume diagnosis contraindications hepatic artery embolization
1, vidarabine recurrent childhood large cell lymphoma diagnosis donor
0, staurosporine stage iv squamous cell carcinoma nasopharynx diagnosis see disease characteristics part ii
0, phenoxodiol prostate cancer diagnosis patients non castrate levels testosterone group negative androgen dependent disease need meet following criteria
0, antibodies monoclonal neuroblastoma diagnosis not specified
1, placebo colorectal cancer diagnosis brain metastasis
0, etoposide phosphate brain central nervous system tumors diagnosis incompletely resected all sites under ten years at diagnosis
1, docetaxel neoplasms diagnosis active alcohol drug abuse
0, sirolimus ovarian endometrioid adenocarcinoma diagnosis patients must be greater equal four weeks from treatment show progressive disease liver after regional therapy must have measurable disease outside liver
1, vaccines previous concurrent experimental treatment tumor
1, etoposide phosphate lymphoma diagnosis active cytomegalovirus cmv retinitis other cmv related organ dysfunction patients history treated cmv infection not excluded
0, poly iclc advanced triple negative breast cancer diagnosis chemoembolization surgery any other local therapy completed at least four weeks prior first dose treatment
1, antibodies monoclonal mesothelioma malignant diagnosis clinically significant heart disease eg congestive heart failure new york heart association class three four angina not well controlled by medication myocardial infarction within six months
0, vincristine diagnosis peripheral cell lymphoma ptcl including following subtypes
1, cisplatin adenocarcinoma diagnosis contraindications radiotherapy
1, prednisone diffuse large cell lymphoma diagnosis pregnant lactating women excluded from because risks an unborn fetus potential risks nursing infants unknown
1, cyclophosphamide glioblastoma multiforme diagnosis history allergic disease allergy car cells product excipients
0, bortezomib multiple myeloma diagnosis doc
1, ispinesib recurrent grade three follicular lymphoma diagnosis diabetes other glucose imbalance
1, metformin cholangiocarcinoma diagnosis serious concomitant systemic disorder that would compromise safety patient at discretion investigator
1, albumin bound paclitaxel bladder cancer diagnosis active untreated central nervous system cns metastases determined by computed tomography ct magnetic resonance imaging mri evaluation during screening prior radiographic assessments
1, levoleucovorin pancreatic cancer diagnosis patients serious kidney malfunction creatininclearance less thirty ml min
1, ly screening asymptomatic patients without history cns metastases is not required
1, fludarabine adult nasal type extranodal nk cell lymphoma diagnosis coli derived proteins
0, antibodies recurrent verrucous carcinoma larynx diagnosis no arterial thromboembolic event within past six months including any following
0, vaccines melanoma skin diagnosis platelet count at least one hundred zero mm three
1, cyclophosphamide lymphoma large cell diffuse diagnosis significant active cardiac disease within previous six months from signing icd including
1, immunoglobulins recurrent adult burkitt lymphoma diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior day one registration
1, cytarabine recurrent adult cell leukemia lymphoma diagnosis serum bilirubin greater three times upper limits normal unless determined be result primary hematologic malignancy attributed gilbert syndrome
0, gemcitabine lung cancer diagnosis absolute neutrophil count at least one five hundred mm three
1, docetaxel prostate cancer diagnosis hemoglobin level greater one doc dl
0, cyclosporine lymphoblastic lymphoma diagnosis diffusion capacity carbon monoxide corrected dlcocorr greater fifty normal
1, ibrutinib recurrent mantle cell lymphoma diagnosis prior exposure ibrutinib
0, bevacizumab stage iiib esophageal cancer diagnosis patients must have eastern cooperative oncology group ecog performance status zero one
0, vitamin b colorectal cancer diagnosis no other concurrent chemotherapy immunotherapy
0, imatinib mesylate lung cancer diagnosis alkaline phosphatase no greater five times uln
1, atorvastatin calcium ductal breast carcinoma situ diagnosis participants may not be receiving any other investigational agents
0, cisplatin metastatic malignant neoplasm lung diagnosis unresectable stage iiib nsclc
1, formyltetrahydrofolates uncontrolled intercurrent illness including but not limited ongoing active infection symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmia psychiatric illness social situations that would limit compliance requirements
1, immunoglobulins ovarian cancer diagnosis patients not willing sign written informed consent
1, albumin bound paclitaxel history uncontrolled symptomatic angina history arrhythmias requiring medications clinically significant myocardial infarction less six months from entry uncontrolled symptomatic congestive heart failure ejection fraction below institutional normal limit any other cardiac condition which is opinion treating physician would make this protocol unreasonably hazardous patient
0, camptothecin recurrent adult diffuse large cell lymphoma diagnosis platelet count at least one hundred zero mm three
0, erlotinib hydrochloride adenocarcinoma colon diagnosis no other concurrent uncontrolled illness that would preclude study
1, transoral robotic surgery stage iii mucoepidermoid carcinoma oral cavity diagnosis this is not an exclusion criterion non surgical arm
0, albumin bound paclitaxel stage iiib fallopian tube cancer diagnosis an approved informed consent authorization permitting release personal health information must be signed by patient guardian
0, ifosfamide primary peritoneal cavity cancer diagnosis no cns metastases
1, vidarabine stage ii multiple myeloma diagnosis eligible high priority curative autologous transplant
1, poly iclc risk colorectal cancer diagnosis presence an active acute chronic infection
0, capecitabine extrahepatic bile duct cancer diagnosis no intractable nausea vomiting
0, bi neoplasms diagnosis eastern cooperative oncology group ecog rone seven hundred eighty seven performance score zero one
0, albumin bound paclitaxel pancreatic cancer diagnosis renal
0, arginine powder form glioblastoma multiforme diagnosis renal function within normal limits creatinine bun
0, metronidazole recurrent colon cancer diagnosis fertile patients must use effective contraception at least one month before female patients only during at least three months after participation
1, orteronel stage iv prostate cancer diagnosis prior treatment tak seven hundred
0, trastuzumab tumors diagnosis adequate organ function indicated by following laboratory values
1, etoposide stage adult diffuse large cell lymphoma diagnosis expected survival less two months
1, carboplatin non small cell lung cancer diagnosis significant neurological mental disorder
1, cyclosporine hepatosplenic cell lymphoma diagnosis positive crossmatch between donor recipients
0, cetuximab head neck cancer diagnosis uncontrolled congestive heart failure
0, vismodegib stage iv adult soft tissue sarcoma diagnosis all patients must have measurable disease defined by recist doc
0, everolimus stage iv renal cell cancer diagnosis pt inr less doc
1, immunoglobulins stage iv skin melanoma diagnosis history grade three four bowel toxicity from immune checkpoint inhibitor within twelve weeks registration
1, docetaxel head neck carcinoma diagnosis has known psychiatric substance abuse disorders that would interfere cooperation requirements trial
1, albumin bound paclitaxel stage ib breast cancer diagnosis patients who not eligible based on ac wp regimen bp criteria but who meet tc regimen bp criteria eligible forty seven if intended chemotherapy regimen is changed tc
1, avr carcinoma diagnosis does not have access telephone
1, antibodies ovarian clear cell adenocarcinoma diagnosis other medical conditions including but not limited to
0, camptothecin high grade glioma diagnosis patients karnofsky performance status greater seventy
1, antibodies stage ib breast cancer diagnosis uncontrolled hypertension defined sustained systolic blood pressure bp greater one hundred fifty mm hg diastolic bp greater ninety mm hg patients initial bp elevations eligible if initiation adjustment bp medication lowers pressure meet entry criteria
1, sildenafil citrate prostate cancer diagnosis history significant cardiac conduction defect within ninety days baseline visit
1, linifanib recurrent colon cancer diagnosis subjects known human immunodeficiency virus hiv infection excluded
0, dexamethasone phosphate intraocular lymphoma diagnosis willing return participating medical institutions follow up
1, placebo water breast cancer diagnosis pregnant lactating
0, niacinamide recurrent rectal cancer diagnosis john wort rifampin
0, letrozole hertwo negative breast cancer diagnosis platelets greater equal one hundred zero mcl
1, niacinamide advanced solid tumors diagnosis concurrent prior within two weeks prior day one consumption grapefruit whole fruit fruit juice
1, pentostatin renal cell carcinoma diagnosis recipient
1, estrogens conjugated usp prostate cancer diagnosis detection more five bone metastases
0, gemcitabine ovarian cancer diagnosis life expectancy
1, cyclophosphamide stage iiia breast cancer diagnosis have uncontrolled hypertension greater one hundred fifty one hundred mm hg despite optimal medical therapy
1, laboratory biomarker analysis stage iva thyroid gland papillary carcinoma diagnosis clinically significant cardiac arrhythmias
0, rituximab noncontiguous stage ii mantle cell lymphoma diagnosis patients may not have received prior murine compounds due risk hama formation
1, docetaxel carcinoma non small cell lung diagnosis patients history severe hypersensitivity reaction taxotere other drugs formulated polysorbate eighty must be excluded
1, vidarabine childhood burkitt lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
1, dacarbazine glioblastoma multiforme diagnosis evidence bleeding diathesis coagulopathy absence therapeutic anticoagulation
1, somatostatin pregnant breast feeding woman
0, palbociclib advanced breast cancer diagnosis rb proficiency means that there is an intact rb pathway indicative responsiveness pd
0, vitamin b peritoneal cavity cancer diagnosis surgery
1, gemcitabine cholangiocarcinoma diagnosis other severe medical conditions
0, cyclophosphamide small intestine cancer diagnosis not specified
0, bortezomib non small cell lung cancer diagnosis stable previously treated brain metastases allowed if clinically stable without steroid treatment ten days
0, thiotepa liver cancer diagnosis ineligible other irb approved myeloablative regimens
0, alemtuzumab testicular germ cell tumor diagnosis other
0, vaccines head neck cancer no indication irradiation resistance intolerance platinum containing chemotherapy
1, carboxymethylcellulose sodium melanoma diagnosis mild arthritis requiring nsaid medications
1, albumin bound paclitaxel history previous invasive breast cancer
0, sunitinib malignant conjunctival neoplasm diagnosis no concurrent grapefruit grapefruit juice
0, vincristine stage iii multiple myeloma diagnosis include only values obtained prior initiation protocol treatment
0, aldesleukin melanoma skin diagnosis immunologic
0, leucovorin recurrent esophageal cancer diagnosis patients detectable viral titers required receive treatment four weeks prior starting protocol therapy
0, topotecan stage fours neuroblastoma diagnosis creatinine clearance radioisotope glomerular filtration rate gfr greater equal seventy ml min doc three two serum creatinine based on age gender follows
0, cisplatin oesophagogastric cancer diagnosis inhaled steroids allowed
1, bb multiple myeloma diagnosis significant neuropathy grade three grade four grade two pain at time first dose within four days before enrollment
0, irinotecan stage iv pancreatic cancer diagnosis platelets greater equal one hundred zero mcl
0, sunitinib kidney cancer diagnosis indinavir
0, capecitabine stage iii pancreatic cancer diagnosis echoendoscopic staging will be permitted an adjunctive modality but all stage definitions below will be determined using ct mri outlined below
0, levoleucovorin colorectal cancer diagnosis surgery
1, fludarabine recurrent adult diffuse small cleaved cell lymphoma diagnosis human immunodeficiency virus hiv positive patients
0, total skin electron beam therapy tsebt lymphomas non hodgkin peripheral cell diagnosis required wash out period prior therapies note
1, albumin bound paclitaxel esophageal neoplasms diagnosis have had myocardial infarction less six months prior start treatment
0, doxorubicin recurrent childhood grade iii lymphomatoid granulomatosis diagnosis radiation therapy xrt
0, albumin bound paclitaxel stage iv melanoma diagnosis ecog zero two
1, cetuximab stage iva oropharyngeal squamous cell carcinoma diagnosis patients known immunodeficiency disorder presumed be unable respond anti cytotoxic lymphocyte associated protein four ctla four monoclonal antibody mab
1, fludarabine childhood immunoblastic large cell lymphoma diagnosis uncontrolled diabetes mellitus cardiovascular disease active serious infection other condition which opinion treating physician would make this protocol unreasonably hazardous patient
0, topotecan neoplasm diagnosis at least fourteen days after last dose long acting growth factor neulasta seven days short acting growth factor
1, everolimus somatostatinoma diagnosis active acute chronic uncontrolled severe infection liver disease such cirrhosis decompensated liver disease active chronic hepatitis quantifiable hepatitis virus hbv dna positive hbsag quantifiable hepatitis virus hcv rna
1, bevacizumab adult anaplastic oligodendroglioma diagnosis evidence history bleeding diathesis greater normal risk bleeding hereditary hemorrhagic telangiectasia type hht one coagulopathy absence therapeutic anti coagulation any hemorrhage bleeding event greater grade three within four weeks prior registration note
0, antibodies monoclonal stage iiib hodgkin lymphoma diagnosis karnofsky performance status greater thirty given aggressiveness this disease often severely debilitated nature patients at initial presentation
1, esophagectomy esophageal neoplasms diagnosis patients considered salvage surgery after definitive chemoradiotherapy
1, doxorubicin ovarian endometrioid tumor diagnosis history myocardial infarction within six twelve months patients history myocardial infarction within six months excluded from study
1, satraplatin hormone refractory prostate cancer diagnosis prior platinum containing compounds
0, paclitaxel head neck cancer diagnosis distant metastases allowed provided both following true
0, heparin low molecular weight malignant neoplasm diagnosis negative serum urine pregnancy test done equal less twenty four hours prior randomization women childbearing potential only note
1, trastuzumab progressive breast cancer diagnosis nyha grade ii greater congestive heart failure
1, immunoglobulins recurrent small lymphocytic lymphoma diagnosis pregnancy breast feeding
1, cyclosporine metachromatic leukodystrophy diagnosis neurologic neurocognitive functions such activities daily living motor function vision hearing interaction environment toileting swallowing other standardized measures
1, antibodies monoclonal follicular lymphoma grade one diagnosis treatment any known non marketed drug substance experimental therapy within five terminal half lives four weeks prior enrollment whichever is longer currently participating any other interventional clinical study
0, capecitabine small intestinal large cell neuroendocrine carcinoma diagnosis platelets greater equal one hundred zero mm three
1, fludarabine phosphate metastatic melanoma diagnosis patients treated cns metastases greater one cm greater three number will be excluded if there is evidence progressive cns disease on brain imaging at least ninety days after treatment surgery radiation therapy
0, pemetrexed lung cancer diagnosis women childbearing potential must agree use adequate contraception hormonal barrier method birth control abstinence duration participation six six months after discontinuation drugs
0, coenzyme q breast cancer diagnosis normal organ marrow function defined as
1, veliparib stage ii breast cancer diagnosis history bleeding diathesis extensive bleeding requiring blood transfusion within fourteen days enrollment
0, immunoglobulins stage grade two follicular lymphoma diagnosis previously untreated note
0, antibodies recurrent osteosarcoma diagnosis nb mibg positive skeletal lesions
0, cediranib stage iv nasal cavity paranasal sinus squamous cell carcinoma diagnosis atrioventricular av conduction abnormalities
1, etoposide b cell lymphoma unclassifiable features intermediate between diffuse large cell lymphoma burkitt lymphoma diagnosis patients who have had major surgery within four weeks prior registration not eligible
0, antibodies monoclonal stage iv squamous cell carcinoma paranasal sinus nasal cavity diagnosis no psychiatric illness social situation that would preclude compliance
1, thalidomide multiple myeloma diagnosis twenty three
1, immunoglobulins splenic marginal zone lymphoma diagnosis diffusion capacity lung carbon monoxide dlco less thirty five total lung capacity tlc less thirty five forced expiratory volume lung one second fevone less thirty five receiving supplementary continuous oxygen fhcrc principal investigator pi must approve enrollment all patients pulmonary nodules
1, bb rectal cancer diagnosis patient must not have obstruction gi gu tract
1, carboplatin carcinoma non small cell lung diagnosis presence uncontrolled brain leptomeningeal metastases
0, pancrelipase adenocarcinoma diagnosis ast sgot alt sgpt less doc uln less five uln if liver metastases
0, methotrexate cutaneous cell lymphoma diagnosis female patients who post menopausal surgically sterile agree practice two effective methods contraception agree practice true abstinence when this is line preferred usual lifestyle subject
0, immunoglobulins stage iib prostate cancer diagnosis psa progression is defined three rising levels minimum interval two weeks between each determination
1, flucytosine adult gliosarcoma diagnosis patients who currently receiving chemotherapy radiotherapy enrolled another treatment clinical trial
0, cyclosporins recurrent adult diffuse mixed cell lymphoma diagnosis acute myeloid leukemia aml crone except patients low risk features defined as
1, interferons severe greater two positive tumor associated edema
0, fluorouracil stage iiic esophageal cancer diagnosis aspartate aminotransferase ast alanine aminotransferase alt must be less uln
1, endothelial growth factors ovarian carcinoma diagnosis uncontrolled high blood pressure systolic blood pressure greater one hundred fifty mm hg diastolic blood pressure greater ninety five mm hg
1, bevacizumab endometrial transitional cell carcinoma diagnosis history liver disease such cirrhosis chronic active hepatitis chronic persistent hepatitis hepatitis c
1, maleic acid fallopian tube transitional cell carcinoma diagnosis prior treatment trastuzumab
1, mycophenolate mofetil stage iii small lymphocytic lymphoma diagnosis donor
0, dexamethasone renal cancer diagnosis serum free light chain
1, antibodies monoclonal history another cancer previous five years except appropriately treated carcinoma situ cervix non melanoma skin cancer stage uterine cancer other cancers that curable
0, hydrocortisone acetate plasmablastic lymphoma diagnosis patients must have ability understand willingness sign written informed consent prior registration on study
0, fludarabine phosphate lymphoma diagnosis no fully matched single antigen mismatched sibling donor available
0, fludarabine clear cell renal cell carcinoma diagnosis donor
1, immunoglobulins stage ivb cervical cancer diagnosis new york heart association class ii greater congestive heart failure
0, immunoglobulins recurrent colon carcinoma diagnosis absolute neutrophil count greater one five hundred mcl
1, lenalidomide marginal zone cell lymphoma diagnosis prior use lenalidomide
1, bevacizumab ovarian brenner tumor diagnosis major surgical procedure anticipated during course this includes but is not limited abdominal surgery laparotomy laparoscopy prior disease progression such colostomy enterostomy reversal secondary cytoreductive surgery second look surgery please consult sdc randomization desk prior patient entry any questions related classification surgical procedures
1, everolimus unspecified adult solid tumor protocol specific diagnosis other concurrent investigational agents other temsirolimus metformin
0, mycophenolate mofetil stage iii adult immunoblastic large cell lymphoma diagnosis donor
1, neratinib recurrent breast carcinoma diagnosis active uncontrolled cardiac disease including cardiomyopathy congestive heart failure new york heart association functional classification greater equal two including individuals who currently use digitalis specifically congestive heart failure unstable angina myocardial infarction within two month enrollment ventricular arrhythmia
0, oxaliplatin esophageal cancer diagnosis radiotherapy
1, immunosuppressive agents noncontiguous stage ii adult lymphoblastic lymphoma diagnosis patient donor history hepatitis or positive serology consistent previous hepatitis infection patients donor who received hepatitis vaccination acceptable
0, brachytherapy breast cancer diagnosis other
0, panobinostat recurrent adult cell leukemia lymphoma diagnosis bone marrow lymphoplasmacytosis greater ten lymphoplasmacytic cells aggregates sheets lymphocytes plasma cells lymphoplasmacytic cells on bone marrow biopsy quantitative igm monoclonal protein greater one zero mg dl
1, bortezomib noncontiguous stage ii adult burkitt lymphoma diagnosis patient has greater doc uln total bilirubin
1, pembrolizumab stage iva thyroid gland papillary carcinoma diagnosis prior treatment previous vegfr active multikinase inhibitor
0, afuresertib gc fed state cancer diagnosis non childbearing potential defined pre menopausal females documented tubal ligation hysterectomy postmenopausal defined twelve months spontaneous amenorrhea child bearing potential negative pregnancy test determined by serum human chorionic gonadotropin hcg test at screening prior dosing and
0, cyclosporine extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis donors must be capable giving informed consent
0, bevacizumab sarcoma kaposi diagnosis decreased range joint motion due ks
0, mycophenolic acid non hodgkin lymphoma diagnosis cll adverse cytogenetics mcl cell nhl
0, multiple fraction stereotactic body radiation therapy sbrt lung cancer diagnosis severely reduced diffusion capacity
1, ascorbic acid prostatic neoplasms diagnosis has known history human immunodeficiency virus hiv hiv one two antibodies
0, liposomal doxorubicin pretext stage three hepatoblastoma diagnosis one mg dl
1, dexamethasone acetate peripheral neuropathy grade two higher defined by national cancer institute common terminology criteria nci ctc version four
1, cyclosporins stage childhood lymphoblastic lymphoma diagnosis karnofsky performance status less seventy adults lanksy score less fifty pediatrics
0, gemcitabine urothelial carcinoma urinary bladder diagnosis all grossly visible disease bladder must be fully resected pathologic stage will be confirmed at institution
0, varenicline gastric cancer diagnosis addiction recovery institute
0, albumin bound paclitaxel recurrent cervical carcinoma diagnosis platelets greater equal one hundred zero mcl
1, laboratory biomarker analysis thyroid gland medullary carcinoma diagnosis fine needle aspirate within seven days prior enrollment
1, bevacizumab ovarian cancer diagnosis post operative prophylaxis low molecular weight heparin sc is allowed
1, immunoglobulins metastatic adenocarcinoma colon rectum diagnosis left ventricular ejection fraction lvef less forty determined by screening echocardiogram echocardiogram results obtained within ninety days prior screening acceptable
1, therapeutic conventional surgery breast cancer diagnosis patient is lactating breastfeeding
1, musculoskeletal complications management prevention recurrent small lymphocytic lymphoma diagnosis prior history non traumatic fracture
1, vaccines malignant melanoma diagnosis pregnancy breastfeeding
1, antibodies monoclonal endometrial serous adenocarcinoma diagnosis child pugh classification
0, vorinostat recurrent childhood supratentorial primitive neuroectodermal tumor diagnosis karnofsky performance status ps sixty one hundred patients greater sixteen years age lansky pssixty one hundred patients less sixteen years age
0, mutation analysis hereditary wilms tumor diagnosis normal tissue samples if available
0, gefitinib stage ivb verrucous carcinoma oral cavity diagnosis patients must be able swallow oral medication pill form patients may not receive medication through feeding tube
0, liposomal doxorubicin stage iii adult hodgkin lymphoma diagnosis serum creatinine less doc mg dl
1, paclitaxel triple negative breast carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition rofour million nine hundred twenty nine thousand ninety seven other agents used study
0, camptothecin colorectal cancer diagnosis not specified
0, sorafenib stage iv adult soft tissue sarcoma diagnosis eastern cooperative oncology group ecog performance status equal less two
1, vaccines pancreatic cancer diagnosis pregnancy ongoing breast feeding chemotherapy may pose substantial risk fetus infant
1, microwave ablation secondary malignant neoplasm liver diagnosis underlying liver cirrhosis child pugh grade c
0, lenograstim multiple myeloma diagnosis twice weekly bortezomib on days one four eight oneone one day cycle without dexamethasone
0, methotrexate recurrent breast cancer diagnosis platelet count at least one hundred zero mm three
0, irreversible electroporation ire renal cell cancer diagnosis mri incompatibility
0, sorafenib fallopian tube cancer diagnosis patients who require hematopoietic growth factor support epogen darbepoetin non steroidal anti inflammatory drugs nsaids other maintenance medications prior entry will be allowed continue their supportive therapies
1, fludarabine recurrent adult hodgkin lymphoma diagnosis significant elevation bilirubin transaminases should be discussed at participating institutions patient review committees case by case basis evidence synthetic dysfunction severe cirrhosis will result patient exclusion
0, letrozole breast cancer diagnosis no concurrent radiotherapy
1, sirolimus stage ivb oropharyngeal squamous cell carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition temsirolimus cetuximab
0, laparoscopic proximal gastrectomy gastric cancer diagnosis performance status ps zero one on eastern cooperative oncology group ecog scale performance status ps iii on american society anesthesiologists asa score
0, romidepsin carcinoma non small cell lung diagnosis patients may have received localized radiation therapy non target lesions provided that radiotherapy is completed fourteen days prior commencing therapy patient has recovered from any toxicity
1, dexamethasone phosphate multiple myeloma diagnosis history allergic reactions attributed agents
1, lenograstim contiguous stage ii adult diffuse small cleaved cell lymphoma diagnosis patient has creatinine greater doc mg dl within fourteen days before enrollment
1, vaccines melanoma diagnosis patients have diagnosis evidence organic brain syndrome significant impairment basal cognitive function any psychiatric disorder that might preclude participation protocol
1, irinotecan history prior malignancies except cured non melanoma skin cancer curatively treated situ carcinoma cervix other cancer curatively treated no evidence disease at least five years
0, gemcitabine metastatic pancreatic cancer diagnosis prior adjuvant chemotherapy completely resected disease chemoradiotherapy locally advanced disease is allowed but must have been administered greater six months prior registration
0, albumin bound paclitaxel prostate cancer diagnosis eighteen over performance status
1, gemcitabine recurrent ovarian carcinoma diagnosis history cerebrovascular attack cva within six months
0, cisplatin diffuse large cell lymphoma diagnosis obtain negative pregnancy test before starting medically supervised therapy study
1, dexamethasone acetate refractory plasma cell myeloma diagnosis bilirubin greater two normal values
1, carboplatin adult anaplastic oligodendroglioma diagnosis patients that have been treated greater three prior chemotherapy regimens
1, antibodies monoclonal melanoma diagnosis prior live vaccine therapy within past four weeks
1, immunoglobulins adult anaplastic astrocytoma diagnosis no serious concurrent infection medical illness that would jeopardize ability patient receive treatment outline this protocol reasonable safety
1, everolimus chemotherapy naive prostate cancer diagnosis current use chronic steroids equivalent twentymg prednisone daily
1, imatinib mesylate sarcoma diagnosis patient grade iii iv cardiac problems defined by new york heart association criteria
1, ixazomib lymphoma cell diagnosis ongoing active systemic infection active hepatitis virus infection hiv positive
0, cisplatin stage iii squamous cell carcinoma lip oral cavity diagnosis only patients intermediate stage disease tone two none ntwoa tthree nzero one eligible radiotherapy alone gefitinib
1, gemcitabine co existing tumors different histologic origin except non melanomatous localized skin cancer situ cervical carcinoma
1, everolimus adenocarcinoma esophagus diagnosis patients unwilling unable comply protocol
0, antibodies stage iv ovarian cancer diagnosis anc greater equal one five hundred mm three
1, gemtuzumab other concurrent active malignancy except basal cell carcinoma
0, methotrexate breast cancer diagnosis time since prior therapy first dose drug
0, cyclosporins extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis patients must be not eligible conventional transplants must have disease expected be stable at least one hundred days without chemotherapy patients hematologic malignancies treatable hematopoietic stem cell transplant hsct b cell malignancy except those treatable autologous transplant will be included
0, albumin bound paclitaxel ovarian cancer diagnosis at least seven days since prior no concurrent cypthreeafour inhibitors
0, vorinostat childhood central nervous system choriocarcinoma diagnosis doc mg dl one less two years age
1, mitoxantrone lymphoma non hodgkin diagnosis patients known positivity human immunodeficiency virus hiv hepatitis c
1, ifosfamide untreated childhood supratentorial primitive neuroectodermal tumor diagnosis contralateral pleural effusion contralateral pleural nodules
1, carboplatin non small cell lung cancer diagnosis pregnant women
0, tivozanib stage iv adult soft tissue sarcoma diagnosis total bilirubin equal less doc upper limit normal uln except patients known gilbert syndrome
0, dexamethasone multiple myeloma diagnosis age
0, counseling intervention stage iii marginal zone lymphoma diagnosis any type transplant autologous allogeneic myeloablative non myeloablative marrow peripheral blood stem cells
0, docetaxel non small cell lung cancer diagnosis adequate organ function defined as
0, levoleucovorin esophageal cancer diagnosis creatinine less doc mg dl creatinine clearance greater fifty ml min cardiovascular
0, mitogens renal cell carcinoma diagnosis documentation flu vaccination if enrolled during flu season defined by availability vaccine
1, standard colonoscopy colorectal cancer diagnosis previous colonic surgery except appendectomy
1, cisplatin solid tumor diagnosis during phase ii enrollment
0, paclitaxel breast cancer diagnosis planned initial treatment combination paclitaxel trastuzumab trastuzumab pertuzumab based combination
1, fluorouracil pancreas neoplasms diagnosis albumin less doc dl
1, vidarabine recurrent childhood lymphoblastic lymphoma diagnosis calculated creatinine clearance less forty cc min by modified cockroft gault formula adults schwartz formula pediatrics
1, definitive chemoradiation esophageal cancers diagnosis investigators excluded those patients who had distant metastasis solid visceral organs local invasion into trachea descending aorta recurrent laryngeal nerve
0, oxaliplatin stage iiia colon cancer diagnosis fertile patients must use effective contraception
0, bevacizumab ovarian epithelial cancer recurrent diagnosis patients must be able receive dexamethasone its equivalent premedication trabectedin
0, antibodies monoclonal melanoma diagnosis hemoglobin greater nine dl
1, sirolimus carcinoma renal cell diagnosis other concurrent severe uncontrolled medical disease which could compromise participation uncontrolled diabetes severe infection severe malnutrition ventricular arrhythmias chronic liver renal disease active upper gi tract ulceration
0, everolimus pancreatic cell adenoma diagnosis creatinine equal less doc uln
1, fludarabine phosphate peripheral cell lymphoma diagnosis females who pregnant
1, immunoglobulins recurrent colorectal carcinoma diagnosis seasonal influenza vaccines injection generally inactivated flu vaccines allowed however intranasal influenza vaccines flu mist live attenuated vaccines not allowed
1, nivolumab stage iv urethral cancer diagnosis myocardial infarction
0, interleukin recurrent adrenocortical carcinoma diagnosis patients must have histologically proven hertwo overexpressing malignancy determined by any standardized assay currently clinical use
1, delanzomib lymphoma non hodgkin diagnosis signs indicating potential major bone marrow involvement
1, fludarabine phosphate splenic marginal zone lymphoma diagnosis poorly controlled hypertension
0, albumin bound paclitaxel recurrent non small cell lung cancer diagnosis hemoglobin at least doc dl
1, progesterone breast cancer diagnosis pregnancy testing must be performed within two weeks prior randomization according institutional standards women childbearing potential
1, camptothecin pancreas cancer diagnosis patient is enrolled any outside outside baylor university medical center texas oncology clinical protocol investigational trial
1, etoposide phosphate prostate cancer diagnosis any coexisting medical condition including uncontrolled cardiac hepatic renal psychiatric disease defined grade three ctcae version three
0, docetaxel breast cancer diagnosis age
0, immunoglobulins brain central nervous system tumors diagnosis ast alt less doc times upper limit normal uln
1, etoposide phosphate synchronous prior invasive malignancy within three years except nonmelanomatous skin cancer pregnant women effective contraception required fertile patients
1, regorafenib gastrointestinal stromal tumors gists diagnosis uncontrolled hypertension systolic blood pressure greater one hundred fifty mmhg diastolic blood pressure greater one hundred mmhg without anti hypertensive medication
1, questionnaire prostate cancer diagnosis contraindications external beam radiation therapy include previous pelvic radiation inflammatory bowel disease history collagen vascular disease
1, fludarabine phosphate noncontiguous stage ii grade three follicular lymphoma diagnosis pregnancy
1, paclitaxel primary peritoneal serous adenocarcinoma diagnosis history stroke transient ischemic attack within six months
1, prednisone prostate cancer diagnosis significant cardiovascular disease
0, cetuximab squamous cell head neck carcinoma diagnosis platelets greater one hundred fifty zero mmthree
1, radioembolisation sir spheresÂ® microspheres ascites which is detectable on physical examination clinically symptomatic but patients having ascites discovered by imaging only should not be excluded
1, therapeutic conventional surgery stage iva hypopharyngeal squamous cell carcinoma diagnosis use medications that have been linked occurrence torsades de pointes
0, vaccines recurrent pediatric low grade glioma diagnosis patients adequate organ function measured by
0, everolimus stage iv adult soft tissue sarcoma diagnosis platelets plts greater equal one hundred zero Î¼l
1, antibodies metastatic digestive system neuroendocrine tumor gone diagnosis patients on anticoagulant therapy
1, bevacizumab malignant gliomas diagnosis patients hypertension eligible if their blood pressures become less ninety fiveth percentile after anti hypertensive medications
1, nivolumab ebv related hodgkin lymphoma diagnosis severe active intercurrent infection
0, everolimus chemotherapy naive prostate cancer diagnosis age minimum
1, somatostatin carcinoid tumor small bowel diagnosis either serum creatinine greater one hundred fifty Âµmol greater doc mg dl creatinine clearance less fifty ml min calculated by cockroft gault method eventually confirmed by measured creatinine clearance measured glomerular filtration rate gfr using plasma clearance methods not gamma camera based less fifty ml min measured creatinine clearance gfr is required only confirmatory exam
1, bevacizumab history other malignancies except other solid tumors curatively treated no evidence disease greater three years prior enrollment
1, laboratory biomarker analysis stage ivc thyroid gland papillary carcinoma diagnosis any following equal less six months before first dose treatment
0, topotecan malignant ovarian serous tumor diagnosis hepatic function
1, palbociclib recurrent colon cancer diagnosis diabetes mellitus
1, prednisolone acetate head neck cancer diagnosis current treatment tyrosine kinase inhibitors
0, freund s adjuvant primary peritoneal cavity cancer diagnosis no new york heart association class iii iv heart disease
0, paclitaxel stage iiib non small cell lung cancer diagnosis total bilirubin equal less doc upper limit normal uln
0, antibodies monoclonal addition eligibility criteria based on tumor type apply
1, surgery non small cell lung cancer diagnosis cannot achieve acceptable srt planning meet minimal requirement target coverage dose volume constraints critical structures see rt techniques
0, pembrolizumab melanoma diagnosis ability provide written informed consent assent trial
1, placebo rectal cancer diagnosis history gastrointestinal genitourinary obstruction porphyria
0, liposomal doxorubicin adult malignant mesenchymoma diagnosis doc mg dl male doc mg dl female thirteen years less sixteen years age
1, immunoglobulins intraocular lymphoma diagnosis myocardial infarction unstable angina within six months
0, antibodies small lymphocytic lymphoma diagnosis cdfour positive cell count greater equal lower limit institutional normal
1, hormones prostate cancer diagnosis patients who have received up six months hormonal therapy neoadjuvant therapy before radical prostatectomy while on radiation therapy long more one year has elapsed between discontinuation neoadjuvant hormonal therapy initiation hormonal treatment relapsing disease
1, camptothecin esophageal cancer diagnosis pregnant breast feeding
0, antibodies metastatic gastrointestinal carcinoid tumor diagnosis no prior interferon
1, endoscopic retrograde cholangiopancreatoscopy ercp gall bladder cancer diagnosis severe liver kidney disease
1, gemcitabine other malignancies within past three years except adequately treated carcinoma cervix basal squamous cell carcinomas skin adenocarcinoma prostate that has been treated
0, doxorubicin hepatocellular carcinoma diagnosis patients child pugh grade b
1, dasatinib solid tumors diagnosis consideration should be given using alternative medications not impacting cypthreeafour while on dasatinib therapy
0, carboplatin stage iii ovarian epithelial cancer diagnosis at least four weeks since prior chemotherapy recovered
0, dexamethasone phosphate multiple myeloma diagnosis adequate hepatic function
1, paclitaxel primary breast cancer diagnosis active infection
0, bb non hodgkin lymphoma diagnosis written informed consent accordance federal local institutional guidelines
0, etanidazole adult anaplastic ependymoma diagnosis no unstable angina pectoris
0, leucovorin colorectal cancer diagnosis disease characteristics
0, everolimus brain central nervous system tumors diagnosis hemoglobin doc dl may receive rbc transfusions
0, epigallocatechin gallate cervical cancer diagnosis ecog performance status less two
1, bez advanced solid tumor diagnosis patients unresolved diarrhea greater ctcae grade two
0, hypofractionated radiation therapy melanoma skin diagnosis pathologic fracture impending pathologic fracture at metastatic site
1, vitamin b complex undifferentiated fallopian tube carcinoma diagnosis uncontrolled intercurrent illness including but not limited to
0, dacarbazine childhood oligodendroglioma diagnosis at least six months since prior total body radiotherapy tbi craniospinal radiotherapy radiotherapy greater fifty pelvis
0, sirolimus bladder carcinoma diagnosis prior radiation therapy is allowed less twenty five bone marrow
0, antibodies monoclonal stage iv rectal cancer diagnosis ast sgot alt sgpt equal less doc institutional upper limit normal
1, antibodies multiple myeloma diagnosis above information is not intended contain all considerations relevant patient potential participation clinical trial
1, etoposide recurrent childhood non hodgkin lymphoma diagnosis female patients who pregnant breastfeeding
1, bevacizumab colorectal carcinoma diagnosis known unstable uncompensated respiratory cardiac disease
0, leuprolide stage iii prostate cancer diagnosis ability understand willingness provide written informed consent document
0, pass octÂ® spinal system spinal neoplasms diagnosis patient with
1, temozolomide malignant glioma brain diagnosis systemic corticosteroid therapy greater two mg dexamethasone daily equivalent at enrollment
1, carboplatin ovarian cancer diagnosis patient who have had previous treatment selinexor
0, aspirin characteristics tumor
1, thalidomide aids related hodgkin lymphoma diagnosis patients relapsed refractory dlbcl hl who eligible willing undergo potentially curative stem cell transplant
0, mercaptopurine lymphoblastic lymphoma diagnosis acute lymphoblastic leukemia pro common pre early thymic mature t
0, dalteparin gynecologic neoplasms diagnosis provide written informed consent
0, dexamethasone acetate newly diagnosed multiple myeloma diagnosis one atients must meet following clinical laboratory criteria
1, niacinamide metastatic renal cell carcinoma diagnosis patients recent active bleeding diathesis
0, dexamethasone histologically confirmed intrahepatic cholangiocarcinoma also variously reported peripheral cholangiocarcinoma cholangiolar carcinoma cholangiocellular carcinoma icc
1, lenograstim stage ib breast cancer diagnosis known existing uncontrolled coagulopathy
1, antibodies monoclonal stage ivc squamous cell carcinoma larynx diagnosis patients any history hyperglycemia elevated blood glucose level on blood chemistries should be considered initiation metformin treatment five hundredmg po twice daily prior starting bkmone hundred twenty
0, interleukin sarcoma diagnosis creatinine clearance radioisotope glomerular filtration rate at least sixty ml min
0, dexamethasone acetate recurrent grade two follicular lymphoma diagnosis patients must have southwest oncology group swog performance status zero one two
1, pazopanib ovarian cancer diagnosis difficult upper limb arterial access assessed by an easily palpable brachial artery
0, lenalidomide lymphoma large cell diffuse diagnosis absolute neutrophil count anc greater one zero mcl
1, antibodies monoclonal lung cancer diagnosis patient has history stroke transient ischemic attack within six months prior day one cycle one
1, fludarabine stage cutaneous cell non hodgkin lymphoma diagnosis donor
1, isophosphamide mustard uterine cancer diagnosis hemoglobin less doc dl patient may be transfused prior entry
0, laboratory biomarker analysis mucinous adenocarcinoma rectum diagnosis eastern cooperative oncology group ecog performance status less two
1, irinotecan colorectal cancer metastatic diagnosis occurrence deep vein thrombosis within four weeks prior randomization
0, nivolumab stage iii bone sarcoma diagnosis re registration
1, capecitabine pancreatic polypeptide tumor diagnosis current ongoing treatment full dose warfarin
0, hypofractionated radiation therapy ovarian cancer diagnosis four fewer sites extracranial lesions less five cm size
1, nivolumab chondrosarcoma diagnosis there is potential hepatic toxicity nivolumab nivolumab ipilimumab combinations drugs predisposition hepatoxicity should be used caution patients treated nivolumab containing regimen
1, antibodies monoclonal recurrent primary peritoneal carcinoma diagnosis men women childbearing potential their sexual partners who unwilling employ adequate contraception diaphragm birth control pills injections intrauterine device iud surgical sterilization subcutaneous implants abstinence etc
1, aprepitant ovarian serous cystadenocarcinoma diagnosis patients clinical symptoms signs gastrointestinal obstruction those who require parenteral hydration nutrition patients history current diagnosis inflammatory bowel disease not eligible
0, fludarabine phosphate stage iii adult lymphoblastic lymphoma diagnosis compatibility at four most informative hla loci
1, immunoglobulins recurrent grade two follicular lymphoma diagnosis patient received cytotoxic agents cytoreduction within three weeks interval which cycle standard chemotherapy would be administered non transplant setting prior initiating nonmyeloablative transplant conditioning exceptions hydroxyurea imatinib mesylate
0, busulfan solid tumors diagnosis having hla identical sibling donor hla hla hla dr antigens hla mismatch on only one antigen having ten ten pheno identical donor compatible cord blood
0, liposomal doxorubicin prostate cancer diagnosis patient characteristics
1, intraoperative electron radiotherapy invasive ductal breast cancer diagnosis pure dcis all grades
1, afatinib urothelial carcinoma diagnosis acute chronic liver renal pancreas disease
0, clinical observation gastric cancer diagnosis patient characteristics
1, n monoacetylcystine recurrent squamous cell carcinoma larynx diagnosis immunocompromised patients patients known be human immunodeficiency virus hiv positive currently receiving antiretroviral therapy note
1, mycophenolic acid nodal marginal zone cell lymphoma diagnosis prior extensive radiation therapy that radiation oncologist feels precludes additional tbi
0, mycophenolate mofetil lymphoma non hodgkin nhl diagnosis graft rejection
1, gemcitabine unspecified adult solid tumor protocol specific diagnosis patients known brain metastases excluded from this clinical trial because their poor prognosis because they often develop progressive neurologic dysfunction that would confound evaluation neurologic other adverse events
1, carboplatin cancer diagnosis prior treatment any hspninety inhibitor
0, rituximab stage adult diffuse large cell lymphoma diagnosis patients aml all mds scheduled myeloablative conditioning should have equal less ten blasts bone marrow peripheral blood at start conditioning
0, ziv aflibercept stage iii bladder cancer diagnosis cerebrovascular accident within past six months
0, melphalan ewing family tumors diagnosis glomerular filtration rate gfr greater fifty ml min doc threem two serum creatinine less doc upper limit normal uln age
1, albumin bound paclitaxel breast cancer diagnosis baseline grade greater two peripheral neuropathy
0, fludarabine recurrent adult lymphoblastic lymphoma diagnosis at least twelve weeks must have passed since radioimmunotherapy prior fludarabine treatment is not restricted
1, everolimus small cell lung cancer diagnosis other concurrent severe uncontrolled medical disease which could compromise participation uncontrolled diabetes uncontrolled hypertension severe infection severe malnutrition unstable angina congestive heart failure
0, ketoconazole unspecified adult solid tumor protocol specific diagnosis patient characteristics
0, androgens adenocarcinoma prostate diagnosis progressive castration resistant disease
0, albumin bound paclitaxel stage ia breast cancer diagnosis note
1, poly iclc melanoma diagnosis presence laboratory evidence autoimmune disease positive ana titer without symptoms
1, nivolumab lymphoma diagnosis has diagnosis immunodeficiency is receiving systemic steroid therapy more equivalent twenty mg day prednisone any other form immunosuppressive therapy within seven days prior first dose trial treatment
1, interventional therapy patients other primary tumor except pancreatic cancer
0, doxorubicin breast cancer diagnosis not specified
0, cetuximab stage iva squamous cell carcinoma paranasal sinus nasal cavity diagnosis two
0, oxaliplatin addition patients completely resected non melanoma skin cancer cervical carcinoma situ may be included
0, palonosetron malignant glioma diagnosis serum creatinine less doc mg dl serum glutamate oxaloacetate transaminase sgot bilirubin less doc times upper limit normal
0, vincristine lymphoma diagnosis able sufficiently fluent willing complete quality life questionnaires either english french
1, antibodies monoclonal recurrent gastric carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition olaparib ramucirumab
0, etoposide non hodgkin lymphoma diagnosis patients must be suitable undergo stem cell transplant
1, fludarabine stage grade one follicular lymphoma diagnosis active bacterial fungal infections unresponsive medical therapy
1, carboplatin childhood central nervous system germ cell tumor diagnosis patients bifocal pineal positive suprasellar involvement pineal lesion diabetes insipidus hcgÎ² less one hundred miu ml institutional normal afp serum csf eligible no histologic confirmation required
1, cytarabine symptomatic neurologic disease compromising normal activities daily living requiring medication
1, antidiarrheals cancer diagnosis chronic diarrhea prior clinical introduction targeted therapy
1, irinotecan colorectal cancer metastatic diagnosis related methodology
0, mycophenolate mofetil myelodysplastic myeloproliferative neoplasms diagnosis life expectancy must not be limited by disease other malignancy
0, docetaxel breast cancer diagnosis pt inr within doc uln
0, bevacizumab pilomyxoid astrocytoma diagnosis histology
1, albumin bound paclitaxel her two positive advanced gastric cancer diagnosis patients history hypersensitivity trastuzumab who have been treated medicine including cremophor el
0, vincristine childhood nodular sclerosis classical hodgkin lymphoma diagnosis not pregnant nursing
1, cyclosporins recurrent mantle cell lymphoma diagnosis current serious systemic illness
0, endothelial growth factors liver cancer diagnosis no known cns disease
1, fulvestrant advanced solid tumors an alteration pikthreeca gene diagnosis patient diarrhea nci ctc grade greater two
0, trastuzumab recurrent breast carcinoma diagnosis hemoglobin must be greater equal ten dl
0, rexin g dose pancreatic cancer diagnosis serum creatinine less doc mg dl females less doc mg dl males
1, bevacizumab malignant gliomas diagnosis patients prior history hypertensive crisis hypertensive encephalopathy
0, antibodies monoclonal contiguous stage ii marginal zone lymphoma diagnosis absolute neutrophil count greater doc ten nine l
1, liposomal doxorubicin rhabdomyosarcoma extraosseous ewing sarcoma primitive neuroectodermal tumor osteosarcoma chondrosarcoma kaposi sarcoma aggressive fibromatosis
0, laboratory biomarker analysis recurrent adult lymphoblastic lymphoma diagnosis seventy five cells ul
1, veliparib endometrial carcinoma diagnosis active seizure history seizure disorder
0, interleukin recurrent neuroblastoma diagnosis more four weeks since prior chemotherapy
0, albumin bound paclitaxel adult solid neoplasm diagnosis ability understand willingness sign written informed consent document
0, bortezomib extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis more four weeks since prior radiotherapy
1, dexamethasone phosphate multiple myeloma diagnosis pregnant lactating females
0, antineoplaston a malignant mesothelioma diagnosis cardiovascular
1, aprepitant solid tumors diagnosis known hiv infection
1, dutasteride neoplasms prostate diagnosis participation any investigational marketed drug trial within thirty days prior first dose drug anytime during period
0, docetaxel breast cancer diagnosis normal heart function
0, fludarabine recurrent refractory childhood hodgkin lymphoma diagnosis myelodysplastic syndromes
0, lenograstim wilms tumor diagnosis serum glutamate pyruvate transaminase sgpt alt less one hundred thirty five l
1, metformin prostatic neoplasms diagnosis patient at least one following criteria could not be included
0, rituximab stage ii small lymphocytic lymphoma diagnosis patients must have confirmed diagnosis cll sll
1, laboratory biomarker analysis stage iii prostate cancer diagnosis aua score greater fifteen spite optimal therapy
0, melphalan recurrent plasma cell myeloma diagnosis have seventeenp deletion cytogenetic abnormality relapsed at any time point after initial chemotherapy
1, docetaxel stage iva verrucous carcinoma larynx diagnosis any condition which investigator opinion makes subject unsuitable trial participation
1, sirolimus stage iv adult soft tissue sarcoma diagnosis patients may not have received prior igfrone inhibitors
0, oxaliplatin metastatic cancer diagnosis hemoglobin greater nine dl
0, pharmacological unspecified adult solid tumor protocol specific diagnosis unstable angina
0, antibodies monoclonal recurrent adult diffuse large cell lymphoma diagnosis patients who met criteria persistence progression aml all cml aggressive nhl currently complete remission after reinduction therapy not require measurable evaluable disease be eligible
0, denosumab subjects early stage disease who estrogen receptor positive who have completed their treatment pathway surgery chemo therapy radiation hormone therapy currently on will initiate aromatase inhibitor therapy expected stay on aromatase inhibitor therapy duration twenty four month study
0, hormones metastatic cancer diagnosis progression any unidimensionally bidimensionally measurable malignant lesion
1, ifosfamide symptomatic brain metastases baseline ct scan is not required asymptomatic patients
0, cortisone stage iv diffuse large cell lymphoma diagnosis female subjects childbearing potential should be willing use two methods birth control be surgically sterile abstain from heterosexual activity course through onetwo days after last dose medication subjects childbearing potential those who have not been surgically sterilized have not been free from menses greater one year
1, laboratory biomarker analysis stage zerois bladder urothelial carcinoma diagnosis patients who have had chemotherapy radiotherapy immunotherapy within four weeks prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
0, everolimus stage iia fallopian tube cancer diagnosis hematology biochemistry laboratory results within limits normally expected patient population without evidence major organ failure
1, hormones liver cancer diagnosis significant neurologic psychiatric diseases preventing patients give valid informed consent
1, laparoscopic assisted resection colorectal carcinoma colorectal carcinoma diagnosis patients previous abdominal surgery near region colorectal surgery
0, tamoxifen neoplasm metastasis diagnosis no patients insulin dependent diabetes mellitus fasting blood glucose gte one hundred fifty mg dl
0, lenalidomide relapsed refractory multiple myeloma diagnosis female participants who can become pregnant must agree use two separate forms effective birth control at same time four weeks before while taking four weeks after stopping lenalidomide
0, antibodies stage iii multiple myeloma diagnosis no known brain metastases
1, vincristine contiguous stage ii grade three follicular lymphoma diagnosis positive serology because prior vaccination is allowed
0, gemcitabine gallbladder cancer diagnosis stage ii iii disease
0, megestrol acetate endometrial cancer diagnosis surgery
0, capecitabine stage iv grade two follicular lymphoma diagnosis creatinine within normal institutional limits creatinine clearance greater equal sixty ml min doc three two patients creatinine levels above institutional normal two hour urine collection creatinine clearance can be measured if indicated
1, megestrol acetate stage iiic breast cancer diagnosis active infection
1, mycophenolic acid stage iii childhood large cell lymphoma diagnosis patient rapidly progressive aggressive nhl unless minimal disease state
1, sirolimus recurrent digestive system neuroendocrine tumor gone diagnosis prior therapy vascular endothelial growth factor receptor vegfr targeting agents mammalian target rapamycin mtor inhibitors except hcc islet cell single agent bevacizumab alone cohort where prior mtor inhibitor is allowed note
1, docetaxel carcinoma renal pelvis diagnosis received more one prior systemic treatment regimen metastatic disease
0, succinylcholine stage iva nasopharyngeal carcinoma diagnosis absolute neutrophil count anc greater equal one five hundred cells mm three
1, placebo stage iii squamous cell carcinoma hypopharynx diagnosis brachytherapy interstitial implantation treatment
1, dexamethasone acetate multiple myeloma diagnosis prior external beam radiation therapy resulting greater twenty total bone marrow receiving greater twenty gy
1, therapeutic conventional surgery stage iii renal cell cancer diagnosis prior therapy tyrosine kinase inhibitor rcc
0, etoposide recurrent childhood grade iii lymphomatoid granulomatosis diagnosis platelet plt greater seventy five zero ul
1, cisplatin breast cancer diagnosis metastatic disease on baseline staging scans
0, bb disease free prior malignancies five years more exception currently treated basal cell squamous cell carcinoma skin carcinoma situ cervix breast
1, mesna hodgkin lymphoma diagnosis female subject is pregnant breast feeding
1, albumin bound paclitaxel inflammatory breast cancer stage iv diagnosis history significant neurological psychiatric disorders including psychotic disorders dementia seizures that would prohibit understanding giving informed consent
0, docetaxel recurrent non small cell lung cancer diagnosis ecog zero one
0, vaccines glioblastoma multiforme diagnosis aspartate aminotransferase ast alanine transaminase alt less doc upper limit normal uln if liver metastases less five uln
0, podophyllotoxin recurrent mantle cell lymphoma diagnosis all subjects must have ability understand willingness sign written informed consent
1, ethanol mucinous cystic tumor moderate dysplasia diagnosis inability undergo mri metal implants cardiac pacemaker defibrillator claustrophobia
1, intracavitary ultrasound lung cancer diagnosis patients less eighteen years old
1, carboplatin non small cell lung cancer diagnosis no known hiv disease infection
0, irinotecan recurrent squamous cell carcinoma oropharynx diagnosis no concurrent combination antiretroviral therapy hiv positive patients
1, carboplatin gastrointestinal stromal tumor gist diagnosis prior therapy anti vegf agents
1, rituximab intraocular lymphoma diagnosis intraventricular chemotherapy radiation therapy within four days starting treatment
0, niacinamide stage iii multiple myeloma diagnosis no patients evidence biliary renal obstruction patients should be observed at least one week after treatment stents drains biliary renal obstruction ensure their organ dysfunction has stabilized before registration this protocol
1, oxaliplatin pregnant woman lactating woman
1, immunoconjugates renal cell carcinoma diagnosis active infection viral bacterial fungal
0, histone deacetylase inhibitors non small cell lung cancer diagnosis expected survival time not less six months
0, immunoglobulins recurrent pancreatic cancer diagnosis more seven days since prior core biopsy
0, fluoroquinolones unspecified adult solid tumor protocol specific diagnosis not pregnant nursing
1, niacinamide hepatocellular cancer diagnosis evidence severe uncorrectable bleeding diathesis coagulopathy
0, prednisolone hemisuccinate stage iii childhood large cell lymphoma diagnosis no known history congenital immune deficiency laboratory evidence acquired immune deficiency
0, idelalisib mantle cell lymphoma diagnosis cohort seven only
0, citric acid stage iiia uterine corpus cancer diagnosis note
0, saracatinib stage iva squamous cell carcinoma oropharynx diagnosis measurable disease defined at least one lesion that can be accurately measured at least one dimension longest diameter be recorded greater twenty mm conventional techniques greater ten mm spiral computed tomography ct scan
1, immunoglobulins recurrent adult diffuse small cleaved cell lymphoma diagnosis inability understand give an informed consent
1, mycophenolic acid malignant lymphoma large cell type diagnosis donor
0, alternative product therapy primary central nervous system lymphoma diagnosis no hepatic insufficiency
1, paclitaxel squamous cell carcinoma diagnosis any ecg abnormality that opinion investigator would preclude safe participation patients pacemakers where qtc is not reliable measure will require an evaluation by cardiologist exclude co existing cardiac conditions which would prohibit safe participation study
0, dacarbazine recurrent melanoma diagnosis hemoglobin greater equal ninegm mcl
0, bb recurrent childhood grade iii lymphomatoid granulomatosis diagnosis doc mg dl female patients greater thirteen years
0, sorafenib recurrent salivary gland cancer diagnosis patients may have received one regimen induction concomitant chemoradiotherapy adjuvant chemotherapy part their initial treatment curative intent which must have been completed minimum four months prior treatment patient must have been progression free at least four months since completion treatment curative intent
1, antibodies extranodal marginal zone cell lymphoma mucosa associated lymphoid tissue diagnosis bone marrow bm donors
0, carboplatin diffuse large cell lymphoma diagnosis previously treated chemotherapy containing anthracyclines rituximab
0, tacrolimus refractory multiple myeloma diagnosis eighteen seventy years age
1, dexamethasone phosphate recurrent mantle cell lymphoma diagnosis pregnancy testing is not required post menopausal surgically sterilized women
1, camptothecin solid tumors diagnosis female patient is pregnant breastfeeding childbearing potential but not take contraceptive measures
1, vincristine recurrent ewing sarcoma peripheral primitive neuroectodermal tumor diagnosis radiotherapy surgery local control recurrent disease concurrently bevacizumab bevacizumab must be held if radiotherapy surgery is required
0, fludarabine phosphate lymphoma diagnosis no active cns malignancy
1, additional radiation boost primary tumor volume history other malignancies within five years except non melanoma skin cancer situ carcinoma cervix ductal carcinoma breast
1, dexamethasone phosphate adult cell leukemia lymphoma diagnosis initiation treatment topical corticosteroids while on is not permitted except treat an acute rash
0, antibodies monoclonal stage iv colon cancer diagnosis no concurrent antiplatelet agents dipyridamole ticlopidine clopidogrel cilostazol
1, lurtotecan other prior concurrent malignancy except adequately treated cone biopsied carcinoma situ cervix basal cell squamous cell skin cancer
1, albumin bound paclitaxel neoplasms breast diagnosis active uncontrolled infection
0, levoleucovorin recurrent rectal cancer diagnosis patients permitted receive thyroid hormone supplements treat underlying hypothyroidism
0, pharmacological stage iiic breast cancer diagnosis patient must have ability understand willingness sign written informed consent document
1, fludarabine splenic marginal zone lymphoma diagnosis left ventricular ejection fraction less thirty five
1, laboratory biomarker analysis recurrent adult soft tissue sarcoma diagnosis prior malignancy except following
1, bendamustine hydrochloride mature cell nk cell non hodgkin lymphoma diagnosis pregnant women excluded from this breastfeeding should be discontinued if mother is treated abt eight hundred eighty eight
1, endothelial growth factors pancreatic delta cell adenoma diagnosis men women childbearing potential their sexual partners who unwilling employ adequate contraception diaphragm birth control pills injections intrauterine device iud surgical sterilization subcutaneous implants abstinence etc
1, erlotinib hydrochloride reccurent metastatic solid tumor disease diagnosis patients who have only bone brain metastases
0, temozolomide unspecified childhood solid tumor protocol specific diagnosis at least two months since prior autologous stem cell transplantation recovered
0, etoposide alveolar childhood rhabdomyosarcoma diagnosis hemoglobin at least one doc dl red blood cell transfusion allowed
1, albumin bound paclitaxel breast cancer diagnosis pregnancy breastfeeding
0, vaccines recurrent colon cancer diagnosis must be maintaining reasonable state nutrition equal less ten weight loss past month
1, lomustine malignant glioma who grade iii iv diagnosis prior chemotherapy non alkylating agents within two weeks before enrollment unless patient has recovered from expected toxic effects such therapy
0, dasatinib lung cancer diagnosis participants allowed have received systemic chemotherapy investigational therapy intervening period prior trial enrollment
1, proton prostate cancer diagnosis prior concurrent invasive malignancy
0, questionnaires spinal tumor diagnosis eighteen years old
0, gemcitabine primary peritoneal carcinoma diagnosis more three years since prior therapy
0, antibodies monoclonal stage iiic primary peritoneal cancer diagnosis bilirubin less equal doc upper limit normal uln ctcae grade one
0, prednisolone recurrent adult non hodgkin lymphoma diagnosis donor
0, niacinamide lymphoma diagnosis greater equal twenty four weeks must have elapsed if prior tbi craniospinal xrt if
1, fludarabine phosphate stage ii childhood lymphoblastic lymphoma diagnosis poorly controlled hypertension
1, laser ablation hepatocellular carcinoma diagnosis wbc less two thousand ml hb less ninetyg plt less fifty thousand ml
0, sirolimus recurrent colorectal carcinoma diagnosis any human leukocyte antigen hla type historic hla typing is permitted
0, pembrolizumab stage iv skin melanoma diagnosis note
0, fluorouracil esophageal adenocarcinoma diagnosis life expectancy greater three months
0, antibodies monoclonal prostatic neoplasms diagnosis adequate hepatic function bilirubin less doc upper limit normal uln alanine aminotransferase alt less doc uln aspartate aminotransferase ast less doc uln
0, mycophenolate mofetil stage iv mantle cell lymphoma diagnosis must have received prior chemotherapy consolidation chemotherapy by autografting prior nonmyeloablative hct is permitted
1, methylprednisolone acetate multiple myeloma diagnosis any other clinically significant medical disease psychiatric condition that investigator opinion may interfere protocol adherence patient ability give informed consent
0, oxaliplatin nasopharyngeal neoplasms diagnosis adequate renal hepatic functions
1, maleic acid ovarian serous adenocarcinoma diagnosis unstable angina
1, ferric compounds tubular breast cancer stage ii diagnosis currently active infection
0, recombinant human interleukin rhil neuroblastoma diagnosis patients less eighteen years age their legal guardian must give informed consent
0, blood sample pediatric young adult cancer survivors diagnosis english speaking
0, pd cancer diagnosis fasting glucose less one hundred twenty six mg dl
0, immunoglobulins recurrent squamous cell carcinoma hypopharynx diagnosis patients brain metastases not eligible
1, gemcitabine recurrent fallopian tube carcinoma diagnosis patients who have had radiotherapy within four weeks prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
1, ispinesib stage iv adult lymphoblastic lymphoma diagnosis inducers cypthreeafour
0, asn dose escalation lymphoma large cell diffuse diagnosis at screening life expectancy at least three months
0, alvespimycin hydrochloride stage iii verrucous carcinoma oral cavity diagnosis no congenital long qt syndrome
0, saracatinib estrogen receptor negative breast cancer diagnosis unstable angina pectoris
0, hmn labetuzumab colon cancer diagnosis patients karnofsky performance status greater seventy equivalent ecog zero one expected survival at least three months
0, cyclophosphamide stage adult cell leukemia lymphoma diagnosis viral load must be equal less ten zero copies ml
0, fluorides stage iv renal cell cancer diagnosis ideally there should be no chemotherapy radiotherapy immune biologic therapy biopsy between other imaging pet cts mri diagnostic cts eighteenf fspg pet ct scheduled performed exceptions by investigator discretion
0, leuprolide histological cytological proven adenocarcinoma prostate requiring hormone therapy
1, prednisolone hemisuccinate lymphoma non hodgkin diagnosis prior autologous allogeneic hematopoietic cell transplantation other autologous sct sixty one hundred twenty days prior registration
0, amoxicillin potassium clavulanate combination lymphoma diagnosis surgery
1, paclitaxel advanced solid tumors diagnosis platelet count less one hundred zero Âµl
1, albumin bound paclitaxel stage iiic breast cancer diagnosis poor venous access drug administration
0, hydroxocobalamin cancer diagnosis each patient will be allocated following three groups
0, carboplatin lung cancer diagnosis urine protein
0, cisplatin stage iva cervical cancer diagnosis negative pregnancy test
1, oxaliplatin metastatic colorectal cancer diagnosis clinical evidence brain metastases history evidence upon physical examination cns disease unless adequately treated
1, ixazomib multiple myeloma diagnosis inability unwillingness receive antithrombotic therapy
1, doxorubicin breast neoplasm diagnosis subject who is pregnant breastfeeding is unwilling use adequate contraception
1, sirolimus metastatic renal cell carcinoma diagnosis women child bearing potential must have negative serum pregnancy test within seven days prior first administration drug
0, diagnostic laboratory biomarker analysis recurrent childhood large cell lymphoma diagnosis myelosuppressive chemotherapy
1, aldesleukin stage iiic melanoma diagnosis any underlying medical psychiatric condition which opinion investigator will make administration ipilimumab hazardous obscure interpretation adverse events aes such condition associated frequent diarrhea
0, propranolol primary peritoneal carcinoma diagnosis surgery neoadjuvant chemotherapy must be scheduled at least seventy two hours advance order patient take at least forty eight hours prescribed propranolol have stable vital signs confirmed
1, endothelial growth factors stage ivb rectal cancer diagnosis radiation greater twenty five bone marrow
1, endothelial growth factors stage iib ovarian cancer diagnosis patients anticipation invasive procedures defined below
1, dexamethasone multiple myeloma diagnosis plasma cell leukemia
0, reverse transcriptase polymerase chain reaction stage iv mantle cell lymphoma diagnosis voluntary informed consent is given
1, methylprednisolone prior chemotherapy prostate cancer
0, counseling intervention colorectal cancer diagnosis disease characteristics
0, tacrolimus stage iv adult burkitt lymphoma diagnosis reduction more fifty disease burden regardless number lines therapy received
1, oxaliplatin prior therapy metastatic cancer
0, asparaginase lymphoma diagnosis endocrine therapy
0, freund s adjuvant lung cancer diagnosis no serious unstable medical illness
1, dacarbazine prior low grade glioma without prior rt now malignant progression eligible
1, fludarabine phosphate stage mantle cell lymphoma diagnosis poorly controlled hypertension
1, gemcitabine extranodal nk cell lymphoma nasal type diagnosis patients suffered before surgery less four weeks after less six weeks
1, rituximab stage grade one follicular lymphoma diagnosis pregnant breast feeding females lactating females must agree not breast feed while taking lenalidomide
1, tpi patients serious infection life threatening illness unrelated tumor that is greater grade two nci ctcae doc active serious infections requiring parenteral antibiotic therapy within four weeks prior screening
1, etoposide phosphate patients who grade ependymoma including ependymoma variants
1, genistein rhabdomyosarcoma diagnosis enrolled on therapeutic supportive care clinical trial within last thirty days
0, mechlorethamine brain central nervous system tumors diagnosis age
1, olaparib triple negative breast carcinoma diagnosis history stroke transient ischemic attack within six months
0, thiotepa breast cancer diagnosis lymphoproliferative diseases
1, erlotinib hydrochloride recurrent non small cell lung carcinoma diagnosis has an active infection requiring intravenous systemic therapy
0, vorinostat stage iii adult diffuse small cleaved cell lymphoma diagnosis philadelphia chromosome positive ph positive metaphases greater zero but less thirty five
0, vaccines prostate neoplasms diagnosis willing travel nih follow up visits
1, bi prostatic neoplasms castration resistant diagnosis patients small cell neuroendocrine tumours
0, antibodies monoclonal stage iv rectal cancer diagnosis laboratory values must be met pre surgery pre therapy
0, antibodies monoclonal localized non resectable adult liver carcinoma diagnosis two prior chemotherapy regimens
0, aldesleukin kidney cancer diagnosis renal
0, imatinib mesylate lung cancer diagnosis performance status
1, mycophenolic acid recurrent childhood large cell lymphoma diagnosis patients active bacterial fungal infections unresponsive medical therapy
0, deferasirox stage iv adult diffuse large cell lymphoma diagnosis iron score greater equal two
0, prednisolone multiple myeloma plasma cell neoplasm diagnosis evidence evolution aml refractory anemia excess blasts raeb raeb transformation
0, methotrexate diagnosis all fab lthree all burkitt leukemia lymphoma ll cell lymphoblastic lymphoma
0, dexamethasone must provide an archival tumor tissue sample tumor tissue from newly obtained core excisional biopsy from soft tissue if lesion is clinically accessible cohort soft tissue disease must provide core excisional biopsy from soft tissue lesion if clinically accessible within one year screening after developing mcrpc an archival specimen if available
0, vorinostat stage iii adult immunoblastic large cell lymphoma diagnosis hematopoietic growth factors colony stimulating factors treatment cytopenia may be permitted at discretion principal investigator
1, mycophenolate mofetil myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis performance status less eighty tju karnofsky patients greater sixty years old less seventy patients less sixty
1, bevacizumab stage ic fallopian tube cancer diagnosis patients may have minor surgical procedures mediport insertion fine needle aspiration core biopsies long it is performed greater seven days prior first date bevacizumab therapy there is no evidence wound disruption impaired healing
0, bortezomib recurrent mantle cell lymphoma diagnosis creatinine up including two mg dl
0, laboratory biomarker analysis primary peritoneal cavity cancer diagnosis no known brain metastases
1, trastuzumab stage iiia breast cancer diagnosis another anthracycline more one anthracycline used cumulative dose exceeding equivalent doxorubicin five hundred mg two
1, antibodies fallopian tube serous adenocarcinoma diagnosis congestive heart failure requiring use ongoing maintenance therapy life threatening ventricular arrhythmias
0, camptothecin recurrent squamous cell carcinoma larynx diagnosis patients must not have nasopharyngeal subtypes who ii iii
1, alovudine clear cell renal cell carcinoma diagnosis patients any following conditions excluded
0, deoxyglucose stage ib cervical cancer diagnosis platelet count greater one hundred zero mmÂ³
1, diphosphonates multiple myeloma stage diagnosis previous treatment bisphosphonates
1, paclitaxel triple negative breast carcinoma diagnosis history idiopathic pulmonary fibrosis pneumonitis including drug induced organizing pneumonia evidence active pneumonitis on screening chest computed tomography ct scan history radiation pneumonitis radiation field fibrosis is permitted
0, rituximab recurrent adult lymphoblastic lymphoma diagnosis ecog zero one
0, sorafenib stage ivc squamous cell carcinoma paranasal sinus nasal cavity diagnosis ability understand willingness sign written informed consent document
0, succinylcholine head neck squamous cell carcinoma diagnosis women childbearing potential wocbp male patients wocbp partner must be using an adequate method contraception avoid pregnancy throughout up twelve weeks after last dose investigational product such manner that risk pregnancy is minimized wocbp include any female who has experienced menarche who has not undergone successful surgical sterilization hysterectomy bilateral tubal ligation bilateral oophorectomy is not postmenopausal post menopause is defined as
1, irinotecan receiving any other investigational agent which would be considered treatment primary neoplasm
1, ly ovarian cancer diagnosis pregnant lactating
1, bevacizumab colorectal cancer diagnosis known positivity human immunodeficiency virus hiv
0, rituximab lymphoma non hodgkin nhl diagnosis human immunodeficiency virus hiv negative
0, fludarabine phosphate recurrent adult lymphoblastic lymphoma diagnosis patients must have an eastern cooperative oncology group ecog performance status equal less two
0, levoleucovorin pancreatic cancer diagnosis surgery
1, cabozantinib s malate stage ii thyroid gland papillary carcinoma diagnosis active peptic ulcer disease evidenced by esophagogastroduodenoscopy egd
1, estradiol breast cancer diagnosis myocardial infarction within last three months
1, fludarabine phosphate recurrent adult diffuse mixed cell lymphoma diagnosis liver alkaline phosphatase greater equal three upper limit normal
0, dexamethasone multiple myeloma diagnosis performance status greater equal two per swog scale
1, mycophenolic acid stage childhood lymphoblastic lymphoma diagnosis diffusion capacity carbon monoxide dlco less forty total lung capacity tlc less forty forced expiratory volume one second fevone less forty receiving supplementary continuous oxygen
1, capecitabine prior radiotherapy region cancer that would result overlap radiation therapy fields
1, mycophenolate mofetil mantle cell lymphoma diagnosis females childbearing potential must have blood test urine within fourteen days prior registration rule out pregnancy
0, erlotinib hydrochloride wilms tumor diagnosis patients must not have received myelosuppressive chemotherapy within two weeks enrollment onto this six weeks if prior nitrosourea
0, cisplatin gastric adenocarcinoma including adenocarcinoma esophagogastric junction histologically proven
1, megestrol acetate recurrent breast cancer diagnosis patients an active bleeding diathesis
0, physical therapy psychosocial effects cancer its treatment diagnosis not specified
1, carboplatin recurrent vaginal cancer diagnosis active unstable cardiovascular disease cardiac disease requiring drug device intervention history coronary artery disease congestive heart failure
1, exemestane breast cancer diagnosis patients who less twenty one days after their most recent chemotherapy have not recovered from side effects
1, everolimus recurrent verrucous carcinoma oral cavity diagnosis patients known multiple sclerosis
1, fludarabine phosphate recurrent childhood grade iii lymphomatoid granulomatosis diagnosis patient is female who is pregnant breastfeeding
0, prednisone lymphoma diagnosis however this protocol uses former terminology
1, cyclosporins contiguous stage ii adult diffuse large cell lymphoma diagnosis unable provide informed consent
0, antibodies monoclonal recurrent squamous cell carcinoma larynx diagnosis no concurrent warfarin heparin including low molecular weight heparin
0, epirubicin hertwo positive breast cancer diagnosis other tests may be performed clinically indicated
0, prednisone small intestine cancer diagnosis no other concurrent chemotherapy
1, antibodies monoclonal metastatic melanoma diagnosis patients absolute lymphocyte count less five hundred cells microliter who known be hiv positive who have clinically significant active autoimmune disease receiving immunosuppression following solid organ stem cell transplant
0, cyclosporine recurrent adult lymphoblastic lymphoma diagnosis any phase mds if patient is less twenty one years age
1, controlled ovarian hyperstimulation coh breast cancer diagnosis hysterectomy
0, cabozantinib s malate stage ii thyroid gland follicular carcinoma diagnosis prior external beam radiation systemic cytotoxic chemotherapy bra negative non vegfr targeted therapies will be allowed provided that greater equal four weeks has elapsed since receiving prior treatment they have recovered equal less grade one treatment related toxicities
0, cyclophosphamide breast cancer diagnosis have at least one target lesion according recist criteria
1, melphalan metastatic cancer diagnosis pregnant positive human chorionic gonadotropin hcg test lactating
1, zoledronic acid symptomatic bulky lymphadenopathy causing scrotal pedal edema significant local invasive disease bladder invasion
1, immunoglobulins recurrent digestive system neuroendocrine tumor gone diagnosis clinical signs symptoms gastrointestinal gi obstruction require parental hydration nutrition tube feeding
1, liposomal doxorubicin breast cancer diagnosis patients who medically unstable including but not limited active infection acute hepatitis deep vein thrombosis requiring anticoagulant therapy gastrointestinal bleeding uncontrolled hypercalcemia uncontrolled diabetes dementia seizures superior vena cava syndrome patients whose circumstances not permit completion required follow up
1, blood collection colorectal neoplasms diagnosis multiple diseases
0, thalidomide recurrent adult cell leukemia lymphoma diagnosis baseline qtcf interval greater five hundred msec absence correctable electrolyte imbalance any patient congenital history qtc prolongation
1, ace mg carcinoma non small cell lung diagnosis received treatment another investigational drug device within twenty eight days prior day one if half life previous product is known within five times half life prior dosing whichever may be longer
0, estrogens breast cancer diagnosis patient completed any prior radiotherapy greater two weeks prior receiving first dose treatment has recovered from any radiation related toxicity
0, diindolylmethane adenocarcinoma prostate diagnosis disease is confined within prostate gland
1, fludarabine phosphate recurrent childhood hodgkin lymphoma diagnosis donor
0, belinostat recurrent adult burkitt lymphoma diagnosis fertile patients must use effective contraception
1, mycophenolic acid stage iv grade three follicular lymphoma diagnosis human immunodeficiency virus hiv positive patients
1, sirolimus diffuse large cell lymphoma diagnosis cardiac ejection fraction less thirty five if unable obtain ejection fraction shortening fraction less twenty six ejection fraction is required if age greater fifty years there is history anthracycline exposure history cardiac disease patients shortening fraction less twenty six may be enrolled if approved by cardiologist
0, gemcitabine bladder cancer diagnosis renal
1, melphalan retinoblastoma diagnosis pregnant breastfeeding
1, modafinil lung cancer diagnosis patients who pregnant
0, albumin bound paclitaxel undifferentiated ovarian carcinoma diagnosis abnormal cardiac conduction bundle branch block heart block that has been stable past six months allowed
0, irinotecan colorectal neoplasms diagnosis men women all races ethnic groups eligible this trial
0, toga tools pleural neoplasms diagnosis residents nursing homes assisted living facilities will be eligible this if they thought be appropriate surgical candidates
1, thalidomide recurrent adult immunoblastic large cell lymphoma diagnosis known hypersensitivity thalidomide
1, poly adp ribose polymerase inhibitors medulloblastoma diagnosis patients an inability return follow up visits obtain follow up studies required assess toxicity therapy
0, prednisone recurrent prostate cancer diagnosis no significant cardiovascular disease including any following
0, fludarabine stage iv melanoma diagnosis patients history ekg abnormalities symptoms cardiac ischemia arrhythmias must have normal cardiac stress test lvef greater forty five
0, vaccines sarcomas diagnosis patient guardian given copy informed consent
0, immunoglobulins myelodysplastic myeloproliferative neoplasms diagnosis lvef greater forty
0, fludarabine multiple myeloma plasma cell neoplasm diagnosis ast less three times uln
0, topotecan primary peritoneal carcinoma diagnosis gog zero one
0, selumetinib plexiform neurofibroma diagnosis alanine aminotransferase alt serum glutamate pyruvate transaminase sgpt aspartate aminotransferase ast serum glutamic oxaloacetic transaminase sgot equal less doc uln
1, prednisolone phosphate mediastinal thymic large cell lymphoma diagnosis immunized hbsag anti hbc antibody positive
1, fluorouracil gastric cancer diagnosis patients history severe hypersensitivity reaction taxotere other drugs formulated polysorbate eighty
1, carboplatin non small cell lung cancer diagnosis biological immunotherapies
0, busulfan rhabdomyosarcoma diagnosis metastatic at time diagnosis relapsed after therapy
0, antibodies stage iii colon cancer diagnosis irinotecan hydrochloride oxaliplatin
1, hiv protease inhibitors resectable pancreatic cancer diagnosis antimycobacterial
0, bibw neoplasms diagnosis good clinical practice ich gcp guidelines
1, biological sample carcinoma diagnosis under eighteen years old
0, methotrexate burkitt lymphoma diagnosis donor
1, aldesleukin penile cancer diagnosis history severe immediate hypersensitivity reaction cyclophosphamide fludarabine
1, vorinostat stage iv small lymphocytic lymphoma diagnosis patients who have undergone treatment either stem cell bone marrow transplant
1, carboplatin previous anticancer therapy radiation therapy chemotherapy other use corticosteroids
1, mitogens stage ii multiple myeloma diagnosis presence generalized rash involving more fifty body surface
0, buparlisib bkm primary central nervous system lymphoma diagnosis subjects must be at least eighteen years age on day consenting study
0, quality life assessment cancer survivor diagnosis prior concurrent therapy
0, docetaxel stage ic uterine sarcoma diagnosis patients must be entered no more twelve weeks post operatively
1, doxorubicin sarcoma diagnosis uncontrolled brain metastases
1, albumin bound paclitaxel ovarian cancer diagnosis history abdominal fistula gastrointestinal perforation intra abdominal abscess current signs symptoms bowel obstruction current dependency on iv hydration tpn
1, histone deacetylase inhibitors recurrent colon cancer diagnosis pregnant breast feeding patients reproductive potential not using two effective methods birth control women childbearing potential wocbp must have negative serum pregnancy test within seven days first administration oral lbhfive hundred eighty nine
1, antibodies monoclonal primary diagnosis lymphoma central nervous system cns malignancy
0, everolimus brain central nervous system tumors diagnosis ast less doc uln
1, cyclosporins stage marginal zone lymphoma diagnosis donor
0, radiation therapy untreated childhood anaplastic oligodendroglioma diagnosis enrollment must be no later twenty eight days after date radiographic diagnosis surgery whichever is later date
0, levoleucovorin recurrent rectal cancer diagnosis no prior myocardial infarction
0, hpph head neck cancer diagnosis biopsy confirmed diagnosis one following
0, cisplatin adenocarcinoma diagnosis adequate liver function evidenced by bilirubin less doc laboratory upper limit normal uln alt ast less three laboratory uln if no liver involvement alt ast less five times laboratory uln liver involvement
0, olaparib hrpos breast neoplasms diagnosis case inflammatory disease extent inflammation can be used measurable lesion
1, liposomal doxorubicin stage iiib uterine corpus cancer diagnosis patients whose circumstances will not permit completion adequate follow up
1, cadexomer iodine lymphoma large cell follicular diagnosis known brain leptomeningeal metastases
1, epirubicin breast cancer diagnosis myocardial infarction documented by elevated cardiac enzymes persistent regional wall abnormalities on assessment lv function history documented chf documented cardiomyopathy
0, sunitinib meningioma diagnosis hemoglobin greater eightgm dl
1, fluorouracil prior radiation therapy breast cancer
0, sorafenib stage iv grade one follicular lymphoma diagnosis no treatment cytochrome pfour hundred fifty enzyme inducing antiepileptic drugs phenytoin carbamazepine phenobarbital rifampin st
0, ganciclovir stage iii grade three follicular lymphoma diagnosis organ function requirements
1, cixutumumab adult solid neoplasm diagnosis patient has active hepatitis on treatment
0, immunoglobulins male breast carcinoma diagnosis patients must have pretreatment multi gated acquisition muga scan echocardiogram left ventricular ejection fraction lvef above institutional lower limit normal
1, picture warning lung cancer diagnosis english not main language
0, gl onc fallopian tube cancer diagnosis one platinum resistant recurrence progression less six months two platinum refractory progression while on platinum based therapy patient must have failed either at least two consecutive therapies not eligible additional cytotoxic therapies
0, dna analysis precancerous condition diagnosis must have had receptive insertive anal intercourse another man within past six months
0, cisplatin gastric cancer diagnosis measurable disease according recist criteria
1, sirolimus stage iia ovarian cancer diagnosis known hepatitis hepatitis human immunodeficiency virus hiv
0, prednisone multiple myeloma diagnosis corrected serum calcium less fourteen mg dl doc mmol l
1, cyclosporine stage adult immunoblastic large cell lymphoma diagnosis diffusing capacity lung carbon monoxide dlco less forty receiving supplementary continuous oxygen
1, mitoxantrone recurrent childhood lymphoblastic lymphoma diagnosis at least seven days after last dose biologic agent agents that have known adverse events occurring beyond seven days after administration this period must be extended beyond time during which adverse events known occur duration this interval must be discussed chair
1, bb multiple myeloma diagnosis active prior malignancy diagnosed treated within last three years
1, gemcitabine urothelial cancer diagnosis has had nci ctcae version doc grade three four hemorrhage within four weeks starting treatment
1, vaccines astrocytoma diagnosis mild arthritis requiring nsaid medications will not be exclusionary
1, transoral robotic surgery stage iv squamous cell carcinoma oropharynx diagnosis presence medical conditions which contraindicate general anesthesia
0, antibodies monoclonal recurrent colon cancer diagnosis creatinine equal less doc mg dl creatinine clearance greater equal sixty ml min doc three two patients creatinine levels above institutional normal
0, immunoglobulins recurrent primary peritoneal carcinoma diagnosis platelets
0, radiofrequency ablation metastatic cancer diagnosis pain refractory non opioid analgesic medication radiotherapy or
1, temozolomide adult glioblastoma diagnosis acute bacterial fungal infection requiring intravenous antibiotics at time step two registration
1, prednisolone recurrent grade three follicular lymphoma diagnosis prior hematopoietic stem cell transplant autologous allogeneic
0, paclitaxel poliglumex fallopian tube cancer diagnosis no active uncontrolled infection
0, sirolimus prostate cancer diagnosis life expectancy at least three months
0, histone deacetylase inhibitors recurrent grade two follicular lymphoma diagnosis other concurrent chemotherapy immunotherapy radiotherapy any ancillary therapy considered investigational utilized non fda approved indication context research investigation patients should have recovered from any immunotherapy chemotherapy radiation therapy related toxicities
0, fludarabine phosphate kidney cancer diagnosis no history allergic reaction attributed compounds similar biological composition vaccine
1, rituximab grade threeb follicular lymphoma diagnosis participants viral hepatitis who not meet criteria will not be eligible all participants who present acute hepatitis including those normal transaminases who hbsag positive igm positive hepatitis core antigen will not be eligible participants who hepatitis core antibody positive eligible only if they start on prophylactic therapy hepatitis viral load should be confirmed negative on all participants who hepatitis core antibody positive participants refusing take any anti hepatitis therapy during will also be excluded participants diagnosed hepatitis eligible if they meet criteria
0, testosterone enanthate castration resistant metastatic prostate cancer diagnosis platelet count greater one hundred zero platelet mmthree one hundred one hundred nine l
1, prednisone diffuse large cell lymphoma diagnosis severe chronic obstructive pulmonary disease hypoxemia
1, albumin bound paclitaxel breast cancer diagnosis use any investigation agent within four weeks prior randomization
0, fludarabine contiguous stage ii grade one follicular lymphoma diagnosis hairy cell leukemia
1, thalidomide history prior malignancy within last five years exception curatively treated basal squamous cell carcinoma skin low grade situ carcinoma cervix
1, ifosfamide atypical fibroxanthoma diagnosis prior therapy
0, quality life assessment stage ii breast cancer diagnosis hormone receptor status
1, lanreotide diagnosis any second malignancy within last five years except adequately treated basal cell squamous cell skin cancer situ carcinoma cervix uteri
1, lapatinib carcinoma small cell lung diagnosis uncontrolled hypertension bp greater equal one hundred fifty ninety five despite optimal therapy
1, carboxymethylcellulose sodium stage iiia skin melanoma diagnosis congestive heart failure new york heart association class iii iv active angina pectoris recent myocardial infarction within last six months
0, rituximab b cell lymphoma diagnosis signed inform consent
1, pyridoxal cancer related fatigue diagnosis tuberculosis
0, everolimus stage ivc nasal cavity paranasal sinus squamous cell carcinoma diagnosis platelets greater equal one hundred zero mcl
0, cisplatin stage iiib fallopian tube cancer diagnosis serum glutamic oxaloacetic transaminase sgot serum glutamate pyruvate transaminase sgpt less doc institutional upper limit normal uln
1, bevacizumab epithelial ovarian cancer diagnosis patients who have received prior therapy any anti vegf drug including bevacizumab
0, carboplatin ovarian cancer diagnosis ecog zero two
0, topotecan cancer diagnosis adult patients at least eighteen years old
0, tacrolimus recurrent grade three follicular lymphoma diagnosis any one following symptoms
0, immunoglobulins stage ib hodgkin lymphoma diagnosis previously untreated either chemotherapy radiation therapy either brentuximab vedotin nivolumab another check point inhibitor
1, antibodies monoclonal recurrent metastatic squamous neck cancer occult primary diagnosis patients untreated brain metastases excluded however patients treated brain metastases eligible if they greater four weeks from therapy completion including radiation surgery clinically stable at time entry not receiving corticosteroid therapy at time entry
1, aldesleukin solid tumors diagnosis currently being treated bronchodilators corticosteroids
1, bortezomib diffuse large cell lymphoma recurrent diagnosis uncontrolled severe cardiovascular disease including myocardial infarction within six months enrollment new york heart association nyha class iii iv heart failure uncontrolled angina clinically significant pericardial disease cardiac amyloidosis
1, sirolimus recurrent childhood burkitt lymphoma diagnosis donor
1, trastuzumab non small cell lung cancer diagnosis investigational therapy participation another clinical therapeutic intent less equal twenty one days before first treatment
1, cisplatin cervical cancer diagnosis uncontrolled cardiac disease defined cardiac function which would preclude hydration during cisplatin administration any contraindication paclitaxel
0, crizotinib adenocarcinoma lung diagnosis anc greater equal one five hundred ul
1, bb refractory multiple myeloma diagnosis subjects who have received greater three hundred mg mtwo lifetime cumulative dose doxorubicin alone doxil alone doxorubicin plus doxil
0, carboplatin ovarian cancer diagnosis acceptable liver renal bone marrow function including following
0, fludarabine not requiring pressor support no symptomatic cardiac arrhythmias no acute coronary syndrome uncontrolled hypertension
1, thalidomide multiple myeloma diagnosis any serious underlying medical condition at judgment investigator which could impair ability patient participate trial active autoimmune disease uncontrolled diabetes
1, ferrosoferric oxide neuroendocrine neoplasm diagnosis patients who receiving any other investigational agents
1, etoposide phosphate myeloid sarcoma diagnosis patients constitutional trisomy twenty one constitutional mosaicism trisomy twenty one note
0, camptothecin stage iv verrucous carcinoma oral cavity diagnosis negative pregnancy test
0, tacrolimus lymphoma diagnosis creatinine clearance greater sixty ml min
1, organic germanium localized breast cancer diagnosis current history uncontrolled hypertension insulin dependent uncontrolled diabetes cardiovascular disease unless controlled stable six months more bleeding disorders autoimmune disorders such fibromyalgia chronic fatigue syndrome lupus
1, dexamethasone phosphate concurrent treatment other chemotherapy anti lymphoma therapy including corticosteroids unless on stable dose corticosteroids less equivalent twenty mg prednisone each day treatment disease not related lymphoma
0, hipec ovarian epithelial cancer recurrent diagnosis age over eighteen under seventy years
0, rituximab lymphoma large cell diffuse diagnosis absolute neutrophil count anc greater doc one hundred nine without growth factor support seven days fourteen days if subject received pegfilgrastim
0, antibodies stage iiic ovarian cancer diagnosis granulocytes greater equal one zero mm three
0, immunoglobulins adult oligodendroglioma diagnosis not pregnant nursing
0, paclitaxel non small cell lung cancer diagnosis female subjects must be postmenopausal surgically sterile using effective contraception
0, disulfiram stage iv pancreatic cancer diagnosis withdrawal
0, gemcitabine pancreatic neoplasms diagnosis have given written informed consent prior any specific procedures
1, octreotide paraganglioma diagnosis ongoing active infection requiring parenteral therapy at time registration
1, gemcitabine non small cell lung cancer diagnosis known alcohol drug abuse
1, mycophenolic acid adult diffuse large cell lymphoma diagnosis patients who homozygous at mismatched hla class locus ii locus donor is excluded if homozygous at mismatched locus patient is homozygous one
0, cancer prevention intervention recurrent mantle cell lymphoma diagnosis creatinine no greater doc mg dl
1, cyclosporine contiguous stage ii mantle cell lymphoma diagnosis patients evidence hepatitis hepatitis pcr positivity hepatitis reactivation following myelosuppressive therapy can lead fatal complications
0, radiation protons brain tumors diagnosis indication high dose except group four radiotherapy radiochemotherapy
0, proton radiation therapy myoepithelial carcinoma diagnosis nasal endoscopy within twenty eight days prior entry ct chest within sixty days prior entry
1, immunoglobulins recurrent colon cancer diagnosis patients on potent cypthreeafour inducers inhibitors
1, isotretinoin other concurrent anticancer therapy
0, aromatase inhibitors metastatic carcinoma diagnosis any haemopoietic growth factors filgrastim granulocyte colony stimulating factor csf sargramostim granulocyte macrophage colony stimulating factor gm csf
0, paclitaxel stage iia breast cancer diagnosis patients alkaline phosphatase that is greater uln but equal less doc uln unexplained bone pain eligible inclusion if bone scan pet ct scan pet scan performed within ninety days prior randomization does not demonstrate metastatic disease
0, fludarabine myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis mds lower ipss score int one less severe clinical features such severe neutropenia thrombocytopenia high risk chromosome abnormalities such monosomy seven
1, cisplatin concurrent hormonal cancer therapy
1, tivozanib av carcinoma renal cell diagnosis creatinine greater doc uln calculated clcr less fifty ml min doc three mtwo
1, n monoacetylcystine stage iii lymphoepithelioma oropharynx diagnosis greater equal grade two dry mouth prior chemoradiotherapy greater equal grade two mucositis
1, antibodies stage iiic rectal cancer diagnosis patients significant neuropathy greater grade two not controlled despite medications
1, capecitabine stage ia breast cancer diagnosis current use digitalis beta blockers congestive heart failure chf
0, fludarabine phosphate recurrent adult diffuse large cell lymphoma diagnosis must be refractory fludarabine patients who fail have complete partial response after therapy regimen containing fludarabine another nucleoside analog two cladribine cda pentostatin experience disease relapse within two months after completing therapy regimen containing fludarabine another nucleoside analog
0, paclitaxel melanoma skin diagnosis urine protein
1, mk neoplasms diagnosis participant has known hypersensitivity components drug its analogs
0, carboplatin untreated childhood medulloblastoma diagnosis isotretinoin is contraindicated patients parabens allergy patients soybean allergy concurrent use tetracyclines should be avoided intake vitamin should be limited duration isotretinoin treatment
1, mri guided transurethral ultrasound ablation prostate cancer diagnosis patients that have had curative treatment previous malignancy no recurrence that malignancy within past two years will be allowed
0, nicotine prostate cancer diagnosis life expectancy
1, erlotinib hydrochloride pancreatic cancer diagnosis patient must demonstrate post operative performance status zero one
0, fludarabine phosphate testicular lymphoma diagnosis bone marrow will be collected from donors less twelve years age
0, antibodies monoclonal stage iii lymphoepithelioma nasopharynx diagnosis not pregnant nursing
0, sirolimus anaplastic oligoastrocytoma diagnosis prothrombin time pt international normalized ratio inr equal less doc uln patients receiving anticoagulation therapy pt inr equal less three
0, carmustine glioblastoma diagnosis must have biopsy proven gbm
1, paclitaxel recurrent breast cancer diagnosis baseline qtc greater four hundred seventy msec average triplicate ecg recordings consistent method qtc calculation must be used each patient qtc measurements
1, cyclosporins recurrent childhood anaplastic large cell lymphoma diagnosis donor
1, mick assay ovarian neoplasms diagnosis women child bearing potential defined include any female who has experienced menarche has not undergone successful surgical sterilization hysterectomy bilateral tubal ligation bilateral oophorectomy is not post menopausal defined amenorrhea more twelve consecutive months these includes also females using oral implanted injectable contraceptive hormones mechanical devices barrier methods prevent pregnancy
0, irradiated haploidentical allogeneic lymphocytes multiple myeloma plasma cell neoplasm diagnosis fludarabine resistant chronic lymphocytic leukemia
0, tacrolimus recurrent adult lymphoblastic lymphoma diagnosis not pregnant lactating
0, calcium dietary stage ii colon cancer diagnosis patients eligible if adjacent structures bladder small intestine ovary etc
0, prednisone lymphoma hodgkin diagnosis no lymph node mass more ten cm greatest transaxial diameter
1, oxaliplatin pancreatic cancer diagnosis subjects who require chronic systemic corticosteroids after beginning treatment will be removed from study
0, osimertinib lung adenocarcinoma diagnosis inclusion subjects should fulfill following criteria
1, heparin low molecular weight cancer diagnosis severe arterial hypertension systolic blood pressure over two hundred mmhg diastolic blood pressure over one hundred twenty mmhg
1, cytology specimen collection procedure a second active malignancy except adequately treated non melanoma skin cancer other non invasive situ neoplasm
1, paclitaxel lung cancer diagnosis therapeutic anticoagulation warfarin heparins heparinoids
1, nov poziotinib adenocarcinoma lung stage iv diagnosis patients who received other investigational products except gefitinib erlotinib within four weeks before participation
0, veliparib astrocytoma diagnosis stem cell transplant
0, biopsy stage iv skin melanoma diagnosis total bilirubin less equal twenty micromol except patients gilbert syndrome who must have total bilirubin less fifty micromol l
0, cyclosporine contiguous stage ii adult diffuse mixed cell lymphoma diagnosis eligible after initial therapy greater equal crone greater equal prone
1, anlotinib non small cell lung cancer diagnosis brain metastases patients accompanied by symptoms symptom control less two months
1, mitogens pancreatic cancer diagnosis pregnant lactating patient
0, gemcitabine breast cancer diagnosis no metastatic disease
0, oxaliplatin colorectal cancer diagnosis not pregnant nursing
0, antibodies monoclonal adult gliosarcoma diagnosis new york heart association class ii iv congestive heart failure requiring hospitalization within past twelve months
1, alemtuzumab stage iii childhood large cell lymphoma diagnosis positive cross match exists between donor recipient
0, cyclophosphamide inflammatory breast cancer diagnosis no dermal lymphatic involvement clinical inflammatory changes
1, cetuximab stage iv salivary gland cancer diagnosis previous current uveitis
0, methylprednisolone hemisuccinate lymphoma diagnosis transfusion dependent refractory anemia ra ra excess blasts raeb raeb transformation chronic myelomonocytic leukemia cmml
1, antibodies monoclonal recurrent childhood anaplastic large cell lymphoma diagnosis central nervous system cns involvement disease refractory intrathecal chemotherapy
0, vatalanib brain central nervous system tumors diagnosis serious uncontrolled cardiac arrhythmia
1, testosterone undecanoate prostate cancer diagnosis calcium greater eleven mg dl
1, vidarabine recurrent adult burkitt lymphoma diagnosis kidneys twelve gy
1, fludarabine stage iii childhood large cell lymphoma diagnosis current serious systemic illness that would result increased risk csf mobilization harvest peripheral blood stem cells pbsc
0, antibodies breast neoplasm diagnosis age greater equal eighteen years
0, capecitabine stage iiib breast cancer diagnosis patients regular menses
0, antibodies monoclonal metastatic malignant neoplasm lymph nodes diagnosis history myocardial infarction within twelve months patients history myocardial infarction within six months excluded
1, gemcitabine metastatic pancreatic adenocarcinoma diagnosis pregnant women
1, cetuximab larynx carcinoma diagnosis karnofsky performance status less seventy
0, topotecan retinoblastoma diagnosis prior concurrent therapy
1, immunoglobulins cutaneous cell non hodgkin lymphoma diagnosis urine protein should be screened by dipstick urine analysis proteinuria greater one positive urine protein
1, hydroxystaurosporine extensive stage small cell lung cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition ucn one other agents used study
0, pharmacological stage iii verrucous carcinoma larynx diagnosis more six months
0, sirolimus stage iv breast cancer diagnosis serum bilirubin equal less doc upper limit normal uln equal less doc if gilbert syndrome
1, tacrolimus recurrent adult diffuse small cleaved cell lymphoma diagnosis infection hiv
1, angiogenesis inhibitors glioblastoma diagnosis note
1, carboplatin stage ivb vulvar cancer diagnosis any other major illness which investigator judgment will substantially increase risk associated patient participation this study
1, nintedanib ovarian clear cell carcinoma diagnosis patients preserved reproductive capacity must have negative pregnancy test hcg test urine serum prior commencing treatment
1, vinorelbine cervical cancer recurrent persistent diagnosis social family geographic conditions that suggest poor compliance
0, low let electron therapy breast cancer diagnosis not specified
1, placebo stage zero paranasal sinus nasal cavity cancer diagnosis although there no known adverse effects black raspberries upon fetus if patients become pregnant during period lyophilized black raspberries lbr administration then lbr will be discontinued patient will be removed from we should however emphasize given this is food based that risks likely extremely low even though participant should become pregnant such we not recommending active contraception women but rather if participants become pregnant that they notify their doctor that they will likely be removed from there no expected logical risks if men were father child such no contraception will be recommended men
1, gemcitabine stage iia pancreatic cancer diagnosis dihydroergotamine ergonovine ergotamine methylergonovine
0, laboratory biomarker analysis recurrent bladder cancer diagnosis creatinine clearance greater equal thirty ml min
0, cyclophosphamide neuroblastoma diagnosis one hundred zero ul transfusion independent no platelet transfusions within seven days blood draw documenting eligibility
1, methylprednisolone hemisuccinate prostate cancer diagnosis hemoglobin less one doc dl
0, carboplatin stage childhood liver cancer diagnosis measurable metastatic disease lungs other organs
1, antibodies ovarian cancer diagnosis previous chemotherapy disease under study
1, docetaxel breast cancer diagnosis ongoing radiation induced diarrhea constipation planned radiotherapy abdomen pelvis while on study
1, melphalan refractory diffuse large cell lymphoma diagnosis bilirubin greater doc mg dl transaminases greater three times upper normal limit
0, dexamethasone acetate prostate cancer diagnosis hepatic
0, levoleucovorin colorectal cancer diagnosis no known gilbert syndrome
0, selenium bladder cancer diagnosis gthree pta
0, triapine unspecified adult solid tumor protocol specific diagnosis not specified radiotherapy
0, irinotecan diffuse adenocarcinoma stomach diagnosis no bone fracture
1, trifluridine advanced solid tumors diagnosis known sensitivity tas one hundred two its components
0, immunoglobulins recurrent grade two follicular lymphoma diagnosis history repeated clinically relevant episodes syncope other paroxysmal ventricular other significant arrhythmias
1, gemcitabine renal pelvis cancer diagnosis patients unwilling unable comply protocol
1, rituximab refractory mantle cell lymphoma diagnosis patients known brain metastases should be excluded from this clinical trial
1, gemcitabine subject has received any anti cancer therapy including chemotherapy immunotherapy radiotherapy biologic any investigational therapy within twenty eight days prior administration
1, camptothecin prior radio therapy colorectal cancer
1, e cancer malignant tumors diagnosis patients history uncontrolled seizures
1, heat killed whole cell m obuense imm mg melanoma diagnosis concurrent uses drugs likely reduce inflammation at local injection site dampen modulate immune system
1, rituximab contiguous stage ii marginal zone lymphoma diagnosis prior use lenalidomide either concurrently rituximab within eight weeks following dose rituximab
0, vaccines melanoma skin diagnosis no prior preoperative infusion perfusion therapy
0, busulfan recurrent grade three follicular lymphoma diagnosis patients aml all cml scheduled reduced intensity conditioning non myeloablative conditioning should be complete morphologic remission at start conditioning residual disease by flow cytometry cytogenetics incomplete recovery neutrophil platelet count acceptable
1, fluorine f d fmau recurrent prostate cancer diagnosis subject has received prior treatment small molecule kinase inhibitor hormonal therapy including investigational kinase inhibitors hormones within fourteen days five half lives compound active metabolites whichever is longer before first dose treatment patients receiving lhrh gonadotropin releasing hormone gnrh agonists maintain castrate levels testosterone patients on bisphosphonate denosumab may be maintained on these agents
1, medical imaging cancer diagnosis comorbidity may increase risk death during course trial
1, pembrolizumab stage iv follicular lymphoma diagnosis has known history human immunodeficiency virus hiv hiv one two antibodies
0, fludarabine phosphate stage iv adult immunoblastic large cell lymphoma diagnosis left ventricular ejection fraction greater equal forty five shortening fraction greater twenty six
0, busulfan recurrent cutaneous cell non hodgkin lymphoma diagnosis acute myeloid leukemia aml
0, albumin bound paclitaxel unresectable melanoma diagnosis is post menopausal
0, sunitinib recurrent small lymphocytic lymphoma diagnosis sotalol
1, vinorelbine metastatic breast cancer diagnosis prior doxil vinorelbine
0, paclitaxel cervical cancer diagnosis biologic therapy
1, mitogens stage iv adult diffuse small cleaved cell lymphoma diagnosis prior diagnosis chronic gvhd requiring systemic immunosuppressive treatment
0, camptothecin colorectal cancer diagnosis ecog zero two
0, bces week program one diagnosis stage ii iii breast cancer
0, pentamidine pancreatic cancer diagnosis normal ecg
0, vidarabine recurrent adult lymphoblastic lymphoma diagnosis human leukocyte antigen hla genotypically phenotypically identical related donor
0, etoposide refractory mature cell non hodgkin lymphoma diagnosis creatinine cr less doc
0, dexamethasone acetate plasma cell neoplasm diagnosis hepatic
0, liposomal doxorubicin her two positive breast cancer diagnosis eastern cooperative oncology group ecog performance status zero one
1, ots po relapsed refractory locally advanced metastatic breast cancer triple negative breast cancer diagnosis patients may have received red blood cell product transfusion prior if clinically warranted
1, liposomal doxorubicin breast cancer diagnosis pregnancy lactation
1, vorinostat breast cancer diagnosis patients stable brain metastases will need an mri within four weeks prior start therapy
0, topotecan ovarian cancer diagnosis renal
1, antibodies monoclonal urothelial carcinoma diagnosis any other diseases metabolic dysfunction physical examination finding clinical laboratory finding giving reasonable suspicion disease condition that contraindicates use an investigational drug that may affect interpretation results render patient at high risk from treatment complications
0, vincristine multiple myeloma plasma cell neoplasm diagnosis see disease characteristics
0, follow up diagnosed prostate cancer on before december thirty one two thousand three
1, vaccines ovarian cancer diagnosis patients should have no evidence being immunocompromised listed below
1, modafinil psychosocial effects cancer its treatment diagnosis john wort phenytoin phenobarbital diazepam tricyclic antidepressants
0, endothelial growth factors malignant ovarian mixed epithelial tumor diagnosis primary surgery patients
0, antibodies monoclonal recurrent colon cancer diagnosis at least twenty eight days since prior radiotherapy recovered
1, trastuzumab breast cancer diagnosis pertuzumab less twenty one days prior first dose treatment
0, rituximab breast neoplasms diagnosis must not have any coexisting medical psychiatric condition that is likely interfere procedures results
1, cisplatin stage ii bladder urothelial carcinoma diagnosis any following
1, bay neoplasms diagnosis pre existing cataract is not an exclusion criterion
1, vincristine stage iii adult hodgkin lymphoma diagnosis chronic current infectious disease requiring systemic antibiotics antifungal antiviral treatment such but not limited chronic renal infection chronic chest infection bronchiectasis tuberculosis active hepatitis c
1, lenalidomide intraocular lymphoma diagnosis receiving any medications that prolong corrected qt qtc have known risk torsades de pointes note
0, carboplatin stage iva uterine sarcoma diagnosis written voluntary informed consent
1, paclitaxel lung neoplasm diagnosis all treatment which should have been completed six months prior signing informed consent form
1, melphalan multiple myeloma diagnosis corrected carbon dioxide diffusing capacity dlco greater equal forty on pulmonary function tests
1, pancrelipase pancreas cancer diagnosis patients history pulmonary embolism untreated deep vein thrombosis within past six months
1, poly i c melanoma diagnosis participants an active autoimmune disorder requiring these therapies also excluded
1, cisplatin epithelial ovarian cancer diagnosis unstable angina within twelve months before screening
1, paclitaxel prior malignancy within past five years except adequately treated basal cell squamous cell skin cancer carcinoma situ cervix
0, regn lymphoma diagnosis willing able comply clinic visits related procedures
1, biliary stent hepatocellular carcinoma diagnosis eastern cooperative oncology group performance status four
1, asn ascending doses colorectal neoplasm diagnosis have received prior treatment monoclonal antibodies within six weeks first dose day one
0, plitidepsin adult patients unresectable locally advanced metastatic relapsed refractory dedifferentiated liposarcoma diagnosis creatine phosphokinase cpk less doc uln
1, sirolimus breast cancer diagnosis patients known chronic liver diseases chronic active hepatitis cirrhosis
0, alvespimycin hydrochloride stage iii renal cell cancer diagnosis naringenin
1, camptothecin stage iiia colon cancer diagnosis unstable angina pectoris
0, fludarabine childhood diffuse large cell lymphoma diagnosis any single serologically detectable hla or antigen positive
0, bortezomib small intestine lymphoma diagnosis male subject agrees use an acceptable method contraception duration study
1, etoposide phosphate recurrent adult hodgkin lymphoma diagnosis participants who receiving any other investigational agents
0, glucuronyl glucosamine glycan sulfate hepatocellular carcinoma diagnosis age greater eighteen years old able consent
0, vaccines glioblastoma multiforme diagnosis no chemotherapy investigational agent at least three weeks prior start sl seven hundred one at least six weeks elapsed time from last dose nitrosoureas
1, mycophenolate mofetil recurrent childhood small noncleaved cell lymphoma diagnosis donor
1, etoposide glioma diagnosis subjects rapidly progressing central nervous system cns disease associated neurological deterioration
1, thalidomide stage iii enteropathy associated cell lymphoma diagnosis known seropositive active viral infection human immunodeficiency virus hiv hepatitis virus hbv hepatitis virus hcv patients who seropositive because hepatitis virus vaccine eligible
0, vinblastine lymphoma diagnosis at least two weeks since prior chemotherapy three weeks nitrosoureas recovered
0, cisplatin lung cancer diagnosis not specified
1, cisplatin stage iib ovarian cancer diagnosis patients serious non healing wound ulcer bone fracture this includes history abdominal fistula gastrointestinal perforation intra abdominal abscess within twenty eight days patients granulating incisions healing by secondary intention no evidence fascial dehiscence infection eligible but require weekly wound examinations
1, melphalan stage iv small lymphocytic lymphoma diagnosis patients who opinion treating physician unlikely comply restrictions allogeneic stem cell transplantation based on formal psychosocial screening
0, celecoxib colorectal neoplasms diagnosis clinical stage ttwo none two tthree four nzero two patients who require diverting loop colostomy eligible
0, vaccines lymphoma diagnosis karnofsky seventy one hundred
1, capecitabine cancer diagnosis patients prior treatment regorafenib excluded from entering expanded cohort
0, enzalutamide if no tumor samples available participant might still be eligible following discussion between investigator medical monitor
0, antibodies primary peritoneal cavity cancer diagnosis creatinine less doc times uln
0, deoxyglucose breast cancer diagnosis measurable nonmeasurable disease by recist criteria
1, bortezomib multiple myeloma diagnosis screening twelve lead ecg measurable qtc interval according fridericia correction greater four hundred fifty msecs
1, doxorubicin breast cancer diagnosis excisional biopsy lumpectomy performed prior randomization
1, laboratory biomarker analysis recurrent squamous cell carcinoma oropharynx diagnosis antibiotics
0, antibodies monoclonal plasmablastic lymphoma diagnosis calculated creatinine clearance greater equal thirty ml min
1, cyclophosphamide multiple myeloma diagnosis radiation therapy within two weeks prior first dose
0, immunoglobulins stage ia breast cancer diagnosis patients must not have hypersensitivity paclitaxel drugs using vehicle cremophor chinese hamster ovary cell products other recombinant human antibodies
1, prednisolone phosphate non hodgkin lymphoma diagnosis positive hbsag
1, erlotinib hydrochloride non small cell lung carcinoma diagnosis ww rizonacer rg medical pros drug lists drug list tm
0, lenalidomide noncontiguous stage ii small lymphocytic lymphoma diagnosis previously untreated disease refuse ineligible approved chem negative immunotherapy options untreated cll sll pll
1, fluorouracil colorectal tumors diagnosis systemic metastases liver lung
0, dalteparin pancreatic cancer diagnosis disease characteristics
1, liposomal doxorubicin high grade ovarian serous adenocarcinoma diagnosis known clinically significant liver disease including active viral alcoholic other hepatitis cirrhosis fatty liver inherited liver disease
1, fludarabine solid tumors diagnosis history hypersensitivity reaction drugs used this study
1, everolimus head neck cancer diagnosis addition these patients at increased risk lethal infections when treated marrow suppressive therapy
0, docetaxel breast cancer diagnosis alt ast normal alkaline phosphatase no greater five times uln
0, vaccines lung cancer diagnosis not specified
0, vinorelbine breast neoplasm diagnosis subject must be older eighteen younger eighty five
1, octreotide pancreatic neoplasms diagnosis cognitive communication issues any factors affecting capacity consent participation
1, n monoacetylcystine stage iva verrucous carcinoma oral cavity diagnosis history myocardial infarction equal less six months congestive heart failure requiring use ongoing maintenance therapy life threatening ventricular arrhythmias
1, antibodies monoclonal bladder cancer diagnosis topical inhaled corticosteroids allowed
1, fludarabine phosphate myelodysplastic myeloproliferative neoplasm unclassifiable diagnosis bilirubin greater equal three upper limit normal
0, palbociclib metastatic malignant neoplasm brain diagnosis patients who have had prior wbrt srs eligible but there needs be unequivocal evidence progression at least one lesion treated by radiation tissue diagnosis
0, antibodies monoclonal recurrent small lymphocytic lymphoma diagnosis creatinine equal less two institutional uln
1, nivolumab cancer rectum diagnosis patients history pneumonitis interstitial lung disease
1, placebo head neck cancer thyroid gland other subsite involving thyroid gland
1, fludarabine phosphate skin cancer diagnosis concurrent opportunistic infections experimental treatment being evaluated this protocol depends on an intact immune system
0, lenograstim clear cell sarcoma diagnosis at least three half lives antibody after last dose monoclonal antibody
0, pomalidomide multiple myeloma diagnosis alt sgpt less three upper limit normal
0, vaccines malignant mesothelioma diagnosis stage iii iv disease
0, methotrexate lymphoma diagnosis patient characteristics
0, fludarabine low grade non hodgkin lymphoma meeting one following criteria
1, immunoglobulins recurrent verrucous carcinoma larynx diagnosis pulmonary hemorrhage bleeding event greater ctcae grade two within four weeks first dose drug
0, procarbazine lymphoma diagnosis bilirubin less two mg dl
0, bevacizumab well differentiated gastrointestinal tract endocrine tumors duodeno pancreatic endocrine tumors
1, cilengitide recurrent prostate cancer diagnosis patients may continue on daily multi vitamin but all other herbal alternative food supplements pc spes saw palmetto st john wort etc
0, belinostat recurrent adult diffuse mixed cell lymphoma diagnosis neutrophils dlt
0, vitamin b lymphoma diagnosis ps less two
0, conventional surgical treatment sarcoma bone tumor diagnosis surgery center
1, paclitaxel epithelial ovarian cancer diagnosis previous therapy hdac inhibitors
1, succinylcholine vaginal adenosquamous carcinoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition three ap triapine other agents used study
0, hypofractionated radiation therapy lung cancer diagnosis patient characteristics
0, erlotinib hydrochloride stage iii squamous cell carcinoma oropharynx diagnosis prothrombin time within normal institutional limits
1, palbociclib hertwo negative breast cancer diagnosis subject is unable unwilling abide by protocol cooperate fully investigator designee
0, liposomal doxorubicin esophageal cancer diagnosis creatinine less doc times uln cardiovascular
0, fludarabine phosphate melanoma experimental diagnosis platelet count greater one hundred zero mm three
1, romidepsin mesothelioma diagnosis myocardial infarction within one year study
1, fluorouracil past current history neoplasm other entry diagnosis exception treated non melanoma skin cancer carcinoma situ cervix other cancers cured by local therapy alone disease free survival greater equal five years
1, protein kinase inhibitors non small cell lung carcinoma diagnosis major surgery significant traumatic injury occurring within twenty one days prior treatment
0, estradiol breast cancer diagnosis patients must have had disease progression during treatment everolimus combination either exemestane any country fulvestrant us only duration treatment greater four weeks must have tolerated everolimus treatment combination exemestane any country fulvestrant us only adequately according treating physician judgment
1, laboratory biomarker analysis stage ivb hepatocellular carcinoma diagnosis history active connective tissue disease scleroderma
0, bevacizumab recurrent rectal cancer diagnosis cardiac arrhythmia requiring anti arrhythmic drugs
1, laboratory biomarker analysis stage iib soft tissue sarcoma diagnosis viral infections requiring intermittent chronic systemic intravenous oral treatment an anti herpetic drug acyclovir other intermittent topical use
0, dexamethasone acetate stage ii ovarian cancer diagnosis paclitaxel one hundred thirty five mg mtwo iv over three hours on day one and
0, dexamethasone phosphate prolactin secreting adenoma diagnosis at least three months since prior stem cell transplantation rescue without tbi no evidence active graft vs host disease
1, yoga therapy adult brain stem glioma diagnosis have practiced yoga on regular basis at least once week within past four weeks recruit participants who not already regularly practicing yoga given that benefits yoga likely more immediate long term however we will enroll participants who have previously had yoga practice
1, abiraterone acetate prostate cancer diagnosis application any lhrh therapy lhrh analogue lhrh antagonist within three months patients receiving three months formulation one months patients receiving one month formulation prior cycle one day one
1, dexamethasone phosphate diffuse large cell lymphoma diagnosis subjects not willing unable take dvt prophylaxis
1, stent rectal cancer diagnosis right side colonic obstruction
0, quality life assessment soft tissue sarcoma diagnosis treated at one survivorship centers excellence their community affiliates
0, topotecan subjects advanced solid tumors
0, albumin bound paclitaxel unspecified adult solid tumor protocol specific diagnosis no concurrent corticosteroids except physiologic replacement
1, procarbazine stage iv aids related lymphoma diagnosis inability swallow oral medications
0, succinylcholine prostatic neoplasms diagnosis total bilirubin level less doc institutional upper limit normal uln
1, temozolomide stage ivc thyroid gland medullary carcinoma diagnosis active uncontrolled infection psychiatric illness social situation that would limit compliance requirements any medical condition which opinion investigator places subject at an unacceptably high risk toxicities
0, etoposide phosphate recurrent childhood large cell lymphoma diagnosis other malignant lymphoproliferative disorders
0, dexamethasone multiple myeloma plasma cell neoplasm diagnosis new york heart association class iii iv heart failure
1, pemetrexed lung neoplasms diagnosis have brain metastasis that is uncontrolled
1, lenalidomide multiple myeloma diagnosis myocardial infarction within six months prior enrollment has nyha class iii iv heart failure uncontrolled angina severe uncontrolled ventricular arrhythmias electrocardiographic evidence acute ischemia active conduction system abnormalities
0, granisetron gestational trophoblastic tumor diagnosis ast alt less three times upper limit normal uln
0, antibodies recurrent uterine corpus carcinoma diagnosis prior systemic treatments metastatic disease permitted including targeted therapies biologic response modifiers chemotherapy hormonal therapy investigational therapy exception
1, cyclophosphamide lung cancer diagnosis doc patients who initially rendered ned have mrd following standard therapy but exhibit disease progression prior initiation vaccination will be excluded from study
0, paclitaxel angiosarcomas diagnosis serum creatinine less equal doc mg dl
1, bortezomib melanoma diagnosis cardiac ventricular arrhythmias requiring anti arrhythmic therapy
0, fluorouracil esophageal cancer diagnosis no concurrent radiotherapy
0, topotecan malignant solid tumor diagnosis central nervous system function defined as
0, metronidazole lung cancer diagnosis sex
0, dexamethasone phosphate lymphoma non hodgkin diagnosis should flow cytometric analyses suggest relapse by reappearance similar immunophenotype original leukemia presence less five blasts morphologically repeat bone marrow test is recommended confirm relapse
1, niacinamide lung cancer diagnosis clinically serious active infection
0, therapeutic conventional surgery recurrent adult brain tumor diagnosis hiv positive patients on combination antiretroviral therapy ineligible
1, niacinamide stage iva salivary gland cancer diagnosis inability comply protocol
0, antibodies monoclonal ovarian mucinous adenocarcinoma diagnosis cluster differentiation cd four positive cell count greater equal two hundred fifty cells mm three
1, taxane hertwo negative breast cancer diagnosis significant cardiovascular impairment history congestive heart failure greater new york heart association nyha class ii unstable angina myocardial infarction within past six months serious cardiac arrhythmia
0, laboratory biomarker analysis superficial spreading malignant melanoma diagnosis no other prior malignancy is allowed except following
1, cabozantinib s malate recurrent renal cell carcinoma diagnosis patients who receiving systemic treatment anticoagulation not eligible patients receiving prophylactic systemic anticoagulation will be allowed long eligibility inr requirements met
1, immunoglobulins carcinoma renal cell diagnosis c
0, isophosphamide mustard lymphoma diagnosis age
0, bendamustine hydrochloride lymphomatous involvement non cutaneous extranodal site diagnosis total bilirubin equal less two upper normal institutional limits patients gilbert disease documented liver metastases total bilirubin up three upper limits normal uln will be allowed
0, gefitinib stage iii follicular thyroid cancer diagnosis patients must have performance status zero two by zubrod standards
1, fluorine f d fmau recurrent prostate cancer diagnosis bone brain metastasis within fourteen days first dose treatment
0, antibodies non small cell lung cancer diagnosis prior radiation is permitted at least one week must have elapsed since completion prior radiation therapy must have recovered from all associated toxicities at time registration
0, etoposide phosphate lung cancer diagnosis patients significant cardiac history even if controlled should have lvef greater fifty
1, interview physical activity lung cancer diagnosis regular use an ambulatory aid cane walker
1, fludarabine lymphoma diagnosis serious medical psychiatric illness likely interfere participation this clinical study
1, carboplatin carcinoma non small cell lung diagnosis history thrombotic hemorrhagic disorders
1, temozolomide malabsorption syndrome due prior surgery gastrointestinal disease other unknown reason concurrent nonmalignant systemic disease active uncontrolled infection frequent vomiting medical condition that could interfere oral medication uptake partial bowel obstruction bowel resection partial intestinal bypass external biliary diversion prior concurrent malignancies at other sites except carcinoma situ cervix adequately treated basal squamous cell skin cancer hiv negative aids related illness not pregnant nursing fertile patients must use effective contraception
0, irinotecan metastatic colorectal cancer diagnosis patients must have ability understand willingness sign written informed contact document
1, pembrolizumab head neck squamous cell carcinoma diagnosis if subject received major surgery they must have recovered adequately from toxicity complications from intervention prior starting therapy
1, fludarabine phosphate stage cutaneous cell non hodgkin lymphoma diagnosis donor
0, prednisolone hemisuccinate nodal marginal zone cell lymphoma diagnosis fevone dlco corrected must be greater equal sixty normal
0, bevacizumab colorectal cancer diagnosis age eighteen
1, immunoglobulin g ovarian clear cell cystadenocarcinoma diagnosis requirement inotropic support excluding digoxin
1, antibodies monoclonal renal cell carcinoma diagnosis known human immunodeficiency virus hiv acquired immunodeficiency syndrome aids related illness
0, epinephryl borate total testosterone greater one hundred fifty ng dl which suggests possibility virilizing neoplasm
1, denileukin diftitox germ cell stromal cell cancers ovaries
0, caspofungin unspecified adult solid tumor protocol specific diagnosis other
1, multimodal treatment compression bandaging manual lymph drainage arm lymphedema after breast cancer diagnosis heart disease
1, antibodies stage iv squamous cell carcinoma hypopharynx diagnosis supraventricular nodal arrhythmias requiring pacemaker not controlled medication
0, bortezomib lymphoma diagnosis men women reproductive potential must agree follow accepted birth control methods duration study
0, jm recurrent adult lymphoblastic lymphoma diagnosis platelet count greater equal one hundred ten nine l
0, zileuton head neck cancer diagnosis pt ptt no greater uln
0, ifosfamide recurrent mantle cell lymphoma diagnosis no other concurrent investigational agents
0, bevacizumab stage iiib colon cancer diagnosis at time randomization postoperative platelet count must be greater equal one hundred zero mm three
0, temozolomide primary central nervious system lymphoma diagnosis men women age greater equal eighteen years
0, vincristine brain tumors diagnosis performance status
0, bevacizumab neuroendocrine tumors diagnosis doc uln alt ast less doc uln
0, megestrol acetate lung cancer diagnosis resected stage iiib nsclc
0, azacitidine recurrent rectal cancer diagnosis not candidate curative resection
0, camptothecin gastric cancer diagnosis platelet count one hundred zero mmthree
1, gemcitabine unspecified adult solid tumor protocol specific diagnosis nursing women
0, thalidomide myeloma diagnosis lytic bone lesions osteoporosis
0, thalidomide intraocular lymphoma diagnosis fourteen days again within twenty four hours prior prescribing lenalidomide cycle one prescriptions must be filled within seven days must either commit continued abstinence from heterosexual intercourse begin two acceptable methods birth control one highly effective method one additional effective method at same time at least twenty eight days before she starts taking lenalidomide fcbp must also agree ongoing pregnancy testing men must agree use latex condom during sexual contact fcbp even if they have had successful vasectomy
1, exercise intervention stage iiic breast cancer diagnosis patient has severe disabilities limiting moderate physical activity such severe orthopedic conditions
1, opb salivary gland cancer diagnosis concurrent prior treatment related toxicity grade two higher
1, romidepsin multiple myeloma diagnosis patients known hepatitis infection
1, gossypol acetic acid contiguous stage ii grade two follicular lymphoma diagnosis any prior use racemic gossypol at one hundred one
0, bb subject has symptomatic primary metastatic central nervous system cns disease
0, erlotinib hydrochloride non small cell lung cancer diagnosis sign informed consent
0, capecitabine liver cancer diagnosis disease that has progressed on standard therapy
1, imatinib mesylate gastrointestinal stromal tumors gists diagnosis last dose radiotherapy received within four weeks before start treatment excluding palliative radiotherapy
0, celecoxib recurrent non small cell lung cancer diagnosis no evidence coagulopathy defined pt ptt equal less doc uln platelets greater equal one hundred zero
1, ebus gs olympus lung cancer diagnosis absence bronchus leading adjacent lesion from ct scan
1, liposomal doxorubicin stage iv adult diffuse mixed cell lymphoma diagnosis pregnant females
0, cladribine lymphoma lymphoblastic diagnosis at least two week interval last cycle chemotherapy decision individual cases if rapid progression
1, carboplatin more one prior regimen including consolidation chemotherapy ovarian epithelial cancer primary peritoneal cancer fallopian tube cancer
0, normal saline liver cancer diagnosis subjects willing comply protocol sign informed consent form
1, chemotherapy colorectal cancer diagnosis history organ allograft
1, amrubicin thymus cancer diagnosis doc
0, hydroxyurea recurrent salivary gland cancer diagnosis urine protein no greater trace
1, imatinib mesylate gastrointestinal stromal tumors diagnosis major concurrent disease affecting cardiovascular system liver kidneys haematopoietic system else considered clinically important by investigator that could be incompatible patient participation this trial would likely interfere procedures results
0, immunoglobulins stage iiic primary peritoneal cancer diagnosis absolute neutrophil count greater equal one five hundred ul
1, azacitidine primary small cell lung cancers diagnosis patients whom digitalis cannot be discontinued
0, cyclophosphamide sarcoma diagnosis completely resected microscopic residual disease
1, fludarabine aids related lymphoblastic lymphoma diagnosis donor
0, bortezomib multiple myeloma plasma cell neoplasm diagnosis patient characteristics
1, albumin bound paclitaxel stage iii malignant testicular germ cell tumor diagnosis surgery radiotherapy chemotherapy hormonal therapy during three weeks prior initiation therapy
0, tacrolimus stage adult immunoblastic large cell lymphoma diagnosis donor
1, doxorubicin noncontiguous stage ii mantle cell lymphoma diagnosis history prior malignancy unless at least one following conditions met
1, afp stage iv breast cancer diagnosis human immunodeficiency virus hiv positive patients on combination antiretroviral therapy
0, glycine follicular lymphoma diagnosis histopathologic confirmation
0, cyclophosphamide contiguous stage ii small lymphocytic lymphoma diagnosis serum creatinine less doc mg dl
0, carboplatin nonsquamous nonsmall cell neoplasm lung diagnosis platelets greater ten doc zero Âµl
0, vidarabine splenic marginal zone lymphoma diagnosis performance status
1, romidepsin stage iiia colorectal cancer diagnosis concurrent medications associated known risk corrected qt interval qtc prolongation torsades de pointes not allowed within two weeks initiation treatment those medications listed possible risk causing qtc prolongation torsades de pointes will be allowed although if an alternative medication can be substituted that would be preferable granisetron is an acceptable antiemetic on this but ondansetron is not
0, cyclophosphamide lymphoma diagnosis no active hepatitis infection
1, recombinant human interleukin recurrent renal cell carcinoma diagnosis patients who have had chemotherapy within four weeks six weeks nitrosoureas mitomycin radiotherapy within two weeks prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
0, alvespimycin hydrochloride stage iii colon cancer diagnosis no congenital long qt syndrome
0, cyclophosphamide neuroblastoma diagnosis surgery
1, survivor survey post visit received diagnosis cancer that was not breast prostate colorectal cancer
0, oxaliplatin stage iv colorectal cancer diagnosis patient must have signed dated an institutional review board irb approved consent form that conforms federal institutional guidelines
1, erlotinib hydrochloride neuroblastoma diagnosis disease specific exclusions
1, sirolimus carcinoma squamous cell diagnosis received chemotherapy targeted monoclonal antibody therapy investigational therapy within thirty days prior enrollment
1, docetaxel neoplasms prostatic diagnosis receipt an investigational agent within twenty eight days sixty days an antibody based therapy before first planned dose drugs
1, temozolomide malignant glioma diagnosis patients human immunodeficiency virus hiv excluded
0, fludarabine phosphate lymphoma diagnosis recurrent disease after autologous stem cell transplantation
1, chlorotrianisene hepatocellular carcinoma diagnosis female patients who pregnant lactating possibly pregnant planning become pregnant
0, rituximab lymphoma diagnosis patients performance status two less zubrod
0, temozolomide malignant glioma brain diagnosis because risk adverse events patients less eighteen years age children excluded from this but will be eligible future pediatric trials
1, liposomal doxorubicin stage iii adult lymphoblastic lymphoma diagnosis six hundred cgy chest irradiation if medically necessary
1, mycophenolic acid stage iv childhood anaplastic large cell lymphoma diagnosis any current central nervous system cns involvement disease refractory intrathecal chemotherapy
1, talazoparib primary peritoneal serous adenocarcinoma diagnosis patients who have had chemotherapy radiotherapy within four weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered from adverse events due agents administered more four weeks earlier
1, cyclophosphamide splenic marginal zone lymphoma diagnosis patients who have had major surgical procedures significant traumatic injury within twenty eight days prior treatment
1, lenograstim lymphoma diagnosis myocardial infarction equal less six months
0, nk cell infusion brain tumors diagnosis patients less eighteen years age their legal guardian must give informed consent
0, panobinostat colorectal cancer diagnosis serum albumin greater lln threeg dl
1, carboxymethylcellulose sodium breast cancer diagnosis active tuberculosis not on active antitubercular agents
0, rituximab contiguous stage ii mantle cell lymphoma diagnosis patients must have relapsed primary refractory lymphoid malignancy including cell cell hodgkins disease untreated nhl mcl
1, cediranib adult brain stem glioma diagnosis note
1, capecitabine metastatic breast cancer diagnosis measurable disease must be completely outside radiated field there must be pathological proof progressive disease
0, carboplatin cancer breast diagnosis either commit true abstinence from heterosexual contact which must be reviewed on monthly basis agree use be able comply two physician approved effective contraception methods oral injectable implantable hormonal contraceptive tubal ligation intra uterine device barrier contraceptive spermicide vasectomized partner without interruption twenty eight days longer required by local guidelines prior starting drug during therapy including dose interruptions twenty eight days after discontinuation longer required by local guidelines
0, radiation therapy breast cancer diagnosis fertile patients must use effective barrier contraception
1, laboratory biomarker analysis stage iva squamous cell carcinoma paranasal sinus nasal cavity diagnosis phenytoin carbamazepine phenobarbital oxcarbazepine
0, peginterferon alfa b unspecified adult solid tumor protocol specific diagnosis no congestive heart failure
1, fosaprepitant non small cell lung cancer diagnosis serum creatinine greater mg dl
0, temsirolimus prostate cancer diagnosis not specified
1, trametinib endometrial adenocarcinoma diagnosis patients who pregnant nursing women childbearing potential should be advised avoid pregnancy use effective methods contraception if patient becomes pregnant while patient receives trametinib gsktwo million one hundred forty one thousand seven hundred ninety five potential hazard fetus should be explained patient
0, carboplatin squamous cell lung cancer diagnosis creatinine normal
1, dexamethasone phosphate multiple myeloma diagnosis if test is positive patient must be excluded from study
1, vaccines sarcoma diagnosis patients who pregnant nursing ineligible
0, management therapy complications ovarian cancer diagnosis scheduled undergo course radical adjuvant pelvic radiotherapy greater forty five gy
1, laboratory biomarker analysis stage iiib gallbladder cancer diagnosis history allergic reactions attributed compounds similar chemical biologic composition mk two thousand two hundred six azdsix thousand two hundred forty four hydrogen sulfate other agents used study
1, bevacizumab non small cell lung cancer diagnosis systemic chemotherapy radiotherapy investigational treatment within twenty eight days prior randomization
1, albumin bound paclitaxel recurrent ovarian cancer diagnosis history hypersensitivity paclitaxel
1, leucovorin stage iiic rectal cancer diagnosis patients only non measurable disease defined all other lesions including small lesions longest diameter less twenty mm conventional techniques less ten mm spiral ct scan truly non measurable lesions which include following
1, erlotinib hydrochloride tumors diagnosis history chronic hepatitis
1, dabrafenib metastatic melanoma diagnosis strong inhibitors cypthreea cyptwoceight
0, sirolimus stage iii ovarian germ cell tumor diagnosis last radiation therapy within last four weeks before start therapy except palliative radiotherapy
1, proton beam radiation prostate cancer diagnosis major medical psychiatric illness
1, immunoglobulins lymphoma diagnosis patients severe intercurrent infection
1, behavioral dietary intervention stage ib breast cancer diagnosis patient requires regional lymph node irradiation therapy
1, bevacizumab recurrent childhood lymphoblastic lymphoma diagnosis uncontrolled systemic vascular hypertension systolic blood pressure greater one hundred forty mmhg diastolic blood pressure greater ninety mmhg
1, bortezomib recurrent primary peritoneal carcinoma diagnosis patients history prior myocardial infarction last twelve months patients new electrocardiographic evidence acute ischemia new conduction abnormalities ineligible
0, carmustine lymphoma hodgkin disease diagnosis assessment response last chemotherapy prior registration is mandatory
1, maleic acid stage iv breast cancer diagnosis hiv positive patients on combination antiretroviral therapy ineligible
1, sirolimus thyroid cancer diagnosis prior treatment any investigational drug within preceding three weeks
0, albumin bound paclitaxel male breast carcinoma diagnosis no serious non healing wound skin ulcers bone fracture no abdominal fistula gastrointestinal perforation intra abdominal abscess within past six months no major surgical procedure within twenty eight days prior randomization anticipation need major surgery during course study
0, cyclophosphamide rhabdoid tumor kidney diagnosis newly diagnosed disease one following histologic types
1, cetuximab stage iii verrucous carcinoma oral cavity diagnosis glucose less forty mg dl less doc mmol greater two hundred fifty mg dl greater fourteenmmol l
0, epirubicin fallopian tube cancer diagnosis hepatic
1, imatinib mesylate advanced metastatic cholangiocellular carcinoma bile duct diagnosis patients severe decrease bone marrow function
1, vinblastine carcinoma non small cell lung diagnosis pregnancy lactation period
1, mitogens stage iv adult lymphoblastic lymphoma diagnosis presence generalized rash involving more fifty body surface
1, endothelial growth factors endometrial serous adenocarcinoma diagnosis evidence bleeding diathesis coagulopathy absence therapeutic anticoagulation
0, rabeprazole solid tumors diagnosis willingness ability give written informed consent comply procedures
0, antibodies stage ivb colon cancer diagnosis no recent concurrent thrombolytic agents
0, antibodies recurrent verrucous carcinoma oral cavity diagnosis erythromycin
1, everolimus neuroendocrine tumor diagnosis chronic treatment systemic steroids another immunosuppressive agent
1, pemetrexed pancreatic cancer diagnosis women child bearing potential must have negative serum urine pregnancy test within seven days prior start treatment
0, cyclophosphamide stage iiic breast cancer diagnosis patients enrolled gilbert syndrome must have total bilirubin less three uln
1, immunoglobulins ovarian serous cystadenocarcinoma diagnosis patients who have received prior therapy any anti vascular endothelial growth factor vegf drug including bevacizumab
0, hand assisted laparoscopic proctectomy rectal cancer diagnosis age greater equal eighteen years age
1, albumin bound paclitaxel stage iib breast cancer diagnosis intrinsic lung disease resulting dyspnea
0, bb recurrent childhood brain stem glioma diagnosis not pregnant nursing
0, succinylcholine stage ivc lip oral cavity squamous cell carcinoma diagnosis patients must have completed any previous surgery radiotherapy greater equal four weeks prior enrollment
0, bortezomib recurrent grade one follicular lymphoma diagnosis dyspnea on off exertion
0, rituximab adult non hodgkin lymphoma diagnosis able take aspirin eighty one three hundred twenty five mg daily prophylactic anticoagulation subjects intolerant asa may use warfarin low molecular weight heparin
0, sofosbuvir hepatocellular carcinoma diagnosis males females age greater eighteen years old
0, tretinoin neoplasm residual diagnosis central nervous syste negative patients seizure disorder may be enrolled if on anticonvulsants wellcontrolled
0, antibodies stage iv marginal zone lymphoma diagnosis absolute neutrophil count greater equal one five hundred mm three
0, dacarbazine solid tumors diagnosis biologic anti neoplastic agent
1, docetaxel curatively treated basal cell skin cancer
1, sorafenib malignant melanoma diagnosis thrombotic embolic events such cerebrovascular accident including transient ischemic attacks within past six months
0, laboratory biomarker analysis prostate cancer diagnosis patients receive standard care
1, androgen receptor antagonists breast cancer female diagnosis medical indication subject desire undergo bc surgery prior completing at least fourteen days treatment odm two hundred one
0, albumin bound paclitaxel recurrent fallopian tube carcinoma diagnosis measurable disease
1, vincristine central nervous system tumors diagnosis exceptions need be approved by principal investigator
1, cyclophosphamide splenic marginal zone lymphoma diagnosis enrollment subjects who require concurrent radiotherapy which must be localized its field size should be deferred until radiotherapy is completed three weeks have elapsed since last date therapy
0, metronidazole breast cancer diagnosis no other acute chronic exfoliative skin conditions atopic dermatitis burns impetigo varicella zoster severe acne other open rashes wounds
1, antibodies monoclonal lymphoma non hodgkin diagnosis known central nervous system involvement
0, antibodies monoclonal recurrent childhood hodgkin lymphoma diagnosis advanced stage iii iv at diagnosis who relapse less one year from end initial therapy
1, vidarabine childhood diffuse large cell lymphoma diagnosis diffusion capacity carbon monoxide dlco less thirty five total lung capacity tlc less thirty five forced expiratory volume one second fevone less thirty five receiving supplementary continuous oxygen
0, thalidomide hepatocellular carcinoma diagnosis hv ivc thrombosis
1, irinotecan recurrent colon carcinoma diagnosis note
1, antibodies monoclonal somatostatin producing neuroendocrine tumor diagnosis unstable angina pectoris myocardial infarction within six months start drug
0, levoleucovorin stage iv childhood hepatocellular carcinoma diagnosis twenty eight days have elapsed since that therapy lesions that have not been treated local therapy must be present measureable
0, educational intervention cancer survivor diagnosis currently does not independently self manage follow up care according self report reports low readiness score one two out four assume total responsibility care using an item from readiness transition questionnaire
0, antibodies recurrent grade two follicular lymphoma diagnosis creatinine equal less two mg dl
1, antibodies stage iv mantle cell lymphoma diagnosis anticipation need major surgical procedures during course study
1, aminopurine cognitive side effects cancer therapy diagnosis female patients childbearing potential not eligible unless negative pregnancy test result has been obtained
1, mycophenolate mofetil peripheral cell lymphoma diagnosis fhcrc pi must approve enrollment all patients pulmonary nodules
1, taxane breast neoplasms diagnosis within six months have had serious heart condition
0, dexamethasone phosphate recurrent childhood anaplastic astrocytoma diagnosis one hundred zero mm three transfusion independent defined not receiving platelet transfusions within seven days prior registration
1, bb multiple myeloma diagnosis major surgery within twenty one days prior enrolment
1, albumin bound paclitaxel recurrent ovarian carcinoma diagnosis co morbid systemic illnesses other severe concurrent disease which judgment investigator would make patient inappropriate entry into this interfere significantly proper assessment safety toxicity prescribed regimens
0, cyclosporins nodal marginal zone cell lymphoma diagnosis first subsequent chronic phase
1, antibodies monoclonal metastatic bladder cancer diagnosis serious intercurrent medical psychiatric illness including serious active infection
1, bevacizumab ovarian neoplasm diagnosis therapeutic anticoagulation coumadin heparins heparinoids
1, mitomycins non muscle invasive bladder cancer diagnosis high grade urine cytology
0, oxaliplatin colorectal cancer diagnosis no uncontrolled blood pressure bp defined bp greater one hundred fifty one hundred mm hg
0, fludarabine stage ii childhood lymphoblastic lymphoma diagnosis donor
0, immunoglobulins contiguous stage ii mantle cell lymphoma diagnosis histologically confirmed cdthirty positive ebv positive lymphoid malignancy addition there must be evidence cdtwenty expression at any level
0, cognitive assessment lymphoma diagnosis fhcrc sixty six doc four
1, magnetic resonance imaging mri anal cancer patients diagnosis evidence distant metastasis mone
0, adjuvant therapy colorectal cancer diagnosis disease characteristics
0, bryostatin stage iv renal cell cancer diagnosis ast alt no greater doc times uln
0, dasatinib lymphoma non hodgkin diagnosis male patients even if surgically sterilized post vasectomy must agree one following
1, mycophenolic acid recurrent childhood small noncleaved cell lymphoma diagnosis presence active serious infection mucormycosis uncontrolled aspergillosis tuberculosis
1, rituximab non hodgkin lymphoma diagnosis patient has platelet count less seventy five zero mm three within fourteen days before enrollment
1, docetaxel esophagus cancer diagnosis patients must be fully recovered from any reversible side effects prior intervention
1, fluorouracil squamous cell carcinoma head neck diagnosis known hypersensitivity allergic reaction against any components trial treatment
0, complementary alternative therapy recurrent mantle cell lymphoma diagnosis no history renal conditions that contraindicate high dosages sodium
1, prednisolone acetate stomatitis diagnosis patients known history impaired fasting glucose diabetes mellitus dm may be included however blood glucose antidiabetic treatment must be monitored closely throughout trial adjusted necessary
0, irinotecan unresectable advanced cancer diagnosis seventy five years
0, everolimus advanced cancers diagnosis patients must have been off previous chemotherapy radiotherapy two weeks prior start treatment
0, albumin bound paclitaxel stage iiib non small cell lung cancer diagnosis ast alt no greater doc times upper limit normal
1, dacarbazine unspecified adult solid tumor protocol specific diagnosis severe uncontrolled ventricular arrhythmias
0, vidarabine stage iii mantle cell lymphoma diagnosis chronic phase intolerant unresponsive imatinib other tyrosine kinase inhibitors second chronic phase accelerated phase who ineligible conventional myeloablative transplantation
1, histone deacetylase inhibitors recurrent colon cancer diagnosis may not have received any other investigational agents within twenty eight days entry chemotherapy any investigational drug undergone major surgery less four weeks prior starting drug who have not recovered from side effects such therapy
0, capecitabine stage ia breast cancer diagnosis life expectancy greater three months
1, educational materials cervix cancer diagnosis unable unwilling give informed consent
1, questionnaire prostate cancer diagnosis patients currently enrolled another study
0, cediranib cholangiocarcinoma extrahepatic bile duct diagnosis patients who chemotherapy naive unless chemotherapy was given adjuvant post surgical treatment at least six months have elapsed since adjuvant chemotherapy
1, metformin other solid malignant tumors diagnosis hemoglobin less nine dl
1, antibodies monoclonal stage ivb colorectal cancer diagnosis active infection including hepatitis hepatitis human immunodeficiency virus hiv
0, immunoglobulins stage iva rectal cancer diagnosis international normalized ratio inr less doc unless patients receiving anti coagulation therapy patients receiving anti coagulation therapy an agent such warfarin heparin allowed participate if inr equal less doc
1, ibrutinib blastoid variant mantle cell lymphoma diagnosis use coumadin warfarin other vitamin antagonists anticoagulation non coumadin anticoagulation is permitted
0, camptothecin recurrent adult diffuse small cleaved cell lymphoma diagnosis karnofsky seventy one hundred
1, antibodies monoclonal recurrent adult primary liver cancer diagnosis at least four weeks since prior invasive surgery including open biopsy
0, gemcitabine recurrent uterine corpus sarcoma diagnosis patients should be free active infection requiring antibiotics exception an uncomplicated uti
1, cyclosporins stage ii childhood anaplastic large cell lymphoma diagnosis females who pregnant
0, sirolimus recurrent adult soft tissue sarcoma diagnosis patients brain metastasis that have been treated definitive surgery radiation have been clinically stable three months following procedure no neurological signs symptoms no requirement systemic glucocorticoids eligible study
0, antibodies monoclonal contiguous stage ii small lymphocytic lymphoma diagnosis men must agree use latex condom during sexual contact fcbp even if they have had successful vasectomy
0, cyclosporine mantle cell lymphoma diagnosis voluntary written consent adult parental guardian
0, staurosporine lymphoma diagnosis fev one greater seventy predicted
0, carotenoids prostate cancer diagnosis life expectancy
1, atenolol advanced cancer diagnosis patients on methotrexate
1, sirolimus lymphoma diagnosis acidosis will be defined blood ph less doc five
0, rituximab contiguous stage ii mantle cell lymphoma diagnosis patients may not have received prior external beam radiation therapy greater twenty five active bone marrow involved field regional
0, albumin bound paclitaxel metastatic malignant melanoma diagnosis absolute neutrophil count anc greater doc one hundred nine l
0, carboplatin progressive breast cancer diagnosis prior trastuzumab is allowed
1, processed human nerve tissue scaffold prostate cancer diagnosis history penile implant prosthesis
1, cisplatin primary cancers nasal paranasal cavities nasopharynx
0, interleukin melanoma skin diagnosis performance status
1, busulfan recurrent grade three follicular lymphoma diagnosis host disease complications greater risk recurrence after autologous bmt
1, etoposide stage iv grade three follicular lymphoma diagnosis any serious medical condition laboratory abnormality psychiatric illness that would prevent subject from signing informed consent form
0, cetuximab stage iv squamous cell carcinoma lip oral cavity diagnosis inr less doc
1, rigosertib lung squamous cell carcinoma diagnosis female patients who pregnant lactating
0, doxorubicin lymphoma diagnosis however this protocol uses former terminology
0, quality life assessment lung cancer diagnosis prior concurrent therapy
1, sirolimus mixed adenocarcinoma stomach diagnosis patients receiving chronic systemic treatment corticosteroids prednisone greater ten mg per day another immunosuppressive agent topical inhaled corticosteroids allowed
1, camptothecin intestinal adenocarcinoma stomach diagnosis inflammatory bowel disease crohn disease ulcerative colitis
0, cyclophosphamide lymphoma diagnosis not specified
1, cadexomer iodine thyroid neoplasms diagnosis chemotherapy radiotherapy history
0, idelalisib follicular lymphoma diagnosis presence radiographically measurable lymphadenopathy extranodal lymphoid malignancy
1, antibodies monoclonal recurrent adult diffuse small cleaved cell lymphoma diagnosis identical twin
1, hysteroscopic resection bipolar energy myoma larger five cm
1, pioglitazone simultaneous treatment another investigational agent simultaneous anticancer treatment outside this trial
0, tlr agonist sd recurrent follicular lymphoma diagnosis patients must have at least one site measurable disease other injection site which is not included radiation field
0, succinylcholine localized unresectable neuroblastoma diagnosis total bilirubin less doc times upper limit normal uln age
0, fludarabine stage iv grade one follicular lymphoma diagnosis at least two weeks since prior chemotherapy radiation treatment surgery
1, bevacizumab recurrent glioblastoma multiforme diagnosis life expectancy less twelve weeks
1, melatonin advanced cancer diagnosis patients on methotrexate
0, fludarabine phosphate noncontiguous stage ii adult diffuse large cell lymphoma diagnosis patients may have received prior autologous bone marrow transplant bmt prior myeloablative allogeneic bmt at least sixty days have elapsed
1, gossypol acetic acid squamous cell carcinoma head neck scchn diagnosis pregnant nursing women
0, cyclosporine recurrent adult burkitt lymphoma diagnosis patients crtwo prtwo initial short remission less six months eligible
0, cyclophosphamide follicular lymphoma diagnosis patients less twenty one years however eligible mtwo marrow less two blasts marrow after having failed one more cycles chemotherapy
1, docetaxel undifferentiated fallopian tube carcinoma diagnosis myocardial infarction cardiac arrhythmia unstable angina less six months prior registration
0, oxaliplatin adenocarcinoma colon diagnosis no other concurrent medical condition that would preclude participation
1, misonidazole stage iiia non small cell lung cancer diagnosis nyha classification iii iv
1, liposomal doxorubicin metastatic leiomyosarcoma diagnosis uncontrolled intercurrent medical condition including but not limited to
1, ifosfamide malignant cutaneous granular cell tumor diagnosis cardiac arrhythmia
0, gemcitabine peritoneal cancer diagnosis use an effective means contraception women childbearing potential
1, antibodies undifferentiated fallopian tube carcinoma diagnosis patients who require parental hydration nutrition
0, everolimus stage iiia skin melanoma diagnosis serum aspartate aminotransferase serum glutamic oxaloacetic transaminase sgot aspartate aminotransferase ast serum alanine aminotransferase serum glutamate pyruvate transaminase sgpt alanine aminotransferase alt equal less three uln
0, dabrafenib melanoma brain metastases diagnosis anti epileptic therapy indicated order prevent neurologic symptoms caused by pre existing condition not related brain metastasis is allowed
1, gemcitabine previous malignancy other pancreatic cancer last five years except basal cell cancer skin pre invasive cancer cervix superficial bladder tumor ta tis tone
0, doxorubicin lymphoma diagnosis not pregnant nursing
1, pembrolizumab malignant glioma diagnosis have cluster differentiation cd four counts above four 
1, estradiol benzoate has one following excluded tumor types trametinib therapy has been shown have minimal benefit these populations
0, carboplatin esophagogastric cancer diagnosis part a
0, melphalan multiple myeloma plasma cell neoplasm diagnosis eighteen sixty five
0, everolimus aids related hodgkin lymphoma diagnosis no acquired immune deficiency syndrome aids defining illness and
0, oxaliplatin unspecified adult solid tumor protocol specific diagnosis no concurrent combination antiretroviral therapy hiv positive patients
1, dexamethasone central nervous system lymphoma diagnosis major surgery equal less four weeks prior registration have not recovered from side effects such therapy
1, dimensional breast ultrasound early stage breast cancer diagnosis prior ipsilateral breast thoracic radiotherapy
1, crizotinib carcinoma non small cell lung diagnosis rosone positive patients
1, fluorouracil hepatocellular carcinoma diagnosis evidence hepatic decompensation including refractory ascites esophageal gastric variceal bleeding hepatic encephalopathy
1, liposomal doxorubicin primary peritoneal serous adenocarcinoma diagnosis patients following risk factors should have baseline cardiac function assessment
1, mycophenolate mofetil stage iv adult immunoblastic lymphoma diagnosis donor
0, bevacizumab colorectal cancer diagnosis patient characteristics
0, vaccines cervical cancer diagnosis not immunocompromised suggestive severe immune deficiency
1, antibodies hepatocellular carcinoma diagnosis known presence clinical evidence central nervous system brain metastases
1, carboplatin stage iiib primary peritoneal cancer diagnosis any tissue biopsy such core biopsy within seven days prior first date bevacizumab therapy cycle two
0, lii diagnosed first invasive non metastatic breast carcinoma histologically confirmed
1, bb stage grade one follicular lymphoma diagnosis patient has received systemic steroid therapy within one month entry into protocol
1, immunoenzyme technique breast cancer diagnosis patients who unable consent biopsy
1, viscum album peptide superficial bladder cancer diagnosis male patients planning father child sperm donation from first administration medication until three months after last administration medication
1, bevacizumab gliosarcoma diagnosis pts acute chronic renal insufficiency those acute renal insufficiency any severity due hepato renal syndrome peri operative liver transplantation period
0, oxaliplatin colorectal neoplasms diagnosis pnn greater one thousand five hundred mmthree platelets greater one hundred zero mmthree hb greater nine dlq
1, carboplatin stage iia non small cell lung cancer diagnosis active systemic pulmonary pericardial infection
0, pharmacological stage iv midline lethal granuloma paranasal sinus nasal cavity diagnosis kidney
1, fdg pet mr cervical squamous cell carcinoma diagnosis inability tolerate mri inability lie flat greater one hour
1, asparaginase hodgkins lymphoma diagnosis pregnant potential pregnancy
0, paclitaxel breast cancer diagnosis any status performance status
0, immunoglobulins stage iv squamous cell carcinoma lip oral cavity diagnosis urine protein
0, view presentation regarding current chance having an advanced adenoma colorectal cancer diagnosis age fifty seventy five years old
0, bortezomib multiple myeloma plasma cell neoplasm diagnosis no active systemic infection requiring therapy
1, ixazomib refractory plasma cell myeloma diagnosis known allergy any medications their analogues excipients various formulations any agent
0, bortezomib stage iii adult soft tissue sarcoma diagnosis no known active untreated brain metastases brain metastases requiring ongoing therapy corticosteroids
1, vaccines hormone refractory prostate cancer diagnosis inability understand language clinical protocol
0, cetuximab colorectal neoplasms diagnosis irinotecan oxaliplatin fluoropyrimidine
1, dietary intervention red tomato juice stage iia prostate cancer diagnosis have history uncontrolled pituitary hormone diseases that currently require varying doses supplemental hormonal administration thyroid hormones adrenocorticotropic hormone acth growth hormone other endocrine disorders requiring varying doses hormone administration exception diabetes osteoporosis
1, pharmaceutical solutions neoplasm metastasis diagnosis absence accurate histopathological data
0, abt kidney cancer diagnosis absolute neutrophil count at least one five hundred mm three
0, gemcitabine stage iii pancreatic cancer diagnosis tipranavir
0, iodine thyroid cancer diagnosis who performance status zero
1, vatalanib cervical cancer diagnosis pregnant breast feeding
1, axitinib has ongoing acute clinical adverse events nci ctcae grade greater one resulting from prior cancer therapies except alopecia tki related hand foot syndrome thyroid dysfunction
1, ifosfamide childhood germ cell tumor diagnosis drugs used this pregnancy category d
0, epothilones stage ivc salivary gland cancer diagnosis negative serum pregnancy test is required equal less two weeks randomization women childbearing potential
0, fludarabine phosphate recurrent adult hodgkin lymphoma diagnosis hct ci score less four points patients greater sixty years old less five points patients less sixty years old
0, albumin bound paclitaxel cervical cancer diagnosis bilirubin no greater doc times normal
0, vincristine stage ii childhood hodgkin lymphoma diagnosis serum glutamic oxalo acetic transaminase sgot aspartate aminotransferase ast serum glutamate pyruvate transaminase sgpt alanine aminotransferase alt less doc times upper limit normal uln
0, deoxyuridine stage iii adult immunoblastic large cell lymphoma diagnosis cardiac arrhythmia
1, albumin bound paclitaxel endometrial clear cell adenocarcinoma diagnosis history cerebrovascular accident cva stroke transient ischemic attack tia subarachnoid hemorrhage within six months first date therapy
0, ifosfamide pancreatic adenocarcinoma proven either by histology surgical biopsy cytology negative endoscopic guided
1, paclitaxel stage iiib non small cell lung cancer diagnosis previous nonpulmonary malignancy confined surgically resected no evidence active malignancy
1, antibodies colorectal cancer diagnosis minors under age eighteen
1, mycophenolic acid anaplastic large cell lymphoma diagnosis uncontrolled central nervous system cns disease hematologic malignancies
1, fluorouracil history another active cancer within past five years except cervical cancer situ situ carcinoma bladder squamous cell basal cell carcinoma skin
0, cisplatin head neck cancer diagnosis creatinine less doc mg dl creatinine clearance greater fifty ml min
0, mycophenolate mofetil testicular lymphoma diagnosis not pregnant lactating
0, melphalan diffuse large cell lymphoma not otherwise specified diagnosis creatinine equal less doc mg dl creatinine clearance calculated clearance permitted greater equal forty ml min by cockcroft gault formula
0, gemcitabine histologically cytologically confirmed adenocarcinoma pancreas
0, dexamethasone peripheral cholangiocarcinoma diagnosis patients must be able understand sign informed consent
1, carboplatin recurrent adult immunoblastic large cell lymphoma diagnosis any prior use racemic gossypol at one hundred one
1, clinical assessments stage iiib breast cancer diagnosis rheumatoid arthritis other types autoimmune inflammatory joint disease exception osteoarthritis fibromyalgia
0, vinblastine non small cell lung cancer diagnosis creatinine within normal institutional limits or
1, cyclophosphamide recurrent childhood lymphoblastic lymphoma diagnosis karnofsky performance status less sixty adult patients
0, albumin bound paclitaxel refractory stage iv breast cancer received high dose chemotherapy hdc autologous syngeneic peripheral blood stem cell transplantation pbsct stage iv breast cancer failed achieve complete response hdc autologous syngeneic pbsct at initial restaging following hdc no enrollment on protocol fhcrc nine hundred seventy six unless evidence no response progressive disease at initial restaging following transplantation hormone receptor status
0, dehydroepiandrosterone estrogen receptor positive breast cancer diagnosis patients must exhibit geographic proximity that allows regular access institute clinical instrumental examinations is required
1, dacarbazine systemic lymphoma outside cns
1, panobinostat patients only peripheral lung lesions any nsclc histology will also be eligible peripheral lesion is defined lesion which epicenter tumor is less equal two cm from costal diaphragmatic pleura three dimensional orientation based on each lobe lung is less equal two cm from trachea main lobar bronchi
1, busulfan ewings sarcoma diagnosis patients who have following levels organ system dysfunction not eligible
0, vinblastine gastric cancer diagnosis total bilirubin less doc ng dl
1, trastuzumab breast cancer diagnosis periodic abstinence calendar ovulation symptothermal post ovulation methods withdrawal not acceptable methods contraception women considered post menopausal not child bearing potential if they have had twelve months natural spontaneous amenorrhea an appropriate clinical profile age appropriate history vasomotor symptoms have had surgical bilateral oophorectomy without hysterectomy tubal ligation at least six weeks ago
1, dacarbazine ganglioneuroblastoma diagnosis patients must not have received enzyme inducing anticonvulsants including phenytoin phenobarbital valproic acid carbamazepine at least seven days prior enrollment patients receiving non enzyme inducing anticonvulsants such gabapentin levetiracetam will be eligible
1, trametinib metastatic uveal melanoma diagnosis patient is pregnant breastfeeding
0, docetaxel adenosquamous cell lung cancer diagnosis bone lesions
0, podophyllotoxin recurrent small lymphocytic lymphoma diagnosis must have capacity give informed consent
0, prednisone stage iib hodgkin lymphoma diagnosis male doc mg dl female doc mg dl
0, warfarin prostate cancer diagnosis no prior radical prostatectomy
0, gefitinib bladder cancer diagnosis patients history cardiac disease an ejection fraction ef less fifty at time initiation chemotherapy must be demonstrated have an ejection fraction at least forty
1, paclitaxel non small cell lung cancer diagnosis patient has serious non healing wound ulcer bone fracture major surgical procedure within thirty days prior first dose medication
0, antibodies stage iii adult cell leukemia lymphoma diagnosis platelets greater equal fifty zero mcl
1, laboratory biomarker analysis stage iii childhood large cell lymphoma diagnosis patients who have received gonadotropin release hormone agonist antagonist lupron prior entry not eligible
0, dexamethasone multiple myeloma diagnosis patients meeting all following criteria will be considered admission trial
0, bevacizumab recurrent melanoma diagnosis no active chronic infection hepatitis c
0, melphalan progression multiple myeloma plasma cell leukemia diagnosis failed any aggressive chemotherapy regimen such fludarabine cyclophosphamide rituximab fcr at any time point
1, laboratory biomarker analysis invasive ductal breast carcinoma diagnosis clinically significant pulmonary dysfunction cardiomyopathy any history clinically significant congestive heart failure chf unstable angina pectoris cardiac arrhythmia
1, adct lymphoma mantle cell diagnosis known history positive serum human anti drug antibody ada known allergy any component adct three hundred one
0, cisplatin measurable nonmeasurable disease defined by response evaluation criteria solid tumors recist version doc
0, counseling intervention splenic marginal zone lymphoma diagnosis able communicate english indicated by ability communicate adequately staff participate clinical phone calls complete patient reported outcomes pro assessments english
1, antibodies monoclonal refractory small lymphocytic lymphoma diagnosis male partner sterilization appropriate post vasectomy documentation absence sperm ejaculate female subjects vasectomized male partner should be sole partner that patient
1, docetaxel breast cancer diagnosis active cardiac disease
0, quality life assessment recurrent lymphoepithelioma oropharynx diagnosis eastern cooperative oncology group ecog performance status zero two
0, liposomal doxorubicin lymphoma diagnosis clinically significant anemia hemoglobin no greater eleven dl
0, tacrolimus recurrent mantle cell lymphoma diagnosis any patient high risk hematologic oncologic diagnosis which allogeneic hsct is thought be beneficial whom front line therapy has already been applied
0, vincristine lymphoma diagnosis at least two weeks since prior monoclonal antibody therapy
0, vaccines undifferentiated fallopian tube carcinoma diagnosis creatinine equal less doc mg dl
0, tacrolimus malignant neoplasm diagnosis patients must have related donor who is two more allele mismatch at hla b dr loci
0, tegafur breast cancer diagnosis at least three months hematopoietic
1, paclitaxel stage iiic breast cancer diagnosis major surgical procedure open biopsy significant traumatic injury within twenty eight days prior enrollment anticipation need major surgical procedure during course core biopsy other minor surgical procedure example placement vascular access device excluded from this requirement
1, lenalidomide adult cell lymphoma diagnosis known hypersensitivity thalidomide
1, liposomal doxorubicin recurrent childhood lymphoblastic lymphoma diagnosis patients requiring corticosteroids who have not been on stable decreasing dose corticosteroid prior seven days
1, etoposide other primary malignancies within past five years except carcinoma situ cervix nonmelanoma skin cancer
1, melphalan lymphoma diagnosis evidence either cirrhosis stage three four liver fibrosis patients chronic hepatitis positive hepatitis serology
0, irinotecan kidney cancer diagnosis chemotherapy
1, axitinib carcinoma renal cell diagnosis topical inhaled steroids allowed
0, fludarabine phosphate stage adult cell leukemia lymphoma diagnosis only single allele disparity will be allowed hla b defined by high resolution typing
1, sampling blood urine sebum saliva previous cancer treatment
1, irinotecan colorectal neoplasms diagnosis pregnant breastfeeding women
1, atorvastatin calcium myelodysplastic myeloproliferative neoplasm diagnosis donor
0, pazopanib hydrochloride midgut carcinoid tumor diagnosis insertion vascular access device thoracentesis paracentesis endoscopic ultrasonographic procedures not considered be major minor surgeries
0, temozolomide high grade gliomas diagnosis histological diagnosis
1, succinylcholine ovarian carcinosarcoma diagnosis patients who pregnant nursing
0, paclitaxel urethral cancer diagnosis hematopoietic
0, sirolimus malignant neoplasm diagnosis patients enrolled expansion cohorts may be on antidiabetic treatment but baseline glucose should be equal less one hundred twenty
0, akt inhibitor mk nodal marginal zone lymphoma diagnosis dominant lymph node masses include up six nodal masses that clearly measurable two perpendicular dimensions greater doc cm each dimension
1, vaccines malignant solid tumors diagnosis concurrent use systemic steroids except physiologic doses systemic steroid replacement local topical nasal inhaled steroid use
0, pain therapy metastatic cancer diagnosis negative pregnancy test
0, doxorubicin clear cell sarcoma soft tissue diagnosis absolute neutrophil count greater equal one thousand five hundred ul note
1, cisplatin squamous cell carcinoma head neck diagnosis subjects not recovered from all previous acute radiotherapy related toxicities
0, sodium thiosulfate central nervous system lymphoma diagnosis hematocrit greater equal twenty five may be reached by transfusion
0, antibodies monoclonal stage iii rectal cancer diagnosis note
0, etoposide recurrent adult burkitt lymphoma diagnosis serum creatinine less doc mg dl creatinine clearance greater sixty ml per minute by following formula all tests must be performed within twenty eight days prior registration
0, prednisone lymphoma diagnosis at least thirty days since prior no other concurrent investigational drugs participation another investigational trial
1, immunoglobulins pancreatic cancer diagnosis prior allergic reaction gadolinium contrast
1, bevacizumab metastatic colorectal cancer diagnosis clinical radiological evidence cns metastases
1, carboplatin non small cell lung cancer diagnosis active infection fever greater three doc within three days prior day one cycle one
0, doxorubicin stage iv childhood small noncleaved cell lymphoma diagnosis no prior radiotherapy except emergency radiotherapy initiated within seventy two hours entry
1, antibodies stage iv renal cell cancer diagnosis it is also appropriate exclude subjects whom there is reasonable possibility that they will require major surgical procedures during trial
0, cyclophosphamide osteosarcoma diagnosis diagnosis
0, leucovorin colorectal cancer diagnosis no prior radiotherapy more twenty five bone marrow
1, camptothecin stage ivb colon cancer diagnosis other active malignancy equal less three years prior registration exceptions
0, albumin bound paclitaxel epithelial ovarian cancer diagnosis female subject is eligible enter participate if she is
0, pembrolizumab tumors diagnosis females childbearing potential must be willing use contraception described above duration through one hundred twenty days after last dose one hundred twenty days after drug discontinuation
1, endothelial growth factors ovarian endometrioid adenocarcinoma diagnosis patients medical history conditions not otherwise previously specified which opinion investigator should exclude participation this examples this would be
1, complement factor h cancer diagnosis subjects who have had brain metastases resected have received radiation therapy ending at least four weeks prior day one eligible if they meet all following criteria
1, docetaxel subjects inflammatory breast cancer
0, vitamin b breast cancer diagnosis give written informed consent
0, management therapy complications multiple myeloma plasma cell neoplasm diagnosis not specified
1, dasatinib stage ivb salivary gland cancer diagnosis patients may not be receiving any other investigational agents
1, acupuncture therapy gastrointestinal carcinoma diagnosis severely complication after surgery
1, pac head neck cancers diagnosis has any other severe uncontrolled medical condition including uncontrolled dm unstable chf
1, docetaxel unspecified adult solid tumor protocol specific diagnosis patients who have received any continuous intermittent small molecule therapeutics excluding monoclonal antibodies equal less five effective half lives prior starting drug who have not recovered from side effects such therapy
1, vaccines metastatic malignant neoplasm soft tissues diagnosis patients cannot have concurrent enrollment on other phase ii iii investigational treatment studies
0, antibodies monoclonal stage iii oral cavity squamous cell carcinoma diagnosis hemoglobin greater equal doc dl
1, dacarbazine recurrent central nervous system neoplasm diagnosis major surgical procedure laparoscopic procedure open biopsy significant traumatic injury within twenty eight days prior enrollment
0, antibodies monoclonal recurrent mediastinal thymic large cell cell lymphoma diagnosis provide informed written consent
0, vinblastine regional gastrointestinal carcinoid tumor diagnosis exclusion
1, melphalan plasma cell myeloma diagnosis active uncontrolled infection
1, interleukin stage ivb cervical cancer diagnosis clinically significant gastrointestinal bleeding uncontrolled peptic ulcer disease
1, methylphenidate cancer related fatigue diagnosis treatment psychostimulants past two weeks before screening
1, dexamethasone multiple myeloma diagnosis lab abnormality
1, idelalisib refractory follicular lymphoma diagnosis history chronic diarrhea colitis intestinal perforation that opinion investigator precludes utilization idelalisib
0, sirolimus breast neoplasms diagnosis except ongoing therapy letrozole participant must not have received prior systemic endocrine therapy metastatic disease
1, palbociclib head neck cancer diagnosis concurrent administration strong inducers inhibitors cypthreea enzyme cypthreea substrates narrow therapeutic window
1, endothelial growth factors adult glioblastoma diagnosis history allergic reactions attributed compounds similar chemical biologic composition mlnone hundred twenty eight bevacizumab
1, gemcitabine fallopian tube mucinous adenocarcinoma diagnosis patients undergoing pre treatment secondary cytoreduction will undergo therapy bevacizumab on cycle two
1, softscan optical breast imaging system breast cancer diagnosis subjects history significant acute breast abnormalities involving either breast and
1, immunoglobulin g stage ii oropharyngeal squamous cell carcinoma diagnosis patients body weight less equal thirty kg
0, gemcitabine nasopharyngeal carcinoma diagnosis normal liver function test
1, fluorouracil solid tumors diagnosis intensive chemotherapy treatment
1, everolimus neurofibromatoses diagnosis oral contraceptives not acceptable alone
1, cyclophosphamide childhood burkitt lymphoma diagnosis patients who have not recovered from adverse events due agents administered more four weeks earlier or
0, antibodies monoclonal contiguous stage ii grade two follicular lymphoma diagnosis there is likelihood rapid disease progression while hla typing results preliminary search donor pool suggests that ten ten hla b drbone dqbone matched unrelated donor will not be found
0, placebo lip oral cavity squamous cell carcinoma diagnosis patients must have karnofsky performance score seventy above
0, sunitinib pancreatic cancer diagnosis more seven twelve days since prior no concurrent drugs that known cypthreeafour inhibitors
1, paclitaxel peritoneal cancer diagnosis pre existing duodenal stent any other gastrointestinal disorder defect that would opinion investigator interfere absorption rucaparib
0, sirolimus lymphoma diagnosis chronic myeloid leukemia chronic phase accelerated phase
0, glutamine childhood malignant fibrous histiocytoma bone diagnosis must have caregiver parent other relative friend available perform daily mucositis assessments
0, white light withdrawal colon cancer diagnosis patients scheduled elective colonoscopies
1, ifosfamide clear cell sarcoma soft tissue diagnosis patients chronically receiving medications known be metabolized by cypthreeafour narrow therapeutic indices within seven days prior enrollment including but not limited pimozide aripiprazole triazolam ergotamine halofantrine not eligible note
0, cediranib lung cancer diagnosis cardiovascular
1, cyclosporine recurrent adult burkitt lymphoma diagnosis addition cytotoxic agents cytoreduction exception hydroxyurea imatinib mesylate will not be allowed within two weeks initiation conditioning
1, cetuximab esophageal cancer diagnosis no history current brain metastasis
1, everolimus gastrinoma diagnosis chronic treatment corticosteroids other immunosuppressive agents
0, etoposide phosphate noncontiguous stage ii small lymphocytic lymphoma diagnosis alternatively patients legal guardians who can read understand sign written informed consent may also enroll
1, docetaxel uterine corpus leiomyosarcoma diagnosis patients anticipation invasive procedures defined below
0, alvespimycin hydrochloride stage iv melanoma diagnosis negative pregnancy test
1, fludarabine cutaneous cell non hodgkin lymphoma diagnosis age greater seventy five years
0, mycophenolate mofetil lymphoma diagnosis prior stem cell bone marrow transplantation allowed
1, antibodies noncontiguous stage ii adult lymphoblastic lymphoma diagnosis known hypersensitivity thalidomide
1, vincristine brain central nervous system tumors diagnosis note
0, cortisone acetate stage iv prostate cancer diagnosis patient must have castrate resistant disease defined follows
1, megestrol acetate stage iiic endometrial carcinoma diagnosis an acute pelvic inflammatory disease medical conditions such but not limited acquired immunodeficiency syndrome aids chronic immunosuppression that may be associated an increased susceptibility infections
0, stereotactic body radiotherapy sbrt non small cell lung cancer stage diagnosis patients childbearing reproductive potential should use adequate birth control measures defined by investigator during treatment period
1, trastuzumab neoplasms breast diagnosis serious medical psychiatric disorder that would interfere patient safety informed consent
0, deoxyuridine splenic marginal zone lymphoma diagnosis psychiatric illness social situation that would preclude compliance requirements
1, antibodies monoclonal stage ii non contiguous mantle cell lymphoma diagnosis unwilling unable follow protocol requirements
1, rrx lymphomas diagnosis subjects serious co morbid medical condition
0, temozolomide adult mixed glioma diagnosis leukocytes greater three zero mcl
1, mycophenolic acid aids related lymphoblastic lymphoma diagnosis patients medical history noncompliance haart medical therapy
0, ifosfamide sarcoma diagnosis advanced metastatic disease not amenable standard higher priority investigational neoadjuvant therapies
0, aldesleukin anaplastic astrocytoma diagnosis opinion neurosurgeon research participant requires on going dexamethasone therapy
0, immunoglobulin g recurrent nasal cavity paranasal sinus squamous cell carcinoma diagnosis patients must have recovered grade one better from any acute effects prior surgery chemotherapy radiation therapy should be greater four weeks post surgery chronic late xerostomia speech swallowing abnormalities resulting from prior radiation surgery permitted if nutritional status is stable
0, everolimus intracranial meningioma diagnosis patients must be eighteen years age
1, fludarabine stage grade one follicular lymphoma diagnosis diffusion capacity carbon monoxide dlco less thirty five total lung capacity tlc less thirty five forced expiratory volume one second fevone less thirty five receiving supplementary continuous oxygen
1, bi middle dose qw neoplasms diagnosis aspartate aminotransferase ast alanine aminotransferase alt greater doc uln case known liver metastases ast alt greater five uln
1, two stage esophagectomy esophageal cancer diagnosis subject is participating another investigational trial
0, dexamethasone stage iii multiple myeloma diagnosis no active serious infection that cannot be controlled antibiotics
1, doxorubicin fallopian tube endometrioid adenocarcinoma diagnosis stage not greater ia grade one two no more superficial myometrial invasion without vascular lymphatic invasion no poorly differentiated subtypes including papillary serous serous clear cell other federation gynecology obstetrics figo grade three lesions
1, cisplatin stage iva oral cavity squamous cell carcinoma diagnosis treatment refractory hypertension defined blood pressure systolic greater one hundred forty mmhg diastolic greater ninety mmhg which cannot be controlled by anti hypertensive therapy
0, lenograstim childhood burkitt lymphoma diagnosis prior monoclonal antibody therapy allowed including rituximab
0, interleukin metastatic uveal melanoma diagnosis platelet count greater equal one hundred zero mm three
1, docetaxel colorectal carcinoma diagnosis ten patient has history severe hypersensitivity reaction docetaxel other drugs formulated polysorbate
0, iodine recurrent marginal zone lymphoma diagnosis donor
1, mycophenolate mofetil recurrent childhood non hodgkin lymphoma diagnosis karnofsky score less sixty pediatric criteria
1, fondaparinux lung neoplasms diagnosis cerebral spinal ophthalmologic operation history
0, fludarabine recurrent adult burkitt lymphoma diagnosis stratum one nhl
0, antibodies monoclonal adult nasal type extranodal nk cell lymphoma diagnosis has not undergone hysterectomy bilateral oophorectomy or
1, liposomal doxorubicin breast tumors diagnosis cardiac ventricular arrhythmias requiring anti arrhythmic therapy
0, pemetrexed cervical cancer diagnosis life expectancy
0, cyclophosphamide refractory plasma cell myeloma diagnosis haploidentical donor selection will be based on standard institutional criteria otherwise no specific prioritization will be made amongst suitable available donors donors will not be selected based on killer cell immunoglobulin like receptor kir status
0, erlotinib hydrochloride recurrent basal cell carcinoma lip diagnosis creatinine less doc times uln
1, nintedanib endometrial clear cell carcinoma diagnosis major injuries surgery within past twenty eight days prior start treatment planned surgery during on treatment period
1, dexamethasone acetate hepatic cancer diagnosis patients who have clinical ascites
1, fludarabine stage iii cutaneous cell non hodgkin lymphoma diagnosis donor
1, oxaliplatin rectal adenocarcinoma diagnosis currently has serious nonhealing wound ulcer bone fracture
0, ifosfamide sarcoma diagnosis no history congestive heart failure
1, antibodies monoclonal any unresolved toxicity nci ctcae grade greater two from previous anticancer therapy exception alopecia vitiligo laboratory values defined inclusion criterion
1, carboplatin lymphoma large cell diffuse diagnosis history autologous allogeneic stem cell transplant
0, alemtuzumab nodal marginal zone cell lymphoma diagnosis must have failed previous myelosuppressive chemotherapy hct have less five marrow blasts at time transplant
0, dexamethasone acetate stage mantle cell lymphoma diagnosis no known hypersensitivity ofatumumab humanized antibodies chemotherapy agents throughout protocol
0, trastuzumab stage ii bladder cancer diagnosis able tolerate systemic chemotherapy pelvic radiotherapy
0, antibodies monoclonal noncontiguous stage ii adult diffuse mixed cell lymphoma diagnosis bi dimensionally measurable disease at least one cm
0, bevacizumab small cell lung cancer diagnosis one previous chemotherapy regimen metastatic sclc
0, antibodies monoclonal non small cell lung cancer metastatic diagnosis radiographic disease recurrence progression during after front line platinum based doublet chemotherapy
1, antibodies monoclonal melanoma diagnosis women childbearing potential who
0, vinblastine unspecified adult solid tumor protocol specific diagnosis obstructive jaundice requires drainage procedure prior treatment
0, linac based radiosurgery edge histopathologically confirmation primary solid tumor
1, laboratory biomarker analysis splenic marginal zone lymphoma diagnosis active autoimmune disease requiring systemic immunosuppressive therapy
1, trametinib colorectal cancer diagnosis patients who have been infected hbv hcv including those inactive disease
0, interferons histologically cytologically confirmed recurrent small cell lung cancer sclc clinically confirmed measurable disease
0, oxaliplatin colorectal cancer diagnosis lab values within fourteen days prior registration
0, oxaliplatin esophageal cancer diagnosis patient must be non pregnant non nursing women child bearing potential must have negative serum urine pregnancy test minimum sensitivity twenty five iu equivalent units human chorionic gonadotropin hcg within seventy two hours prior randomization women child bearing potential include any female who has experienced menarche who has not undergone surgical sterilization hysterectomy bilateral tubal ligation bilateral oophorectomy is not postmenopausal defined amenorrhea greater equal twelve consecutive months women on hormone replacement therapy hrt documented serum follicle stimulating hormone fsh level greater thirty fivemiu ml even women who using oral implanted injectable contraceptive hormones mechanical products such an intrauterine device barrier methods diaphragm condoms spermicides prevent pregnancy practicing abstinence where partner is sterile vasectomy should be considered be child bearing potential
1, antibodies monoclonal recurrent small lymphocytic lymphoma diagnosis patients history impaired cardiac status including history severe coronary artery disease cardiomyopathy congestive heart failure arrhythmia if patient history is questionable measurement left ventricular ejection fraction should be obtained within forty two days prior registration patients left ventricular ejection fraction less fifty not eligible
1, dacarbazine glioblastoma diagnosis therapeutic anticoagulation use
1, mg kg Î± tea metastatic carcinoma diagnosis patients history ischemia ameliorated stent placement coronary artery bypass grafting who have no evidence ischemia by exercise physiological stress testing eligible
1, cyclosporins recurrent adult lymphoblastic lymphoma diagnosis serum glutamate pyruvate transaminase sgpt serum glutamic oxaloacetic transaminase sgot four upper limit normal
1, endothelial growth factors ovarian gynandroblastoma diagnosis patients clinically significant cardiovascular disease this includes
0, bevacizumab stage ia gastric cancer diagnosis serum creatinine cr equal less doc mg creatinine clearance greater equal sixty cc min
1, tg multiple myeloma diagnosis patients who have undergone previous stem cell transplantation procedure
0, bevacizumab pancreatic cancer diagnosis no significant traumatic injury within past twenty eight days
1, vidarabine childhood burkitt lymphoma diagnosis diffusing capacity lung carbon monoxide dlco less thirty total lung capacity tlc less thirty forced expiratory volume one second fevone less thirty receiving supplementary continuous oxygen fhcrc principal investigator pi must approve enrollment all patients pulmonary nodules
0, fludarabine recurrent marginal zone lymphoma diagnosis patient donor must be matched at least one drbone allele one dqbone allele
0, vaccines ovarian cancer diagnosis lymphocyte count greater five hundred mm three
1, antibodies monoclonal stage iiia fallopian tube cancer diagnosis patients anticipation invasive procedures defined below
0, gemcitabine breast cancer diagnosis hepatic
1, carboplatin fallopian tube transitional cell carcinoma diagnosis major surgical procedure anticipated during course this includes but is not limited abdominal surgery laparotomy laparoscopy prior disease progression such colostomy enterostomy reversal secondary cytoreductive surgery second look surgery please consult sdc randomization desk prior patient entry any questions related classification surgical procedures
1, fludarabine phosphate active infection not pregnant nursing negative pregnancy test hiv negative history allergic reaction taxane polysorbate eighty grade two worse peripheral neuropathy second malignancy within past two years except basal cell skin cancer carcinoma situ cervix tumor previously treated curative intent other clinically significant comorbid illnesses
0, everolimus stage iv melanoma diagnosis no congestive heart failure
1, erlotinib hydrochloride tumors mixed histology nsclc small cell lung cancer sclc
1, vincristine history treated prior malignancy unless remission greater two years except treated nonmelanoma carcinomas skin situ cervical carcinomas prostatic carcinomas
1, bb glaucoma
0, methylprednisolone hemisuccinate prostate cancer diagnosis psa greater twentyng ml
0, cisplatin recurrent gastric cancer diagnosis metastatic unresectable disease
1, management therapy complications stage iii adenoid cystic carcinoma oral cavity diagnosis history renal failure compromise
0, alvespimycin hydrochloride stage iv verrucous carcinoma oral cavity diagnosis colon
0, glucocorticoids mixed glioma diagnosis bilirubin less doc
0, antibodies stage iva squamous cell carcinoma larynx diagnosis absolute neutrophil count anc greater equal doc ten nine l
0, antibodies monoclonal advanced cancer diagnosis exception bevacizumab positive erlotinib positive cetuximab arm bevacizumab positive trastuzumab positive lapatinib arm
1, dihydrotestosterone prior diagnosis cancer except non melanoma skin cancer
0, temozolomide brain central nervous system tumors diagnosis hepatic
0, cisplatin resected pancreatic adenocarcinoma diagnosis women childbearing potential fertile men must use adequate contraceptive measures during at least three months female six months male after completion therapy adequate methods women oral contraceptives estrogen progesterone vaginal rings contraceptive patches estrogen free ovulation inhibitors intrauterine devices progesterone three month injections depot progesterone implants setting free progesterone abstinence sterilization vasectomy male partner
1, lenograstim breast neoplasm diagnosis patients who pregnant breastfeeding not eligible
0, belinostat stage iii adult immunoblastic large cell lymphoma diagnosis grade three qtc prolongation
1, irinotecan colon cancer diagnosis known history clinically significant active copd other moderate severe chronic respiratory illness present within six months
1, bevacizumab other malignancy within past five years except adequately treated basal cell squamous cell skin cancer carcinoma situ cervix adequately treated stage ii cancer currently complete remission
1, albumin bound paclitaxel unknown primary tumors diagnosis immunocompromised patients eg patients who known be serologically positive human immunodeficiency virus hiv
0, antibodies stage ivb laryngeal squamous cell carcinoma diagnosis alkaline phosphatase greater doc but equal less five uln ast alt normal
0, cabozantinib s malate adult hepatocellular carcinoma diagnosis at least seven days must have elapsed since completion therapy growth factor at least fourteen days must have elapsed after receiving pegfilgrastim
0, cytarabine stage iv childhood large cell lymphoma diagnosis histologically cytologically proven cell malignancies either burkitt leukemia al equal burkitt leukemia equal lthree al diffuse large cell nhl aggressive mature cell nhl non otherwise specified specifiable phase iii
0, mycophenolic acid mantle cell lymphoma diagnosis patients bulky disease should be considered debulking chemotherapy before transplant
1, docetaxel breast cancer diagnosis women child bearing potential must have negative serum pregnancy test within ten days starting drug on day one cycle one
1, topoisomerase i inhibitors recurrent small cell lung carcinoma diagnosis unwilling unable follow protocol requirements
0, fluorodeoxyglucose f lung cancer diagnosis at least one month since prior radiotherapy except palliative radiotherapy non target lesions
1, patients negative pet after salvage therapy neoplasia last three years except carcinoma situ uterus neck basal skin cancer prostate cancer early stage localized exeresi treated surgery brachytherapy curative intent good prognosis dcis breast treated surgery alone
0, fludarabine phosphate recurrent marginal zone lymphoma diagnosis patient donor pairs homozygous at mismatched allele graft rejection vector considered two allele mismatch patient is one hundred one donor is two hundred one this type mismatch is not allowed
0, cytarabine lymphoma diagnosis pregnant nursing women may not participate
0, antibodies monoclonal stage ivb laryngeal squamous cell carcinoma diagnosis total bilirubin within normal institutional limits unless proven gilbert disease which after principal investigator pi approval patient may be included
0, thalidomide diffuse intrinsic pontine glioma diagnosis breast development is estrogen stimulated since ovulation cannot occur without estrogen tanner stage two will be reliable marker definition fertility
1, pemetrexed stage iiib non small cell lung cancer diagnosis known human immunodeficiency virus hiv positive patients
0, high risk factors breast cancer diagnosis hepatic
1, albumin bound paclitaxel her two positive breast cancer diagnosis pregnant lactating patients
0, etoposide stage ii diffuse large cell lymphoma diagnosis bilirubin equal less two upper limit normal alt ast equal less three upper limit normal clinical evaluation rule out cirrhosis
0, melphalan multiple myeloma plasma cell neoplasm diagnosis hypoploidy less forty four chromosomes
1, capecitabine infiltrating duct lobular carcinoma situ diagnosis pure dcis diagnoses not elegible
0, oxycodone myelodysplastic myeloproliferative neoplasms diagnosis more three days since prior no concurrent transdermal fentanyl oxymorphone buprenorphine
1, cortisone stage iv prostate adenocarcinoma diagnosis immunotherapy sipuleucel ipilimumab
1, interferon alpha clinical radiological laboratory pathological evidence incompletely resected melanoma any distant metastatic disease
0, behavioral dietary intervention unspecified adult solid tumor protocol specific diagnosis healthy participant
1, dexamethasone acetate multiple myeloma diagnosis major surgery within fourteen days prior start treatment
0, radiofrequency ablation rfa other local tumor control measures not recommended malignant lesion based on review multidisciplinary team conference patient refuses recommended local tumor control measures
1, cyclophosphamide noncutaneous extranodal lymphoma diagnosis patients who have had major surgical procedures significant traumatic injury within twenty eight days prior treatment
0, fludarabine childhood burkitt lymphoma diagnosis low grade nh negative less six month duration complete remission cr between courses conventional therapy
1, dermatologic complications management prevention stage ib breast cancer diagnosis patients who pregnant breastfeeding
1, bevacizumab anaplastic oligodendroglioma diagnosis known gastrointestinal disease history gastrointestinal surgery that could interfere absorption orally administered medication
1, vaccines recurrent ovarian epithelial cancer diagnosis pregnant women excluded from this study
1, vaccines ovarian carcinoma diagnosis known hiv positivity
1, fulvestrant er positive breast cancer diagnosis inability complete informed consent process adhere protocol treatment plan follow up requirements
0, paclitaxel but antitumoral hormonal therapy must be terminated prior enrollment up date randomization
0, etoposide phosphate aids related diffuse small cleaved cell lymphoma diagnosis if child bearing potential must have negative serum urine pregnancy test within seven days treatment
1, mycophenolic acid stage iii adult lymphoblastic lymphoma diagnosis fertile men women unwilling use contraceptive techniques during twelve months following treatment
0, carboplatin lung cancer diagnosis subjects childbearing potential those who have not been surgically sterilized have not been free from menses greater one year
1, vitamins bladder neoplasm diagnosis uncontrolled hypertension
1, etoposide phosphate aids related diffuse mixed cell lymphoma diagnosis forced vital capacity fvc forced expiratory volume one second fevone diffusion capacity lung carbon monoxide dlco parameters less sixty predicted corrected hemoglobin
0, niacinamide pancreatic cancer diagnosis patients neurological symptoms must undergo ct scan mri brain exclude brain metastases
1, androgens prostate cancer diagnosis prior treatment cytarabine
0, merestinib solid tumor diagnosis serum creatinine less doc institutional uln
1, interferon alpha sarcoma kaposi diagnosis medical contraindication
1, immunoglobulins recurrent marginal zone lymphoma diagnosis patients who have had chemotherapy radiotherapy within three weeks six weeks nitrosoureas mitomycin prior entering those who have not recovered baseline not at stable grade equal less two from adverse events due agents administered more three weeks earlier patients who have received immunotherapy radioimmunotherapy within three months unless disease has progressed since treatment patients who have been administered abt eight hundred eighty eight part single limited dosing such phase zero will not be excluded from participating this solely because receiving prior abt eight hundred eighty eight
1, etoposide patients other prior malignancies except adequately treated basal cell carcinoma squamous cell carcinoma skin cervical cancer situ other cancer from which patient has been disease free five years greater unless approved by protocol chair co chair
1, paclitaxel stage iv squamous cell carcinoma larynx diagnosis since zidovudine stavudine have potential severe hematological toxicity potentially overlapping toxicities therapy treatment these agents will be disallowed
0, levoleucovorin colorectal cancer diagnosis disease characteristics
1, etoposide phosphate extensive stage small cell lung cancer diagnosis history another active malignancy
1, adct lymphoma mantle cell diagnosis failure recover from acute non hematologic toxicity except alopecia due previous therapy prior screening
1, cytarabine mantle cell lymphoma diagnosis female subject is pregnant breast feeding pregnancy testing is mandatory premenopausal women
0, fludarabine phosphate stage iv mantle cell lymphoma diagnosis patient donor pairs homozygous at mismatched allele graft rejection vector considered two allele mismatch patient is one hundred one donor is two hundred one this type mismatch is not allowed
0, carboplatin stage iv verrucous carcinoma larynx diagnosis eastern cooperative oncology group ecog performance status equal less two karnofsky greater equal fifty
1, shorter wb fractionation boost carcinoma ductal breast diagnosis women who pregnant lactating
1, sirolimus glioma diagnosis patients an active bleeding diathesis on oral anti vitamin medication except low dose coumarin
0, abiraterone acetate before chemotherapy prostate cancer regimen containing paclitaxel docetaxel
1, management therapy complications recurrent small lymphocytic lymphoma diagnosis osteopenia osteoporosis score equal less than
0, gemcitabine extrahepatic bile duct cancer diagnosis no repeat scan needed if negative scan was performed within thirty five days prior randomization
0, paclitaxel ihc must be performed ihc staining results must indicate score one positive situ hybridization ish testing is not required two positive ish must also be performed must indicate that tumor is hertwo low described below
1, ifosfamide malignant triton tumor diagnosis note
0, cediranib recurrent colon carcinoma diagnosis hemoglobin greater equal ninety l greater equal nine dl
0, magnetic resonance imaging breast cancer diagnosis prior concurrent therapy
0, tamoxifen breast cancer diagnosis adequate renal function defined by creatinine less doc mg dl
0, cytarabine recurrent childhood lymphoblastic lymphoma diagnosis creatinine clearance gfr at least sixty ml min doc threemtwo
1, cyclosporine recurrent adult burkitt lymphoma diagnosis any current central nervous system cns involvement disease
0, prednisone recurrent prostate cancer diagnosis history mobitz ii second degree third degree heart block without permanent pacemaker place
1, everolimus advanced solid tumors diagnosis stable dose corticosteroids at least two weeks
0, radiation therapy endometrial cancer diagnosis performance status
0, paclitaxel squamous cell carcinoma head neck diagnosis eighteen years
0, dexamethasone phosphate prior local radiotherapy local myeloma progression allowed
0, immunoglobulins diffuse adenocarcinoma stomach diagnosis no concurrent chronic daily aspirin greater three hundred twenty five mg day
0, etoposide phosphate central nervous system tumors diagnosis three twenty one performance status
0, cyclosporins recurrent hodgkin lymphoma diagnosis myelodysplasia mds myeloproliferative syndrome mps
0, obinutuzumab prior therapy any inhibitor bruton tyrosine kinase btk spleen tyrosine kinase syk phosphatidylinositol three kinase pithreek cell lymphoma two bcl two obinutuzumab
1, sirolimus non clear cell renal cell carcinoma nccrcc diagnosis no sperm donation is allowed during period twenty eight days after drug discontinuation
1, tacrolimus stage iv mantle cell lymphoma diagnosis fertile men women unwilling use contraceptive techniques during twelve months following treatment
1, cyclophosphamide stage iv adult immunoblastic large cell lymphoma diagnosis women childbearing potential who pregnant beta hcg positive breast feeding
1, fludarabine recurrent adult diffuse small cleaved cell lymphoma diagnosis known allergy filgrastim csf
1, ramucirumab have symptomatic uncontrolled brain metastases spinal cord compression leptomeningeal disease requiring concurrent treatment
1, dasatinib unspecified adult solid tumor protocol specific diagnosis prolonged qtc interval on pre entry electrocardiogram greater four hundred fifty msec
0, ifosfamide recurrent adult grade iii lymphomatoid granulomatosis diagnosis all patients must be informed investigational nature this have given written consent accordance institutional federal guidelines
1, interleukin documented child pugh score hepatocellular carcinoma patients known underlying liver dysfunction
1, cyclophosphamide nodal marginal zone cell lymphoma diagnosis potential donors who psychological physiological medical reasons cannot tolerate administration csf apheresis
1, docetaxel recurrent squamous cell carcinoma paranasal sinus nasal cavity diagnosis evidence history bleeding diathesis coagulopathy
0, cyclophosphamide lymphoma diagnosis any patient hematologic oncologic diagnosis which allogeneic hsct is thought be beneficial whom front line therapy has already been applied
0, gsk foretinib neoplasms head neck diagnosis subject has measurable disease defined at least one lesion that can be accurately measured at least one dimension longest diameter be recorded equal twenty mm conventional techniques equal ten mm spiral computerized tomography ct scan
1, rituximab stage adult diffuse large cell lymphoma diagnosis no current malignancy
0, oxaliplatin primary peritoneal cavity cancer diagnosis creatinine less doc mg dl creatinine clearance greater sixty ml min
1, gvhd prophylaxis precursor cell lymphoblastic leukemia lymphoma diagnosis had an autologous hematopoietic stem cell transplant three months before entry
0, cisplatin untreated metastatic squamous neck cancer occult primary diagnosis ability understand willingness sign written informed consent document
0, cisplatin stage iv endometrial carcinoma diagnosis urine protein
1, high performance liquid chromatography adult primary liver cancer diagnosis pregnant women excluded from this serum pregnancy must be performed be negative all women child bearing potential within two weeks prior enrollment because there is an unknown but potential risk adverse events nursing infants secondary treatment mother same breastfeeding should be discontinued if mother is treated same
1, rituximab diffuse large cell lymphoma diagnosis uncontrolled hypertension
1, everolimus adult mixed glioma diagnosis patients must not have received prior therapy cci seven hundred seventy nine temsirolimus osi seven hundred seventy four erlotinib other mtor epidermal growth factor receptor inhibitors
1, carboplatin active infections serum calcium within institutional normal range history hypercalcemia prior malignancy other nasopharyngeal carcinoma allowed concurrent malignancy not pregnant lactating fertile patients must use effective contraception
0, vorinostat stage iv adult lymphoblastic lymphoma diagnosis patients unstable untreated non irradiated brain metastases should be excluded
0, interferons intraocular melanoma diagnosis bidimensionally measurable evaluable disease
0, fosaprepitant hematopoietic lymphoid cancer diagnosis no severe cognitive compromise
0, antibodies melanoma diagnosis if patient has known liver metastases an alt ast less equal five uln allowed
0, antibodies recurrent adult immunoblastic large cell lymphoma diagnosis no prior grade three four acute graft vs host disease
0, bevacizumab recurrent childhood small noncleaved cell lymphoma diagnosis ast sgot alt sgpt equal less doc institutional upper limit normal patients liver involvement will be allowed equal less doc institutional upper normal limit
0, gamma secretase inhibitor ro recurrent primary peritoneal carcinoma diagnosis ecog performance status equal less two karnofsky greater equal sixty
1, albumin bound paclitaxel breast cancer diagnosis patients untreated active brain metastases
0, vaccines multiple myeloma diagnosis age greater eighteen years at time signing informed consent form
0, ambulatory surgery early breast cancer diagnosis clinically node negative
1, rituximab recurrent grade one follicular lymphoma diagnosis known hama haca human anti mouse anti chimeric antibodies
1, exemestane metastatic er positive her negative breast cancer diagnosis potential patients must not have taken anastrozole letrozole fulvestrant any chemotherapy at least two weeks bevacizumab at least three weeks before randomization
0, everolimus histologically confirmed invasive mammary carcinoma
1, surgery needed by patientÂ´s tumor stage sarcoma diagnosis toxicity liver medullar renal insufficiency that advise against participation
0, cortisone t lymphoblastic lymphoma diagnosis per good clinical practice any toxicity related prior therapies that opinion investigator would potentially be worsened da epoch positive
0, topotecan ovarian seromucinous carcinoma diagnosis creatinine equal less doc uln
1, cyclosporins noncontiguous stage ii grade two follicular lymphoma diagnosis diffusion capacity carbon monoxide dlco less thirty five total lung capacity tlc less thirty five forced expiratory volume one second fevone less thirty five receiving supplementary continuous oxygen
1, vincristine burkitt lymphoma diagnosis patients who have undergone allogeneic stem cell organ transplantation any time
1, temozolomide gliosarcoma diagnosis history myocardial infarction unstable angina within six months prior enrollment
1, gossypol noncontiguous stage ii adult immunoblastic large cell lymphoma diagnosis concurrent treatment an investigational agent other investigational agent used this treatment within four weeks entry any investigational agent device s
0, fludarabine phosphate contiguous stage ii grade three follicular lymphoma diagnosis acute myeloid leukemia aml
0, docetaxel non small cell lung cancer diagnosis eastern cooperative oncology group ecog performance status zero one
1, prednisone hormone refractory prostate cancer diagnosis clinical evidence brain leptomeningeal metastases
1, flow cytometry john wort pc spes other herbal remedies taken purpose treating prostate cancer may be given during protocol treatment patients allowed have received neoadjuvant adjuvant chemotherapy that was completed at least six months prior registration protocol
1, albumin bound paclitaxel squamous cell lung carcinoma diagnosis end stage renal disease ie on dialysis dialysis has been recommended
0, radiation therapy lung cancer diagnosis complete response partial response stable disease after definitive locoregional therapy surgery radiation therapy without chemotherapy chemotherapy alone does not constitute definitive therapy
0, liposomal doxorubicin metastatic cancer diagnosis see disease characteristics
1, etoposide recurrent adult cell leukemia lymphoma diagnosis had evidence active central nervous system cns involvement
1, bortezomib stage iii small lymphocytic lymphoma diagnosis serious medical psychiatric illness likely interfere participation this clinical study
1, methylprednisolone prostate cancer diagnosis has uncontrolled hypertension systolic blood pressure greater equal one hundred sixty millimeter mercury diastolic blood pressure greater equal ninety five millimeter mercury
0, fluorouracil gastroesophageal cancer diagnosis no known allergy any drugs
0, dexamethasone acetate adult nasal type extranodal nk cell lymphoma diagnosis serum creatinine less doc times upper limit normal creatinine clearance greater fifty ml per minute
1, proton radiotherapy carcinoma hepatocellular diagnosis ongoing medically significant active infection
1, hormones metastatic breast cancer diagnosis has undergone major surgery within past twenty one days has had major surgery performed greater twenty one days prior screening wound remains unhealed
0, cisplatin urethral cancer diagnosis chemotherapy
1, fluorouracil renal cell carcinoma diagnosis patients requiring any non corticosteroids any reason excluded
1, veliparib breast cancer diagnosis history immediate delayed hypersensitivity reaction other contraindication contrast agents including but not limited gadolinium iodine
1, albumin bound paclitaxel ovarian cancer diagnosis patients requiring drainage gastrostomy peg tube parenteral hydration nutrition not eligible
0, calcium dietary recurrent malignant extragonadal germ cell tumor diagnosis no prior alvocidib
1, immunoglobulins stage ivc verrucous carcinoma oral cavity diagnosis investigational therapy within four weeks entry
0, gossypol acetic acid stage adult lymphoblastic lymphoma diagnosis total bilirubin within normal institutional limits
1, antibodies angioimmunoblastic cell lymphoma diagnosis inability understand give an informed consent
1, lde hepatocellular carcinoma diagnosis women child bearing potential must use highly effective contraception during through six months after final dose treatment
1, pemetrexed cancer diagnosis french subject has participated any using an investigational treatment during previous thirty days
1, leucovorin stage ivb colorectal cancer diagnosis history severe anti egfr toxicity requiring drug discontinuation dose modification within first four months prior anti egfr therapy
0, erlotinib hydrochloride cancer that was treated more five years ago patient has remained disease free
0, immunoglobulins recurrent small lymphocytic lymphoma diagnosis patients must have documented cell lymphocytosis greater five ten nine at some point since initial diagnosis cll
0, antibodies monoclonal recurrent lymphoepithelioma oropharynx diagnosis no arterial thromboembolic event within past six months including any following
0, dexamethasone phosphate malignant neoplasm diagnosis patients must be willing participate daily diary entries five days following chemotherapy agree have five minute follow up call on day two three day five six seven
0, paclitaxel ovarian mucinous cystadenocarcinoma diagnosis no clinical symptoms signs gastrointestinal obstruction who require parenteral hydration nutrition applies part only
1, azd prostate cancer diagnosis refractory nausea vomiting chronic gastrointestinal diseases inability swallow formulated product previous significant bowel resection that would preclude adequate absorption azdthree thousand five hundred fourteen
1, albumin bound paclitaxel non small cell lunch cancer diagnosis patient has received any prior systemic therapies metastatic nsclc
1, docetaxel symptomatic brain metastases clinically diagnosed leptomeningeal metastases
0, alvocidib unspecified adult solid tumor protocol specific diagnosis no cns metastases
1, fluorouracil advanced gastrointestinal cancer diagnosis history cardiac disease
0, antibodies refractory small lymphocytic lymphoma diagnosis life expectancy must be greater sixty days
0, mycophenolate mofetil recurrent childhood grade iii lymphomatoid granulomatosis diagnosis pbmc only will be permitted hsc source on this protocol
1, rexin g sarcoma diagnosis fertile patients unless they agree use barrier contraception condoms spermicide jelly during vector infusion period six weeks after infusion
1, sirolimus neuroendocrine tumor diagnosis prior treatment cytotoxic chemotherapy radiation immunotherapy any investigational drug within preceding four weeks
1, sunitinib refractory multiple myeloma diagnosis any major surgery less four weeks prior entry
0, tace therapy patients diagnosis hepatocellular carcinoma
0, cyclosporine lymphoma diagnosis renal function
0, prednisolone acetate multiple myeloma plasma cell neoplasm diagnosis no development gvhd after prior donor lymphocyte infusion
0, dacarbazine unspecified adult solid tumor protocol specific diagnosis no peripheral neuropathy greater grade one
1, levoleucovorin stage iiib gallbladder cancer diagnosis active uncontrolled bleeding
1, pomalidomide cancer treated curative intent greater five years before enrollment without evidence recurrence will be allowed
0, resistance exercise program prostate cancer
0, methotrexate recurrent refractory childhood hodgkin lymphoma diagnosis donors who have poor peripheral venous access may require central venous line placement stem cell apheresis
1, denileukin diftitox recurrent non small cell lung cancer diagnosis patients any clinically significant autoimmune disease uncontrolled treatment
1, sunitinib ciliary body choroid melanoma small size diagnosis current evidence hematemesis melena gross hematuria
1, questionnaire administration recurrent mantle cell lymphoma diagnosis detailed assessment hepatitis c medical history risk factors must be done at screening all patients hepatitis surface antigen hbsag hepatitis virus hcv ribonucleic acid rna polymerase chain reaction pcr testing required at screening all patients positive medical history based on risk factors confirmation prior hepatitis virus hbv infection
1, pixantrone metastatic cancer diagnosis known human immunodeficiency virus
1, romidepsin recurrent renal cell carcinoma diagnosis note
0, laboratory biomarker analysis stage ib fallopian tube cancer diagnosis group b
1, dexamethasone newly diagnosed multiple myeloma diagnosis uncontrolled hypertension uncontrolled diabetes within fourteen days prior first dose drug
0, cyclophosphamide testicular lymphoma diagnosis serum glutamic oxaloacetic transaminase sgot less two times normal clearance by ccf physician
1, ixazomib lymphoma diagnosis john wort within fourteen days before first dose ixazomib
1, bevacizumab metastatic melanoma diagnosis taxane based chemotherapy regimens including paclitaxel docetaxel cabazitaxel nab paclitaxel
0, interferon alpha kidney cancer diagnosis at least three weeks since prior major surgery requiring general anesthesia
1, laboratory biomarker analysis refractory mantle cell lymphoma diagnosis requires anticoagulation warfarin equivalent vitamin antagonists phenprocoumon
0, paclitaxel head neck cancer diagnosis not pregnant nursing fertile patients must use effective contraception
0, niacinamide non squamous cell lung cancer diagnosis patients receiving anti coagulation treatment an agent such warfarin heparin may be allowed participate
1, sunitinib stage iiic ovarian epithelial cancer diagnosis low molecular weight heparin is permitted provided patient international normalized ratio inr is equal less doc inr must be done within seven days prior registration
1, fludarabine phosphate stage iv childhood anaplastic large cell lymphoma diagnosis poorly controlled hypertension
0, everolimus mantle cell lymphoma diagnosis organ function criteria
0, cediranib recurrent fallopian tube carcinoma diagnosis patients may not have previously received parp inhibitor
0, afp recurrent renal cell cancer diagnosis patients receiving subcutaneous low molecular weight heparin
0, pharmacodynamic studies recurrent grade one follicular lymphoma diagnosis patients malabsorption any other condition that opinion principal investigator could cause difficulty absorption drug
0, erlotinib hydrochloride stage iv squamous cell carcinoma lip oral cavity diagnosis more seven days since other prior cypthreeafour inhibitors
1, tacrolimus stage iv childhood large cell lymphoma diagnosis donor
0, albumin bound paclitaxel cancer esophagus gastroesophageal junction stomach diagnosis contraception must be continued one month following discontinuation drugs
1, listerine prostatic neoplasms diagnosis serious infection less equal two weeks before first dose drug
1, albumin bound paclitaxel recurrent fallopian tube carcinoma diagnosis history serious ventricular arrhythmia ventricular tachycardia ventricular fibrillation cardiac arrhythmias requiring anti arrhythmic medications except atrial fibrillation that is well controlled antiarrhythmic medication
0, immunoglobulins mantle cell lymphoma diagnosis per world health organization who criteria
1, capecitabine prior chemotherapy unresectable locally advanced metastatic adenocarcinoma stomach gastro esophageal junction gej
1, bortezomib contiguous stage ii adult diffuse mixed cell lymphoma diagnosis patient has greater equal grade two peripheral neuropathy within fourteen days before enrollment
0, immunoglobulin g malignant pancreatic somatostatinoma diagnosis selective internal radiation therapy such brachytherapy cyberknife radiolabeled microsphere embolization etc
0, laboratory biomarker analysis breast cancer diagnosis hormone receptor status not specified
1, cyclosporine recurrent plasma cell myeloma diagnosis patients refractory anemia excess blasts raeb who have not received myelosuppressive chemotherapy induction chemotherapy
0, bevacizumab pancreatic cancer diagnosis negative pregnancy test
1, estradiol beta cypionate cancer diagnosis patients active thrombophlebitis
1, trastuzumab hertwo positive early locally advanced breast cancer diagnosis known hypersensitivity murine proteins
1, cyclin dependent kinase inhibitor proteins adult solid tumor diagnosis subject has uncontrolled intercurrent illness including but not limited to
1, albumin bound paclitaxel pancreatic cancer diagnosis is not considered form systemic treatment
0, antibodies stage iiic breast cancer diagnosis creatinine ratio less doc twenty four hour protein
0, cetuximab nasopharyngeal carcinoma diagnosis pathologically confirmed untreated npc patients
1, adalimumab hepatosplenic cell lymphoma diagnosis patient patient hcp is unwilling participate this study
0, prednisone lymphoma diagnosis performance status
1, leucovorin stage iv rectal cancer diagnosis received an investigational agent within thirty clays prior enrollment
0, vidarabine contiguous stage ii adult immunoblastic large cell lymphoma diagnosis following diseases will be permitted although other diagnoses can be considered if approved by pcc participating institution patient review committees principal investigator
0, erlotinib hydrochloride histologically confirmed measurable squamous cell carcinoma vulvar an assessable lesion on vulva measurable metastatic disease
0, thalidomide multiple myeloma diagnosis see disease characteristics prior thalidomide allowed if received less three months therapy recovered from prior biologic therapy chemotherapy
0, antibodies monoclonal adenosquamous cell lung cancer diagnosis no concurrent full dose anticoagulants low molecular weight unfractionated heparin warfarin
1, antibodies monoclonal follicular variant peripheral cell lymphoma diagnosis any history evidence opportunistic infection within six months screening including tuberculosis severe cytomegalovirus cmv herpetic infections such disseminated herpes herpes encephalitis ophthalmic herpes
1, everolimus stage iv mucoepidermoid carcinoma oral cavity diagnosis history allergic reactions attributed compounds similar chemical biologic composition agents used study
1, doxorubicin burkitt lymphoma diagnosis systemic infection requiring iv antibiotic therapy within fourteen days preceding first dose drug other severe infection
0, bortezomib stage iiib non small cell lung cancer diagnosis absolute neutrophil count greater one five hundred mm three
0, carboplatin recurrent melanoma diagnosis no prior radiotherapy greater twenty five bone marrow
1, medroxyprogesterone advanced persistent recurrent endometrial cancer diagnosis st
0, antibodies monoclonal multiple myeloma diagnosis females must agree abstain from breastfeeding during participation twenty eight days after drug discontinuation
0, pv rose bengal disodium melanoma diagnosis renal function
0, fludarabine recurrent childhood hodgkin lymphoma diagnosis only filgrastim csf mobilized peripheral blood mononuclear cell pbmc only will be permitted hsc source on this protocol
1, niacinamide salivary gland squamous cell carcinoma diagnosis ketoconazole itraconazole ritonavir cyclosporine carbamazepine phenytoin phenobarbital products containing grapefruit juice will not be allowed while on study
1, fludarabine phosphate stage iii small lymphocytic lymphoma diagnosis whole brain thirty gy enrollment patients who previously receive higher allowed dose radiation small volume lungs liver brain will be determine by discretion radiation oncologist on study
0, antibodies monoclonal stage iic colon cancer diagnosis patients must consent be must have signed dated an irb approved consent form conforming federal institutional guidelines
1, etoposide advanced solid tumor diagnosis radiotherapy except palliative reasons endocrine therapy immunotherapy chemotherapy during previous four weeks six weeks nitrosoureas mitomycin four weeks investigational medicinal products less four drug half lives whichever greater before first dose drug
1, computed tomography cancer survivor diagnosis current clinical evidence moderate severe obstructive pulmonary disease reactive airway diseases
0, tacrolimus multiple myeloma plasma cell neoplasm diagnosis see disease characteristics endocrine therapy
0, prednisolone hemisuccinate recurrent childhood large cell lymphoma diagnosis no known hypersensitivity etanercept
0, bevacizumab recurrent rectal cancer diagnosis absolute neutrophil count greater equal one thousand five hundred ul
1, antibodies monoclonal recurrent lymphoblastic lymphoma diagnosis and intrathecal intraventricular therapy
0, vorinostat colorectal cancer diagnosis patients must have received at least one prior chemotherapy regimen advanced disease
0, freund s adjuvant ovarian cancer diagnosis more four weeks since prior participation any other investigational study
